Cluster,Size,Density,Internal weight,External weight,Quality,P-value,Members,Top GO Terms,Top GO Term p-values,Top GO FDRs,Top GO Term Fold Enrichments
1,20,0.4069,77.31,15300.0,0.005013,1.0,A1BG ACR ANHX C8orf33 CHAMP1 MZF1 PARD6G PCMTD2 PGBD2 RABL2B SLC27A5 ZBTB45 ZNF10 ZNF132 ZNF324 ZNF324B ZNF497 ZNF672 ZNF891 ZSCAN22,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",6.989e-06|0.0001157|0.0001161|0.0001176|0.0002347,0.1102|0.9129|0.6102|0.4639|0.7406,4.38|3.27|3.269|3.264|3.03
2,86,0.2362,863.2,68990.0,0.012329999999999999,1.0,A1CF ACTA2 ADIRF AFAP1L2 AGAP5 AGAP6 AGAP9 ANK3 ANKRD22 ANXA7 ANXA8L1 AP3M1 CALHM3 CEP57L1 CFAP70 COL13A1 COMTD1 CXCL12 CYP17A1 CYP26A1 CYP26C1 CYP2C19 CYP2C8 CYP2C9 DDX50 DNAJB12 DUPD1 DUSP13 FAM25A FFAR4 GDF2 GPRIN2 GSTO1 GSTO2 HKDC1 IDE IFIT1 IFIT1B IFIT2 IFIT3 IFIT5 LDB3 LIPA LIPF LIPJ LIPK LIPM LIPN LRRC18 LRRC20 MORN4 MYOZ1 NUTM2A NUTM2B OPN4 OR13A1 PAPSS2 PDZD7 PLA2G12B PNLIPRP1 PPP3CB PSD PTPN20 RET SAMD8 SEMA4G SFTPA1 SFTPA2 SFXN2 SHLD2 SORCS1 SORCS3 SRGN SYNPO2L SYT15 TMEM72 UNC5B WASHC2C ZNF22 ZNF239 ZNF32 ZNF33B ZNF37A ZNF485 ZNF488 ZNF503,lipid catabolic process|cellular response to type I interferon|omega-hydroxylase P450 pathway|xenobiotic metabolic process|response to type I interferon,7.207e-07|1.421e-05|1.487e-05|1.711e-05|2.08e-05,0.01137|0.1121|0.07816|0.06749|0.06562,7.878|17.35|79.83|11.59|15.97
3,50,0.2915,357.1,38860.0,0.009082999999999999,1.0,A2M APOLD1 C12orf60 C3AR1 CLEC12A CLEC12B CLEC1B CLEC2A CLEC2B CLEC4A CLEC4C CLEC4D CLEC4E CLEC6A CLEC7A CLEC9A GALNT8 GYS2 IAPP KCNA1 KCNA5 KCNA6 KLRC1 KLRC4 KLRF1 KLRG1 PIANP PKP2 PRB1 PRB4 PRH2 PZP RERG RERGL SLC2A3 SLCO1B1 SLCO1B3 SLCO1B7 SLCO1C1 STYK1 TAS2R10 TAS2R13 TAS2R14 TAS2R19 TAS2R20 TAS2R30 TAS2R50 TAS2R7 TAS2R8 TAS2R9,detection of chemical stimulus involved in sensory perception of bitter taste|sensory perception of taste|sensory perception of bitter taste|detection of chemical stimulus involved in sensory perception of taste|sodium-independent organic anion transport,1.346e-15|3.674e-15|3.771e-15|4.57e-15|1.554e-07,2.123e-11|2.898e-11|1.983e-11|1.802e-11|0.0004902,101|59.39|88.64|86.53|101
4,22,0.4074,94.11,14340.0,0.0065,1.0,ADAT2 ALKBH8 CTU1 CTU2 DPH3 DUS2 EIF1 ELP5 ELP6 METTL1 MOCS3 NR2C2AP PDAP1 PPP1R15B PUS3 RNF25 SSB TRMT1 URM1 WDR4 XPOT ZPR1,tRNA modification|tRNA processing|RNA modification|tRNA metabolic process|ncRNA processing,1.27e-34|5.168e-32|2.961e-30|8.139e-30|1.241e-23,2.003e-30|4.076e-28|1.557e-26|3.209e-26|3.915e-20,162.1|110.5|85.81|80.6|33.77
5,7,0.8653,18.17,4680.0,0.003856,0.9992989999999999,AVEN DIS3L FOCAD HBS1L PELO SKIV2L TTC37,RNA catabolic process|nucleobase-containing compound catabolic process|heterocycle catabolic process|cellular nitrogen compound catabolic process|aromatic compound catabolic process,5.311e-09|4.237e-08|7.236e-08|7.762e-08|9.317e-08,8.377e-05|0.0003342|0.0003804|0.0003061|0.0002939,59.8|39.23|35.19|34.7|33.43
6,101,0.2831,1430.0,77400.0,0.018090000000000002,1.0,ADORA2A AIFM3 APOBEC3A APOBEC3B APOBEC3C APOBEC3D APOBEC3F APOBEC3G APOL1 APOL2 APOL5 ARHGAP8 BCL2L13 C22orf15 C22orf23 C22orf31 C22orf46 CACNA1I CASTOR1 CBY1 CCDC116 CCDC157 CRYBA4 CRYBB1 CRYBB3 CYTH4 DGCR6 DGCR6L DMC1 DRICH1 EMID1 FOXRED2 GAL3ST1 GGT1 GGTLC2 GSTT2B GUCD1 HIC2 HMOX1 HORMAD2 HPS1 IGLL1 IGLL5 KLHL22 LRRC75B LZTR1 MGAT3 MICALL1 MIF MMP11 MPPE1 MPST MTFP1 NIPSNAP1 OSBP2 P2RX6 PNPLA5 RAC2 RASD2 RFPL2 RFPL3 RGL4 RIMBP3 RNF215 RSPH14 SDF2L1 SEC14L2 SEC14L3 SEC14L4 SEC14L6 SELENOM SEPT3 SEPT5 SERHL2 SGSM1 SIRPA SLC5A1 SLC5A4 SLC7A4 SPECC1L SULT4A1 SUSD2 SYNGR1 TANGO2 TBC1D10A TCN2 TEX33 THAP7 TNRC6B TOP3B TPST2 TRIOBP TSSK2 TST TUBA8 UPB1 USP18 VPREB1 YPEL1 ZDHHC8 ZNF74,DNA cytosine deamination|pyrimidine nucleoside catabolic process|cytidine metabolic process|cytidine catabolic process|cytidine deamination,1.069e-10|1.219e-10|2.458e-10|2.458e-10|2.458e-10,1.686e-06|9.617e-07|1.292e-06|9.692e-07|7.753e-07,118.8|60.27|99.01|99.01|99.01
7,5,0.4384,4.3839999999999995,4012.0,0.0010890000000000001,0.996692,A4GNT CASR IFT80 KATNAL2 MRPS12,negative regulation of epithelial cell proliferation|connective tissue development|articular cartilage development|osteoblast proliferation|receptor localization to non-motile cilium,0.0004085|0.0009569|0.0009706|0.001456|0.001456,1|1|1|1|1,62.89|40.78|1373|823.8|823.8
8,19,0.5355,91.57,12560.0,0.007215000000000001,1.0,AAAS AHCTF1 CDCA3 CLCC1 KPNA2 NDC1 NUP133 NUP153 NUP160 NUP188 NUP35 NUP37 NUP43 NUP50 NUP98 POM121 POM121C SENP2 TMEM201,intracellular transport of virus|tRNA-containing ribonucleoprotein complex export from nucleus|tRNA export from nucleus|transport of virus|multi-organism localization,4.954e-32|1.948e-31|1.948e-31|2.25e-31|3.37e-31,7.815e-28|1.536e-27|1.024e-27|8.874e-28|1.063e-27,281|414.5|414.5|248.8|240.9
9,7,0.4249,8.924,5835.0,0.001523,0.9992989999999999,AACS ADAMTS3 DISP1 FAM78B GNG4 SRRM5 TRAFD1,response to oleic acid|positive regulation of vascular endothelial growth factor signaling pathway|vascular endothelial growth factor production|cellular response to testosterone stimulus|diaphragm development,0.002376|0.002376|0.002715|0.003054|0.003054,1|1|1|1|1,490.4|490.4|420.3|367.8|367.8
10,24,0.3408,94.07,19280.0,0.004843,1.0,AADAC ARHGEF26 CPA3 CPB1 ERICH6 GPR171 GPR87 HTR3D HTR3E IGSF10 NPHP3 P2RY12 P2RY13 P2RY14 PLSCR1 PLSCR2 PQLC2L SCHIP1 SELENOT SERPINI1 SERPINI2 TFDP2 TM4SF18 TM4SF4,G protein-coupled purinergic nucleotide receptor signaling pathway|purinergic nucleotide receptor signaling pathway|negative regulation of adenylate cyclase activity|plasma membrane phospholipid scrambling|negative regulation of cyclase activity,1.575e-11|3.432e-09|0.0002957|0.0002957|0.0003832,2.485e-07|2.707e-05|1|1|1,306.5|91.29|85.81|85.81|74.62
11,10,0.4013,18.06,7829.0,0.0022949999999999997,0.999933,AADACL2 ARGFX C6orf48 HLA-DMB MSH5 SAYSD1 STK19 TAP1 TAP2 TNXB,antigen processing and presentation of endogenous peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen|antigen processing and presentation of endogenous antigen|antigen processing and presentation of peptide antigen|antigen processing and presentation,9.343e-08|1.262e-07|2.988e-07|1.627e-06|2.86e-06,0.001474|0.000995|0.001571|0.006417|0.009023,363.4|325.2|237.6|42.68|36.94
12,10,0.409,18.41,8205.0,0.0022329999999999997,0.999933,AADACL3 C11orf52 C1QB C1orf123 HTR6 MTFR1L NBL1 PLA2G5 PQLC2 WDTC1,positive regulation of phagosome maturation|positive regulation of antifungal innate immune response|positive regulation of opsonization|positive regulation of immune complex clearance by monocytes and macrophages|regulation of antifungal innate immune response,0.0007765|0.0007765|0.001164|0.001164|0.001164,1|1|1|1|1,2574|2574|1287|1287|1287
13,26,0.6754,219.5,17550.0,0.012320000000000001,1.0,ACTR2 ACTR3 ARPC2 ARPC3 ARPC4 CCDC93 COMMD10 COMMD2 COMMD3 COMMD4 COMMD5 COMMD6 COMMD7 COMMD8 COMMD9 LZIC RAB21 RAB7A SNX17 VPS26C VPS29 VPS35 VPS35L WASHC3 WASHC4 WASHC5,"retrograde transport, endosome to plasma membrane|vesicle-mediated transport|endosomal transport|vesicle-mediated transport to the plasma membrane|Arp2/3 complex-mediated actin nucleation",1.376e-14|6.052e-12|9.556e-12|1.583e-11|1.106e-10,2.171e-10|4.773e-08|5.024e-08|6.243e-08|3.49e-07,198|6.877|30.6|66.01|198
14,23,0.3823,96.72,18060.0,0.005313,1.0,AAED1 AKAP2 AMBP C9orf3 C9orf47 C9orf84 FAM206A FBP1 FBP2 GNA14 KIF12 MUSK NUTM2G OR1J1 OR1J4 OR1L1 OR1L8 OR1N2 PALM2 TXNDC8 ZNF484 ZNF510 ZNF782,"sucrose biosynthetic process|sucrose metabolic process|disaccharide biosynthetic process|fructose 1,6-bisphosphate metabolic process|detection of chemical stimulus involved in sensory perception of smell",5.922e-06|9.864e-06|2.069e-05|5.405e-05|7.081e-05,0.09342|0.0778|0.1088|0.2132|0.2234,980.7|653.8|392.3|217.9|11.12
15,23,0.4391,111.1,15000.0,0.0073290000000000004,1.0,AAGAB AGFG1 ANKH AP2A1 AP2A2 AP2B1 AP2M1 AP2S1 C10orf88 CCDC32 CLTC DNM2 FCHO2 ITSN2 PICALM PPP6C RAB5C RALGAPB SH3GL1 SLC11A2 STEAP3 TFRC WDR7,clathrin-dependent endocytosis|receptor-mediated endocytosis|receptor metabolic process|endocytosis|low-density lipoprotein particle receptor catabolic process,5.597e-20|6.208e-16|1.64e-15|2.136e-15|5.569e-15,8.829e-16|4.896e-12|8.625e-12|8.422e-12|1.757e-11,280.8|41.52|80.24|21.65|561.7
16,12,0.4172,27.54,8399.0,0.003259,0.999986,ATXN10 EIF3D PES1 RANGAP1 RPL3 RRP7A SF3A1 TFIP11 THOC5 TOMM22 TUBGCP6 ZMAT5,ribonucleoprotein complex subunit organization|RNA processing|ribonucleoprotein complex assembly|ribonucleoprotein complex biogenesis|gene expression,6.451e-08|2.42e-07|3.554e-06|4.192e-06|5.441e-06,0.001018|0.001909|0.01868|0.01653|0.01716,43.56|13.02|36.13|18.45|6.281
17,6,0.4054,6.081,5006.0,0.00121,0.998474,AAMDC AQP8 CCPG1 CDC20B CFAP126 SGTB,regulation of Rho guanyl-nucleotide exchange factor activity|positive regulation of chaperone-mediated protein folding|positive regulation of anaphase-promoting complex-dependent catabolic process|regulation of anaphase-promoting complex-dependent catabolic process|positive regulation of protein folding,0.0008735|0.0008735|0.001165|0.001165|0.001456,1|1|1|1|1,1716|1716|1144|1144|858.1
18,6,0.456,6.84,4031.0,0.001689,0.998474,AAMP CHMP7 LEMD2 NUP35 PDE2A ZNF574,mitotic nuclear envelope reassembly|mitotic nuclear membrane organization|nuclear envelope reassembly|nuclear membrane organization|nuclear envelope organization,3.386e-07|3.386e-07|3.993e-07|4.909e-07|1.392e-06,0.005341|0.00267|0.002099|0.001936|0.004392,201.9|201.9|190.7|177.5|124.1
19,9,0.4048,14.57,7630.0,0.001902,0.9998530000000001,AANAT EBPL GPR142 MCRIP1 MIF4GD NT5C RHBDF2 SNED1 SSTR2,IMP catabolic process|dGMP catabolic process|dGMP metabolic process|melatonin biosynthetic process|melatonin metabolic process,0.0008734|0.00131|0.00131|0.00131|0.00131,1|1|1|1|1,2288|1144|1144|1144|1144
20,11,0.4057,22.31,7048.0,0.003146,0.999969,AAR2 CD2BP2 DDX23 EAF1 GEMIN4 ICE2 INTS14 NCDN PHAX TOE1 USPL1,RNA metabolic process|gene expression|nucleic acid metabolic process|nucleobase-containing compound metabolic process|heterocycle metabolic process,8.395e-11|1.844e-09|2.265e-09|1.584e-08|3.027e-08,1.324e-06|1.454e-05|1.191e-05|6.246e-05|9.55e-05,11.71|8.565|8.388|6.886|6.447
21,28,0.3305,124.9,22800.0,0.005436,1.0,AARD C8orf76 COL14A1 COLEC10 DCDC2 ENPP2 FAM83A FAM84B FBXO32 GNPNAT1 GSDMC HSD17B4 KLHL38 MTBP MTSS1 NETO2 NOV PLXNC1 PMP2 RNF139 RRM2B SLC22A4 SLC30A8 SYBU TRMT12 WDYHV1 WISP1 ZHX2,semaphorin-plexin signaling pathway involved in axon guidance|semaphorin-plexin signaling pathway involved in neuron projection guidance|chemotaxis|taxis|semaphorin-plexin signaling pathway,0.0001475|0.0001982|0.0009332|0.0009561|0.001441,1|1|1|1|1,129.1|109.3|6.503|6.468|37.38
22,24,0.3945,108.9,17030.0,0.006337,1.0,AARS CDT1 CENPT CFDP1 CIAO2B CIAPIN1 COG4 EXOSC6 GINS2 GINS3 KARS MPHOSPH6 NIP7 NOB1 NUP93 NUTF2 ORC6 PSMD7 RPL13 SF3B3 SLC7A6OS TANGO6 UTP4 ZC3H18,cellular component biogenesis|ribosome biogenesis|DNA-dependent DNA replication|ncRNA processing|rRNA processing,1.159e-07|1.481e-06|2.327e-06|6.597e-06|9.403e-06,0.001829|0.01168|0.01223|0.02602|0.02967,4.641|16.18|23.08|12.44|17.22
23,120,0.3983,2844.0,83510.0,0.03285,1.0,AARS2 AURKAIP1 DAP3 DDX28 EARS2 ERAL1 FARS2 GADD45GIP1 GATB GATC GFM1 GFM2 GTPBP10 HARS2 KIAA0391 LARS2 LRPPRC MALSU1 MARS2 MIPEP MRM3 MRPL10 MRPL11 MRPL12 MRPL13 MRPL14 MRPL15 MRPL16 MRPL17 MRPL18 MRPL19 MRPL2 MRPL20 MRPL21 MRPL22 MRPL23 MRPL27 MRPL28 MRPL3 MRPL30 MRPL32 MRPL33 MRPL34 MRPL35 MRPL36 MRPL37 MRPL38 MRPL39 MRPL4 MRPL40 MRPL41 MRPL42 MRPL43 MRPL44 MRPL45 MRPL46 MRPL47 MRPL48 MRPL49 MRPL50 MRPL51 MRPL53 MRPL54 MRPL55 MRPL57 MRPL9 MRPS10 MRPS11 MRPS12 MRPS14 MRPS16 MRPS17 MRPS18A MRPS18B MRPS18C MRPS2 MRPS21 MRPS22 MRPS23 MRPS24 MRPS25 MRPS26 MRPS27 MRPS28 MRPS30 MRPS31 MRPS33 MRPS35 MRPS5 MRPS6 MRPS7 MRPS9 MTERF3 MTG1 MTG2 MTPAP NARS2 NGRN NSUN4 PNPT1 POLG POLG2 POLRMT PTCD1 PTCD3 QRSL1 RARS2 RPUSD4 SARS2 SLC25A26 SSBP1 SUPV3L1 TARS2 TFAM TFB1M TFB2M TRMT10C TRUB2 TWNK VARS2,mitochondrial gene expression|mitochondrial translation|mitochondrial translational elongation|mitochondrial translational termination|translational termination,3.195e-168|1.528e-155|6.959e-138|1.295e-137|1.559e-135,5.04e-164|1.205e-151|3.659e-134|5.108e-134|4.918e-132,114.6|132.3|147.7|146.1|134
24,5,0.4425,4.425,3813.0,0.0011560000000000001,0.996692,AARSD1 CALCA GLTPD2 IGSF22 PDZD3,artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure|baroreceptor response to increased systemic arterial blood pressure|regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback|alanyl-tRNA aminoacylation|calcitonin gene-related peptide receptor signaling pathway,0.0004854|0.000728|0.000728|0.0009706|0.0009706,1|1|1|1|1,4119|2060|2060|1373|1373
25,6,0.4164,6.245,4848.0,0.001283,0.998474,AASDH CDK20 CNR1 COBL MMD2 TSPAN33,"amino acid activation for nonribosomal peptide biosynthetic process|positive regulation of neuron projection development|collateral sprouting in absence of injury|induction of synaptic vesicle exocytosis by positive regulation of presynaptic cytosolic calcium ion concentration|trans-synaptic signaling by endocannabinoid, modulating synaptic transmission",0.0005824|0.0008701|0.0008735|0.001165|0.001165,1|1|1|1|1,3432|43.73|1716|1144|1144
26,13,0.4247,33.13,8544.0,0.003851,0.999993,ACACA ACLY CHP1 FASN GPAT4 GPI HK2 PFKP PGP SLC25A1 TMEM120B VDAC1 VKORC1L1,purine ribonucleotide metabolic process|ribonucleotide metabolic process|purine nucleotide metabolic process|ribose phosphate metabolic process|purine-containing compound metabolic process,1.905e-11|2.941e-11|3.082e-11|3.706e-11|4.956e-11,3.005e-07|2.319e-07|1.62e-07|1.461e-07|1.564e-07,34.98|33.08|32.89|32.12|30.94
27,23,0.4006,101.3,15690.0,0.0064,1.0,AATF CDC6 DHX8 PSMB3 PSMD11 PSMD3 RPL11 RPL14 RPL17 RPL18 RPL18A RPL19 RPL23 RPL23A RPL27 RPL37 RPL4 RPL7 RPL9 RPLP2 RPS15A RPS6 ZNF830,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,4.464e-32|9.428e-32|3.813e-31|6.454e-31|7.342e-31,7.042e-28|7.436e-28|2.005e-27|2.545e-27|2.316e-27,149.2|141.9|129.1|124.6|123.5
28,12,0.4081,26.94,9724.0,0.0027559999999999998,0.999986,AATK BAIAP2 CSNK1D DCXR LRRC45 MAFG PYCR1 RAC3 RFNG SLC25A10 SLC38A10 TEPSIN,"regulation of epidermal cell differentiation|regulation of epidermis development|positive regulation of cell morphogenesis involved in differentiation|modification of synaptic structure, modulating synaptic transmission|positive regulation of cell differentiation",0.000702|0.0008659|0.001157|0.001261|0.001402,1|1|1|1|1,51.94|46.6|40.11|1584|7.663
29,28,0.3291,124.4,21870.0,0.005642,1.0,AKAP2 ALDH1A1 C9orf16 C9orf84 CERCAM CIZ1 FAM129B GBGT1 KIF12 NTMT1 OR1J1 OR1J2 OR1J4 OR1L1 OR1L8 OR1N2 OR1Q1 PALM2 PIP5KL1 PTBP3 RABEPK SH2D3C TOR1B TXNDC8 UCK1 USP20 ZBTB6 ZNF483,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,1.003e-06|1.482e-06|1.897e-06|3.026e-06|3.866e-06,0.01582|0.01169|0.009977|0.01193|0.0122,12.57|11.85|11.41|10.62|10.23
30,7,0.4064,8.533999999999999,5752.0,0.001478,0.9992989999999999,ABCA10 ASPSCR1 EPHB4 GRID1 LAPTM5 NGFR ZNF609,activation of cysteine-type endopeptidase activity involved in apoptotic process|induction of programmed cell death|ion transport|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of odontogenesis of dentin-containing tooth,0.0004172|0.0006794|0.0008819|0.0009416|0.001019,1|1|1|1|1,64.66|2942|5.106|42.64|1471
31,5,0.4243,4.243,3861.0,0.0010949999999999998,0.996692,ABCA12 CSRP2 JAG1 JAG2 NRARP,regulation of Notch signaling pathway|Notch signaling pathway|tissue development|inner ear auditory receptor cell differentiation|epidermal cell differentiation,1.43e-06|1.96e-06|4.24e-06|2.331e-05|3.595e-05,0.02256|0.01546|0.02229|0.09192|0.1134,116.6|104.7|11.89|274.6|39.1
32,6,0.4024,6.0360000000000005,4718.0,0.001275,0.998474,ABCA13 APOA5 CAPN12 PI16 PRAM1 TMEM136,positive regulation of very-low-density lipoprotein particle remodeling|regulation of neutrophil degranulation|regulation of very-low-density lipoprotein particle remodeling|positive regulation of lipoprotein lipase activity|regulation of intestinal lipid absorption,0.001019|0.002376|0.002376|0.003393|0.003393,1|1|1|1|1,1471|490.4|490.4|326.9|326.9
33,29,0.3266,132.6,23580.0,0.0055780000000000005,1.0,ABCA2 AK8 ARRDC1 ASB6 C9orf43 CERCAM CIZ1 DBH DPP7 ENTPD2 ENTR1 FAM69B GLT6D1 LCN10 LCN15 LCN6 LCN8 MYMK NPDC1 NTMT1 PHPT1 RNF224 SARDH STKLD1 TOR1B TUBB4B UAP1L1 USP20 ZNF79,amine catabolic process|cellular biogenic amine catabolic process|cellular response to stimulus|N-terminal peptidyl-proline methylation|N-terminal peptidyl-serine methylation,0.001042|0.001042|0.002244|0.00281|0.00281,1|1|1|1|1,44.39|44.39|0.2098|710.2|710.2
34,14,0.4117,37.46,10510.0,0.003542,0.9999969999999999,ADAMTS15 ADAMTS8 CCDC153 FLI1 FXYD6 KCNJ1 KCNJ5 NTM NXPE4 OR10G9 OR4D5 OR6M1 OR6X1 TMEM136,system process|detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus,0.0001725|0.0001808|0.0002266|0.0002614|0.0003426,1|1|1|1|1,5.048|13.34|12.57|12.11|11.27
35,19,0.4035,69.0,13250.0,0.005166,1.0,ALG14 ATP5PB BCAS2 CDC7 DDX20 DNTTIP2 GLMN HEATR3 PRPF38B PSMA5 RABGGTB RNPC3 RPAP2 RPF1 RPL5 SARS SASS6 WARS2 WDR3,RNA metabolic process|nucleobase-containing compound metabolic process|RNA processing|nucleic acid metabolic process|heterocycle metabolic process,7.282e-07|1.279e-06|1.302e-06|1.627e-06|2.608e-06,0.01149|0.01009|0.006848|0.006415|0.008229,6.44|4.545|8.925|5.075|4.255
36,5,0.4367,4.367,3983.0,0.001093,0.996692,ABCA5 GRM1 HOGA1 MND1 PLXNB2,oxalate metabolic process|glyoxylate catabolic process|4-hydroxyproline metabolic process|4-hydroxyproline catabolic process|pyruvate biosynthetic process,0.0004854|0.0009706|0.001213|0.001213|0.001698,1|1|1|1|1,4119|1373|1030|1030|686.5
37,38,0.3331,234.2,27640.0,0.008378,1.0,ACCS ACCSL ALX4 ANO3 BDNF CAT CHRM4 COMMD9 CRY2 EHF ELF5 F2 FBXO3 HARBI1 KCNC1 LARGE2 LIN7C MAPK8IP1 MRGPRX1 MRGPRX3 MYBPC3 OR4A47 OR4A5 OR4B1 OR4C12 OR4C13 OR4C3 OR4C46 OR4S1 OR4X1 PAMR1 PDHX PTPRJ RAPSN SAA2 SLC1A2 TP53I11 TRIM49B,detection of stimulus|detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus,1.19e-07|1.942e-07|3.172e-07|4.328e-07|7.775e-07,0.001878|0.001532|0.001668|0.001707|0.002453,7.696|10.25|9.66|9.302|8.661
38,67,0.3777,835.1,52050.0,0.01575,1.0,CBR1 CBR3 CHODL CLDN14 CLDN17 CLDN8 COL6A1 COL6A2 CRYZL1 DNAJC28 FAM243A HUNK IFNAR2 IFNGR2 IL10RB ITSN1 KCNJ6 KRTAP10-11 KRTAP10-3 KRTAP10-6 KRTAP10-8 KRTAP10-9 KRTAP11-1 KRTAP12-1 KRTAP12-2 KRTAP12-3 KRTAP12-4 KRTAP13-1 KRTAP13-2 KRTAP13-3 KRTAP13-4 KRTAP15-1 KRTAP19-1 KRTAP19-2 KRTAP19-3 KRTAP19-4 KRTAP19-5 KRTAP19-6 KRTAP19-7 KRTAP19-8 KRTAP20-1 KRTAP20-2 KRTAP21-1 KRTAP21-2 KRTAP22-1 KRTAP23-1 KRTAP24-1 KRTAP27-1 KRTAP6-1 KRTAP6-2 KRTAP8-1 MAP3K7CL MRAP MX2 OLIG1 OLIG2 PCBP3 RIPPLY3 SIM2 SON TCP10L TIAM1 TMEM50B TMPRSS2 TMPRSS3 TRPM2 UBASH3A,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,5.251e-47|1.106e-44|2.026e-42|9.215e-40|1.394e-38,8.283e-43|8.72e-41|1.065e-38|3.634e-36|4.398e-35,45.56|38.42|32.59|26.89|24.69
39,26,0.4056,131.8,20620.0,0.006336,1.0,ABCA8 ACSF2 CSH2 CSHL1 EPX GDPD1 GH2 HOXB5 HOXB9 LIMD2 LPO METTL2B MIF4GD MKS1 MPO MYCBPAP NME1 NME2 OR4D1 OR4D2 PLEKHM1 PRR29 RSAD1 SCPEP1 SEPT4 STRADA,response to growth hormone|growth hormone receptor signaling pathway|cellular response to growth hormone stimulus|hydrogen peroxide catabolic process|positive regulation of receptor signaling pathway via JAK-STAT,1.585e-07|3.099e-06|3.539e-06|8.614e-06|1.704e-05,0.002499|0.02444|0.01861|0.03397|0.05377,90.53|118.8|113.2|81.94|64.23
40,7,0.4119,8.649,5746.0,0.0014990000000000001,0.9992989999999999,ABCA9 ADD2 ATP11A C19orf81 CRLF3 DLEC1 TMC3,aminophospholipid translocation|aminophospholipid transport|lipid transport|leukocyte tethering or rolling|transmembrane transport,0.002715|0.003393|0.006231|0.007114|0.00716,1|1|1|1|1,420.3|326.9|16.17|147.1|6.832
41,18,0.357,54.62,14150.0,0.003836,1.0,C6orf203 ENPP1 ENPP3 FUCA2 GABRR1 PHACTR2 PTPRK RAET1G RAET1L TAAR2 TAAR6 TAAR8 TCF21 ULBP1 ULBP2 ULBP3 VNN2 WISP3,natural killer cell mediated cytotoxicity|natural killer cell mediated immunity|leukocyte mediated cytotoxicity|cell killing|natural killer cell activation,6.403e-09|8.562e-09|3.83e-08|2.795e-06|1.398e-05,0.000101|6.753e-05|0.0002014|0.01102|0.04411,201.9|186.4|124.3|40.38|66.08
42,44,0.2921,276.3,33810.0,0.008086,1.0,ABCB10 ADAL APBA2 ARHGAP11A ARHGAP11B BMF BNIP2 C15orf53 CHRFAM7A CHRNA7 DEXI DMXL2 DUOXA1 DUOXA2 EPB42 GABRA5 GOLGA8H GOLGA8M GOLGA8R HCN2 LPCAT4 MYO5A MYO5C NIPA1 NIPA2 OCA2 PLA2G4D PLA2G4E PLA2G4F PLEKHO2 PPIB RPUSD2 SCG5 SNURF SQOR STRC TGM5 TGM7 TMCO5A TMOD2 TRIM69 TYRO3 UBE2Q2L WHAMM,phosphatidylserine acyl-chain remodeling|phosphatidylethanolamine acyl-chain remodeling|phosphatidylcholine acyl-chain remodeling|phosphatidylserine metabolic process|phosphatidylinositol acyl-chain remodeling,2.845e-07|5.183e-07|8.715e-07|1.701e-06|1.253e-05,0.004488|0.004087|0.004582|0.006708|0.03953,83.21|70.41|61.02|50.85|76.28
43,11,0.4114,22.62,9116.0,0.00247,0.999969,ABCB11 BBS5 CASP10 CPO CRYGA CRYGB CRYGC CRYGD CXCR2 SLC11A1 TFPI,lens development in camera-type eye|visual perception|sensory perception of light stimulus|camera-type eye development|eye development,1.466e-07|1.627e-07|1.779e-07|3.742e-05|6.43e-05,0.002312|0.001283|0.0009351|0.1476|0.2029,83.38|36.67|36.01|19.93|17.31
44,58,0.3464,572.5,44750.0,0.0126,1.0,ABCB4 ABHD11 ARPC1B ASL C7orf43 C7orf61 CASTOR3 CLDN3 CLIP2 CYP3A4 CYP3A43 CYP3A5 CYP3A7 DLX6 FBXO24 GNAI1 GNAT3 GNG11 GRM8 GUSB IFT22 KCTD7 MOGAT3 MUC12 PILRA PILRB PMS2 PON1 PON3 PVRIG RNF148 SEMA3E SEPT14 SLC26A4 SLC26A5 SPDYE1 TBL2 TECPR1 TMEM248 TPST1 TRIM50 TRIM73 TYW1 VKORC1L1 VPS50 WNT2 ZKSCAN1 ZNF138 ZNF273 ZNF394 ZNF479 ZNF679 ZNF727 ZNF736 ZNF804B ZNF92 ZSCAN21 ZSCAN25,oxidative demethylation|lipid hydroxylation|demethylation|alkaloid catabolic process|retinoic acid metabolic process,4.764e-07|2.487e-06|4.471e-05|7.709e-05|0.0001405,0.007515|0.01962|0.2351|0.304|0.4433,74.75|152.2|21.52|236.7|32.28
45,64,0.2969,598.5,50900.0,0.011590000000000001,1.0,ABCA13 ABCB5 ADCYAP1R1 AEBP1 AGR2 AGR3 AMZ1 CALM1 CYP2W1 DBNL DPY19L1 EGR3 FKBP9 GCK GHRHR GPCPD1 GSDME HOXA1 HOXA5 HOXA6 HOXA7 HOXA9 IGFBP3 INHBA INMT KIAA0895 MINDY4 MTURN MYL7 MYO1G NIPSNAP2 NME8 NPC1L1 NPY NREP NUPR2 PDE1C PHKG1 PKD1L1 POM121L12 POU6F2 PRR15 PSPH RBAK RNASET2 RP9 RSPH10B RSPH10B2 SCIN SEPT14 SLC29A4 SPATA48 SUGCT SUMF2 UBE2D4 UPP1 URGCP VWC2 WIPF3 ZNF12 ZNF479 ZNF713 ZNF716 ZNRF2,embryonic skeletal system morphogenesis|embryonic skeletal system development|lung goblet cell differentiation|regulation of myeloid cell differentiation|lobar bronchus epithelium development,1.617e-05|5.367e-05|9.988e-05|0.0001226|0.0001495,0.2551|0.4233|0.5252|0.4834|0.4717,16.6|12.79|208|7.933|156
46,28,0.3971,150.1,19070.0,0.0077870000000000005,1.0,ATP5MF BET1 BUD31 COPS6 CPSF4 CRCP CUL1 EXOC4 LAMTOR4 LSM8 MCM7 MEPCE NOM1 NRF1 NUP205 ORC5 PMPCB POP7 PSMC2 PTCD1 RBM18 RBM28 RBM48 RINT1 SEM1 SRRT TNPO3 ZNHIT1,nucleic acid metabolic process|nucleobase-containing compound metabolic process|heterocycle metabolic process|cellular aromatic compound metabolic process|organic cyclic compound metabolic process,2.247e-06|3.216e-06|7.058e-06|8.435e-06|2.129e-05,0.03544|0.02536|0.03711|0.03326|0.06715,4.284|3.787|3.546|3.493|3.228
47,65,0.2946,612.8,51510.0,0.011729999999999999,1.0,ADAM30 AKR7A3 AMIGO1 AMY2A AMY2B C1orf162 CASQ2 CD101 CHIA CLCA4 CYB561D1 DENND2C EXTL2 FAM19A3 FAM69A FNDC7 GBP1 GBP4 GBP5 GBP6 GNAI3 GNAT2 GPR61 GSTM1 GSTM2 GSTM3 GSTM4 GSTM5 HAO2 HENMT1 HMGCS2 HSD3B1 HSD3B2 IFI44 INKA2 KCNA10 KCNA2 KCNA3 KCND3 LRIG2 MCOLN3 MOV10 MYBPHL NGF NRBF2 OVGP1 PHTF1 PNRC2 PPM1J PSRC1 PTPN22 RAP1A REG4 RHOC RSBN1 SLC22A15 SLC25A24 SLC6A17 SYPL2 TMEM167B TMEM56 TRIM45 TSHB UBL4B VANGL1,nitrobenzene metabolic process|glutathione derivative biosynthetic process|glutathione derivative metabolic process|xenobiotic catabolic process|detoxification of nitrogen compound,5.807e-09|1.863e-08|1.863e-08|1.482e-07|1.57e-06,9.161e-05|0.000147|9.798e-05|0.0005845|0.004954,321.8|73.14|73.14|107.3|193.1
48,7,0.4114,8.64,5459.0,0.001576,0.9992989999999999,ABCB9 ARL6IP4 HCAR2 HCAR3 P2RX4 PITPNM2 TRAFD1,neutrophil apoptotic process|positive regulation of adiponectin secretion|microglial cell migration|sensory perception of touch|positive regulation of neutrophil apoptotic process,0.001019|0.001019|0.001019|0.001698|0.002037,1|1|1|1|1,1471|1471|1471|735.5|588.4
49,80,0.3454,1091.0,61760.0,0.01732,1.0,ABCC6 ACSM1 ACSM2A ACSM2B ACSM3 ACSM5 AHSP ARL6IP1 ATP2A1 BCKDK BFAR C16orf45 C16orf92 CA5A CCDC189 CHP2 CLN3 CORO7 DCTPP1 DNAH3 DOC2A FAM57B GDPD3 HIRIP3 HS3ST2 HSD3B7 IL21R ITGAD ITGAL ITGAM ITGAX KIAA2013 LAT MARF1 METTL22 MPV17L MYH11 MYLPF NFATC2IP NOMO1 NOMO2 NPIPA5 NPIPB6 ORAI3 OTOA PDZD9 PHKG2 PKD1 PLA2G10 PRR14 PRSS21 PYCARD PYDC1 QPRT SBK1 SCNN1B SCNN1G SEPT1 SEPT12 SH2B1 SLC5A2 SPN STX1B SULT1A1 SULT1A2 SYT17 TBX6 TMC7 USP31 VKORC1 YPEL3 ZG16 ZNF500 ZNF688 ZNF689 ZNF747 ZNF764 ZNF771 ZNF785 ZNF843,purine nucleoside bisphosphate metabolic process|ribonucleoside bisphosphate metabolic process|nucleoside bisphosphate metabolic process|integrin-mediated signaling pathway|long-chain fatty acid metabolic process,1.181e-06|1.181e-06|1.181e-06|3.114e-06|9.447e-06,0.01863|0.009316|0.006211|0.01228|0.0298,13.55|13.55|13.55|15.76|12.87
50,25,0.4033,121.0,18950.0,0.006327,1.0,BTN2A1 BTN2A2 GPX6 HIST1H1T HLA-A HLA-DPA1 HLA-DPB1 HLA-F HLA-G OR14J1 OR2B3 OR2B6 OR2J2 OR2J3 OR2W1 PSORS1C2 SLC17A1 SLC17A2 SLC17A4 TRIM10 TRIM26 ZKSCAN4 ZNF184 ZSCAN16 ZSCAN31,"interferon-gamma-mediated signaling pathway|cellular response to interferon-gamma|sialic acid transport|response to interferon-gamma|antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent",5.219e-10|4.659e-08|9.923e-08|1.016e-07|2.916e-07,8.233e-06|0.0003675|0.0005217|0.0004007|0.00092,66.01|30.08|475.3|26.26|297
51,73,0.3177,834.8,58440.0,0.01405,1.0,ABCC11 ABCC12 ADGRG3 ADGRG5 AGRP C16orf78 C16orf86 CA7 CALB2 CBLN1 CCDC102A CDH5 CES1 CES2 CES3 CES4A CES5A CETP CHST5 CHST6 CKLF CLEC18A CLEC18B CLEC18C CMTM1 CMTM2 CMTM4 CPNE2 CTRB1 CTRB2 DPEP2 DRC7 DUS2 FUK GLG1 HSD11B2 HSF4 IRX3 IRX5 IRX6 LCAT LDHD MMP15 MMP2 MT1A MT1B MT1F MT1G MT1H MT1M MT1X MT2A MT4 MTSS1L NLRC5 NRN1L PARD6A PDP2 PDPR PDXDC1 PHKB PLA2G15 PLLP SHCBP1 SMPD3 TEPP TMED6 TMEM170A TPPP3 WWP2 ZDHHC1 ZNF19 ZNF23,detoxification of copper ion|stress response to copper ion|detoxification of inorganic compound|stress response to metal ion|cellular response to zinc ion,1.002e-16|1.002e-16|2.286e-16|3.359e-16|2.508e-15,1.58e-12|7.902e-13|1.202e-12|1.325e-12|7.914e-12,158.7|158.7|141.1|133.6|101.6
52,6,0.4206,6.309,5010.0,0.001255,0.998474,ABCC2 AP4E1 GDF11 HCN2 TMEM184A ZNF232,spinal cord anterior/posterior patterning|benzylpenicillin metabolic process|beta-lactam antibiotic metabolic process|bilirubin transport|mercury ion transport,0.0005824|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,3432|3432|3432|3432|3432
53,6,0.427,6.405,5072.0,0.001258,0.998474,ABCC3 ADPRHL1 BFSP1 PDZD3 REEP2 USP34,glucuronoside transport|negative regulation of guanylate cyclase activity|protein transport into membrane raft|canalicular bile acid transport|glycoside transport,0.0006794|0.001358|0.001698|0.001698|0.002037,1|1|1|1|1,2942|980.7|735.5|735.5|588.4
54,5,0.4011,4.011,3824.0,0.001045,0.996692,ABCC5 MACF1 MEGF10 PRKAB2 SAA1,regulation of cell adhesion|transport|establishment of localization|skeletal muscle cell proliferation|skeletal muscle satellite cell proliferation,0.0004184|0.0004999|0.0005901|0.000728|0.000728,1|1|1|1|1,17.02|4.576|4.426|2060|2060
55,5,0.4375,4.375,3914.0,0.001114,0.996692,ABCC8 CHRFAM7A FAM92B HCN2 TLDC1,regulation of ion transmembrane transport|regulation of transmembrane transport|negative regulation of acetylcholine-gated cation channel activity|positive regulation of uterine smooth muscle relaxation|regulation of uterine smooth muscle relaxation,0.0002161|0.0002217|0.0004854|0.0004854|0.0004854,1|1|1|1|1,21.31|21.12|4119|4119|4119
56,5,0.4081,4.081,3927.0,0.001035,0.996692,ABCC9 C1orf226 CIRBP MUM1 SELENOK,protein acylation|respiratory burst after phagocytosis|positive regulation of gene expression|immune effector process|respiratory burst involved in defense response,0.000738|0.0009706|0.001309|0.001392|0.00194,1|1|1|1|1,46.54|1373|11.53|11.28|588.4
57,7,0.4063,8.532,5515.0,0.001541,0.9992989999999999,ABCD2 ARL8B C12orf40 CPNE8 FOXI1 SLC8B1 VPS18,calcium export from the mitochondrion|long-chain fatty acid import into peroxisome|very long-chain fatty acid catabolic process|regulation of cardiac muscle cell membrane potential|positive regulation of unsaturated fatty acid biosynthetic process,0.001019|0.001698|0.002376|0.002715|0.003393,1|1|1|1|1,1471|735.5|490.4|420.3|326.9
58,15,0.532,55.86,10230.0,0.005413,0.999999,CCDC12 CCDC130 CFAP20 CLASRP CRIPT CWF19L1 CWF19L2 DHX35 ESS2 FRA10AC1 GPATCH1 ISY1 LENG1 PPIE WDR83,"RNA splicing|mRNA processing|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions",2.835e-14|1.051e-11|1.406e-11|1.406e-11|1.519e-11,4.471e-10|8.288e-08|7.393e-08|5.545e-08|4.791e-08,33.73|25.53|36.37|36.37|36.01
59,45,0.3553,351.7,26300.0,0.01315,1.0,ADSL ADSS AHCY ATIC CAD CTPS1 DHFR DHFR2 DHODH DTYMK FH FPGS GART GCLC GMPS GNPNAT1 IMPDH2 IPPK MTHFD1 MTR NAMPT NMNAT1 PAICS PFAS PGD PGM3 PPAT PPCDC PPCS RFK RPE RPIA SDHA SDHB SDHC SLC4A7 TFRC TKT TPK1 TRPM7 TYMS UGP2 UMPS UXS1 YRDC,small molecule metabolic process|nucleobase-containing small molecule metabolic process|nucleotide biosynthetic process|nucleoside phosphate biosynthetic process|organophosphate metabolic process,1.116e-36|1.575e-31|1.899e-29|2.484e-29|4.837e-28,1.76e-32|1.242e-27|9.982e-26|9.797e-26|1.526e-24,10.41|22.35|39.57|39.06|13.76
60,33,0.3629,191.6,22840.0,0.008295,1.0,ABCE1 CLNS1A COPB2 CSE1L EIF2S1 EIF3CL ETF1 ISY1 NARS NBEAL1 NEDD8 NUTF2 PSMA1 PSMA2 PSMA3 PSMA4 PSMA5 PSMA6 PSMB3 RPL14 RPL17 RPL18 RPL18A RPL19 RPL7 RPS17 SMU1 SNRPD1 SNRPD2 SNU13 SRP54 VCP YARS,cellular macromolecule biosynthetic process|macromolecule biosynthetic process|ribonucleoprotein complex biogenesis|cellular macromolecule catabolic process|cellular component biogenesis,1.551e-15|2.521e-15|6.006e-15|6.607e-15|8.403e-15,2.446e-11|1.988e-11|3.158e-11|2.605e-11|2.651e-11,7.919|7.728|18.79|11.63|5.545
61,15,0.5576,58.55,10570.0,0.005493,0.999999,ABCF1 DHX16 EXOC2 FARS2 MRPS18B NOL7 NUP153 PAK1IP1 PPP1R10 PRPF4B RIOK1 RPP40 SNRNP48 TUBB4B WDR46,gene expression|RNA processing|maturation of SSU-rRNA|ribosomal small subunit biogenesis|RNA metabolic process,3.352e-07|1.743e-06|7.148e-06|2.296e-05|6.334e-05,0.005287|0.01375|0.03759|0.09055|0.1998,6.281|10.41|82.38|54.92|6.011
62,8,0.4139,11.59,6097.0,0.0018920000000000002,0.9996790000000001,ABCF2 DRG1 EVI5 HSPA14 MPG TRMT2A TYROBP ZC3H15,cytoplasmic translation|positive regulation of hippocampal neuron apoptotic process|stimulatory killer cell immunoglobulin-like receptor signaling pathway|'de novo' cotranslational protein folding|positive regulation of microglial cell mediated cytotoxicity,0.0006084|0.001455|0.001455|0.001455|0.00194,1|1|1|1|1,54.92|1030|1030|1030|686.5
63,6,0.6926,10.39,4443.0,0.002327,0.998474,ABCF3 NFIA NFIB NFIC NFIX PTGES3,DNA replication|cellular macromolecule biosynthetic process|macromolecule biosynthetic process|positive regulation of macromolecule biosynthetic process|positive regulation of nucleobase-containing compound metabolic process,4.563e-07|1.891e-05|2.133e-05|3.296e-05|3.641e-05,0.007198|0.1492|0.1122|0.13|0.1149,50.66|10.37|10.12|9.262|9.076
64,26,0.4009,130.3,17660.0,0.007305,1.0,ABCG1 BUB3 CNIH4 DUX4 HSPE1 OR2A25 RPL11 RPL12 RPL13 RPL14 RPL17 RPL18 RPL18A RPL19 RPL23 RPL23A RPL27 RPL37 RPL4 RPL6 RPL9 RPLP0 RPLP2 RPS13 RPS15A RPS6,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,1.536e-40|3.85e-40|2.147e-39|4.105e-39|4.811e-39,2.424e-36|3.036e-36|1.129e-35|1.619e-35|1.518e-35,158.9|151|137.4|132.7|131.5
65,48,0.3244,365.9,36370.0,0.009935,1.0,ACTR3B AGBL3 AKR1D1 CLEC5A CPA1 CPA2 CPA5 EPHB6 FAM71F2 HYAL4 KEL KIAA1147 MGAM OR2A12 OR2A2 OR2A5 OR2A7 OR2F2 OR6B1 OR6V1 OR9A2 OR9A4 PRSS1 PRSS37 PRSS58 RAB19 RNF148 SPAM1 STRA8 TAS2R3 TAS2R38 TAS2R39 TAS2R40 TAS2R41 TAS2R60 TCAF2 THAP5 TRPV5 TRPV6 TSGA13 WNT16 WNT2 ZNF212 ZNF282 ZNF398 ZNF425 ZNF783 ZNF786,sensory perception of chemical stimulus|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|detection of stimulus involved in sensory perception|detection of stimulus,1.641e-12|6.201e-12|1.568e-11|3.386e-11|9.378e-10,2.588e-08|4.891e-08|8.245e-08|1.335e-07|2.959e-06,11.63|12.11|11.27|10.62|8.195
66,19,0.3683,62.98,13900.0,0.004497999999999999,1.0,ABRAXAS2 ARRDC4 C1QL1 CCDC96 CTSO CYS1 DNAL4 IER5 ITPKA MDK PCMTD1 POLR1E PTRH1 PWP1 SALL3 TAC3 TCOF1 TMEM82 TSPAN17,nucleolar large rRNA transcription by RNA polymerase I|transcription by RNA polymerase I|rRNA transcription|transcription elongation from RNA polymerase I promoter|termination of RNA polymerase I transcription,9.864e-06|1.344e-05|0.0002468|0.0004812|0.0005119,0.1556|0.106|1|1|1,653.8|68.42|93.4|65.38|63.27
67,24,0.3325,91.78,18370.0,0.004957,1.0,ADAMTSL5 BCL2L15 CYBC1 DDC DEF8 EIF2D FDX1 GGACT KCNK13 KLHDC3 MAFB MAPKAPK5 NAT8L PSKH1 QPCTL RDH10 RPH3A SELE SLC5A12 TAL2 TNFRSF19 UCKL1 VWA5A WNT8A,primary lung bud formation|rhombomere 6 development|positive regulation of retinoic acid biosynthetic process|positive regulation of isoprenoid metabolic process|canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,0.002327|0.002327|0.002327|0.002327|0.003488,1|1|1|1|1,858.1|858.1|858.1|858.1|429.1
68,43,0.2937,265.2,34660.0,0.007575,1.0,ABHD3 ANKRD29 B4GALT6 C18orf32 CABLES1 CDH20 CDH7 CELF4 CHST9 CNDP2 CTIF DSC1 DSC3 DSEL DSG1 DSG2 DSG3 DSG4 FAM69C GALNT1 HRH4 KIAA1328 LAMA3 MAPRE2 PQLC1 PSTPIP2 RIT2 SERPINB10 SERPINB12 SERPINB2 SERPINB3 SERPINB5 SERPINB7 SERPINB8 SLC14A2 ST8SIA3 SYT4 TPGS2 ZBTB7C ZNF24 ZNF396 ZNF397 ZNF521,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|cell-cell adhesion|cornification|cell adhesion,3.214e-12|2.011e-10|6.657e-10|6.036e-09|5.257e-07,5.069e-08|1.586e-06|3.5e-06|2.38e-05|0.001658,28.03|18.07|10.93|29|5.906
69,27,0.3604,126.5,20290.0,0.006181,1.0,ANO1 BBS1 CABP2 CABP4 CARNS1 CCDC36 CREM CTTN FADD FGF19 FGF4 FOLR1 FOLR2 GSTP1 KRTAP5-10 KRTAP5-9 MRGPRD MRGPRF MYEOV NUDT8 P2RY6 PITPNM1 POLD4 TBC1D10C TBX10 TESMIN TMEM134,cellular response to folic acid|folate import across plasma membrane|regulation of ERK1 and ERK2 cascade|folate transmembrane transport|folic acid transport,9.889e-06|3.453e-05|3.67e-05|4.6e-05|7.381e-05,0.156|0.2723|0.1929|0.1814|0.2328,762.8|305.1|13.11|254.3|190.7
70,8,0.4423,12.38,6436.0,0.001916,0.9996790000000001,DBNDD1 GAS8 MC1R NRG4 PTH SPG7 TCF25 VPS9D1,positive regulation of osteoclast proliferation|adenylate cyclase-activating G protein-coupled receptor signaling pathway|regulation of osteoclast proliferation|negative regulation of bone mineralization involved in bone maturation|hormone-mediated apoptotic signaling pathway,0.00131|0.00151|0.002182|0.002182|0.002182,1|1|1|1|1,1144|34.15|572.1|572.1|572.1
71,38,0.3542,249.0,29640.0,0.008309,1.0,ABHD12 ACSS1 APMAP BANF2 BFSP1 CFAP61 CST1 CST11 CST2 CST3 CST4 CST5 CST7 CST8 CST9 CST9L CSTL1 DDRGK1 FOXA2 GGTLC1 GZF1 KIF16B MGME1 NANP NAPB NINL NKX2-4 OTOR PAX1 PCSK2 PLCB4 RBBP9 SIVA1 SYNDIG1 TGM3 THBD ZNF133 ZNF337,negative regulation of endopeptidase activity|negative regulation of proteolysis|negative regulation of peptidase activity|regulation of peptidase activity|regulation of endopeptidase activity,7.745e-13|1.047e-12|1.176e-12|2.315e-11|2.326e-10,1.222e-08|8.26e-09|6.184e-09|9.129e-08|7.337e-07,24.33|18.91|23.38|14.39|14.06
72,20,0.4116,78.2,13570.0,0.005712,1.0,CCNK CINP DDX24 DYNC1H1 EIF2B2 EIF2S1 EIF5 ERH LRR1 NRDE2 POLE2 PSMA3 PSMA6 PSMC1 PSMC6 RBM25 RPS29 SNAPC1 WARS WDR25,cellular macromolecule biosynthetic process|macromolecule biosynthetic process|posttranscriptional regulation of gene expression|cellular biosynthetic process|organic substance biosynthetic process,2.751e-10|3.724e-10|2.486e-08|1.129e-07|1.706e-07,4.339e-06|2.937e-06|0.0001307|0.0004453|0.0005383,8.089|7.893|15.06|4.942|4.774
73,5,0.4255,4.255,4099.0,0.001034,0.996692,ABHD13 ACSL5 FBLN1 GAPDHS RASAL1,"negative regulation of transformation of host cell by virus|regulation of transformation of host cell by virus|positive regulation of long-chain fatty acid import across plasma membrane|positive regulation of long-chain fatty acid import into cell|positive regulation of substrate-dependent cell migration, cell attachment to substrate",0.0004854|0.0004854|0.000728|0.0009706|0.0009706,1|1|1|1|1,4119|4119|2060|1373|1373
74,46,0.3108,321.7,36090.0,0.008813,1.0,ABHD14A ABHD14B ACKR2 APEH CACNA2D2 CAMP CCDC71 CCR2 CCR3 CCR5 CCR8 CCR9 CCRL2 COL7A1 CXCR6 DNAH1 FAM198A GLYCTK GNAT1 HYAL1 HYAL3 IQCF1 IQCF2 IQCF3 IQCF5 IQCF6 ITIH3 ITIH4 KLHDC8B KRBOX1 MUSTN1 MYL3 NISCH NT5DC2 PFKFB4 SCN10A SCN11A SEMA3G SLC22A14 SPINK8 TLR9 TRANK1 VIPR1 XCR1 ZNF445 ZNF502,chemokine-mediated signaling pathway|cellular response to chemokine|response to chemokine|calcium-mediated signaling|cell chemotaxis,3.648e-13|9.882e-13|9.882e-13|6.053e-11|9.997e-10,5.754e-09|7.794e-09|5.196e-09|2.387e-07|3.154e-06,49.92|44.31|44.31|27.2|19.52
75,70,0.3497,844.4,54460.0,0.01523,1.0,ADAM11 AOC2 AOC3 ARL5C CCR7 DHRS11 EPOP FKBP10 GAS2L2 GAST GSDMA GSDMB HAP1 HEXIM2 HSPB9 KLHL11 KRT10 KRT12 KRT13 KRT15 KRT16 KRT19 KRT20 KRT222 KRT23 KRT24 KRT25 KRT26 KRT27 KRT28 KRT31 KRT32 KRT33A KRT33B KRT34 KRT35 KRT36 KRT37 KRT39 KRT40 KRT9 KRTAP1-1 KRTAP1-3 KRTAP1-4 KRTAP1-5 KRTAP3-1 KRTAP3-2 KRTAP3-3 KRTAP4-11 KRTAP4-2 KRTAP4-3 KRTAP4-4 KRTAP4-6 KRTAP4-8 KRTAP4-9 KRTAP9-1 KRTAP9-3 KRTAP9-8 KRTAP9-9 LGALS9 LRRC3C P3H4 RDM1 RND2 STAT5A TBKBP1 TMSB10 TMUB2 TUBG2 ZPBP2,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,2.291e-61|1.581e-58|9.36e-56|1.721e-52|4.874e-51,3.614e-57|1.247e-54|4.921e-52|6.788e-49|1.538e-47,53.16|44.83|38.02|31.37|28.81
76,25,0.3562,106.9,19080.0,0.005555,1.0,AIF1 C6orf222 C6orf48 GSTA3 HLA-DMB HLA-F HSPA1L LY6G5C LY6G6F MICB MPIG6B MSH5 NCR3 NUDT3 OR14J1 OR2B6 OR2J3 PPT2 PSORS1C2 STK19 TAP1 TAP2 TNXB TRIM10 TRIM26,antigen processing and presentation of endogenous peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen|antigen processing and presentation of endogenous antigen|antigen processing and presentation of peptide antigen|antigen processing and presentation,9.916e-09|1.465e-08|4.507e-08|3.527e-06|7.016e-06,0.0001564|0.0001155|0.000237|0.01391|0.02214,193.8|173.4|126.7|21.34|18.47
77,8,0.4046,11.33,6760.0,0.0016690000000000001,0.9996790000000001,ABHD16B CCR4 FBLN2 PLGRKT SLC1A6 SMIM14 TCIRG1 ZUP1,"RNA phosphodiester bond hydrolysis, exonucleolytic|nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay|response to silver ion|dentin mineralization|memory T cell activation",0.0002075|0.0004075|0.0009704|0.0009704|0.001455,1|1|1|1|1,95.79|67.52|2060|2060|1030
78,14,0.4057,36.92,9879.0,0.003713,0.9999969999999999,ATP6V0B CDC20 CLSPN EBNA1BP2 EIF3I GNL2 IPO13 PABPC1 PSMB2 SF3A3 SNIP1 TRAPPC3 UTP11 YARS,ribonucleoprotein complex biogenesis|cellular component biogenesis|RNA processing|gene expression|nucleic acid metabolic process,1.02e-05|0.0001265|0.0002609|0.0002667|0.0003039,0.1609|0.998|1|1|0.9587,15.82|4.357|7.969|4.711|4.614
79,39,0.3381,250.5,30140.0,0.008222,1.0,ACSM5 BICDL2 C16orf45 C16orf89 C16orf90 C16orf92 CA5A CASKIN1 CDIP1 CLDN6 CLDN9 CLUAP1 CORO7 GLIS2 HAGH HBZ HCFC1R1 HMOX2 ITGAD KREMEN2 LAT NMRAL1 NOMO1 OR1F1 OR2C1 PAQR4 PRSS21 PRSS27 PRSS33 SEPT12 SULT1A2 SYT17 TBX6 TNFRSF12A TPSAB1 ZNF174 ZNF213 ZNF500 ZSCAN10,cellular macromolecule metabolic process|calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules|cellular protein metabolic process|macromolecule modification|regulation of transcription from RNA polymerase II promoter involved in kidney development,6.336e-05|0.0008155|0.0009902|0.002739|0.00368,0.9994|1|1|1|1,0|51.62|0|0|542
80,6,0.4178,6.267,4848.0,0.001288,0.998474,ABHD18 AGBL2 APOA4 CD19 CLBA1 RUFY2,positive regulation of lipid metabolic process|negative regulation of plasma lipoprotein oxidation|regulation of plasma lipoprotein oxidation|response to lipid hydroperoxide|B-1 B cell differentiation,0.0008378|0.0008735|0.0008735|0.001165|0.001746,1|1|1|1|1,44.58|1716|1716|1144|686.5
81,7,0.434,9.113,5681.0,0.001598,0.9992989999999999,ABCG5 ABHD2 DCBLD2 GJA5 RAB38 SLC10A6 TSPAN18,regulation of Purkinje myocyte action potential|vasomotion|sodium-dependent organic anion transport|Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling|bundle of His cell to Purkinje myocyte communication by electrical coupling,0.0006794|0.0006794|0.0006794|0.0006794|0.0006794,1|1|1|1|1,2942|2942|2942|2942|2942
82,6,0.4428,6.642,4729.0,0.001399,0.998474,ABHD4 ACADVL CSF2 FBXL15 HBEGF OR10Q1,negative regulation of elastin biosynthetic process|regulation of elastin biosynthetic process|response to silicon dioxide|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of interleukin-23 production,0.0005824|0.0005824|0.001165|0.001331|0.001746,1|1|1|1|1,3432|3432|1144|35.21|686.5
83,7,0.4459,9.363999999999999,5393.0,0.0017289999999999999,0.9992989999999999,ABHD5 BLCAP CLCF1 HS3ST4 MARCH6 MEF2C TMX1,positive regulation of B cell proliferation|regulation of B cell proliferation|sinoatrial valve morphogenesis|sinoatrial valve development|positive regulation of lymphocyte proliferation,8.877e-05|0.0002037|0.0006794|0.0006794|0.0009416,1|1|1|1|1,143.5|93.4|2942|2942|42.64
84,7,0.4113,8.638,6195.0,0.001389,0.9992989999999999,ABHD6 CAPN13 EMX1 ENO2 HNRNPLL MEGF11 SHISA4,"lysobisphosphatidic acid metabolic process|regulation of endocannabinoid signaling pathway|regulation of vacuole fusion, non-autophagic|cerebral cortex regionalization|monoacylglycerol catabolic process",0.001019|0.001358|0.001698|0.002376|0.002715,1|1|1|1|1,1471|980.7|735.5|490.4|420.3
85,6,0.4162,6.242000000000001,4671.0,0.0013310000000000002,0.998474,ABHD8 CYP4F11 MAN2B1 OR9G4 RGS7BP TNPO2,oxylipin biosynthetic process|oxylipin metabolic process|vitamin K catabolic process|menaquinone catabolic process|quinone catabolic process,0.0008735|0.0008735|0.001456|0.001456|0.001746,1|1|1|1|1,1716|1716|858.1|858.1|686.5
86,5,0.4149,4.149,3847.0,0.001075,0.996692,ABI3 ADCY9 EPHA10 MFN1 SVIP,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly|regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly|mitochondrial membrane fusion|negative regulation of ER-associated ubiquitin-dependent protein catabolic process|positive regulation of protein lipidation,0.0004854|0.0004854|0.000728|0.0009706|0.001213,1|1|1|1|1,4119|4119|2060|1373|1030
87,136,0.2628,2412.0,105500.0,0.0223,1.0,ACP7 APLP1 ARHGAP33 ATP1A3 BCKDHA C19orf12 C5AR2 CAPNS1 CATSPERG CCDC61 CEACAM1 CEACAM21 CEACAM3 CEACAM4 CEACAM5 CEACAM6 CEACAM7 CEACAM8 CLC CXCL17 CYP2A13 CYP2A6 CYP2A7 CYP2B6 CYP2F1 CYP2S1 EID2 EID2B EML2 ETV2 FAM187B FAM98C FBXO27 FFAR1 FFAR2 FFAR3 FXYD3 GMFG GRAMD1A HKR1 IFNL1 IFNL2 IFNL3 IGFL1 IGFLR1 ITPKC KCNN4 KCTD15 KIR2DL1 KIR2DL3 LAIR2 LGALS13 LGALS14 LGALS16 LGALS7B LGI4 LHB LIPE LRFN3 MAG MSRB1 NCCRP1 PGLYRP1 PLEKHF1 PLEKHG2 PRX PSG1 PSG11 PSG2 PSG3 PSG4 PSG5 PSG6 PSG8 PSG9 PVR RAB4B RASGRP4 RYR1 SBSN SCGB2B2 SERTAD1 SERTAD3 SLC7A9 SULT2B1 TDGF1 TTC9B U2AF1L4 UPK1A WDR87 WDR88 ZFP14 ZFP30 ZFP82 ZNF155 ZNF181 ZNF222 ZNF225 ZNF226 ZNF230 ZNF233 ZNF234 ZNF284 ZNF285 ZNF296 ZNF30 ZNF302 ZNF345 ZNF382 ZNF383 ZNF415 ZNF45 ZNF461 ZNF527 ZNF529 ZNF536 ZNF540 ZNF546 ZNF565 ZNF566 ZNF567 ZNF568 ZNF569 ZNF570 ZNF571 ZNF573 ZNF577 ZNF585A ZNF585B ZNF599 ZNF607 ZNF780B ZNF790 ZNF792 ZNF793 ZNF829,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|nitrogen compound metabolic process",9.621e-12|2.769e-09|2.795e-09|4.721e-09|1.236e-08,1.518e-07|2.184e-05|1.47e-05|1.862e-05|3.9e-05,2.787|2.251|2.25|2.247|0.3626
88,14,0.4045,36.81,8975.0,0.004072,0.9999969999999999,ABL1 BCR EGFR FGFR1 FRS2 GAB1 GAB2 GRB2 LMO2 MYB PTPN1 PTPN11 QRFP SOS1,transmembrane receptor protein tyrosine kinase signaling pathway|enzyme linked receptor protein signaling pathway|epidermal growth factor receptor signaling pathway|ERBB signaling pathway|positive regulation of protein kinase B signaling,9.974e-16|3.753e-14|9.018e-13|6.031e-12|1.528e-11,1.573e-11|2.96e-10|4.741e-09|2.378e-08|4.821e-08,31.18|22.29|176.5|126.1|56.89
89,23,0.4013,101.5,17340.0,0.005804,1.0,ANO1 BBS1 CARNS1 CCDC36 CPT1A CTTN FGF19 FGF4 FOLR1 FOLR2 GAL GSTP1 IGHMBP2 KRTAP5-10 KRTAP5-9 MRGPRD MRGPRF MYEOV P2RY6 POLD4 TBX10 TESMIN ZNF20,cellular response to folic acid|folate import across plasma membrane|folate transmembrane transport|folic acid transport|cellular modified amino acid metabolic process,9.158e-06|3.198e-05|4.26e-05|6.836e-05|0.0001024,0.1445|0.2522|0.224|0.2696|0.3232,792.1|316.8|264|198|16.42
90,24,0.3812,105.2,18830.0,0.005542,1.0,AKAP2 C9orf16 C9orf3 C9orf84 FAM129B FAM206A FBP1 FBP2 FRRS1L GNA14 KIF12 NUTM2G OR1J1 OR1J2 OR1J4 OR1L1 OR1L8 OR1N2 PALM2 TXNDC8 ZBTB6 ZNF484 ZNF510 ZNF782,detection of chemical stimulus involved in sensory perception of smell|sucrose biosynthetic process|sensory perception of smell|detection of chemical stimulus involved in sensory perception|sucrose metabolic process,5.581e-06|6.513e-06|7.807e-06|9.657e-06|1.085e-05,0.08803|0.05137|0.04105|0.03808|0.03422,12.74|936.1|12|11.56|624.1
91,7,0.4013,8.427,5571.0,0.001507,0.9992989999999999,ABLIM2 ARMC12 METRN MIOX QDPR RBBP8NL TEX35,inositol catabolic process|polyol metabolic process|dihydrobiopterin metabolic process|response to aluminum ion|tetrahydrobiopterin biosynthetic process,0.0006794|0.0007518|0.001019|0.002037|0.002715,1|1|1|1|1,2942|47.84|1471|588.4|420.3
92,86,0.2835,1036.0,66710.0,0.01526,1.0,ACADVL ACAP1 AIPL1 ALDH3A1 ALOX12B ALOX15 ALOX15B ALOXE3 ARHGEF15 ASGR1 ASGR2 C17orf107 C17orf51 CCDC144A CCDC144NL CDRT1 CDRT15 CDRT15L2 CFAP52 CHRNB1 CLEC10A DNAH2 DNAH9 DRC3 DYNLT1 FBXO39 FOXO3 GID4 GP1BA HS3ST3A1 HS3ST3B1 INCA1 KCTD11 KRBA2 KRT16 KRT17 LLGL1 MFAP4 MFSD6L MIEF2 MINK1 MYH1 MYH10 MYH2 MYH3 MYH4 MYH8 MYO15A OR1A1 OR1A2 OR1D5 OR1E2 OR1G1 OR3A1 OR3A3 OVCA2 P2RX1 P2RX5 PIK3R5 PLD2 PMP22 PRPSAP2 RCVRN SAT2 SHBG SLC16A11 SLC16A13 SLC2A4 SLC47A1 SLC47A2 SMCR8 SPEM1 SPNS3 STX8 TBC1D28 TMEM107 TMEM256 TNFRSF13B TNFSF12 TNFSF13 TRPV2 ULK2 VAMP2 ZNF287 ZNF624 ZSWIM7,hepoxilin biosynthetic process|hepoxilin metabolic process|lipoxygenase pathway|linoleic acid metabolic process|actin filament-based movement,2.124e-07|2.124e-07|1.407e-06|3.614e-06|1.561e-05,0.003351|0.001675|0.007398|0.01425|0.04926,104|104|58.51|44.58|11.8
93,5,0.4442,4.442,3925.0,0.0011279999999999999,0.996692,ABRA IL5RA KLF11 OR56B4 RNF113B,interleukin-5-mediated signaling pathway|snoRNA splicing|sno(s)RNA processing|sno(s)RNA metabolic process|regulation of interleukin-5 production,0.000728|0.000728|0.003636|0.00412|0.004845,1|1|1|1|1,2060|2060|294.2|257.4|216.8
94,44,0.2901,274.4,35120.0,0.007732999999999999,1.0,ABCA8 ACE ACSF2 ADAM11 BCAS3 C17orf47 C17orf67 CFAP97D1 CRHR1 CSH2 CSHL1 CYB561 EFCAB3 EPX FMNL1 GALK1 GH2 HOXB5 HOXB6 HOXB7 HOXB8 HOXB9 KCNJ2 LIMD2 LPO LRRC46 METTL2B MKS1 MPO MTMR4 MYCBPAP NME1 NME2 OR4D1 OR4D2 PLEKHM1 RNFT1 RSAD1 SCPEP1 SEPT4 SGCA TBKBP1 TBX21 WNT9B,embryonic skeletal system morphogenesis|embryonic skeletal system development|response to growth hormone|embryonic organ morphogenesis|skeletal system morphogenesis,6.761e-08|2.943e-07|1.399e-06|2.892e-06|8.89e-06,0.001067|0.002321|0.007357|0.0114|0.02805,29.88|23.02|53.49|11.3|12.54
95,4,0.4629,2.7769999999999997,3048.0,0.000908,0.9929309999999999,ABTB2 ACKR2 PURB TUSC1,chemokine-mediated signaling pathway|cellular response to chemokine|response to chemokine|cellular response to toxic substance|calcium-mediated signaling,0.01545|0.01736|0.01736|0.02234|0.02805,1|1|1|1|1,65.17|57.85|57.85|44.77|35.51
96,16,0.9543,114.5,10220.0,0.01105,0.999999,ACBD5 ACOX1 HSD17B4 PEX1 PEX10 PEX12 PEX13 PEX16 PEX19 PEX2 PEX26 PEX3 PEX5 PEX6 PEX7 SCP2,protein targeting to peroxisome|establishment of protein localization to peroxisome|protein localization to peroxisome|peroxisomal transport|peroxisome organization,1.993e-36|1.993e-36|1.993e-36|2.386e-36|7.979e-36,3.143e-32|1.572e-32|1.048e-32|9.409e-33|2.517e-32,228.8|228.8|228.8|226|208
97,57,0.3418,545.5,44200.0,0.012159999999999999,1.0,APTX AQP7 BAG1 CCL19 CCL21 CD274 CNTFR CREB3 DNAI1 DNAJA1 DNAJB5 FAM205A FAM219A FBXO10 FRMPD1 GALT GBA2 GLIPR2 HACD4 IFNA1 IFNA10 IFNA14 IFNA16 IFNA17 IFNA2 IFNA21 IFNA4 IFNA5 IFNA6 IFNA7 IFNA8 IFNB1 IFNE IFNK IFNW1 IL11RA INSL6 KIF24 MTAP NPR2 OR13J1 OR2S2 PDCD1LG2 PRSS3 RCL1 RLN1 RLN2 SIGMAR1 SNAPC3 SPAG8 SPINK4 TESK1 TMEM215 TMEM8B TOMM5 TYRP1 UBAP2,positive regulation of peptidyl-serine phosphorylation of STAT protein|natural killer cell activation involved in immune response|regulation of peptidyl-serine phosphorylation of STAT protein|B cell proliferation|response to exogenous dsRNA,7.834e-33|4.02e-32|4.02e-32|5.967e-29|6.579e-28,1.236e-28|3.17e-28|2.114e-28|2.353e-25|2.076e-24,289.1|251.4|251.4|141|118
98,7,0.415,8.716000000000001,5958.0,0.001457,0.9992989999999999,ACAD10 ATP2B4 KIAA1614 SEMA4G SMPDL3B SWT1 TSPAN8,negative regulation of response to external stimulus|negative regulation of citrulline biosynthetic process|regulation of citrulline biosynthetic process|negative regulation of cellular amine catabolic process|regulation of cellular amine catabolic process,0.0006211|0.0006794|0.0006794|0.0006794|0.0006794,1|1|1|1|1,16.05|2942|2942|2942|2942
99,5,0.4538,4.538,3879.0,0.001165,0.996692,ACAD11 ACVR1C TRMT13 UCK2 ZNF639,trophectodermal cell proliferation|negative regulation of chorionic trophoblast cell proliferation|CTP salvage|pyrimidine ribonucleotide salvage|regulation of chorionic trophoblast cell proliferation,0.000728|0.000728|0.0009706|0.001456|0.001456,1|1|1|1|1,2060|2060|1373|823.8|823.8
100,6,0.4003,6.005,4859.0,0.001231,0.998474,ACAD8 C1QTNF5 FAP MADCAM1 NHLRC1 TEKT4,melanocyte apoptotic process|melanocyte proliferation|negative regulation of cell proliferation involved in contact inhibition|valine catabolic process|negative regulation of extracellular matrix disassembly,0.0006794|0.001358|0.001698|0.001698|0.001698,1|1|1|1|1,2942|980.7|735.5|735.5|735.5
101,103,0.375,1970.0,69610.0,0.02744,1.0,ACAD9 ATPAF2 BCS1L CARS2 COA3 COA5 COA6 COA7 COQ2 COQ4 COQ7 COX10 COX11 COX14 COX15 COX16 COX18 COX19 COX4I1 COX5B COX6B1 COX6C COX7C CYC1 CYCS DARS2 DMAC1 ECSIT FASTKD5 FOXRED1 GFM2 GLRX5 GRSF1 GTPBP10 GTPBP8 IBA57 ISCA2 MCAT METTL17 MRM2 MRM3 MTFMT MTG1 MTIF2 MTIF3 MTO1 MTRF1L NDUFA10 NDUFA11 NDUFA2 NDUFA3 NDUFA5 NDUFA6 NDUFA8 NDUFA9 NDUFAF1 NDUFAF3 NDUFAF4 NDUFAF6 NDUFAF7 NDUFAF8 NDUFB10 NDUFB2 NDUFB3 NDUFB4 NDUFB5 NDUFB6 NDUFB7 NDUFB8 NDUFB9 NDUFC1 NDUFC2 NDUFS1 NDUFS2 NDUFS3 NDUFS5 NDUFS7 NDUFS8 NDUFV1 NDUFV2 NFU1 NOA1 NSUN4 NUBPL PDSS1 PDSS2 PET100 PET117 POLG PYURF RTN4IP1 SCO1 SCO2 SURF1 TFB1M TIMMDC1 UQCR10 UQCRB UQCRC1 UQCRC2 UQCRFS1 UQCRQ YBEY,mitochondrial respiratory chain complex assembly|ATP synthesis coupled electron transport|respiratory electron transport chain|mitochondrial ATP synthesis coupled electron transport|oxidative phosphorylation,1.041e-85|6.343e-71|4.413e-70|4.766e-69|2.284e-68,1.641e-81|5.002e-67|2.32e-66|1.88e-65|7.206e-65,102|96.81|82.51|95.68|74.26
102,6,0.4122,6.183,5006.0,0.001231,0.998474,ACADL C20orf194 PPM1J SNCAIP TMEM167B TRIM59,"carnitine catabolic process|carnitine metabolic process, CoA-linked|amino-acid betaine catabolic process|constitutive secretory pathway|long-chain fatty acid catabolic process",0.0005824|0.001165|0.001165|0.001746|0.001746,1|1|1|1|1,3432|1144|1144|686.5|686.5
103,23,0.4036,102.1,18880.0,0.005365,1.0,AGO1 AGO3 AGO4 BEST4 BSDC1 BSND C1QB C1orf123 CYP4X1 ERMAP FAAH GJA4 GJB3 GJB4 GJB5 LURAP1 MFSD2A PCSK9 TSSK3 ZFP69 ZFP69B ZNF684 ZNF691,"miRNA loading onto RISC involved in gene silencing by miRNA|RNA secondary structure unwinding|small RNA loading onto RISC|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation",1.448e-07|1.989e-07|2.65e-07|6.726e-07|6.726e-07,0.002284|0.001569|0.001393|0.002652|0.002122,383.8|335.8|298.5|206.6|206.6
104,5,0.418,4.18,3666.0,0.0011359999999999999,0.996692,ACADSB DAZAP1 HNRNPL MKI67 S1PR4,"regulation of mRNA splicing, via spliceosome|regulation of mRNA processing|regulation of RNA splicing|isoleucine catabolic process|isoleucine metabolic process",0.0002499|0.000472|0.0005261|0.001213|0.00194,1|1|1|1|1,80.76|58.43|55.29|1030|588.4
105,5,0.4363,4.363,3862.0,0.001125,0.996692,ACAN DNAJC10 GNG13 KIAA1107 MTRNR2L5,negative regulation of mitochondrial membrane permeability involved in apoptotic process|clathrin-dependent synaptic vesicle endocytosis|cellular response to staurosporine|response to staurosporine|negative regulation of mitochondrial membrane permeability,0.001213|0.001213|0.001456|0.001456|0.001698,1|1|1|1|1,1030|1030|823.8|823.8|686.5
106,16,0.4152,49.83,10740.0,0.004606,0.999999,ACAP2 ARF6 DENND4C EXOC1 EXOC2 EXOC3 EXOC5 EXOC7 EXOC8 RAB10 RAB35 RAB8A RABIF RALGAPB SBF1 SBF2,protein transport|peptide transport|amide transport|vesicle-mediated transport to the plasma membrane|establishment of protein localization,2.402e-11|3.02e-11|3.927e-11|4.525e-11|5.002e-11,3.789e-07|2.382e-07|2.065e-07|1.784e-07|1.578e-07,10.56|10.35|10.12|91.94|9.914
107,5,0.4275,4.275,3890.0,0.0010949999999999998,0.996692,ACAP3 AP1G2 CHST2 ZC3H3 ZFC3H1,positive regulation of activin receptor signaling pathway|regulation of mRNA polyadenylation|Golgi to vacuole transport|N-acetylglucosamine metabolic process|regulation of activin receptor signaling pathway,0.00194|0.004362|0.004845|0.004845|0.006054,1|1|1|1|1,588.4|242.3|216.8|216.8|171.6
108,6,0.434,6.51,4971.0,0.0013050000000000002,0.998474,ACAT1 APBB3 E2F5 POM121L12 RNF133 TMEM74B,cholesterol esterification|sterol esterification|steroid esterification|metanephric proximal convoluted tubule development|proximal convoluted tubule development,1.483e-06|1.483e-06|1.483e-06|0.0006794|0.0006794,0.0234|0.0117|0.0078|1|1,1471|1471|1471|2942|2942
109,20,0.4077,77.47,12200.0,0.006291,1.0,ACAT2 ADSL CMPK1 DTYMK FDFT1 FDPS GMPPB GMPS HMGCR HMGCS1 LSS MAT2A MSMO1 MVD MVK PGD PMVK SQLE UBIAD1 YRDC,secondary alcohol biosynthetic process|cholesterol biosynthetic process|sterol biosynthetic process|cholesterol metabolic process|small molecule metabolic process,2.31e-24|2.31e-24|8.925e-24|1.054e-21|1.865e-21,3.644e-20|1.822e-20|4.693e-20|4.158e-18|5.882e-18,269.7|269.7|234.5|95.68|12.09
110,7,0.403,8.463,5172.0,0.001629,0.9992989999999999,ACBD3 BRMS1 DDHD2 DENND4A FLT3 TFCP2 ZFP64,pro-B cell differentiation|myeloid progenitor cell differentiation|positive regulation of anoikis|regulation of Rab protein signal transduction|common myeloid progenitor cell proliferation,0.001698|0.002376|0.002715|0.002715|0.002715,1|1|1|1|1,735.5|490.4|420.3|420.3|420.3
111,6,0.4082,6.122999999999999,4957.0,0.001231,0.998474,ACBD4 CCDC28B CELF5 LRRC28 NCF2 SEC22C,superoxide anion generation|respiratory burst|mRNA splice site selection|superoxide metabolic process|cell redox homeostasis,0.004942|0.006391|0.009574|0.01159|0.01332,1|1|1|1|1,214.5|163.5|107.3|88.01|76.28
112,9,0.409,14.72,7305.0,0.002006,0.9998530000000001,ACBD6 C1orf105 DNM3 FMO3 MYOC OCLM PRG4 SELP SLC25A38,positive regulation of phosphatidylinositol 3-kinase signaling|ERBB2-ERBB3 signaling pathway|glycine import into mitochondrion|skeletal muscle hypertrophy|ERBB3 signaling pathway,0.0007108|0.0008734|0.0008734|0.0008734|0.00131,1|1|1|1|1,50.29|2288|2288|2288|1144
113,24,0.4188,115.6,16420.0,0.006972,1.0,AFDN ARHGAP29 CDC42 CDH1 CDH2 CRB3 CTNNA1 CTNND1 F11R HNF1B IRF6 MPP5 PARD3 PARD6B PATJ PAX8 PKN2 PRKCI RASSF7 RASSF8 RIPK4 TAX1BP3 TJP1 TP53BP2,cell-cell junction organization|cell-cell junction assembly|cell junction assembly|apical junction assembly|cell junction organization,1.204e-24|1.787e-22|4.332e-22|8.977e-19|2.008e-18,1.9e-20|1.41e-18|2.278e-18|3.54e-15|6.334e-15,66.44|84.33|44.13|123|24.66
114,6,0.4302,6.452999999999999,4706.0,0.001366,0.998474,ACER1 DDX21 KCNJ11 PAX6 WDR17 ZBTB39,pancreatic A cell development|forebrain-midbrain boundary formation|epithalamus development|response to alkaline pH|habenula development,0.0006794|0.0006794|0.001358|0.001358|0.001358,1|1|1|1|1,2942|2942|980.7|980.7|980.7
115,19,0.3937,67.33,14480.0,0.0046159999999999994,1.0,ACER3 CAPN5 CTTN FCHSD2 FGF19 FOLR1 FOLR2 GDPD4 KCTD21 KRTAP5-9 MRGPRD MRGPRF OMP P2RY2 P2RY6 PLEKHB1 POLD4 THRSP UCP3,cellular response to folic acid|folate import across plasma membrane|folate transmembrane transport|folic acid transport|response to folic acid,5.359e-06|1.872e-05|2.495e-05|4.005e-05|6.93e-05,0.08453|0.1477|0.1312|0.1579|0.2186,1030|411.9|343.3|257.4|187.2
116,6,0.4004,6.006,4822.0,0.001241,0.998474,ACHE FST GPA33 HYKK SLC7A2 TPM2,"synaptic transmission, cholinergic|negative regulation of synaptic transmission, cholinergic|acetylcholine catabolic process|acetylcholine catabolic process in synaptic cleft|acetate ester metabolic process",3.725e-05|0.0006794|0.001019|0.001019|0.002037,0.5876|1|1|1|1,226.3|2942|1471|1471|588.4
117,10,0.4226,19.02,6514.0,0.002902,0.999933,ACIN1 BCAS2 CCNL1 CDK11A CTNNBL1 PNISR PPP1R8 PRPF19 SNRPA WBP11,RNA splicing|mRNA processing|RNA processing|mRNA metabolic process|nucleic acid metabolic process,3.869e-10|1.27e-09|2.464e-09|1.5e-08|9.399e-08,6.103e-06|1.002e-05|1.296e-05|5.914e-05|0.0002965,32.2|27.08|16.23|18.88|7.549
118,6,0.4195,6.292999999999999,4950.0,0.001266,0.998474,ACKR1 C15orf65 C22orf15 DENND6B GIN1 GPR139,DNA integration|chemokine-mediated signaling pathway|regulation of chemokine production|cellular response to chemokine|response to chemokine,0.005522|0.02308|0.02536|0.02593|0.02593,1|1|1|1|1,190.7|43.45|39.45|38.57|38.57
119,5,0.4007,4.007,3812.0,0.001047,0.996692,ACKR3 ALDH3B2 GCSAML HLA-DQA2 TMEM221,positive regulation of mesenchymal stem cell migration|regulation of mesenchymal stem cell migration|ethanol catabolic process|primary alcohol catabolic process|ethanol metabolic process,0.0009706|0.0009706|0.003152|0.003878|0.005329,1|1|1|1|1,1373|1373|343.3|274.6|196.1
120,6,0.4013,6.019,4848.0,0.0012369999999999998,0.998474,ACKR4 ANGPTL7 DMRTA2 SCCPDH SLC2A13 VTI1B,negative regulation of vasculature development involved in avascular cornea development in camera-type eye|avascular cornea development in camera-type eye|platelet degranulation|myo-inositol transport|cerebral cortex regionalization,0.0005824|0.0005824|0.000583|0.001456|0.002037,1|1|1|1|1,3432|3432|53.63|858.1|572.1
121,23,0.361,91.34,18230.0,0.004972,1.0,ADSSL1 AK7 APOPT1 CEP170B CRIP1 CYP46A1 FBLN5 GON7 GPR68 IFI27 PPP4R4 RIN3 SERPINA1 SERPINA11 SERPINA12 SERPINA3 SERPINA4 SERPINA6 SERPINA9 SLC24A4 TMEM121 UBR7 ZBTB42,negative regulation of endopeptidase activity|negative regulation of peptidase activity|negative regulation of hydrolase activity|negative regulation of proteolysis|regulation of endopeptidase activity,3.77e-09|4.936e-09|9.593e-09|3.7e-08|1.501e-07,5.946e-05|3.893e-05|5.044e-05|0.0001459|0.0004735,28.02|26.92|17.24|19.96|16.19
122,6,0.4476,6.7139999999999995,4953.0,0.001351,0.998474,ACOD1 JPH2 MIEF1 PITPNC1 SWSAP1 ZSWIM7,double-strand break repair via homologous recombination|recombinational repair|tolerance induction to lipopolysaccharide|protein stabilization|double-strand break repair,0.0003665|0.0003809|0.0008735|0.001344|0.001426,1|1|1|1|1,67.97|66.65|1716|35.03|33.99
123,7,0.4193,8.805,5824.0,0.001506,0.9992989999999999,ACOT1 C10orf113 DNAJB4 KLRG1 MGST3 TSLP ZNF586,positive regulation of chemokine (C-C motif) ligand 1 production|regulation of chemokine (C-C motif) ligand 1 production|positive regulation of granulocyte colony-stimulating factor production|positive regulation of macrophage colony-stimulating factor production|regulation of granulocyte colony-stimulating factor production,0.0006794|0.0006794|0.001358|0.001358|0.001698,1|1|1|1|1,2942|2942|980.7|980.7|735.5
124,8,0.4118,11.53,5713.0,0.002009,0.9996790000000001,ASCL1 ATP6V1C1 DYNC1I2 FOXA2 MYCL NKX2-1 SOX1 TOX3,forebrain neuron differentiation|cell fate commitment|forebrain generation of neurons|neuron fate commitment|dorsal/ventral pattern formation,8.416e-07|1.232e-06|1.368e-06|1.738e-06|2.773e-06,0.01328|0.009718|0.007195|0.006855|0.008749,157.6|43.45|133.2|122.6|104.4
125,5,0.4057,4.0569999999999995,3722.0,0.001086,0.996692,ACOT12 ATP2B2 AVPI1 GOLT1B RAB10,regulation of cardiac conduction|negative regulation of citrulline biosynthetic process|regulation of citrulline biosynthetic process|negative regulation of cellular amine catabolic process|regulation of cellular amine catabolic process,0.000116|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,122.6|3432|3432|3432|3432
126,21,0.4025,84.53,16860.0,0.0049759999999999995,1.0,BSND C1orf123 CD101 CLCA2 CLCA4 CYP4X1 FAM69A GBP5 GBP6 GNAT2 GPX7 GSTM2 GSTM5 IFI44 IFI44L KCNA10 MCOLN3 PCSK9 PLA2G12A TMEM56 ZYG11B,chloride transmembrane transport|chloride transport|inorganic anion transmembrane transport|glutathione derivative biosynthetic process|glutathione derivative metabolic process,0.0001189|0.0001413|0.000204|0.0002437|0.0002437,1|1|1|0.9609|0.7687,31.85|29.99|26.4|93.61|93.61
127,102,0.2388,1230.0,75740.0,0.01594,1.0,ADAMTSL4 APOA2 AQP10 ATP1A2 ATP1A4 CD1B CD1C CD1E CD5L CHIT1 CIART CLK2 CTSK DEDD ECM1 EFNA1 EFNA3 EFNA4 FAM129A FAM189B FCGR2A FCGR2B FCGR3A FCRL1 FCRL2 FCRL3 FCRL5 FLG2 FMO2 FMO3 FMO4 GABPB2 GBA HAPLN2 HIST2H2AB HIST2H2BE HJV HRNR HSPA6 IFI16 ITLN1 ITLN2 KCNJ10 LCE1A LCE1B LCE1E LCE2A LCE3A LCE3D LCE3E LCE4A LCE5A LCE6A LIX1L LYSMD1 METTL13 MINDY1 MNDA NECTIN4 OR10J3 OR10J5 OR10T2 OR6K2 OR6K6 OR6N1 OR6N2 OR6Y1 PAQR6 PGLYRP3 PGLYRP4 PIAS3 PRR9 PRUNE1 S100A12 S100A13 S100A2 S100A3 S100A4 S100A5 S100A6 S100A7 S100A7A S100A8 S100A9 SELENBP1 SHE SLAMF7 SPRR1A SPRR2F SPRR2G SPRR4 SV2A THBS3 THEM5 TMCO1 TNN TRIM46 TSACC TTC24 XCL1 YY1AP1 ZNF687,keratinocyte differentiation|keratinization|skin development|epidermal cell differentiation|epidermis development,5.826e-13|7.76e-13|8.702e-13|6.257e-12|3.421e-11,9.19e-09|6.121e-09|4.575e-09|2.468e-08|1.079e-07,12.17|13.53|9.583|10.32|8.313
128,6,0.4253,6.38,4918.0,0.001292,0.998474,ACOT4 CA2 FBN1 ITPR3 KCNS2 NPAS1,regulation of osteoclast differentiation|regulation of myeloid leukocyte differentiation|unsaturated monocarboxylic acid metabolic process|saturated monocarboxylic acid metabolic process|regulation of oligopeptide transport,0.0001644|0.0005221|0.0005824|0.0005824|0.0008735,1|1|1|1|1,102.5|56.74|3432|3432|1716
129,21,0.7671,161.1,14920.0,0.01065,1.0,CD46 CD55 DPM1 DPM3 GPAA1 PGAP2 PIGC PIGH PIGK PIGL PIGM PIGN PIGO PIGP PIGQ PIGS PIGT PIGU PIGV PIGW PIGY,GPI anchor biosynthetic process|GPI anchor metabolic process|glycolipid biosynthetic process|protein lipidation|lipoprotein biosynthetic process,1.334e-49|2.102e-49|1.498e-44|6.729e-43|1.489e-42,2.104e-45|1.658e-45|7.878e-41|2.654e-39|4.696e-39,582.3|564.7|278.1|221.8|211.7
130,5,0.4423,4.423,3761.0,0.001172,0.996692,ACOT7 BTN3A3 GRSF1 PRR3 ZNF311,long-chain fatty-acyl-CoA catabolic process|palmitic acid biosynthetic process|palmitic acid metabolic process|medium-chain fatty-acyl-CoA catabolic process|positive regulation of mitochondrial RNA catabolic process,0.0005824|0.0008735|0.0008735|0.0008735|0.001165,1|1|1|1|1,3432|1716|1716|1716|1144
131,30,0.3673,159.8,20140.0,0.007848,1.0,C19orf70 CHCHD3 CLPB CLUH CRLS1 DNAJC11 FAM136A GHITM HAX1 HTRA2 IMMP2L IMMT MFN2 MINOS1 MTCH2 MTX1 MTX2 OCIAD1 OPA1 OPA3 PARL ROMO1 SAMM50 STOML2 TIMM13 TIMM17A TIMM23 TIMM44 TMEM11 YME1L1,mitochondrion organization|inner mitochondrial membrane organization|mitochondrial membrane organization|protein localization to mitochondrion|mitochondrial transport,1.085e-28|1.329e-23|7.512e-21|3.934e-15|1.212e-14,1.711e-24|1.048e-19|3.95e-17|1.551e-11|3.823e-11,32.63|163.9|65.94|77.95|34.11
132,6,0.4206,6.31,5056.0,0.001243,0.998474,ACOXL ANKRD44 ARL6IP6 INSL5 RHBDD3 TSGA10,negative regulation of natural killer cell activation|positive regulation of feeding behavior|fatty acid beta-oxidation using acyl-CoA oxidase|regulation of feeding behavior|positive regulation of behavior,0.002909|0.0032|0.004651|0.007839|0.008128,1|1|1|1|1,381.4|343.2|228.8|132|127.1
133,5,0.4216,4.216,3846.0,0.001092,0.996692,ACP1 C16orf86 DAB2IP NOL3 TCHHL1,response to injury involved in regulation of muscle adaptation|intrinsic apoptotic signaling pathway|inhibition of cysteine-type endopeptidase activity involved in apoptotic process|negative regulation of muscle atrophy|negative regulation of mitochondrial membrane permeability involved in apoptotic process,0.0004854|0.0005123|0.000728|0.000728|0.001213,1|1|1|1|1,4119|56.04|2060|2060|1030
134,6,0.4049,6.0729999999999995,4794.0,0.0012619999999999999,0.998474,ACP2 ADAM12 INSC KRTAP12-4 LHFPL2 SFTPD,regulation of adhesion of symbiont to host epithelial cell|regulation of asymmetric cell division|negative regulation by host of symbiont molecular function|positive regulation of fertilization|induction of bacterial agglutination,0.0005824|0.001456|0.001746|0.001746|0.001746,1|1|1|1|1,3432|858.1|686.5|686.5|686.5
135,5,0.4204,4.204,4020.0,0.001042,0.996692,ACP4 CLNK EIF4EBP2 HKDC1 MDGA2,negative regulation of ERBB4 signaling pathway|regulation of synaptic plasticity|peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity|positive regulation of natural killer cell cytokine production|negative regulation of natural killer cell activation,0.0004854|0.000788|0.002183|0.002183|0.002425,1|1|1|1|1,4119|45.02|514.9|514.9|457.7
136,5,0.4344,4.343999999999999,3994.0,0.001084,0.996692,ACP5 BIRC7 LANCL1 SEZ6L2 SPACA9,regulation of natural killer cell apoptotic process|riboflavin metabolic process|flavin-containing compound metabolic process|synapse maturation|regulation of protein kinase C signaling,0.0004854|0.00194|0.002183|0.003152|0.004604,1|1|1|1|1,4119|588.4|514.9|343.3|228.8
137,42,0.4007,345.0,31280.0,0.010879999999999999,1.0,CD1B CD1C CIART CLK2 CTSK CTSS EFNA3 EFNA4 FCRL3 FLG2 GABPB2 GBA GOLPH3L HIST2H2AB HIST2H2BE HRNR ITLN2 LCE1B LCE1E LCE2A LCE3A LCE3E LCE5A OR10J5 OR6K6 PGLYRP3 S100A12 S100A2 S100A3 S100A4 S100A5 S100A6 S100A7A S100A8 S100A9 SELENBP1 SLAMF7 SPRR1A SPRR2G TNFAIP8L2 YY1AP1 ZNF687,skin development|keratinization|keratinocyte differentiation|epidermis development|epidermal cell differentiation,2.022e-10|7.052e-10|2.99e-09|8.188e-09|1.201e-08,3.189e-06|5.562e-06|1.572e-05|3.229e-05|3.788e-05,14.43|20|16.87|12.05|14.31
138,6,0.4221,6.332000000000001,4811.0,0.0013109999999999999,0.998474,ABRA ACP7 APOPT1 CEP72 EXOC3L4 MAT2B,cellular protein-containing complex localization|gamma-tubulin complex localization|S-adenosylmethionine biosynthetic process|exocyst localization|protein-containing complex localization,1.19e-05|0.0009706|0.001213|0.001456|0.001536,0.1877|1|1|1|1,392.3|1373|1030|823.8|32.05
139,5,0.4368,4.368,3886.0,0.00112,0.996692,ACPP DPT OR13F1 RND1 SLC6A13,positive regulation of adenosine receptor signaling pathway|creatine transmembrane transport|thiamine metabolic process|regulation of adenosine receptor signaling pathway|gamma-aminobutyric acid import,0.0009706|0.0009706|0.001213|0.001213|0.001213,1|1|1|1|1,1373|1373|1030|1030|1030
140,7,0.4171,8.759,5909.0,0.001477,0.9992989999999999,ACRV1 DEFB129 DPCD FNDC7 LCP1 MC4R WNT2B,lung induction|third ventricle development|regulation of grooming behavior|regulation of branching involved in lung morphogenesis|mesenchymal-epithelial cell signaling,0.001358|0.001698|0.002037|0.002376|0.002715,1|1|1|1|1,980.7|735.5|588.4|490.4|420.3
141,5,0.4245,4.245,4019.0,0.001052,0.996692,ACSBG1 FGD5 FZD6 KRT18 MBLAC2,cholangiocyte apoptotic process|embryonic nail plate morphogenesis|Golgi to plasma membrane CFTR protein transport|establishment of body hair planar orientation|establishment of body hair or bristle planar orientation,0.0004854|0.000728|0.000728|0.0009706|0.0009706,1|1|1|1|1,4119|2060|2060|1373|1373
142,7,0.4196,8.811,5541.0,0.001584,0.9992989999999999,ACSBG2 CD300LF CD300LG CPZ DDRGK1 F2RL2 WASF1,interleukin-13-mediated signaling pathway|negative regulation of MyD88-dependent toll-like receptor signaling pathway|negative regulation of apoptotic cell clearance|positive regulation of interleukin-4-mediated signaling pathway|dendritic transport of mitochondrion,0.0006794|0.001019|0.001019|0.001019|0.001019,1|1|1|1|1,2942|1471|1471|1471|1471
143,7,0.4141,8.697000000000001,5845.0,0.001482,0.9992989999999999,ACSF3 DPPA4 MYH1 PSKH1 PSTPIP2 TSPAN11 XAF1,malonate catabolic process|dicarboxylic acid catabolic process|long-chain fatty-acyl-CoA biosynthetic process|long-chain fatty-acyl-CoA metabolic process|fatty-acyl-CoA biosynthetic process,0.0006794|0.006101|0.006777|0.008802|0.01082,1|1|1|1|1,2942|173.1|154.8|117.7|94.91
144,11,0.653,35.91,6845.0,0.005202,0.999969,ACSL3 AGPAT2 AMFR C12orf49 CYB5B LPIN1 MBTPS1 SCAP SCD SREBF1 TMEM41A,regulation of cholesterol biosynthetic process|regulation of sterol biosynthetic process|regulation of cholesterol metabolic process|regulation of lipid biosynthetic process|regulation of alcohol biosynthetic process,8.448e-09|8.448e-09|2.413e-08|3.794e-08|5.528e-08,0.0001333|6.663e-05|0.0001269|0.0001496|0.0001744,170.2|170.2|129.1|47.52|104
145,6,0.4511,6.767,4922.0,0.001369,0.998474,ACSL6 AQP1 EMILIN1 FDXACB1 RPS6KC1 SHISA4,maintenance of symbiont-containing vacuole by host|carbon dioxide transmembrane transport|positive regulation of saliva secretion|negative regulation of collagen fibril organization|cerebrospinal fluid secretion,0.0005824|0.0008735|0.0008735|0.0008735|0.001165,1|1|1|1|1,3432|1716|1716|1716|1144
146,6,0.4527,6.791,5034.0,0.001344,0.998474,ACSM4 C4orf17 GCKR NGEF PURA TMEM229B,dendritic transport of messenger ribonucleoprotein complex|dendritic transport of ribonucleoprotein complex|negative regulation of glucokinase activity|negative regulation of hexokinase activity|negative regulation of dendritic spine morphogenesis,0.001165|0.001165|0.001746|0.001746|0.002037,1|1|1|1|1,1144|1144|686.5|686.5|572.1
147,24,0.3957,109.2,16530.0,0.0065450000000000005,1.0,ATP6V1C1 BOP1 COX6C CYC1 EIF3E EIF3H EMC2 EXOSC4 INTS8 MRPL13 MRPS28 MTBP MTERF3 NBN POP1 PUF60 RPL30 RPL7 RPL8 RRS1 UQCRB UTP23 VIRMA VPS28,ribonucleoprotein complex biogenesis|gene expression|ncRNA processing|RNA processing|ribosome biogenesis,1.685e-12|8.652e-11|8.494e-10|2.256e-09|2.942e-09,2.658e-08|6.824e-07|4.466e-06|8.896e-06|9.283e-06,20.3|6.281|17.88|10.23|20.68
148,6,0.4069,6.103,4948.0,0.0012289999999999998,0.998474,ACSS2 BIN2 CPTP GBX2 LLCFC1 SLC37A1,organophosphate ester transport|acetyl-CoA biosynthetic process from acetate|acetate biosynthetic process|rhombomere 2 development|acetate metabolic process,0.0006192|0.0008735|0.0008735|0.0008735|0.0008735,1|1|1|1|1,52.01|1716|1716|1716|1716
149,5,0.4201,4.2010000000000005,3931.0,0.001065,0.996692,ACSS3 GCSAML SNN ZDHHC1 ZNF205,positive regulation of protein oligomerization|regulation of protein oligomerization|positive regulation of hydrogen peroxide biosynthetic process|positive regulation of hydrogen peroxide metabolic process|regulation of hydrogen peroxide biosynthetic process,0.0009706|0.001213|0.001456|0.00194|0.002183,1|1|1|1|1,1373|1030|823.8|588.4|514.9
150,6,0.416,6.24,4741.0,0.0013109999999999999,0.998474,ACTA1 C1orf198 FBXO28 FGFRL1 GRID2IP TSPAN4,skeletal muscle fiber adaptation|mesenchyme migration|skeletal muscle thin filament assembly|skeletal myofibril assembly|skeletal muscle adaptation,0.001456|0.001746|0.002037|0.002619|0.004071,1|1|1|1|1,858.1|686.5|572.1|429.1|264
151,11,0.4067,22.37,8765.0,0.002539,0.999969,ACTBL2 CCDC30 FST GAPT HTT ITGA2 NDUFS4 PLK2 RAB3C RASSF4 ZNF691,positive regulation of epithelial cell migration|regulation of epithelial cell migration|learning or memory|negative regulation of synaptic transmission|cognition,0.0001087|0.00038|0.0004885|0.000702|0.0007614,1|1|1|1|1,31.68|20.57|18.86|51.94|16.17
152,4,0.4676,2.806,2891.0,0.0009668,0.9929309999999999,ACTC1 C16orf89 PPRC1 ZFP36L1,response to raffinose|cellular response to raffinose|septum transversum development|proepicardium development|mesenchyme development,0.0003883|0.0003883|0.0003883|0.0003883|0.0006717,1|1|1|1|1,5149|5149|5149|5149|47.24
153,8,0.446,12.49,5043.0,0.002462,0.9996790000000001,ACTG1 CAP1 CAPZB CFL1 CORO1C IQGAP1 SSH2 WDR1,actin cytoskeleton organization|actin filament-based process|cytoskeleton organization|regulation of actin cytoskeleton organization|regulation of actin filament-based process,8.145e-10|2.021e-09|2.443e-07|3.765e-07|6.332e-07,1.285e-05|1.594e-05|0.001285|0.001485|0.001998,27.51|24.11|11.97|28.93|26
154,7,0.4111,8.634,5693.0,0.00151,0.9992989999999999,ACTG2 ADORA2B BACH1 C20orf27 CALHM1 REPIN1 ZNF843,spermatogonial cell division|regulation of transcription involved in G2/M transition of mitotic cell cycle|meiotic DNA double-strand break processing involved in reciprocal meiotic recombination|meiotic DNA double-strand break processing|mesenchyme migration,0.001164|0.001164|0.001164|0.00194|0.002328,1|1|1|1|1,1287|1287|1287|643.6|514.9
155,21,0.4022,84.47,16250.0,0.005156,1.0,ACTL7A AKAP2 C9orf16 C9orf3 C9orf84 FAM129B FAM206A FBP1 FBP2 KIF12 OR1J1 OR1J2 OR1J4 OR1L1 OR1L8 OR1N2 PALM2 TXNDC8 ZBTB6 ZNF483 ZNF782,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|sucrose biosynthetic process|detection of chemical stimulus,2.147e-06|3.013e-06|3.735e-06|4.824e-06|5.606e-06,0.03386|0.02376|0.01964|0.01902|0.01769,14.75|13.9|13.38|1084|12.46
156,13,0.6006,46.84,10040.0,0.004633,0.999993,AGAP6 ALOX5 BCL11B C10orf53 C10orf71 CHAT DRGX ERCC6 FAM170B SLC18A3 TMEM273 VSTM4 WASHC2A,olfactory bulb axon guidance|leukotriene A4 biosynthetic process|neurotransmitter secretion|signal release from synapse|leukotriene production involved in inflammatory response,0.001261|0.001261|0.001587|0.001587|0.001891,1|1|1|1|1,1584|1584|34.07|34.07|792.1
157,22,0.4006,92.55,17980.0,0.005109000000000001,1.0,AGO1 AGO3 AGO4 ARMH1 AZIN2 BSDC1 BSND C1QA C1QB C1orf123 FAAH GJA4 GJB3 GJB4 GJB5 LURAP1 PLA2G2D TSSK3 ZBTB8A ZFP69 ZFP69B ZNF684,"miRNA loading onto RISC involved in gene silencing by miRNA|RNA secondary structure unwinding|small RNA loading onto RISC|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation",1.259e-07|1.73e-07|2.306e-07|5.853e-07|5.853e-07,0.001986|0.001365|0.001212|0.002308|0.001846,401.2|351.1|312|216|216
158,6,0.4177,6.265,4683.0,0.001333,0.998474,ACTL9 C10orf88 CCDC190 DAOA ESM1 STK32B,positive regulation of hepatocyte growth factor receptor signaling pathway|negative regulation of D-amino-acid oxidase activity|regulation of D-amino-acid oxidase activity|regulation of hepatocyte growth factor receptor signaling pathway|negative regulation of oxidoreductase activity,0.0004854|0.0004854|0.0004854|0.001213|0.006778,1|1|1|1|1,4119|4119|4119|1030|152.6
159,14,0.4192,38.15,9531.0,0.003975,0.9999969999999999,AURKA CSE1L DSN1 NFS1 PPP6R3 PSMA7 RAE1 RBM39 RPN2 RPS21 RTF2 TP53RK TPX2 TTI1,protein export from nucleus|mitotic spindle organization|nuclear export|viral gene expression|microtubule cytoskeleton organization involved in mitosis,0.0001776|0.0002213|0.0002292|0.000254|0.0003135,1|1|1|1|0.989,27.1|25.12|24.81|23.95|22.26
160,5,0.4054,4.053999999999999,3879.0,0.001041,0.996692,ACTN2 EVC EVI5L LDLRAD3 MGST2,actin filament uncapping|phospholipase C-activating angiotensin-activated signaling pathway|microspike assembly|positive regulation of endocytic recycling|regulation of endocytic recycling,0.000728|0.000728|0.001213|0.001698|0.003152,1|1|1|1|1,2060|2060|1030|686.5|343.3
161,14,0.4235,38.54,9502.0,0.004027,0.9999969999999999,ARIH2 ARIH2OS CUL1 CUL5 DCUN1D1 DCUN1D3 DCUN1D5 NAE1 RNF7 SENP8 SOCS6 UBE2F UBE2Q1 UBE2R2,protein modification by small protein conjugation or removal|protein modification by small protein conjugation|protein neddylation|post-translational protein modification|cellular protein modification process,9.767e-18|6.941e-17|1.27e-15|8.004e-13|2.82e-11,1.541e-13|5.474e-13|6.68e-12|3.156e-09|8.895e-08,18.64|21.74|633.7|34.23|6.367
162,20,0.4029,76.54,13650.0,0.005559000000000001,1.0,ACTR10 ATP6V1D CCNK DYNC1H1 EIF2B2 EIF2S1 EIF5 ERH EXOC5 LIN52 LRR1 NRDE2 POLE2 PSMA3 PSMC6 RBM25 SNAPC1 TIMM9 TRMT5 WARS,cellular macromolecule biosynthetic process|macromolecule biosynthetic process|posttranscriptional regulation of gene expression|antigen processing and presentation of exogenous peptide antigen|antigen processing and presentation of exogenous antigen,9.995e-07|1.251e-06|1.02e-05|2.55e-05|3.018e-05,0.01577|0.009867|0.05363|0.1005|0.0952,6.222|6.072|11.3|23.14|22.15
163,13,0.404,31.51,8332.0,0.0037560000000000002,0.999993,ACTR1A ANAPC15 DYNC1LI1 DYNC1LI2 DYNLRB1 MAD2L1BP NDE1 PAFAH1B1 SGO1 SPAG5 UBE2C UBE2S ZWINT,biological phase|mitotic cell cycle phase|cell cycle phase|anaphase|mitotic anaphase,3.113e-17|3.113e-17|3.113e-17|7.979e-17|7.979e-17,4.91e-13|2.455e-13|1.637e-13|3.146e-13|2.517e-13,61.64|61.64|61.64|90.82|90.82
164,7,0.4004,8.408,6112.0,0.001371,0.9992989999999999,ACTRT2 ADCYAP1 HCN4 IDUA TLDC2 ZNF57 ZNF765,heparin catabolic process|dermatan sulfate catabolic process|negative regulation of acute inflammatory response to non-antigenic stimulus|positive regulation of somatostatin secretion|regulation of somatostatin secretion,0.0006794|0.0006794|0.0006794|0.001019|0.001358,1|1|1|1|1,2942|2942|2942|1471|980.7
165,13,0.4092,31.92,8972.0,0.0035340000000000002,0.999993,AQP7 CCL19 DCTN3 DMAC1 EXOSC3 FAM205A HAUS6 NOL6 RCL1 RPS6 SMU1 SNAPC3 UBAP1,"rRNA processing|rRNA metabolic process|ribosome biogenesis|maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|ncRNA processing",1.719e-05|1.989e-05|4.418e-05|0.0001184|0.0001214,0.2711|0.1569|0.2323|0.4668|0.3831,24.37|23.47|19.09|132|14.67
166,25,0.3635,109.0,17560.0,0.006155,1.0,ACVR1 ACVR1B ACVR2A BAMBI BMPR1A BMPR2 CNEP1R1 CTDNEP1 FKBP1A HECTD1 IPO8 LEMD3 LRIG1 LRIG3 MIB1 NEO1 PMEPA1 RGMB SMAD1 SMAD6 SMAD7 SMURF2 TGFBR1 TGFBR2 UBAC1,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway|transmembrane receptor protein serine/threonine kinase signaling pathway|negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway|regulation of cellular response to growth factor stimulus|regulation of BMP signaling pathway,7.315e-25|3.603e-22|5.919e-22|5.574e-18|4.525e-17,1.154e-20|2.842e-18|3.112e-18|2.198e-14|1.427e-13,52.51|58.54|76.5|36.68|80.76
167,6,0.4389,6.582999999999999,4915.0,0.001334,0.998474,ACVR2B BCHE MOSPD3 PLEKHA6 PTPRU RNF222,cocaine metabolic process|tropane alkaloid metabolic process|response to glucocorticoid|response to corticosteroid|neuroblast differentiation,0.0005824|0.0005824|0.0007245|0.0009141|0.001746,1|1|1|1|1,3432|3432|48.01|42.64|686.5
168,81,0.2867,928.8,60440.0,0.015090000000000001,1.0,ACVRL1 AGAP2 ANKRD33 AQP2 AQP5 AQP6 ARF3 ASB8 ASIC1 ATF7 CSRNP2 DNAJC14 FAM19A2 GLIPR1L1 GRASP HOXC10 HOXC11 HOXC12 HOXC4 HOXC5 HOXC6 HOXC8 IKZF4 INHBC INHBE KIF5A KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT7 KRT71 KRT72 KRT73 KRT74 KRT75 KRT76 KRT77 KRT78 KRT79 KRT80 KRT82 KRT83 KRT84 KRT85 KRT86 LACRT MARCH9 METTL7B MSRB3 MYO1A NDUFA4L2 NR4A1 OR10A7 OR10AD1 OR10P1 OR2AP1 OR6C1 OR6C2 OR6C3 OR6C4 OR6C6 OR6C65 OR6C75 OR6C76 OR8S1 OR9K2 OS9 PCED1B POU6F1 PPP1R1A RDH16 RDH5 SDR9C7 SLC38A4 TUBA1A VDR ZNF385A,cornification|keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development,4.668e-32|9.567e-26|3.601e-24|1.207e-22|7.258e-21,7.363e-28|7.545e-22|1.893e-20|4.76e-19|2.29e-17,52.4|26.2|22.09|18.74|15.46
169,9,0.4292,15.45,5963.0,0.002577,0.9998530000000001,ANKRD17 BTG1 CNOT2 CNOT3 CNOT4 CNOT6 CNOT7 CNOT8 G3BP1,"nuclear-transcribed mRNA poly(A) tail shortening|regulation of G1/S transition of mitotic cell cycle|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|signal transduction involved in mitotic G1 DNA damage checkpoint|signal transduction involved in mitotic DNA integrity checkpoint",3.747e-16|5.071e-14|5.888e-14|6.486e-14|6.486e-14,5.911e-12|3.999e-10|3.096e-10|2.558e-10|2.046e-10,597|105.4|236.7|232.7|232.7
170,25,0.3912,117.4,15730.0,0.007379999999999999,1.0,ATL2 BNIP1 C19orf25 FITM2 GOLT1B IER3IP1 INPP5K NAPG NBAS RAB18 RAB3GAP1 RAB3GAP2 RABL3 RINT1 SCFD1 SCFD2 SCYL1 STX18 TBC1D20 TMEM167A TRAPPC13 UNC50 USE1 YIPF5 ZW10,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum|Golgi vesicle transport|protein localization|macromolecule localization|establishment of protein localization",2.603e-13|1.519e-12|4.523e-12|5.013e-12|7.162e-12,4.106e-09|1.198e-08|2.378e-08|1.977e-08|2.26e-08,71.79|21.19|6.362|5.683|7.833
171,7,0.4267,8.961,5756.0,0.001551,0.9992989999999999,ACYP1 DDX58 DIRAS2 GALNT16 PTGDR PTGER2 RDH12,cellular response to prostaglandin E stimulus|cellular response to prostaglandin stimulus|response to prostaglandin E|negative regulation of inflammatory response to antigenic stimulus|regulation of inflammatory response to antigenic stimulus,2.012e-05|3.324e-05|4.268e-05|5.71e-05|6.912e-05,0.3174|0.2622|0.2244|0.2252|0.2181,321.8|245.2|214.5|37.13|34.79
172,51,0.3009,383.6,39990.0,0.009477,1.0,ADAP2 ALDOC C17orf50 C17orf75 CCL1 CCL11 CCL13 CCL14 CCL2 CCL5 CCL7 CORO6 CRYBA1 DHRS11 EFCAB5 EPOP EVI2A FNDC8 GAS2L2 GSDMA GSDMB HAP1 KRT25 KRT26 KRT28 KRT40 KRTAP4-2 KRTAP4-8 KRTAP9-8 LGALS9 LYRM9 MYO18A NOS2 PIGS PIPOX PTGES3L RDM1 SEBOX SEZ6 SLC13A2 SLFN12 SLFN12L SLFN14 SLFN5 SPAG5 TIAF1 TLCD1 TMEM97 TWF1 UNC119 VTN,eosinophil chemotaxis|eosinophil migration|monocyte chemotaxis|lymphocyte chemotaxis|cellular response to interferon-gamma,2.343e-11|3.117e-11|3.787e-11|1.174e-10|4.641e-10,3.695e-07|2.459e-07|1.991e-07|4.63e-07|1.464e-06,134.6|127.1|65.12|54.48|21.72
173,60,0.2943,520.9,48450.0,0.01061,1.0,ADA BCAS4 BPI BPIFA1 BPIFA3 BPIFB1 BPIFB4 C20orf173 CNBD2 COX4I2 CPNE1 DEFB115 DEFB116 DLGAP4 DUSP15 EPPIN FAM209A FAM209B FAM83C FOXS1 GDF5 GGT7 GHRH HCK KIAA1755 LBP MAP1LC3A MATN4 MMP24 MMP9 MYH7B MYLK2 NECAB3 NNAT NOL4L OCSTAMP PKIG PXMP4 R3HDML RBPJL RIPOR3 SAMHD1 SEMG2 SLC12A5 SLC13A3 SLC32A1 SLPI SNTA1 TLDC2 TM9SF4 TMEM189 VSTM2L WFDC11 WFDC3 WFDC6 WFDC8 WISP2 XKR7 ZNF341 ZSWIM1,antimicrobial humoral response|antibacterial humoral response|defense response to bacterium|response to bacterium|defense response to other organism,2.093e-08|2.759e-08|5.898e-08|8.457e-07|6.095e-06,0.0003301|0.0002176|0.0003101|0.003335|0.01923,17.9|36.11|10.12|5.834|4.397
174,7,0.4127,8.667,6185.0,0.001396,0.9992989999999999,ADAD1 AKAP12 CAPN7 KLHL2 MSH4 PDE5A RAET1E,positive regulation of hepatic stellate cell migration|positive regulation of oligodendrocyte apoptotic process|hepatic stellate cell activation|regulation of hepatic stellate cell migration|regulation of oligodendrocyte apoptotic process,0.0006794|0.0006794|0.001019|0.001019|0.001019,1|1|1|1|1,2942|2942|1471|1471|1471
175,9,0.4008,14.43,6897.0,0.002082,0.9998530000000001,B4GAT1 CSKMT HRASLS5 LRRC10B MACROD1 MAP4K2 NUDT22 RARRES3 TMEM179B,N-acylphosphatidylethanolamine metabolic process|phosphatidylethanolamine metabolic process|positive regulation of protein-glutamine gamma-glutamyltransferase activity|regulation of protein-glutamine gamma-glutamyltransferase activity|peptidyl-glutamate ADP-deribosylation,9.31e-06|8.893e-05|0.00131|0.00131|0.001746,0.1468|0.7014|1|1|1,508.5|147.6|1144|1144|762.8
176,16,0.4036,48.43,11990.0,0.004013,0.999999,ADAM10 APH1A GXYLT1 HES1 JAG1 METRNL NCSTN NOTCH1 NOTCH3 POFUT1 POGLUT1 PSEN1 PSENEN RFNG TGFBR2 TSPAN14,"Notch signaling pathway|regulation of Notch signaling pathway|Notch receptor processing, ligand-dependent|amyloid-beta formation|Notch receptor processing",1.589e-21|4.217e-17|1.113e-13|4.215e-13|4.215e-13,2.506e-17|3.326e-13|5.853e-10|1.662e-09|1.33e-09,120|109.3|919.4|643.6|643.6
177,7,0.4042,8.488,5429.0,0.001557,0.9992989999999999,ADAM17 MRM2 OMD PTCD1 SOCS1 SPN UBLCP1,positive regulation of T cell migration|positive regulation of lymphocyte migration|regulation of T cell migration|regulation of lymphocyte migration|positive regulation of mononuclear cell migration,4.885e-05|7.289e-05|9.729e-05|0.0001975|0.0002165,0.7705|0.5749|0.5115|0.7789|0.683,196.1|159|136.8|94.91|90.53
178,60,0.3059,541.4,48350.0,0.01105,1.0,ADAM18 ADAM2 ADAM28 ADAM32 ADAM7 ADGRA2 ADRB3 ANK1 AP3M2 BIN3 C8orf58 CHRNA2 CHRNA6 CHRNB3 DDHD2 DEFA4 DEFA5 DEFB108B DEFB4A DKK4 DMTN DOK2 ERLIN2 FUT10 GOT1L1 HGSNAT HOOK3 HTRA4 KCNU1 LETM2 NAT1 NAT2 NKX6-3 PEBP4 PLPP5 POMK PRSS55 RHOBTB2 RNF170 RNF5 SARAF SCARA3 SGCZ SLC20A2 SMIM18 SORBS3 SOX7 STAR STC1 STMN4 TEX15 TM2D2 TNFRSF10A TNFRSF10B TNFRSF10C TNFRSF10D VDAC3 ZDHHC2 ZMAT4 ZNF705B,sperm-egg recognition|TRAIL-activated apoptotic signaling pathway|glutamine transport|cell-cell recognition|binding of sperm to zona pellucida,2.192e-06|2.58e-06|5.044e-06|7.244e-06|1.662e-05,0.03457|0.02035|0.02652|0.02856|0.05244,25.58|156|117|19.75|28.37
179,6,0.4181,6.271,4973.0,0.001257,0.998474,ADAM19 DMAC2 FAM81A PLD3 PRKAG3 UTP14C,response to muscle activity involved in regulation of muscle adaptation|positive regulation of cell-cell adhesion mediated by cadherin|amyloid precursor protein catabolic process|response to stimulus involved in regulation of muscle adaptation|membrane protein ectodomain proteolysis,0.001165|0.00349|0.004942|0.005232|0.006101,1|1|1|1|1,1144|312|214.5|201.9|171.6
180,9,0.4059,14.61,7262.0,0.002003,0.9998530000000001,ADAM20 ADAM21 ESR2 JKAMP PCNX1 PTGDR RDH11 RDH12 TMEM229B,cellular detoxification of aldehyde|cellular response to aldehyde|binding of sperm to zona pellucida|retinol metabolic process|sperm-egg recognition,7.619e-06|1.539e-05|0.0001738|0.0002055|0.0003267,0.1202|0.1214|0.9139|0.8105|1,572.1|381.4|104|95.35|75.03
181,6,0.4232,6.348,4838.0,0.001307,0.998474,ADAM29 ERBB4 GPR22 NAPEPLD NKG7 TRAM1L1,central nervous system morphogenesis|host-mediated regulation of intestinal microbiota composition|negative regulation of eating behavior|cardiac muscle tissue regeneration|N-acylethanolamine metabolic process,0.0008735|0.0008735|0.001165|0.001456|0.001746,1|1|1|1|1,1716|1716|1144|858.1|686.5
182,62,0.3757,710.4,48230.0,0.014480000000000002,1.0,ADAP2 AOC2 AOC3 C17orf50 C17orf75 CCL13 CCL2 CCL7 DHRS11 EPOP EVI2A FKBP10 GAS2L2 GSDMA GSDMB HAP1 HSPB9 KRT12 KRT13 KRT15 KRT16 KRT19 KRT20 KRT222 KRT23 KRT24 KRT25 KRT26 KRT27 KRT28 KRT31 KRT32 KRT33A KRT33B KRT35 KRT36 KRT40 KRT9 KRTAP1-4 KRTAP1-5 KRTAP3-1 KRTAP3-2 KRTAP3-3 KRTAP4-11 KRTAP4-2 KRTAP4-3 KRTAP4-4 KRTAP4-8 KRTAP4-9 KRTAP9-3 KRTAP9-8 KRTAP9-9 LGALS9 LRRC3C LYRM9 RDM1 RND2 SLFN12 SLFN5 STAT5A TUBG2 UNC119,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,6.506e-48|1.378e-45|2.543e-43|1.168e-40|1.775e-39,1.026e-43|1.087e-41|1.337e-39|4.605e-37|5.6e-36,47.67|40.2|34.09|28.13|25.83
183,5,0.4347,4.3469999999999995,3994.0,0.001084,0.996692,ADAM8 CSNK1G1 NGF SLFN13 SPINK7,regulation of proteolysis|positive regulation of fibronectin-dependent thymocyte migration|regulation of fibronectin-dependent thymocyte migration|negative regulation of neuron apoptotic process|positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,0.0004321|0.0004854|0.0004854|0.000492|0.000728,1|1|1|1|1,16.84|4119|4119|57.21|2060
184,6,0.4101,6.151,4862.0,0.00126,0.998474,ADAM9 BROX GPANK1 MMP16 PCDH20 TMEM14C,protein processing|regulation of tetrapyrrole biosynthetic process|regulation of heme biosynthetic process|regulation of tetrapyrrole metabolic process|positive regulation of macrophage fusion,0.001076|0.001165|0.001165|0.001456|0.001746,1|1|1|1|1,39.23|1144|1144|858.1|686.5
185,11,0.5872,32.29,7255.0,0.004418,0.999969,AFG3L2 CEP192 FAM210A NDC80 NDUFV2 PRELID3B SEH1L THOC1 TRIM37 TXNDC2 ZBTB14,attachment of mitotic spindle microtubules to kinetochore|attachment of spindle microtubules to kinetochore|mitotic spindle organization|mitotic prometaphase|microtubule cytoskeleton organization involved in mitosis,2.349e-05|7.72e-05|8.224e-05|8.671e-05|0.0001169,0.3706|0.6089|0.4324|0.3419|0.3686,312|162.8|34.25|33.63|30.36
186,7,0.4051,8.508,5704.0,0.001486,0.9992989999999999,ADAMTS10 COBL LYAR NOX4 PRSS12 SLC36A4 TYR,response to cAMP|response to organophosphorus|melanin biosynthetic process from tyrosine|collateral sprouting in absence of injury|proline import across plasma membrane,0.0004821|0.0009283|0.001019|0.001019|0.001019,1|1|1|1|1,60.04|42.95|1471|1471|1471
187,25,0.4068,122.0,19570.0,0.006181,1.0,ADAMTS12 ANXA2R C1QTNF3 C7 C9 CCL28 CDH10 CDH12 CDH6 CDH9 EXOC3 FBXO4 HCN1 ICE1 LMBRD2 NIM1K NNT OXCT1 PDZD2 PRLR SLC1A3 SLC45A2 TMEM267 UGT3A1 UGT3A2,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|adherens junction organization|cytolysis|cell-cell junction assembly|homophilic cell adhesion via plasma membrane adhesion molecules,2.649e-07|1.151e-06|1.095e-05|1.775e-05|5.041e-05,0.004179|0.009078|0.05756|0.06998|0.159,78.46|53.15|74.89|25.95|19.73
188,5,0.4408,4.408,3984.0,0.001102,0.996692,ADAMTS13 C17orf78 HRCT1 MICAL2 TRAF1,sulfur oxidation|positive regulation of transcription via serum response element binding|cellular response to tumor necrosis factor|response to tumor necrosis factor|actin filament depolymerization,0.000728|0.001213|0.001432|0.001767|0.003152,1|1|1|1|1,2060|1030|33.22|29.85|343.3
189,5,0.4283,4.283,4031.0,0.001059,0.996692,ADAMTS14 CHRM1 GPA33 SELP TEDDM1,phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway|positive regulation of platelet activation|saliva secretion|positive regulation of leukocyte tethering or rolling|adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway,0.0009706|0.001213|0.001456|0.002183|0.002183,1|1|1|1|1,1373|1030|823.8|514.9|514.9
190,7,0.4164,8.745,5949.0,0.001464,0.9992989999999999,ADAMTS16 CTGF FAM167A GABRG3 PKHD1 SLC30A3 ZNF429,branching morphogenesis of an epithelial tube|morphogenesis of a branching epithelium|zinc ion import into synaptic vesicle|zinc ion import into organelle|morphogenesis of a branching structure,0.000583|0.0008592|0.0008735|0.0008735|0.0009591,1|1|1|1|1,53.63|44.01|1716|1716|41.61
191,39,0.3534,261.8,31140.0,0.008317,1.0,ABHD12 AP5S1 APMAP AVP C20orf194 C20orf202 CDC25B CST1 CST11 CST2 CST3 CST4 CST5 CST7 CST8 CST9 CST9L CSTL1 HSPA12B LZTS3 MAVS OXT PLCB1 PLCB4 PRND PROKR2 PTPRA RASSF2 RSPO4 SIRPA SIRPB1 SIRPG SMOX SPEF1 TGM3 TGM6 TMEM239 ZNF337 ZNF343,negative regulation of endopeptidase activity|negative regulation of peptidase activity|negative regulation of proteolysis|regulation of endopeptidase activity|regulation of peptidase activity,3.129e-14|4.935e-14|1.489e-12|1.591e-11|3.275e-11,4.935e-10|3.892e-10|7.828e-09|6.274e-08|1.033e-07,25.86|24.85|18.42|14.95|14.02
192,6,0.4031,6.047000000000001,4798.0,0.001255,0.998474,ACRV1 ADAMTS19 FES NRXN1 OR5B12 RBM20,protein-containing complex assembly involved in synapse maturation|positive regulation of presynapse assembly|positive regulation of presynaptic active zone assembly|regulation of presynaptic active zone assembly|guanylate kinase-associated protein clustering,0.0005824|0.0008735|0.0008735|0.0008735|0.0008735,1|1|1|1|1,3432|1716|1716|1716|1716
193,25,0.3294,98.83,16770.0,0.005841,1.0,AMOTL2 CAB39 DIP2B DLG5 FAM49B FRMD6 FRYL KIRREL1 LATS2 MAP4K4 MOB4 NF2 NRP1 PDCD10 PKN2 PLXNA1 PPM1F PTPN14 RALGAPB RAP2B RNF146 SAV1 STK24 TAOK1 TAOK2,regulation of cell motility|regulation of locomotion|regulation of cellular component movement|regulation of cell migration|intracellular signal transduction,5.049e-10|8.335e-10|1.246e-09|4.161e-09|1.281e-08,7.965e-06|6.574e-06|6.553e-06|1.641e-05|4.042e-05,10.04|9.601|9.265|9.846|6.538
194,90,0.3988,1597.0,61610.0,0.0252,1.0,ACAD9 ATPAF2 C12orf65 CARS2 COA6 COA7 COQ4 COQ7 COX4I1 CYC1 DARS2 DDX28 DMAC1 ECSIT FASTKD5 FOXRED1 GFM2 GLRX5 GRSF1 GTPBP10 GTPBP8 IBA57 ISCA2 MALSU1 MCAT METTL17 MRM2 MRM3 MRPL1 MRPL41 MRPL50 MRPL58 MRRF MTERF3 MTERF4 MTFMT MTG1 MTIF2 MTIF3 MTO1 MTRF1L NDUFA10 NDUFA11 NDUFA2 NDUFA3 NDUFA5 NDUFA6 NDUFA8 NDUFA9 NDUFAF1 NDUFAF3 NDUFAF4 NDUFAF6 NDUFAF7 NDUFAF8 NDUFB10 NDUFB2 NDUFB3 NDUFB4 NDUFB5 NDUFB6 NDUFB7 NDUFB8 NDUFB9 NDUFC1 NDUFC2 NDUFS1 NDUFS2 NDUFS3 NDUFS5 NDUFS7 NDUFS8 NDUFV1 NDUFV2 NFU1 NGRN NOA1 NSUN4 NUBPL PET117 PTCD1 RMND1 RPUSD3 RTN4IP1 SSBP1 TFB1M TIMMDC1 TRUB2 UQCRC2 YBEY,"NADH dehydrogenase complex assembly|mitochondrial respiratory chain complex I assembly|mitochondrial respiratory chain complex assembly|ATP synthesis coupled electron transport|mitochondrial electron transport, NADH to ubiquinone",7.022e-68|7.022e-68|4.13e-64|1.554e-49|6.817e-48,1.108e-63|5.538e-64|2.171e-60|6.129e-46|2.151e-44,133.7|133.7|89.63|80.47|129.3
195,5,0.4453,4.453,3914.0,0.0011330000000000001,0.996692,ADAMTS4 CABS1 DGKQ TACC2 TRPM4,response to ATP|response to organophosphorus|positive regulation of atrial cardiac muscle cell action potential|positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization|response to purine-containing compound,2.795e-05|0.0004461|0.0004854|0.0004854|0.0005471,0.4409|1|1|1|1,249.6|60.13|4119|4119|54.2
196,25,0.3691,110.7,19980.0,0.005499,1.0,ADAMTS7 BNIP2 C15orf53 CHRNB4 CSNK1G1 CSPG4 DEXI DUOXA1 DUOXA2 EPB42 GOLGA6B IGDCC3 MAP2K5 MYO5C PLA2G4D PLA2G4E PLEKHO2 PPIB RAB8B SCAMP2 SLC24A1 SNURF SNX22 TGM5 UBE2Q2L,positive regulation of hydrogen peroxide biosynthetic process|regulation of thyroid hormone generation|positive regulation of hydrogen peroxide metabolic process|regulation of hydrogen peroxide biosynthetic process|phosphatidylinositol acyl-chain remodeling,2.953e-05|3.934e-05|5.054e-05|6.313e-05|0.0002646,0.4657|0.3103|0.2657|0.2489|0.8347,329.5|274.6|235.4|205.9|91.53
197,27,0.3346,117.4,21560.0,0.005404,1.0,ATP9A BCAS4 BMP7 CASS4 CNBD2 CTSZ EEF1A2 FAM209A FAM209B GGT7 GNAS MTRNR2L3 NPBWR2 OPRL1 PCK1 PHACTR3 PMEPA1 PPDPF RBM38 RIPOR3 SLC2A4RG STX16 TFAP2C WFDC11 WISP2 ZGPAT ZNF831,opioid receptor signaling pathway|negative regulation of molecular function|cellular response to glucagon stimulus|response to estradiol|response to organic cyclic compound,0.0001081|0.0006304|0.000702|0.0008115|0.0008729,1|1|1|1|1,152.6|4.56|54.48|16.58|5.166
198,9,0.4129,14.86,6125.0,0.002414,0.9998530000000001,ADCY6 AHR ANKMY2 ARNT DNAJA2 HSPA4 PTGES3 STIP1 TIPARP,"response to 2,3,7,8-tetrachlorodibenzodioxine|cellular response to forskolin|response to forskolin|xenobiotic metabolic process|cellular response to xenobiotic stimulus",2.542e-06|1.117e-05|1.117e-05|1.87e-05|2.099e-05,0.04009|0.08809|0.05873|0.07373|0.06622,1144|457.7|457.7|55.36|53.22
199,51,0.3787,482.9,40170.0,0.01185,1.0,PCDHA1 PCDHA10 PCDHA11 PCDHA12 PCDHA13 PCDHA2 PCDHA3 PCDHA4 PCDHA5 PCDHA6 PCDHA7 PCDHA8 PCDHA9 PCDHAC2 PCDHB10 PCDHB11 PCDHB12 PCDHB13 PCDHB14 PCDHB15 PCDHB16 PCDHB3 PCDHB4 PCDHB5 PCDHB6 PCDHB7 PCDHB8 PCDHGA1 PCDHGA10 PCDHGA11 PCDHGA12 PCDHGA2 PCDHGA3 PCDHGA4 PCDHGA5 PCDHGA6 PCDHGA7 PCDHGA8 PCDHGA9 PCDHGB1 PCDHGB2 PCDHGB3 PCDHGB4 PCDHGB6 PCDHGB7 PCDHGC3 PCDHGC4 PCDHGC5 SEPT8 SLC22A4 SLC22A5,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|cell-cell adhesion|cell adhesion|biological adhesion,5.118e-94|8.159e-86|1.941e-72|4.474e-60|6e-60,8.073e-90|6.435e-82|1.02e-68|1.764e-56|1.893e-56,116.1|74.84|37.71|20.38|20.25
200,6,0.4274,6.4110000000000005,4783.0,0.001335,0.998474,ADAMTSL3 ENTPD4 EVC SLC10A2 UTRN ZFP2,UDP catabolic process|pyrimidine ribonucleoside diphosphate catabolic process|pyrimidine nucleoside diphosphate catabolic process|GDP catabolic process|UDP metabolic process,0.0008735|0.0008735|0.0008735|0.0008735|0.001165,1|1|1|1|1,1716|1716|1716|1716|1144
201,11,0.8248,45.36,7322.0,0.006139,0.999969,ADAR EIF2AK2 IFNAR1 IFNAR2 IRF9 ISG15 JAK1 STAT1 STAT2 TYK2 USP18,type I interferon signaling pathway|cellular response to type I interferon|response to type I interferon|innate immune response|response to virus,4.787e-21|5.411e-21|1.092e-20|1.436e-13|4.44e-13,7.551e-17|4.267e-17|5.74e-17|5.662e-10|1.401e-09,247.8|244.2|224.7|22.29|48.63
202,7,0.4077,8.562000000000001,5775.0,0.001477,0.9992989999999999,ADARB1 BST2 COL18A1 EXTL2 IGIP PITPNM3 UTS2R,regulation of viral genome replication|hypoglossal nerve morphogenesis|hypoglossal nerve development|negative regulation of plasmacytoid dendritic cell cytokine production|regulation of plasmacytoid dendritic cell cytokine production,0.0003568|0.0006794|0.0006794|0.0006794|0.0006794,1|1|1|1|1,70.05|2942|2942|2942|2942
203,7,0.4014,8.43,5824.0,0.001442,0.9992989999999999,ADARB2 ARHGAP44 CNPY1 PDZRN3 QRICH2 TM4SF5 TNFSF13,"modification of dendritic spine|regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane|negative regulation of Rac protein signal transduction|negative regulation of filopodium assembly|regulation of endosome to plasma membrane protein transport",0.001019|0.001358|0.001358|0.002037|0.002037,1|1|1|1|1,1471|980.7|980.7|588.4|588.4
204,5,0.419,4.19,3795.0,0.0011,0.996692,ADAT1 MARC2 REXO4 SULT1C3 WASHC4,xenobiotic metabolic process|cellular response to xenobiotic stimulus|response to xenobiotic stimulus|nitrate metabolic process|detoxification of nitrogen compound,0.0003667|0.0003963|0.0004397|0.001213|0.001456,1|1|1|1|1,66.44|63.86|60.57|1030|823.8
205,17,0.4071,55.37,11100.0,0.004947999999999999,1.0,AASDHPPT ADAT2 ADAT3 CDIPT DNLZ DOLK FDXR HSCB MRE11 PGS1 PMVK PTPMT1 RTCB RTRAF TPI1 TRMT6 TRMT61A,tRNA processing|tRNA metabolic process|phospholipid biosynthetic process|primary metabolic process|cardiolipin biosynthetic process,2.038e-09|1.265e-08|9.402e-08|1.16e-07|1.453e-07,3.215e-05|9.976e-05|0.0004944|0.0004575|0.0004583,49.27|35.93|25.41|2.65|361.3
206,18,0.4093,62.62,12320.0,0.005044,1.0,ALG11 ARGLU1 BORA CDC16 CENPJ DIS3 EXOSC8 GTF3A MRPS31 MZT1 NUP58 PCID2 POMP RBM27 SKA3 TUBGCP3 USPL1 ZC3H13,microtubule nucleation|microtubule polymerization|microtubule polymerization or depolymerization|microtubule nucleation by microtubule organizing center|mitotic cell cycle,1.614e-06|4.627e-06|1.426e-05|1.509e-05|3.291e-05,0.02546|0.03649|0.07496|0.05949|0.1038,143|98.07|66.01|457.7|9.021
207,44,0.4568,432.2,30640.0,0.013869999999999999,1.0,H2AFX HIST1H1A HIST1H1B HIST1H1C HIST1H1D HIST1H1E HIST1H2AA HIST1H2AC HIST1H2AD HIST1H2AE HIST1H2AG HIST1H2AI HIST1H2AJ HIST1H2BA HIST1H2BB HIST1H2BC HIST1H2BD HIST1H2BE HIST1H2BF HIST1H2BG HIST1H2BH HIST1H2BI HIST1H2BJ HIST1H2BK HIST1H2BL HIST1H2BM HIST1H2BN HIST1H2BO HIST1H3A HIST1H3B HIST1H3C HIST1H3D HIST1H3F HIST1H3G HIST1H3H HIST1H3I HIST1H3J HIST1H4A HIST1H4E HIST1H4I HIST1H4L HIST2H2AC HIST2H2BE HIST2H2BF,"regulation of gene expression, epigenetic|chromatin organization|chromosome organization|chromatin organization involved in negative regulation of transcription|negative regulation of gene expression, epigenetic",2.5e-08|4.533e-08|3.678e-07|5.608e-07|5.824e-07,0.0003943|0.0003575|0.001934|0.002212|0.001837,96.35|29.55|19.41|160.5|158.4
208,6,0.4065,6.098,4578.0,0.001327,0.998474,ADCY3 LIG4 NHEJ1 RFFL SHLD1 XRCC4,double-strand break repair via nonhomologous end joining|non-recombinational repair|immunoglobulin V(D)J recombination|DNA ligation involved in DNA repair|establishment of integrated proviral latency,6.238e-07|8.125e-07|1.978e-06|2.543e-06|3.178e-06,0.00984|0.006408|0.0104|0.01003|0.01003,163.5|149.2|1144|980.7|858.1
209,49,0.3754,441.5,35940.0,0.0121,1.0,ADCY4 ANG BCL2L2 CARMIL3 CEBPE CHMP4A CIDEB CMA1 CMTM5 CTSG DHRS2 DHRS4 EDDM3A EDDM3B FITM1 GZMB GZMH IL25 LTB4R LTB4R2 MYH6 MYH7 OR10G2 OR10G3 OR11G2 OR11H4 OR11H6 OR4E2 OR4K13 OR4K17 OR4M2 OR4N4 OR4Q3 OR5AU1 OR6S1 RBM23 REC8 RNASE1 RNASE13 RNASE3 RNASE4 RNASE6 RNASE7 RNASE8 RNF212B SLC7A7 SLC7A8 TM9SF1 TSSK4,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,3.033e-11|6.209e-11|9.775e-11|2.303e-10|3.609e-10,4.785e-07|4.897e-07|5.14e-07|9.08e-07|1.139e-06,12.39|11.68|11.24|10.47|10.08
210,5,0.4486,4.486000000000001,4006.0,0.001116,0.996692,ADCY5 DCAF11 EPN2 HSD11B1 SELENOK,respiratory burst after phagocytosis|adenylate cyclase-inhibiting dopamine receptor signaling pathway|respiratory burst involved in defense response|foam cell differentiation|macrophage derived foam cell differentiation,0.0009706|0.001456|0.00194|0.00194|0.00194,1|1|1|1|1,1373|823.8|588.4|588.4|588.4
211,7,0.4092,8.593,5850.0,0.001463,0.9992989999999999,ADCY7 B4GALT2 CEP126 ITGA10 LYZL6 SLC28A1 ZNF821,cytidine transport|purine nucleobase transmembrane transport|pyrimidine nucleoside transport|uridine transport|pyrimidine nucleobase transport,0.0006794|0.001698|0.002037|0.002037|0.002037,1|1|1|1|1,2942|735.5|588.4|588.4|588.4
212,42,0.335,288.4,32310.0,0.008824,1.0,ADCY8 ARC ARHGAP39 C8orf33 C8orf82 CYP11B2 DENND3 FAM135B FBXL6 FOXH1 GLI4 GML GPIHBP1 GRINA GSDMC GSDMD KCNQ3 LRRC24 LY6D LY6E LY6K LYPD2 MAPK15 MROH6 NAPRT NRBP2 PLEC PPP1R16A PSCA RHPN1 SLURP2 TG TRAPPC9 TSNARE1 WISP1 ZFP41 ZNF16 ZNF250 ZNF34 ZNF623 ZNF696 ZNF707,regulation of long-term synaptic depression|regulation of signaling receptor activity|pyroptosis|regulation of neurotransmitter receptor activity|macromolecule metabolic process,0.0004765|0.0006918|0.0007506|0.0008142|0.002197,1|1|1|1|1,70.05|10.11|54.48|16.91|0.3167
213,10,0.512,23.04,6554.0,0.0034920000000000003,0.999933,CNOT1 CNOT10 CNOT11 EIF3K EIF3L EIF4E2 FAM193A GGNBP2 GIGYF2 GPBP1,gene silencing|regulation of translation|regulation of cellular amide metabolic process|mitotic G1 DNA damage checkpoint|mitotic G1/S transition checkpoint,5.519e-09|6.786e-09|1.742e-08|2.525e-08|2.675e-08,8.706e-05|5.352e-05|9.161e-05|9.958e-05|8.44e-05,68.65|33.58|28.6|124.8|123
214,25,0.3231,96.92,17220.0,0.00558,1.0,ARHGAP21 ARHGEF12 BTBD9 FLII GNA13 GRK2 LPAR2 LRRFIP2 LUZP1 MYH9 MYL12A MYL12B MYL6 MYO9A MYO9B PKN2 RHOA RHOC RIC8A ROCK1 ROCK2 S1PR2 SIAH1 TMOD3 UNC45A,Rho protein signal transduction|actin filament-based process|actomyosin structure organization|positive regulation of hydrolase activity|muscle contraction,1.579e-10|1.012e-09|3.275e-09|1.204e-08|1.413e-08,2.49e-06|7.983e-06|1.722e-05|4.747e-05|4.457e-05,81.03|13.78|47.53|10.6|23.73
215,6,0.4219,6.327999999999999,4912.0,0.001284,0.998474,ADGRA1 CD3E KRTAP10-3 LRRC3 SGSH TLX1,heparan sulfate proteoglycan catabolic process|positive regulation of T cell anergy|proteoglycan catabolic process|positive regulation of lymphocyte anergy|positive regulation of cell-cell adhesion mediated by integrin,0.001165|0.001456|0.001456|0.001456|0.002037,1|1|1|1|1,1144|858.1|858.1|858.1|572.1
216,5,0.4054,4.053999999999999,3893.0,0.001038,0.996692,ADGRB1 FYB2 NPFFR2 RPRML SEZ6L2,synapse maturation|positive regulation of myoblast fusion|engulfment of apoptotic cell|regulation of myoblast fusion|regulation of protein kinase C signaling,0.003152|0.003878|0.00412|0.004604|0.004604,1|1|1|1|1,343.3|274.6|257.4|228.8|228.8
217,7,0.414,8.693999999999999,5807.0,0.001491,0.9992989999999999,ADGRB2 HNRNPUL2 KCNE3 SIX5 STARD4 TEX35 WFDC5,negative regulation of membrane repolarization during cardiac muscle cell action potential|negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential|cholesterol transport involved in cholesterol storage|cholesterol storage|lipid transport involved in lipid storage,0.0006794|0.0006794|0.0006794|0.001019|0.001019,1|1|1|1|1,2942|2942|2942|1471|1471
218,7,0.4189,8.797,5729.0,0.001529,0.9992989999999999,ADGRB3 ANPEP B4GALNT4 CRYGN DENND6A PHYHIPL SH3BP2,motor learning|positive regulation of cell-cell adhesion mediated by cadherin|neuron remodeling|maintenance of synapse structure|regulation of cell-cell adhesion mediated by cadherin,0.002376|0.004071|0.004409|0.006777|0.007452,1|1|1|1|1,490.4|267.5|245.2|154.8|140.1
219,6,0.412,6.178999999999999,4813.0,0.001279,0.998474,ADGRD1 ALKAL2 DNAJB2 NID1 PUSL1 RHOD,cell-matrix adhesion|positive regulation of ERK5 cascade|regulation of ERK5 cascade|cell-substrate adhesion|negative regulation of protein deubiquitination,0.0005653|0.0008735|0.0008735|0.0012|0.001456,1|1|1|1|1,54.48|1716|1716|37.11|858.1
220,6,0.4136,6.202999999999999,5046.0,0.001225,0.998474,ADGRE1 ARNTL CD37 KHK PPFIA3 ZNF225,oxidative stress-induced premature senescence|fructose catabolic process|fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate|positive regulation of skeletal muscle cell differentiation|negative regulation of glucocorticoid receptor signaling pathway,0.001456|0.001746|0.001746|0.002037|0.002037,1|1|1|1|1,858.1|686.5|686.5|572.1|572.1
221,24,0.4058,112.0,16500.0,0.0067209999999999995,1.0,CCT3 COPA COPB2 EIF2S1 ETF1 PSMA1 PSMA2 PSMA3 PSMA4 PSMA5 PSMA6 PSMB3 PSMB4 PSMD4 RPL17 SARS SF3A1 SF3B4 SMU1 SNRNP200 SNRPD1 SNU13 SRP54 VCP,proteasomal ubiquitin-independent protein catabolic process|regulation of cellular amino acid metabolic process|S phase|pre-replicative complex assembly|mitotic S phase,7.695e-18|1.164e-16|1.164e-16|1.164e-16|1.164e-16,1.214e-13|9.179e-13|6.119e-13|4.59e-13|3.672e-13,299.6|114.1|114.1|114.1|114.1
222,31,0.3227,150.1,24810.0,0.005997,1.0,AGO1 AGO3 AGO4 BEST4 C1QB C1orf123 C1orf50 CCDC30 CFAP57 COL9A2 CYP4A11 CYP4A22 CYP4X1 CYP4Z1 ERMAP EXO5 FAM183A GJB4 LURAP1 MFSD2A MPL PCSK9 PPT1 RAB3C TMEM53 ZFP69 ZFP69B ZMYM4 ZNF606 ZNF684 ZNF691,"miRNA loading onto RISC involved in gene silencing by miRNA|RNA secondary structure unwinding|small RNA loading onto RISC|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation",3.309e-07|4.546e-07|6.055e-07|1.535e-06|1.535e-06,0.00522|0.003585|0.003184|0.006055|0.004844,294.2|257.4|228.8|158.4|158.4
223,21,0.3419,71.79,16550.0,0.004309,1.0,ATP12A C1QTNF9 C1QTNF9B CTAGE1 ENOX1 GJB2 GJB6 HTR2A KBTBD7 KCNRG N4BP2L1 PCDH8 POSTN RCBTB2 RNF6 SIAH3 SLC25A30 SOHLH2 SPATA13 WASF3 ZAR1L,gap junction-mediated intercellular transport|intercellular transport|gap junction assembly|cell communication by electrical coupling|negative regulation of potassium ion transport,2.757e-05|3.542e-05|4.425e-05|0.0002255|0.0005762,0.4349|0.2794|0.2327|0.8892|1,326.9|280.2|245.2|98.07|59.44
224,36,0.3118,196.5,28520.0,0.006823,1.0,ADGRF1 BAG2 CRISP1 CRISP2 DLK2 ENPP4 ENPP5 FBXO9 GFRAL GLYATL3 GSTA1 GSTA2 GSTA3 GSTA4 GSTA5 GUCA1A HCRTR2 IL17A IL17F KLHL31 LRRC1 LST1 MAPK13 MLIP MUT NCR3 OPN5 PAQR8 PGC PKHD1 RAB23 SPATS1 TFAP2B TFAP2D TMEM217 ZNF451,glutathione derivative biosynthetic process|glutathione derivative metabolic process|glutathione metabolic process|positive regulation of antimicrobial peptide production|regulation of antimicrobial peptide production,1.272e-07|1.272e-07|1.558e-07|4.427e-07|6.316e-07,0.002006|0.001003|0.000819|0.001746|0.001993,101.2|101.2|42.82|278.3|238.6
225,6,0.4205,6.307,4763.0,0.0013189999999999999,0.998474,ADGRF3 CASD1 CCDC66 GNPDA1 PPIL3 WDR27,glucosamine catabolic process|N-acetylglucosamine catabolic process|glucosamine metabolic process|N-acetylneuraminate catabolic process|regulation of protein localization to cilium,0.0008735|0.001165|0.001456|0.002037|0.002619,1|1|1|1|1,1716|1144|858.1|572.1|429.1
226,16,0.3829,45.95,12200.0,0.003742,0.999999,ALK ASCL1 GATA3 HAND2 IGF2BP1 INSM2 ISL1 LDAH LIN28B MAB21L1 MYT1 PDK1 PHOX2A PHOX2B SOX11 TFAP2B,sympathetic nervous system development|autonomic nervous system development|noradrenergic neuron differentiation|nervous system development|neuron differentiation,1.191e-16|1.759e-14|2.181e-13|2.139e-08|6.426e-08,1.878e-12|1.387e-10|1.147e-09|8.435e-05|0.0002027,381.4|170.4|817.3|6.272|10.02
227,29,0.3661,148.6,23130.0,0.006368,1.0,ADGRF1 CRISP1 CRISP2 ENPP4 ENPP5 FBXO9 GLYATL3 GSTA1 GSTA3 GSTA4 GUCA1A HCRTR2 IL17A IL17F KLHL31 LRRC73 MLIP MUT NCR2 PAQR8 PGC PKHD1 POLH RAB23 SPATS1 TFAP2D TMEM217 YIPF3 ZNF318,positive regulation of antimicrobial peptide production|regulation of antimicrobial peptide production|positive regulation of antimicrobial humoral response|regulation of antimicrobial humoral response|positive regulation of humoral immune response,2.088e-07|2.98e-07|2.98e-07|7.081e-07|4.344e-06,0.003293|0.00235|0.001567|0.002793|0.0137,355.1|304.4|304.4|213.1|106.5
228,29,0.3616,146.8,22110.0,0.0065780000000000005,1.0,ADGRG7 ALCAM ARL13B CCDC80 CD200R1 CD200R1L CDV3 CLDND1 IFT57 IMPG2 MAATS1 MTRNR2L8 NXPE3 OR5AC2 OR5H1 OR5H14 OR5H15 OR5H2 OR5H6 OR5K1 OR5K3 OR5K4 PROS1 SLC9C1 ST3GAL6 STX19 TAGLN3 TMPRSS7 ZPLD1,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,4.95e-09|8.213e-09|1.132e-08|2.076e-08|2.854e-08,7.809e-05|6.477e-05|5.952e-05|8.187e-05|9.004e-05,15.01|14.14|13.62|12.68|12.21
229,37,0.4053,269.9,24360.0,0.01093,1.0,AP3B1 AP3D1 ARL8B BLOC1S1 BORCS7 FNIP1 GDAP2 GNPTAB HTT KXD1 LAMTOR1 LAMTOR2 LAMTOR3 LAMTOR4 MIOS MTMR9 NPC1 NPC2 PSAP RAB7A RRAGA RRAGC SEH1L SNAPIN SPG21 TBC1D5 TMEM251 VPS16 VPS18 VPS26A VPS29 VPS33A VPS35 VPS39 VPS41 WDR24 WDR59,positive regulation of TOR signaling|lysosomal transport|vacuolar transport|cellular localization|regulation of TOR signaling,2.108e-20|3.992e-20|2.117e-18|4.984e-18|8.756e-17,3.326e-16|3.148e-16|1.113e-14|1.965e-14|2.762e-13,135.1|62.98|45.46|5.275|58.68
230,45,0.313,309.9,35420.0,0.008651,1.0,ADH1A ADH4 AFM AFP ALB AMBN ARL9 CFAP299 CXCL1 CXCL2 CXCL3 CXCL5 CXCL6 ENAM FAM47E FDCSP HERC3 HERC5 HNRNPDL HPSE HSD17B11 HTN3 KIT ODAPH PARM1 PDGFRA PF4 PF4V1 PPBP SEPT11 SLC9B2 SULT1B1 SULT1E1 THEGL TMEM150C TMPRSS11B TMPRSS11D TMPRSS11E UGT2A1 UGT2A3 UGT2B11 UGT2B15 UGT2B28 UGT2B4 UGT2B7,cellular glucuronidation|uronic acid metabolic process|glucuronate metabolic process|cellular hormone metabolic process|hormone metabolic process,1.266e-13|5.016e-13|5.016e-13|5.784e-13|9.022e-13,1.996e-09|3.956e-09|2.638e-09|2.281e-09|2.846e-09,161.4|127.8|127.8|33.97|24.85
231,5,0.4528,4.5280000000000005,3901.0,0.0011560000000000001,0.996692,ADGRL4 HEPHL1 NLGN1 STRA6 ZNF517,positive regulation of behavior|regulation of behavior|vitamin A import|vitamin A transport|cytoskeletal matrix organization at active zone,1.909e-05|0.0001131|0.0004854|0.0004854|0.0004854,0.3011|0.8918|1|1|1,305.1|121.1|4119|4119|4119
232,10,0.4168,18.75,8445.0,0.002211,0.999933,ACAP1 ADGRV1 CDH12 FER FST GAPT ITGA2 POU5F2 RAB3C ZNF33A,cell population proliferation|detection of mechanical stimulus involved in sensory perception|detection of mechanical stimulus|cell adhesion|biological adhesion,5.508e-05|0.0001324|0.0002993|0.0007693|0.0007877,0.8688|1|1|1|1,17.27|121.1|79.21|8.662|8.608
233,28,0.3926,148.4,22150.0,0.006639,1.0,ABCA8 ACSF2 C17orf47 CACNG4 CSH2 CSHL1 EFCAB3 EPX GDPD1 GH2 HOXB5 HOXB9 LIMD2 LPO METTL2B MKS1 MPO MRC2 MYCBPAP NME1 NME2 OR4D1 OR4D2 PLEKHM1 RNFT1 RSAD1 SCPEP1 SEPT4,response to growth hormone|growth hormone receptor signaling pathway|cellular response to growth hormone stimulus|hydrogen peroxide catabolic process|positive regulation of receptor signaling pathway via JAK-STAT,2.163e-07|3.898e-06|4.451e-06|1.083e-05|2.141e-05,0.003413|0.03074|0.0234|0.0427|0.06755,84.06|110.3|105.1|76.09|59.64
234,37,0.3749,249.7,29620.0,0.008339,1.0,AGAP5 AGAP6 AGAP9 ANKRD22 ANXA8L1 CALHM3 CFAP70 CYP2C9 DUPD1 DUSP13 DYDC1 FAM213A GPRIN2 IFIT1 IFIT1B IFIT5 LIPA LIPJ LIPM MAT1A NUTM2A NUTM2B PALD1 PPP3CB PTPN20 RASGEF1A SFTPA1 SFTPA2 SYNPO2L SYT15 WASHC2C ZNF22 ZNF239 ZNF32 ZNF33B ZNF37A ZNF485,peptidyl-tyrosine dephosphorylation|protein dephosphorylation|dephosphorylation|cellular response to type I interferon|response to type I interferon,4.411e-05|4.443e-05|0.000271|0.0002908|0.0003682,0.6958|0.3504|1|1|1,21|12.88|8.697|24.2|22.26
235,7,0.4125,8.663,5661.0,0.001524,0.9992989999999999,ADIPOQ BARX1 C18orf63 MICAL1 MPZL3 SPAG1 ZNF670,negative regulation of metanephros development|negative regulation of metanephric mesenchymal cell migration|positive regulation of renal albumin absorption|positive regulation of metanephric glomerular visceral epithelial cell development|regulation of metanephric glomerular visceral epithelial cell development,0.0006794|0.0006794|0.0006794|0.0006794|0.0006794,1|1|1|1|1,2942|2942|2942|2942|2942
236,6,0.4343,6.515,4499.0,0.001442,0.998474,ADIPOR1 DIAPH3 DNAJC5 MET MFAP3 SIM2,negative regulation of thrombin-activated receptor signaling pathway|regulation of thrombin-activated receptor signaling pathway|negative regulation of hydrogen peroxide-mediated programmed cell death|regulation of epithelial cell migration|negative regulation of guanyl-nucleotide exchange factor activity,0.001165|0.001165|0.001746|0.001854|0.002037,1|1|1|1|1,1144|1144|686.5|29.72|572.1
237,29,0.3336,135.5,20970.0,0.0064010000000000004,1.0,ADIPOR2 BCL6 CD19 CD79A CD79B CD81 CEPT1 CYB561A3 DMXL1 DOCK2 EBF1 EPS15L1 IKZF3 IRF8 ITSN2 LDLRAP1 MEF2B ODC1 PAX5 PIK3CD POU2AF1 POU2F2 RAC2 RASGRP3 SH3GL1 SLC38A1 SRM SYK TTC7A,leukocyte differentiation|lymphocyte activation|mononuclear cell differentiation|hemopoiesis|hematopoietic or lymphoid organ development,1.801e-12|5.274e-12|7.678e-12|1.29e-11|3.168e-11,2.842e-08|4.16e-08|4.037e-08|5.087e-08|9.994e-08,21.39|19.31|23.92|14.4|13.31
238,6,0.4267,6.401,4837.0,0.001318,0.998474,ADM5 EDAR LYG2 SENP1 SNCB SPHKAP,cell wall macromolecule catabolic process|cell wall organization or biogenesis|cell wall macromolecule metabolic process|salivary gland cavitation|tube lumen cavitation,0.0008735|0.001165|0.001165|0.001746|0.001746,1|1|1|1|1,1716|1144|1144|686.5|686.5
239,22,0.4015,92.74,17180.0,0.0053549999999999995,1.0,ADNP BCAS4 CEBPB CNBD2 EPPIN FAM209A FAM209B GGT7 GHRH LBP MAP1LC3A PABPC1L RBPJL RIPOR3 SERINC3 TFAP2C TMEM189 WFDC11 WFDC6 WISP2 YWHAB ZGPAT,defense response to bacterium|response to external stimulus|response to bacterium|acute-phase response|response to extracellular stimulus,0.0003847|0.0004393|0.0006668|0.0008702|0.001813,1|1|1|1|1,11.37|3.519|6.829|47.84|7.472
240,5,0.4528,4.5280000000000005,4079.0,0.001106,0.996692,ADNP2 CIDEA CLEC11A GDF9 STARD6,regulation of progesterone secretion|oocyte growth|regulation of lipid localization|regulation of transmembrane receptor protein serine/threonine kinase signaling pathway|regulation of female gonad development,0.000728|0.000728|0.0007545|0.001466|0.001698,1|1|1|1|1,2060|2060|46.02|32.82|686.5
241,13,0.4082,31.84,8412.0,0.003759,0.999993,ADPGK DERL1 GPI GSR NFE2L2 PGD PGP RPE SLC33A1 SLC35B4 SUCO TAPT1 TKT,glucose 6-phosphate metabolic process|monosaccharide metabolic process|pentose-phosphate shunt|generation of precursor metabolites and energy|pentose metabolic process,2.702e-09|1.035e-07|1.39e-07|1.524e-07|2.024e-07,4.262e-05|0.0008165|0.000731|0.0006009|0.0006386,245.2|40.86|339.5|21.96|294.2
242,16,0.4055,48.66,12820.0,0.003771,0.999999,ADPRHL2 AGO1 AGO3 AGO4 C1QB DCDC2B GJA4 GJB3 GJB4 GJB5 TMEM39B TSSK3 ZFP69 ZFP69B ZNF684 ZSCAN20,"miRNA loading onto RISC involved in gene silencing by miRNA|RNA secondary structure unwinding|small RNA loading onto RISC|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation",4.59e-08|6.309e-08|8.408e-08|2.136e-07|2.136e-07,0.0007241|0.0004976|0.0004421|0.0008424|0.0006739,551.7|482.7|429.1|297|297
243,5,0.4525,4.525,3783.0,0.001192,0.996692,ADPRM CYP4F22 NGB OR52K2 WIZ,positive regulation of nuclear cell cycle DNA replication|positive regulation of DNA-dependent DNA replication|regulation of nuclear cell cycle DNA replication|oxygen transport|gas transport,0.001698|0.003152|0.003636|0.003636|0.004845,1|1|1|1|1,686.5|343.3|294.2|294.2|216.8
244,53,0.3312,456.4,42370.0,0.01063,1.0,C5AR1 CGB7 ERVV-2 FFAR3 GP6 GPR32 KIR2DL1 KIR2DL3 KLK11 KLK3 KLK5 KLK6 LAIR1 LAIR2 LILRA4 LILRB2 LILRB5 NLRP11 NLRP4 NLRP9 RFPL4A RFPL4AL1 SIGLEC11 SIGLEC12 SIGLEC5 SIGLEC7 SIGLEC9 SULT2B1 VN1R4 ZFP28 ZNF175 ZNF28 ZNF320 ZNF415 ZNF432 ZNF528 ZNF534 ZNF571 ZNF577 ZNF578 ZNF581 ZNF587 ZNF610 ZNF613 ZNF614 ZNF665 ZNF667 ZNF677 ZNF701 ZNF808 ZNF813 ZNF880 ZSCAN5B,"regulation of gene expression|regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process",1.959e-09|1.191e-08|1.698e-07|1.708e-07|1.759e-07,3.091e-05|9.392e-05|0.0008929|0.0006736|0.0005549,2.613|3.475|2.811|2.81|2.806
245,7,0.4075,8.557,5915.0,0.001441,0.9992989999999999,ADRA1B ANKRD13D C8orf48 CSF1 F10 LARGE1 NR2C2,positive regulation of macrophage colony-stimulating factor signaling pathway|mammary gland fat development|positive regulation of odontogenesis of dentin-containing tooth|regulation of macrophage colony-stimulating factor signaling pathway|macrophage colony-stimulating factor signaling pathway,0.0007765|0.0007765|0.001164|0.001552|0.00194,1|1|1|1|1,2574|2574|1287|858.1|643.6
246,28,0.3805,143.8,20160.0,0.007065000000000001,1.0,B4GALT1 BEST3 CPM CPSF6 FAM3C FAM49A FGF8 FGFR4 FRS2 LFNG LRRC10 LYZ MDM2 MEGF10 MYCN MYOG NUP107 PAX3 PDK1 PTPRG RAB3IP RAP1B RUNX2 SLC35E3 SOX8 ST3GAL4 TCF12 ZBTB18,tissue development|anatomical structure development|muscle organ development|muscle structure development|developmental process,2.03e-07|1.195e-06|2.451e-06|2.958e-06|4.977e-06,0.003203|0.009429|0.01289|0.01166|0.0157,5.33|2.697|15.22|10.81|2.479
247,19,0.4094,70.0,12960.0,0.005357,1.0,ARHGAP21 ARHGAP29 ARHGEF12 BTBD9 GNA13 KCTD10 LPAR2 LRRFIP2 LUZP1 MYH9 MYL6 MYO9A MYO9B RHOA RHOC RIC8A ROCK1 ROCK2 TMOD3,Rho protein signal transduction|regulation of small GTPase mediated signal transduction|positive regulation of hydrolase activity|small GTPase mediated signal transduction|regulation of hydrolase activity,1.51e-13|5.842e-12|1.358e-11|5.211e-11|1.498e-10,2.382e-09|4.607e-08|7.142e-08|2.055e-07|4.725e-07,124.4|29.83|15.35|33.1|9.944
248,5,0.4472,4.4719999999999995,3861.0,0.0011539999999999999,0.996692,AEN HMGCLL1 LCA5 LRFN5 SLC38A6,leucine catabolic process|glutamine transport|leucine metabolic process|ketone body biosynthetic process|cellular ketone body metabolic process,0.001698|0.002183|0.002183|0.002425|0.00291,1|1|1|1|1,686.5|514.9|514.9|457.7|374.5
249,18,0.4021,61.52,13660.0,0.0044729999999999995,1.0,AES ATCAY CELF5 FUT3 FUT5 FUT6 GNA15 MUM1 PLIN3 SEMA6B SGTA SLC25A23 TNFSF14 UQCR11 ZNF554 ZNF555 ZNF556 ZNF77,fucosylation|oligosaccharide biosynthetic process|oligosaccharide metabolic process|fucose catabolic process|L-fucose catabolic process,6.315e-07|3.001e-06|2.586e-05|3.943e-05|3.943e-05,0.009961|0.02367|0.136|0.1555|0.1244,201.9|114.4|53.63|254.3|254.3
250,5,0.4062,4.062,3981.0,0.001017,0.996692,AFAP1 IDI1 MBOAT4 SPP2 XPA,peptidyl-serine octanoylation|protein octanoylation|dimethylallyl diphosphate metabolic process|dimethylallyl diphosphate biosynthetic process|nucleotide-excision repair involved in interstrand cross-link repair,0.0005824|0.0005824|0.0008735|0.0008735|0.0008735,1|1|1|1|1,3432|3432|1716|1716|1716
251,33,0.4037,213.2,26720.0,0.007895000000000001,1.0,AFAP1L2 ANKRD22 CALHM3 CYP26A1 CYP2C9 DUPD1 DUSP13 GOLGA7B GPRIN2 IFIT1 IFIT1B IFIT2 IFIT5 LIPA LIPF LIPJ LIPK LIPM MORN4 NUTM2A NUTM2B OPN4 PNLIP PPP3CB PTPN20 SAMD8 SEMA4G SFTPA1 SFTPA2 SORCS1 SYT15 ZNF239 ZNF33B,lipid catabolic process|cellular response to type I interferon|response to type I interferon|lipid metabolic process|type I interferon signaling pathway,5.051e-07|5.464e-06|7.492e-06|9.748e-05|0.000198,0.007967|0.0431|0.03939|0.3844|0.6245,14.37|36.18|33.28|4.596|27.53
252,11,0.4123,22.68,8638.0,0.002612,0.999969,CDK18 CHIT1 HHAT IGFN1 PEF1 REN RGS18 RGS2 RGS21 TMEM81 TROVE2,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway|negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process|regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process|negative regulation of glycine import across plasma membrane|regulation of glycine import across plasma membrane,0.001067|0.001067|0.001067|0.001601|0.001601,1|1|1|1|1,1872|1872|1872|936.1|936.1
253,17,0.5438,73.96,11030.0,0.006640999999999999,1.0,CCDC134 CNPY2 CPD FURIN HSP90B1 IGF1R INSR IRS1 IRS2 KBTBD2 OST4 OSTC PTEN SSR1 SSR2 SSR3 STT3A,response to endogenous stimulus|phosphatidylinositol-mediated signaling|cellular response to hormone stimulus|inositol lipid-mediated signaling|response to hormone,1.579e-08|1.658e-08|1.764e-08|2.087e-08|2.589e-08,0.0002491|0.0001307|9.273e-05|8.229e-05|8.168e-05,7.999|63.56|15.75|60.57|11.48
254,17,0.4118,56.01,12610.0,0.00441,1.0,AAGAB AFTPH AGFG1 AP1B1 AP1G1 AP1M1 AP1M2 AP1S1 AP2B1 HEATR5B RAB11A RAB14 SCYL2 SYNRG TBC1D14 TBCK VIPAS39,intracellular transport|protein transport|peptide transport|amide transport|establishment of protein localization,1.067e-17|7.556e-16|1.01e-15|1.409e-15|1.914e-15,1.684e-13|5.959e-12|5.309e-12|5.555e-12|6.038e-12,12.93|12.42|12.18|11.91|11.66
255,5,0.4304,4.303999999999999,3926.0,0.001092,0.996692,AGAP1 ATP1B2 PHACTR3 SLC51B TXNL1,neuronal-glial interaction involved in hindbrain glial-mediated radial cell migration|positive regulation of sodium ion export across plasma membrane|regulation of sodium ion export across plasma membrane|third ventricle development|negative regulation of glial cell migration,0.0004854|0.001213|0.001213|0.001213|0.001456,1|1|1|1|1,4119|1030|1030|1030|823.8
256,6,0.4231,6.346,4732.0,0.001336,0.998474,AGAP3 C8orf86 CD302 GMPPB SLC46A2 SOCS2,positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway|regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway|GDP-mannose biosynthetic process|positive regulation of nucleotide-binding oligomerization domain containing signaling pathway|GDP-mannose metabolic process,0.001165|0.001456|0.001746|0.002037|0.002619,1|1|1|1|1,1144|858.1|686.5|572.1|429.1
257,14,0.734,66.8,11270.0,0.005878,0.9999969999999999,ATOH1 C7orf33 CHRM2 CTLA4 IK IL33 KIAA0319 KIAA0586 LLCFC1 MLF2 MMP27 PRR9 SLC44A5 TBC1D1,positive regulation of inner ear receptor cell differentiation|regulation of CD86 production|positive regulation of CD86 production|regulation of CD80 production|auditory receptor cell fate specification,0.001358|0.001358|0.001358|0.001358|0.001358,1|1|1|1|1,1471|1471|1471|1471|1471
258,16,0.4083,49.0,12670.0,0.003843,0.999999,C6orf203 COL19A1 ENPP1 ENPP3 FAM135A GABRR1 KHDC1L LGSN TAAR1 TAAR2 TAAR6 TAAR8 TCF21 ULBP3 VNN2 WISP3,nucleoside triphosphate catabolic process|negative regulation of hh target transcription factor activity|water-soluble vitamin metabolic process|nucleoside phosphate catabolic process|G protein-coupled receptor signaling pathway,5.898e-05|0.001455|0.001705|0.001705|0.001958,0.9304|1|1|1|1,196.1|1373|33.08|33.08|5.166
259,6,0.4369,6.553999999999999,4844.0,0.001348,0.998474,AGBL5 CD81 FAM177B PBK SLC25A15 ZNF214,"positive regulation of adaptive immune memory response|CD4-positive, alpha-beta T cell costimulation|protein branching point deglutamylation|positive regulation of 1-phosphatidylinositol 4-kinase activity|regulation of 1-phosphatidylinositol 4-kinase activity",0.0005824|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,3432|3432|3432|3432|3432
260,20,0.403,76.56,15300.0,0.004967,1.0,AGER AIF1 BTN2A2 C6orf48 HLA-A HLA-DMB HLA-F LY6G6F MCCD1 MICB MSH5 NEU1 NUDT3 OR14J1 OR2J3 PSORS1C2 STK19 TAPBP TRIM10 TRIM26,immune response|regulation of T cell proliferation|antigen processing and presentation of endogenous peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen|regulation of lymphocyte proliferation,4.687e-07|6.158e-07|8.809e-07|1.188e-06|2.286e-06,0.007393|0.004857|0.004632|0.004687|0.007213,5.744|29.93|181.7|162.6|22.78
261,6,0.4189,6.284,4852.0,0.0012900000000000001,0.998474,AGFG2 APLNR FAM71F2 ITGBL1 SOHLH2 SOX1,positive regulation of inhibitory G protein-coupled receptor phosphorylation|regulation of inhibitory G protein-coupled receptor phosphorylation|apelin receptor signaling pathway|ventral spinal cord interneuron specification|cell fate specification involved in pattern specification,0.0005824|0.0005824|0.001165|0.002328|0.002328,1|1|1|1|1,3432|3432|1144|490.4|490.4
262,21,0.4066,85.38,15090.0,0.005612,1.0,AHCTF1 C1orf131 COG2 DDX59 DTL EPRS EXOC8 GGPS1 GUK1 HEATR1 IARS2 INTS7 NUP133 NVL RRP15 SDE2 SRP9 TBCE TOMM20 URB2 UTP25,ncRNA metabolic process|gene expression|nuclear pore organization|ribosome biogenesis|isoprenoid biosynthetic process,7.418e-06|9.714e-05|0.0001064|0.0002732|0.0004088,0.117|0.7662|0.5596|1|1,11.95|4.24|147.1|12.41|71.02
263,16,0.4014,48.17,10730.0,0.004458,0.999999,AGK CIAO1 CIAO2B FDX2 FDXR FXN HSCB LYRM4 SLC25A28 SLC25A37 STARD7 STOML2 TIMM10 TIMM22 TIMM29 TIMM9,protein insertion into mitochondrial inner membrane|mitochondrial transport|metallo-sulfur cluster assembly|iron-sulfur cluster assembly|protein insertion into mitochondrial membrane,6.128e-13|3.229e-12|1.372e-11|1.372e-11|1.657e-11,9.667e-09|2.546e-08|7.211e-08|5.409e-08|5.226e-08,585.1|44.97|279.8|279.8|268.2
264,6,0.4021,6.032,4983.0,0.001206,0.998474,AGL CAPZA3 DCAF11 NYAP2 RNF222 SEC24D,antigen processing and presentation of exogenous peptide antigen via MHC class II|antigen processing and presentation of peptide antigen via MHC class II|antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|antigen processing and presentation of exogenous peptide antigen|antigen processing and presentation of exogenous antigen,0.0003524|0.0003665|0.0003737|0.001113|0.001213,1|1|1|1|1,69.34|67.97|67.3|38.57|36.91
265,5,0.411,4.11,4006.0,0.0010220000000000001,0.996692,AGMAT P2RY12 SPOCK3 SPTSSB TRMT44,"putrescine biosynthetic process from arginine, using agmatinase|putrescine biosynthetic process from arginine|cytosolic calcium signaling involved in initiation of cell movement in glial-mediated radial cell migration|initiation of movement involved in cerebral cortex radial glia guided migration|positive regulation of integrin activation by cell surface receptor linked signal transduction",0.0004854|0.0004854|0.0004854|0.0004854|0.000728,1|1|1|1|1,4119|4119|4119|4119|2060
266,5,0.4296,4.296,3844.0,0.001113,0.996692,AGMO OR2B11 SERINC3 UGT8 ZNF814,membrane lipid metabolic process|sphingolipid metabolic process|protein localization to paranode region of axon|cellular lipid metabolic process|galactolipid biosynthetic process,1.073e-05|0.0006201|0.0009706|0.0009926|0.001698,0.1693|1|1|1|1,58.84|50.85|1373|12.67|686.5
267,8,0.7664,21.46,5659.0,0.0037670000000000004,0.9996790000000001,AGO2 ANKRD52 DGCR8 DICER1 DROSHA TARBP2 TNRC6A XPO5,gene silencing by miRNA|post-transcriptional gene silencing by RNA|posttranscriptional gene silencing|miRNA metabolic process|gene silencing by RNA,5.187e-18|1.779e-17|3.062e-17|7.794e-17|2.612e-16,8.182e-14|1.403e-13|1.61e-13|3.074e-13|8.24e-13,375.4|310.7|286|735.5|207.1
268,33,0.3995,210.9,20960.0,0.00993,1.0,ARFRP1 ARL1 CLEC16A COG1 COG2 COG3 COG4 COG5 COG6 COG7 COG8 EIPR1 GET4 GPR107 PTAR1 RAB1A RAB1B RAB2A RAB6A RGP1 RIC1 SLC10A7 SLC39A9 SYS1 TM9SF3 TRAPPC1 TRAPPC13 UNC50 VPS51 VPS52 VPS53 VPS54 YKT6,Golgi vesicle transport|intracellular transport|establishment of protein localization|protein transport|vesicle-mediated transport,8.435e-26|1.173e-21|2.975e-21|2.108e-20|2.635e-20,1.331e-21|9.254e-18|1.564e-17|8.315e-17|8.312e-17,30.59|10.1|9.72|9.937|8.043
269,6,0.4071,6.106,4767.0,0.001276,0.998474,ADGRG1 AGPAT3 ASIP MLF1 PAQR9 PTTG1IP,"regulation of molecular function, epigenetic|cerebral cortex regionalization|myeloid progenitor cell differentiation|positive regulation of secondary metabolite biosynthetic process|positive regulation of melanin biosynthetic process",0.0008735|0.002037|0.002037|0.002328|0.002328,1|1|1|1|1,1716|572.1|572.1|490.4|490.4
270,15,0.4011,42.12,11150.0,0.0037549999999999997,0.999999,ARMS2 CFAP53 ISL2 KIF22 LHX3 LRP8 MAN1A2 MGAT1 NEUROD1 NLK OTP OTX2 PRDX6 SCLY STMN1,central nervous system development|neuron differentiation|ventral spinal cord development|forebrain development|brain development,4.757e-06|6.053e-06|6.498e-06|8.169e-06|1.343e-05,0.07504|0.04774|0.03417|0.03221|0.04237,9.092|8.765|85.81|16.94|10.37
271,6,0.4344,6.517,4713.0,0.001377,0.998474,AGRN ATP5MPL CTAGE15 DCLRE1C HES4 XCR1,positive regulation of synaptic growth at neuromuscular junction|positive regulation of neuromuscular junction development|regulation of synaptic growth at neuromuscular junction|clustering of voltage-gated sodium channels|protection from non-homologous end joining at telomere,0.0005824|0.0008735|0.001746|0.002037|0.002328,1|1|1|1|1,3432|1716|686.5|572.1|490.4
272,9,0.405,14.58,6971.0,0.002082,0.9998530000000001,AGT CCDC71 FAM71A GNAT1 HYAL1 ITIH4 PFKFB4 TDRD10 TRANK1,hyaluronan metabolic process|sulfur compound catabolic process|positive regulation of membrane hyperpolarization|negative regulation of hydrolase activity|mucopolysaccharide metabolic process,0.0001251|0.0003336|0.0009704|0.001165|0.001258,1|1|1|1|1,124.8|74.89|2060|13.58|37.79
273,20,0.4002,76.05,15300.0,0.004933,1.0,AIF1 ATAT1 BTN2A2 C6orf48 CLIC1 HLA-A HLA-DMB HLA-DPB1 HLA-F MICB MSH5 NEU1 NUDT3 OR14J1 OR2J3 PSORS1C2 TAPBP TNXB TRIM10 TRIM26,cellular response to interferon-gamma|immune response|regulation of T cell proliferation|antigen processing and presentation of exogenous peptide antigen|response to interferon-gamma,4.093e-07|4.687e-07|6.158e-07|7.262e-07|7.87e-07,0.006457|0.003697|0.003238|0.002864|0.002483,32.59|5.744|29.93|28.93|28.45
274,13,0.419,32.69,7902.0,0.004106,0.999993,BRAF DUSP4 DUSP6 ELAVL1 GRB2 MAP2K1 MAP2K2 MAPK1 PEA15 PTPN11 SHOC2 SOX10 SOX9,MAPK cascade|positive regulation of intracellular signal transduction|regulation of MAPK cascade|regulation of intracellular signal transduction|regulation of MAP kinase activity,3.551e-13|2.215e-11|3.763e-11|1.277e-10|2.958e-10,5.601e-09|1.747e-07|1.979e-07|5.036e-07|9.333e-07,34.86|15.61|20.54|9.857|35.89
275,11,0.4118,22.65,7088.0,0.003175,0.999969,AHCYL1 DHODH FAM13B KIDINS220 MAPK6 MAPKAPK5 PPCDC SLC20A1 SLC4A2 SLC4A7 XPR1,inorganic anion transport|phosphate ion transmembrane transport|phosphate ion transport|anion transmembrane transport|bicarbonate transport,1.164e-06|3.508e-05|5.95e-05|7.263e-05|0.0002421,0.01836|0.2767|0.3128|0.2864|0.7638,47.4|249.6|187.2|16.35|89.16
276,7,0.9996,20.99,4168.0,0.004994,0.999333,GID8 MAEA RANBP9 RMND5A UBE2H WDR26 YPEL5,proteasome-mediated ubiquitin-dependent protein catabolic process|proteasomal protein catabolic process|ubiquitin-dependent protein catabolic process|modification-dependent protein catabolic process|modification-dependent macromolecule catabolic process,4.147e-06|5.369e-06|2.939e-05|3.093e-05|3.345e-05,0.06542|0.04235|0.1545|0.122|0.1055,31.88|29.85|19.32|19.07|18.69
277,31,0.3753,174.5,19830.0,0.008695999999999999,1.0,ARHGEF7 BCAR1 BCAR3 CD151 CRK CRKL DOCK5 ELMO2 FERMT1 FERMT2 ILK ITGA3 ITGAV ITGB1 ITGB5 LIMS1 MYO10 NCKAP1 PTK2 PTPN12 PXN RAC1 RAPGEF1 RAPH1 RSU1 SRC TLN1 TNS3 TRIO VCL YES1,regulation of cell-substrate adhesion|cell-matrix adhesion|enzyme linked receptor protein signaling pathway|integrin-mediated signaling pathway|cell surface receptor signaling pathway,7.359e-20|6.254e-19|1.161e-18|4.145e-18|4.324e-18,1.161e-15|4.932e-15|6.105e-15|1.635e-14|1.364e-14,42.86|63.27|16.47|74.57|6.681
278,6,0.4028,6.041,4997.0,0.0012050000000000001,0.998474,AHRR CHP2 FZD10 KCTD3 KIAA0556 STATH,non-canonical Wnt signaling pathway via JNK cascade|saliva secretion|non-canonical Wnt signaling pathway via MAPK cascade|cerebrospinal fluid circulation|secretion by tissue,0.001746|0.001746|0.002037|0.0032|0.005232,1|1|1|1|1,686.5|686.5|572.1|343.2|201.9
279,10,0.4002,18.01,6693.0,0.002675,0.999933,AHR AHSA1 ARNT DNAJA2 HSF1 HSP90AA1 HSPA4 STIP1 TIPARP USP19,"outer mitochondrial membrane organization|protein insertion into mitochondrial outer membrane|response to 2,3,7,8-tetrachlorodibenzodioxine|response to heat|protein refolding",3.177e-06|3.177e-06|3.177e-06|1.26e-05|4.43e-05,0.05011|0.02505|0.0167|0.04968|0.1398,1030|1030|1030|64.36|216.8
280,6,0.4314,6.472,4850.0,0.0013289999999999999,0.998474,AHSG FTCD MYOM3 PLXNA2 TMEM238 TUBB3,cerebellar granule cell precursor tangential migration|hindbrain tangential cell migration|formamide metabolic process|histidine catabolic process to glutamate and formate|histidine catabolic process to glutamate and formamide,0.0008735|0.001165|0.001456|0.001456|0.001456,1|1|1|1|1,1716|1144|858.1|858.1|858.1
281,18,0.384,58.75,12010.0,0.004852,1.0,AMOTL2 CAB39 CCM2 FRYL ITGB1BP1 KIRREL1 KRIT1 LATS2 MAP3K2 MAP4K4 NF2 PDCD10 PTPN14 RALGAPB RNF146 STK24 TAOK1 TLNRD1,intracellular signal transduction|regulation of protein kinase activity|regulation of kinase activity|regulation of transferase activity|negative regulation of cell migration,1.038e-08|1.615e-07|4.337e-07|1.08e-06|2.871e-06,0.0001637|0.001273|0.002281|0.004261|0.009056,7.991|11.48|10.08|8.93|21.43
282,11,0.4123,22.68,7582.0,0.002973,0.999969,ATXN10 EIF3D PES1 RPL3 RRP7A SAMM50 SF3A1 TFIP11 THOC5 TOMM22 TUBGCP6,ribonucleoprotein complex subunit organization|cellular protein-containing complex assembly|ribonucleoprotein complex assembly|ribonucleoprotein complex biogenesis|RNA processing,3.794e-08|2.073e-06|2.387e-06|2.493e-06|3.142e-06,0.0005985|0.01635|0.01255|0.00983|0.009911,47.52|13.08|39.42|20.13|12.17
283,11,0.5444,29.94,6932.0,0.004287,0.999969,ATM CDKN1A CHEK2 DCLRE1B MDM2 MDM4 PPM1D PPM1G TP53 UBE2D3 USP28,"signal transduction by p53 class mediator|DNA damage response, signal transduction by p53 class mediator|cell cycle checkpoint|signal transduction in response to DNA damage|cellular response to DNA damage stimulus",2.535e-16|5.595e-15|9.742e-15|3.091e-14|7.534e-14,3.998e-12|4.413e-11|5.122e-11|1.219e-10|2.377e-10,126.9|165.9|79.25|128.5|23.79
284,6,0.4121,6.182,4830.0,0.001275,0.998474,AJM1 BICDL2 GPR149 IL32 MMP25 PGC,collagen catabolic process|collagen metabolic process|negative regulation of ovulation|Golgi to secretory granule transport|positive regulation of type III interferon production,9.729e-05|0.0001914|0.0006794|0.001019|0.001019,1|1|1|1|1,136.8|96.46|2942|1471|1471
285,7,0.4194,8.807,6032.0,0.0014550000000000001,0.9992989999999999,AK1 IFI6 KLHL26 MYO5C RIPOR1 SLC2A12 TYMP,nucleoside monophosphate metabolic process|negative regulation of Rho guanyl-nucleotide exchange factor activity|dTMP catabolic process|dTMP metabolic process|ADP biosynthetic process,0.0003011|0.001019|0.001358|0.002037|0.002037,1|1|1|1|1,76.42|1471|980.7|588.4|588.4
286,50,0.4025,493.1,38970.0,0.012459999999999999,1.0,ADAP2 ALDOC AOC2 C17orf50 C17orf75 CCL13 CCL2 CCL7 DHRS11 EPOP EVI2A GAS2L2 GSDMA GSDMB HAP1 KRT12 KRT15 KRT16 KRT19 KRT20 KRT23 KRT24 KRT25 KRT26 KRT27 KRT28 KRT31 KRT33A KRT33B KRT40 KRTAP1-4 KRTAP1-5 KRTAP3-1 KRTAP3-2 KRTAP4-11 KRTAP4-2 KRTAP4-3 KRTAP4-4 KRTAP4-8 KRTAP4-9 KRTAP9-8 KRTAP9-9 LGALS9 LYRM9 RDM1 SLC13A2 SLFN12 SLFN14 SPAG5 UNC119,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,2.135e-38|1.587e-36|1.048e-34|1.426e-32|1.26e-31,3.368e-34|1.252e-32|5.508e-31|5.623e-29|3.975e-28,47.32|39.9|33.84|27.92|25.64
287,6,0.4117,6.175,4955.0,0.001242,0.998474,AK5 ASCC2 CREB5 DCLK2 MB UVSSA,dADP biosynthetic process|slow-twitch skeletal muscle fiber contraction|purine deoxyribonucleoside diphosphate biosynthetic process|voluntary skeletal muscle contraction|dADP metabolic process,0.0005824|0.0008735|0.0008735|0.001165|0.001165,1|1|1|1|1,3432|1716|1716|1144|1144
288,24,0.3592,99.14,16300.0,0.006027,1.0,AK6 C18orf21 C1D DHX33 EXOSC1 EXOSC10 HEATR1 IMP3 METAP1 METAP2 NEPRO NOC4L NOL6 NOP9 PARN POP1 POP4 POP5 POP7 RPP14 RPP38 RPP40 WDR43 WDR75,ncRNA processing|ncRNA metabolic process|rRNA processing|rRNA metabolic process|ribosome biogenesis,1.196e-24|2.758e-23|3.466e-22|5.975e-22|1.187e-20,1.887e-20|2.175e-19|1.823e-18|2.356e-18|3.745e-17,33|27.58|45.7|44.01|35.79
289,17,0.4018,54.65,13540.0,0.004009,1.0,AK7 APOPT1 BAG5 CEP170B CRIP1 GPR68 IFI27 MOK PPP1R13B PPP4R4 SERPINA11 SERPINA12 SERPINA3 SERPINA4 TMEM121 UBR7 ZBTB42,negative regulation of proteolysis|negative regulation of hydrolase activity|negative regulation of catalytic activity|negative regulation of endopeptidase activity|negative regulation of peptidase activity,5.068e-06|1.931e-05|2.213e-05|3.376e-05|3.937e-05,0.07994|0.1523|0.1164|0.1331|0.1242,18.71|14.14|9.488|21.02|20.19
290,6,0.4114,6.171,4916.0,0.001251,0.998474,AK9 PCSK1 RIPOR2 SAMD14 TMEM198 TSPOAP1,AMP phosphorylation|CDP phosphorylation|dAMP phosphorylation|CMP phosphorylation|dCMP phosphorylation,0.0005824|0.0005824|0.0005824|0.0005824|0.0005824,1|0.6562|0.7067|0.7656|0.8352,3432|3432|3432|3432|3432
291,28,0.4018,151.9,17820.0,0.008426000000000001,1.0,AP3B1 AP3D1 ARFRP1 ARL1 COG1 COG3 COG4 COG5 COG6 COG7 EIPR1 HTT PTAR1 RAB14 RAB1B RAB6A RGP1 RIC1 SYS1 UNC50 VIPAS39 VPS26A VPS33B VPS50 VPS51 VPS52 VPS53 VPS54,intracellular transport|establishment of localization in cell|protein transport|peptide transport|amide transport,7.727e-28|1.918e-24|2.365e-24|3.818e-24|6.618e-24,1.219e-23|1.513e-20|1.243e-20|1.506e-20|2.088e-20,12.37|8.128|11.73|11.5|11.25
292,6,0.4331,6.496,5077.0,0.001275,0.998474,AKAP13 LGALS4 PEX11G RGS9BP SOSTDC1 XPA,negative regulation of determination of dorsal identity|nucleotide-excision repair involved in interstrand cross-link repair|regulation of peroxisome size|mammary gland bud morphogenesis|regulation of determination of dorsal identity,0.0008735|0.0008735|0.001165|0.001165|0.001456,1|1|1|1|1,1716|1716|1144|1144|858.1
293,6,0.4201,6.301,4828.0,0.0013,0.998474,AKAP3 BAG2 CCDC113 GCM1 KIAA1024L MT1M,detoxification of copper ion|stress response to copper ion|detoxification of inorganic compound|stress response to metal ion|cellular response to zinc ion,1.079e-05|1.079e-05|1.34e-05|1.481e-05|2.473e-05,0.1703|0.08513|0.07046|0.0584|0.07803,429.1|429.1|381.4|361.3|274.6
294,7,0.4012,8.424,5624.0,0.001492,0.9992989999999999,AKAP6 B2M CEBPG HMX3 KIF13A TRIM25 ZNFX1,"interferon-gamma-mediated signaling pathway|response to estrogen|antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent|cellular response to iron(III) ion|positive regulation of transferrin receptor binding",0.0003514|0.0004106|0.0007765|0.001164|0.001164,1|1|1|1|1,71.51|66.01|2574|1287|1287
295,7,0.4266,8.959,5644.0,0.0015810000000000002,0.9992989999999999,AKAP7 C1QB EPS15 ONECUT3 RPS6KA1 SLC9A1 SMPD2,positive regulation of biological process|positive regulation of ion transmembrane transporter activity|positive regulation of transporter activity|intracellular signal transduction|positive regulation of calcium:sodium antiporter activity,0.0002362|0.0005725|0.0006704|0.0009964|0.001019,1|1|1|1|1,3.298|54.99|50.73|7.472|1471
296,24,0.4007,110.6,19100.0,0.005742000000000001,1.0,BCAS4 CASS4 CNBD2 EPPIN FAM209A FAM209B GGT7 LBP MAP1LC3A MTRNR2L3 MYH7B NPBWR2 OPRL1 PMEPA1 R3HDML RBM38 RBPJL RIPOR3 SLC2A4RG TFAP2C WFDC11 WFDC6 WISP2 ZGPAT,opioid receptor signaling pathway|negative regulation of molecular function|negative regulation of calcium ion transport|positive regulation of cytolysis|organic substance metabolic process,7.803e-05|0.001488|0.002093|0.00223|0.002276,1|1|1|1|1,179.1|4.588|30.35|895.4|0.2273
297,25,0.5455,163.7,16980.0,0.00952,1.0,CCDC77 CCP110 CENPJ CEP120 CEP135 CEP152 CEP295 CEP41 CEP44 MIIP PCM1 PCNT PLK4 POC1A PPP1R35 RTTN SASS6 SPICE1 STIL TBC1D31 TEDC1 TEDC2 TUBD1 TUBE1 WRAP73,centrosome cycle|microtubule organizing center organization|centrosome duplication|microtubule cytoskeleton organization|centriole replication,2.076e-24|9.703e-24|2.667e-21|3.287e-21|3.042e-20,3.275e-20|7.653e-20|1.402e-17|1.296e-17|9.596e-17,121.7|107.1|235.4|24.74|322.4
298,11,0.4198,23.09,7510.0,0.0030559999999999997,0.999969,AKIRIN1 DDI2 INAFM1 NFE2L1 NGLY1 PLAA RAD23B UBB UBC USP14 USP15,proteolysis involved in cellular protein catabolic process|cellular protein catabolic process|protein catabolic process|cellular macromolecule catabolic process|macromolecule catabolic process,7.948e-11|1.214e-10|2.319e-10|2.243e-09|6.564e-09,1.254e-06|9.575e-07|1.219e-06|8.846e-06|2.071e-05,25.13|23.81|21.93|16.42|14.32
299,12,0.3944,26.03,9274.0,0.002791,0.999986,ABCC9 AKR1C1 AKR1C2 AKR1C3 AKR1C4 AKR1E2 CALML3 CALML5 CHAC1 FAM208B ITIH2 NET1,cellular response to jasmonic acid stimulus|response to jasmonic acid|doxorubicin metabolic process|daunorubicin metabolic process|polyketide metabolic process,9.31e-12|9.31e-12|9.491e-11|9.491e-11|9.491e-11,1.469e-07|7.343e-08|4.991e-07|3.743e-07|2.994e-07,1471|1471|653.8|653.8|653.8
300,5,0.4225,4.225,3807.0,0.001106,0.996692,ACY3 AKR7A2 SLC13A1 TIMM8B TNFAIP8L2,organic heteropentacyclic compound metabolic process|mycotoxin metabolic process|aflatoxin metabolic process|toxin metabolic process|secondary metabolic process,7.2e-06|7.2e-06|7.2e-06|1.909e-05|8.02e-05,0.1136|0.05679|0.03786|0.07526|0.253,514.9|514.9|514.9|305.1|144.5
301,43,0.3577,323.0,28290.0,0.01126,1.0,AP3B1 AP3D1 ARL8B BLOC1S1 BLOC1S2 BORCS5 BORCS7 BORCS8 DNAJC13 EIPR1 FNIP1 GDAP2 HTT KXD1 LAMTOR1 LAMTOR2 LAMTOR3 LAMTOR4 MIOS MLST8 MTMR6 MTMR9 MTOR NPC1 RAB7A RRAGA RRAGC SEH1L SNAPIN SPG21 SPNS1 TBC1D5 VPS16 VPS18 VPS26A VPS29 VPS33A VPS35 VPS39 VPS41 WDR24 WDR59 WDR91,positive regulation of TOR signaling|cellular localization|cellular response to amino acid starvation|response to amino acid starvation|response to starvation,6.998e-22|4.199e-19|5.488e-19|8.231e-19|1.732e-18,1.104e-17|3.312e-15|2.885e-15|3.246e-15|5.464e-15,130.6|5.144|70.21|67.67|30.13
302,29,0.4067,165.1,18180.0,0.008971,1.0,C12orf66 DEPDC5 FNIP1 ITFG2 KPTN LAMTOR1 LAMTOR2 LAMTOR3 LAMTOR4 MIOS MLST8 MTOR NPRL2 RRAGA RRAGC SEH1L SESN2 SPG21 SZT2 TBC1D5 TBC1D7 TSC1 TSC2 VPS18 VPS33A VPS39 VPS41 WDR24 WDR59,regulation of TOR signaling|cellular response to amino acid starvation|response to amino acid starvation|response to starvation|cellular response to nutrient levels,1.608e-44|2.7e-38|5.039e-38|6.136e-37|1.14e-36,2.536e-40|2.13e-34|2.65e-34|2.42e-33|3.595e-33,157.8|168.7|162.6|67.05|65.1
303,6,0.4156,6.234,4672.0,0.0013289999999999999,0.998474,AKTIP C6 IFI44 MEIOB NOMO2 SMAGP,female meiosis I|resolution of meiotic recombination intermediates|meiotic chromosome separation|male meiosis I|early endosome to late endosome transport,0.002909|0.005522|0.006391|0.00697|0.00697,1|1|1|1|1,381.4|190.7|163.5|149.2|149.2
304,14,0.4037,36.73,8901.0,0.004097,0.9999969999999999,ALDH18A1 ASNS ATF4 EIF2AK4 GCN1 NADK2 NARS2 PC SLC38A2 SLC3A2 SLC7A1 SLC7A11 SLC7A5 TRPM7,L-amino acid transport|amino acid transmembrane transport|amino acid import across plasma membrane|amino acid import|amino acid transport,7.816e-10|5.416e-09|1.183e-08|2.659e-08|3.433e-08,1.233e-05|4.272e-05|6.219e-05|0.0001049|0.0001083,114.4|76.28|166.4|134|52.01
305,6,0.4234,6.351,4726.0,0.0013390000000000001,0.998474,ALDH1A3 CSN1S1 GRM4 ORM1 PGF SLC35F6,nucleus accumbens development|response to 11-deoxycorticosterone|response to dehydroepiandrosterone|olfactory pit development|Harderian gland development,0.0005824|0.0005824|0.0005824|0.001165|0.001456,1|1|1|1|1,3432|3432|3432|1144|858.1
306,7,0.4285,8.998,6074.0,0.0014759999999999999,0.9992989999999999,ACP7 ADGRL3 ALDH1L2 ANO4 CHST11 NOX3 TMC6,detection of gravity|polysaccharide localization|10-formyltetrahydrofolate catabolic process|folic acid-containing compound catabolic process|pteridine-containing compound catabolic process,0.0006794|0.001019|0.001019|0.001358|0.001358,1|1|1|1|1,2942|1471|1471|980.7|980.7
307,7,0.4299,9.029,5713.0,0.001574,0.9992989999999999,ALDH4A1 CKS2 GNA14 HLA-DOB TMEM42 TRPM3 TRPM6,protein tetramerization|negative regulation of antigen processing and presentation of peptide antigen via MHC class II|negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|proline catabolic process to glutamate|4-hydroxyproline metabolic process,0.0003651|0.001019|0.001358|0.001358|0.001698,1|1|1|1|1,69.23|1471|980.7|980.7|735.5
308,7,0.4247,8.919,5933.0,0.001497,0.9992989999999999,ALDH5A1 ASIC4 BBS9 CALHM5 FAM78A PTPRA VSTM2A,positive regulation of white fat cell proliferation|gamma-aminobutyric acid catabolic process|regulation of white fat cell proliferation|positive regulation of fat cell proliferation|gamma-aminobutyric acid metabolic process,0.001019|0.001019|0.001358|0.001698|0.002037,1|1|1|1|1,1471|1471|980.7|735.5|588.4
309,22,0.4069,93.99,17680.0,0.005275,1.0,AGO1 AGO3 AGO4 BEST4 C1orf123 C1orf50 CFAP57 CYP4A22 CYP4X1 CYP4Z1 ERMAP EXO5 HPCAL4 LURAP1 MFSD2A PPT1 ZBTB8A ZBTB8B ZFP69 ZFP69B ZNF684 ZNF691,"miRNA loading onto RISC involved in gene silencing by miRNA|RNA secondary structure unwinding|small RNA loading onto RISC|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation",1.088e-07|1.495e-07|1.992e-07|5.058e-07|5.058e-07,0.001716|0.001179|0.001047|0.001994|0.001596,420.3|367.8|326.9|226.3|226.3
310,71,0.3116,774.4,54950.0,0.013859999999999999,1.0,ABHD11 ALKBH4 ANKIB1 ANKRD7 ARPC1A ARPC1B ASL AZGP1 C7orf43 C7orf61 CASTOR3 CLDN15 CLDN3 CLDN4 CNPY4 CPA1 CYP3A4 CYP3A43 CYP3A5 CYP3A7 CYP51A1 DLX6 FAM71F2 FBXO24 GALNT17 GJC3 GNAI1 GNAT3 GNG11 GRM3 GUSB IFT22 LRCH4 MBLAC1 MOGAT3 MUC12 NAPEPLD NYAP1 PCOLCE PILRA PILRB PON1 PON2 PON3 PVRIG RASA4 RASA4B RNF148 SEMA3A SEMA3C SEMA3E SLC12A9 SLC26A3 SLC26A4 SLC26A5 SPDYE1 TBL2 TECPR1 THAP5 TRIM50 TYW1 VPS50 WNT2 ZKSCAN1 ZNF394 ZNF736 ZNF789 ZNF804B ZNF92 ZSCAN21 ZSCAN25,oxidative demethylation|demethylation|lipid hydroxylation|oxalate transport|chloride transmembrane transport,1.799e-08|1.884e-07|4.781e-06|1.131e-05|2.856e-05,0.0002837|0.001486|0.02514|0.04459|0.09009,75.27|26|122.6|85.81|14.74
311,16,0.5863,70.36,10610.0,0.006567,0.999999,ARCN1 BUD13 CCDC84 CHORDC1 CWF19L2 DDX10 DPAGT1 HYOU1 NKAPD1 PPP2R1A RPS25 SRFBP1 SRPRA TRAPPC4 ZPR1 ZW10,RNA processing|endoplasmic reticulum to Golgi vesicle-mediated transport|RNA metabolic process|mRNA metabolic process|Golgi vesicle transport,2.977e-06|1.429e-05|0.000105|0.0001415|0.0002114,0.04696|0.1127|0.552|0.5579|0.6668,9.762|26.27|5.635|9.274|13
312,20,0.4008,76.15,15150.0,0.004989,1.0,C6orf48 CYP21A2 HLA-DMB HLA-DPB1 HLA-F LY6G6F MICB MSH5 NUDT3 OR14J1 OR2B6 OR2J3 PSMB8 PSORS1C2 STK19 TAP1 TAP2 TNXB TRIM10 TRIM26,antigen processing and presentation of peptide antigen|antigen processing and presentation|antigen processing and presentation of endogenous peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen|antigen processing and presentation of exogenous peptide antigen,5.073e-10|1.346e-09|3.814e-09|5.636e-09|1.628e-08,8.002e-06|1.061e-05|2.005e-05|2.222e-05|5.135e-05,37.35|32.32|242.3|216.8|34.71
313,5,0.4474,4.474,3883.0,0.0011480000000000001,0.996692,ALG10B DSC3 METTL4 SMAGP TMEM217,cornification|positive regulation of inward rectifier potassium channel activity|DNA methylation on adenine|snRNA (adenine-N6)-methylation|homophilic cell adhesion via plasma membrane adhesion molecules,0.0006369|0.001019|0.001019|0.001019|0.001367,1|1|1|1|1,52.07|1471|1471|1471|35.24
314,36,0.3811,240.1,23150.0,0.01023,1.0,ALG12 ALG3 ALG5 ALG6 ALG8 ALG9 AUP1 DERL2 DNAJB11 DNAJC3 DOLPP1 DPM1 DPM2 DPM3 FAF2 GANAB HERPUD1 HSP90B1 MANF MPDU1 MPI OST4 PMM2 PRKCSH SEC62 SEC63 SEL1L SERP1 SLC33A1 STT3A SURF4 SYVN1 TMEM41B UBE2G2 UBE2J1 UGP2,glycoprotein metabolic process|protein N-linked glycosylation|protein glycosylation|macromolecule glycosylation|glycosylation,6.088e-29|1.001e-26|3.576e-23|3.576e-23|8.339e-23,9.604e-25|7.891e-23|1.88e-19|1.41e-19|2.631e-19,32.92|111.3|39.1|39.1|37.11
315,5,0.4596,4.596,3897.0,0.001175,0.996692,ALG1L C1QTNF12 PRKAG1 SCNN1D TNFRSF4,regulation of carbohydrate metabolic process|regulation of small molecule metabolic process|negative regulation of gluconeogenesis|regulation of cAMP-dependent protein kinase activity|positive regulation of insulin receptor signaling pathway,0.001072|0.004342|0.004604|0.005087|0.005812,1|1|1|1|1,38.5|18.85|228.8|205.9|179.1
316,6,0.4441,6.662000000000001,5067.0,0.00131,0.998474,ADM2 ALKAL1 FAM181B GATM NOX3 TNFRSF13C,detection of gravity|creatine biosynthetic process|positive regulation of ERK5 cascade|regulation of ERK5 cascade|B cell costimulation,0.0005824|0.0008735|0.0008735|0.0008735|0.001456,1|1|1|1|1,3432|1716|1716|1716|858.1
317,6,0.4032,6.047999999999999,4647.0,0.001296,0.998474,ALKBH7 GAS2L3 IPCEF1 RAB11FIP5 SDSL UBXN7,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death|isoleucine biosynthetic process|negative regulation of adiponectin secretion|threonine catabolic process|branched-chain amino acid biosynthetic process,0.001165|0.001165|0.001456|0.001746|0.001746,1|1|1|1|1,1144|1144|858.1|686.5|686.5
318,7,0.4138,8.689,5792.0,0.0014939999999999999,0.9992989999999999,ALLC GFRA2 HTR6 NID1 ODF3L1 TNFSF13B ZBTB14,allantoin catabolic process|positive regulation of germinal center formation|allantoin metabolic process|cellular amide catabolic process|B cell costimulation,0.0006794|0.001019|0.001358|0.001698|0.001698,1|1|1|1|1,2942|1471|980.7|735.5|735.5
319,6,0.4199,6.297999999999999,4696.0,0.001336,0.998474,ALOX12 APBB1IP CMTM5 OR6C68 SLC12A4 SLC45A3,lipoxin B4 biosynthetic process|lipoxin B4 metabolic process|leukotriene A4 metabolic process|positive regulation of endothelial tube morphogenesis|lipoxin A4 biosynthetic process,0.0005824|0.0005824|0.0008735|0.0008735|0.001165,1|1|1|1|1,3432|3432|1716|1716|1144
320,6,0.4106,6.159,4939.0,0.001243,0.998474,ALOX5AP ELMOD2 L1TD1 PHOX2B SCGB3A1 TPP2,medullary reticular formation development|efferent axon development in a lateral line nerve|lateral line nerve development|retrotrapezoid nucleus neuron differentiation|retrotrapezoid nucleus development,0.0005824|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,3432|3432|3432|3432|3432
321,8,0.4321,12.1,6489.0,0.0018559999999999998,0.9996790000000001,ALPI CHRND CHRNG KCNJ13 MMP25 NEU2 PDE6D TRAK2,"collagen catabolic process|collagen metabolic process|excitatory postsynaptic potential|chemical synaptic transmission, postsynaptic|anterograde dendritic transport of mitochondrion",0.0002075|0.0004075|0.0004472|0.000503|0.0009704,1|1|1|1|1,95.79|67.52|64.36|60.57|2060
322,48,0.3605,406.7,38160.0,0.01052,1.0,ERVV-2 FCAR GP6 GPR32 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2 KLK11 KLK3 LAIR1 LAIR2 LILRA1 LILRA4 LILRB1 LILRB2 LILRB4 LILRB5 NLRP11 NLRP12 NLRP4 NLRP9 PTPRH RFPL4A SHISA7 VN1R4 ZFP28 ZNF264 ZNF28 ZNF304 ZNF324 ZNF415 ZNF524 ZNF528 ZNF534 ZNF578 ZNF581 ZNF587 ZNF610 ZNF665 ZNF667 ZNF701 ZNF772 ZNF773 ZNF805 ZNF880 ZSCAN5B,"regulation of transcription by RNA polymerase II|regulation of gene expression|immune response-inhibiting cell surface receptor signaling pathway|immune response-inhibiting signal transduction|regulation of transcription, DNA-templated",6.886e-09|9.059e-09|1.485e-08|2.993e-08|7.275e-08,0.0001086|7.144e-05|7.809e-05|0.000118|0.0002295,3.663|2.621|205.9|164.8|2.973
323,6,0.4148,6.222,4761.0,0.001302,0.998474,ALPK3 KLHL18 LARP6 PCCB RAB24 TOM1L2,positive regulation of mRNA binding|positive regulation of RNA binding|biotin metabolic process|regulation of mRNA binding|short-chain fatty acid catabolic process,0.002328|0.002619|0.002909|0.002909|0.002909,1|1|1|1|1,490.4|429.1|381.4|381.4|381.4
324,8,0.4147,11.61,6776.0,0.001707,0.9996790000000001,ALPL APLNR CELA2A GUCA2B HTR6 PANX1 TEKT2 ZNF683,response to oxygen-containing compound|response to organic cyclic compound|cellular response to organic cyclic compound|positive regulation of inhibitory G protein-coupled receptor phosphorylation|regulation of inhibitory G protein-coupled receptor phosphorylation,0.0001246|0.0002106|0.0007392|0.0007765|0.0007765,1|1|1|1|1,8.126|11.62|15.45|2574|2574
325,9,0.4088,14.72,6222.0,0.002353,0.9998530000000001,C2orf69 EIF2AK4 GCN1 GLUL HNRNPH3 QARS SLC1A5 SLC7A11 SREK1,cellular response to leucine starvation|regulation of cellular amide metabolic process|lipid import into cell|import into cell|peptide metabolic process,1.396e-05|3.753e-05|6.847e-05|8.29e-05|8.702e-05,0.2201|0.296|0.36|0.3269|0.2745,411.9|19.07|171.6|33.76|15.34
326,7,0.428,8.987,5916.0,0.001513,0.9992989999999999,ALS2 CCDC14 COL20A1 CYP27A1 KRTAP20-3 LGALS4 RPH3AL,cellular alcohol biosynthetic process|cellular alcohol metabolic process|calcitriol biosynthetic process from calciol|vitamin D biosynthetic process|regulation of endosome size,0.001698|0.001698|0.001698|0.001698|0.002037,1|1|1|1|1,735.5|735.5|735.5|735.5|588.4
327,6,0.408,6.121,4823.0,0.0012640000000000001,0.998474,ALS2CL APPBP2 DNAJC22 LIPF PRKCD TMIE,positive regulation of glucosylceramide catabolic process|regulation of glucosylceramide catabolic process|positive regulation of phospholipid scramblase activity|regulation of phospholipid scramblase activity|positive regulation of lipid transporter activity,0.0005824|0.0005824|0.0005824|0.0005824|0.0008735,1|1|1|1|1,3432|3432|3432|3432|1716
328,6,0.421,6.314,4787.0,0.001314,0.998474,ALX3 CRIPAK CROCC PLSCR3 RAX TDRP,limb development|appendage development|ciliary basal body organization|positive regulation of protein localization to cilium|skeletal system morphogenesis,0.001498|0.001498|0.001698|0.002037|0.002426,1|1|1|1|1,33.62|33.62|735.5|588.4|26.27
329,11,0.4098,22.54,6902.0,0.0032450000000000005,0.999969,AMBRA1 CCND3 CDK4 CDK6 CDKN1B CDKN2C DYRK1A FAM117B FAM53C GLCCI1 MAU2,regulation of G1/S transition of mitotic cell cycle|regulation of cell cycle G1/S phase transition|regulation of cyclin-dependent protein serine/threonine kinase activity|regulation of cyclin-dependent protein kinase activity|G1 phase,1.072e-08|1.958e-08|1.891e-07|2.205e-07|2.277e-07,0.0001692|0.0001544|0.0009944|0.0008695|0.0007182,61.59|54.43|75.65|72.71|267.5
330,14,0.4228,38.47,9403.0,0.004063000000000001,0.9999969999999999,ATP13A1 BAK1 BAX BCL2 BCL2L1 BCL2L2 MARCH5 MCL1 PMAIP1 RER1 THAP3 UBE2J2 VDAC2 WSB2,signal transduction in absence of ligand|extrinsic apoptotic signaling pathway in absence of ligand|apoptotic mitochondrial changes|apoptotic signaling pathway|intrinsic apoptotic signaling pathway,5.446e-14|5.446e-14|2.077e-12|3.295e-12|3.725e-12,8.59e-10|4.295e-10|1.092e-08|1.299e-08|1.175e-08,294.2|294.2|152.2|42.64|70.05
331,4,0.4457,2.674,3043.0,0.0008756,0.9929309999999999,AMER2 ANGPTL6 MTRNR2L1 RAD52,regulation of nucleotide-excision repair|DNA repair complex assembly|DNA recombinase assembly|double-strand break repair via single-strand annealing|DNA double-strand break processing involved in repair via single-strand annealing,0.0009706|0.0009706|0.0009706|0.001165|0.001165,1|1|1|1|1,1287|1287|1287|1030|1030
332,5,0.4658,4.658,3969.0,0.001169,0.996692,AMER3 CLEC4E COL27A1 OR10A2 ZP1,growth plate cartilage chondrocyte development|chondrocyte development involved in endochondral bone morphogenesis|growth plate cartilage chondrocyte differentiation|chondrocyte differentiation involved in endochondral bone morphogenesis|growth plate cartilage development,0.001456|0.002183|0.002425|0.003878|0.004362,1|1|1|1|1,823.8|514.9|457.7|274.6|242.3
333,5,0.4598,4.598,3976.0,0.001152,0.996692,AMH CLDN1 DNAJC6 LRRN3 MAN2A1,positive regulation of cell junction assembly|xenobiotic transport across blood-nerve barrier|cellular response to butyrate|response to butyrate|liver development,0.0003386|0.0005824|0.0005824|0.0005824|0.0006566,1|1|1|1|1,70.77|3432|3432|3432|50.48
334,6,0.4077,6.115,5024.0,0.001213,0.998474,AMHR2 FBRSL1 GPR27 PLXNB1 TNFRSF10D ZDHHC2,anti-Mullerian hormone signaling pathway|positive regulation of postsynaptic membrane organization|positive regulation of endosome to plasma membrane protein transport|positive regulation of AMPA glutamate receptor clustering|semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,0.0005824|0.0008735|0.0008735|0.0008735|0.0008735,1|1|1|1|1,3432|1716|1716|1716|1716
335,7,0.414,8.693999999999999,6247.0,0.001387,0.9992989999999999,ACBD4 AMMECR1L CCDC103 CSNK1G2 HIGD1B PDGFA VWA3B,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling|embryonic lung development|negative regulation of phosphatidylinositol biosynthetic process|positive regulation of metanephric mesenchymal cell migration|positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,0.0006794|0.001019|0.001019|0.001358|0.001358,1|1|1|1|1,2942|1471|1471|980.7|980.7
336,5,0.445,4.45,3999.0,0.001109,0.996692,AMN RAB28 SORD TMEM161A TRMO,hexitol catabolic process|sorbitol catabolic process|L-xylitol metabolic process|L-xylitol catabolic process|pentitol catabolic process,0.0004854|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,4119|4119|4119|4119|4119
337,20,0.4093,77.77,16060.0,0.004808,1.0,AK4 ALG10 AMN1 BICD1 CBLB ETFBKMT FAR2 H3F3C IL17RE ITPR2 KIAA1551 KLHL42 LMNTD1 MANSC4 RASSF8 SLCO1C1 SYT10 TM7SF3 TMTC1 TSPAN11,regulation of microtubule-based process|negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway|negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase|regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase|negative regulation of electron transfer activity,0.001284|0.001843|0.001843|0.001843|0.001843,1|1|1|1|1,13.84|1084|1084|1084|1084
338,11,0.6944,38.19,7698.0,0.004922999999999999,0.999969,C16orf72 CAND1 COPS2 COPS3 COPS4 COPS6 COPS7A COPS7B COPS8 DDA1 GPS1,"protein deneddylation|nucleotide-excision repair, DNA damage recognition|transcription-coupled nucleotide-excision repair|post-translational protein modification|nucleotide-excision repair",8.957e-24|1.612e-21|6.53e-18|3.436e-17|9.615e-17,1.413e-19|1.271e-17|3.433e-14|1.355e-13|3.033e-13,1498|651.2|205.2|51.86|144
339,6,0.4381,6.571000000000001,4940.0,0.001325,0.998474,AMPD2 AOC2 FAM200B GJD2 IGFBP4 SPINK6,IMP salvage|negative regulation of serine-type peptidase activity|purine nucleotide salvage|negative regulation of serine-type endopeptidase activity|regulation of serine-type peptidase activity,0.001456|0.002328|0.002328|0.002328|0.002909,1|1|1|1|1,858.1|490.4|490.4|490.4|381.4
340,5,0.4327,4.327,3949.0,0.001092,0.996692,AMPD3 ARVCF INSYN1 OGG1 PPIF,"nucleotide catabolic process|nucleoside phosphate catabolic process|nucleobase-containing small molecule biosynthetic process|negative regulation of double-strand break repair via single-strand annealing|regulation of proton-transporting ATPase activity, rotational mechanism",0.0001299|0.0001669|0.0003163|0.0004854|0.0004854,1|1|1|1|1,112.8|99.25|71.63|4119|4119
341,6,0.4347,6.521,5011.0,0.001297,0.998474,ALDH1A2 AMTN DLL4 DTX3 IGSF9B PRODH,Notch signaling pathway|retinoic acid receptor signaling pathway involved in somitogenesis|regulation of endothelial cell proliferation|cardiac muscle tissue development|blood vessel lumenization,0.0004971|0.0005824|0.0006378|0.000775|0.0008735,1|1|1|1|1,58.18|3432|51.23|46.39|1716
342,6,0.4042,6.062,4630.0,0.0013039999999999998,0.998474,AMZ2 ESR2 KCNQ5 MADD SIK3 TCF3,positive regulation of TORC2 signaling|regulation of TORC2 signaling|B cell lineage commitment|immunoglobulin V(D)J recombination|regulation of Rab protein signal transduction,0.001019|0.001019|0.002376|0.002376|0.002715,1|1|1|1|1,1471|1471|490.4|490.4|420.3
343,12,0.4298,28.37,8511.0,0.003312,0.999986,ANAPC1 DARS DDX18 IMP4 MCM6 NIFK ORC4 ORC6 RANBP2 SPC25 WDR33 ZC3H8,nucleic acid metabolic process|mitotic cell cycle process|DNA replication initiation|mitotic cell cycle|cellular nitrogen compound metabolic process,2.514e-06|3.317e-06|3.723e-06|6.057e-06|8.112e-06,0.03966|0.02616|0.01958|0.02389|0.02559,5.932|12.89|102.6|11.6|4.318
344,29,0.4058,164.8,20230.0,0.008057,1.0,ABCE1 ALG11 COPB2 CSE1L DDX19B EIF2S1 HSPA9 NARS NBEAL1 NEDD8 NUTF2 PSMA1 PSMA2 PSMA3 PSMA4 PSMA5 PSMA6 RPL14 RPL17 RPL18 RPL18A RPL7 RPS17 SMU1 SNRPD1 SNU13 SRP54 VCP YARS,cellular macromolecule biosynthetic process|macromolecule biosynthetic process|proteasomal ubiquitin-independent protein catabolic process|cellular macromolecule catabolic process|cellular component biogenesis,7.116e-13|1.076e-12|2.048e-12|9.12e-12|1.904e-11,1.122e-08|8.487e-09|1.077e-08|3.596e-08|6.008e-08,7.466|7.286|187.2|10.54|5.083
345,21,0.3882,81.52,14930.0,0.005414,1.0,ANAPC11 CHMP6 EIF4A3 FTSJ3 GPS1 HGS INTS2 LUC7L3 NOL11 NPLOC4 NUP85 PSMC5 PSMD12 RPL38 SAP30BP SRP68 TBCD TSEN54 USP36 UTP18 VMP1,ncRNA processing|cellular component biogenesis|ncRNA metabolic process|RNA processing|cellular catabolic process,1.7e-07|2.513e-07|5.619e-07|2.02e-06|3.732e-06,0.002682|0.001982|0.002955|0.007965|0.01177,15.89|4.72|13.28|8.5|5.458
346,18,0.4168,63.77,11800.0,0.00536,1.0,ACTR1A ANAPC13 ANAPC15 ANAPC5 BORA CCNF CDC16 CDC27 MAD2L1BP PRPF39 SGO1 SGO2 SKA1 SKA3 SPAG5 TRNAU1AP UBE2C UBE2S,cell division|cell cycle|biological phase|mitotic cell cycle phase|cell cycle phase,6.758e-20|1.992e-15|4.488e-15|4.488e-15|4.488e-15,1.066e-15|1.571e-11|2.36e-11|1.77e-11|1.416e-11,32.56|12.35|44.52|44.52|44.52
347,19,0.3829,65.47,13380.0,0.004857,1.0,ALG2 ANAPC2 C9orf78 CDC26 EXOSC2 GLE1 IARS NDOR1 NOL8 NUP214 PRPF4 RPL12 RPL35 RPL7A SEC16A SEC61B SPOUT1 SURF6 TXN,protein localization to endoplasmic reticulum|protein localization to organelle|ribosome biogenesis|cellular macromolecule localization|SRP-dependent cotranslational protein targeting to membrane,1.848e-07|2.543e-07|4.213e-07|5.097e-07|1.911e-06,0.002915|0.002005|0.002215|0.00201|0.006028,38.17|10.96|19.59|6.589|45.16
348,12,0.41,27.06,8154.0,0.0032979999999999997,0.999986,ANAPC4 CKAP5 CLTC DHX15 GAK GRPEL1 GTSE1 HAUS3 LETM1 NOP14 STX18 TACC3,regulation of cell cycle process|cell cycle|cell division|regulation of cell cycle|mitotic cell cycle,2.16e-06|3.793e-06|5.506e-06|2.65e-05|4.462e-05,0.03407|0.02992|0.02895|0.1045|0.1408,13.34|8.643|17.44|8.61|11.28
349,7,0.5814,12.21,5331.0,0.0022789999999999998,0.9992989999999999,ANAPC7 C17orf58 DND1 LRRC37A LRRC37A2 LRRC37A3 LRRC37B,UNCLASSIFIED|biological_process|metaphase/anaphase transition of mitotic cell cycle|metaphase/anaphase transition of cell cycle|positive regulation of mitotic sister chromatid separation,0.0007013|0.0007013|0.002715|0.002715|0.005086,1|1|1|1|1,5.359|0.3297|420.3|420.3|210.2
350,6,0.4265,6.397,4849.0,0.001314,0.998474,ANGEL1 BBOF1 DNAAF3 FPR1 STOM WDR18,motile cilium assembly|regulation of acid-sensing ion channel activity|positive regulation by host of viral genome replication|regulation of DNA-dependent DNA replication initiation|complement receptor mediated signaling pathway,2.473e-05|0.0005824|0.002619|0.002619|0.004071,0.3901|1|1|1|1,274.6|3432|429.1|429.1|264
351,6,0.4042,6.064,4691.0,0.001288,0.998474,ANGEL2 EFHB FBXL14 MRPL35 MRPS5 ZNF8,mitochondrial translational elongation|mitochondrial translational termination|translational termination|mitochondrial translation|translational elongation,0.0002799|0.0002862|0.0003386|0.0004409|0.0005565,1|1|1|1|1,78.01|77.13|70.77|61.85|54.92
352,6,0.4275,6.412999999999999,4898.0,0.0013050000000000002,0.998474,ANGPT1 AP3S2 ERI2 IGFBP3 KCNIP2 RRAS,positive regulation of endothelial cell migration|regulation of MAPK cascade|positive regulation of epithelial cell migration|regulation of endothelial cell migration|regulation of macrophage migration inhibitory factor signaling pathway,0.0004179|0.0007144|0.0007956|0.001017|0.001165,1|1|1|1|1,63.56|14.84|45.77|40.38|1144
353,6,0.4026,6.04,4512.0,0.001333,0.998474,ANGPT2 AP2S1 NKIRAS2 OPCML RALGAPB THEGL,negative regulation of positive chemotaxis|Tie signaling pathway|low-density lipoprotein particle receptor catabolic process|low-density lipoprotein receptor particle metabolic process|glomerulus vasculature development,0.0005824|0.001456|0.0032|0.0032|0.005522,1|1|1|1|1,3432|858.1|343.2|343.2|190.7
354,7,0.4127,8.667,5669.0,0.001523,0.9992989999999999,ANGPT4 DDX49 DPCD IRX2 OPN4 SLC26A9 ST14,regulation of rRNA catabolic process|regulation of rRNA stability|embryonic epithelial tube formation|epithelial tube formation|tube morphogenesis,0.0006794|0.0006794|0.0007518|0.0008504|0.0009861,1|1|1|1|1,2942|2942|47.84|44.92|13.68
355,7,0.4198,8.815,5755.0,0.001526,0.9992989999999999,ANGPTL2 CCDC178 IBTK NLRP8 PCYOX1 TPGS1 VNN1,prenylcysteine metabolic process|prenylcysteine catabolic process|prenylated protein catabolic process|pantothenate metabolic process|positive regulation of T cell differentiation in thymus,0.001019|0.001019|0.001358|0.002715|0.003732,1|1|1|1|1,1471|1471|980.7|420.3|294.2
356,6,0.4131,6.197,4772.0,0.001294,0.998474,ANGPTL3 CBLB ECHDC3 EREG MTRNR2L4 SPATA46,regulation of signaling receptor activity|regulation of epidermal growth factor-activated receptor activity|negative regulation of epidermal growth factor receptor signaling pathway|negative regulation of ERBB signaling pathway|negative regulation of signaling receptor activity,1.686e-05|3.493e-05|8.606e-05|0.0001043|0.0001597,0.266|0.2755|0.4525|0.4111|0.5037,53.08|228.8|143|129.5|104
357,44,0.2923,276.5,31920.0,0.008567,1.0,C19orf66 CALR CLEC17A CNN1 DAND5 ELAVL3 ICAM1 ICAM3 IL12RB1 OR7C2 P2RY11 PRDX2 QTRT1 STX10 SYCE2 TMED1 TMEM205 ZNF121 ZNF20 ZNF433 ZNF439 ZNF441 ZNF442 ZNF443 ZNF486 ZNF490 ZNF491 ZNF562 ZNF563 ZNF564 ZNF625 ZNF627 ZNF682 ZNF69 ZNF700 ZNF709 ZNF714 ZNF737 ZNF763 ZNF791 ZNF799 ZNF844 ZNF878 ZNF91,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of cellular macromolecule biosynthetic process",5.242e-17|1.355e-15|1.367e-15|1.426e-15|4.353e-15,8.269e-13|1.069e-11|7.185e-12|5.622e-12|1.373e-11,5.309|4.228|4.227|4.221|3.86
358,6,0.414,6.211,4861.0,0.001273,0.998474,ANK2 BTC CBR4 CCDC92 MGAT4D PI4K2A,protein localization to T-tubule|protein localization to M-band|negative regulation of protein glycosylation|regulation of SA node cell action potential|regulation of atrial cardiac muscle cell action potential,0.0008735|0.0008735|0.001165|0.001165|0.001456,1|1|1|1|1,1716|1716|1144|1144|858.1
359,7,0.4064,8.535,5756.0,0.001477,0.9992989999999999,ANKAR ARNTL CD37 CYP26B1 TMEM38A USP25 VSX2,positive regulation of skeletal muscle cell differentiation|regulation of skeletal muscle cell differentiation|positive regulation of tongue muscle cell differentiation|regulation of tongue muscle cell differentiation|positive regulation of skeletal muscle fiber differentiation,2.768e-06|2.072e-05|0.001019|0.001019|0.001358,0.04366|0.1634|1|1|1,980.7|309.7|1471|1471|980.7
360,14,0.4056,36.91,9665.0,0.0037939999999999996,0.9999969999999999,CARS EIF3CL GGPS1 GUK1 KARS NARS NEDD8 OSGEP PSMA2 PSMA6 RABGGTA RABGGTB SNRPD1 YARS,tRNA aminoacylation for protein translation|tRNA aminoacylation|amino acid activation|tRNA metabolic process|primary metabolic process,4.101e-08|5.208e-08|5.622e-08|1.583e-07|2.013e-07,0.0006469|0.0004108|0.0002956|0.0006243|0.0006352,119.4|112.1|109.8|37.93|2.797
361,5,0.4502,4.502,3820.0,0.001174,0.996692,ACADSB ANKDD1B C8G GNAI3 TP53INP2,positive regulation of autophagy|isoleucine catabolic process|isoleucine metabolic process|positive regulation of NAD(P)H oxidase activity|regulation of autophagy,0.0003552|0.001213|0.00194|0.00194|0.002523,1|1|1|1|1,67.52|1030|588.4|588.4|24.89
362,11,0.6734,37.04,7727.0,0.004757,0.999969,ATP6V1E1 CDC45 CRK DGCR8 ESS2 GNB1L MRPL40 PI4KA PPIL2 TFIP11 UFD1,cellular response to endothelin|negative regulation of DNA ligation|negative regulation of DNA ligase activity|viral replication complex formation and maintenance|mitotic DNA replication preinitiation complex assembly,0.001067|0.001067|0.001067|0.001067|0.001067,1|1|1|1|1,1872|1872|1872|1872|1872
363,6,0.404,6.061,4742.0,0.001273,0.998474,ANKFN1 GIMAP5 IK MCF2L RNF213 SAMD9,negative regulation of non-canonical Wnt signaling pathway|endosomal vesicle fusion|equilibrioception|negative regulation by symbiont of host apoptotic process|modulation by symbiont of host apoptotic process,0.002037|0.002619|0.002619|0.0032|0.00349,1|1|1|1|1,572.1|429.1|429.1|343.2|312
364,8,0.4096,11.47,5638.0,0.0020239999999999998,0.9996790000000001,ANKLE2 NUP50 POLE SFSWAP SMU1 SNRNP35 USP14 VCP,"mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|DNA synthesis involved in DNA repair|RNA splicing",0.0001703|0.0001703|0.0001752|0.0001939|0.0004067,1|1|0.9215|0.7647|1,25.57|25.57|25.32|97.15|18.98
365,6,0.4042,6.063,4849.0,0.0012460000000000001,0.998474,ABCB8 ANKMY1 EMX2 KLK8 RAC3 TEX19,receptor transactivation|cerebral cortex regionalization|cell dedifferentiation|dedifferentiation|cellular developmental process,0.002037|0.002376|0.002376|0.002376|0.00239,1|1|1|1|1,588.4|490.4|490.4|490.4|4.13
366,21,0.3659,76.85,15140.0,0.005037,1.0,DCTN4 DDX41 DDX46 GEMIN5 HARS IK LARS NHP2 NOP16 PTTG1 RACK1 RARS RBM22 RPS14 SLU7 SPDL1 THG1L THOC3 TTC1 WDR55 ZMAT2,RNA metabolic process|gene expression|nucleic acid metabolic process|RNA processing|nucleobase-containing compound metabolic process,8.263e-13|3.287e-12|4.528e-12|1.423e-11|9.295e-11,1.303e-08|2.593e-08|2.381e-08|5.612e-08|2.933e-07,9.2|7.178|7.03|12.75|5.771
367,5,0.4117,4.117,4078.0,0.001006,0.996692,ANKRD10 EVPL OSMR SYNJ1 TRIM23,positive regulation of endosome organization|regulation of endosome organization|synaptic vesicle uncoating|clathrin coat disassembly|vesicle uncoating,0.0004854|0.001213|0.001213|0.001456|0.001698,1|1|1|1|1,4119|1030|1030|823.8|686.5
368,12,0.4159,27.45,7941.0,0.003435,0.999986,EIF3A EIF3D EIF3E EIF3F EIF3G EIF3H EIF3I EIF3M EIF4G1 EIF4G2 PRRC2A PRRC2C,cytoplasmic translational initiation|translational initiation|formation of cytoplasmic translation initiation complex|cytoplasmic translation|translation,8.173e-23|2.174e-22|1.171e-21|1.409e-19|8.423e-18,1.289e-18|1.715e-18|6.156e-18|5.555e-16|2.657e-14,475.3|121.9|792.1|190.1|45.38
369,6,0.425,6.375,4855.0,0.001308,0.998474,ANKRD12 CTSE IL20 MSR1 PNMA2 SLC26A9,positive regulation of cholesterol storage|oxalate transport|lipoprotein transport|lipoprotein localization|regulation of cholesterol storage,0.002715|0.003732|0.004748|0.005086|0.005763,1|1|1|1|1,420.3|294.2|226.3|210.2|183.9
370,5,0.4203,4.203,4044.0,0.001036,0.996692,ANKRD13A CT62 EXOC6B KITLG RABGAP1,negative regulation of mast cell apoptotic process|negative regulation of protein localization to endosome|regulation of mast cell apoptotic process|positive regulation of mast cell proliferation|positive regulation of melanocyte differentiation,0.0004854|0.0004854|0.000728|0.000728|0.001213,1|1|1|1|1,4119|4119|2060|2060|1030
371,8,0.4085,11.44,6417.0,0.001775,0.9996790000000001,ANKRD13B CHRDL2 EGFLAM RELN RHOG SIAE TOMM20L UTS2R,positive regulation of lateral motor column neuron migration|regulation of lateral motor column neuron migration|positive regulation of motor neuron migration|regulation of motor neuron migration|tRNA import into mitochondrion,0.0007765|0.0007765|0.0007765|0.0007765|0.001164,1|1|1|1|1,2574|2574|2574|2574|1287
372,6,0.4039,6.058,4680.0,0.0012900000000000001,0.998474,ANKRD13C ATAD3B NECTIN3 OR2T33 ST3GAL3 TUBB1,ganglioside biosynthetic process via lactosylceramide|protein retention in ER lumen|maintenance of protein localization in endoplasmic reticulum|ganglioside biosynthetic process|sialylation,0.001746|0.002909|0.004361|0.004942|0.006101,1|1|1|1|1,686.5|381.4|245.2|214.5|171.6
373,12,0.4083,26.95,9282.0,0.0028870000000000002,0.999986,AKR1C1 AKR1C3 AKR1C4 AKR1E2 ANKRD16 CALML3 CALML5 FAM208B ITIH2 NET1 ZNF25 ZNF33A,cellular response to jasmonic acid stimulus|response to jasmonic acid|doxorubicin metabolic process|daunorubicin metabolic process|polyketide metabolic process,8.72e-09|8.72e-09|5.47e-08|5.47e-08|5.47e-08,0.0001375|6.877e-05|0.0002876|0.0002157|0.0001726,1103|1103|490.4|490.4|490.4
374,6,0.4179,6.269,4543.0,0.001374,0.998474,AGAP1 ANKRD18A C8orf34 NR5A2 PAX8 SOX17,animal organ formation|metanephros development|cellular response to leukemia inhibitory factor|response to leukemia inhibitory factor|regulation of thyroid-stimulating hormone secretion,5.213e-05|0.0002211|0.0002799|0.0002862|0.0005824,0.8223|1|1|1|1,185.5|88.01|78.01|77.13|3432
375,6,0.4136,6.204,4851.0,0.001274,0.998474,ACSL6 ANKRD2 EMILIN1 FDXACB1 GFAP HSPG2,extracellular matrix organization|extracellular structure organization|external encapsulating structure organization|negative regulation of angiogenesis|negative regulation of blood vessel morphogenesis,0.0001242|0.0001252|0.0001271|0.0003737|0.0003809,1|0.9873|0.6683|1|1,26.96|26.89|26.75|67.3|66.65
376,27,0.3414,119.8,21160.0,0.0056159999999999995,1.0,ANKRD36B ASTL C2orf49 CCDC74B CFC1 CFC1B CNNM4 FAHD2A IL1F10 IL1RN IL36G LYG1 LYG2 MGAT4A MITD1 MRPL30 MZT2A POTEI PROC PSD4 RNF149 SCTR SLC9A2 SULT1C2 TRIM43 TUBA3D TUBA3E,cell wall macromolecule catabolic process|cell wall organization or biogenesis|cell wall macromolecule metabolic process|inflammatory response to antigenic stimulus|peptidoglycan metabolic process,1.065e-05|1.773e-05|1.773e-05|1.832e-05|4.952e-05,0.168|0.1398|0.09323|0.07223|0.1562,735.5|490.4|490.4|63.05|245.2
377,5,0.429,4.29,4082.0,0.001047,0.996692,ANKRD24 CCDC88A CHCHD4 MEP1A TYMP,maintenance of protein location in plasma membrane|maintenance of protein location in membrane|dTMP catabolic process|protein import into mitochondrial intermembrane space|peptidyl-cysteine oxidation,0.000728|0.000728|0.0009706|0.0009706|0.0009706,1|1|1|1|1,2060|2060|1373|1373|1373
378,22,0.3825,88.35,16110.0,0.005438,1.0,ANKRD26 BID C2CD3 CASP2 CCP110 CCSAP CEP120 CEP135 CEP44 CEP76 CEP83 CNTROB CRADD FOPNL KIAA0753 PCM1 PIBF1 PIDD1 SCLT1 SSNA1 TUBE1 WRAP73,cell cycle process|cell cycle|centrosome cycle|microtubule organizing center organization|microtubule cytoskeleton organization,1.747e-16|2.615e-16|3.652e-16|1.082e-15|2.335e-15,2.755e-12|2.062e-12|1.92e-12|4.267e-12|7.368e-12,14|11.45|95.74|84.25|21.5
379,17,0.414,56.31,12350.0,0.004527000000000001,1.0,ANKRD30A ATP5F1C CDC123 CREM GTPBP4 HSD17B7 KIN MCM10 MTRNR2L7 PRPF18 RBM17 RPP38 UPF2 ZNF248 ZNF25 ZNF33A ZNF37A,organic cyclic compound metabolic process|RNA processing|nucleobase-containing compound metabolic process|heterocycle metabolic process|cellular aromatic compound metabolic process,0.0003816|0.0007198|0.0007418|0.001158|0.001281,1|1|1|1|1,3.418|6.563|3.564|3.337|3.288
380,28,0.4019,151.9,17530.0,0.008564,1.0,ARMH3 COG1 COG2 COG3 COG4 COG5 COG6 COG7 COG8 COL4A3BP EIPR1 GET4 PI4KB PTAR1 RAB1B RGP1 RIC1 SPTLC2 SPTSSA SYS1 TM9SF2 TRAPPC13 UNC50 VPS51 VPS52 VPS53 VPS54 YKT6,Golgi vesicle transport|intracellular transport|protein localization|establishment of protein localization|protein transport,3.765e-17|9.671e-16|1.651e-15|1.952e-15|1.533e-14,5.94e-13|7.628e-12|8.681e-12|7.699e-12|4.838e-11,26|9.323|7.158|8.97|9.05
381,8,0.4064,11.38,6362.0,0.0017809999999999998,0.9996790000000001,ANKRD31 CSH2 LIMD2 METTL2A METTL2B MRI1 PRR29 ZNF646,tRNA methylation|RNA methylation|tRNA modification|meiotic DNA double-strand break formation involved in reciprocal meiotic recombination|positive regulation of meiotic DNA double-strand break formation,0.0001182|0.0004967|0.0005427|0.0007765|0.0007765,1|1|1|1|1,125.6|59.87|57.21|2574|2574
382,36,0.3197,201.4,28180.0,0.007078,1.0,ADAMTS12 ANXA2R C1QTNF3 C5orf34 C5orf51 C7 CAPSL CCL28 CDH10 CDH12 CDH18 CDH6 CDH9 DNAH5 EGFLAM EXOC3 FAM173B FBXO4 FGF10 GHR HCN1 ICE1 IL7R NIM1K NNT OTULINL OXCT1 PLCXD3 PRLR SLC1A3 SLC45A2 TMEM267 TTC23L UBE2QL1 UGT3A1 UGT3A2,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|adherens junction organization|cell-cell junction assembly|homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell junction organization,1.52e-08|9.343e-08|2.765e-06|1.008e-05|1.672e-05,0.0002398|0.0007369|0.01454|0.03973|0.05276,70.05|47.45|23.17|17.62|15.82
383,26,0.3931,127.8,20740.0,0.006108,1.0,APBB2 CHRNA9 CNGA1 COMMD8 CORIN CWH43 FRYL GABRA2 GABRA4 GABRB1 GABRG1 KCTD8 MRFAP1L1 NIPAL1 OCIAD1 OCIAD2 SH3TC1 SLC10A4 SLIT2 TEC TLR1 TLR10 TLR6 TXK WDR19 ZAR1,"gamma-aminobutyric acid signaling pathway|regulation of postsynaptic membrane potential|synaptic transmission, GABAergic|chloride transmembrane transport|chloride transport",7.156e-08|2.296e-07|1.612e-06|8.723e-06|1.097e-05,0.001129|0.001811|0.008476|0.0344|0.0346,113|38.14|152.6|31.45|29.62
384,8,0.4011,11.23,6779.0,0.00165,0.9996790000000001,AAK1 ANKRD34B CTDSPL EMP2 GGCT LHX5 PAFAH2 ZNF512,positive regulation of integrin-mediated signaling pathway|cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation|bleb assembly|positive regulation of cerebellar granule cell precursor proliferation|membrane raft assembly,0.003103|0.003103|0.003877|0.003877|0.004264,1|1|1|1|1,367.8|367.8|286|286|257.4
385,6,0.4176,6.265,4899.0,0.001274,0.998474,ANKRD34C HLA-DOA MYRIP NCKIPSD PDE1B SPTBN5,negative regulation of antigen processing and presentation of peptide antigen via MHC class II|negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|regulation of antigen processing and presentation of peptide antigen via MHC class II|negative regulation of antigen processing and presentation of peptide antigen|regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,0.0008735|0.001165|0.001456|0.001456|0.001746,1|1|1|1|1,1716|1144|858.1|858.1|686.5
386,5,0.4032,4.032,3971.0,0.0010119999999999999,0.996692,ANKRD39 KCTD3 NPTX2 SPTBN2 THNSL1,protein K6-linked ubiquitination|cerebellar Purkinje cell layer morphogenesis|regulation of postsynaptic neurotransmitter receptor activity|behavior|cerebellar Purkinje cell layer development,0.002425|0.004362|0.004845|0.006745|0.006778,1|1|1|1|1,457.7|242.3|216.8|15.03|152.6
387,6,0.406,6.09,4721.0,0.001285,0.998474,ABLIM3 ANKRD40 CCT6B PCDHA5 PCDHA7 RCSD1,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|cellular hyperosmotic response|hyperosmotic response|cell-cell adhesion,0.000982|0.002319|0.00349|0.00697|0.008785,1|1|1|1|1,41.11|26.51|312|149.2|13.36
388,6,0.4013,6.02,4746.0,0.001263,0.998474,ANKRD42 C11orf16 GLTPD2 IRX4 LACRT MYL1,establishment of animal organ orientation|tear secretion|establishment of anatomical structure orientation|ceramide 1-phosphate transport|positive regulation of epithelial cell proliferation involved in wound healing,0.0008735|0.0008735|0.001165|0.002619|0.002909,1|1|1|1|1,1716|1716|1144|429.1|381.4
389,6,0.4148,6.222,4727.0,0.0013109999999999999,0.998474,ANKRD46 CCL26 CDK15 CYP2C19 FETUB MAP3K19,monoterpenoid metabolic process|omega-hydroxylase P450 pathway|T cell chemotaxis|eosinophil chemotaxis|eosinophil migration,0.002037|0.002909|0.004361|0.005232|0.005522,1|1|1|1|1,572.1|381.4|245.2|201.9|190.7
390,9,0.4216,15.18,5985.0,0.002522,0.9998530000000001,ANKRD49 CSNK1A1 CSNK1D FKBPL MRE11 ORC3 ORC4 ORC5 VEZT,DNA replication initiation|DNA-dependent DNA replication|pre-replicative complex assembly|DNA replication|mitotic cell cycle phase transition,8.666e-07|1.004e-06|2.847e-06|3.712e-06|4.519e-06,0.01367|0.007918|0.01497|0.01464|0.01426,159.7|47.18|105.6|33.78|32.12
391,8,0.415,11.62,6924.0,0.0016710000000000002,0.9996790000000001,ANKRD50 FBXO34 MB NPAS3 SIPA1L1 STXBP6 TNFRSF10C VSTM2L,vesicle-mediated transport to the plasma membrane|slow-twitch skeletal muscle fiber contraction|voluntary skeletal muscle contraction|twitch skeletal muscle contraction|TRAIL-activated apoptotic signaling pathway,0.0004744|0.001164|0.001552|0.001552|0.002715,1|1|1|1|1,61.29|1287|858.1|858.1|429.1
392,15,0.4024,42.25,12630.0,0.0033280000000000002,0.999999,ADGRV1 ANKRD55 ARSB BHMT BHMT2 CD180 CDH12 DMGDH F2R F2RL2 FST GAPT GZMK ITGA1 ITGA2,amino-acid betaine catabolic process|B cell proliferation involved in immune response|choline catabolic process|L-methionine salvage|L-methionine biosynthetic process,4.938e-06|1.381e-05|1.381e-05|1.775e-05|1.775e-05,0.07789|0.1089|0.07261|0.06998|0.05599,915.3|457.7|457.7|392.3|392.3
393,7,0.4022,8.445,5417.0,0.001552,0.9992989999999999,ANKRD6 PHLPP1 PKDREJ RNF219 USP46 WDR20 WDR48,protein deubiquitination|protein modification by small protein removal|protein modification by small protein conjugation or removal|regulation of JNK cascade|cellular protein modification process,8.438e-05|0.0001004|0.0001962|0.0008252|0.0011,1|0.7922|1|1|1,31.75|29.92|11.41|45.61|4.873
394,7,0.4115,8.641,5814.0,0.00148,0.9992989999999999,ANKRD62 CYP26B1 HRH4 IMPACT IRGC NIPAL1 SLC35G3,response to benomyl|cellular response to benomyl|positive regulation of tongue muscle cell differentiation|regulation of tongue muscle cell differentiation|GCN2-mediated signaling,0.0006794|0.0006794|0.001019|0.001019|0.001019,1|1|1|1|1,2942|2942|1471|1471|1471
395,5,0.4472,4.4719999999999995,3896.0,0.001144,0.996692,ANKRD65 BTNL9 IRX4 MTFP1 TMEM240,establishment of animal organ orientation|establishment of anatomical structure orientation|mitochondrial fission|response to muscle activity|response to activity,0.000728|0.0009706|0.005329|0.006295|0.01831,1|1|1|1|1,2060|1373|196.1|164.8|54.92
396,5,0.4016,4.016,3788.0,0.001056,0.996692,ANKRD66 CHGB OR10H4 PCOLCE2 ZNF589,"G protein-coupled serotonin receptor signaling pathway|serotonin receptor signaling pathway|G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger|cellular response to dopamine|response to dopamine",0.008467|0.009672|0.0164|0.01975|0.01999,1|1|1|1|1,121.1|105.6|61.48|50.85|50.23
397,7,0.4006,8.413,5893.0,0.001422,0.9992989999999999,ANKRD9 DACT1 DNAAF3 FZD7 MEDAG STX11 TJP2,regulation of establishment of planar polarity|negative regulation of ectodermal cell fate specification|regulation of ectodermal cell fate specification|regulation of JNK cascade|embryonic hindgut morphogenesis,0.000648|0.0006794|0.0006794|0.0008252|0.001019,1|1|1|1|1,51.62|2942|2942|45.61|1471
398,5,0.4251,4.251,3831.0,0.001106,0.996692,ANKS1B FAM160A2 GOLPH3L KDELR3 TNFAIP8L2,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum|regulation of synaptic plasticity by receptor localization to synapse|protein localization|macromolecule localization|vesicle organization",0.0001749|0.0004854|0.0005544|0.001062|0.002219,1|1|1|1|1,96.92|4119|7.635|6.461|26.57
399,5,0.4381,4.381,3996.0,0.001092,0.996692,ANKS3 BCL7C FPGT NEK7 PLD1,regulation of microvillus assembly|regulation of synaptic vesicle cycle|regulation of microvillus organization|fucose metabolic process|positive regulation of telomere capping,0.001698|0.002183|0.003394|0.00412|0.004362,1|1|1|1|1,686.5|514.9|316.8|257.4|242.3
400,5,0.447,4.47,3959.0,0.001125,0.996692,ANKS4B ETNK2 OR2T27 SERPINF1 WDFY4,protein localization to microvillus|cellular response to cobalt ion|brush border assembly|negative regulation of epithelial cell proliferation involved in prostate gland development|response to cobalt ion,0.000728|0.001213|0.001456|0.001698|0.002667,1|1|1|1|1,2060|1030|823.8|686.5|411.9
401,4,0.4586,2.752,3052.0,0.0008986,0.9929309999999999,ANKS6 FAM131C ISLR NR2F2,radial pattern formation|lymphatic endothelial cell fate commitment|endothelial cell fate commitment|lymphatic endothelial cell differentiation|in utero embryonic development,0.0003883|0.0007766|0.001747|0.001747|0.001756,1|1|1|1|1,5149|1716|643.6|643.6|29.01
402,42,0.3036,261.4,32780.0,0.007892,1.0,ADCY10 ANKZF1 ANO2 AP5M1 ATXN7L3B AZU1 BBS7 BRINP2 C8orf44 CARNS1 CCDC25 CCNB1IP1 CTDSP1 DHX32 DPYSL5 DTWD1 ERMARD FEZF2 INIP KIAA1257 KIF26B LRRN1 LYRM1 MAP3K7CL MCOLN3 NDRG3 NECAP2 NIPSNAP3B PCBP4 PCDHA4 PCDHB12 PCDHB13 PCDHGA9 RAB22A RNF114 SDR39U1 SLC25A36 SLC25A40 TMEM100 TXNDC16 ZNF286A ZNF512B,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|regulation of biological process|fractalkine production|carnosine biosynthetic process,0.0004364|0.002153|0.003118|0.004163|0.004163,1|1|1|1|1,11.47|7.397|0.606|479|479
403,10,0.4136,18.61,6756.0,0.002739,0.999933,ANLN BIRC5 DIAPH3 ECT2 FLII KIF20A KIF23 NUF2 PRC1 RACGAP1,mitotic cytokinesis|cytoskeleton-dependent cytokinesis|cell division|cytokinesis|mitotic cell cycle process,3.621e-13|2.62e-12|4.906e-12|5.179e-12|6.671e-11,5.712e-09|2.066e-08|2.579e-08|2.042e-08|2.105e-07,181.7|128.7|33.49|114.4|24.05
404,10,0.4016,18.07,7881.0,0.002282,0.999933,BEAN1 JAG2 LRP10 LRRC61 PREP RBM47 STARD10 SUSD6 TMEM127 WWP2,odontogenesis of dentin-containing tooth|epithelial cell apoptotic process involved in palatal shelf morphogenesis|regulation of Notch signaling pathway|positive regulation of presynaptic membrane organization|regulation of presynaptic membrane organization,0.00103|0.001164|0.001736|0.001746|0.001746,1|1|1|1|1,42.38|1716|32.38|858.1|858.1
405,5,0.4288,4.288,3923.0,0.0010890000000000001,0.996692,ALMS1 ALS2CR12 ANO9 CXCL14 TMEFF2,regulation of stress fiber assembly|regulation of actomyosin structure organization|regulation of actin filament bundle assembly|negative regulation of intracellular calcium activated chloride channel activity|negative regulation of integrin biosynthetic process,0.0001913|0.0002265|0.0002452|0.0004854|0.000728,1|1|1|1|1,92.56|84.93|81.56|4119|2060
406,6,0.4313,6.468999999999999,4576.0,0.001408,0.998474,ANP32A ERH IKZF2 IRAK2 PPP1R3D PTGER4,JNK cascade|stress-activated MAPK cascade|stress-activated protein kinase signaling cascade|negative regulation of eosinophil extravasation|regulation of eosinophil extravasation,0.0002676|0.0004255|0.0005478|0.0005824|0.0005824,1|1|1|1|1,79.83|62.98|55.36|3432|3432
407,7,0.4045,8.494,5772.0,0.001466,0.9992989999999999,ACVR1C ANTXR1 ARL14EPL GKN1 KRT71 SLC24A5 TEX35,negative regulation of extracellular matrix assembly|trophectodermal cell proliferation|negative regulation of chorionic trophoblast cell proliferation|positive regulation of peptidase activity|regulation of chorionic trophoblast cell proliferation,0.0006794|0.001019|0.001019|0.001888|0.002037,1|1|1|1|1,2942|1471|1471|29.87|588.4
408,7,0.4338,9.111,5683.0,0.0015970000000000001,0.9992989999999999,ANTXR2 ETV3L KCNN2 RASGRP1 RMND5B TCP10 WDR47,atrial cardiac muscle cell membrane repolarization|membrane repolarization during atrial cardiac muscle cell action potential|positive regulation of natural killer cell differentiation|positive regulation of T cell differentiation in thymus|regulation of natural killer cell differentiation,0.002037|0.002037|0.002715|0.003732|0.004071,1|1|1|1|1,588.4|588.4|420.3|294.2|267.5
409,6,0.4398,6.597,4872.0,0.001349,0.998474,ANTXRL KCNH2 KIAA0408 OTOP3 PDIA5 PPFIA1,regulation of heart rate by hormone|negative regulation of potassium ion export across plasma membrane|regulation of heart rate by chemical signal|regulation of potassium ion export across plasma membrane|ventricular cardiac muscle cell membrane repolarization,0.0008735|0.001165|0.002037|0.002328|0.003781,1|1|1|1|1,1716|1144|572.1|490.4|286
410,6,0.4331,6.497000000000001,4758.0,0.0013599999999999999,0.998474,ANXA1 C3orf18 DAB1 MAN1C1 MARCH7 SLC9A3R1,Golgi localization|negative regulation of cell adhesion|negative regulation of T cell activation|renal phosphate ion absorption|cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration,8.468e-06|5.028e-05|0.0004971|0.0005824|0.0005824,0.1336|0.3966|1|1|1,490.4|36.65|58.18|3432|3432
411,7,0.4234,8.89,5986.0,0.00148,0.9992989999999999,ANXA11 COL22A1 COTL1 KLHL38 MYADML2 NYAP1 PPP1R27,endothelial cell morphogenesis|epithelial cell morphogenesis|cytokinetic process|phosphatidylinositol 3-kinase signaling|defense response to fungus,0.004748|0.01116|0.01217|0.01318|0.01486,1|1|1|1|1,226.3|91.94|84.06|77.42|68.42
412,6,0.4021,6.032,4811.0,0.0012490000000000001,0.998474,ADORA2B ANXA3 LRRC32 NPSR1 RIDA RXRB,negative regulation of immune system process|regulation of transforming growth factor beta3 activation|positive regulation of macromolecule metabolic process|positive regulation of biological process|positive regulation of metabolic process,0.0004274|0.0005824|0.0006653|0.0007784|0.0009817,1|1|1|1|1,17.69|3432|5.002|3.298|4.615
413,9,0.4051,14.58,7661.0,0.0018960000000000001,0.9998530000000001,ANXA4 FOSL2 KHK MESD PLB1 SPDYA TMIE TOGARAM2 TRIM54,positive regulation of skeletal muscle acetylcholine-gated channel clustering|fructose catabolic process|fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate|regulation of skeletal muscle acetylcholine-gated channel clustering|positive regulation of receptor clustering,0.001746|0.002618|0.002618|0.002618|0.00349,1|1|1|1|1,762.8|457.7|457.7|457.7|326.9
414,7,0.422,8.861,5815.0,0.001518,0.9992989999999999,ANXA5 BTN3A2 DNASE1 MYCBPAP NEURL1 TDGF1 TMEM246,mammary gland development|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of long-term neuronal synaptic plasticity|regulation of neutrophil mediated cytotoxicity|regulation of peptidyl-tyrosine phosphorylation,0.0008252|0.001851|0.002037|0.002376|0.00322,1|1|1|1|1,45.61|30.18|588.4|490.4|22.72
415,7,0.4118,8.647,5832.0,0.001477,0.9992989999999999,AOAH CTRL FAM69C PLA2G12A SFI1 TNK2 ZNF70,lipopolysaccharide catabolic process|lipopolysaccharide metabolic process|lipid catabolic process|phosphatidylinositol acyl-chain remodeling|phosphatidylglycerol acyl-chain remodeling,0.0006794|0.0006794|0.004396|0.006439|0.006439,1|1|1|1|1,2942|2942|19.36|163.5|163.5
416,23,0.4986,126.1,16100.0,0.007751000000000001,1.0,ATG10 ATG101 ATG12 ATG13 ATG14 ATG16L1 ATG3 ATG4B ATG5 ATG7 ATG9A BECN1 DNAJC13 EPG5 GABARAP IRF3 PIK3C3 PIK3R4 RB1CC1 TBK1 TMEM173 ULK1 WIPI2,macroautophagy|autophagy|process utilizing autophagic mechanism|autophagosome assembly|autophagosome organization,1.018e-35|4.956e-32|4.956e-32|9.17e-30|1.645e-29,1.606e-31|3.909e-28|2.606e-28|3.616e-26|5.188e-26,92.64|58.13|58.13|208|198.6
417,7,0.4397,9.234,5753.0,0.001599,0.9992989999999999,AP1AR ATP2C2 CD300LG F2RL2 PARP16 PDGFB WASF1,regulation of Arp2/3 complex-mediated actin nucleation|positive regulation of calcium ion import|regulation of actin nucleation|regulation of calcium ion import|metanephric glomerular mesangial cell development,2.495e-05|2.722e-05|4.885e-05|9.298e-05|0.0006794,0.3936|0.2146|0.2568|0.3667|1,280.2|267.5|196.1|140.1|2942
418,6,0.4011,6.017,4871.0,0.001231,0.998474,AP1S3 GALNT18 KLHL30 MADD PVR UGT1A7,susceptibility to T cell mediated cytotoxicity|susceptibility to natural killer cell mediated cytotoxicity|flavone metabolic process|positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target|regulation of Rab protein signal transduction,0.0008735|0.001165|0.002037|0.002037|0.002328,1|1|1|1|1,1716|1144|572.1|572.1|490.4
419,20,0.4023,76.44,16360.0,0.00464,1.0,AP3B2 BNIP2 C15orf53 CELF6 CSNK1G1 DUOXA1 FBXL22 GOLGA6B MAP2K5 MYO5C PLA2G4D PLA2G4E PLEKHO2 PPIB RAB8B SCAMP2 SCAMP5 SLC24A1 SNX22 THAP10,phosphatidylinositol acyl-chain remodeling|phosphatidylserine acyl-chain remodeling|phosphatidylethanolamine acyl-chain remodeling|glycerophospholipid catabolic process|phosphatidylcholine acyl-chain remodeling,0.0001514|0.0002195|0.0002999|0.0003683|0.0003927,1|1|1|1|1,120.4|98.54|83.38|74.75|72.26
420,30,0.3814,165.9,23720.0,0.006927,1.0,ADCY10 AP5M1 ARMC1 ATXN7L3B C8orf44 CCNB1IP1 FEZF2 KIAA1257 KIF26B LRRN1 LYRM1 MAP3K7CL NECAP2 NIPSNAP3B PCDH10 PCDHA4 PCDHB10 PCDHB12 PCDHB13 PCDHB16 PCDHGA9 PCDHGB1 RNF114 RNF150 SDR39U1 SLC25A36 TMEM100 TXNDC16 ZNF286A ZNF512B,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|cell-cell adhesion|response to stimulus|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,1.527e-10|4.329e-09|7.534e-07|2.598e-05|4.179e-05,2.409e-06|3.414e-05|0.003961|0.1024|0.1319,31.83|20.52|10.34|0.1564|47.45
421,6,0.4025,6.037000000000001,4844.0,0.001242,0.998474,AP4M1 ENO2 OR51M1 TMPRSS11A UGT2A1 ZNF732,"regulation of vacuole fusion, non-autophagic|protein localization to basolateral plasma membrane|Golgi to lysosome transport|Golgi to endosome transport|Golgi to vacuole transport",0.001456|0.002328|0.00349|0.005232|0.005812,1|1|1|1|1,858.1|490.4|312|201.9|180.7
422,6,0.4079,6.117999999999999,4670.0,0.0013050000000000002,0.998474,AP5Z1 GNPDA2 NADK NMRK1 RDM1 SNAP25,pyridine nucleotide biosynthetic process|nicotinamide nucleotide biosynthetic process|pyridine nucleotide metabolic process|nicotinamide nucleotide metabolic process|pyridine-containing compound biosynthetic process,3.718e-05|3.718e-05|4.434e-05|4.434e-05|4.687e-05,0.5864|0.2932|0.2331|0.1749|0.1479,221.5|221.5|201.9|201.9|196.1
423,15,0.4022,42.23,12140.0,0.0034590000000000003,0.999999,APBA1 C9orf3 FAM189A2 FBP1 FBP2 FOXB2 GNA14 NUTM2G PALM2 PIP5K1B PRKACG TXNDC8 ZNF484 ZNF510 ZNF782,"sucrose biosynthetic process|sucrose metabolic process|disaccharide biosynthetic process|fructose 1,6-bisphosphate metabolic process|disaccharide metabolic process",3.387e-06|5.642e-06|1.184e-05|3.095e-05|4.385e-05,0.05342|0.0445|0.06224|0.122|0.1383,1287|858.1|514.9|286|234
424,6,0.4405,6.608,4888.0,0.001347,0.998474,APBA3 C19orf38 GPR27 MCFD2 PRADC1 TBC1D26,positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway|regulation of phospholipase C-activating G protein-coupled receptor signaling pathway|protein transport|peptide transport|amide transport,0.001456|0.001746|0.006108|0.006456|0.00688,1|1|1|1|1,858.1|686.5|7.039|6.902|6.748
425,5,0.7577,7.577000000000001,3329.0,0.002264,0.996692,APC AXIN1 CSNK1A1 CTNNBIP1 ZNRF3,negative regulation of Wnt signaling pathway|beta-catenin destruction complex assembly|cell-cell signaling by wnt|Wnt signaling pathway|regulation of Wnt signaling pathway,1.298e-10|3.843e-10|1.457e-09|1.457e-09|1.845e-09,2.047e-06|3.031e-06|7.663e-06|5.747e-06|5.821e-06,96.24|2471|59.01|59.01|56.27
426,5,0.4514,4.513999999999999,4051.0,0.0011099999999999999,0.996692,APCDD1L ARHGAP12 CCNY GPR135 PTGER2,cellular response to prostaglandin E stimulus|cellular response to prostaglandin stimulus|response to prostaglandin E|response to prostaglandin|cellular response to alcohol,1.079e-05|1.784e-05|2.29e-05|3.718e-05|0.0002676,0.1703|0.1407|0.1204|0.1466|0.8442,429.1|326.9|286|221.5|79.83
427,6,0.4235,6.352,4736.0,0.001336,0.998474,APCS BCAR3 CCDC150 KCNT2 MFNG SLC27A6,negative regulation of exo-alpha-sialidase activity|negative regulation by host of viral glycoprotein metabolic process|modulation by host of viral glycoprotein metabolic process|negative regulation by host of viral exo-alpha-sialidase activity|modulation by host of viral catalytic activity,0.0008735|0.0008735|0.0008735|0.0008735|0.0008735,1|1|1|1|1,1716|1716|1716|1716|1716
428,5,0.4454,4.454,3956.0,0.0011220000000000002,0.996692,APH1B CDH13 LMO7 PGBD4 TMEM87A,"low-density lipoprotein particle mediated signaling|lipoprotein particle mediated signaling|Notch receptor processing, ligand-dependent|amyloid-beta formation|Notch receptor processing",0.0009706|0.0009706|0.00194|0.002667|0.002667,1|1|1|1|1,1373|1373|588.4|411.9|411.9
429,10,0.4216,18.97,6732.0,0.002802,0.999933,ACIN1 API5 CHTOP DDX39B POLDIP3 RBM33 SARNP SNRPA THOC6 ZC3HC1,mRNA 3'-end processing|mRNA processing|mRNA export from nucleus|mRNA-containing ribonucleoprotein complex export from nucleus|ribonucleoprotein complex export from nucleus,4.159e-10|4.717e-10|1.277e-09|1.277e-09|2.456e-09,6.56e-06|3.72e-06|6.717e-06|5.038e-06|7.747e-06,117|29.79|92.77|92.77|81.08
430,4,0.4494,2.697,2797.0,0.0009605000000000001,0.9929309999999999,APIP CDKN1A TFAP4 ZNF865,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|DNA damage response, signal transduction resulting in transcription|negative regulation of cyclin-dependent protein serine/threonine kinase activity|negative regulation of cyclin-dependent protein kinase activity|DNA damage response, signal transduction by p53 class mediator",3.843e-06|4.323e-06|1.313e-05|1.4e-05|9.117e-05,0.06061|0.03409|0.06902|0.05521|0.2876,686.5|643.6|355.1|343.2|130.3
431,9,0.401,14.44,7539.0,0.001907,0.9998530000000001,APLF CD300LG DDRGK1 F2RL2 IFT172 LBH PSKH1 TNFSF11 WASF1,regulation of intracellular estrogen receptor signaling pathway|mammary gland epithelium development|regulation of response to stimulus|regulation of signal transduction|regulation of intracellular steroid hormone receptor signaling pathway,0.0001663|0.0002963|0.0003814|0.0005902|0.0006512,1|1|1|1|1,106.4|78.91|3.778|4.506|52.61
432,7,0.4111,8.632,5691.0,0.001511,0.9992989999999999,APOA1 CCL1 RGMA SDS TBKBP1 VAT1 VTN,negative regulation of response to wounding|regulation of response to external stimulus|regulation of hydrolase activity|negative regulation of response to external stimulus|smooth muscle cell-matrix adhesion,0.0005545|0.0006342|0.0009311|0.0009738|0.001164,1|1|1|1|1,56.58|8.712|7.873|14.04|1287
433,6,0.4105,6.157,4806.0,0.001276,0.998474,APOBEC2 CALHM4 LARGE1 PIH1D1 RIPPLY2 RPAP3,negative regulation of histone H3-K9 dimethylation|positive regulation of glucose mediated signaling pathway|regulation of glucose mediated signaling pathway|negative regulation of histone H4-K16 acetylation|regulation of histone H3-K9 dimethylation,0.0008735|0.001165|0.001165|0.001165|0.001165,1|1|1|1|1,1716|1144|1144|1144|1144
434,6,0.4335,6.502999999999999,4738.0,0.001367,0.998474,APOBEC3H GGT5 PI4KA RAB3IP RCN3 RPTN,viral replication complex formation and maintenance|organonitrogen compound catabolic process|collagen biosynthetic process|leukotriene D4 biosynthetic process|leukotriene D4 metabolic process,0.0005824|0.00257|0.002909|0.0032|0.0032,1|1|1|1|1,3432|9.535|381.4|343.2|343.2
435,52,0.3184,422.2,41290.0,0.0101,1.0,C5AR1 ERVV-1 ERVV-2 FFAR3 FPR1 FPR2 FPR3 GPR32 KIR2DL1 KIR2DL3 KLK11 KLK3 LILRA4 NLRP11 SIGLEC10 SIGLEC12 SIGLEC5 SIGLEC7 SIGLEC8 SIGLEC9 SULT2B1 VN1R4 ZFP28 ZNF175 ZNF28 ZNF320 ZNF347 ZNF415 ZNF416 ZNF432 ZNF480 ZNF528 ZNF534 ZNF571 ZNF577 ZNF578 ZNF600 ZNF610 ZNF613 ZNF614 ZNF615 ZNF649 ZNF665 ZNF677 ZNF701 ZNF765 ZNF808 ZNF813 ZNF816 ZNF83 ZNF841 ZNF880,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|cellular process",6.59e-14|1.286e-10|1.296e-10|1.344e-10|6.731e-10,1.039e-09|1.014e-06|6.812e-07|5.298e-07|2.124e-06,4.424|3.303|3.302|3.297|0.4679
436,7,0.4466,9.379,5624.0,0.001661,0.9992989999999999,APOC2 CD96 COL4A1 FXR1 FXR2 KY OTUD4,"regulation of filopodium assembly|regulation of alternative mRNA splicing, via spliceosome|regulation of mRNA splicing, via spliceosome|positive regulation of response to DNA damage stimulus|positive regulation of translation",0.0001155|0.0001735|0.0005213|0.0006043|0.0009151,1|1|1|1|1,125.2|101.5|57.69|53.49|43.27
437,6,0.4049,6.0729999999999995,4936.0,0.0012259999999999999,0.998474,APOC3 CELA3B HOXD1 RAB11B TMCO4 TTC12,negative regulation of high-density lipoprotein particle clearance|negative regulation of sterol import|negative regulation of cholesterol import|regulation of high-density lipoprotein particle clearance|regulation of sterol import,0.0005824|0.0008735|0.0008735|0.001165|0.001456,1|1|1|1|1,3432|1716|1716|1144|858.1
438,67,0.4002,884.9,52710.0,0.01647,1.0,APOC2 APOC4 C5AR1 CATSPERG CBLC CCDC61 CEACAM19 CEACAM4 CEACAM6 CEACAM8 CLC CYP2A13 CYP2B6 EID2 EID2B EML2 FBXO27 FFAR2 FFAR3 HKR1 IFNL1 IFNL3 IGFL1 IGFL2 IGFL3 IGFL4 LGALS13 LGALS14 LGALS16 LGALS7B MAG PGLYRP1 PLEKHG2 PSG6 PSG8 PVR SCGB2B2 UPK1A WDR87 ZFP14 ZFP82 ZNF155 ZNF222 ZNF230 ZNF284 ZNF285 ZNF302 ZNF382 ZNF383 ZNF45 ZNF461 ZNF527 ZNF540 ZNF546 ZNF566 ZNF567 ZNF568 ZNF569 ZNF570 ZNF571 ZNF573 ZNF585B ZNF599 ZNF607 ZNF780B ZNF790 ZNF792,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of gene expression",7.303e-10|7.77e-09|7.826e-09|8.112e-09|2.171e-08,1.152e-05|6.128e-05|4.115e-05|3.199e-05|6.849e-05,3.396|2.798|2.797|2.793|2.362
439,6,0.4291,6.436,4880.0,0.001314,0.998474,APOE COL23A1 PLCB1 SIRPD SPHKAP TNNC1,skeletal muscle contraction|actin-myosin filament sliding|muscle filament sliding|musculoskeletal movement|multicellular organismal movement,5.523e-05|7.671e-05|7.671e-05|0.0001017|0.0001017,0.8712|0.605|0.4034|0.401|0.3208,183.9|154.8|154.8|133.7|133.7
440,6,0.4042,6.063,4881.0,0.0012380000000000002,0.998474,AMDHD2 APOF CHST3 HAL PRDX5 RIN1,N-acetylglucosamine metabolic process|glucosamine-containing compound metabolic process|amino sugar metabolic process|regulation of apoptosis involved in tissue homeostasis|N-acetylglucosamine catabolic process,1.481e-05|2.663e-05|6.35e-05|0.0005824|0.001165,0.2336|0.21|0.3339|1|1,361.3|264|167.4|3432|1144
441,14,0.403,36.67,9704.0,0.003754,0.9999969999999999,ESR1 FOXA1 GATA3 GRHL2 LMX1B QRICH1 QSER1 SEPHS1 SPDEF TFAP2A TFAP2C TOB1 TRPS1 ZNF652,"positive regulation of RNA metabolic process|positive regulation of transcription by RNA polymerase II|lung epithelial cell differentiation|lung cell differentiation|negative regulation of transcription, DNA-templated",2.711e-07|3.093e-07|4.384e-07|5.008e-07|5.11e-07,0.004276|0.002439|0.002305|0.001975|0.001612,7.706|9.758|220.7|210.2|9.137
442,6,0.4123,6.184,5009.0,0.00123,0.998474,APOL6 ATP8B4 CAMTA2 CDA PAH RIN3,"tyrosine biosynthetic process|aromatic amino acid family biosynthetic process, prephenate pathway|aromatic amino acid family biosynthetic process|negative regulation of mast cell chemotaxis|cytosine metabolic process",0.0005824|0.0005824|0.0005824|0.0005824|0.0008735,1|1|1|1|1,3432|3432|3432|3432|1716
443,8,0.4121,11.54,6157.0,0.001866,0.9996790000000001,APP ATP6V0A2 KCNK5 NOTCH1 NPEPPS PPP2CB SLC12A7 SUCLA2,response to lead ion|cellular response to oxygen levels|astrocyte differentiation|negative regulation of neuron differentiation|response to oxygen levels,3.94e-05|6.378e-05|0.0001869|0.0003144|0.0003407,0.6215|0.503|0.9827|1|1,223.9|35.76|99.01|75.72|20.16
444,4,0.435,2.61,3102.0,0.0008384999999999999,0.9929309999999999,AQP11 HAS1 RALA RBM15B,hydrogen peroxide transmembrane transport|protein glycosylation in endoplasmic reticulum|extracellular polysaccharide biosynthetic process|extracellular polysaccharide metabolic process|endosomal lumen acidification,0.0003883|0.0005825|0.0007766|0.0007766|0.0009706,1|1|1|1|1,5149|2574|1716|1716|1287
445,5,0.4399,4.399,4115.0,0.001065,0.996692,AQP12B C2orf50 CRELD1 LRRC7 SSMEM1,regulation of NMDA receptor activity|receptor localization to synapse|endocardial cushion development|establishment or maintenance of epithelial cell apical/basal polarity|receptor clustering,0.009913|0.009913|0.01064|0.01088|0.01112,1|1|1|1|1,103|103|95.79|93.61|91.53
446,6,0.4064,6.096,4973.0,0.001221,0.998474,AQP3 COBLL1 FRMD1 KLHL18 SPSB1 TMEM236,renal water absorption|renal water transport|positive regulation of hippo signaling|cellular response to oxygen-glucose deprivation|glycerol transport,0.001165|0.001746|0.001746|0.002328|0.002328,1|1|1|1|1,1144|686.5|686.5|490.4|490.4
447,6,0.4118,6.1770000000000005,4860.0,0.001266,0.998474,AQP4 ASIC4 EPPIN LRP5L PRLH TRIM2,negative regulation of cilium-dependent cell motility|negative regulation of flagellated sperm motility|negative regulation of cilium movement|reduction of food intake in response to dietary excess|retinal blood vessel morphogenesis,0.001456|0.001456|0.001456|0.001746|0.002037,1|1|1|1|1,858.1|858.1|858.1|686.5|572.1
448,29,0.4006,162.6,22790.0,0.00707,1.0,AQP9 ARHGAP11B BNIP2 C15orf53 CHRFAM7A CHRNA7 DEXI DUOXA1 DUOXA2 EPB42 GABRA5 GOLGA8M MYO5A MYO5C NIPA2 PIGH PLA2G4D PLA2G4E PLEKHO2 PPIB RASGRP1 RPUSD2 SCAMP2 SNURF SNX22 TGM5 TMCO5A TYRO3 WDR76,"synaptic transmission, cholinergic|regulation of postsynaptic membrane potential|positive regulation of hydrogen peroxide biosynthetic process|regulation of thyroid hormone generation|positive regulation of hydrogen peroxide metabolic process",9.891e-06|1.511e-05|4.276e-05|5.696e-05|7.316e-05,0.156|0.1192|0.2248|0.2246|0.2308,79.21|27.46|274.6|228.8|196.1
449,13,0.6657,51.92,8358.0,0.006155,0.999993,CHMP5 CHMP6 CLTC HGS PTPN23 SNF8 STAMBP TFG UBAP1 USP8 VPS25 VPS36 VPS37A,endosomal transport|multivesicular body assembly|multivesicular body organization|endosome organization|ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,1.197e-17|5.604e-17|6.867e-17|7.56e-17|7.616e-15,1.888e-13|4.42e-13|3.611e-13|2.981e-13|2.403e-11,67.99|369.7|357.7|164.6|413.3
450,6,0.4165,6.247999999999999,4573.0,0.001361,0.998474,AREG BSPRY CMIP DEFB135 PDE7A ZNF646,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis|epithelial cell proliferation involved in mammary gland duct elongation|thelarche|branch elongation involved in mammary gland duct branching|mammary gland branching involved in thelarche,0.0005824|0.001456|0.001746|0.001746|0.001746,1|1|1|1|1,3432|858.1|686.5|686.5|686.5
451,7,0.4086,8.58,4191.0,0.002036,0.9992989999999999,ARF1 ARF4 COPG1 MON2 SLC39A9 TM9SF3 UNC50,Golgi vesicle transport|protein localization|macromolecule localization|protein transport|peptide transport,4.678e-06|8.504e-06|2.27e-05|3.393e-05|3.733e-05,0.07379|0.06707|0.1194|0.1338|0.1178,29.72|8.18|6.923|10.06|9.86
452,6,0.4128,6.192,4863.0,0.001268,0.998474,ARFGAP2 FBXL15 HECTD2 SMLR1 TRIM42 ZNRF1,protein polyubiquitination|protein ubiquitination|protein modification by small protein conjugation|COPI-coated vesicle budding|COPI coating of Golgi vesicle,7.511e-05|0.0008646|0.001165|0.002037|0.002037,1|1|1|1|1,31.98|13.9|12.54|572.1|572.1
453,7,0.4039,8.482999999999999,4993.0,0.001691,0.9992989999999999,ARFGAP3 GRK3 MDM2 MDM4 UBE2D1 UBE2D2 UBE2D3,TRIF-dependent toll-like receptor signaling pathway|MyD88-independent toll-like receptor signaling pathway|protein K48-linked ubiquitination|protein autoubiquitination|protein polyubiquitination,1.305e-07|1.707e-07|8.151e-07|1.418e-06|2.075e-06,0.002058|0.001346|0.004286|0.005592|0.006546,294.2|267.5|154.8|127.9|36.55
454,7,0.4093,8.594,5713.0,0.001498,0.9992989999999999,ARFGEF3 COL6A1 HGF IL10RB MAP2 TIMP4 TMPRSS3,negative regulation of hydrolase activity|negative regulation of catalytic activity|negative regulation of microtubule motor activity|negative regulation of molecular function|positive regulation of anterograde dense core granule transport,2.803e-05|0.0002648|0.0008734|0.001052|0.00131,0.4421|1|1|1|1,20.12|11.24|2288|7.817|1144
455,5,0.4534,4.534,3974.0,0.001137,0.996692,ARFIP1 CHRNE MCRIP2 SLC30A4 SNCAIP,"negative regulation of retrograde transport, endosome to Golgi|negative regulation of cytoplasmic transport|regulation of sequestering of zinc ion|regulation of retrograde transport, endosome to Golgi|regulation of inclusion body assembly",0.0004854|0.0009706|0.001456|0.001698|0.004604,1|1|1|1|1,4119|1373|823.8|686.5|228.8
456,5,0.4352,4.352,3891.0,0.001114,0.996692,ARFIP2 BTN1A1 IQCA1 SLC17A4 TMEM170B,sialic acid transport|regulation of Arp2/3 complex-mediated actin nucleation|ruffle organization|regulation of actin nucleation|lamellipodium assembly,0.001456|0.005329|0.006778|0.007502|0.008949,1|1|1|1|1,823.8|196.1|152.6|137.3|114.4
457,5,0.441,4.41,3969.0,0.0011070000000000001,0.996692,ARG1 CCDC186 FAM131B IL12RB2 NXPH3,regulation of L-arginine import|positive regulation of neutrophil mediated killing of fungus|regulation of neutrophil mediated killing of fungus|arginine catabolic process to ornithine|positive regulation of neutrophil mediated killing of symbiont cell,0.0004854|0.000728|0.000728|0.000728|0.0009706,1|1|1|1|1,4119|2060|2060|2060|1373
458,8,0.4071,11.4,6592.0,0.0017219999999999998,0.9996790000000001,ADAM21 ARG2 ECI2 FGR MEP1A NICN1 PACS1 WSCD2,"negative regulation of chemokine (C-C motif) ligand 4 production|regulation of chemokine (C-C motif) ligand 4 production|negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process|arginine catabolic process to ornithine|negative regulation of lymphocyte activation",0.0007765|0.0007765|0.001164|0.001164|0.001509,1|1|1|1|1,2574|2574|1287|1287|33.87
459,7,0.4246,8.917,6090.0,0.001459,0.9992989999999999,ARHGAP10 BMP7 ERGIC1 IL5RA KLF11 TACR3 TMC5,nephrogenic mesenchyme morphogenesis|interleukin-5-mediated signaling pathway|allantois development|response to estradiol|regulation of hyaluranon cable assembly,0.001164|0.001164|0.001164|0.00125|0.001552,1|1|1|1|1,1287|1287|1287|37.31|858.1
460,6,0.4019,6.029,4749.0,0.001265,0.998474,ARHGAP15 CLDND2 GCA NAGLU OTX1 TACC2,metencephalon development|ear morphogenesis|hindbrain development|brain development|head development,0.0004409|0.0004889|0.000775|0.0008783|0.001034,1|1|1|1|1,61.85|58.68|46.39|13.82|13.07
461,6,0.4217,6.3260000000000005,4692.0,0.001343,0.998474,ARHGAP18 GNS HIP1 MAP3K5 STATH STXBP5,positive regulation of hydrolase activity|regulation of hydrolase activity|positive regulation of catalytic activity|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of molecular function,2.893e-05|0.0002214|0.0003004|0.0006756|0.0007071,0.4563|1|1|1|1,17.67|10.5|9.703|49.75|7.775
462,5,0.4556,4.556,4004.0,0.001134,0.996692,ARHGAP19 LRRN4 TRIM62 ZNF524 ZNF865,negative regulation of viral transcription|regulation of viral release from host cell|long-term memory|negative regulation of epithelial to mesenchymal transition|regulation of viral transcription,0.004942|0.008996|0.01015|0.01044|0.01275,1|1|1|1|1,214.5|114.4|101|98.07|79.83
463,5,0.4134,4.1339999999999995,3993.0,0.001032,0.996692,ACTN1 ARHGAP20 BSDC1 NRSN2 PTDSS2,phosphatidylserine biosynthetic process|actin filament network formation|platelet formation|platelet morphogenesis|focal adhesion assembly,0.001213|0.003152|0.004604|0.004845|0.00702,1|1|1|1|1,1030|343.3|228.8|216.8|147.1
464,5,0.4364,4.364,3937.0,0.001104,0.996692,ARHGAP22 ASCL5 CYB561D1 MX2 PDE4A,regulation of synapse structure or activity|synaptic vesicle budding from presynaptic endocytic zone membrane|dynamin family protein polymerization involved in mitochondrial fission|dynamin family protein polymerization involved in membrane fission|postsynaptic endocytosis,0.001122|0.00194|0.002183|0.002183|0.002425,1|1|1|1|1,37.62|588.4|514.9|514.9|457.7
465,5,0.4349,4.349,4014.0,0.00108,0.996692,ARHGAP23 MRPL9 SOCS7 SYNJ2BP TMEM150B,phosphatidylinositol phosphorylation|regulation of phosphatidylinositol 3-kinase activity|regulation of lipid kinase activity|lipid phosphorylation|phosphatidylinositol metabolic process,0.0001201|0.0001242|0.0001791|0.0001892|0.00115,1|0.9795|0.9415|0.746|1,120.4|118.4|98.07|95.35|37.93
466,6,0.4211,6.317,4525.0,0.00139,0.998474,ARHGAP24 C8orf59 FAM207A LPO SLC24A4 ZNF277,"thiocyanate metabolic process|negative regulation of Rac protein signal transduction|negative regulation of ruffle assembly|wound healing, spreading of epidermal cells|ribosome biogenesis",0.0005824|0.001165|0.002037|0.0032|0.003765,1|1|1|1|1,3432|1144|572.1|343.2|20.68
467,7,0.4247,8.92,5708.0,0.001556,0.9992989999999999,ADAMTSL2 ARHGAP25 HTR3C LTF NOTO SIX3 TRABD2A,dorsal/ventral pattern formation|negative regulation of signal transduction|negative regulation of cell communication|negative regulation of signaling|siderophore-dependent iron import into cell,0.0002787|0.0004459|0.0005904|0.0005954|0.0006794,1|1|1|1|1,79.52|9.223|8.571|8.553|2942
468,41,0.4001,328.1,32560.0,0.009949,1.0,GP6 KIR2DL1 KIR2DL3 KLK11 LAIR1 LAIR2 LILRA4 LILRB4 LILRB5 NLRP11 NLRP13 NLRP4 NLRP7 NLRP9 SHISA7 VN1R4 ZFP28 ZIM3 ZNF135 ZNF160 ZNF211 ZNF264 ZNF28 ZNF304 ZNF324 ZNF324B ZNF416 ZNF460 ZNF524 ZNF534 ZNF548 ZNF581 ZNF587 ZNF665 ZNF667 ZNF701 ZNF772 ZNF773 ZNF805 ZNF880 ZSCAN5B,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of gene expression",8.727e-14|7.87e-11|7.922e-11|8.187e-11|8.599e-11,1.377e-09|6.207e-07|4.166e-07|3.229e-07|2.713e-07,4.93|3.681|3.679|3.674|3.019
469,6,0.423,6.343999999999999,4856.0,0.001301,0.998474,ARHGAP28 C12orf57 LRRC30 NUDT7 SIGLEC6 TMEM200C,butyryl-CoA catabolic process|coenzyme A catabolic process|propionyl-CoA catabolic process|medium-chain fatty-acyl-CoA catabolic process|acetyl-CoA catabolic process,0.0005824|0.0005824|0.0005824|0.0008735|0.0008735,1|1|1|1|1,3432|3432|3432|1716|1716
470,11,0.411,22.6,8265.0,0.0027199999999999998,0.999969,ARHGAP32 CLDN25 FLI1 FXYD6 HTR3A HTR3B KCNJ1 KCNJ5 NXPE4 POU2F3 TMEM136,ion transmembrane transport|regulation of ion transmembrane transport|regulation of transmembrane transport|serotonin receptor signaling pathway|potassium ion import across plasma membrane,0.0001248|0.0001798|0.0001858|0.00021|0.0002421,1|1|0.9769|0.8283|0.7638,8.907|12.91|12.8|96.01|89.16
471,5,0.4124,4.124,3813.0,0.001078,0.996692,ARHGDIB C1orf54 KIAA1551 LGI3 POLB,"immunoglobulin heavy chain V-D-J recombination|base-excision repair, base-free sugar-phosphate removal|DNA dephosphorylation|base-excision repair, DNA ligation|cellular response to redox state",0.000728|0.000728|0.000728|0.0009706|0.001213,1|1|1|1|1,2060|2060|2060|1373|1030
472,7,0.431,9.05,5703.0,0.0015810000000000002,0.9992989999999999,ARHGDIG CD300A CD7 FOXR1 PTPN6 RPL22 RPP25,negative regulation of antigen receptor-mediated signaling pathway|negative regulation of cell adhesion|regulation of T cell receptor signaling pathway|leukocyte activation|negative regulation of peptidyl-tyrosine phosphorylation,4.885e-05|8.708e-05|8.877e-05|0.0001344|0.0001457,0.7705|0.6868|0.4667|0.5299|0.4596,196.1|31.41|143.5|12.59|111
473,15,0.5798,60.88,10200.0,0.005915,0.999999,BRIX1 CCT5 DROSHA EXOC3 ICE1 MRPL36 MRPS30 NUP155 RAD1 RPL37 TARS WDR70 ZFR ZNF131 ZNF622,ribosome biogenesis|ribonucleoprotein complex biogenesis|translation|peptide biosynthetic process|amide biosynthetic process,4.273e-06|2.142e-05|0.0001881|0.0002389|0.0006239,0.0674|0.1689|0.989|0.942|1,19.39|13.84|13.41|12.59|9.751
474,5,0.4359,4.359,4032.0,0.001077,0.996692,ARHGEF11 GBP7 HAL LGALS3 SCOC,negative regulation of immunological synapse formation|negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell|regulation of immunological synapse formation|negative regulation of protein tyrosine phosphatase activity|formamide metabolic process,0.000728|0.0009706|0.0009706|0.0009706|0.001213,1|1|1|1|1,2060|1373|1373|1373|1030
475,7,0.4339,9.112,6036.0,0.001504,0.9992989999999999,ARHGEF17 CD248 DNAJC5G GPR4 MDFI SLC9A3R2 ZNF384,glomerular mesangial cell development|mesangial cell development|glomerular mesangial cell differentiation|mesangial cell differentiation|glomerular mesangium development,0.002037|0.002376|0.002376|0.002715|0.003054,1|1|1|1|1,588.4|490.4|490.4|420.3|367.8
476,6,0.4323,6.484,4849.0,0.001332,0.998474,ARHGEF19 DAGLA DFFA GUF1 NID2 SEMA3G,negative regulation of deoxyribonuclease activity|endocannabinoid signaling pathway|negative regulation of apoptotic DNA fragmentation|retrograde trans-synaptic signaling by endocannabinoid|retrograde trans-synaptic signaling by lipid,0.0008735|0.001165|0.001165|0.001165|0.001165,1|1|1|1|1,1716|1144|1144|1144|1144
477,5,0.4511,4.511,3966.0,0.0011330000000000001,0.996692,ARHGEF12 ARHGEF2 DPEP1 HPS1 LRIT1,cellular lactam catabolic process|antibiotic metabolic process|cellular lactam metabolic process|regulation of catalytic activity|negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,0.0004854|0.000728|0.0009706|0.001008|0.001213,1|1|1|1|1,4119|2060|1373|6.548|1030
478,10,0.4091,18.41,7694.0,0.002381,0.999933,ARHGEF28 FSHR LHCGR NAT8 OXER1 POMK REG3G SIX3 STON1 TEX261,cellular response to gonadotropin stimulus|response to gonadotropin|adenylate cyclase-modulating G protein-coupled receptor signaling pathway|activation of adenylate cyclase activity|ovulation cycle process,3.609e-05|7.96e-05|0.0001419|0.0001894|0.0001894,0.5693|0.6278|0.7461|0.7469|0.5975,242.3|158.4|28.08|100.5|100.5
479,35,0.4024,239.4,26370.0,0.008976000000000001,1.0,ACTR3B AGBL3 AKR1D1 ARHGEF35 ARHGEF5 CPA1 CPA5 CTAGE15 CTAGE9 EPHB6 FAM71F2 HYAL4 KEL MGAM OR2A2 OR2A5 OR2A7 OR6B1 OR6V1 OR9A2 OR9A4 PRSS1 PRSS37 PRSS58 RNF148 STRA8 TAS2R39 TAS2R41 TAS2R60 THAP5 TRPV5 TRPV6 ZNF398 ZNF783 ZNF786,sensory perception of chemical stimulus|detection of chemical stimulus involved in sensory perception|G protein-coupled receptor signaling pathway|detection of chemical stimulus|detection of stimulus involved in sensory perception,2.356e-08|1.296e-07|1.985e-07|2.347e-07|3.84e-07,0.0003716|0.001023|0.001044|0.0009257|0.001211,10.56|10.59|5.596|9.864|9.294
480,8,0.4114,11.52,6620.0,0.0017329999999999997,0.9996790000000001,ACSBG2 ARHGEF37 CPB2 DOK3 IRX4 NTMT1 RAB17 TFF1,peptidyl-alanine modification|N-terminal peptidyl-proline dimethylation|N-terminal peptidyl-glycine methylation|N-terminal peptidyl-alanine trimethylation|N-terminal peptidyl-alanine methylation,0.0007765|0.0007765|0.0007765|0.0007765|0.0007765,1|1|1|1|1,2574|2574|2574|2574|2574
481,6,0.4378,6.567,5110.0,0.00128,0.998474,ARHGEF38 BTG4 CACHD1 HSPB3 SHISAL1 SLC37A1,glucose-6-phosphate transport|hexose phosphate transport|phosphate ion transmembrane transport|phosphate ion transport|inorganic ion transmembrane transport,0.002037|0.002037|0.004651|0.006101|0.01436,1|1|1|1|1,572.1|572.1|228.8|171.6|10.34
482,42,0.3874,333.5,32810.0,0.01004,1.0,APTX AQP7 BAG1 CD274 CDC37L1 CNTLN CREB3 DDX58 DNAJB5 FAM205A GALT IFNA1 IFNA10 IFNA14 IFNA16 IFNA17 IFNA2 IFNA21 IFNA4 IFNA5 IFNA6 IFNA7 IFNA8 IFNB1 IFNE IFNK IFNW1 INSL6 MPL OR2S2 PDCD1LG2 PLPP6 RLN1 RLN2 SIGMAR1 SPAG8 SPATA6L TMEM8B TOMM5 TPD52L3 TYRP1 ZDHHC21,positive regulation of peptidyl-serine phosphorylation of STAT protein|natural killer cell activation involved in immune response|regulation of peptidyl-serine phosphorylation of STAT protein|response to exogenous dsRNA|response to dsRNA,2.311e-35|1.188e-34|1.188e-34|9.71e-33|5.197e-32,3.645e-31|9.37e-31|6.247e-31|3.829e-29|1.64e-28,392.3|341.1|341.1|170.1|151.6
483,19,0.4013,68.63,13210.0,0.0051530000000000005,1.0,CASP8 CFLAR CHMP5 IKBKB IL1R1 IL1RAP KHDRBS1 NCOA5 RBCK1 RELA RIPK1 RNF31 TAB2 TNFRSF10A TNFRSF10B TRADD TRAF2 TRAF6 ZNF638,regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation of I-kappaB kinase/NF-kappaB signaling|I-kappaB kinase/NF-kappaB signaling|positive regulation of NF-kappaB transcription factor activity|positive regulation of DNA-binding transcription factor activity,8.826e-21|4.872e-20|7.738e-20|1.769e-18|3.739e-16,1.392e-16|3.843e-16|4.068e-16|6.977e-15|1.18e-12,55.09|66.79|147.1|69.49|41.95
484,10,0.4194,18.87,6281.0,0.002986,0.999933,ARIH1 CAND1 CUL3 KCTD10 KEAP1 NAA35 NAE1 NEDD8 UBA3 UBE2M,protein modification by small protein conjugation|protein modification by small protein conjugation or removal|post-translational protein modification|protein neddylation|cellular protein modification process,2.582e-12|1.964e-11|6.276e-11|6.636e-11|4.653e-09,4.073e-08|1.549e-07|3.3e-07|2.617e-07|1.468e-05,22.58|17.98|39.93|633.7|6.822
485,17,0.4141,56.32,12810.0,0.004364,1.0,ALDOC ARL10 BPNT1 CCDC102A DVL3 GML IFIT2 OR5AU1 OR8I2 PIGS PLEKHG4 PM20D1 PSD4 RTN3 VASH1 WFDC11 WRN,positive regulation of strand invasion|regulation of strand invasion|negative regulation of lymphangiogenesis|endoplasmic reticulum tubular network formation|regulation of oxidative phosphorylation uncoupler activity,0.001649|0.001649|0.003295|0.004117|0.004117,1|1|1|1|1,1211|1211|403.8|302.9|302.9
486,5,0.4392,4.3919999999999995,3841.0,0.001139,0.996692,ANKRD65 ARL14 ERP27 TCAF1 ZNF189,positive regulation of anion channel activity|regulation of anion channel activity|positive regulation of protein targeting to membrane|regulation of protein targeting to membrane|positive regulation of anion transmembrane transport,0.001213|0.002667|0.007744|0.00919|0.01496,1|1|1|1|1,1030|411.9|132.9|111.3|67.52
487,8,0.4047,11.33,5153.0,0.002187,0.9996790000000001,ADSL ARL15 CCDC107 GART PTP4A1 PTP4A2 SLC4A7 TRPM7,'de novo' IMP biosynthetic process|IMP biosynthetic process|IMP metabolic process|purine ribonucleoside monophosphate biosynthetic process|purine nucleoside monophosphate biosynthetic process,3.69e-06|8.691e-06|1.579e-05|3.324e-05|3.94e-05,0.0582|0.06854|0.08302|0.1311|0.1243,858.1|514.9|367.8|245.2|223.9
488,10,0.4116,18.52,6780.0,0.0027170000000000002,0.999933,ARL2 PDRG1 PFDN1 PFDN2 PFDN6 TBCB TBCC TBCD TBCE TUBB4B,protein folding|tubulin complex assembly|post-chaperonin tubulin folding pathway|negative regulation of amyloid fibril formation|regulation of amyloid fibril formation,2.676e-12|1.996e-11|4.604e-09|3.734e-08|6.691e-08,4.221e-08|1.574e-07|2.421e-05|0.0001472|0.0002111,63.23|915.3|1236|514.9|411.9
489,5,0.4211,4.211,3904.0,0.001075,0.996692,ANP32D ARL3 CAMP TMF1 ZC3H12A,cellular response to lipid|biological process involved in interaction with symbiont|positive regulation of lipid localization|modulation of process of other organism|regulation of cytokine production,0.00024|0.0002862|0.0004488|0.0007445|0.0007541,1|1|1|1|1,21.54|77.13|61.29|47.34|14.57
490,6,0.433,6.495,4799.0,0.001348,0.998474,ARL4C C1orf54 CHST15 COL5A3 HRG OSTF1,positive regulation of blood vessel remodeling|negative regulation of lamellipodium assembly|negative regulation of endothelial cell chemotaxis|negative regulation of lamellipodium organization|regulation of blood vessel remodeling,0.0008735|0.001165|0.001456|0.001746|0.002037,1|1|1|1|1,1716|1144|858.1|686.5|572.1
491,6,0.4046,6.069,4927.0,0.001227,0.998474,ARL4D ATP2A1 FOXJ3 ITGA6 ITGB4 ZSCAN18,nail development|skin morphogenesis|hemidesmosome assembly|cell-substrate junction assembly|cell-substrate junction organization,3.883e-06|5.506e-06|6.423e-06|7.275e-05|7.597e-05,0.06126|0.04343|0.03377|0.2869|0.2397,762.8|624.1|572.1|156|152.6
492,6,0.4581,6.872000000000001,4656.0,0.00147,0.998474,ARL6IP1 CIB2 REEP3 REEP4 RETREG3 XRCC4,endoplasmic reticulum tubular network organization|endoplasmic reticulum organization|mitotic nuclear envelope reassembly|mitotic nuclear membrane organization|nuclear envelope reassembly,1.118e-08|2.401e-06|9.677e-05|9.677e-05|0.0001081,0.0001764|0.01894|0.5088|0.3816|0.3411,686.5|103|134.6|134.6|127.1
493,6,0.4067,6.101,4640.0,0.00131,0.998474,ARL6IP5 MARCH3 MKRN2OS MYOG NEURL1 SOX8,skeletal muscle tissue development|skeletal muscle organ development|striated muscle tissue development|muscle organ development|muscle tissue development,4.201e-06|5.306e-06|4.23e-05|4.975e-05|4.975e-05,0.06627|0.04184|0.2224|0.1962|0.157,85.1|78.61|38.86|36.78|36.78
494,8,0.4351,12.18,6290.0,0.001928,0.9996790000000001,ACAD11 ARL8A DVL1 FZD5 LGR4 LRP5 SCMH1 WLS,canonical Wnt signaling pathway|cell-cell signaling by wnt|Wnt signaling pathway|cell surface receptor signaling pathway involved in cell-cell signaling|morphogenesis of an epithelium,1.668e-10|2.017e-09|2.017e-09|5.928e-09|4.817e-07,2.631e-06|1.591e-05|1.061e-05|2.338e-05|0.00152,136.2|39.34|39.34|32.77|26.61
495,26,0.4008,130.3,20190.0,0.0063950000000000005,1.0,ADCY10 AP5M1 ARMC1 ATXN7L3B CCNB1IP1 EAPP KIAA1257 KIF26B LRRN1 LYRM1 MAP3K7CL MCOLN3 NECAP2 NIPSNAP3B PCDHA4 PCDHB12 PCDHB13 PCDHB16 PCDHGA9 PCDHGB1 RNF114 SDR39U1 SLC25A36 TMEM100 ZNF286A ZNF512B,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|cell-cell adhesion|response to stimulus|cell adhesion,8.173e-08|1.004e-06|4.709e-05|0.0002345|0.001258,0.001289|0.00792|0.2476|0.9249|1,27.41|17.67|8.904|0.1796|4.812
496,19,0.3649,62.4,12140.0,0.005096,1.0,BUB1B CKAP5 CLTC DHX9 DLGAP5 DSN1 GAK GTSE1 HAUS4 HAUS6 KIF15 KIF18B KNTC1 MAD2L1BP MAPRE1 MKI67 MYBL2 TACC3 TRIP13,mitotic cell cycle|cell cycle|mitotic cell cycle process|spindle organization|regulation of cell cycle process,1.276e-18|2.074e-18|1.551e-15|2.584e-15|7.058e-15,2.012e-14|1.636e-14|8.155e-12|1.019e-11|2.227e-11,21.37|13.26|20.57|48.18|18.25
497,6,0.4018,6.027,4780.0,0.001256,0.998474,ANKRD30A ARMC4 ENO3 GRN KCNJ10 MTHFSD,central nervous system development|regulation of vacuole organization|glial cell development|positive regulation of lysosome organization|monovalent inorganic cation homeostasis,7.504e-05|8.956e-05|0.0004488|0.0005824|0.000775,1|0.7064|1|1|1,13.85|140.1|61.29|3432|46.39
498,11,0.4155,22.85,7040.0,0.003225,0.999969,ARMC5 CD2BP2 CMTR1 EAF1 GEMIN4 GEMIN6 ICE2 INTS14 PHAX TOE1 USPL1,RNA metabolic process|gene expression|nucleic acid metabolic process|nucleobase-containing compound metabolic process|heterocycle metabolic process,8.395e-11|1.844e-09|2.265e-09|1.584e-08|3.027e-08,1.324e-06|1.454e-05|1.191e-05|6.246e-05|9.55e-05,11.71|8.565|8.388|6.886|6.447
499,5,0.4505,4.505,3935.0,0.00114,0.996692,ARMC6 NLRP7 TF THEM6 TRPM2,hemopoiesis|hematopoietic or lymphoid organ development|transition metal ion transport|activation of plasma proteins involved in acute inflammatory response|immune system development,0.0004062|0.0005117|0.0005306|0.0005824|0.0006063,1|1|1|1|1,18|16.64|56.27|3432|15.7
500,14,0.4131,37.59,9315.0,0.004007999999999999,0.9999969999999999,ARMC7 CCDC84 DDX59 DHX9 IARS2 PDCD7 PPIH RBM48 RNPC3 SCNM1 SNRNP25 TXNL4B ZCRB1 ZMAT5,"mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|RNA splicing|mRNA processing",6.776e-14|6.776e-14|7.391e-14|9.349e-13|4.296e-12,1.069e-09|5.344e-10|3.886e-10|3.687e-09|1.355e-08,43.84|43.84|43.41|32.53|27.35
501,5,0.4541,4.541,4151.0,0.00109,0.996692,ARMC9 ATP8B4 MLN SH3RF1 WEE2,negative regulation of calcium ion import into sarcoplasmic reticulum|female pronucleus assembly|negative regulation of catalytic activity|negative regulation of calcium ion binding|regulation of calcium ion binding,0.0008735|0.0008735|0.001136|0.001165|0.001165,1|1|1|1|1,1716|1716|12.65|1144|1144
502,20,0.4122,78.31,13830.0,0.005615,1.0,BCL10 CFLAR CYLD IKBKB IL1R1 IL1RAP MYD88 N4BP1 NCOA5 RBCK1 RELA RIPK1 RNF31 TAB2 TNFAIP3 TNIP1 TRADD TRAF2 TRAF6 ZNF638,regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation of NF-kappaB transcription factor activity|I-kappaB kinase/NF-kappaB signaling|regulation of DNA-binding transcription factor activity|positive regulation of DNA-binding transcription factor activity,9.746e-25|1.565e-22|5.802e-22|4.346e-21|8.604e-20,1.537e-20|1.234e-18|3.051e-18|1.714e-17|2.714e-16,60.54|78.22|154.1|33.97|47.22
503,6,0.4273,6.409,4831.0,0.001322,0.998474,AK3 ARPC5L HCLS1 PLXND1 SELENOM TNNT1,ADP biosynthetic process|purine ribonucleoside diphosphate biosynthetic process|ribonucleoside diphosphate biosynthetic process|purine nucleoside diphosphate biosynthetic process|nucleoside diphosphate biosynthetic process,2.076e-06|2.076e-06|2.768e-06|2.768e-06|6.521e-06,0.03275|0.01638|0.01455|0.01092|0.02057,1177|1177|980.7|980.7|588.4
504,6,0.4008,6.0120000000000005,4856.0,0.001233,0.998474,ANKS1A ARPIN IGFALS ITGB7 NLRP6 RNF19A,"negative regulation of lamellipodium morphogenesis|regulation of ephrin receptor signaling pathway|cell-matrix adhesion involved in ameboidal cell migration|directional locomotion|regulation of protein catabolic process at postsynapse, modulating synaptic transmission",0.0008735|0.0008735|0.0008735|0.001165|0.001165,1|1|1|1|1,1716|1716|1716|1144|1144
505,5,0.4186,4.186,3687.0,0.001131,0.996692,ARPP19 IFNA8 MRFAP1 TPH1 ZCCHC4,serotonin biosynthetic process|primary amino compound biosynthetic process|indole-containing compound biosynthetic process|indolalkylamine biosynthetic process|serotonin metabolic process,0.0009706|0.001456|0.001456|0.001456|0.002667,1|1|1|1|1,1373|823.8|823.8|823.8|411.9
506,13,0.4174,32.56,8551.0,0.003782,0.999993,ATXN2L CNOT1 CNOT10 CNOT11 CNOT4 CNOT9 EIF3K EIF3L G3BP2 GGNBP2 LSM12 NUFIP2 PUM1,"nuclear-transcribed mRNA poly(A) tail shortening|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|signal transduction involved in mitotic G1 DNA damage checkpoint|signal transduction involved in mitotic DNA integrity checkpoint|signal transduction involved in mitotic DNA damage checkpoint",4.055e-12|2.868e-10|3.11e-10|3.11e-10|3.11e-10,6.397e-08|2.262e-06|1.635e-06|1.226e-06|9.81e-07,344.4|136.6|134.3|134.3|134.3
507,7,0.4255,8.936,4746.0,0.0018739999999999998,0.9992989999999999,ARHGEF7 ARRB2 GIT2 ITGB1 MARK2 PAK2 PTPN14,regulation of anatomical structure morphogenesis|regulation of GTPase activity|positive regulation of fibroblast migration|positive regulation of apoptotic process|positive regulation of programmed cell death,4.222e-06|1.079e-05|1.185e-05|1.685e-05|1.873e-05,0.0666|0.08513|0.0623|0.06646|0.05909,15.4|24.02|420.3|21.44|20.87
508,6,0.4179,6.268,4919.0,0.0012699999999999999,0.998474,ARRDC2 EGR4 HEPN1 MATN1 WDPCP ZDHHC6,chondrocyte morphogenesis|growth plate cartilage chondrocyte morphogenesis|chondrocyte morphogenesis involved in endochondral bone morphogenesis|growth plate cartilage morphogenesis|regulation of embryonic cell shape,0.0005824|0.0005824|0.0005824|0.0008735|0.001165,1|1|1|1|1,3432|3432|3432|1716|1144
509,5,0.4596,4.596,3761.0,0.001217,0.996692,ACBD5 ARRDC5 DDX19A DDX19B VPS37D,protein transport|peptide transport|amide transport|establishment of protein localization|nitrogen compound transport,1.826e-06|2.014e-06|2.254e-06|2.5e-06|5.153e-06,0.02881|0.01589|0.01185|0.009858|0.01626,14.08|13.8|13.5|13.22|11.44
510,5,0.4496,4.496,3948.0,0.001135,0.996692,ARSA OR51V1 PLXNC1 TARSL2 TEF,threonyl-tRNA aminoacylation|response to methylmercury|semaphorin-plexin signaling pathway involved in axon guidance|semaphorin-plexin signaling pathway involved in neuron projection guidance|semaphorin-plexin signaling pathway,0.0009706|0.001698|0.00291|0.003394|0.009431,1|1|1|1|1,1373|686.5|374.5|316.8|108.4
511,6,0.433,6.495,4936.0,0.0013109999999999999,0.998474,ARSI CNNM2 IAPP IBSP TCF7L2 TECTB,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition|positive regulation of protein kinase B signaling|positive regulation of calcium ion import across plasma membrane|positive regulation of heparan sulfate proteoglycan biosynthetic process|regulation of heparan sulfate proteoglycan biosynthetic process,0.0008735|0.00115|0.001165|0.001165|0.001165,1|1|1|1|1,1716|37.93|1144|1144|1144
512,8,0.4033,11.29,6917.0,0.001626,0.9996790000000001,ARSJ C2CD2 DSPP IGDCC3 NKD2 PRRT3 ST6GAL2 TENM3,odontoblast differentiation|regulation of homophilic cell adhesion|regulation of odontoblast differentiation|Golgi vesicle fusion to target membrane|dentinogenesis,0.001552|0.001552|0.00194|0.00194|0.002715,1|1|1|1|1,858.1|858.1|643.6|643.6|429.1
513,5,0.4313,4.313,3798.0,0.001131,0.996692,ART1 ART5 FGD3 HES6 PTPDC1,peptidyl-arginine ADP-ribosylation|peptidyl-arginine modification|protein ADP-ribosylation|plasma membrane bounded cell projection assembly|filopodium assembly,7.067e-07|1.909e-05|2.185e-05|0.004983|0.005087,0.01115|0.1505|0.1149|1|1,2060|305.1|284.1|17.57|205.9
514,10,0.9681,43.56,6029.0,0.00715,0.999933,CDK5RAP3 DDRGK1 DNAJC21 EFL1 ODR4 UBA5 UFC1 UFL1 UFM1 UFSP2,protein ufmylation|protein K69-linked ufmylation|protein polyufmylation|reticulophagy|regulation of intracellular estrogen receptor signaling pathway,1.825e-18|2.051e-15|2.051e-15|5.028e-14|1.383e-11,2.879e-14|1.617e-11|1.078e-11|1.983e-10|4.362e-08,2060|2060|2060|858.1|239.5
515,5,0.4321,4.321000000000001,3893.0,0.001106,0.996692,ART4 EPB41L4B FZD7 KIF14 STX11,protein ADP-ribosylation|substrate adhesion-dependent cell spreading|cerebellar granular layer structural organization|negative regulation of ectodermal cell fate specification|regulation of ectodermal cell fate specification,3.275e-05|0.000116|0.0005824|0.0005824|0.0005824,0.5166|0.915|1|1|1,236.7|122.6|3432|3432|3432
516,5,0.4357,4.357,3855.0,0.001126,0.996692,ARTN DMRTB1 ERMN OR10S1 PTRHD1,Peyer's patch morphogenesis|lymphocyte migration into lymphoid organs|Peyer's patch development|mucosa-associated lymphoid tissue development|induction of positive chemotaxis,0.0009706|0.00194|0.002183|0.002183|0.003878,1|1|1|1|1,1373|588.4|514.9|514.9|274.6
517,6,0.4344,6.517,4837.0,0.001342,0.998474,ACRBP ARV1 FASTKD3 QRFPR SRD5A1 TMEM43,"endomembrane system organization|steroid biosynthetic process|regulation of plasma membrane sterol distribution|circadian sleep/wake cycle, REM sleep|circadian sleep/wake cycle, sleep",0.0002551|0.0005653|0.0005824|0.0008735|0.001165,1|1|1|1|1,21.1|54.48|3432|1716|1144
518,6,0.4129,6.193,5027.0,0.001228,0.998474,ASAH1 CLOCK HOPX IFNGR1 SMIM12 XKR6,negative regulation of glucocorticoid receptor signaling pathway|regulation of glucocorticoid receptor signaling pathway|phosphatidylserine exposure on apoptotic cell surface|negative regulation of amyloid-beta clearance|regulation of type B pancreatic cell development,0.002037|0.002619|0.002619|0.002909|0.0032,1|1|1|1|1,572.1|429.1|429.1|381.4|343.2
519,5,0.4074,4.074,3847.0,0.0010550000000000002,0.996692,ASAH2B FAM45A PTPRS RSPH6A ZSCAN9,manchette disassembly|negative regulation of toll-like receptor 9 signaling pathway|negative regulation of interferon-alpha production|negative regulation of collateral sprouting|regulation of toll-like receptor 9 signaling pathway,0.0003883|0.0009706|0.001359|0.001941|0.002328,1|1|1|1|1,5149|1287|858.1|572.1|468.1
520,6,0.4445,6.667999999999999,4878.0,0.001362,0.998474,ASAP2 NPFFR2 PIPOX POMT1 SEZ6L2 SUN5,L-lysine catabolic process to acetyl-CoA via L-pipecolate|positive regulation of protein O-linked glycosylation|regulation of protein O-linked glycosylation|L-lysine catabolic process|L-lysine catabolic process to acetyl-CoA,0.0005824|0.001165|0.001165|0.001456|0.001456,1|1|1|1|1,3432|1144|1144|858.1|858.1
521,9,0.4036,14.53,7207.0,0.002007,0.9998530000000001,ASAP3 C1QB CLCNKA FAM131C L3HYPDH MMP23B MTFR1L PQLC2 SLC35E2B,synapse pruning|cell junction disassembly|mitochondrial fission|blastocyst hatching|organism emergence from protective structure,0.004651|0.005038|0.008512|0.01044|0.01044,1|1|1|1|1,234|214.5|122.6|99.01|99.01
522,5,0.4532,4.532,3826.0,0.00118,0.996692,ASB1 GAMT LDLRAP1 RPS6KB1 TRAPPC9,positive regulation of smooth muscle cell proliferation|regulation of smooth muscle cell proliferation|creatine biosynthetic process|positive regulation of receptor-mediated endocytosis involved in cholesterol transport|positive regulation of low-density lipoprotein particle clearance,0.0001789|0.0004208|0.000728|0.000728|0.000728,1|1|1|1|1,95.79|61.94|2060|2060|2060
523,5,0.4325,4.325,3914.0,0.001101,0.996692,ASB10 CAPN11 LELP1 MC1R SLC38A8,positive regulation of protein kinase C signaling|melanin biosynthetic process|melanin metabolic process|UV-damage excision repair|UV protection,0.002667|0.003152|0.003394|0.003394|0.003394,1|1|1|1|1,411.9|343.3|316.8|316.8|316.8
524,5,0.4063,4.063,3845.0,0.001053,0.996692,ASB18 C12orf75 DMRT2 SERPINA11 TMPRSS9,regulation of myotome development|positive regulation of myotome development|regulation of somitogenesis|cellular process|embryonic skeletal system development,0.0004854|0.0004854|0.001698|0.01519|0.0295,1|1|1|1|1,4119|4119|686.5|0.266|33.76
525,10,0.5642,25.39,6926.0,0.0036420000000000003,0.999933,ESR1 FOXA1 GATA3 GRHL2 LMX1B SPDEF TFAP2A TFAP2C TRPS1 ZNF652,"regulation of transcription by RNA polymerase II|positive regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process",9.925e-10|5.745e-09|1.836e-08|1.841e-08|1.868e-08,1.566e-05|4.531e-05|9.654e-05|7.261e-05|5.893e-05,7.964|13.66|5.945|5.944|5.935
526,6,0.4355,6.532,4906.0,0.001326,0.998474,ASB4 BCL2L13 CYB5D1 DUOX2 PCED1A TMEM252,adenohypophysis morphogenesis|hypophysis morphogenesis|diencephalon morphogenesis|cuticle development|hydrogen peroxide biosynthetic process,0.0005824|0.0008735|0.001165|0.001165|0.002909,1|1|1|1|1,3432|1716|1144|1144|381.4
527,16,0.4122,49.46,11210.0,0.004382,0.999999,CASP8 CFLAR CHMP5 FAM208B KHDRBS1 NCOA5 PPHLN1 RBCK1 RIPK1 RNF31 TAB2 TNFRSF10A TNFRSF10B TRADD TRAF2 ZNF638,regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|positive regulation of I-kappaB kinase/NF-kappaB signaling|regulation of extrinsic apoptotic signaling pathway via death domain receptors|regulation of tumor necrosis factor-mediated signaling pathway,4.879e-16|1.926e-15|5.201e-15|2.22e-14|3.848e-14,7.697e-12|1.519e-11|2.734e-11|8.755e-11|1.214e-10,52.97|231|62.62|158.1|145.3
528,20,0.4009,76.17,14950.0,0.005054,1.0,BBS1 CTTN FCHSD2 FGF19 FOLR1 FOLR2 KCTD21 KRTAP5-1 KRTAP5-10 KRTAP5-7 KRTAP5-9 MRGPRD MRGPRF MYEOV P2RY2 P2RY6 PLEKHB1 POLD4 TESMIN UCP3,keratinization|cellular response to folic acid|keratinocyte differentiation|epidermal cell differentiation|folate import across plasma membrane,2.973e-06|5.922e-06|6.714e-06|1.471e-05|2.069e-05,0.0469|0.04671|0.0353|0.058|0.06527,21.7|980.7|18.3|15.52|392.3
529,6,0.4184,6.276,4983.0,0.001255,0.998474,ASIC5 ITGA2 MCFD2 MYO1G STAP1 XRCC4,"positive regulation of phagocytosis, engulfment|positive regulation of membrane invagination|regulation of phagocytosis, engulfment|regulation of membrane invagination|positive regulation of phagocytosis",1.037e-05|1.037e-05|1.343e-05|1.51e-05|0.0002101,0.1636|0.08178|0.07059|0.05955|0.6628,452.6|452.6|392.3|367.8|91.94
530,30,0.4028,175.2,18510.0,0.00935,1.0,ARFRP1 ASNA1 CAMLG COG1 COG2 COG3 COG4 COG5 COG6 COG7 COG8 EIPR1 GET4 PTAR1 RAB1A RAB1B RAB6A RGP1 RIC1 SYS1 TM9SF3 TRAPPC13 UNC50 VPS45 VPS51 VPS52 VPS53 VPS54 WRB YKT6,Golgi vesicle transport|intracellular transport|establishment of protein localization|protein transport|peptide transport,4.022e-22|2.433e-21|5.769e-21|6.002e-20|9.121e-20,6.344e-18|1.919e-17|3.033e-17|2.367e-16|2.877e-16,30.49|10.9|10.48|10.68|10.47
531,5,0.431,4.31,3929.0,0.001093,0.996692,ASNSD1 DUS1L F13B MUTYH RIT1,olfactory bulb axon guidance|asparagine biosynthetic process|lymphoid lineage cell migration into thymus|lymphoid lineage cell migration|striatal medium spiny neuron differentiation,0.0005824|0.0008735|0.0008735|0.0008735|0.001456,1|1|1|1|1,3432|1716|1716|1716|858.1
532,5,0.4426,4.426,3835.0,0.00115,0.996692,ASPDH CCDC85C HIST1H2AI NDUFA4 RIIAD1,"chromatin silencing|chromatin organization involved in negative regulation of transcription|negative regulation of gene expression, epigenetic|chromatin organization involved in regulation of transcription|gene silencing",0.0001081|0.0002156|0.0002211|0.0002862|0.0007956,1|1|1|1|1,127.1|89.16|88.01|77.13|45.77
533,6,0.43,6.45,5072.0,0.001267,0.998474,ASPG CBLN1 CCDC105 LYSMD4 THADA VPS9D1,negative regulation of inhibitory synapse assembly|negative regulation of ATPase-coupled calcium transmembrane transporter activity|regulation of inhibitory synapse assembly|negative regulation of synapse assembly|positive regulation of long-term synaptic depression,0.0006794|0.001698|0.001698|0.002376|0.002376,1|1|1|1|1,2942|735.5|735.5|490.4|490.4
534,13,0.415,32.37,8391.0,0.003831,0.999993,ASPM CCT4 MSTO1 PDCD5 PFDN1 PFDN4 TBCA TCP1 TUBA1B TUBA1C TUBB TUBB4B TXNDC9,protein folding|RNA localization to nucleus|RNA localization to Cajal body|scaRNA localization to Cajal body|microtubule cytoskeleton organization,2.116e-07|7.701e-06|7.701e-06|7.701e-06|1.717e-05,0.003337|0.06073|0.04049|0.03037|0.05418,34.74|633.7|633.7|633.7|13.99
535,6,0.4128,6.192,4558.0,0.001353,0.998474,ASPRV1 LENEP PCID2 TUBGCP3 ZBTB7B ZNF543,positive regulation of lymphocyte differentiation|negative regulation of NK T cell proliferation|positive regulation of leukocyte differentiation|positive regulation of hemopoiesis|positive regulation of SREBP signaling pathway,0.0003737|0.0005824|0.0008378|0.0008378|0.0008735,1|1|1|1|1,67.3|3432|44.58|44.58|1716
536,6,0.4254,6.381,4872.0,0.0013050000000000002,0.998474,ASRGL1 CHI3L1 FAM163A ITGA4 SWT1 TYRP1,asparagine catabolic process via L-aspartate|asparagine catabolic process|clathrin-dependent extracellular exosome endocytosis|negative regulation of protein homodimerization activity|acetoacetic acid metabolic process,0.0005824|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,3432|3432|3432|3432|3432
537,5,0.4512,4.512,3976.0,0.001131,0.996692,ASTE1 C22orf39 LRRC73 PHOSPHO1 ZFYVE16,bone mineralization involved in bone maturation|phosphatidylethanolamine biosynthetic process|ossification involved in bone maturation|bone maturation|animal organ maturation,0.00194|0.003878|0.003878|0.004604|0.005571,1|1|1|1|1,588.4|274.6|274.6|228.8|187.2
538,8,0.4035,11.3,6711.0,0.0016769999999999999,0.9996790000000001,ASTN2 BLNK CALHM3 GDF6 IMPACT MTMR11 SORCS3 UNC5B,response to benomyl|cellular response to benomyl|GCN2-mediated signaling|positive regulation of translational initiation in response to starvation|regulation of translational initiation in response to starvation,0.0007765|0.0007765|0.001164|0.001164|0.001164,1|1|1|1|1,2574|2574|1287|1287|1287
539,5,0.4427,4.427,3963.0,0.001113,0.996692,ATAD1 CLRN1 DSC1 MAN2A2 MEP1B,"equilibrioception|epidermal cell differentiation|mannose metabolic process|negative regulation of synaptic transmission, glutamatergic|regulation of postsynaptic neurotransmitter receptor internalization",0.002183|0.002304|0.002425|0.002667|0.003152,1|1|1|1|1,514.9|26.07|457.7|411.9|343.3
540,9,0.4196,15.11,7231.0,0.0020800000000000003,0.9998530000000001,ATAD3B ATAD3C C1QB CLCNKA FAM131C MMP23B PQLC2 SLC35E2B ST3GAL3,ganglioside biosynthetic process via lactosylceramide|synapse pruning|cell junction disassembly|ganglioside biosynthetic process|sialylation,0.002328|0.004651|0.005038|0.006583|0.008126,1|1|1|1|1,514.9|234|214.5|160.9|128.7
541,17,0.3784,51.46,11690.0,0.004370000000000001,1.0,ATAD5 CDS2 CRLS1 CRNKL1 DDRGK1 ESF1 FASTKD5 GINS1 MRPS26 NAA20 NOP56 SHLD1 SIVA1 SYNDIG1 TRMT6 VPS16 XRN2,phosphatidylglycerol biosynthetic process|RNA processing|gene expression|nucleic acid metabolic process|phosphatidylglycerol metabolic process,5.586e-05|9.597e-05|0.0002663|0.0003077|0.0004711,0.8811|0.7569|1|1|1,208|7.438|4.187|4.101|65.38
542,6,0.4065,6.098,4814.0,0.0012619999999999999,0.998474,ATF5 DVL2 MAP4 NAA80 TNFSF12 TVP23B,N-terminal peptidyl-aspartic acid acetylation|convergent extension involved in neural plate elongation|neural plate elongation|microtubule sliding|N-terminal peptidyl-glutamic acid acetylation,0.0005824|0.0008735|0.0008735|0.0008735|0.001165,1|1|1|1|1,3432|1716|1716|1716|1144
543,20,0.4034,76.65,15460.0,0.004921,1.0,ACTL7A AKAP2 C9orf16 C9orf43 C9orf84 CERCAM FAM129B GBGT1 KIF12 OR1J1 OR1J2 OR1J4 OR1L1 OR1L8 OR1N2 PALM2 PTBP3 TOR1B TXNDC8 ZBTB6,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,1.496e-06|2.103e-06|2.609e-06|3.921e-06|4.857e-06,0.0236|0.01658|0.01372|0.01546|0.01532,15.57|14.67|14.13|13.15|12.67
544,5,0.4437,4.437,3694.0,0.001196,0.996692,ATG16L2 OR10R2 S100A14 S100A16 TOMM40L,negative stranded viral RNA replication|viral RNA genome replication|protein import into mitochondrial matrix|toll-like receptor 4 signaling pathway|positive regulation of monocyte chemotaxis,0.0009706|0.003394|0.005087|0.005329|0.005571,1|1|1|1|1,1373|316.8|205.9|196.1|187.2
545,6,0.4366,6.5489999999999995,5214.0,0.0012519999999999999,0.998474,ATG2B CMBL LIPG LIPI SLC34A2 SORCS2,triglyceride metabolic process|acylglycerol metabolic process|neutral lipid metabolic process|triglyceride catabolic process|acylglycerol catabolic process,2.026e-06|4.829e-06|4.965e-06|4e-05|7.289e-05,0.03196|0.03809|0.02611|0.1577|0.23,113.2|84.06|83.27|217.9|159
546,20,0.4006,76.12,16190.0,0.004668,1.0,AGO1 AGO3 AGO4 ARMH1 ATG4C BEST4 BSND C1orf123 CYP4X1 FAAH GJB3 GJB4 GPX7 LURAP1 PCSK9 PLA2G12A TSSK3 ZFP69 ZNF684 ZYG11B,"miRNA loading onto RISC involved in gene silencing by miRNA|RNA secondary structure unwinding|small RNA loading onto RISC|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation",9.33e-08|1.282e-07|1.708e-07|4.338e-07|4.338e-07,0.001472|0.001011|0.0008982|0.001711|0.001368,441.3|386.2|343.2|237.6|237.6
547,9,0.4186,15.07,6132.0,0.002445,0.9998530000000001,ANLN ECT2 KIF23 MCM5 PRC1 RACGAP1 RFC2 RFC5 TOP2A,cell cycle process|cell cycle|cell division|mitotic spindle midzone assembly|spindle elongation,2.87e-12|2.995e-11|1.618e-10|9.492e-09|9.492e-09,4.527e-08|2.362e-07|8.51e-07|3.743e-05|2.995e-05,19.25|14.82|32.56|858.1|858.1
548,6,0.437,6.555,5014.0,0.001302,0.998474,ATOH8 FMC1 GPR160 SCARF2 VSTM2B ZBTB7C,myoblast proliferation|mitochondrial proton-transporting ATP synthase complex assembly|proton-transporting ATP synthase complex assembly|positive regulation of endothelial cell differentiation|regulation of type B pancreatic cell proliferation,0.001456|0.002037|0.002328|0.00349|0.003781,1|1|1|1|1,858.1|572.1|490.4|312|286
549,7,0.4264,8.955,4637.0,0.0019219999999999999,0.9992989999999999,ATOX1 NAIF1 SLC30A1 SLC39A10 SLC39A6 UBE3D WDR73,cellular transition metal ion homeostasis|transition metal ion transport|transition metal ion homeostasis|zinc ion transmembrane transport|zinc ion transport,3.413e-08|4.602e-08|6.837e-08|7.001e-08|1.075e-07,0.0005383|0.000363|0.0003595|0.0002761|0.0003392,104.1|96.46|87.17|367.8|315.2
550,6,0.4287,6.43,4736.0,0.001352,0.998474,ATP10A IL2 ODF2L PTDSS2 RWDD3 SRXN1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway|regulation of hypoxia-inducible factor-1alpha signaling pathway|regulation of T cell homeostatic proliferation|positive regulation of plasma cell differentiation|phosphatidylserine biosynthetic process,0.0005824|0.0005824|0.001165|0.001165|0.001456,1|1|1|1|1,3432|3432|1144|1144|858.1
551,5,0.429,4.29,4065.0,0.001052,0.996692,ATP10D CRH FNDC7 IDNK STEAP2,"D-gluconate catabolic process|aldonic acid catabolic process|negative regulation of circadian sleep/wake cycle, REM sleep|D-gluconate metabolic process|aldonic acid metabolic process",0.000728|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,2060|2060|2060|2060|2060
552,6,0.4202,6.303999999999999,4681.0,0.001341,0.998474,ADIPOR1 ATP11B DLG1 DNAJC5 KIAA1191 MET,negative regulation of intracellular signal transduction|positive regulation of protein polymerization|branching morphogenesis of an epithelial tube|morphogenesis of a branching epithelium|morphogenesis of a branching structure,0.0002613|0.0005565|0.000583|0.0008592|0.0009591,1|1|1|1|1,20.93|54.92|53.63|44.01|41.61
553,14,0.4192,38.15,8815.0,0.004296,0.9999969999999999,CEP350 COP1 DET1 DUSP4 FGFR1OP FOSL1 JUN JUNB MAP2K4 MAP2K7 MAP3K1 PPP2R3C STK40 TRIB1,regulation of protein kinase activity|regulation of macromolecule metabolic process|regulation of cellular protein metabolic process|regulation of kinase activity|regulation of protein metabolic process,6.553e-07|6.821e-07|9.322e-07|1.563e-06|1.678e-06,0.01034|0.00538|0.004901|0.006165|0.005294,12.06|3.051|5.634|10.58|5.291
554,5,0.4377,4.377,4003.0,0.00109,0.996692,ATP2A3 FAM227B PKIB TTLL5 ZNF232,calcium ion transport from cytosol to endoplasmic reticulum|cytosol to endoplasmic reticulum transport|negative regulation of cAMP-dependent protein kinase activity|protein polyglutamylation|negative regulation of receptor binding,0.000728|0.001213|0.002425|0.003394|0.003636,1|1|1|1|1,2060|1030|457.7|316.8|294.2
555,5,0.407,4.07,3838.0,0.001057,0.996692,ATP2B1 CASC10 GRK5 NTHL1 SYNDIG1,cellular response to corticosterone stimulus|calcium ion export across plasma membrane|cellular response to mineralocorticoid stimulus|regulation of vascular associated smooth muscle contraction|tachykinin receptor signaling pathway,0.0005825|0.001165|0.001553|0.001747|0.001747,1|1|1|1|1,2574|1030|735.5|643.6|643.6
556,11,0.4002,22.01,7718.0,0.0028350000000000003,0.999969,CCT8 CFAP298 DONSON MCM3AP PAXBP1 PWP2 RRP1 SOD1 URB1 WDR18 WRB,rRNA processing|rRNA metabolic process|ribosome biogenesis|ncRNA processing|ribonucleoprotein complex biogenesis,1.469e-07|1.766e-07|4.84e-07|1.744e-06|2.493e-06,0.002318|0.001393|0.002545|0.006876|0.007864,36.01|34.67|28.2|21.67|20.13
557,14,0.8961,81.54,9259.0,0.008704,0.9999969999999999,ATP5F1A ATP5F1B ATP5F1C ATP5F1D ATP5F1E ATP5ME ATP5MF ATP5MG ATP5MPL ATP5PB ATP5PD ATP5PF ATP5PO TMEM242,"mitochondrial ATP synthesis coupled proton transport|ATP synthesis coupled proton transport|energy coupled proton transport, down electrochemical gradient|cristae formation|ATP biosynthetic process",1.049e-33|9.303e-33|9.303e-33|1.139e-31|5.173e-31,1.655e-29|7.338e-29|4.892e-29|4.493e-28|1.632e-27,929.1|735.5|735.5|569.4|490.4
558,6,0.4115,6.172000000000001,4983.0,0.001234,0.998474,ALDH4A1 ATP5IF1 GNA14 HLA-DOB PIN1 TMEM42,negative regulation of antigen processing and presentation of peptide antigen via MHC class II|negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|proline catabolic process to glutamate|4-hydroxyproline metabolic process|4-hydroxyproline catabolic process,0.0008735|0.001165|0.001165|0.001456|0.001456,1|1|1|1|1,1716|1144|1144|858.1|858.1
559,5,0.4521,4.521,4039.0,0.001115,0.996692,ATP5MC2 CCL23 KRT14 RAB5IF XIRP2,negative regulation of C-C chemokine binding|regulation of C-C chemokine binding|intermediate filament bundle assembly|mitochondrial respirasome assembly|hemidesmosome assembly,0.0004854|0.0004854|0.00194|0.002667|0.003152,1|1|1|1|1,4119|4119|588.4|411.9|343.3
560,5,0.421,4.21,3924.0,0.0010689999999999999,0.996692,ATP5MC3 AZI2 CFAP206 OLFML3 TREML2,dendritic cell proliferation|T cell activation|lymphocyte activation|regulation of cilium beat frequency|mitochondrial ATP synthesis coupled proton transport,0.000728|0.001365|0.003495|0.003636|0.004845,1|1|1|1|1,2060|34.04|21.07|294.2|216.8
561,20,0.3852,73.19,13950.0,0.0052060000000000006,1.0,AATF ATAD5 CDC6 CWC25 DDX52 DHX8 NLE1 NSRP1 PSMB3 PSMD11 PSMD3 RPL18 RPL18A RPL19 RPL23 RPL23A RPL27 UTP6 ZNF207 ZNF830,ribosome biogenesis|ribonucleoprotein complex biogenesis|RNA processing|rRNA processing|rRNA metabolic process,2.209e-13|5.771e-12|6.365e-12|8.089e-11|1.083e-10,3.485e-09|4.552e-08|3.347e-08|3.19e-07|3.416e-07,31.02|22.15|13.39|31.68|30.51
562,15,0.4126,43.33,10170.0,0.004229999999999999,0.999999,BIRC6 DNAJA1 DNAJC7 EIF2AK1 EIF2B4 HECTD1 KCMF1 PLAA PPP1R15B UBA6 UBR4 USP15 USP19 VCPIP1 ZRANB1,protein modification by small protein conjugation or removal|cellular protein metabolic process|ubiquitin-dependent protein catabolic process|modification-dependent protein catabolic process|modification-dependent macromolecule catabolic process,7.793e-09|1.241e-08|4.373e-08|4.776e-08|5.474e-08,0.0001229|9.79e-05|0.0002299|0.0001884|0.0001727,11.99|4.9|18.03|17.8|17.44
563,19,0.5187,88.7,11610.0,0.007556,1.0,AP2M1 AP2S1 ATP6V0B ATP6V0C ATP6V0D1 ATP6V1A ATP6V1B2 ATP6V1C1 ATP6V1D ATP6V1E1 ATP6V1F ATP6V1G1 ATP6V1H CCDC115 EMC3 EMC7 TFRC TMEM199 WDR7,intracellular pH reduction|pH reduction|transferrin transport|regulation of intracellular pH|phagosome acidification,9.057e-30|1.81e-29|2.833e-28|1.113e-26|1.758e-26,1.429e-25|1.428e-25|1.49e-24|4.391e-23|5.545e-23,293.6|276.3|361.3|160.1|425.8
564,6,0.4087,6.131,4714.0,0.001296,0.998474,ALDH1L1 AP4S1 ATP6V0E2 B3GALT1 TMEM183A ZC2HC1C,10-formyltetrahydrofolate catabolic process|folic acid-containing compound catabolic process|pteridine-containing compound catabolic process|10-formyltetrahydrofolate metabolic process|galactolipid biosynthetic process,0.0008735|0.001165|0.001165|0.001746|0.002037,1|1|1|1|1,1716|1144|1144|686.5|572.1
565,14,0.4151,37.77,8622.0,0.0043479999999999994,0.9999969999999999,CBL DUSP6 GRB2 LZTR1 MAPK1 NF1 NRAS PTPN11 RAF1 RASA2 SHOC2 SOS1 SPRED1 SPRED2,MAPK cascade|fibroblast growth factor receptor signaling pathway|response to growth factor|regulation of intracellular signal transduction|cellular response to fibroblast growth factor stimulus,1.01e-14|6.795e-14|1.328e-13|1.856e-13|5.941e-13,1.593e-10|5.359e-10|6.984e-10|7.318e-10|1.874e-09,35.97|127.1|27.65|10.82|91.94
566,7,0.4003,8.407,5747.0,0.001457,0.9992989999999999,ATP6V1C2 CDKN2D CGA DGKQ MOK SYNE1 TIGD6,regulation of steroid biosynthetic process|adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation|regulation of hormone levels|regulation of steroid metabolic process|positive regulation of dense core granule biogenesis,0.0005194|0.0007765|0.0008845|0.0009359|0.001164,1|1|1|1|1,58.51|2574|14.52|43.27|1287
567,6,0.4112,6.167999999999999,4661.0,0.001318,0.998474,ADGRF5 ATP6V1E2 C22orf42 C6orf226 PPP3R1 SOCS3,cell surface receptor signaling pathway|pharyngeal arch artery morphogenesis|positive regulation of phospholipid biosynthetic process|calcineurin-NFAT signaling cascade|surfactant homeostasis,0.002609|0.002619|0.00349|0.003781|0.003781,1|1|1|1|1,5.523|429.1|312|286|286
568,7,0.4136,8.686,5868.0,0.001475,0.9992989999999999,ATP8B1 BFSP1 MSANTD3 PSD3 SIRPD SLC28A1 SLC35B3,purine-containing compound transmembrane transport|carbohydrate derivative transport|cytidine transport|organophosphate ester transport|3'-phospho-5'-adenylyl sulfate transmembrane transport,2.279e-05|0.0002787|0.0006794|0.0008632|0.001019,0.3594|1|1|1|1,294.2|79.52|2942|44.58|1471
569,6,0.43,6.45,4712.0,0.001364,0.998474,ATP9B C12orf50 FICD SERPINB5 SLC17A9 ST8SIA3,protein deadenylylation|protein denucleotidylation|organophosphate ester transport|guanine nucleotide transport|protein nucleotidylation,0.0005824|0.0005824|0.0006192|0.0008735|0.0008735,1|1|1|1|1,3432|3432|52.01|1716|1716
570,7,0.4042,8.488999999999999,5506.0,0.001535,0.9992989999999999,ATPAF1 GPER1 GPR146 OPTN RBAK RNF216 USP32,"protein catabolic process at synapse|protein catabolic process, modulating synaptic transmission|nuclear fragmentation involved in apoptotic nuclear change|positive regulation of cardiac vascular smooth muscle cell differentiation|regulation of cardiac vascular smooth muscle cell differentiation",0.0006794|0.0006794|0.0006794|0.001019|0.001358,1|1|1|1|1,2942|2942|2942|1471|980.7
571,13,0.4052,31.61,9016.0,0.003483,0.999993,ATR COPB2 DBR1 ISY1 MCM2 PIK3R4 RPN1 SEC61A1 SRPRB TOPBP1 U2SURP VCP XAB2,DNA repair|DNA metabolic process|cellular response to DNA damage stimulus|cellular response to stress|DNA replication initiation,7.313e-08|9.833e-07|1.035e-06|1.585e-06|5.709e-06,0.001154|0.007755|0.00544|0.00625|0.01801,17|11.54|11.45|6.601|89.8
572,16,0.4143,49.72,10410.0,0.004738,0.999999,ATR ATRIP CIP2A H2AFX HUS1 MAD2L2 MCM9 NBN PALB2 RAD1 RAD17 RAD51B RAD9A RFC5 RHNO1 TOPBP1,DNA repair|DNA metabolic process|cellular response to DNA damage stimulus|DNA replication|cell cycle checkpoint,1.873e-19|3.821e-17|4.245e-17|7.559e-17|2.292e-16,2.955e-15|3.014e-13|2.232e-13|2.981e-13|7.231e-13,30.22|20.51|20.35|46.44|60.54
573,19,0.3918,67.0,14970.0,0.004444,1.0,C6orf203 COL19A1 DDX43 DPPA5 ENPP1 ENPP3 FAM135A GABRR1 KHDC1 KHDC1L KHDC3L LGSN SMAP1 TAAR2 TAAR6 TAAR8 TCF21 VNN2 WISP3,nucleoside triphosphate catabolic process|negative regulation of hh target transcription factor activity|muscle organ development|water-soluble vitamin metabolic process|nucleoside phosphate catabolic process,9.584e-05|0.001843|0.002108|0.002745|0.002745,1|1|1|1|1,154.8|1084|11.61|26.12|26.12
574,4,0.4644,2.786,3144.0,0.0008833000000000001,0.9929309999999999,ATXN1 CEP162 MST1 SMO,positive regulation of mammary gland epithelial cell proliferation|positive regulation of epithelial cell proliferation|regulation of mammary gland epithelial cell proliferation|regulation of macrophage chemotaxis|regulation of macrophage migration,3.108e-06|8.493e-06|9.879e-06|2.045e-05|4.239e-05,0.04902|0.06698|0.05195|0.08063|0.1337,823.8|63.7|433.6|294.2|200.9
575,5,0.4434,4.434,3905.0,0.001131,0.996692,ATXN1L BTG4 CIC ENTPD7 STK32C,biological process involved in intraspecies interaction between organisms|social behavior|memory|learning|UTP catabolic process,6.219e-05|6.219e-05|0.0003163|0.0004786|0.0004854,0.9811|0.4905|1|1|1,164.8|164.8|71.63|58.01|4119
576,14,0.3851,35.04,9383.0,0.00371,0.9999969999999999,ATXN2L CCNI CNOT10 CNOT11 CNOT2 CNOT4 CNOT9 G3BP2 LARP1 LARP4 LARP4B LSM12 NUFIP2 PUM1,"nuclear-transcribed mRNA poly(A) tail shortening|regulation of translation|regulation of cellular amide metabolic process|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|signal transduction involved in mitotic G1 DNA damage checkpoint",6.301e-12|3.111e-11|1.088e-10|4.449e-10|4.824e-10,9.939e-08|2.454e-07|5.719e-07|1.755e-06|1.522e-06,319.8|31.98|27.24|126.8|124.7
577,6,0.408,6.12,4803.0,0.001269,0.998474,ATXN3 FZD8 GJD4 HIST1H4C MCUR1 SLIRP,negative regulation of mitochondrial RNA catabolic process|protein localization to cytosolic proteasome complex involved in ERAD pathway|protein localization to cytosolic proteasome complex|negative regulation of megakaryocyte differentiation|regulation of mitochondrial RNA catabolic process,0.0008735|0.0008735|0.0008735|0.001746|0.001746,1|1|1|1|1,1716|1716|1716|686.5|686.5
578,5,0.4441,4.441,4102.0,0.0010789999999999999,0.996692,AUH C2CD4B GREB1L LTBP1 TGFB1,"regulation of vascular permeability|negative regulation of transforming growth factor beta receptor signaling pathway|regulation of transforming growth factor beta receptor signaling pathway|regulation of cellular response to transforming growth factor beta stimulus|putrescine biosynthetic process from arginine, using agmatinase",6.96e-05|0.0002438|0.0005221|0.0005478|0.0005824,1|1|1|1|1,159.7|83.72|56.74|55.36|3432
579,5,0.439,4.39,3967.0,0.001103,0.996692,AUNIP GPR150 NRXN3 NUPR1 OXCT2,negative regulation of type B pancreatic cell proliferation|positive regulation of oxidative phosphorylation|ketone body catabolic process|regulation of female gonad development|negative regulation of double-strand break repair via nonhomologous end joining,0.000728|0.0009706|0.001213|0.001698|0.00194,1|1|1|1|1,2060|1373|1030|686.5|588.4
580,5,0.4249,4.249,3889.0,0.001088,0.996692,ARMT1 AVL9 PPP1R3A RNF151 TMEM116,regulation of glycogen biosynthetic process|regulation of glucan biosynthetic process|regulation of glycogen metabolic process|regulation of polysaccharide biosynthetic process|regulation of polysaccharide metabolic process,0.007744|0.007744|0.009431|0.009672|0.01136,1|1|1|1|1,132.9|132.9|108.4|105.6|89.54
581,4,0.4544,2.727,3026.0,0.0008977999999999999,0.9929309999999999,AVPR1B C6orf163 CPXM2 NIP7,regulation of systemic arterial blood pressure by vasopressin|positive regulation of arachidonic acid secretion|positive regulation of phospholipase A2 activity|regulation of arachidonic acid secretion|regulation of phospholipase A2 activity,0.001165|0.001359|0.001553|0.001747|0.002716,1|1|1|1|1,1030|858.1|735.5|643.6|396.1
582,36,0.4025,253.6,29450.0,0.008516,1.0,ADA BPIFA3 BPIFB4 CCM2L CDH22 CNBD2 CPNE1 DEFB116 DUSP15 EPB41L1 FAM209A FAM209B FAM83C FOXS1 GGT7 GHRH HCK KIAA1755 KIF3B LBP MAP1LC3A MYH7B MYLK2 NECAB3 NOL4L SLA2 SLC12A5 SNTA1 SOGA1 TLDC2 TM9SF4 WFDC11 WFDC6 WISP2 XKR7 ZNF341,"regulation of circadian sleep/wake cycle, sleep|regulation of circadian sleep/wake cycle|positive regulation of multicellular organism growth|response to isoquinoline alkaloid|lipopolysaccharide-mediated signaling pathway",0.0004696|0.0006918|0.001606|0.001699|0.001699,1|1|1|1|1,69.23|56.04|35.66|34.61|34.61
583,21,0.403,84.64,16780.0,0.005006,1.0,ASTL C2orf49 CCDC74B CFC1 CFC1B CNNM4 FAHD2A FAM178B IL1F10 IL1RN IL36G LYG1 MGAT4A MRPL30 POTEI RNF149 SCN1A SCTR SULT1C2 TRIM43 TUBA3D,inflammatory response to antigenic stimulus|nodal signaling pathway|sulfation|purine ribonucleoside bisphosphate metabolic process|3'-phosphoadenosine 5'-phosphosulfate metabolic process,8.683e-06|9.815e-05|0.0003478|0.0003754|0.0003754,0.137|0.7741|1|1|1,80.24|156|78.01|74.89|74.89
584,7,0.4017,8.435,5980.0,0.001405,0.9992989999999999,B3GALT4 HTR6 IFI6 MDM1 QSOX1 SCYL3 STK32B,negative regulation of mitochondrial depolarization|negative regulation of membrane depolarization|negative regulation of centriole replication|negative regulation of centrosome duplication|negative regulation of centrosome cycle,0.002376|0.002715|0.002715|0.004409|0.004409,1|1|1|1|1,490.4|420.3|420.3|245.2|245.2
585,7,0.4235,8.894,5617.0,0.001577,0.9992989999999999,B3GALT5 BATF2 FAM107B GULP1 SCGB2A2 SNX32 SYCP2,male anatomical structure morphogenesis|male genitalia morphogenesis|poly-N-acetyllactosamine biosynthetic process|poly-N-acetyllactosamine metabolic process|genitalia morphogenesis,0.001698|0.001698|0.004409|0.004748|0.004748,1|1|1|1|1,735.5|735.5|245.2|226.3|226.3
586,21,0.6732,141.4,13450.0,0.01037,1.0,B3GALT6 B3GAT3 B4GALT7 C3orf58 EXT1 EXT2 EXTL3 FAM20B FGFR1 FRS2 GLCE GRB2 HS2ST1 NDST1 PTPN11 SLC35B2 SLC39A9 TM9SF3 TMEM165 UGDH XYLT2,proteoglycan biosynthetic process|heparan sulfate proteoglycan biosynthetic process|proteoglycan metabolic process|heparan sulfate proteoglycan metabolic process|glycoprotein biosynthetic process,3.593e-25|5.903e-24|1.65e-23|4.313e-23|3.241e-19,5.668e-21|4.656e-20|8.678e-20|1.701e-19|1.022e-15,196.1|445.8|138.5|350.3|42.5
587,17,0.4067,55.3,13440.0,0.0040880000000000005,1.0,C6orf203 CGAS COL19A1 DDX43 DPPA5 ENPP3 FAM135A GABRR1 GJB7 KHDC1 KHDC1L KHDC3L LGSN TAAR2 TAAR6 TCF21 VNN2,regulation of double-strand break repair|basophil activation involved in immune response|glutamine biosynthetic process|activation of cysteine-type endopeptidase activity involved in apoptotic process|basophil activation,0.002351|0.002472|0.002472|0.002621|0.003295,1|1|1|1|1,28.17|605.7|605.7|26.63|403.8
588,8,0.4098,11.47,6817.0,0.0016760000000000002,0.9996790000000001,ACACB ADRB3 B3GLCT DCT DOK2 EDNRB RCBTB2 TEX15,vasodilation|developmental pigmentation|pigmentation|enteric smooth muscle cell differentiation|blood vessel diameter maintenance,8.727e-05|0.0001021|0.0005194|0.0007765|0.001046,1|0.8057|1|1|1,147.1|135.5|58.51|2574|40.86
589,20,0.4092,77.75,13630.0,0.005654,1.0,ALG6 ALG8 B3GNT2 B3GNT5 B4GALT3 B4GALT5 GALE OST4 OSTC SLC35A3 SPPL3 SSR1 SSR2 SSR3 STT3A TM9SF2 TMEM165 UGCG UGP2 UXS1,carbohydrate derivative biosynthetic process|protein glycosylation|macromolecule glycosylation|glycosylation|carbohydrate derivative metabolic process,1.184e-14|6.192e-14|6.192e-14|1.025e-13|2.595e-13,1.868e-10|4.883e-10|3.256e-10|4.044e-10|8.186e-10,19.27|37|37|35.12|12.46
590,17,0.386,52.49,12890.0,0.004045,1.0,ADAMTS8 C11orf53 CLDN25 CRYAB FXYD6 HTR3A HTR3B KCNJ1 NXPE1 NXPE2 NXPE4 OR10G9 OR4D5 OR6M1 POU2F3 TIMM8B TMEM136,system process|serotonin receptor signaling pathway|cellular metabolic process|nervous system process|ion transmembrane transport,9.996e-05|0.0005152|0.0005725|0.0005936|0.00129,1|1|1|1|1,4.751|62.13|0|5.267|5.763
591,26,0.3521,114.4,19970.0,0.005683,1.0,BIRC3 C11orf88 CARD16 CASP5 CCDC81 CCDC89 CEP126 CFAP300 DYNC2H1 FAM76B FOLR1 FOLR2 KRTAP5-9 MMP1 MMP10 MMP13 MMP20 MMP27 MMP3 MMP7 MMP8 P2RY2 P2RY6 PLEKHB1 SYT9 UCP3,collagen catabolic process|collagen metabolic process|extracellular matrix disassembly|extracellular matrix organization|extracellular structure organization,1.321e-17|2.3e-16|5.784e-12|1.451e-09|1.484e-09,2.084e-13|1.814e-12|3.041e-08|5.721e-06|4.68e-06,153.9|108.5|78.01|17.33|17.28
592,7,0.4109,8.628,5651.0,0.001521,0.9992989999999999,B3GNT7 CYBA ETV2 HMBS PPOX SPTA1 TCHHL1,porphyrin-containing compound biosynthetic process|tetrapyrrole biosynthetic process|porphyrin-containing compound metabolic process|tetrapyrrole metabolic process|protoporphyrinogen IX biosynthetic process,2.286e-07|2.286e-07|8.92e-07|2.36e-06|7.244e-06,0.003607|0.001803|0.00469|0.009305|0.02285,249.1|249.1|154.5|110.3|572.1
593,7,0.4333,9.097999999999999,5930.0,0.0015279999999999998,0.9992989999999999,B3GNT9 CYP7A1 ENAH NLRP2 SULT1C3 TMEM150C TRPV2,cholesterol metabolic process|secondary alcohol metabolic process|sterol metabolic process|proprioception|actin polymerization-dependent cell motility,0.0007518|0.000876|0.000955|0.002037|0.002715,1|1|1|1|1,47.84|44.24|42.33|588.4|420.3
594,6,0.4189,6.2829999999999995,4921.0,0.0012720000000000001,0.998474,B3GNTL1 BCL7C CGREF1 PLD1 RNF222 TUBA3C,regulation of microvillus assembly|regulation of synaptic vesicle cycle|regulation of microvillus organization|phosphatidic acid biosynthetic process|phosphatidic acid metabolic process,0.002037|0.002619|0.004071|0.01448|0.01534,1|1|1|1|1,572.1|429.1|264|70.05|66.01
595,5,0.4541,4.541,3888.0,0.001164,0.996692,B4GALNT1 GPR182 MDK STMN2 ZNF254,positive regulation of neuron projection development|glial cell projection elongation|positive regulation of inflammatory response to wounding|negative regulation of inflammatory response to wounding|positive regulation of blood vessel branching,0.0005831|0.000728|0.000728|0.0009706|0.0009706,1|1|1|1|1,52.47|2060|2060|1373|1373
596,6,0.4251,6.377000000000001,4886.0,0.0013,0.998474,B4GALNT2 CCDC70 DHRS12 NLK PTTG2 SPRY4,UDP-N-acetylgalactosamine metabolic process|serine phosphorylation of STAT protein|negative regulation of cell adhesion|lipid glycosylation|negative regulation of substrate adhesion-dependent cell spreading,0.001358|0.001698|0.003773|0.004409|0.005086,1|1|1|1|1,980.7|735.5|20.94|245.2|210.2
597,6,0.4317,6.476,4784.0,0.001349,0.998474,B4GALT4 BPIFB1 ELF1 GFM2 TTYH3 ZNF266,ribosome disassembly|negative regulation of toll-like receptor 4 signaling pathway|regulation of toll-like receptor 4 signaling pathway|innate immune response in mucosa|regulation of B cell receptor signaling pathway,0.002619|0.0032|0.006681|0.00697|0.00755,1|1|1|1|1,429.1|343.2|156|149.2|137.3
598,21,0.4029,84.6,17450.0,0.0048130000000000004,1.0,AARD BAALC C8orf76 COL14A1 DCDC2 ENPP2 FBXO32 GNPNAT1 GSDMC KLHL38 MTSS1 NECAB1 NETO2 NOV PPDPFL RNF139 SLC22A4 SLC30A8 TRMT12 WDYHV1 ZFHX4,nephron tubule epithelial cell differentiation|smooth muscle cell proliferation|regulation of kainate selective glutamate receptor activity|negative regulation of sensory perception of pain|epithelial cell proliferation,0.003343|0.003343|0.004455|0.004455|0.004589,1|1|1|1|1,447.7|447.7|298.5|298.5|20.12
599,12,0.4128,27.25,8095.0,0.0033450000000000003,0.999986,CDC6 CDT1 GMNN MRE11 ORC1 ORC2 ORC3 ORC4 ORC5 ORC6 PNKP USP37,DNA replication initiation|DNA-dependent DNA replication|G1/S transition of mitotic cell cycle|cell cycle G1/S phase transition|pre-replicative complex assembly,4.366e-22|8.573e-22|6.77e-21|7.881e-21|1.308e-20,6.887e-18|6.762e-18|3.56e-17|3.108e-17|4.126e-17,359.2|97.31|137.3|135.1|237.6
600,15,0.407,42.74,11410.0,0.003722,0.999999,ADAMTS15 ADAMTS8 BACE1 C11orf53 CRYAB FXYD6 HTR3A HTR3B KCNJ1 NXPE1 NXPE2 NXPE4 POU2F3 RNF214 TMEM136,serotonin receptor signaling pathway|ion transmembrane transport|cellular response to dopamine|response to dopamine|transmembrane transport,0.0003988|0.0006824|0.001626|0.001665|0.001727,1|1|1|1|1,70.41|6.532|33.9|33.49|5.313
601,6,0.4275,6.412000000000001,4826.0,0.001323,0.998474,BACE2 CACNG3 CCDC28A CNPY3 CSGALNACT2 PRCP,"dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process|chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process|plasma kallikrein-kinin cascade|kinin cascade|glucose homeostasis",0.0005824|0.0008735|0.001165|0.001165|0.001252,1|1|1|1|1,3432|1716|1144|1144|36.32
602,6,0.4167,6.251,4881.0,0.001276,0.998474,BACH2 BANK1 CCDC122 FAT4 GPR135 PTGER2,cellular response to prostaglandin E stimulus|cellular response to prostaglandin stimulus|response to prostaglandin E|response to prostaglandin|cellular response to alcohol,1.51e-05|2.495e-05|3.204e-05|5.199e-05|0.0003736,0.2382|0.1968|0.1684|0.205|1,367.8|280.2|245.2|189.8|68.42
603,5,0.4242,4.242,3836.0,0.001102,0.996692,BAD GDF7 OR52K1 TMEM231 TMEM89,roof plate formation|positive regulation of tendon cell differentiation|regulation of tendon cell differentiation|positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress|cellular response to chromate,0.0004854|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,4119|4119|4119|4119|4119
604,7,0.416,8.736,5742.0,0.001515,0.9992989999999999,BAG3 CCDC9B FOLR1 LCA5 SEMA7A TENM4 WNT11,heart formation|mesenchymal cell differentiation|ameboidal-type cell migration|mesenchyme development|movement of cell or subcellular component,1.51e-05|1.543e-05|2.351e-05|4.129e-05|5.1e-05,0.2382|0.1217|0.1236|0.1628|0.1609,367.8|56.58|49.04|40.49|9.246
605,6,0.4201,6.3020000000000005,4851.0,0.001294,0.998474,BAIAP3 FUT2 MISP PPP1R16B TRAK2 UBE2E3,anterograde dendritic transport of mitochondrion|regulation of dense core granule exocytosis|regulation of endothelial cell proliferation|dendritic transport of mitochondrion|negative regulation of peptidyl-serine dephosphorylation,0.0005824|0.0005824|0.0006378|0.0008735|0.001165,1|1|1|1|1,3432|3432|51.23|1716|1144
606,18,0.4055,62.04,13870.0,0.004443,1.0,AKAP2 BARHL1 C9orf16 C9orf84 FAM129B GBGT1 KIF12 OR13C3 OR1J1 OR1J2 OR1J4 OR1L1 OR1L8 OR1N2 PALM2 RALGAPA1 TXNDC8 ZBTB6,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,2.113e-08|3.158e-08|4.075e-08|6.6e-08|8.504e-08,0.0003333|0.000249|0.0002143|0.0002603|0.0002683,20.43|19.25|18.54|17.26|16.62
607,6,0.4206,6.309,4705.0,0.001336,0.998474,BARHL2 CACNG8 HOOK2 ME3 SERPINE2 TRIM58,"regulation of synaptic transmission, glutamatergic|lysosomal transport|mating plug formation|seminal vesicle epithelium development|positive regulation of synaptic transmission",0.0001791|0.0004255|0.0005824|0.0005824|0.000601,1|1|1|1|1,98.07|62.98|3432|3432|52.81
608,19,0.3923,67.08,13080.0,0.0050869999999999995,1.0,CCND2 FURIN HERPUD1 IKBKB IKZF3 IRF4 IRS1 MAF MEF2C NFKB1 POU2AF1 PRDM1 RELA RELB SMAD7 TCF3 TRAF5 UBALD2 ZNF296,positive regulation of macromolecule metabolic process|positive regulation of metabolic process|regulation of primary metabolic process|regulation of cellular metabolic process|regulation of macromolecule metabolic process,4.143e-11|1.55e-10|7.021e-10|1.363e-09|2.443e-09,6.534e-07|1.222e-06|3.692e-06|5.373e-06|7.706e-06,5.102|4.707|3.321|3.204|3.105
609,11,0.4083,22.46,7104.0,0.0031420000000000003,0.999969,BATF3 IKZF1 IRF4 JUNB MYB PTPN1 PTPN11 RORC SBNO2 SOS1 STAT3,hemopoiesis|hematopoietic or lymphoid organ development|leukocyte differentiation|immune system development|myeloid cell differentiation,5.754e-11|1.07e-10|1.457e-10|1.689e-10|8.2e-10,9.076e-07|8.442e-07|7.66e-07|6.661e-07|2.587e-06,26.19|24.2|37.13|22.83|49.93
610,8,0.4095,11.47,6461.0,0.0017670000000000001,0.9996790000000001,ANO8 BBS2 HSD11B2 KRT40 PAQR4 PSMB10 RAB26 ZNF423,Golgi to plasma membrane protein transport|establishment of protein localization to plasma membrane|Golgi to plasma membrane transport|vesicle-mediated transport to the plasma membrane|regulation of blood volume by renal aldosterone,6.506e-05|0.0001537|0.0001869|0.0004744|0.001164,1|1|0.9827|1|1,171.6|109.5|99.01|61.29|1287
611,6,0.4323,6.485,5026.0,0.001286,0.998474,BCAN ERGIC1 ITGB1BP1 RASGRF1 TBC1D26 TMC5,regulation of GTPase activity|activation of GTPase activity|negative regulation of cell adhesion involved in substrate-bound cell migration|negative regulation of protein targeting to membrane|blood vessel endothelial cell proliferation involved in sprouting angiogenesis,0.0002582|0.0004807|0.001165|0.002037|0.002328,1|1|1|1|1,21.02|59.18|1144|572.1|490.4
612,55,0.3511,521.4,43660.0,0.011770000000000001,1.0,ERVV-2 GP6 KIR2DL1 KIR2DL3 KLK3 KLK4 LAIR1 LAIR2 LILRA4 LILRB2 LILRB5 NLRP11 NLRP13 NLRP4 NLRP9 RFPL4A SHISA7 SMIM17 VN1R1 VN1R4 ZFP28 ZIM3 ZNF135 ZNF211 ZNF264 ZNF28 ZNF304 ZNF324 ZNF324B ZNF329 ZNF415 ZNF416 ZNF460 ZNF524 ZNF528 ZNF534 ZNF543 ZNF548 ZNF550 ZNF581 ZNF586 ZNF587 ZNF610 ZNF665 ZNF667 ZNF677 ZNF701 ZNF772 ZNF773 ZNF805 ZNF808 ZNF880 ZSCAN22 ZSCAN5A ZSCAN5B,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of gene expression",6.875e-18|7.68e-15|7.75e-15|8.113e-15|2.081e-14,1.085e-13|6.057e-11|4.075e-11|3.199e-11|6.564e-11,4.89|3.755|3.754|3.749|3.041
613,6,0.4266,6.399,4889.0,0.0013039999999999998,0.998474,ABCA13 ADAMTS13 BCAS1 TMEM8B TRAF1 USP30,cell-matrix adhesion|protein K6-linked deubiquitination|cell-substrate adhesion|negative regulation of mitophagy|cellular response to tumor necrosis factor,0.0005653|0.001165|0.0012|0.001746|0.002131,1|1|1|1|1,54.48|1144|37.11|686.5|27.68
614,6,0.4244,6.3660000000000005,4825.0,0.001315,0.998474,BCKDHB BPIFB4 FKTN GNPDA2 IFT52 KCNB1,glucosamine catabolic process|N-acetylglucosamine catabolic process|intraciliary anterograde transport|glucosamine metabolic process|positive regulation of norepinephrine secretion,0.0008735|0.001165|0.001165|0.001456|0.001456,1|1|1|1|1,1716|1144|1144|858.1|858.1
615,6,0.4271,6.407,4408.0,0.0014470000000000002,0.998474,ACBD3 BCL11A DDHD2 FLT3 GAB2 ZFP64,negative regulation of branching morphogenesis of a nerve|negative regulation of protein homooligomerization|negative regulation of protein oligomerization|negative regulation of neuron remodeling|regulation of neuron remodeling,0.0005824|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,3432|3432|3432|3432|3432
616,7,0.4015,8.431000000000001,5846.0,0.001437,0.9992989999999999,BCL2L11 BLOC1S2 GMPR NEIL2 PPM1M SCGN SPINT3,mitochondrial outer membrane permeabilization|positive regulation of mitochondrial membrane permeability involved in apoptotic process|mitochondrial outer membrane permeabilization involved in programmed cell death|positive regulation of mitochondrial membrane permeability|regulation of mitochondrial membrane permeability involved in apoptotic process,1.51e-05|1.875e-05|2.279e-05|2.958e-05|3.459e-05,0.2382|0.1479|0.1198|0.1166|0.1091,367.8|326.9|294.2|255.8|235.4
617,6,0.4405,6.607,4911.0,0.00134,0.998474,BCL2L12 FCRLB GPR148 IFT80 PMAIP1 TNFAIP6,negative regulation of response to stimulus|regulation of extrinsic apoptotic signaling pathway|inhibition of cysteine-type endopeptidase activity involved in apoptotic process|regulation of intrinsic apoptotic signaling pathway|articular cartilage development,0.0007674|0.0008592|0.0008735|0.000881|0.001165,1|1|1|1|1,7.611|44.01|1716|43.45|1144
618,6,0.4108,6.162000000000001,4724.0,0.001299,0.998474,BCL2L14 DPPA4 F13A1 KIRREL2 RMDN2 WNT5B,positive regulation of convergent extension involved in gastrulation|regulation of convergent extension involved in gastrulation|lens fiber cell development|positive regulation of non-canonical Wnt signaling pathway|wound healing,0.0008735|0.0008735|0.004071|0.004651|0.006621,1|1|1|1|1,1716|1716|264|228.8|15.46
619,22,0.4028,93.05,15320.0,0.006019,1.0,BCL10 CYLD IKBKB IL1R1 IL1RAP MYD88 N4BP1 NFKB2 NFKBIA NFKBIB RBCK1 RELA RIPK1 RNF31 SPATA2 STUB1 TAB2 TNFAIP3 TNIP1 TRAF2 TRAF3 TRAF6,regulation of DNA-binding transcription factor activity|positive regulation of NF-kappaB transcription factor activity|pattern recognition receptor signaling pathway|regulation of I-kappaB kinase/NF-kappaB signaling|I-kappaB kinase/NF-kappaB signaling,3.839e-24|5.349e-24|3.982e-23|1.133e-21|2.208e-21,6.056e-20|4.219e-20|2.094e-19|4.466e-18|6.966e-18,35.16|76.91|91.66|51.59|140.7
620,15,0.4092,42.97,9712.0,0.004391,0.999999,BLM CHTF18 CHTF8 DSCC1 FANCM MMS22L NFATC2IP NSMCE1 NSMCE3 NSMCE4A RMI1 RMI2 SMC6 TOP3A TRAIP,DNA metabolic process|DNA replication|DNA repair|nucleic acid metabolic process|DNA recombination,2.091e-19|5.35e-16|3.749e-13|4.332e-13|1.374e-12,3.299e-15|4.219e-12|1.971e-09|1.708e-09|4.334e-09,24.61|50.66|25.91|8.612|49.04
621,7,0.4066,8.54,5756.0,0.001478,0.9992989999999999,BCL9 CAMKK1 KIAA0232 LDB2 MDGA1 MEIOB NEBL,somatic stem cell population maintenance|stem cell population maintenance|maintenance of cell number|cardiac muscle thin filament assembly|regulation of synaptic membrane adhesion,0.0002165|0.0007881|0.0008127|0.001358|0.001698,1|1|1|1|1,90.53|46.7|45.97|980.7|735.5
622,20,0.4104,77.98,13920.0,0.005553,1.0,ACVR1 ACVR2A BAMBI BCL9L BMPR1A FKBP1A FOXA2 HNF1A HNF4A IPO8 LEMD3 LRIG1 LRIG3 MIB1 NEO1 RGMB SMAD1 SMAD7 TCF7L2 UBAC1,transmembrane receptor protein serine/threonine kinase signaling pathway|regulation of transmembrane receptor protein serine/threonine kinase signaling pathway|negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway|regulation of BMP signaling pathway|negative regulation of BMP signaling pathway,1.418e-15|1.472e-14|6.829e-13|6.961e-12|4.205e-11,2.236e-11|1.161e-10|3.591e-09|2.745e-08|1.326e-07,52.27|41.03|58.84|70.67|98.07
623,6,0.4344,6.516,4591.0,0.0014140000000000001,0.998474,BDH2 BRAP SNX13 SNX14 USP47 WDFY1,siderophore biosynthetic process|siderophore metabolic process|positive regulation of histone deacetylase activity|positive regulation of toll-like receptor 3 signaling pathway|regulation of toll-like receptor 3 signaling pathway,0.0006794|0.0006794|0.002376|0.002715|0.003054,1|1|1|1|1,2942|2942|490.4|420.3|367.8
624,22,0.4023,92.93,17860.0,0.005164,1.0,AGO1 AGO3 AGO4 ARMH1 AZIN2 BEST4 C1orf123 C1orf50 CFAP57 CYP4A22 CYP4Z1 ERMAP EXO5 GJB3 LURAP1 MFSD2A PPT1 ZBTB8A ZFP69 ZFP69B ZNF684 ZNF691,"miRNA loading onto RISC involved in gene silencing by miRNA|RNA secondary structure unwinding|small RNA loading onto RISC|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation",1.088e-07|1.495e-07|1.992e-07|5.058e-07|5.058e-07,0.001716|0.001179|0.001047|0.001994|0.001596,420.3|367.8|326.9|226.3|226.3
625,6,0.4174,6.261,4827.0,0.001292,0.998474,BDKRB2 CDC23 COX7A1 PIK3C2G PROK2 ZMAT2,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator|regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator|negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress|regulation of intrinsic apoptotic signaling pathway in response to osmotic stress|metaphase/anaphase transition of mitotic cell cycle,0.0005824|0.0005824|0.001456|0.001746|0.002328,1|1|1|1|1,3432|3432|858.1|686.5|490.4
626,6,0.4028,6.041,4669.0,0.001289,0.998474,ANTXRL BEGAIN KIAA0408 OR1M1 PPFIA1 TRABD,regulation of postsynaptic neurotransmitter receptor activity|negative regulation of protein localization to plasma membrane|negative regulation of protein localization to cell periphery|negative regulation of stress fiber assembly|glutamate secretion,0.005812|0.00726|0.007839|0.008128|0.008707,1|1|1|1|1,180.7|143|132|127.1|118.4
627,9,0.4293,15.45,6623.0,0.002322,0.9998530000000001,ADIPOR2 BCL11A BCL2 BEND4 IRF8 MEF2D SIK3 SLC5A3 ZFP64,regulation of neuron maturation|regulation of cell maturation|negative regulation of cell growth|positive regulation of cellular metabolic process|negative regulation of growth,1.117e-05|4.658e-05|6.224e-05|6.403e-05|0.0001388,0.1762|0.3674|0.3273|0.2525|0.4379,457.7|208|36.71|4.947|27.91
628,7,0.4107,8.624,5330.0,0.001611,0.9992989999999999,BEND5 CD3G CLCN6 DHRS4 DHRS4L2 GRP RNASE3,neuropeptide signaling pathway|positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway|psychomotor behavior|regulation of phospholipase C-activating G protein-coupled receptor signaling pathway|induction of bacterial agglutination,0.001258|0.002424|0.002424|0.002909|0.002909,1|1|1|1|1,37.79|514.9|514.9|411.9|411.9
629,7,0.402,8.442,5684.0,0.0014789999999999998,0.9992989999999999,ATP2C2 BEND6 BSPH1 OR2T35 PCDHB15 RETREG2 ZC3H14,negative regulation of mRNA polyadenylation|negative regulation of mRNA 3'-end processing|manganese ion transmembrane transport|manganese ion transport|regulation of mRNA polyadenylation,0.003054|0.003393|0.003732|0.005763|0.006101,1|1|1|1|1,367.8|326.9|294.2|183.9|173.1
630,6,0.4207,6.31,4841.0,0.001299,0.998474,BFSP2 FBXL14 SLC5A9 SWAP70 TMEM61 TSKS,negative regulation of dephosphorylation|negative regulation of cell-cell adhesion mediated by integrin|negative regulation of peptidyl-serine dephosphorylation|regulation of dephosphorylation|regulation of peptidyl-serine dephosphorylation,0.0004646|0.0008735|0.001165|0.001626|0.001746,1|1|1|1|1,60.22|1716|1144|31.78|686.5
631,6,0.4187,6.281000000000001,4971.0,0.001259,0.998474,BHLHA9 CCDC88C GAS2L1 IDNK RAB15 RAPGEF4,small GTPase mediated signal transduction|protein secretion|establishment of protein localization to extracellular region|protein localization to extracellular region|peptide secretion,4.09e-05|0.0003955|0.0004029|0.0004566|0.0005392,0.6452|1|1|1|1,39.3|65.38|64.76|60.75|55.81
632,8,0.6003,16.81,5622.0,0.002972,0.9996790000000001,IL6R IL6ST JAK1 LIFR SBNO2 SLC39A1 SOCS3 STAT3,cellular response to interleukin-6|response to interleukin-6|interleukin-6-mediated signaling pathway|ciliary neurotrophic factor-mediated signaling pathway|cellular response to cytokine stimulus,1.38e-15|2.462e-15|6.081e-14|2.15e-09|5.251e-09,2.176e-11|1.942e-11|3.197e-10|8.478e-06|1.657e-05,429.1|386.2|715.1|1545|17.9
633,22,0.3871,89.43,16340.0,0.005429,1.0,AQP7 CBWD1 CBWD2 CBWD5 CCL19 CNN2 CNTNAP3 CNTNAP3B FOXD4 FOXD4L4 FOXD4L5 IL11RA OR13J1 OR2S2 PGM5 SPAG8 SPATA31A6 SPATA31A7 ST3GAL1 TESK1 ZNF658 ZNF850,negative regulation of leukocyte apoptotic process|memory B cell differentiation|positive regulation of dendritic cell dendrite assembly|spermatogenesis|male gamete generation,0.00119|0.002133|0.002133|0.002533|0.002863,1|1|1|1|1,40.7|936.1|936.1|6.833|6.604
634,27,0.3762,132.1,19350.0,0.006761,1.0,EPS15L1 GMIP MEF2B OR7C2 SMIM7 SSBP4 ZNF100 ZNF101 ZNF124 ZNF14 ZNF195 ZNF253 ZNF43 ZNF443 ZNF486 ZNF492 ZNF564 ZNF625 ZNF682 ZNF69 ZNF714 ZNF737 ZNF763 ZNF844 ZNF91 ZNF98 ZNF99,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",2.158e-17|1.444e-14|1.454e-14|1.501e-14|7.78e-14,3.404e-13|1.139e-10|7.643e-11|5.919e-11|2.455e-10,6.784|5.065|5.063|5.056|4.693
635,6,0.4389,6.584,5039.0,0.001302,0.998474,BICDL1 FTCD MYOM3 PLXNA2 TLL2 TMEM238,negative regulation of skeletal muscle tissue growth|Golgi to secretory granule transport|cerebellar granule cell precursor tangential migration|hindbrain tangential cell migration|formamide metabolic process,0.0008735|0.0008735|0.0008735|0.001165|0.001456,1|1|1|1|1,1716|1716|1716|1144|858.1
636,6,0.4186,6.278,4786.0,0.001307,0.998474,ACAT2 ACR BIK RABL2B TEX9 VAV2,acrosome matrix dispersal|cholesterol metabolic process|secondary alcohol metabolic process|sterol metabolic process|cholesterol esterification,0.0006794|0.0007518|0.000876|0.000955|0.001698,1|1|1|1|1,2942|47.84|44.24|42.33|735.5
637,13,0.3897,30.39,8181.0,0.0036899999999999997,0.999993,COP1 DDA1 DET1 DUSP4 DUSP5 FOSL1 HIVEP1 JUN JUNB MAPK1 STK40 TRIB1 TRIB2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process|positive regulation of ubiquitin-dependent protein catabolic process|positive regulation of proteasomal protein catabolic process|positive regulation of proteolysis involved in cellular protein catabolic process|regulation of proteasomal ubiquitin-dependent protein catabolic process,3.625e-09|8.341e-09|1.04e-08|2.218e-08|2.475e-08,5.718e-05|6.579e-05|5.468e-05|8.748e-05|7.809e-05,81.73|68.74|65.67|56.15|54.89
638,10,0.4116,18.52,7829.0,0.0023539999999999998,0.999933,BIVM CLYBL COL4A1 COL4A2 F7 KDELC1 PLA2G4A SLITRK5 ZIC2 ZIC5,collagen-activated tyrosine kinase receptor signaling pathway|collagen-activated signaling pathway|central nervous system development|response to carbon dioxide|positive regulation of cobalamin metabolic process,1.539e-05|2.299e-05|0.0005603|0.0008734|0.0008734,0.2428|0.1813|1|1|1,381.4|305.1|9.236|2288|2288
639,6,0.4031,6.047000000000001,5062.0,0.00119,0.998474,BLMH FAM171B FNDC11 HS3ST6 LAMP3 PREX2,homocysteine catabolic process|homocysteine metabolic process|sulfur amino acid catabolic process|response to interferon-alpha|blastocyst hatching,0.001165|0.004071|0.004071|0.00726|0.007839,1|1|1|1|1,1144|264|264|143|132
640,6,0.4156,6.235,4581.0,0.001355,0.998474,ATM BLOC1S4 CTAGE15 DCLRE1C SHLD1 UNC80,V(D)J recombination|somatic diversification of immune receptors via germline recombination within a single locus|somatic cell DNA recombination|somatic diversification of immune receptors|double-strand break repair via nonhomologous end joining,1.079e-05|4.188e-05|4.188e-05|7.275e-05|0.0001458,0.1703|0.3303|0.2202|0.2869|0.4601,429.1|208|208|156|109
641,9,0.4075,14.67,6877.0,0.002123,0.9998530000000001,LAMP3 RNF111 SCN7A STYXL1 TGFBR1 TGFBR2 TGFBR3 TMEM222 UBXN11,pathway-restricted SMAD protein phosphorylation|regulation of transforming growth factor beta receptor signaling pathway|regulation of cellular response to transforming growth factor beta stimulus|ventricular septum morphogenesis|regulation of cardiac muscle cell proliferation,3.218e-08|1.589e-07|1.748e-07|4.825e-07|7.05e-07,0.0005076|0.001253|0.000919|0.001903|0.002224,528.1|75.65|73.82|196.1|171.6
642,4,0.4466,2.679,3111.0,0.0008583,0.9929309999999999,BLVRB C8A HNRNPCL1 PRR22,"complement activation, alternative pathway|pigment catabolic process|porphyrin-containing compound catabolic process|tetrapyrrole catabolic process|heme catabolic process",0.003104|0.003297|0.003297|0.003297|0.003297,1|1|1|1|1,343.2|321.8|321.8|321.8|321.8
643,6,0.4084,6.126,4696.0,0.001299,0.998474,ACOT1 BLZF1 CAPS MMP16 RDH11 TAPBP,MHC class Ib protein complex assembly|peptide antigen stabilization|peptide stabilization|MHC class I protein complex assembly|vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,0.0006794|0.0006794|0.0006794|0.001358|0.002376,1|1|1|1|1,2942|2942|2942|980.7|490.4
644,7,0.406,8.527000000000001,5851.0,0.001452,0.9992989999999999,AANAT BMP1 HOXD12 INA INTU TP53I3 XIRP2,embryonic digit morphogenesis|embryonic limb morphogenesis|embryonic appendage morphogenesis|limb morphogenesis|appendage morphogenesis,0.0001678|0.0006932|0.0006932|0.0009685|0.0009685,1|1|1|1|1,103.2|49.87|49.87|42.03|42.03
645,6,0.4405,6.607,4907.0,0.001341,0.998474,BMP3 FRZB LRRC66 RAPGEF4 SEPT10 SNTG1,negative regulation of hepatocyte differentiation|regulation of hepatocyte differentiation|convergent extension involved in organogenesis|regulation of synaptic vesicle cycle|cell-cell signaling,0.0005824|0.0008735|0.001746|0.002619|0.00289,1|1|1|1|1,3432|1716|686.5|429.1|9.153
646,5,0.4464,4.4639999999999995,3973.0,0.001119,0.996692,BMP5 DRD2 HS6ST3 PLCH2 THEMIS,endocrine system development|allantois development|positive regulation of glial cell-derived neurotrophic factor production|positive regulation of dopamine uptake involved in synaptic transmission|positive regulation of catecholamine uptake involved in synaptic transmission,0.0003609|0.000728|0.0009706|0.0009706|0.0009706,1|1|1|1|1,66.98|2060|1373|1373|1373
647,5,0.4218,4.218,3939.0,0.001067,0.996692,BMPER HECTD3 OR52A1 OR52A5 SLC5A2,alpha-glucoside transport|glucoside transport|glycoside transport|glucose import across plasma membrane|hexose import across plasma membrane,0.000728|0.0009706|0.001456|0.001456|0.001698,1|1|1|1|1,2060|1373|823.8|823.8|686.5
648,7,0.4246,8.916,5820.0,0.001526,0.9992989999999999,BMPR1B CAMK2N2 CASP10 CXCR2 GPBAR1 SPARC TEX44,cell surface bile acid receptor signaling pathway|interleukin-8-mediated signaling pathway|positive regulation of cholangiocyte proliferation|ovarian cumulus expansion|cellular response to interleukin-8,0.0007765|0.001164|0.001164|0.001552|0.001552,1|1|1|1|1,2574|1287|1287|858.1|858.1
649,11,0.4006,22.03,7709.0,0.0028420000000000003,0.999969,BMS1 DDX21 GBF1 HNRNPH1 NCL NOC3L NOLC1 PDCD11 RRP12 SUPV3L1 TIMM23,rRNA processing|rRNA metabolic process|RNA processing|ribosome biogenesis|ncRNA processing,3.786e-09|4.722e-09|7.096e-09|1.584e-08|7.389e-08,5.972e-05|3.725e-05|3.731e-05|6.247e-05|0.0002331,39.61|38.14|14.88|31.02|23.84
650,5,0.4456,4.456,3897.0,0.001139,0.996692,BNC1 FILIP1 MMP25 OR51Q1 WEE2,regulation of oocyte maturation|regulation of cell maturation|collagen catabolic process|collagen metabolic process|female pronucleus assembly,1.978e-06|1.946e-05|6.96e-05|0.000137|0.0008735,0.0312|0.1534|0.3659|0.5402|1,1144|312|159.7|112.5|1716
651,5,0.4498,4.498,3847.0,0.001165,0.996692,BNC2 ECHDC2 GNRH1 HAND1 PIGX,embryonic heart tube formation|cardiac left ventricle formation|response to prolactin|mesenchyme development|cardiac right ventricle formation,0.0004854|0.000728|0.0009706|0.001112|0.001213,1|1|1|1|1,4119|2060|1373|37.79|1030
652,5,0.4204,4.204,4025.0,0.001041,0.996692,BNIPL CSAD FADS1 GPR26 SLITRK6,L-cysteine catabolic process to taurine|L-cysteine catabolic process to hypotaurine|linear vestibuloocular reflex|oxoacid metabolic process|taurine biosynthetic process,0.0004854|0.0004854|0.0004854|0.00069|0.000728,1|1|1|1|1,4119|4119|4119|14.35|2060
653,5,0.4413,4.413,3852.0,0.001141,0.996692,ANKRD45 BOC CDC42BPB MCC SFXN1,serine import into mitochondrion|D-serine transport|L-serine transport|D-amino acid transport|serine transport,0.0009706|0.0009706|0.00194|0.002183|0.002667,1|1|1|1|1,1373|1373|588.4|514.9|411.9
654,6,0.4327,6.4910000000000005,4783.0,0.001352,0.998474,BOD1 C6orf201 CLEC2A FAM217A RAB3B RNF133,"mitotic sister chromatid biorientation|mitotic sister chromatid cohesion, centromeric|positive regulation of catecholamine uptake involved in synaptic transmission|positive regulation of dopamine uptake involved in synaptic transmission|sister chromatid biorientation",0.0005824|0.001165|0.001165|0.001165|0.001165,1|1|1|1|1,3432|1144|1144|1144|1144
655,5,0.4255,4.255,3816.0,0.001111,0.996692,BOD1L1 CPN2 DDX42 NUB1 ZNF594,replication fork processing|DNA-dependent DNA replication maintenance of fidelity|negative regulation of phosphoprotein phosphatase activity|negative regulation of protein dephosphorylation|positive regulation of proteasomal ubiquitin-dependent protein catabolic process,0.009672|0.01184|0.01544|0.01664|0.0219,1|1|1|1|1,105.6|85.81|65.38|60.57|45.77
656,6,0.4126,6.189,4642.0,0.001328,0.998474,BOD1L2 C19orf84 FARP2 H1FNT PCMTD1 TOB1,"spermatid nucleus elongation|negative regulation of nuclear-transcribed mRNA poly(A) tail shortening|negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay|podosome assembly|neuron remodeling",0.001165|0.001165|0.001165|0.001456|0.003781,1|1|1|1|1,1144|1144|1144|858.1|286
657,6,0.4021,6.031000000000001,4802.0,0.001251,0.998474,BOK FAM107A LSMEM2 SPAG16 TRIM3 ZNRF1,regulation of granulosa cell apoptotic process|positive regulation of PERK-mediated unfolded protein response|regulation of chorionic trophoblast cell proliferation|mucociliary clearance|negative regulation of mitochondrial depolarization,0.0008735|0.001456|0.001746|0.001746|0.002037,1|1|1|1|1,1716|858.1|686.5|686.5|572.1
658,6,0.4017,6.025,4657.0,0.001289,0.998474,BOLL C10orf120 FAM71F1 HS3ST5 SEMA3C SUCNR1,glycosaminoglycan biosynthetic process|aminoglycan biosynthetic process|cardiac endothelial to mesenchymal transition|pulmonary myocardium development|renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,0.0005015|0.0005725|0.0006794|0.0006794|0.001019,1|1|1|1|1,58.84|54.99|2942|2942|1471
659,6,0.4174,6.2620000000000005,4825.0,0.0012929999999999999,0.998474,BPHL FOXF2 LMNTD2 PIWIL1 SLC6A12 WFIKKN1,roof of mouth development|establishment of planar polarity of embryonic epithelium|gamma-aminobutyric acid reuptake|amino acid neurotransmitter reuptake|gamma-aminobutyric acid transport,0.0002799|0.001165|0.001456|0.002037|0.002909,1|1|1|1|1,78.01|1144|858.1|572.1|381.4
660,20,0.3815,72.49,14960.0,0.004808,1.0,ADAMTS15 ADAMTS8 CCDC153 FXYD6 HTR3A HTR3B KCNJ1 NTM NXPE2 NXPE4 OR10G8 OR10G9 OR10S1 OR4D5 OR6M1 OR6X1 OR8B2 OR8B8 OR8D4 TMEM136,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,1.411e-10|2.363e-10|3.278e-10|6.088e-10|8.43e-10,2.225e-06|1.864e-06|1.723e-06|2.401e-06|2.659e-06,21.02|19.8|19.07|17.75|17.1
661,33,0.403,212.8,27010.0,0.007797,1.0,ADA BPI BPIFA3 BPIFB2 BPIFB4 CNBD2 CPNE1 DEFB116 DLGAP4 DUSP15 FAM209A FAM209B FAM83C FOXS1 GGT7 GHRH HCK KIAA1755 LBP MAP1LC3A MYH7B MYLK2 NNAT SNTA1 SPAG4 TLDC2 TM9SF4 VSTM2L WFDC11 WFDC6 WISP2 XKR7 ZNF341,"lipopolysaccharide-mediated signaling pathway|regulation of circadian sleep/wake cycle, sleep|regulation of circadian sleep/wake cycle|response to bacterium|response to external stimulus",2.542e-05|0.0003922|0.000578|0.0007602|0.0009758,0.401|1|1|1|1,56.79|75.72|61.29|5.378|2.823
662,34,0.4005,224.7,27750.0,0.008013,1.0,ADA BPIFB3 BPIFB4 CCM2L CNBD2 CPNE1 DEFB115 DEFB116 DLGAP4 DUSP15 EPPIN FAM209A FAM209B FAM83C FOXS1 GGT7 GHRH HCK KIF3B LBP MAP1LC3A MYH7B MYLK2 NOL4L SLC12A5 SOGA1 TLDC2 TM9SF4 VSTM2L WFDC11 WFDC6 WISP2 XKR7 ZNF341,"response to bacterium|defense response to bacterium|response to external stimulus|regulation of circadian sleep/wake cycle, sleep|regulation of circadian sleep/wake cycle",0.0001237|0.0002194|0.0003207|0.0004172|0.0006148,1|1|1|1|1,6.084|9.045|2.986|73.42|59.44
663,6,0.4254,6.38,4898.0,0.0012980000000000001,0.998474,APOL6 BPIFB6 CFC1B COPS7B ERRFI1 POR,cellular organofluorine metabolic process|cellular organohalogen metabolic process|nitrate catabolic process|regulation of growth plate cartilage chondrocyte proliferation|nitric oxide catabolic process,0.0005824|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,3432|3432|3432|3432|3432
664,12,0.4211,27.79,8125.0,0.003399,0.999986,BRAT1 BRF2 DCTN6 FNTA GINS4 INTS14 INTS9 MAK16 PPP2CA PPP2CB TTI2 WDR73,positive regulation of microtubule binding|regulation of microtubule binding|peptidyl-serine dephosphorylation|peptidyl-threonine dephosphorylation|response to lead ion,1.026e-05|2.416e-05|4.386e-05|0.0001006|0.0001093,0.1619|0.1905|0.2306|0.3967|0.3448,528.1|316.8|226.3|144|137.8
665,21,0.4057,85.2,16690.0,0.005065,1.0,BCAS4 BMP7 CASS4 CNBD2 FAM209A FAM209B GGT7 MTRNR2L3 NPBWR2 OPRL1 PCK1 PMEPA1 R3HDML RBM38 RIPOR3 SLC2A4RG STX16 TFAP2C WFDC11 WISP2 ZGPAT,opioid receptor signaling pathway|response to estradiol|cellular response to steroid hormone stimulus|negative regulation of molecular function|response to lipid,6.482e-05|0.0003806|0.000413|0.000883|0.001221,1|1|1|1|1,196.1|21.32|20.72|5.025|5.965
666,8,0.4244,11.88,6641.0,0.001782,0.9996790000000001,BRINP3 CA3 CACNB2 CRB1 CSMD3 CYP7A1 S100A13 SYNE1,interleukin-1 alpha production|establishment of bipolar cell polarity|establishment of bipolar cell polarity involved in cell morphogenesis|post-embryonic retina morphogenesis in camera-type eye|positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,0.0007765|0.0007765|0.0007765|0.001164|0.001164,1|1|1|1|1,2574|2574|2574|1287|1287
667,19,0.737,126.0,12440.0,0.009999,1.0,BRIP1 CENPS CENPX FAAP100 FAAP20 FAAP24 FANCA FANCC FANCD2 FANCE FANCF FANCG FANCI FANCL FANCM RFWD3 SLX4 UBE2T XRCC2,interstrand cross-link repair|DNA repair|DNA metabolic process|cellular response to DNA damage stimulus|cellular response to stress,3.264e-40|1.736e-29|2.423e-26|2.796e-26|9.696e-20,5.149e-36|1.369e-25|1.274e-22|1.103e-22|3.059e-16,312.6|36.92|25.05|24.86|11.15
668,6,0.4099,6.149,5176.0,0.001184,0.998474,BRSK1 LOXL3 PCK2 PMP22 TNFRSF19 WNT9A,epithelium development|system development|fibronectin fibril organization|multicellular organism development|microtubule cytoskeleton organization involved in establishment of planar polarity,0.0002493|0.0004645|0.0006794|0.0009868|0.001019,1|1|1|1|1,10.73|4.125|2942|3.62|1471
669,7,0.4345,9.124,5443.0,0.0016690000000000001,0.9992989999999999,BSCL2 CCER1 CEACAM3 ISLR2 KIR3DL3 TNFSF8 TOP3B,"CD8-positive, alpha-beta T cell differentiation|DNA topological change|lipid droplet formation|CD8-positive, alpha-beta T cell activation|negative regulation of lipid catabolic process",0.003054|0.003393|0.004071|0.004409|0.008802,1|1|1|1|1,367.8|326.9|267.5|245.2|117.7
670,5,0.4304,4.303999999999999,3950.0,0.001086,0.996692,BSN CCDC62 LEPROTL1 MANBAL METTL25,presynapse to nucleus signaling pathway|presynaptic signal transduction|presynaptic active zone assembly|maintenance of presynaptic active zone structure|presynaptic active zone organization,0.000728|0.000728|0.0009706|0.001698|0.002183,1|1|1|1|1,2060|2060|1373|686.5|514.9
671,9,0.4027,14.5,6916.0,0.0020859999999999997,0.9998530000000001,BST1 CHCHD6 DYDC1 INTS4 NUMA1 POLD3 RPS3 SPCS2 WDR72,"positive regulation of microtubule polymerization|positive regulation of microtubule polymerization or depolymerization|DNA damage response, detection of DNA damage|regulation of microtubule polymerization|regulation of microtubule polymerization or depolymerization",8.893e-05|0.0001121|0.0001379|0.0002489|0.0005942,1|0.8839|0.7248|0.9814|1,147.6|130.8|117.4|86.35|55.14
672,12,0.4041,26.67,7717.0,0.003433,0.999986,ARMC7 BTAF1 CCDC84 DDX59 DHX9 DRAP1 PPIH RBM48 SCNM1 SNRPB2 TXNL4B WRAP53,"mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|RNA splicing|mRNA processing",5.164e-07|5.164e-07|5.419e-07|2.2e-06|5.087e-06,0.008146|0.004073|0.002849|0.008675|0.01605,28.41|28.41|28.14|21.08|17.73
673,6,0.4408,6.612,4856.0,0.001356,0.998474,BTBD10 EPHA5 FOXA3 LAMB1 PLA2G2D TMEM87A,"neuronal-glial interaction involved in cerebral cortex radial glia guided migration|pallium development|CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation|regulatory T cell differentiation|telencephalon development",0.0008735|0.001005|0.001456|0.002037|0.002198,1|1|1|1|1,1716|40.62|858.1|572.1|27.24
674,6,0.4321,6.482,4909.0,0.0013160000000000001,0.998474,BTBD16 CCER2 DMAC2 FGF5 GCNT1 MAB21L1,cell adhesion molecule production|signal transduction involved in regulation of gene expression|leukocyte tethering or rolling|leukocyte adhesion to vascular endothelial cell|cellular extravasation,0.001165|0.005812|0.006101|0.006391|0.01304,1|1|1|1|1,1144|180.7|171.6|163.5|78.01
675,5,0.4157,4.157,3753.0,0.001103,0.996692,BTBD2 DLG5 KSR1 ZDHHC5 ZNF557,zonula adherens assembly|positive regulation of protein localization to phagocytic vesicle|regulation of protein localization to phagocytic vesicle|protein localization to adherens junction|positive regulation of hippo signaling,0.000728|0.000728|0.000728|0.001456|0.001456,1|1|1|1|1,2060|2060|2060|823.8|823.8
676,21,0.4028,84.58,14530.0,0.005772,1.0,CNIH4 DUX4 EIF2S1 HSPE1 NBEAL1 NUTF2 OR2A25 RPL11 RPL12 RPL13 RPL17 RPL18A RPL37 RPL4 RPLP2 RPS13 SNU13 ST20 TBC1D3B TSPYL5 UQCRH,translational initiation|SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum,2.253e-16|7.644e-16|1.178e-15|2.637e-15|3.571e-15,3.554e-12|6.029e-12|6.193e-12|1.04e-11|1.126e-11,65.46|87.76|83.42|75.9|73.26
677,6,0.4072,6.108,4723.0,0.001288,0.998474,BTBD6 FICD FSD2 LMBR1 PNPLA2 TMEM150A,protein deadenylylation|protein denucleotidylation|protein nucleotidylation|protein adenylylation|negative regulation of sequestering of triglyceride,0.0005824|0.0005824|0.0008735|0.0008735|0.001746,1|1|1|1|1,3432|3432|1716|1716|686.5
678,5,0.4515,4.515,3904.0,0.001152,0.996692,BTBD7 KLHL20 LRRC14B MAST4 PALM,protein K33-linked ubiquitination|negative regulation of dopamine receptor signaling pathway|cytoskeleton organization|regulation of branching involved in salivary gland morphogenesis|regulation of dopamine receptor signaling pathway,0.0004854|0.0009706|0.001835|0.00194|0.00291,1|1|1|1|1,4119|1373|10.26|588.4|374.5
679,6,0.422,6.331,4923.0,0.001281,0.998474,ANTXR2 BNIP3L BTBD8 FUT4 KIF1B NEUROD6,response to rotenone|clathrin-dependent synaptic vesicle endocytosis|retrograde neuronal dense core vesicle transport|anterograde neuronal dense core vesicle transport|mitochondrial protein catabolic process,0.0005824|0.001456|0.001746|0.001746|0.001746,1|1|1|1|1,3432|858.1|686.5|686.5|686.5
680,8,0.4096,11.47,6666.0,0.001714,0.9996790000000001,BTG2 FAM69C GSDMC KCNQ3 MATN2 RASGRF2 SUN2 WISP1,nuclear migration along microfilament|nuclear matrix anchoring at nuclear membrane|nuclear matrix organization|nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration|pallium development,0.001164|0.001552|0.001552|0.001552|0.001856,1|1|1|1|1,1287|858.1|858.1|858.1|30.47
681,9,0.4261,15.34,6334.0,0.002409,0.9998530000000001,ANKRD17 BTG1 BTG3 CNOT2 CNOT3 CNOT6 CNOT6L CNOT7 CNOT8,"nuclear-transcribed mRNA poly(A) tail shortening|regulation of mitotic cell cycle|negative regulation of mitotic cell cycle|regulation of G1/S transition of mitotic cell cycle|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",3.747e-16|1.357e-14|1.726e-14|5.071e-14|5.888e-14,5.911e-12|1.07e-10|9.077e-11|2e-10|1.858e-10,597|35.03|62.27|105.4|236.7
682,5,0.4604,4.604,3904.0,0.001175,0.996692,BTNL3 BTNL8 DCAF17 RALB RGPD2,regulation of exocyst assembly|regulation of exocyst localization|regulation of vesicle docking|T cell receptor signaling pathway|antigen receptor-mediated signaling pathway,0.0004854|0.0004854|0.000728|0.0007628|0.002067,1|1|1|1|1,4119|4119|2060|45.77|27.55
683,17,0.4049,55.06,13930.0,0.003929,1.0,AK1 AK8 ASB6 CERCAM CIZ1 DBH ENTPD2 GBGT1 LCN6 LCN8 NTMT1 OR1J4 PIP5KL1 RALGPS1 SARDH TOR1B USP20,nucleoside diphosphate metabolic process|nucleoside monophosphate phosphorylation|nucleobase-containing small molecule interconversion|amine catabolic process|cellular biogenic amine catabolic process,4.732e-05|6.68e-05|0.0002566|0.0003536|0.0003536,0.7464|0.5269|1|1|1,43.27|186.4|89.74|75.72|75.72
684,9,0.4047,14.57,6160.0,0.002352,0.9998530000000001,ASPM BYSL LSM2 PFDN1 PFDN6 PPP1R10 RPL7L1 TBCC TUBB4B,negative regulation of amyloid fibril formation|regulation of amyloid fibril formation|protein folding|blastocyst formation|cellular component biogenesis,1.539e-05|2.299e-05|0.0001112|0.0001246|0.000301,0.2428|0.1813|0.5845|0.4915|0.9494,381.4|305.1|30.11|123.7|5.083
685,6,0.4158,6.237,4108.0,0.0015119999999999999,0.998474,ARF4 BZW1 KDELR1 KDELR2 SUCO WIPF1,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum|protein retention in ER lumen|maintenance of protein localization in endoplasmic reticulum|endoplasmic reticulum to Golgi vesicle-mediated transport|maintenance of protein localization in organelle",1.492e-06|3.883e-06|8.468e-06|1.738e-05|6.96e-05,0.02354|0.03063|0.04452|0.06854|0.2196,121.1|762.8|490.4|52.54|159.7
686,7,0.4069,8.545,5860.0,0.0014529999999999999,0.9992989999999999,ANKRD28 C10orf105 GHRH LEAP2 MYL9 PCBD2 SLA2,"positive regulation of circadian sleep/wake cycle, REM sleep|regulation of circadian sleep/wake cycle, REM sleep|growth hormone secretion|positive regulation of circadian sleep/wake cycle, sleep|tetrahydrobiopterin biosynthetic process",0.0006794|0.001698|0.002376|0.002376|0.002715,1|1|1|1|1,2942|735.5|490.4|490.4|420.3
687,7,0.4112,8.635,5764.0,0.001492,0.9992989999999999,ACYP2 C10orf62 HOOK2 OSTN SERPINE2 SPAG16 USP13,mating plug formation|seminal vesicle epithelium development|seminal vesicle development|protein K6-linked deubiquitination|maintenance of unfolded protein,0.0006794|0.0006794|0.001019|0.001358|0.001358,1|1|1|1|1,2942|2942|1471|980.7|980.7
688,7,0.4277,8.982000000000001,5820.0,0.001537,0.9992989999999999,C10orf67 C4orf51 CLCA2 EXTL2 KCTD19 RAB22A SIAE,UDP-N-acetylgalactosamine metabolic process|regulation of vesicle size|N-acetylglucosamine metabolic process|heparan sulfate proteoglycan biosynthetic process|glucosamine-containing compound metabolic process,0.001358|0.004071|0.006777|0.00779|0.009139,1|1|1|1|1,980.7|267.5|154.8|133.7|113.2
689,5,0.4123,4.123,4104.0,0.001001,0.996692,C10orf90 COL5A1 EFCAB13 FAM118A KISS1R,integrin biosynthetic process|negative regulation of endodermal cell differentiation|regulation of endodermal cell differentiation|tendon development|collagen biosynthetic process,0.0004854|0.0009706|0.001456|0.001698|0.002425,1|1|1|1|1,4119|1373|823.8|686.5|457.7
690,5,0.4343,4.343,3673.0,0.001178,0.996692,C10orf99 CCDC73 CFAP161 TTC37 ZNF14,"nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'|exonucleolytic catabolism of deadenylated mRNA|nuclear-transcribed mRNA catabolic process, exonucleolytic|nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay|nuclear-transcribed mRNA catabolic process",0.002328|0.006586|0.006973|0.01199|0.03771,1|1|1|1|1,468.1|156|147.1|84.41|26.27
691,6,0.4198,6.297000000000001,4800.0,0.001307,0.998474,C11orf24 CBWD6 HMSD LONRF1 SERPINB3 SGMS1,negative regulation of endopeptidase activity|negative regulation of peptidase activity|sphingomyelin biosynthetic process|paracrine signaling|autocrine signaling,0.00208|0.00225|0.002328|0.002328|0.002619,1|1|1|1|1,28.02|26.92|490.4|490.4|429.1
692,14,0.4008,36.47,8218.0,0.004403,0.9999969999999999,BRAF DUSP4 ELAVL1 GRB2 MAP2K1 MAPK1 NRAS PEA15 PTPN11 RAF1 SHOC2 SOS1 SOX10 SOX9,MAPK cascade|ERBB signaling pathway|face development|epidermal growth factor receptor signaling pathway|cellular response to growth factor stimulus,1.01e-14|6.031e-12|1.652e-10|2.208e-10|3.565e-10,1.593e-10|4.757e-08|8.685e-07|8.709e-07|1.125e-06,35.97|126.1|156.5|147.1|23.4
693,8,0.4009,11.23,6712.0,0.001666,0.9996790000000001,C11orf45 GHRH OIT3 STEAP1B TMEM161A TMEM211 ZNF341 ZSWIM1,"urate homeostasis|positive regulation of circadian sleep/wake cycle, REM sleep|regulation of circadian sleep/wake cycle, REM sleep|growth hormone secretion|positive regulation of circadian sleep/wake cycle, sleep",0.0007765|0.0007765|0.00194|0.002715|0.002715,1|1|1|1|1,2574|2574|643.6|429.1|429.1
694,5,0.4294,4.294,3762.0,0.001137,0.996692,APBB3 C11orf49 CYB561 KDSR TCERG1L,3-keto-sphinganine metabolic process|sphingoid metabolic process|cellular ketone metabolic process|sphingolipid biosynthetic process|positive regulation of protein secretion,0.0004854|0.005571|0.01879|0.02404|0.03282,1|1|1|1|1,4119|187.2|53.49|41.61|30.29
695,5,0.4253,4.253,4128.0,0.001027,0.996692,C11orf54 DPYSL3 FAM71B LRIT3 PRR35,actin crosslink formation|positive regulation of filopodium assembly|regulation of fibroblast growth factor receptor signaling pathway|regulation of filopodium assembly|response to axon injury,0.003636|0.007502|0.007744|0.0116|0.01232,1|1|1|1|1,294.2|137.3|132.9|87.64|82.38
696,6,0.4234,6.351,4831.0,0.00131,0.998474,ANTXRL C11orf71 FAM222A SLC30A7 SMR3B TBC1D2,sequestering of zinc ion|sequestering of metal ion|zinc ion transport|cellular zinc ion homeostasis|zinc ion homeostasis,0.001456|0.003781|0.008418|0.01044|0.01131,1|1|1|1|1,858.1|286|122.6|98.07|90.33
697,6,0.4263,6.395,4840.0,0.0013160000000000001,0.998474,ARG2 C11orf86 DPYSL4 FBXO34 P2RX3 TSPAN13,"negative regulation of chemokine (C-C motif) ligand 4 production|regulation of chemokine (C-C motif) ligand 4 production|negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process|behavioral response to formalin induced pain|behavioral response to chemical pain",0.0005824|0.0005824|0.0008735|0.0008735|0.0008735,1|1|1|1|1,3432|3432|1716|1716|1716
698,7,0.4009,8.42,5418.0,0.0015480000000000001,0.9992989999999999,AK2 ANKRD61 C11orf87 EBF2 INPP5J NTM TCF24,ADP biosynthetic process|purine ribonucleoside diphosphate biosynthetic process|ribonucleoside diphosphate biosynthetic process|purine nucleoside diphosphate biosynthetic process|nucleoside diphosphate biosynthetic process,0.002037|0.002037|0.002376|0.002376|0.003732,1|1|1|1|1,588.4|588.4|490.4|490.4|294.2
699,5,0.4004,4.004,3712.0,0.001075,0.996692,C11orf91 DBI GSKIP MS4A3 RCN1,negative regulation of protein lipidation|positive regulation of CoA-transferase activity|regulation of CoA-transferase activity|negative regulation of lipoprotein metabolic process|regulation of protein lipidation,0.000728|0.000728|0.000728|0.001456|0.00194,1|1|1|1|1,2060|2060|2060|823.8|588.4
700,8,0.4077,11.42,6273.0,0.001812,0.9996790000000001,C12orf10 CFC1 CFC1B GABRA5 LRP1B PLEKHB2 POTEI SCTR,nodal signaling pathway|activin receptor signaling pathway|determination of left/right symmetry|determination of bilateral symmetry|specification of symmetry,1.198e-05|5.328e-05|0.0009825|0.001063|0.001079,0.1889|0.4203|1|1|1,429.1|190.7|42.2|40.54|40.22
701,6,0.4221,6.331,4783.0,0.0013189999999999999,0.998474,C12orf29 GOLGA3 KRT4 NKIRAS1 PYCR3 WNT1,midbrain-hindbrain boundary maturation|midbrain-hindbrain boundary maturation during brain development|cerebellum formation|hindbrain formation|central nervous system morphogenesis,0.0005824|0.0005824|0.0005824|0.0005824|0.0008735,1|1|1|1|1,3432|3432|3432|3432|1716
702,5,0.4209,4.209,3976.0,0.0010550000000000002,0.996692,C12orf43 REC114 RGMA UPK2 ZPBP,anatomical structure formation involved in morphogenesis|Spemann organizer formation|negative regulation of collateral sprouting|negative regulation of axon regeneration|negative regulation of receptor binding,0.0007113|0.001213|0.002425|0.003636|0.003636,1|1|1|1|1,14.2|1030|457.7|294.2|294.2
703,15,0.403,42.32,10380.0,0.004047,0.999999,AK6 C12orf45 C18orf21 C1D CCDC59 EXOSC1 EXOSC10 HEATR1 KRR1 NOC4L NOP9 PWP1 RBM19 UTP20 WDR43,ribosome biogenesis|rRNA processing|rRNA metabolic process|ribonucleoprotein complex biogenesis|ncRNA processing,1.018e-14|1.015e-13|1.413e-13|2.723e-13|8.683e-12,1.605e-10|8.008e-10|7.428e-10|1.074e-09|2.739e-08,38.77|44.56|42.91|27.68|26.82
704,5,0.4408,4.408,4021.0,0.001092,0.996692,BTG4 C12orf54 FMNL3 KERA MAB21L2,embryonic body morphogenesis|camera-type eye development|cornea development in camera-type eye|eye development|visual system development,0.001698|0.002332|0.00291|0.003071|0.003137,1|1|1|1|1,686.5|25.91|374.5|22.51|22.26
705,6,0.4435,6.652,4778.0,0.001387,0.998474,C12orf60 KDELC1 PLA2G4A RBPMS2 TTLL3 ZNF865,phosphatidylglycerol catabolic process|protein polyglycylation|platelet activating factor biosynthetic process|positive regulation of platelet activation|monoacylglycerol biosynthetic process,0.0004854|0.0009706|0.001213|0.001213|0.00194,1|1|1|1|1,4119|1373|1030|1030|588.4
706,5,0.4328,4.328,3758.0,0.001147,0.996692,ADNP2 C12orf73 KCNJ9 PAMR1 RAPGEF6,microvillus assembly|microvillus organization|potassium ion import across plasma membrane|positive regulation of potassium ion transmembrane transport|cellular response to retinoic acid,0.002328|0.002716|0.008324|0.01199|0.01295,1|1|1|1|1,468.1|396.1|122.6|84.41|78.01
707,5,0.4312,4.312,3997.0,0.001075,0.996692,ANGPTL6 C12orf74 CCDC169 CNTROB SYNJ2,centrosome separation|inositol phosphate dephosphorylation|inositol phosphate catabolic process|phosphorylated carbohydrate dephosphorylation|mitotic cytokinetic process,0.002183|0.004362|0.004845|0.004845|0.005329,1|1|1|1|1,514.9|242.3|216.8|216.8|196.1
708,6,0.4163,6.244,4806.0,0.001294,0.998474,BAG5 C12orf76 HSBP1L1 MTNR1B RHOV SLC16A10,"thyroid-stimulating hormone secretion|positive regulation of circadian sleep/wake cycle, non-REM sleep|negative regulation of protein refolding|regulation of protein refolding|heat acclimation",0.0005824|0.001456|0.001456|0.001456|0.001746,1|1|1|1|1,3432|858.1|858.1|858.1|686.5
709,7,0.4357,9.149,5768.0,0.00158,0.9992989999999999,C14orf119 CYSTM1 DNAH14 EXOSC9 IGIP PCDHGB7 ZIK1,U5 snRNA 3'-end processing|U1 snRNA 3'-end processing|polyadenylation-dependent mRNA catabolic process|nuclear polyadenylation-dependent mRNA catabolic process|tRNA surveillance,0.001358|0.001358|0.001698|0.001698|0.002376,1|1|1|1|1,980.7|980.7|735.5|735.5|490.4
710,6,0.4256,6.3839999999999995,4767.0,0.001334,0.998474,C14orf177 DRD1 LSMEM2 NEURL1B PRKAR1B RASD2,regulation of cAMP-mediated signaling|behavior|locomotory behavior|ubiquitin-dependent endocytosis|negative regulation of inflammatory response to antigenic stimulus,6.35e-05|0.0003583|0.00115|0.001165|0.00151,1|1|1|1|1,167.4|18.79|37.93|1144|33
711,5,0.443,4.43,3835.0,0.001151,0.996692,C14orf28 EPO OR2C1 RNASE11 TRIM41,negative regulation of erythrocyte apoptotic process|regulation of erythrocyte apoptotic process|response to bacterium|defense response to nematode|erythropoietin-mediated signaling pathway,0.0005824|0.0005824|0.0007888|0.0008735|0.001456,1|1|1|1|1,3432|3432|14.34|1716|858.1
712,7,0.4009,8.42,5341.0,0.00157,0.9992989999999999,ANKK1 C15orf40 CARD18 GUCY1A2 HTR3A NXPE4 TCEANC2,positive regulation of nitric oxide mediated signal transduction|inhibition of cysteine-type endopeptidase activity|zymogen inhibition|regulation of nitric oxide mediated signal transduction|cGMP biosynthetic process,0.002037|0.002715|0.003054|0.003393|0.004409,1|1|1|1|1,588.4|420.3|367.8|326.9|245.2
713,15,0.3961,41.59,9435.0,0.004375,0.999999,ATR ATRIP C15orf41 DNAJC9 HUS1 RAD1 RAD17 RAD9A RFC5 RNASEH2A RNASEH2B RNASEH2C TIMELESS TIPIN USP37,DNA replication|DNA integrity checkpoint|cell cycle checkpoint|DNA replication checkpoint|DNA damage checkpoint,7.508e-15|3.498e-13|2.433e-12|7.214e-12|2.307e-11,1.184e-10|2.759e-09|1.279e-08|2.845e-08|7.277e-08,42.22|62.27|48.43|336.5|57.62
714,5,0.4112,4.112,3943.0,0.001039,0.996692,C14orf28 C15orf48 DENND2D EIF4EBP2 EPO,negative regulation of erythrocyte apoptotic process|regulation of erythrocyte apoptotic process|defense response to nematode|erythropoietin-mediated signaling pathway|negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,0.0005824|0.0005824|0.0008735|0.001456|0.001456,1|1|1|1|1,3432|3432|1716|858.1|858.1
715,6,0.4005,6.007999999999999,4681.0,0.001279,0.998474,C15orf61 CAV3 CBWD2 FAM200A METAP1 MPG,negative regulation of sarcomere organization|regulation of signal transduction by receptor internalization|negative regulation of membrane depolarization during cardiac muscle cell action potential|regulation of nerve growth factor receptor activity|protein initiator methionine removal,0.0005824|0.0005824|0.0005824|0.0005824|0.001165,1|1|1|1|1,3432|3432|3432|3432|1144
716,6,0.432,6.48,5195.0,0.001243,0.998474,C15orf62 DENND1A GNB5 LGALS4 RWDD2B SH3TC2,regulation of Rab protein signal transduction|peripheral nervous system myelin maintenance|positive regulation of pseudopodium assembly|regulation of pseudopodium assembly|negative regulation of voltage-gated calcium channel activity,0.002328|0.002619|0.004071|0.004361|0.004942,1|1|1|1|1,490.4|429.1|264|245.2|214.5
717,8,0.4095,11.47,6075.0,0.0018789999999999998,0.9996790000000001,C16orf58 C9orf85 GFRA4 HERC1 LYL1 PIK3R5 SPAST ULK3,spindle disassembly|mitotic spindle disassembly|neuron projection development|positive regulation of microtubule depolymerization|fibroblast activation,0.001164|0.001164|0.001816|0.00194|0.002715,1|1|1|1|1,1287|1287|11.31|643.6|429.1
718,12,0.4011,26.47,9926.0,0.002653,0.999986,AGR3 C16orf71 CYP2W1 DIXDC1 GPER1 GPR146 MICALL2 PTCD1 RBAK RNF216 SCIN VSTM2A,"actin polymerization or depolymerization|protein catabolic process at synapse|protein catabolic process, modulating synaptic transmission|nuclear fragmentation involved in apoptotic nuclear change|positive regulation of cardiac vascular smooth muscle cell differentiation",0.0005765|0.001164|0.001164|0.001164|0.001746,1|1|1|1|1,57.21|1716|1716|1716|858.1
719,6,0.426,6.39,4782.0,0.0013310000000000002,0.998474,C16orf74 GPR84 HILPDA IGSF21 SLC2A7 TP73,autocrine signaling|synapse maturation|negative regulation of cardiac muscle cell proliferation|positive regulation of oligodendrocyte differentiation|negative regulation of cardiac muscle tissue growth,0.002619|0.003781|0.004361|0.006681|0.00726,1|1|1|1|1,429.1|286|245.2|156|143
720,7,0.4066,8.539,5739.0,0.001482,0.9992989999999999,ARSI C16orf87 CFDP1 COLEC12 NKD1 SLCO2A1 SPOCK2,negative regulation of convergent extension involved in axis elongation|regulation of convergent extension involved in axis elongation|positive regulation of non-canonical Wnt signaling pathway via JNK cascade|regulation of non-canonical Wnt signaling pathway via JNK cascade|regulation of cell migration involved in somitogenic axis elongation,0.0006794|0.0006794|0.0006794|0.0006794|0.001019,1|1|1|1|1,2942|2942|2942|2942|1471
721,7,0.4314,9.059,6123.0,0.001474,0.9992989999999999,C16orf95 C17orf97 C8orf82 KIAA0556 MAPK9 POU4F3 RAB2B,protein localization to tricellular tight junction|positive regulation of transcription factor catabolic process|regulation of transcription factor catabolic process|JUN phosphorylation|positive regulation of podosome assembly,0.0008735|0.001165|0.001165|0.001456|0.002909,1|1|1|1|1,1716|1144|1144|858.1|381.4
722,27,0.5135,180.3,17510.0,0.010159999999999999,1.0,BRIP1 CENPS CENPX FAAP100 FAAP20 FAAP24 FANCA FANCC FANCD2 FANCE FANCF FANCG FANCI FANCL FANCM MCM8 MCM9 RAD51 RAD51B RAD51C RAD51D RFWD3 SFR1 SLX4 UBE2T XRCC2 XRCC3,interstrand cross-link repair|DNA repair|DNA metabolic process|cellular response to DNA damage stimulus|cellular response to stress,7.253e-50|6.548e-42|1.821e-37|2.23e-37|4.153e-28,1.144e-45|5.164e-38|9.573e-34|8.793e-34|1.31e-24,289|37.47|25.43|25.23|11.32
723,6,0.4066,6.099,4958.0,0.0012259999999999999,0.998474,ACAD10 ACER2 ATP2B4 C17orf80 CLEC10A SMPDL3B,cellular lipid catabolic process|sphingolipid catabolic process|membrane lipid catabolic process|lipid catabolic process|negative regulation of citrulline biosynthetic process,1.845e-05|3.949e-05|5.213e-05|6.34e-05|0.0005824,0.291|0.3115|0.2741|0.25|1,51.49|214.5|185.5|33.87|3432
724,6,0.4096,6.144,5017.0,0.00122,0.998474,ANGPTL7 C17orf98 CAMK2N2 CFAP97D1 LYSMD3 MOSPD3,negative regulation of vasculature development involved in avascular cornea development in camera-type eye|avascular cornea development in camera-type eye|endoplasmic reticulum membrane organization|endoplasmic reticulum-plasma membrane tethering|endoplasmic reticulum localization,0.0005824|0.0005824|0.002037|0.002037|0.0032,1|1|1|1|1,3432|3432|572.1|572.1|343.2
725,6,0.4353,6.529,4859.0,0.0013390000000000001,0.998474,C17orf99 C8orf34 IGSF9B KCNV1 NRXN1 OPRK1,regulation of ion transmembrane transport|regulation of transmembrane transport|protein-containing complex assembly involved in synapse maturation|adult behavior|learning,0.0004231|0.0004338|0.0005824|0.0006101|0.0007146,1|1|1|1|1,17.75|17.6|3432|52.4|48.35
726,6,0.4168,6.252000000000001,4779.0,0.001303,0.998474,C18orf54 IGDCC4 MC4R PTPN13 RPS27 RTP5,protein targeting to membrane|regulation of grooming behavior|negative regulation of feeding behavior|establishment of protein localization to membrane|diet induced thermogenesis,0.001175|0.001746|0.002909|0.003232|0.00349,1|1|1|1|1,37.51|686.5|381.4|22.36|312
727,7,0.4242,8.908999999999999,5276.0,0.0016809999999999998,0.9992989999999999,ABCF2 C19orf47 DRG1 DUSP1 MPG TRMT2A ZC3H15,cytoplasmic translation|negative regulation of monocyte chemotaxis|negative regulation of p38MAPK cascade|peripheral nervous system myelin maintenance|DNA dealkylation involved in DNA repair,0.0003804|0.002715|0.002715|0.00349|0.004264,1|1|1|1|1,68.65|429.1|429.1|321.8|257.4
728,6,0.4058,6.087000000000001,4976.0,0.001219,0.998474,C19orf67 DSCAM DST HTR2A LACTB2 TPP1,post-embryonic retina morphogenesis in camera-type eye|phospholipase C-activating serotonin receptor signaling pathway|positive regulation of phosphatidylinositol biosynthetic process|vitamin E metabolic process|regulation of phosphatidylinositol biosynthetic process,0.001019|0.001358|0.001358|0.001698|0.002037,1|1|1|1|1,1471|980.7|980.7|735.5|588.4
729,51,0.3827,487.9,40770.0,0.0118,1.0,C19orf73 C5AR1 C5AR2 CABP5 CBLC CCDC61 CEACAM4 CEACAM6 CEACAM7 CLC CRX CYP2A13 CYP2B6 CYP2S1 EML2 FFAR2 FFAR3 FLT3LG FUT1 FUT2 GPR32 IFNL1 IGFL1 IGFL2 IGFL3 IGFL4 KPTN LGALS13 LGALS14 PSG11 PSG2 PSG3 PSG4 PSG6 PSG8 PVR SPACA4 SULT2A1 SULT2B1 TPRX1 ZNF155 ZNF222 ZNF230 ZNF233 ZNF284 ZNF285 ZNF45 ZNF569 ZNF571 ZNF599 ZNF780B,female pregnancy|complement receptor mediated signaling pathway|multi-multicellular organism process|epoxygenase P450 pathway|regulation of immune effector process,9.598e-06|9.769e-06|2.192e-05|3.049e-05|3.808e-05,0.1514|0.07705|0.1153|0.1202|0.1201,12.55|86.41|10.8|56.17|6.333
730,14,0.4086,37.18,9688.0,0.003812,0.9999969999999999,C1GALT1 CMAS GNE MAN1A2 MAN2A1 MGAT1 MGAT2 MGAT5 NANS SLC35A1 SLC39A9 TM9SF1 TM9SF3 UNC50,glycosylation|carbohydrate metabolic process|carbohydrate derivative biosynthetic process|carbohydrate derivative metabolic process|protein glycosylation,5.136e-10|9.218e-10|6.023e-09|1.376e-08|2.068e-08,8.102e-06|7.271e-06|3.167e-05|5.426e-05|6.525e-05,35.33|21.72|17.05|11.52|31.91
731,10,0.4198,18.89,8569.0,0.002195,0.999933,AKR7A3 C1QB C1QC CTRC NBL1 NCALD PLA2G5 PQLC2 SLC2A5 TAS1R2,synapse pruning|cell junction disassembly|regulation of systemic arterial blood pressure|fructose import across plasma membrane|fructose import,1.32e-05|1.539e-05|0.0008049|0.0008734|0.0008734,0.2082|0.1214|1|1|1,416.1|381.4|47.18|2288|2288
732,5,0.441,4.41,4028.0,0.001091,0.996692,ACOX2 C1QL2 FNDC9 TTLL1 ZNF300,immune response in nasopharyngeal-associated lymphoid tissue|immune response in gut-associated lymphoid tissue|regulation of blastocyst development|mucociliary clearance|positive regulation of response to oxidative stress,0.000728|0.000728|0.001213|0.001456|0.00194,1|1|1|1|1,2060|2060|1030|823.8|588.4
733,6,0.4156,6.234,4839.0,0.001283,0.998474,C1QA C1QL3 CRYZ GCH1 PIGR TMEM56,"7,8-dihydroneopterin 3'-triphosphate biosynthetic process|immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor|dihydrobiopterin metabolic process|immunoglobulin transcytosis in epithelial cells|vertebrate eye-specific patterning",0.0005824|0.0008735|0.0008735|0.001165|0.001165,1|1|1|1|1,3432|1716|1716|1144|1144
734,6,0.4098,6.147,4823.0,0.0012699999999999999,0.998474,C1QTNF1 CACNA1C GIMAP5 MCF2L MPP6 TINAGL1,positive regulation of aldosterone secretion|positive regulation of mineralocorticoid secretion|membrane depolarization during atrial cardiac muscle cell action potential|calcium ion transmembrane transport via high voltage-gated calcium channel|calcium-mediated signaling using extracellular calcium source,0.0008735|0.0008735|0.001165|0.001165|0.001456,1|1|1|1|1,1716|1716|1144|1144|858.1
735,5,0.4029,4.029,3772.0,0.001064,0.996692,ACKR3 C1QTNF7 COQ10B LYRM7 NDUFA5,cellular respiration|energy derivation by oxidation of organic compounds|generation of precursor metabolites and energy|mitochondrial respiratory chain complex assembly|positive regulation of mesenchymal stem cell migration,4.546e-06|1.351e-05|7.325e-05|0.0002452|0.0009706,0.07171|0.1066|0.3851|0.9668|1,78.71|54.44|30.74|81.56|1373
736,5,0.4538,4.538,3907.0,0.001157,0.996692,C1QTNF8 CKS2 FAM173A SSTR5 UBE2Q2,somatostatin signaling pathway|somatostatin receptor signaling pathway|positive regulation of cell cycle|positive regulation of cyclin-dependent protein serine/threonine kinase activity|positive regulation of cyclin-dependent protein kinase activity,0.001165|0.001165|0.002124|0.006393|0.007166,1|1|1|1|1,1030|1030|26.34|160.9|143
737,9,0.4047,14.57,7531.0,0.0019260000000000002,0.9998530000000001,C1RL C2CD4A ITGBL1 LBP MMP9 PEAK1 R3HDML RBPJL WFDC11,negative regulation of peptidase activity|negative regulation of proteolysis|acute inflammatory response|cell migration|regulation of peptidase activity,0.0001542|0.0003689|0.0004507|0.0005065|0.0008138,1|1|1|1|1,26.92|19.96|63.56|9.485|15.19
738,23,0.3474,87.9,15370.0,0.0056700000000000006,1.0,BUB3 C1orf109 DAD1 DBR1 DHX33 DPAGT1 EXOSC6 FARSB HSPE1 IMP3 MYBBP1A NIP7 OSGEP PAK1IP1 POP5 RPP21 SPATA5L1 THG1L TIMM10 TRMT112 TXNL4A UTP4 WDR18,ribonucleoprotein complex biogenesis|ribosome biogenesis|ncRNA metabolic process|ncRNA processing|RNA processing,5.629e-11|8.756e-11|1.554e-10|8.494e-10|2.256e-09,8.879e-07|6.905e-07|8.171e-07|3.35e-06|7.117e-06,18.45|23.26|16.6|17.88|10.23
739,6,0.4088,6.132000000000001,4673.0,0.001307,0.998474,C1orf112 CELSR1 FER1L6 FIGNL1 GPNMB MEGF6,osteoblast differentiation|lateral sprouting involved in lung morphogenesis|planar dichotomous subdivision of terminal units involved in lung branching morphogenesis|orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis|dichotomous subdivision of terminal units involved in lung branching,0.0005306|0.0005824|0.0005824|0.0005824|0.0008735,1|1|1|1|1,56.27|3432|3432|3432|1716
740,6,0.406,6.091,4879.0,0.0012439999999999999,0.998474,C1orf115 FOXI2 GRM6 LCT MARC1 RNLS,nitrate metabolic process|detoxification of nitrogen compound|cellular detoxification of nitrogen compound|polysaccharide digestion|adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway,0.001456|0.001746|0.001746|0.002037|0.002328,1|1|1|1|1,858.1|686.5|686.5|572.1|490.4
741,5,0.4467,4.467,4077.0,0.001092,0.996692,ARPIN C1orf116 PSKH1 SCUBE3 STPG4,DNA demethylation of male pronucleus|negative regulation of lamellipodium morphogenesis|chromatin reprogramming in the zygote|directional locomotion|C-5 methylation of cytosine,0.000728|0.000728|0.0009706|0.0009706|0.001213,1|1|1|1|1,2060|2060|1373|1373|1030
742,5,0.4186,4.186,3824.0,0.00109,0.996692,ALDH4A1 C1orf122 NPFFR1 SRXN1 TNFRSF1A,proline catabolic process to glutamate|4-hydroxyproline metabolic process|4-hydroxyproline catabolic process|proline catabolic process|negative regulation of extracellular matrix constituent secretion,0.0009706|0.001213|0.001213|0.001213|0.001213,1|1|1|1|1,1373|1030|1030|1030|1030
743,5,0.4022,4.022,3701.0,0.001083,0.996692,C1orf146 CCT8 MIA2 PRR27 TUBA1C,protein localization to endoplasmic reticulum exit site|positive regulation of establishment of protein localization to telomere|regulation of establishment of protein localization to telomere|positive regulation of protein localization to Cajal body|regulation of protein localization to Cajal body,0.002183|0.002667|0.00291|0.00291|0.00291,1|1|1|1|1,514.9|411.9|374.5|374.5|374.5
744,5,0.4366,4.3660000000000005,3886.0,0.00112,0.996692,C1orf159 CIZ1 DVL3 HRG PLEKHF2,positive regulation of blood vessel remodeling|positive regulation of DNA-dependent DNA replication initiation|negative regulation of lamellipodium assembly|negative regulation of endothelial cell chemotaxis|negative regulation of lamellipodium organization,0.000728|0.000728|0.0009706|0.001213|0.001456,1|1|1|1|1,2060|2060|1373|1030|823.8
745,5,0.4282,4.282,3699.0,0.001153,0.996692,C1orf162 OR51I1 OR56B1 TRIM34 TRIM5,regulation of viral entry into host cell|modulation by symbiont of entry into host|interferon-gamma-mediated signaling pathway|positive regulation of autophagy|regulation of viral life cycle,4.647e-05|6.219e-05|0.0001264|0.0003552|0.0005261,0.733|0.4905|0.6647|1|1,191.6|164.8|114.4|67.52|55.29
746,8,0.4268,11.95,6905.0,0.0017239999999999998,0.9996790000000001,C1orf185 CEP57L1 LIPA MYOZ1 ODF1 REN TMEM81 ZNF76,negative regulation of skeletal muscle tissue regeneration|renin-angiotensin regulation of aldosterone production|skeletal muscle fiber adaptation|regulation of aldosterone secretion|regulation of mineralocorticoid secretion,0.0008734|0.002182|0.002182|0.003054|0.003054,1|1|1|1|1,2288|572.1|572.1|381.4|381.4
747,7,0.4237,8.897,5961.0,0.0014869999999999998,0.9992989999999999,C1orf189 CLCNKB HTR6 IFT172 NCMAP PLA2G2E ZNF683,regulation of extrathymic T cell differentiation|regulation of natural killer cell differentiation involved in immune response|peripheral nervous system myelin formation|cellular response to ionomycin|response to ionomycin,0.001019|0.001358|0.001358|0.002037|0.002037,1|1|1|1|1,1471|980.7|980.7|588.4|588.4
748,6,0.4019,6.028,4654.0,0.0012900000000000001,0.998474,C17orf53 C1orf194 FOXN1 HIST1H4C MCM8 NT5M,interstrand cross-link repair|DNA repair|recombinational repair|cellular macromolecule biosynthetic process|female gamete generation,0.000116|0.0003249|0.0003809|0.0005506|0.0005741,1|1|1|1|1,122.6|19.43|66.65|8.296|54.06
749,7,0.4153,8.722000000000001,5119.0,0.001696,0.9992989999999999,ATP8B2 C1orf21 EVPLL FGFR3 HERPUD1 PRDM1 REEP4,fibroblast growth factor receptor apoptotic signaling pathway|sebum secreting cell proliferation|regulation of extrathymic T cell differentiation|regulation of NK T cell differentiation|positive regulation of ER-associated ubiquitin-dependent protein catabolic process,0.0006794|0.0006794|0.001019|0.002376|0.003054,1|1|1|1|1,2942|2942|1471|490.4|367.8
750,8,0.442,12.38,5464.0,0.0022530000000000002,0.9996790000000001,C1orf210 CAB39 FOXF1 NRBP1 OXSR1 RTP5 TSC22D2 WNK1,chemokine (C-C motif) ligand 21 signaling pathway|response to osmotic stress|cellular hypotonic response|regulation of potassium ion transmembrane transport|hypotonic response,1.977e-06|2.884e-06|5.928e-06|7.696e-06|8.691e-06,0.03119|0.02274|0.03117|0.03035|0.02742,1287|103|643.6|73.55|514.9
751,6,0.4269,6.403,4883.0,0.001306,0.998474,C1orf216 CDH12 KCNH8 SURF1 TMEM218 TMTC3,protein O-linked mannosylation|mitochondrial cytochrome c oxidase assembly|protein mannosylation|respiratory chain complex IV assembly|cytochrome complex assembly,0.005522|0.006681|0.00697|0.007839|0.01073,1|1|1|1|1,190.7|156|149.2|132|95.35
752,18,0.41,62.72,12390.0,0.005023,1.0,AATF CDC6 CWC25 DDX52 DHX8 NLE1 NSRP1 PPIL1 PSMB3 PSMD11 PSMD3 RPL19 RPL23 RPL23A RPL27 SNRNP40 ZNF207 ZNF830,RNA processing|mRNA metabolic process|negative regulation of mitotic cell cycle|ribosome biogenesis|negative regulation of cell cycle process,3.708e-11|6.926e-11|3.662e-09|8.332e-09|8.855e-09,5.849e-07|5.462e-07|1.925e-05|3.286e-05|2.793e-05,13.64|16.49|27.24|24.12|23.91
753,7,0.4167,8.752,5322.0,0.001637,0.9992989999999999,C1orf43 C2CD2L FAM102B GAP43 KIAA0100 KIAA1109 VAPA,positive regulation by host of viral release from host cell|modulation by host of viral release from host cell|axon choice point recognition|positive regulation by host of viral genome replication|negative regulation by host of viral genome replication,0.002037|0.002037|0.002715|0.003054|0.003054,1|1|1|1|1,588.4|588.4|420.3|367.8|367.8
754,24,0.3896,107.5,19520.0,0.005465,1.0,AGO1 AGO3 AGO4 BEST4 C1QA C1QB C1orf123 C1orf50 CFAP57 CYP4A22 CYP4X1 CYP4Z1 ERMAP GJA4 GJB3 GJB4 LURAP1 MFSD2A PPT1 TSSK3 ZFP69 ZFP69B ZNF684 ZNF691,"miRNA loading onto RISC involved in gene silencing by miRNA|RNA secondary structure unwinding|small RNA loading onto RISC|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation",1.448e-07|1.989e-07|2.65e-07|6.726e-07|6.726e-07,0.002284|0.001569|0.001393|0.002652|0.002122,383.8|335.8|298.5|206.6|206.6
755,5,0.4057,4.0569999999999995,3861.0,0.001047,0.996692,C1orf53 CSN1S1 MYL2 PRR5 ROR1,positive regulation of phosphatidylinositol 3-kinase signaling|regulation of phosphatidylinositol 3-kinase signaling|response to 11-deoxycorticosterone|response to dehydroepiandrosterone|positive regulation of the force of heart contraction,0.0001999|0.0003784|0.0004854|0.0004854|0.001456,1|1|1|1|1,90.53|65.38|4119|4119|823.8
756,5,0.4242,4.242,3917.0,0.0010789999999999999,0.996692,C1orf56 PPEF2 PYCR3 TAS1R3 UBE2E2,detection of chemical stimulus involved in sensory perception of sweet taste|proline biosynthetic process|sensory perception of umami taste|sensory perception of sweet taste|ISG15-protein conjugation,0.000728|0.001698|0.001698|0.001698|0.001698,1|1|1|1|1,2060|686.5|686.5|686.5|686.5
757,5,0.4183,4.183,3647.0,0.001143,0.996692,C1orf68 HES6 NIPSNAP3A RALGAPA1 RALGAPB,activation of GTPase activity|regulation of small GTPase mediated signal transduction|positive regulation of GTPase activity|regulation of GTPase activity|positive regulation of hydrolase activity,0.0003217|0.002463|0.003889|0.005427|0.01324,1|1|1|1|1,71.02|25.19|19.95|16.81|10.6
758,5,0.4443,4.4430000000000005,3916.0,0.0011300000000000001,0.996692,APAF1 C1orf74 PELI1 ST3GAL2 ST5,response to G1 DNA damage checkpoint signaling|response to mitotic cell cycle checkpoint signaling|globoside biosynthetic process via lactosylceramide|globoside biosynthetic process|globoside metabolic process,0.0003883|0.0003883|0.0003883|0.0005825|0.0005825,1|1|1|1|1,5149|5149|5149|2574|2574
759,9,0.4404,15.85,7258.0,0.0021739999999999997,0.9998530000000001,MYF5 PAX7 PIK3CD RRAS2 S100A5 SEMA4C SEMA7A TRIO TULP4,axon guidance|neuron projection guidance|axonogenesis|axon development|cell morphogenesis involved in neuron differentiation,4.101e-06|4.159e-06|1.448e-05|2.034e-05|2.662e-05,0.06468|0.0328|0.07612|0.0802|0.08397,32.93|32.81|23.84|21.85|20.39
760,16,0.3641,43.69,10190.0,0.004257,0.999999,CEP55 CHMP1B CHMP3 CHMP4B CHMP5 CIT ECT2 IST1 KIF14 KIF1BP PDCD6IP STAMBP UEVLD VPS4A VPS4B VTA1,cytoskeleton-dependent cytokinesis|cytokinesis|mitotic cytokinesis|multivesicular body assembly|multivesicular body organization,1.025e-25|3.868e-25|1.711e-24|5.701e-22|7.354e-22,1.616e-21|3.05e-21|8.998e-21|2.248e-18|2.32e-18,171.6|152.6|222.1|411.9|398.6
761,6,0.4173,6.26,4890.0,0.001275,0.998474,C20orf144 CLN8 DRGX ITGB7 MPPED1 NEURL4,spinal cord development|glutamate reuptake|age-dependent response to oxidative stress|cell-matrix adhesion involved in ameboidal cell migration|age-dependent general metabolic decline,0.0003881|0.0008735|0.0008735|0.0008735|0.0008735,1|1|1|1|1,66.01|1716|1716|1716|1716
762,10,0.4,18.0,8337.0,0.002149,0.999933,ADGRV1 ANKRD55 C20orf85 CDH12 DDX4 GZMK HECW2 ITGA1 ITGA2 SPATA18,detection of mechanical stimulus involved in sensory perception|positive regulation of phosphatase activity|detection of mechanical stimulus|positive regulation of dephosphorylation|cell adhesion,0.0001324|0.0001324|0.0002993|0.0003821|0.0007693,1|1|1|1|1,121.1|121.1|79.21|69.81|8.662
763,5,0.4367,4.367,3848.0,0.001131,0.996692,AUNIP C21orf62 CELA3B KDELR2 NUP188,negative regulation of double-strand break repair via nonhomologous end joining|protein retention in ER lumen|maintenance of protein localization in endoplasmic reticulum|regulation of double-strand break repair via nonhomologous end joining|negative regulation of double-strand break repair,0.00194|0.002425|0.003636|0.007502|0.008226,1|1|1|1|1,588.4|457.7|294.2|137.3|124.8
764,6,0.4323,6.484,4417.0,0.001462,0.998474,C2CD4C DNAJA3 GFER PAM16 SNRNP25 XAF1,negative regulation of apoptotic DNA fragmentation|negative regulation of DNA catabolic process|activation-induced cell death of T cells|skeletal muscle acetylcholine-gated channel clustering|negative regulation of interferon-gamma-mediated signaling pathway,0.001165|0.001456|0.002037|0.002328|0.002619,1|1|1|1|1,1144|858.1|572.1|490.4|429.1
765,6,0.4295,6.443,4907.0,0.001308,0.998474,C2CD4D FTCD MYOM3 TMEM235 TMEM238 TUBB3,formamide metabolic process|histidine catabolic process to glutamate and formate|histidine catabolic process to glutamate and formamide|dorsal root ganglion development|formate metabolic process,0.001456|0.001456|0.001456|0.002037|0.002037,1|1|1|1|1,858.1|858.1|858.1|572.1|572.1
766,10,0.4036,18.16,7276.0,0.002483,0.999933,ARL15 C2CD5 CDK5 DEPDC5 FIBP PTP4A1 RCE1 SESN2 TMEM94 ZNF330,negative regulation of TORC1 signaling|positive regulation of protein targeting to membrane|regulation of protein targeting to membrane|regulation of TORC1 signaling|negative regulation of TOR signaling,3.609e-05|0.000111|0.0001556|0.0001721|0.0002075,0.5693|0.8757|0.8181|0.6786|0.6548,242.3|132.9|111.3|105.6|95.79
767,6,0.4197,6.295,4916.0,0.001276,0.998474,C2orf15 DNAJC27 MRC1 POLM SFXN5 ZNF583,regulation of MAPK export from nucleus|tricarboxylic acid transport|citrate transport|modulation by symbiont of host defense response|response to host defenses,0.0005824|0.001746|0.001746|0.002619|0.00349,1|1|1|1|1,3432|686.5|686.5|429.1|312
768,6,0.4465,6.6979999999999995,4880.0,0.001367,0.998474,ACOX2 C1QL2 C2orf16 HEPACAM SPATA2L USP25,negative regulation of ERAD pathway|positive regulation of response to oxidative stress|fatty acid beta-oxidation using acyl-CoA oxidase|regulation of ERAD pathway|bile acid biosynthetic process,0.002037|0.002328|0.004651|0.006101|0.008707,1|1|1|1|1,572.1|490.4|228.8|171.6|118.4
769,5,0.4388,4.388,3844.0,0.001137,0.996692,C2orf54 CARD17 CCDC159 HIST1H4I YPEL4,negative regulation of megakaryocyte differentiation|DNA replication-dependent nucleosome assembly|DNA replication-dependent nucleosome organization|positive regulation of histone exchange|regulation of histone exchange,0.001165|0.002134|0.002134|0.002328|0.002328,1|1|1|1|1,1030|514.9|514.9|468.1|468.1
770,11,0.4188,23.03,8677.0,0.002641,0.999969,ARHGAP25 C2orf68 NAT8 REEP1 REG3G SFTPB SIX3 TEX261 THNSL2 TRABD2A WBP1,neuroblast migration|2-oxobutyrate biosynthetic process|peptidyl-lysine N6-acetylation|positive regulation of protein oxidation|regulation of protein oxidation,0.001067|0.001067|0.001601|0.001601|0.001601,1|1|1|1|1,1872|1872|936.1|936.1|936.1
771,8,0.4021,11.26,6691.0,0.0016760000000000002,0.9996790000000001,C2orf70 CCDC88A PEBP1 TACR1 TGOLN2 TLX2 TRIM54 WDPCP,maintenance of protein location in plasma membrane|maintenance of protein location in membrane|regulation of plasma membrane bounded cell projection organization|regulation of cell projection organization|regulation of embryonic cell shape,0.001164|0.001164|0.001382|0.001493|0.001552,1|1|1|1|1,1287|1287|12.44|12.11|858.1
772,26,0.4037,131.2,20410.0,0.006372,1.0,ADCY10 ATXN7L3B CARNS1 CCNB1IP1 GPRC5D KIAA1257 KIF26B LRRN1 LYRM1 MAP3K7CL NECAP2 NIPSNAP3B PCDHA4 PCDHB12 PCDHB13 PCDHB16 PCDHGA9 PCDHGB1 RNF114 SDR39U1 SLC25A36 TMEM100 TMEM184C TXNDC16 ZNF286A ZNF512B,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|cell-cell adhesion|negative regulation of biological process|regulation of cellular process,8.173e-08|1.004e-06|4.709e-05|0.000303|0.0007415,0.001289|0.00792|0.2476|1|1,27.41|17.67|8.904|0|0.4049
773,5,0.4369,4.369,4132.0,0.0010539999999999998,0.996692,C10orf88 C2orf76 MX2 PARD3B ZNF365,regulation of DNA strand resection involved in replication fork processing|cerebellar molecular layer morphogenesis|cerebellar molecular layer development|gamma-tubulin complex localization|protein-containing complex localization,0.0003883|0.0005825|0.0005825|0.0007766|0.0009293,1|1|1|1|1,5149|2574|2574|1716|40.07
774,7,0.4174,8.766,5989.0,0.001458,0.9992989999999999,ATP2B2 AVPI1 C2orf91 CNPY1 GRIK1 HHIP NME3,regulation of cardiac conduction|negative regulation of citrulline biosynthetic process|regulation of citrulline biosynthetic process|negative regulation of cellular amine catabolic process|regulation of cellular amine catabolic process,0.0002157|0.0007765|0.0007765|0.0007765|0.0007765,1|1|1|1|1,91.94|2574|2574|2574|2574
775,16,0.4066,48.79,9779.0,0.004947999999999999,0.999999,ALDOA BSG GAPDH GMPS GPI PGAM1 PGD PGLS PGP PKM RPE RPIA SLC2A1 TKT TPI1 YRDC,monosaccharide metabolic process|carbohydrate metabolic process|carbohydrate biosynthetic process|generation of precursor metabolites and energy|organophosphate metabolic process,3.814e-19|1.333e-18|7.605e-16|2.035e-15|4.563e-15,6.017e-15|1.051e-14|3.999e-12|8.024e-12|1.44e-11,74.03|33.23|80.17|33.15|17.54
776,6,0.4075,6.1129999999999995,4675.0,0.001302,0.998474,C3orf22 KCNMB4 PLCL1 POU4F1 PPM1N TOMM40,negative regulation of transcription elongation by RNA polymerase I|regulation of transcription elongation from RNA polymerase I promoter|proprioception involved in equilibrioception|positive regulation of binding|epithalamus development,0.0005824|0.0005824|0.0005824|0.001088|0.001165,1|1|1|1|1,3432|3432|3432|39.01|1144
777,7,0.4044,8.491,5296.0,0.0015970000000000001,0.9992989999999999,ABHD16B AHSA1 C3orf30 HSF1 HSPA4 LCN15 STIP1,cellular response to nitroglycerin|positive regulation of transcription from RNA polymerase II promoter in response to heat stress|response to nitroglycerin|cellular response to diamide|response to diamide,0.0006794|0.0006794|0.001019|0.001019|0.001019,1|1|1|1|1,2942|2942|1471|1471|1471
778,7,0.4272,8.972000000000001,5919.0,0.00151,0.9992989999999999,C3orf33 COL6A6 DNAJC27 EPDR1 NOL3 PLB1 SVBP,regulation of MAPK export from nucleus|myofibroblast contraction|response to injury involved in regulation of muscle adaptation|inhibition of cysteine-type endopeptidase activity involved in apoptotic process|negative regulation of muscle atrophy,0.0006794|0.0006794|0.0006794|0.001019|0.001019,1|1|1|1|1,2942|2942|2942|1471|1471
779,17,0.403,54.81,11550.0,0.0047090000000000005,1.0,CIAO1 CIAO2B CIAO3 CIAPIN1 FXN GLRX3 HSCB LONP1 LYRM4 NDOR1 NFS1 NUBP1 NUBP2 SOD1 TIMM10 TIMM9 WDR18,metallo-sulfur cluster assembly|iron-sulfur cluster assembly|sulfur compound metabolic process|cellular component biogenesis|cellular component organization or biogenesis,4.198e-31|4.198e-31|5.529e-20|2.113e-10|7.966e-10,6.621e-27|3.311e-27|2.907e-16|8.334e-07|2.513e-06,632.1|632.1|42.68|6.279|3.433
780,7,0.4033,8.468,5562.0,0.001516,0.9992989999999999,C3orf62 FAM174B GREB1L NRXN3 TM4SF19 TPRG1L TRIM71,"negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation|regulation of translation, ncRNA-mediated|neuron cell-cell adhesion|3'-UTR-mediated mRNA destabilization",0.004748|0.004748|0.004748|0.006101|0.006439,1|1|1|1|1,226.3|226.3|226.3|173.1|163.5
781,6,0.4239,6.359,4557.0,0.00139,0.998474,C3orf67 PREB RPS7 TTC27 WDR43 ZNF80,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis|regulation of COPII vesicle coating|positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator|rRNA processing|rRNA metabolic process,0.001456|0.001456|0.001746|0.002337|0.002516,1|1|1|1|1,858.1|858.1|686.5|26.4|25.43
782,6,0.4025,6.037000000000001,4819.0,0.001248,0.998474,APOB C3orf70 LPAR6 NCEH1 NPHP3 PCYOX1,low-density lipoprotein particle clearance|plasma lipoprotein particle clearance|regulation of plasma lipoprotein particle levels|determination of stomach left/right asymmetry|determination of intestine left/right asymmetry,2.29e-05|5.767e-05|0.0002048|0.0005824|0.0005824,0.3613|0.4549|1|1|1,286|176|91.53|3432|3432
783,7,0.408,8.568999999999999,5638.0,0.0015140000000000002,0.9992989999999999,C3orf80 DGLUCY GHSR GLIPR1L1 GLIPR1L2 KCNC2 PRR23C,nitric oxide-cGMP-mediated signaling pathway|negative regulation of locomotion involved in locomotory behavior|positive regulation of small intestinal transit|regulation of small intestinal transit|ghrelin secretion,0.001019|0.001019|0.001019|0.001019|0.001019,1|1|1|1|1,1471|1471|1471|1471|1471
784,7,0.413,8.674,5540.0,0.001559,0.9992989999999999,C4orf33 CLCNKB FAM131C MMP23B PQLC2 PRPF40B SLC35E2B,"mRNA cis splicing, via spliceosome|blastocyst hatching|organism emergence from protective structure|hatching|excretion",0.006391|0.007839|0.007839|0.007839|0.01188,1|1|1|1|1,163.5|132|132|132|85.81
785,9,0.4357,15.69,6073.0,0.002569,0.9998530000000001,ANLN DIAPH3 ECT2 FLII KIF20A RAB35 SEPT11 SEPT2 SMTN,cytoskeleton-dependent cytokinesis|cytokinesis|cell division|mitotic cytokinesis|cell cycle process,1.053e-12|2.081e-12|1.528e-08|1.704e-08|1.467e-06,1.66e-08|1.642e-08|8.035e-05|6.72e-05|0.004628,143|127.1|27.91|134.6|12.83
786,11,0.4147,22.81,8509.0,0.002667,0.999969,ANHX C4orf45 GDF3 LMBR1L ZNF10 ZNF132 ZNF140 ZNF26 ZNF605 ZNF84 ZNF891,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",7.232e-06|6.558e-05|6.573e-05|6.644e-05|0.0001156,0.1141|0.5173|0.3456|0.262|0.3646,5.792|4.324|4.323|4.316|4.007
787,6,0.4217,6.325,4824.0,0.001306,0.998474,C4orf47 FRMD8 GSTZ1 GULP1 PYROXD2 TRHDE,tyrosine catabolic process|regulation of acetyl-CoA biosynthetic process from pyruvate|regulation of acyl-CoA biosynthetic process|L-phenylalanine catabolic process|L-phenylalanine metabolic process,0.001746|0.002619|0.002909|0.00349|0.00349,1|1|1|1|1,686.5|429.1|381.4|312|312
788,5,0.4585,4.585,4042.0,0.0011300000000000001,0.996692,C4orf48 NAB1 RPF1 TMEM182 TMEM45B,ganglion mother cell fate determination|maturation of LSU-rRNA|endochondral ossification|replacement ossification|maturation of 5.8S rRNA,0.0008735|0.008418|0.008996|0.008996|0.01044,1|1|1|1|1,1716|122.6|114.4|114.4|98.07
789,8,0.4161,11.65,6308.0,0.0018390000000000001,0.9996790000000001,C2orf70 C2orf73 C5 CFAP36 GNLY NAT8 STON1 TLX2,"peptidyl-lysine N6-acetylation|negative regulation of macrophage chemotaxis|negative regulation of macrophage migration|negative regulation of dendrite morphogenesis|complement activation, alternative pathway",0.001164|0.002715|0.003877|0.003877|0.006197,1|1|1|1|1,1287|429.1|286|286|171.6
790,6,0.4293,6.439,4928.0,0.001302,0.998474,C5orf24 CELF2 SPHKAP TCAIM TOX2 TSHZ2,"cellular process|mRNA splice site selection|spliceosomal complex assembly|regulation of alternative mRNA splicing, via spliceosome|regulation of mRNA splicing, via spliceosome",0.004476|0.009574|0.01678|0.01706|0.02963,1|1|1|1|1,0.2216|107.3|60.22|59.18|33.65
791,7,0.4127,8.667,5889.0,0.001466,0.9992989999999999,C5orf30 CHST15 DGAT2 KIAA1217 POLA2 PROKR1 ZBED2,"cellular response to oleic acid|fat pad development|response to oleic acid|DNA replication, synthesis of RNA primer|monoacylglycerol biosynthetic process",0.001358|0.002037|0.002376|0.002376|0.002715,1|1|1|1|1,980.7|588.4|490.4|490.4|420.3
792,6,0.4291,6.436,5021.0,0.001277,0.998474,ACTG2 C5orf47 NKD1 OR2V1 SLC2A4 SLC9A1,amylopectin metabolic process|amylopectin biosynthetic process|negative regulation of convergent extension involved in axis elongation|regulation of convergent extension involved in axis elongation|positive regulation of non-canonical Wnt signaling pathway via JNK cascade,0.0005824|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,3432|3432|3432|3432|3432
793,33,0.4051,213.9,26830.0,0.007891,1.0,C5AR1 C5AR2 CABP5 CRX FFAR3 FLT3LG FUT1 FUT2 GPR32 KIR2DL1 KIR2DL3 KLK11 KLK3 KLK6 LILRA4 SIGLEC12 SIGLEC5 SIGLEC9 SPIB SULT2A1 SULT2B1 VN1R4 ZNF175 ZNF28 ZNF415 ZNF528 ZNF534 ZNF571 ZNF610 ZNF665 ZNF677 ZNF701 ZNF880,complement receptor mediated signaling pathway|complement component C5a signaling pathway|regulation of biological process|fucose catabolic process|L-fucose catabolic process,2.467e-06|1.674e-05|0.0001056|0.0001523|0.0001523,0.03892|0.132|0.5555|0.6007|0.4805,135.8|588.4|1.539|130.8|130.8
794,6,0.4451,6.676,5031.0,0.001322,0.998474,C5orf52 DCDC1 FZD3 NSUN7 OR10G7 TMPPE,positive regulation of neural precursor cell proliferation|neural precursor cell proliferation|canonical Wnt signaling pathway|regulation of neural precursor cell proliferation|negative regulation of receptor clustering,0.0001404|0.0002364|0.0003568|0.0003821|0.0006794,1|1|1|1|1,113.2|86.53|70.05|67.64|2942
795,5,0.428,4.28,3977.0,0.001072,0.996692,C5orf63 CDCP1 CTGF LRMP ZFHX4,vesicle fusion|organelle membrane fusion|vesicle targeting|organelle fusion|nucleus organization,0.01583|0.01698|0.01794|0.02081|0.02805,1|1|1|1|1,63.56|59.18|55.96|48.12|35.51
796,6,0.4187,6.28,5185.0,0.001207,0.998474,BEAN1 C6orf10 SEMA4F SFTPB TRIM63 TYROBP,positive regulation of hippocampal neuron apoptotic process|stimulatory killer cell immunoglobulin-like receptor signaling pathway|positive regulation of microglial cell mediated cytotoxicity|regulation of microglial cell mediated cytotoxicity|negative regulation of multicellular organismal process,0.000728|0.000728|0.0009706|0.0009706|0.001075,1|1|1|1|1,2060|2060|1373|1373|12.33
797,19,0.4016,68.67,14790.0,0.004609,1.0,AIF1 ATAT1 C6orf106 C6orf48 CLIC1 EGFL8 HLA-DMB HLA-DPB1 MICB MSH5 NCR3 NUDT3 PSORS1C2 STK19 TAP1 TAP2 TAPBP TNXB TRIM26,antigen processing and presentation of endogenous peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen|antigen processing and presentation of endogenous antigen|antigen processing and presentation of peptide antigen|antigen processing and presentation,2.413e-09|3.566e-09|1.099e-08|1.265e-08|2.924e-08,3.806e-05|2.813e-05|5.781e-05|4.99e-05|9.224e-05,269.2|240.9|176|35.57|30.78
798,21,0.3707,77.84,14770.0,0.005229,1.0,CLASRP CLNS1A EXOSC5 GEMIN7 HNRNPL LENG1 NUP62 PNKP POP4 PSMC4 PSMD8 RBM42 RPS11 RPS16 RPS19 SAE1 SNRPD2 SYMPK TBCB TOMM40 UBA2,mRNA metabolic process|RNA processing|RNA metabolic process|gene expression|ribonucleoprotein complex biogenesis,5.079e-10|7.689e-09|1.079e-07|2.447e-07|2.778e-07,8.012e-06|6.064e-05|0.0005671|0.000965|0.0008763,14.13|10.63|6.747|5.384|14.76
799,5,0.4369,4.369,3964.0,0.001098,0.996692,ANO7 C6orf120 RFTN1 TNFRSF8 ZSCAN9,positive regulation of TRAIL production|regulation of TRAIL production|T cell antigen processing and presentation|dsRNA transport|positive regulation of growth rate,0.000728|0.000728|0.0009706|0.0009706|0.0009706,1|1|1|1|1,2060|2060|1373|1373|1373
800,15,0.4062,42.65,11460.0,0.003699,0.999999,AIF1 BTN2A2 C6orf15 C6orf48 CFB CLIC1 GPSM3 HLA-A HLA-C MCCD1 MICB MSH5 NEU1 OR2J3 TAPBP,"antigen processing and presentation of endogenous peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen|antigen processing and presentation of endogenous antigen|immune response|antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent",3.529e-07|4.763e-07|1.127e-06|2.011e-06|2.217e-05,0.005567|0.003757|0.005924|0.007929|0.06995,242.3|216.8|158.4|6.266|343.2
801,5,0.4295,4.295,3938.0,0.0010869999999999999,0.996692,C6orf223 CD14 RBKS SIT1 TBATA,isoleucine transport|L-isoleucine import across plasma membrane|isoleucine transmembrane transport|D-ribose catabolic process|proline import across plasma membrane,0.0005824|0.0005824|0.0005824|0.0008735|0.0008735,1|1|1|1|1,3432|3432|3432|1716|1716
802,6,0.4434,6.65,4549.0,0.001456,0.998474,ARL6IP1 C6orf47 REEP4 RETREG3 SCGB3A2 THUMPD1,endoplasmic reticulum tubular network organization|endoplasmic reticulum organization|positive regulation of L-glutamate import across plasma membrane|endoplasmic reticulum tubular network formation|endoplasmic reticulum tubular network membrane organization,9.595e-06|0.0003594|0.001165|0.001456|0.001456,0.1514|1|1|1|1,457.7|68.65|1144|858.1|858.1
803,6,0.4194,6.292000000000001,4682.0,0.0013390000000000001,0.998474,C6orf58 MDM1 TMEM86B UBXN6 YIPF2 ZNF429,endosome to lysosome transport via multivesicular body sorting pathway|negative regulation of centriole replication|negative regulation of centrosome duplication|negative regulation of centrosome cycle|ether lipid metabolic process,0.00194|0.00194|0.003152|0.003152|0.005087,1|1|1|1|1,588.4|588.4|343.3|343.3|205.9
804,8,0.4011,11.23,6148.0,0.001819,0.9996790000000001,ATG2B C7orf25 CDH2 FOXR1 GEN1 GTPBP1 GTPBP2 WDR12,translational elongation|mesenchymal cell migration|resolution of mitotic recombination intermediates|resolution of recombination intermediates|positive regulation of synaptic vesicle clustering,0.00103|0.001164|0.001164|0.001164|0.001552,1|1|1|1|1,41.19|1287|1287|1287|858.1
805,12,0.4291,28.32,7613.0,0.003694,0.999986,BRAT1 C7orf26 DCTN6 INTS10 INTS13 INTS14 INTS9 PPP2CA PPP2CB SNRPB2 TTI2 WDR73,snRNA transcription by RNA polymerase II|snRNA transcription|ncRNA transcription|snRNA processing|snRNA metabolic process,7.419e-08|7.835e-08|2.312e-07|1.363e-06|2.912e-06,0.00117|0.0006179|0.001216|0.005373|0.009186,98.07|96.69|73.03|143|109.5
806,6,0.4163,6.244,5058.0,0.00123,0.998474,ANGPT2 C7orf31 GIGYF1 GPR88 NCR3 OSBP2,negative regulation of positive chemotaxis|Tie signaling pathway|motor learning|germ cell development|cellular process involved in reproduction in multicellular organism,0.0005824|0.001456|0.002037|0.002284|0.004243,1|1|1|1|1,3432|858.1|572.1|26.71|19.45
807,20,0.4032,76.62,13860.0,0.005482,1.0,CNIH4 DUX4 EIF2S1 FOXD4 GJA3 HSPE1 NBEAL1 NUTF2 OR2A25 POGZ RPL11 RPL12 RPL17 RPL37 RPL4 RPLP2 RPS13 SNU13 ST20 TSPYL5,translational initiation|SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum,1.29e-12|6.936e-12|9.731e-12|1.829e-11|2.318e-11,2.034e-08|5.47e-08|5.117e-08|7.213e-08|7.314e-08,54.87|71.51|67.97|61.85|59.7
808,5,0.4388,4.388,3860.0,0.001132,0.996692,C7orf57 LUZP6 TIRAP TMEM71 TPM2,positive regulation of interleukin-15 production|regulation of interleukin-15 production|TIRAP-dependent toll-like receptor 4 signaling pathway|TIRAP-dependent toll-like receptor signaling pathway|positive regulation of chemokine (C-X-C motif) ligand 1 production,0.0004854|0.0004854|0.0004854|0.0004854|0.001213,1|1|1|1|1,4119|4119|4119|4119|1030
809,5,0.4121,4.121,3828.0,0.001073,0.996692,C8orf37 DENND6B DUSP19 NKX2-1 RPA1,negative regulation of protein localization to nucleolus|globus pallidus development|club cell differentiation|photoreceptor cell morphogenesis|type II pneumocyte differentiation,0.0005824|0.001165|0.001456|0.001456|0.001746,1|1|1|1|1,3432|1144|858.1|858.1|686.5
810,6,0.4144,6.216,4750.0,0.0013039999999999998,0.998474,C8orf74 CRYL1 CSMD2 ID2 MS4A2 WFDC1,endodermal digestive tract morphogenesis|positive regulation of transcription involved in G1/S transition of mitotic cell cycle|epithelial cell differentiation involved in mammary gland alveolus development|glucuronate catabolic process|xylulose 5-phosphate biosynthetic process,0.0008735|0.001165|0.001456|0.001746|0.001746,1|1|1|1|1,1716|1144|858.1|686.5|686.5
811,4,0.4603,2.762,3022.0,0.0009107000000000001,0.9929309999999999,C8orf88 FOXD3 NEK9 STIM1,activation of store-operated calcium channel activity|positive regulation of store-operated calcium channel activity|store-operated calcium entry|regulation of store-operated calcium channel activity|positive regulation of adenylate cyclase activity,0.001359|0.001553|0.001747|0.001941|0.002134,1|1|1|1|1,858.1|735.5|643.6|572.1|514.9
812,7,0.4012,8.425,5550.0,0.0015119999999999999,0.9992989999999999,C6orf201 C9orf131 CARD11 FAM107A FAM217A PRSS3 RAB3B,positive regulation of catecholamine uptake involved in synaptic transmission|positive regulation of dopamine uptake involved in synaptic transmission|positive regulation of neurotransmitter uptake|regulation of catecholamine uptake involved in synaptic transmission|regulation of dopamine uptake involved in synaptic transmission,0.001358|0.001358|0.002037|0.003054|0.003054,1|1|1|1|1,980.7|980.7|588.4|367.8|367.8
813,7,0.403,8.462,5873.0,0.0014349999999999999,0.9992989999999999,C9orf135 CXCL8 DCAF8 ENTPD6 MYH13 SPINT3 THSD4,negative regulation of cell adhesion molecule production|regulation of entry of bacterium into host cell|regulation of cell adhesion molecule production|elastic fiber assembly|nucleoside diphosphate catabolic process,0.002037|0.002715|0.003732|0.004071|0.004409,1|1|1|1|1,588.4|420.3|294.2|267.5|245.2
814,7,0.4163,8.742,5601.0,0.0015539999999999998,0.9992989999999999,ALDH1A1 C9orf152 C9orf50 GRIN3A NUB1 PTBP3 ZBTB6,fructose catabolic process|fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate|glyceraldehyde-3-phosphate metabolic process|prepulse inhibition|ethanol oxidation,0.002037|0.002037|0.003054|0.004409|0.004409,1|1|1|1|1,588.4|588.4|367.8|245.2|245.2
815,15,0.4248,44.6,9977.0,0.004437,0.999999,ATM CDKN1A CHEK2 DCLRE1B DDX31 HDDC2 MDM2 MDM4 PPM1D PPM1G RPS27L TP53 UBE2D3 USP28 WDR89,"signal transduction by p53 class mediator|DNA damage response, signal transduction by p53 class mediator|cell cycle checkpoint|signal transduction in response to DNA damage|mitotic G1 DNA damage checkpoint",4.659e-17|4.553e-16|2.765e-15|3.17e-15|3.274e-14,7.349e-13|3.591e-12|1.454e-11|1.25e-11|1.033e-10,104.7|139|65.38|107.7|145.6
816,5,0.4488,4.488,3903.0,0.001146,0.996692,C9orf57 CCDC62 MANBAL METTL25 MYF5,positive regulation of skeletal muscle fiber development|regulation of skeletal muscle fiber development|muscle cell fate commitment|cartilage condensation|positive regulation of skeletal muscle tissue development,0.002425|0.003394|0.003636|0.005329|0.005329,1|1|1|1|1,457.7|316.8|294.2|196.1|196.1
817,6,0.4161,6.2410000000000005,4746.0,0.00131,0.998474,ACVR1 ANKRD9 C9orf66 SLC11A1 TMEM45B TRPC3,manganese ion transport|transition metal ion transport|MHC class II biosynthetic process|nitrite transport|endocardial cushion cell fate commitment,7.2e-06|0.0003552|0.0004854|0.0004854|0.0004854,0.1136|1|1|1|1,514.9|67.52|4119|4119|4119
818,6,0.4022,6.0329999999999995,4742.0,0.001267,0.998474,AUNIP C9orf92 DBNDD1 HIST1H2AM NRG4 PTH,positive regulation of osteoclast proliferation|regulation of osteoclast proliferation|negative regulation of bone mineralization involved in bone maturation|hormone-mediated apoptotic signaling pathway|negative regulation of apoptotic process in bone marrow cell,0.001019|0.001698|0.001698|0.001698|0.002037,1|1|1|1|1,1471|735.5|735.5|735.5|588.4
819,34,0.3437,192.8,28100.0,0.0068,1.0,C8orf44 C8orf76 CA1 CA13 CA2 CA3 CA8 CEBPD CHCHD7 CHMP4C CNGB3 CPA6 CYP7A1 FABP12 FABP4 GDAP1 GGH HEY1 MCMDC2 MTFR1 MTSS1 NOV NSMAF OPRK1 PKIA PMP2 PPDPFL PRDM14 SGK3 SNX16 SULF1 TMEM69 TRIM55 UBE2W,one-carbon metabolic process|bicarbonate transport|response to ethanol|organic anion transport|cellular response to fluid shear stress,1.252e-08|1.209e-06|0.0001097|0.0003128|0.0005515,0.0001975|0.009536|0.5769|1|1,73.34|54.48|16.46|8.413|63.56
820,5,0.448,4.48,4066.0,0.001098,0.996692,CA10 EFNA1 GEM IL13 PEAK3,positive regulation of pancreatic stellate cell proliferation|positive regulation of lung goblet cell differentiation|regulation of lung goblet cell differentiation|negative regulation of lung ciliated cell differentiation|regulation of calcium ion transmembrane transport,0.0004854|0.0004854|0.0004854|0.0004854|0.0005471,1|1|1|1|1,4119|4119|4119|4119|54.2
821,33,0.4004,211.4,26730.0,0.007828,1.0,C5AR1 C5AR2 CA11 CABP5 CALM3 CCDC61 CRX CYP2A13 EML2 FFAR3 FLT3LG FUT1 FUT2 GPR32 IGFL1 IGFL2 IGFL3 KIR2DL1 KLK11 KLK3 PSG6 PSG8 SIGLEC11 SIGLEC5 SULT2A1 SULT2B1 VN1R4 ZNF155 ZNF222 ZNF45 ZNF665 ZNF780B ZNF880,complement receptor mediated signaling pathway|complement component C5a signaling pathway|fucose catabolic process|L-fucose catabolic process|L-fucose metabolic process,2.69e-06|1.772e-05|0.0001612|0.0001612|0.0001612,0.04243|0.1398|0.8477|0.6358|0.5086,132|572.1|127.1|127.1|127.1
822,6,0.417,6.255,4624.0,0.001347,0.998474,ATP6V0A2 CA12 CLVS2 EBF1 PIK3CD SLC30A7,cellular transition metal ion homeostasis|transition metal ion transport|transition metal ion homeostasis|inorganic ion homeostasis|ion homeostasis,0.0004566|0.0005306|0.0006471|0.0007824|0.000945,1|1|1|1|1,60.75|56.27|50.85|14.38|13.48
823,5,0.443,4.43,4077.0,0.001083,0.996692,ATG16L1 CA14 FAM167A TAS2R4 ZNF705B,negative stranded viral RNA replication|xenophagy|protein lipidation involved in autophagosome assembly|C-terminal protein lipidation|viral RNA genome replication,0.0009706|0.001213|0.001213|0.00194|0.003394,1|1|1|1|1,1373|1030|1030|588.4|316.8
824,6,0.4175,6.263,4889.0,0.001276,0.998474,C3orf14 CA6 HDHD2 KCNG4 NEDD4L ZFPL1,positive regulation of caveolin-mediated endocytosis|regulation of caveolin-mediated endocytosis|negative regulation of sodium ion transmembrane transporter activity|negative regulation of protein localization to cell surface|negative regulation of sodium ion transmembrane transport,0.001456|0.002328|0.004071|0.004071|0.004361,1|1|1|1|1,858.1|490.4|264|264|245.2
825,6,0.4182,6.273,5064.0,0.001234,0.998474,CA9 CHRNA7 GREM1 MYO1C RNF222 TMEM88,"vesicle transport along actin filament|actin filament-based transport|synaptic transmission, cholinergic|cell surface receptor signaling pathway|epithelial cell differentiation involved in kidney development",2.76e-05|3.324e-05|4.962e-05|7.012e-05|8.257e-05,0.4354|0.2622|0.2609|0.2765|0.2605,271|245.2|198|6.213|151.4
826,7,0.4045,8.493,5443.0,0.0015539999999999998,0.9992989999999999,ACTG1 CAAP1 CALY FADS6 SLURP2 STK32C USP39,positive regulation of retrograde axon cargo transport|regulation of retrograde axon cargo transport|positive regulation of clathrin coat assembly|regulation of clathrin coat assembly|regulation of transepithelial transport,0.0006794|0.0006794|0.001019|0.001019|0.001698,1|1|1|1|1,2942|2942|1471|1471|735.5
827,6,0.4437,6.656000000000001,5022.0,0.0013210000000000001,0.998474,CABP1 MYL9 PRPH2 PTCH1 TXNDC15 ZNF512,regulation of smoothened signaling pathway|response to chlorate|neural plate axis specification|epidermal cell fate specification|visual perception,0.0002381|0.0008735|0.0008735|0.001165|0.001626,1|1|1|1|1,84.75|1716|1716|1144|31.78
828,5,0.422,4.22,3945.0,0.001066,0.996692,CABYR FAM120B RELT SLC22A3 ZNF221,epinephrine uptake|histamine uptake|epinephrine transport|imidazole-containing compound metabolic process|histamine metabolic process,0.000728|0.0009706|0.001213|0.001698|0.001698,1|1|1|1|1,2060|1373|1030|686.5|686.5
829,20,0.4064,77.21,15440.0,0.004964,1.0,AKAP2 C9orf16 C9orf84 FAM129B FBP1 FBP2 GBGT1 KIF12 OR1J1 OR1J2 OR1J4 OR1L1 OR1L8 OR1N2 PALM2 TOR1B TXNDC8 UCK1 ZBTB6 ZNF782,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|sucrose biosynthetic process|detection of chemical stimulus,2.147e-06|3.013e-06|3.735e-06|4.824e-06|5.606e-06,0.03386|0.02376|0.01964|0.01902|0.01769,14.75|13.9|13.38|1084|12.46
830,6,0.4169,6.254,4819.0,0.0012929999999999999,0.998474,CACNA1A CD22 NLRP12 NLRP2 ZNF132 ZNF324,positive regulation of interleukin-1 beta production|positive regulation of interleukin-1 production|regulation of interleukin-1 beta production|negative regulation of NF-kappaB transcription factor activity|regulation of interleukin-1 production,0.0001081|0.0001458|0.0002737|0.0002737|0.0003737,1|1|1|1|1,127.1|109|78.91|78.91|67.3
831,5,0.4435,4.435,3670.0,0.001204,0.996692,CACNA1B LDHAL6B OTOP1 PDE4DIP PPIAL4A,positive regulation of microtubule nucleation|negative regulation of interferon-gamma-mediated signaling pathway|negative regulation of response to interferon-gamma|regulation of microtubule nucleation|astral microtubule organization,0.001698|0.002183|0.002183|0.002183|0.00291,1|1|1|1|1,686.5|514.9|514.9|514.9|374.5
832,10,0.4019,18.08,7440.0,0.002418,0.999933,BPIFB1 CACNA1D IL6ST JAK1 LIFR MEIOB SGCD SLC39A1 SOCS3 STAT3,interleukin-6-mediated signaling pathway|cellular response to interleukin-6|response to interleukin-6|interleukin-35-mediated signaling pathway|interleukin-27-mediated signaling pathway,2.037e-10|2.535e-09|3.761e-09|2.988e-08|2.988e-08,3.214e-06|1.999e-05|1.978e-05|0.0001178|9.426e-05,457.7|228.8|205.9|561.7|561.7
833,6,0.4049,6.0729999999999995,4530.0,0.001335,0.998474,ANGPTL4 C10orf82 CACNA1E HOOK2 IRX6 OR8K1,protein unfolding|negative regulation of lipoprotein lipase activity|negative regulation of lipase activity|regulation of lipoprotein lipase activity|early endosome to late endosome transport,0.001165|0.002037|0.005232|0.006681|0.00697,1|1|1|1|1,1144|572.1|201.9|156|149.2
834,6,0.4366,6.5489999999999995,5052.0,0.001292,0.998474,ACO1 BVES CACNA1G HUS1B KRT32 LGALS2,regulation of heart rate|response to nickel cation|meiotic DNA integrity checkpoint|response to iron(II) ion|citrate metabolic process,0.0003386|0.0005824|0.0008735|0.001746|0.001746,1|1|1|1|1,70.77|3432|1716|686.5|686.5
835,6,0.4145,6.218,4945.0,0.001253,0.998474,CACNA1S CMTM8 OR5T1 PEX11A RGL1 SEMA7A,signaling|regulation of peroxisome size|cellular response to stimulus|peroxisome membrane biogenesis|cellular response to caffeine,0.0003579|0.001165|0.001264|0.001456|0.0032,1|1|1|1|1,3.755|1144|3.042|858.1|343.2
836,10,0.4255,19.15,6182.0,0.003078,0.999933,CCNE2 CCNF CDK4 CDK6 CKS1B E2F3 SKP2 SOX4 TCF19 UBE2Q1,G1 phase|mitotic G1 phase|mitotic cell cycle phase transition|cell cycle phase transition|mitotic cell cycle process,5.336e-13|5.336e-13|1.236e-11|1.495e-11|6.671e-11,8.416e-09|4.208e-09|6.501e-08|5.897e-08|2.105e-07,490.4|490.4|50.58|49.2|24.05
837,7,0.4125,8.662,5484.0,0.001573,0.9992989999999999,ASTL CACNA2D3 CCDC138 CNNM4 LMAN2L PCIF1 THAP7,prevention of polyspermy|negative regulation of fertilization|negative regulation of binding of sperm to zona pellucida|egg activation|regulation of binding of sperm to zona pellucida,0.001019|0.001019|0.001698|0.002037|0.002037,1|1|1|1|1,1471|1471|735.5|588.4|588.4
838,6,0.4147,6.22,4753.0,0.001303,0.998474,CACNB3 CSF3 HEMGN OSBP2 SLC25A39 TNFRSF6B,negative regulation of detection of mechanical stimulus involved in sensory perception of touch|regulation of detection of mechanical stimulus involved in sensory perception of touch|calcium ion transmembrane transport via high voltage-gated calcium channel|regulation of membrane hyperpolarization|positive regulation of high voltage-gated calcium channel activity,0.0005824|0.0005824|0.001165|0.001746|0.001746,1|1|1|1|1,3432|3432|1144|686.5|686.5
839,14,0.482,43.86,8863.0,0.004909,0.9999969999999999,DENND4C EXOC1 EXOC2 EXOC3 EXOC4 EXOC5 EXOC7 EXOC8 RAB10 RABIF RALGAPB SNAP23 STX4 STXBP3,post-Golgi vesicle-mediated transport|protein transport|peptide transport|amide transport|establishment of protein localization,5.616e-17|1.624e-14|2.09e-14|2.793e-14|3.648e-14,8.859e-13|1.281e-10|1.099e-10|1.102e-10|1.151e-10,98.8|13.07|12.82|12.53|12.27
840,7,0.4018,8.439,6113.0,0.001375,0.9992989999999999,CACNG5 GHSR IGDCC3 RCAN3 SERF2 TBC1D21 TENM3,negative regulation of locomotion involved in locomotory behavior|positive regulation of small intestinal transit|regulation of small intestinal transit|ghrelin secretion|regulation of hindgut contraction,0.001019|0.001019|0.001019|0.001019|0.001019,1|1|1|1|1,1471|1471|1471|1471|1471
841,11,0.4099,22.54,8430.0,0.00266,0.999969,CACNG6 CFAP53 FPR2 ISL2 LHX3 MAN1A2 MGAT1 NEUROD1 OTP OTX2 PKDREJ,central nervous system development|spinal cord motor neuron cell fate specification|endocrine system development|forebrain development|neurogenesis,1.617e-05|2.416e-05|6.103e-05|7.428e-05|9.956e-05,0.255|0.1905|0.3209|0.2929|0.3141,9.592|316.8|38.64|16.68|6.943
842,11,0.5917,32.54,7643.0,0.004228,0.999969,ATP5F1C CDC123 GTPBP4 KIN MCM10 PDSS1 PRPF18 RBM17 RPP38 UPF2 ZNF33A,nucleobase-containing compound metabolic process|heterocycle metabolic process|cellular aromatic compound metabolic process|organic cyclic compound metabolic process|nucleic acid metabolic process,1.059e-05|1.743e-05|1.953e-05|3.538e-05|3.933e-05,0.167|0.1375|0.1027|0.1395|0.1241,5.509|5.158|5.081|4.695|5.872
843,6,0.4078,6.1160000000000005,4856.0,0.001255,0.998474,CADM1 CNIH2 MFSD10 NECTIN1 PARM1 YIF1A,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|adherens junction organization|negative regulation of receptor localization to synapse|negative regulation of vesicle transport along microtubule|tetracycline transmembrane transport,8.606e-05|0.0001414|0.0005824|0.0005824|0.0005824,1|1|1|1|1,143|110.7|3432|3432|3432
844,23,0.3668,92.79,15940.0,0.005769,1.0,C1orf109 DDX55 DHX33 IMP3 MAK16 MYBBP1A NOL9 OSGEP PAK1IP1 POP5 PPAN PWP2 RPP21 RRP1 RRP12 RSL1D1 SPATA5L1 TIMM10 TRMT112 URB1 UTP4 WDR12 WDR18,ribosome biogenesis|ribonucleoprotein complex biogenesis|ncRNA processing|rRNA processing|rRNA metabolic process,4.975e-25|1.279e-22|3.229e-21|1.5e-20|2.496e-20,7.848e-21|1.009e-18|1.698e-17|5.917e-17|7.874e-17,42.18|30.12|30.51|44.36|42.72
845,5,0.451,4.51,3965.0,0.0011330000000000001,0.996692,C8B CADM3 LMLN SGSM3 SLC39A2,"regulation of Rab protein signal transduction|plasma membrane to endosome transport|Rap protein signal transduction|complement activation, alternative pathway|zinc ion transmembrane transport",0.00194|0.002183|0.00291|0.003878|0.006054,1|1|1|1|1,588.4|514.9|374.5|274.6|171.6
846,21,0.4043,84.9,16810.0,0.005012,1.0,AGO1 AGO4 BEST4 BSND C1orf123 CFAP57 CYP4X1 CYP4Z1 ERMAP EXO5 FAAH GJB3 PCSK9 PPT1 RAB3B TMEM53 ZFP69 ZFP69B ZNF684 ZNF691 ZYG11B,"miRNA loading onto RISC involved in gene silencing by miRNA|RNA secondary structure unwinding|small RNA loading onto RISC|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation",3.542e-05|4.425e-05|5.405e-05|0.0001029|0.0001029,0.5588|0.349|0.2842|0.4059|0.3248,280.2|245.2|217.9|150.9|150.9
847,7,0.4283,8.994,5662.0,0.001582,0.9992989999999999,C3orf62 CADPS FAM174B LMX1A NFATC1 TRIM71 TUT4,miRNA metabolic process|production of miRNAs involved in gene silencing by miRNA|production of small RNA involved in gene silencing by RNA|dsRNA processing|gene silencing by miRNA,2.495e-05|4.885e-05|6.2e-05|6.2e-05|0.0001203,0.3936|0.3852|0.326|0.2445|0.3795,280.2|196.1|173.1|173.1|122.6
848,6,0.4361,6.542000000000001,4903.0,0.0013289999999999999,0.998474,BAX CADPS2 CERS1 CPLX1 NIPAL1 TTPA,synaptic vesicle exocytosis|ion transport|cellular response to UV|neurotransmitter secretion|signal release from synapse,0.0001201|0.0002851|0.0002925|0.0003119|0.0003119,1|1|1|1|0.9838,120.4|5.957|76.28|73.82|73.82
849,6,0.435,6.526,5121.0,0.0012699999999999999,0.998474,ASCL2 CAGE1 CCDC146 COL4A1 NNAT NUCKS1,modulation by host of viral RNA-binding transcription factor activity|modulation by host of RNA binding by virus|spongiotrophoblast layer development|regulation of DNA strand elongation|modulation by host of viral transcription,0.0005824|0.0005824|0.0005824|0.0008735|0.0008735,1|1|1|1|1,3432|3432|3432|1716|1716
850,5,0.4284,4.284,3961.0,0.001078,0.996692,CALCB RASL10B SLC24A3 SNX9 ZNF551,regulation of systemic arterial blood pressure by atrial natriuretic peptide|lipid tube assembly|cleavage furrow formation|plasma membrane tubulation|cellular calcium ion homeostasis,0.000728|0.001213|0.00194|0.003394|0.00415,1|1|1|1|1,2060|1030|588.4|316.8|19.29
851,44,0.4007,379.0,34560.0,0.01082,1.0,ADAP2 ALDOC C17orf50 C17orf75 CCL13 CCL2 CCL7 CRYBA1 DHRS11 EPOP EVI2A GAS2L2 GSDMA GSDMB HAP1 KRT16 KRT20 KRT25 KRT26 KRT28 KRT31 KRT40 KRTAP1-4 KRTAP1-5 KRTAP3-1 KRTAP3-2 KRTAP4-11 KRTAP4-2 KRTAP4-3 KRTAP4-4 KRTAP4-8 KRTAP4-9 KRTAP9-8 KRTAP9-9 LGALS9 LYRM9 PIPOX RDM1 SLC13A2 SLFN12 SLFN14 SPAG5 TIAF1 UNC119,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,4.005e-25|8.546e-24|1.66e-22|5.323e-21|2.467e-20,6.317e-21|6.74e-20|8.73e-19|2.099e-17|7.784e-17,37.64|31.74|26.92|22.21|20.4
852,5,0.432,4.32,3772.0,0.001141,0.996692,CALCR SNAPC2 SPC24 SPRR1B TEX264,cross-receptor inhibition within G protein-coupled receptor heterodimer|positive regulation of calcium ion import across plasma membrane|regulation of calcium ion import across plasma membrane|protein-DNA covalent cross-linking repair|amylin receptor signaling pathway,0.000728|0.0009706|0.001456|0.001698|0.00194,1|1|1|1|1,2060|1373|823.8|686.5|588.4
853,6,0.4272,6.409,4967.0,0.001285,0.998474,CALCRL DLGAP1 EPHA7 MAT2B STEAP4 TMEM200C,cellular response to sucrose stimulus|cellular response to disaccharide stimulus|calcitonin gene-related peptide receptor signaling pathway|S-adenosylmethionine biosynthetic process|adrenomedullin receptor signaling pathway,0.0005824|0.0005824|0.001165|0.001456|0.001456,1|1|1|1|1,3432|3432|1144|858.1|858.1
854,6,0.4211,6.317,4757.0,0.001323,0.998474,CALD1 CRIM1 KRTAP16-1 MIEF1 MSANTD2 WDR31,insulin-like growth factor receptor signaling pathway|positive regulation of mitochondrial fission|positive regulation of mitochondrial translation|mitochondrial fission|regulation of mitochondrial translation,0.004071|0.005232|0.005232|0.006391|0.007839,1|1|1|1|1,264|201.9|201.9|163.5|132
855,6,0.4329,6.492999999999999,5187.0,0.001247,0.998474,BARHL1 C5AR2 CALHM2 KLHDC9 MYOZ3 SCIMP,regulation of interleukin-6 production|complement component C5a signaling pathway|negative regulation of granulocyte chemotaxis|negative regulation of neutrophil chemotaxis|negative regulation of neutrophil migration,0.0006378|0.0008735|0.001165|0.001165|0.001456,1|1|1|1|1,51.23|1716|1144|1144|858.1
856,6,0.4208,6.312,5030.0,0.00125,0.998474,CALHM6 CCDC88A H6PD PLEKHG5 POR TRIM72,regulation of steroid hormone biosynthetic process|regulation of hormone biosynthetic process|regulation of hormone metabolic process|regulation of alcohol biosynthetic process|regulation of steroid biosynthetic process,5.506e-06|1.784e-05|4.687e-05|0.0001892|0.0002799,0.08685|0.1407|0.2464|0.746|0.8831,624.1|326.9|196.1|95.35|78.01
857,13,0.3668,28.61,8431.0,0.003372,0.999993,ASPM CALM2 CDK5RAP2 DYNLRB1 HMMR KIFC1 NDE1 PAFAH1B1 PCNT PFDN1 TUBA1C TUBB TUBB4B,G2/M transition of mitotic cell cycle|cell cycle G2/M phase transition|microtubule-based process|microtubule cytoskeleton organization|regulation of G2/M transition of mitotic cell cycle,1.347e-12|1.483e-12|2.222e-12|6.237e-12|1.682e-11,2.125e-08|1.17e-08|1.168e-08|2.459e-08|5.306e-08,79.21|78.1|19.73|25.19|54.63
858,18,0.4014,61.41,14740.0,0.004139,1.0,ADAMTS7 BNIP2 CALML4 CELF6 CSPG4 GOLGA6B GOLGA6D MAP2K5 MYO5C PLEKHO2 PPIB RAB8B SCAMP2 SCAMP5 SEMA7A SLC24A1 SNX22 THAP10,positive regulation of growth|negative regulation of chemokine (C-X-C motif) ligand 2 production|ERK5 cascade|macrophage apoptotic process|Golgi vesicle fusion to target membrane,0.001422|0.002618|0.002618|0.003489|0.004359,1|1|1|1|1,13.3|572.1|572.1|381.4|286
859,6,0.4151,6.226,4827.0,0.001285,0.998474,CALN1 CDHR3 CNTNAP5 DDX55 IRX2 WNT7A,asymmetric protein localization involved in cell fate determination|proximal/distal pattern formation involved in metanephric nephron development|positive regulation of protein localization to presynapse|regulation of protein localization to presynapse|positive regulation of excitatory synapse assembly,0.0005824|0.0008735|0.0008735|0.0008735|0.001165,1|1|1|1|1,3432|1716|1716|1716|1144
860,35,0.3902,232.2,28240.0,0.008135,1.0,ADA BPIFA3 BPIFB4 CCM2L CNBD2 COX4I2 CPNE1 DEFB115 DEFB116 DUSP15 EPB41L1 FAM209A FAM209B FAM83C FOXS1 GGT7 GHRH HCK KIAA1755 KIF3B LBP MAP1LC3A MYH7B MYLK2 NOL4L PLAGL2 POFUT1 SOGA1 TLDC2 TM9SF4 WFDC11 WFDC6 WISP2 XKR7 ZNF341,"regulation of circadian sleep/wake cycle, sleep|regulation of circadian sleep/wake cycle|response to bacterium|positive regulation of multicellular organism growth|response to isoquinoline alkaloid",0.000443|0.0006528|0.001063|0.001516|0.001604,1|1|1|1|1,71.26|57.69|5.062|36.71|35.63
861,30,0.3931,171.0,19400.0,0.008711,1.0,CNIH1 COG1 COG2 COG3 COG4 COG5 COG6 COG7 COG8 GET4 GOSR2 PTAR1 RAB18 RAB1A RAB1B SAR1A SCFD1 SEC23IP SEC31A SLC39A9 SURF4 TM9SF3 TRAPPC1 TRAPPC12 TRAPPC13 TRAPPC2L UNC50 VPS52 VPS54 YKT6,Golgi vesicle transport|endoplasmic reticulum to Golgi vesicle-mediated transport|intracellular transport|vesicle-mediated transport|cellular localization,1.176e-33|2.814e-33|9.69e-21|1.134e-19|2.984e-18,1.855e-29|2.22e-29|5.095e-17|4.471e-16|9.413e-15,39.87|70.05|10.53|8.415|5.944
862,7,0.4239,8.902000000000001,5971.0,0.001485,0.9992989999999999,ANKRD13D C8orf48 CAMK1D CARD8 F10 NR2C2 PHTF1,"negative regulation of blood coagulation, extrinsic pathway|regulation of blood coagulation, extrinsic pathway|blood coagulation, extrinsic pathway|inhibition of cysteine-type endopeptidase activity|zymogen inhibition",0.00194|0.00194|0.00194|0.003103|0.00349,1|1|1|1|1,643.6|643.6|643.6|367.8|321.8
863,6,0.4036,6.055,4886.0,0.001235,0.998474,ARV1 CAMK2A GJD3 NEDD4 RUFY2 SKAP2,development involved in symbiotic interaction|negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage|regulation of plasma membrane sterol distribution|regulation of transport|peptidyl-threonine autophosphorylation,0.0005824|0.0005824|0.0005824|0.0006948|0.0008735,1|1|1|1|1,3432|3432|3432|7.81|1716
864,8,0.402,11.26,6757.0,0.0016589999999999999,0.9996790000000001,CAMK2B CCDC47 CD52 FAM114A2 IL17RA MEGF9 STK36 TSPAN19,post-embryonic development|positive regulation of hh target transcription factor activity|signal transduction downstream of smoothened|positive regulation of chemokine (C-X-C motif) ligand 1 production|positive regulation of interleukin-23 production,0.0004744|0.001552|0.001552|0.00194|0.002328,1|1|1|1|1,61.29|858.1|858.1|643.6|514.9
865,7,0.4209,8.839,6126.0,0.001437,0.9992989999999999,CAMK2G CARTPT FHOD3 MCCC2 PRR14 SH3BP5 TTC23,cortical actin cytoskeleton organization|peptide hormone secretion|cortical cytoskeleton organization|hormone secretion|hormone transport,0.0001021|0.0002232|0.0002309|0.000342|0.000442,1|1|1|1|1,135.5|90.33|88.77|72.52|63.56
866,36,0.4036,254.3,27570.0,0.009115,1.0,ACTR3B AGBL3 AKR1D1 CPA1 CPA5 EPHB6 FAM71F2 GIMAP2 GIMAP4 GIMAP6 HYAL4 KEL MGAM OR2A2 OR2A5 OR6V1 OR9A2 OR9A4 PDIA4 PRSS1 PRSS37 PRSS58 RNF148 STRA8 TAS2R39 TAS2R40 TAS2R41 TAS2R60 TRPV5 TRPV6 ZNF212 ZNF282 ZNF398 ZNF425 ZNF783 ZNF786,sensory perception of chemical stimulus|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|detection of stimulus involved in sensory perception|G protein-coupled receptor signaling pathway,4.133e-07|2.139e-06|3.602e-06|5.545e-06|1.478e-05,0.00652|0.01687|0.01894|0.02187|0.04662,9.243|9.162|8.531|8.038|4.607
867,5,0.4454,4.454,3890.0,0.001141,0.996692,CANT1 FSD1 GABRR1 ICK NT5E,adenosine biosynthetic process|AMP catabolic process|intraciliary anterograde transport|regulation of presynaptic membrane potential|purine ribonucleoside monophosphate catabolic process,0.0004854|0.000728|0.0009706|0.001456|0.001456,1|1|1|1|1,4119|2060|1373|823.8|823.8
868,7,0.4003,8.407,5883.0,0.001424,0.9992989999999999,BDKRB2 CANX CEP162 COX7A1 KRTAP27-1 PIK3C2G PROK2,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator|regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator|negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress|regulation of intrinsic apoptotic signaling pathway in response to osmotic stress|regulation of cellular response to osmotic stress,0.0006794|0.0006794|0.001698|0.002037|0.003732,1|1|1|1|1,2942|2942|735.5|588.4|294.2
869,6,0.414,6.21,4882.0,0.001267,0.998474,CAP2 CATSPER3 MTFP1 NKIRAS2 SRRM5 ZNRF3,"Wnt receptor catabolic process|negative regulation of non-canonical Wnt signaling pathway|regulation of Wnt signaling pathway, planar cell polarity pathway|epithelial cell-cell adhesion|mitochondrial fission",0.001019|0.002376|0.005425|0.006439|0.007452,1|1|1|1|1,1471|490.4|196.1|163.5|140.1
870,7,0.4333,9.1,5700.0,0.00159,0.9992989999999999,CAPG CRYGC GNLY OXER1 STON1 TLX2 TRIM56,interferon-beta production|type I interferon production|negative regulation of dendrite morphogenesis|enteric nervous system development|actin filament severing,0.001552|0.002328|0.003877|0.006197|0.006197,1|1|1|1|1,858.1|514.9|286|171.6|171.6
871,9,0.4213,15.17,6257.0,0.002411,0.9998530000000001,BCL9L BMPR1A CAPN15 FOXA2 GATA6 HNF1A HNF4A TCF7L2 UBE2Z,pancreas development|endocrine system development|endocrine pancreas development|positive regulation of transcription by RNA polymerase II|gastrulation,7.44e-11|1.057e-09|2.717e-09|7.815e-08|4.175e-07,1.174e-06|8.333e-06|1.428e-05|0.0003082|0.001317,161.2|93.02|217.9|13.28|59.05
872,6,0.4295,6.442,4573.0,0.001403,0.998474,CAPN2 HIST3H3 LAX1 ST7L TFAP2B WFDC12,positive regulation of neuron death|cellular urea homeostasis|cellular creatinine homeostasis|cellular ammonium homeostasis|urea homeostasis,0.0002174|0.0004854|0.0004854|0.0004854|0.000728,1|1|1|1|1,86.72|4119|4119|4119|2060
873,6,0.4129,6.193,4772.0,0.0012929999999999999,0.998474,CAPN3 FAM111B FBN1 GANC MTMR10 TSNAXIP1,calcium-dependent self proteolysis|positive regulation of satellite cell activation involved in skeletal muscle regeneration|regulation of satellite cell activation involved in skeletal muscle regeneration|G1 to G0 transition involved in cell differentiation|maltose metabolic process,0.0005824|0.0008735|0.0008735|0.001165|0.001165,1|1|1|1|1,3432|1716|1716|1144|1144
874,6,0.4014,6.02,4776.0,0.001256,0.998474,CAPNS2 HPCAL4 LRCH1 SH2D4A ZBTB8A ZNF684,negative regulation of T cell migration|negative regulation of lymphocyte migration|negative regulation of mononuclear cell migration|negative regulation of hydrolase activity|regulation of T cell migration,0.002037|0.004361|0.006681|0.006943|0.01275,1|1|1|1|1,572.1|245.2|156|15.09|79.83
875,9,0.415,14.94,5748.0,0.002584,0.9998530000000001,ANKRD17 CAPRIN1 CNOT2 CNOT3 CNOT4 G3BP1 SERBP1 SRRD USP10,"DNA damage response, signal transduction by p53 class mediator|signal transduction in response to DNA damage|nuclear-transcribed mRNA poly(A) tail shortening|signal transduction by p53 class mediator|regulation of G1/S transition of mitotic cell cycle",5.046e-08|1.357e-07|2.128e-07|2.39e-07|6.408e-07,0.0007959|0.00107|0.001119|0.0009424|0.002022,104.3|80.76|268.6|69.81|54.2
876,6,0.4113,6.169,5063.0,0.001214,0.998474,ANKRD50 CAPS2 CD96 FAS TMPRSS7 TRAK2,anterograde dendritic transport of mitochondrion|dendritic transport of mitochondrion|Fas signaling pathway|negative regulation of natural killer cell cytokine production|motor neuron apoptotic process,0.0007765|0.001164|0.001164|0.001164|0.00194,1|1|1|1|1,2574|1287|1287|1287|643.6
877,5,0.435,4.35,3920.0,0.001106,0.996692,CAPZA1 MYLPF PFKFB2 SLAMF9 ZNF541,"positive regulation of glucokinase activity|fructose 2,6-bisphosphate metabolic process|positive regulation of hexokinase activity|regulation of glucokinase activity|regulation of hexokinase activity",0.001456|0.001456|0.001698|0.002667|0.00291,1|1|1|1|1,823.8|823.8|686.5|411.9|374.5
878,19,0.407,69.6,13150.0,0.005249,1.0,BCL10 CARD10 CYLD IKBKB MALT1 N4BP1 NFKB2 NFKBIA NFKBIB RBCK1 RNF31 SPATA2 STUB1 TAB2 TNFAIP3 TNIP1 TRAF2 TRAF3 TRAF6,regulation of DNA-binding transcription factor activity|regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation of NF-kappaB transcription factor activity|I-kappaB kinase/NF-kappaB signaling|pattern recognition receptor signaling pathway,1.429e-19|1.142e-18|1.769e-18|1.807e-17|2.101e-17,2.254e-15|9.009e-15|9.303e-15|7.125e-14|6.629e-14,33.29|50.85|69.49|132.4|81.08
879,5,0.4514,4.513999999999999,3857.0,0.001166,0.996692,CARD19 CEACAM6 MYBPC1 STUM TMEM39B,positive regulation of endothelial cell-matrix adhesion via fibronectin|negative regulation of autophagosome maturation|regulation of endothelial cell-matrix adhesion via fibronectin|regulation of autophagosome maturation|positive regulation of heterotypic cell-cell adhesion,0.001456|0.001698|0.001698|0.003636|0.00412,1|1|1|1|1,823.8|686.5|686.5|294.2|257.4
880,5,0.4252,4.252,3987.0,0.0010630000000000001,0.996692,CARHSP1 COX8C DDX58 RNFT1 SLC23A2,transepithelial L-ascorbic acid transport|L-ascorbic acid transmembrane transport|regulation of type III interferon production|detection of virus|RIG-I signaling pathway,0.000728|0.000728|0.001213|0.001698|0.001698,1|1|1|1|1,2060|2060|1030|686.5|686.5
881,5,0.4413,4.413,4108.0,0.0010710000000000001,0.996692,CARMIL1 CTRL GRK6 HSF2BP PSD2,barbed-end actin filament uncapping|actin filament uncapping|negative regulation of barbed-end actin filament capping|regulation of barbed-end actin filament capping|double-strand break repair involved in meiotic recombination,0.0004854|0.000728|0.001213|0.001698|0.001698,1|1|1|1|1,4119|2060|1030|686.5|686.5
882,6,0.4254,6.382000000000001,4566.0,0.001392,0.998474,C7orf25 CARNMT1 GTPBP1 GTPBP2 OBSL1 WDR12,peptide metabolic process|translational elongation|carnosine metabolic process|cellular amide metabolic process|histidine catabolic process,0.0003377|0.0005565|0.0008735|0.001112|0.002619,1|1|1|1|1,19.18|54.92|1716|12.74|429.1
883,15,0.4006,42.06,8895.0,0.00469,0.999999,BRAF DUSP6 GRB2 KRAS LZTR1 MAP2K1 MAPK1 NF1 NRAS PTPN11 RAF1 RASA2 RCE1 SHOC2 SOS1,MAPK cascade|intracellular signal transduction|regulation of intracellular signal transduction|face development|astrocyte differentiation,9.368e-21|2.921e-13|1.28e-12|2.472e-10|3.975e-10,1.478e-16|2.304e-09|6.731e-09|9.749e-07|1.254e-06,43.64|11.33|10.1|146.1|132
884,28,0.4068,153.8,21980.0,0.006929,1.0,APBA2 ARHGAP11B BNIP2 C15orf53 CHRFAM7A CHRNA7 DEXI DUOXA1 DUOXA2 EPB42 GABRA5 GNB5 GOLGA8M MYO5A MYO5C NIPA1 NIPA2 PLA2G4D PLA2G4E PLEKHO2 PPIB RPUSD2 SNURF SNX22 TGM5 TGM7 TMCO5A TYRO3,"synaptic transmission, cholinergic|regulation of postsynaptic membrane potential|positive regulation of hydrogen peroxide biosynthetic process|regulation of thyroid hormone generation|positive regulation of hydrogen peroxide metabolic process",8.912e-06|1.315e-05|3.992e-05|5.318e-05|6.831e-05,0.1406|0.1037|0.2099|0.2097|0.2155,81.94|28.41|284.1|236.7|202.9
885,11,0.4114,22.63,7177.0,0.003133,0.999969,ACTR1A DYNC1LI1 DYNC1LI2 DYNLRB1 MAD2L1BP NDE1 PAFAH1B1 PAFAH1B2 SGO1 UBE2C ZWINT,biological phase|mitotic cell cycle phase|cell cycle phase|anaphase|mitotic anaphase,1.075e-13|1.075e-13|1.075e-13|5.714e-13|5.714e-13,1.695e-09|8.475e-10|5.65e-10|2.253e-09|1.803e-09,58.28|58.28|58.28|83.48|83.48
886,16,0.3739,44.86,12140.0,0.003672,0.999999,C11orf53 CASP1 CASP4 CLDN25 CRYAB FXYD6 HTR3A HTR3B KDELC2 NXPE1 NXPE2 NXPE4 OR6B3 POU2F3 TIMM8B TMEM136,positive regulation of tumor necrosis factor-mediated signaling pathway|pyroptosis|protein autoprocessing|serotonin receptor signaling pathway|positive regulation of cytokine-mediated signaling pathway,3.839e-05|9.323e-05|0.0001591|0.0003988|0.0006175,0.6055|0.7353|0.8364|1|1,249.6|152.6|114.4|70.41|56.04
887,5,0.4274,4.274,4001.0,0.001064,0.996692,CASP3 DNAAF1 MARCH7 SLC41A3 VPS13C,negative regulation of T cell proliferation|negative regulation of lymphocyte proliferation|negative regulation of mononuclear cell proliferation|negative regulation of leukocyte proliferation|negative regulation of T cell activation,0.0001163|0.0001709|0.0001749|0.0001999|0.0003327,1|1|0.9195|0.7881|1,119.4|98.07|96.92|90.53|69.81
888,6,0.4191,6.2860000000000005,4943.0,0.001267,0.998474,ACE BPIFA3 CASP6 LYPD6B SERPIND1 ZKSCAN5,cell proliferation in bone marrow|regulation of angiotensin metabolic process|negative regulation of gap junction assembly|regulation of renal output by angiotensin|positive regulation of peptidyl-cysteine S-nitrosylation,0.0005824|0.0008735|0.0008735|0.001165|0.001165,1|1|1|1|1,3432|1716|1716|1144|1144
889,6,0.4117,6.176,4769.0,0.0012900000000000001,0.998474,ASCL2 CASP7 ETFDH FAT1 ME3 SLC1A5,L-glutamine import across plasma membrane|establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis|glutamine secretion|spongiotrophoblast layer development|cellular respiration,0.0005824|0.0005824|0.0005824|0.0005824|0.0008701,1|1|1|1|1,3432|3432|3432|3432|43.73
890,5,0.4026,4.026,3971.0,0.00101,0.996692,CASQ1 CNGA3 ITGA2B PIFO RND2,embryonic heart tube left/right pattern formation|regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion|regulation of skeletal muscle contraction by calcium ion signaling|positive regulation of store-operated calcium channel activity|regulation of store-operated calcium channel activity,0.001213|0.001213|0.001456|0.00194|0.002425,1|1|1|1|1,1030|1030|823.8|588.4|457.7
891,7,0.4224,8.87,5610.0,0.001575,0.9992989999999999,ARHGEF28 CAST LHCGR OXER1 PHYHIP POMK STON1,luteinizing hormone signaling pathway|cellular response to luteinizing hormone stimulus|response to luteinizing hormone|positive regulation of inositol trisphosphate biosynthetic process|adenylate cyclase-modulating G protein-coupled receptor signaling pathway,0.001019|0.001358|0.001698|0.002037|0.002342,1|1|1|1|1,1471|980.7|735.5|588.4|26.75
892,14,0.4114,37.44,9643.0,0.003856,0.9999969999999999,ARGLU1 BORA CARS2 CDC16 DIS3 LIG4 MRPS31 MZT1 PCID2 PRPF39 RBM27 TRNAU1AP TUBGCP3 ZC3H13,gene expression|regulation of mitotic nuclear division|mRNA metabolic process|cellular nitrogen compound metabolic process|regulation of nuclear division,2.109e-06|5.591e-05|6.865e-05|8.398e-05|0.0001035,0.03326|0.4409|0.361|0.3312|0.3265,6.057|40.12|10.6|3.886|32.45
893,5,0.4434,4.434,4036.0,0.001094,0.996692,CATSPER1 EVL ZNF251 ZNF414 ZNF431,negative regulation of ruffle assembly|regulation of cilium beat frequency involved in ciliary motility|regulation of cilium beat frequency|regulation of cilium movement involved in cell motility|regulation of cilium-dependent cell motility,0.001698|0.00194|0.003636|0.006778|0.006778,1|1|1|1|1,686.5|588.4|294.2|152.6|152.6
894,25,0.5665,169.9,15370.0,0.0109,1.0,ACBD5 ACOX1 ACSL3 AMFR C12orf49 CYB5B HSD17B4 MBTPS1 PEX1 PEX10 PEX12 PEX13 PEX16 PEX19 PEX2 PEX26 PEX3 PEX5 PEX6 PEX7 SCAP SCD SCP2 SREBF1 TMEM41A,protein targeting to peroxisome|establishment of protein localization to peroxisome|protein localization to peroxisome|peroxisomal transport|peroxisome organization,1.632e-31|1.632e-31|1.632e-31|1.953e-31|6.512e-31,2.574e-27|1.287e-27|8.579e-28|7.701e-28|2.054e-27,152.6|152.6|152.6|150.7|138.7
895,10,0.4091,18.41,8719.0,0.002102,0.999933,AGTRAP CATSPER4 FAM76A FCN3 GPR3 IFI6 INHBB PDIK1L SPATC1 TRNP1,negative regulation of hepatocyte growth factor production|regulation of hepatocyte growth factor production|positive regulation of ovulation|regulation of ovulation|negative regulation of follicle-stimulating hormone secretion,0.0009704|0.0009704|0.001455|0.00194|0.00194,1|1|1|1|1,2060|2060|1030|686.5|686.5
896,6,0.4036,6.053999999999999,4580.0,0.001317,0.998474,CALU CATSPERB FAM19A2 GREM2 KRT76 RNF41,regulation of cytokine activity|negative regulation of mitophagy|embryonic body morphogenesis|negative regulation of autophagy of mitochondrion|sequestering of BMP from receptor via BMP binding,0.001213|0.001456|0.001698|0.00194|0.002183,1|1|1|1|1,1030|823.8|686.5|588.4|514.9
897,5,0.4025,4.025,3878.0,0.001034,0.996692,CATSPERE HRAS MOK ROPN1L TIGD6,positive regulation of miRNA metabolic process|response to isolation stress|regulation of neurotransmitter receptor localization to postsynaptic specialization membrane|regulation of miRNA metabolic process|MAPK cascade,0.001698|0.002183|0.002425|0.00291|0.003816,1|1|1|1|1,686.5|514.9|457.7|374.5|20.14
898,7,0.4185,8.789,5975.0,0.001465,0.9992989999999999,C20orf173 CAVIN4 CLVS1 CSN3 EFCAB1 F2RL2 KLHL23,regulation of Rho protein signal transduction|regulation of Ras protein signal transduction|thrombin-activated receptor signaling pathway|protein deneddylation|regulation of small GTPase mediated signal transduction,0.0004967|0.002526|0.003877|0.004264|0.00668,1|1|1|1|1,59.87|26|286|257.4|15.75
899,13,0.4047,31.56,8093.0,0.0038729999999999997,0.999993,ABL1 BCR CBFB EGFR FRS2 GAB1 GAB2 GRB2 LMO2 MYB PTPN11 RUNX1 SOS1,epidermal growth factor receptor signaling pathway|transmembrane receptor protein tyrosine kinase signaling pathway|ERBB signaling pathway|regulation of hematopoietic progenitor cell differentiation|enzyme linked receptor protein signaling pathway,5.165e-13|2.903e-12|3.458e-12|1.458e-11|5.598e-11,8.147e-09|2.29e-08|1.818e-08|5.748e-08|1.766e-07,190.1|27.47|135.8|105.6|19.64
900,8,0.9254,25.91,5129.0,0.005011,0.9996790000000001,CBLL1 METTL14 METTL3 RBM15 VIRMA WTAP YTHDF2 ZC3H13,mRNA methylation|mRNA modification|RNA methylation|RNA modification|macromolecule methylation,1.965e-17|1.563e-16|2.418e-16|2.435e-14|3.429e-13,3.1e-13|1.233e-12|1.271e-12|9.603e-11|1.082e-09,965.4|643.6|209.5|106|72.08
901,5,0.4268,4.268,3894.0,0.001092,0.996692,CBLN3 EMX1 LAMB2 LDHAL6A TNFAIP8,substrate adhesion-dependent cell spreading|neuron projection extension|developmental cell growth|cell growth|developmental growth involved in morphogenesis,0.000116|0.000137|0.0002556|0.0002676|0.0004566,1|1|1|1|1,122.6|112.5|81.73|79.83|60.75
902,7,0.4171,8.759,5277.0,0.0016530000000000002,0.9992989999999999,CBS DENND1C GAS2 HOXB13 NXPH1 OR8B3 SAA4,initiation of primordial ovarian follicle growth|cysteine biosynthetic process from serine|cysteine biosynthetic process via cystathionine|homocysteine catabolic process|epithelial cell maturation involved in prostate gland development,0.0006794|0.001019|0.001358|0.001358|0.001358,1|1|1|1|1,2942|1471|980.7|980.7|980.7
903,11,0.3772,20.75,8672.0,0.002381,0.999969,B4GALT7 BTNL8 CANX CBY3 EIF4E1B NSG2 PRR7 RASGEF1C RUFY1 ZNF454 ZNF879,postsynapse to nucleus signaling pathway|positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway|interleukin-35-mediated signaling pathway|interleukin-27-mediated signaling pathway|protein folding in endoplasmic reticulum,0.005327|0.006389|0.006389|0.006389|0.006389,1|1|1|1|1,208|170.2|170.2|170.2|170.2
904,6,0.404,6.061,4787.0,0.001261,0.998474,CC2D1B CXCL9 GDF7 KIR3DL3 OMA1 ZNF526,roof plate formation|positive regulation of tendon cell differentiation|regulation of tendon cell differentiation|HRI-mediated signaling|regulation of cristae formation,0.0005824|0.0005824|0.0005824|0.001456|0.001456,1|1|1|1|1,3432|3432|3432|858.1|858.1
905,6,0.4066,6.099,4974.0,0.001222,0.998474,ANKS1A CC2D2A DEFA4 DEFA6 GALNT8 TOMM34,membrane disruption in other organism|innate immune response in mucosa|mucosal immune response|organ or tissue specific immune response|defense response to fungus,4.66e-06|2.114e-05|3.718e-05|4.687e-05|6.96e-05,0.0735|0.1668|0.1955|0.1848|0.2196,686.5|298.5|221.5|196.1|159.7
906,6,0.4233,6.35,4716.0,0.001341,0.998474,C2orf73 CC2D2B COLGALT1 DMBT1 HP TAS2R31,negative regulation of hydrogen peroxide catabolic process|regulation of hydrogen peroxide catabolic process|positive regulation of collagen fibril organization|induction of bacterial agglutination|detection of bacterial lipoprotein,0.0005824|0.001165|0.001165|0.001746|0.001746,1|1|1|1|1,3432|1144|1144|686.5|686.5
907,8,0.4072,11.4,6436.0,0.0017640000000000002,0.9996790000000001,CCBE1 CORO2B FZD1 NAGK SDHAF3 SLC4A10 SPPL2A TPM1,regulation of stress fiber assembly|regulation of systemic arterial blood pressure|regulation of actomyosin structure organization|regulation of actin filament bundle assembly|positive regulation of heart rate by epinephrine,0.000531|0.0006281|0.0006281|0.0006796|0.0007765,1|1|1|1|1,57.85|53.08|53.08|50.98|2574
908,6,0.4137,6.206,4967.0,0.001245,0.998474,CCDC102B CD86 CDHR2 KHDC3L LRGUK RFX8,negative regulation of cell growth involved in contact inhibition|intermicrovillar adhesion|positive regulation of lymphotoxin A production|regulation of lymphotoxin A production|activation of protein kinase C activity,0.0005824|0.0008735|0.0008735|0.0008735|0.001746,1|1|1|1|1,3432|1716|1716|1716|686.5
909,7,0.4154,8.722999999999999,5874.0,0.0014789999999999998,0.9992989999999999,CCDC117 CPT1C FGA IBTK NT5DC3 RRAS SMTNL2,"positive regulation of vasoconstriction|regulation of vasoconstriction|blood coagulation, common pathway|negative regulation of blood coagulation, common pathway|regulation of blood coagulation, common pathway",5.199e-05|0.0001914|0.0006794|0.0006794|0.0006794,0.8201|1|1|1|1,189.8|96.46|2942|2942|2942
910,13,0.4043,31.54,10560.0,0.00297,0.999993,A4GALT ARHGAP8 C22orf46 CSDC2 DESI1 FAM19A5 MEI1 MPPED2 PNPLA5 PRR5 SEPT3 SMDT1 SULT4A1,globoside biosynthetic process|globoside metabolic process|TORC2 signaling|protein desumoylation|calcium import into the mitochondrion,0.001746|0.001746|0.00465|0.00523|0.006967,1|1|1|1|1,858.1|858.1|245.2|214.5|156
911,7,0.4088,8.585,5854.0,0.0014609999999999998,0.9992989999999999,CCDC126 CLRN2 NWD2 POU5F2 TMSB10 ZNF175 ZNF610,cellular process|sequestering of actin monomers|negative regulation of actin filament polymerization|maintenance of protein location in cell|negative regulation of protein polymerization,0.001287|0.004071|0.02055|0.02255|0.02521,1|1|1|1|1,0.19|267.5|49.04|44.58|39.76
912,21,0.4029,84.6,16740.0,0.0050149999999999995,1.0,C1QTNF3 CCDC127 CDH10 CDH12 CDH18 CDH6 DNAH5 FAM173B HCN1 OTULIN OTULINL OXCT1 PLEKHG4B PRLR ROPN1L SLC1A3 SLC45A2 SLC6A18 SLC6A19 UGT3A1 UGT3A2,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|adherens junction organization|cell-cell junction assembly|homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell junction organization,1.024e-07|4.466e-07|6.973e-06|1.996e-05|3.018e-05,0.001615|0.003522|0.03666|0.07872|0.0952,98.07|66.44|32.43|24.66|22.15
913,4,0.4424,2.655,3020.0,0.0008759,0.9929309999999999,CCDC129 IFT122 REG3G TPRN,stereocilium maintenance|sensory organ morphogenesis|cell wall disruption in other organism|embryonic body morphogenesis|negative regulation of keratinocyte differentiation,0.0004369|0.0004722|0.0007281|0.001019|0.001165,1|1|1|1|1,3432|53.22|1716|1144|980.7
914,17,0.3973,54.03,11730.0,0.004573,1.0,AK6 C18orf21 C1D DDX21 DIS3 EXOSC1 EXOSC10 EXOSC7 EXOSC8 HEATR1 MPHOSPH6 NOP9 PDCD11 POP4 TENT4B WDR43 ZCCHC7,rRNA processing|rRNA metabolic process|ribosome biogenesis|ncRNA processing|ribonucleoprotein complex biogenesis,1.9e-25|3.285e-25|6.658e-24|3.127e-22|9.197e-22,2.996e-21|2.591e-21|3.501e-20|1.233e-18|2.902e-18,62.54|60.22|48.97|37.64|34.97
915,19,0.4018,68.71,12800.0,0.005323,1.0,ALG11 ARGLU1 BORA CDC16 CENPJ COG3 DIS3 EXOSC8 GTF3A MRPS31 MZT1 NUP58 POMP RFC3 SKA3 TPT1 TUBGCP3 USPL1 ZC3H13,microtubule nucleation|microtubule polymerization|microtubule nucleation by microtubule organizing center|microtubule polymerization or depolymerization|mitotic cell cycle,1.915e-06|5.487e-06|1.686e-05|1.69e-05|4.658e-05,0.0302|0.04328|0.08863|0.06663|0.147,135.5|92.91|433.6|62.54|8.546
916,6,0.4116,6.1739999999999995,4992.0,0.001232,0.998474,CCDC148 DLGAP4 GCHFR MYO1C TTLL2 ZBTB1,vesicle transport along actin filament|actin filament-based transport|vesicle cytoskeletal trafficking|positive regulation of pro-T cell differentiation|regulation of pro-T cell differentiation,2.072e-05|2.495e-05|0.0002364|0.0006794|0.0006794,0.3268|0.1968|1|1|1,309.7|280.2|86.53|2942|2942
917,7,0.4011,8.424,5980.0,0.001403,0.9992989999999999,CCDC149 CPLX3 GRM7 PPP4R4 SMOC1 TRIM60 ZNF106,regulation of protein serine/threonine phosphatase activity|negative regulation of glutamate secretion|adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway|regulation of synaptic vesicle fusion to presynaptic active zone membrane|negative regulation of amino acid transport,0.0006794|0.002037|0.002715|0.003054|0.004748,1|1|1|1|1,2942|588.4|420.3|367.8|226.3
918,7,0.4061,8.527000000000001,5648.0,0.001504,0.9992989999999999,CCDC151 FAM183A FAM221A GCC2 NUDT19 ONECUT1 SLC35F6,recycling endosome to Golgi transport|late endosome to Golgi transport|organelle organization|negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway|Golgi ribbon formation,0.001019|0.002037|0.002428|0.003393|0.004748,1|1|1|1|1,1471|588.4|4.116|326.9|226.3
919,25,0.4072,122.2,19430.0,0.006232,1.0,ANXA2R C1QTNF3 C7 CCDC152 CCL28 CDH10 CDH12 CDH6 EXOC3 FAM173B FBXO4 FGF10 HCN1 ICE1 NIM1K NNT OXCT1 PLCXD3 PRLR RANBP3L SLC1A3 SLC45A2 TMEM267 UGT3A1 UGT3A2,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|adherens junction organization|cell-cell junction assembly|cytolysis|homophilic cell adhesion via plasma membrane adhesion molecules,1.904e-05|5.772e-05|0.0004499|0.0007547|0.0009812,0.3003|0.4552|1|1|1,61.29|41.52|20.27|52.01|15.42
920,5,0.4495,4.495,3831.0,0.001169,0.996692,CCDC155 EIF1AD PHETA1 SPIC TAOK3,microtubule cytoskeleton organization involved in homologous chromosome segregation|receptor recycling|chromosome localization to nuclear envelope involved in homologous chromosome segregation|telomere localization|mitotic G2 DNA damage checkpoint,0.0004854|0.002667|0.002667|0.002667|0.005571,1|1|1|1|1,4119|411.9|411.9|411.9|187.2
921,5,0.4152,4.152,3796.0,0.00109,0.996692,CCDC158 GC ME2 MTRNR2L4 WDR31,protein carboxylation|peptidyl-glutamic acid carboxylation|regulation of NADP metabolic process|malate metabolic process|vitamin D metabolic process,0.001165|0.001165|0.001746|0.002619|0.004942,1|1|1|1|1,1144|1144|686.5|429.1|214.5
922,7,0.4379,9.196,5802.0,0.0015789999999999999,0.9992989999999999,BCKDHA CALM3 CCDC166 CCER2 CLDN24 IFIH1 MYO9A,MDA-5 signaling pathway|regulation of type III interferon production|negative regulation of high voltage-gated calcium channel activity|positive regulation of cyclic-nucleotide phosphodiesterase activity|detection of virus,0.001358|0.001698|0.002037|0.002037|0.002376,1|1|1|1|1,980.7|735.5|588.4|588.4|490.4
923,6,0.4135,6.202000000000001,4628.0,0.001335,0.998474,CCDC170 FGF12 GRWD1 KCNJ15 PKIG PNKP,"DNA excision|nucleotide-excision repair, DNA damage removal|polynucleotide 3' dephosphorylation|negative regulation of protein ADP-ribosylation|regulation of neuronal action potential",0.0005824|0.0005824|0.0008735|0.001165|0.001746,1|1|1|1|1,3432|3432|1716|1144|686.5
924,5,0.4216,4.216,4002.0,0.00105,0.996692,CBFA2T3 CCDC173 FAM149A IL7 RAPGEF3,negative regulation of syncytium formation by plasma membrane fusion|regulation of aerobic respiration|regulation of phosphorylation|leukocyte differentiation|Rap protein signal transduction,0.0009706|0.002183|0.00284|0.002861|0.00291,1|1|1|1|1,1373|514.9|8.826|23.34|374.5
925,9,0.7105,25.58,6243.0,0.004069,0.9998530000000001,CCDC174 CHCHD4 LSM3 RPL32 SEC13 SGO1 TAMM41 TRNT1 TSEN2,gene expression|RNA processing|ncRNA processing|establishment of protein localization to organelle|tRNA 3'-terminal CCA addition,9.098e-05|0.0004277|0.0007141|0.0007983|0.0008734,1|1|1|1|1,6.281|9.917|15.89|15.29|2288
926,6,0.4296,6.443,4850.0,0.001324,0.998474,CCDC177 CDC25C CPA3 DKK1 LRRC25 THEGL,"negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment|negative regulation of Wnt-Frizzled-LRP5/6 complex assembly|regulation of Wnt-Frizzled-LRP5/6 complex assembly|negative regulation of canonical Wnt signaling pathway involved in heart development|regulation of Wnt signaling pathway, calcium modulating pathway",0.0006794|0.0006794|0.0006794|0.0006794|0.0006794,1|1|1|1|1,2942|2942|2942|2942|2942
927,31,0.4005,186.2,19970.0,0.00921,1.0,ARFRP1 ARL1 COG1 COG2 COG3 COG4 COG5 COG6 COG7 COG8 EIPR1 HTT PTAR1 RAB14 RAB1A RAB1B RAB2A RAB6A RGP1 RIC1 SYS1 TRAPPC13 UNC50 VIPAS39 VPS33B VPS50 VPS51 VPS52 VPS53 VPS54 YKT6,intracellular transport|Golgi vesicle transport|protein transport|peptide transport|amide transport,2.882e-27|3.542e-26|8.907e-26|1.493e-25|2.699e-25,4.546e-23|2.793e-22|4.683e-22|5.886e-22|8.516e-22,11.66|31.52|11.52|11.29|11.04
928,6,0.415,6.226,4538.0,0.001367,0.998474,CCDC181 FCAMR MSMB PTGES3 SRP9 ZFP36L2,negative regulation of translation|cellular response to steroid hormone stimulus|negative regulation of cellular amide metabolic process|telomerase holoenzyme complex assembly|negative regulation of translational elongation,0.0006661|0.0007146|0.0008919|0.001456|0.001746,1|1|1|1|1,50.11|48.35|43.18|858.1|686.5
929,6,0.4201,6.301,4690.0,0.001338,0.998474,CCDC183 MT1B PPP1R1C UBE2Q2 UBE3A ZER1,protein K48-linked ubiquitination|positive regulation of Golgi lumen acidification|sperm entry|regulation of Golgi lumen acidification|regulation of ubiquitin-dependent protein catabolic process,0.0001201|0.0005824|0.0005824|0.0008735|0.0009591,1|1|1|1|1,120.4|3432|3432|1716|41.61
930,7,0.4215,8.851,5588.0,0.001578,0.9992989999999999,ASIC1 CCDC184 KCNH3 LMBR1L LRRK2 PRPF40B TPH2,negative regulation of synaptic transmission|regulation of membrane potential|regulation of neurotransmitter secretion|regulation of neurotransmitter transport|negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation,0.0001914|0.0003156|0.0004172|0.0005517|0.0006794,1|1|1|1|1,96.46|20.24|64.66|56.04|2942
931,5,0.4193,4.1930000000000005,3989.0,0.001047,0.996692,CCDC185 CFHR4 PDLIM3 SH3RF1 TRABD2B,"positive regulation of protein oxidation|regulation of protein oxidation|regulation of CD8-positive, alpha-beta T cell proliferation|regulation of CD8-positive, alpha-beta T cell activation|regulation of alpha-beta T cell proliferation",0.000728|0.000728|0.002183|0.004845|0.008467,1|1|1|1|1,2060|2060|514.9|216.8|121.1
932,5,0.438,4.38,4137.0,0.0010550000000000002,0.996692,ARHGDIA CCDC191 IQUB TOMM20L TTC38,tRNA import into mitochondrion|cellular response to redox state|RNA import into mitochondrion|response to redox state|protein import into mitochondrial matrix,0.000728|0.001213|0.001456|0.003878|0.005087,1|1|1|1|1,2060|1030|823.8|274.6|205.9
933,6,0.4351,6.527,4939.0,0.0013160000000000001,0.998474,CCDC198 DAGLA NAB1 NID2 TMEM182 TMEM45B,endocannabinoid signaling pathway|retrograde trans-synaptic signaling by endocannabinoid|retrograde trans-synaptic signaling by lipid|diacylglycerol catabolic process|trans-synaptic signaling by endocannabinoid,0.001165|0.001165|0.001165|0.001165|0.001746,1|1|1|1|1,1144|1144|1144|1144|686.5
934,5,0.4347,4.3469999999999995,4041.0,0.001072,0.996692,ABCD2 ARHGAP10 CCDC24 HIBADH NUDCD2,maintenance of Golgi location|valine catabolic process|long-chain fatty acid import into peroxisome|carboxylic acid catabolic process|organic acid catabolic process,0.001165|0.001456|0.001456|0.001746|0.001998,1|1|1|1|1,1144|858.1|858.1|30.65|28.6
935,8,0.4293,12.02,6574.0,0.0018210000000000001,0.9996790000000001,CCDC3 HOXD10 HOXD11 HOXD12 HOXD8 HOXD9 SSFA2 TMEM237,pattern specification process|regionalization|embryonic limb morphogenesis|embryonic appendage morphogenesis|peripheral nervous system neuron development,7.672e-08|1.975e-06|6.799e-06|6.799e-06|8.988e-06,0.00121|0.01558|0.03575|0.02681|0.02835,34.78|37.01|74.8|74.8|490.4
936,7,0.4053,8.511000000000001,5541.0,0.0015300000000000001,0.9992989999999999,CCDC38 GLIPR1L1 MYF5 OAS2 OASL SDSL SLC17A8,regulation of ribonuclease activity|regulation of nuclease activity|negative regulation of viral genome replication|type I interferon signaling pathway|cellular response to type I interferon,5.435e-06|2.722e-05|0.0001511|0.0002364|0.0002432,0.08573|0.2146|0.7943|0.9321|0.7672,653.8|267.5|109|86.53|85.28
937,6,0.4032,6.047999999999999,4773.0,0.0012619999999999999,0.998474,ARMC1 CCDC39 CLN6 PCDH10 SH3BP4 STARD5,establishment of left/right asymmetry|locomotion involved in locomotory behavior|determination of pancreatic left/right asymmetry|determination of liver left/right asymmetry|cholesterol import,0.001165|0.001746|0.001746|0.002037|0.002037,1|1|1|1|1,1144|686.5|686.5|572.1|572.1
938,7,0.4062,8.53,5725.0,0.001484,0.9992989999999999,CCDC42 KRTAP17-1 KRTAP8-1 LTBP1 PAFAH2 TRIM59 TSPYL1,sequestering of TGFbeta in extracellular matrix|keratinization|maintenance of protein location in extracellular region|regulation of transforming growth factor beta activation|keratinocyte differentiation,0.001698|0.002469|0.002715|0.003393|0.003441,1|1|1|1|1,735.5|26.04|420.3|326.9|21.96
939,6,0.4387,6.581,4923.0,0.001332,0.998474,CCDC43 CEP68 DAPK2 MAN1A1 NDUFS6 SLC5A6,pantothenate transmembrane transport|positive regulation of eosinophil chemotaxis|regulation of eosinophil chemotaxis|biotin import across plasma membrane|biotin transport,0.0006794|0.001019|0.001019|0.001019|0.001358,1|1|1|1|1,2942|1471|1471|1471|980.7
940,10,0.4103,18.46,7207.0,0.002548,0.999933,CCDC51 CLPP CLPX DNM1L KLHL12 MFF MIEF1 MPV17L2 SLC25A46 STARD7,mitochondrial fission|positive regulation of mitochondrial fission|regulation of mitochondrial fission|mitochondrial membrane fission|regulation of peroxisome organization,3.521e-10|9.343e-08|3.319e-07|1.271e-06|3.177e-06,5.554e-06|0.0007369|0.001745|0.005013|0.01002,392.3|363.4|228.8|2060|1030
941,5,0.4139,4.138999999999999,3862.0,0.001068,0.996692,CCDC58 CD200R1L CLEC4F PNPLA8 WDR5B,phosphatidylethanolamine catabolic process|phosphatidylcholine catabolic process|prostaglandin biosynthetic process|prostanoid biosynthetic process|linoleic acid metabolic process,0.0009706|0.003152|0.005087|0.005087|0.005329,1|1|1|1|1,1373|343.3|205.9|205.9|196.1
942,15,0.4394,46.14,9012.0,0.005077,0.999999,CCDC6 CYB5R4 FBXO42 LCMT1 PPME1 PPP2CA PPP2R1A PPP2R2A PPP4C PPP4R3A PPP4R3B PPP6C PPP6R3 PTPA TIPRL,protein dephosphorylation|regulation of phosphoprotein phosphatase activity|regulation of protein dephosphorylation|dephosphorylation|regulation of phosphatase activity,1.663e-10|3.88e-10|1.055e-09|2.402e-09|3.822e-09,2.624e-06|3.06e-06|5.546e-06|9.47e-06|1.206e-05,41.71|63.3|53.26|28.16|42.67
943,5,0.4104,4.104,4029.0,0.001015,0.996692,CCDC60 MASP1 NMBR SYNE1 WDR35,response to paclitaxel|cellular response to paclitaxel|bombesin receptor signaling pathway|nuclear matrix anchoring at nuclear membrane|nuclear matrix organization,0.0004854|0.0004854|0.000728|0.0009706|0.0009706,1|1|1|1|1,4119|4119|2060|1373|1373
944,6,0.4261,6.392,5013.0,0.0012699999999999999,0.998474,CCDC63 DEPDC4 FFAR4 GLDN KCNN2 TMEM26,negative regulation of somatostatin secretion|ghrelin secretion|regulation of somatostatin secretion|positive regulation of glucagon secretion|atrial cardiac muscle cell membrane repolarization,0.0005824|0.0008735|0.001165|0.001165|0.001746,1|1|1|1|1,3432|1716|1144|1144|686.5
945,12,0.4006,26.44,8448.0,0.003111,0.999986,ABCE1 ANAPC10 HSPA13 LSM5 LSM6 NAF1 NOP10 PSMA2 SMU1 SPCS3 TMA16 TRAPPC11,snoRNA guided rRNA pseudouridine synthesis|rRNA pseudouridine synthesis|ribosome biogenesis|positive regulation of telomerase RNA localization to Cajal body|pseudouridine synthesis,3.106e-06|2.045e-05|3.099e-05|4.207e-05|5.872e-05,0.04899|0.1613|0.163|0.1659|0.1853,1144|343.2|20.68|228.8|190.7
946,7,0.4092,8.593,5648.0,0.001515,0.9992989999999999,CCDC74A CCDC74B CHFR CLSPN GKN1 SPOCK2 TMPRSS5,meiotic spindle checkpoint|mitotic cell cycle checkpoint|negative regulation of metaphase/anaphase transition of meiotic cell cycle|negative regulation of meiotic chromosome separation|negative regulation of meiotic cell cycle phase transition,0.001019|0.00108|0.001358|0.001358|0.001698,1|1|1|1|1,1471|39.76|980.7|980.7|735.5
947,5,0.4219,4.218999999999999,3818.0,0.001101,0.996692,ATP6V0D1 CCDC8 HDHD5 MEFV OR13D1,negative regulation of macrophage inflammatory protein 1 alpha production|regulation of macrophage inflammatory protein 1 alpha production|negative regulation of NLRP3 inflammasome complex assembly|regulation of autophagy|cellular response to increased oxygen levels,0.0009706|0.001456|0.001456|0.002523|0.003636,1|1|1|1|1,1373|823.8|823.8|24.89|294.2
948,27,0.387,135.8,18520.0,0.007259999999999999,1.0,ABCF1 CCDC137 CDK5RAP3 DDRGK1 DDX31 DNAJC21 EBNA1BP2 EFL1 GNL1 GPATCH4 NEMF NOLC1 NSUN5 ODR4 PINX1 PWP1 RBM34 RPF1 SBDS TRPM7 UBA5 UFC1 UFL1 UFM1 UFSP2 WDR89 ZNF622,protein ufmylation|protein K69-linked ufmylation|protein polyufmylation|reticulophagy|ribosome biogenesis,3.242e-15|7.934e-13|7.934e-13|1.936e-11|4.356e-10,5.115e-11|6.257e-09|4.172e-09|7.633e-08|1.374e-06,735.5|735.5|735.5|306.5|19.94
949,15,0.4158,43.66,9852.0,0.004399,0.999999,ALG1 ALG2 DAD1 DDOST DOLK DPAGT1 HYOU1 OST4 RFT1 RPN1 RPN2 SLC35B1 SLC39A7 STT3A TMEM258,protein N-linked glycosylation|protein glycosylation|macromolecule glycosylation|glycosylation|glycoprotein biosynthetic process,3.434e-29|6.342e-23|6.342e-23|1.227e-22|9.576e-22,5.417e-25|5.002e-19|3.334e-19|4.838e-19|3.021e-18,223.1|69.15|69.15|65.62|55.78
950,10,0.4172,18.78,7151.0,0.002611,0.999933,CCDC86 EEF1G INTS5 NXF1 OSBP POLA2 SART1 STX5 TMEM258 WDR74,maturation of 5S rRNA|ncRNA processing|positive regulation of cytotoxic T cell differentiation|ncRNA metabolic process|regulation of cytotoxic T cell differentiation,0.0009704|0.001004|0.001455|0.00168|0.00194,1|1|1|1|1,2060|14.3|1030|11.95|686.5
951,51,0.4008,511.0,40410.0,0.01245,1.0,C5AR1 C5AR2 CCDC61 CEACAM4 CEACAM6 CEACAM7 CLC CRX CYP2A13 CYP2B6 CYP2S1 EML2 FFAR2 FFAR3 FLT3LG FUT1 IFNL1 IGFL1 IGFL2 IGFL3 IGFL4 LGALS13 LGALS14 PSG1 PSG11 PSG2 PSG3 PSG4 PSG6 PSG8 PSG9 PVR SPACA4 SULT2A1 SULT2B1 TPRX1 ZNF155 ZNF222 ZNF225 ZNF226 ZNF230 ZNF233 ZNF284 ZNF285 ZNF45 ZNF546 ZNF569 ZNF571 ZNF599 ZNF780B ZNF790,female pregnancy|multi-multicellular organism process|epoxygenase P450 pathway|regulation of immune effector process|complement component C5a signaling pathway,5.323e-07|1.407e-06|2.885e-05|3.322e-05|4.014e-05,0.008397|0.0111|0.1517|0.131|0.1266,14.91|12.84|57.21|6.451|381.4
952,7,0.4243,8.91,5924.0,0.001498,0.9992989999999999,CCDC90B MALL MAP1B MFSD6 PROSER1 PRSS38 RIMS3,induction of synaptic plasticity by chemical substance|positive regulation of synaptic plasticity by chemical substance|regulation of synaptic plasticity by chemical substance|regulation of synaptic plasticity|peripheral nervous system axon regeneration,0.0006794|0.0006794|0.0006794|0.001635|0.002376,1|1|1|1|1,2942|2942|2942|32.15|490.4
953,5,0.4396,4.396,3957.0,0.0011070000000000001,0.996692,AZIN2 CCDC91 CHL1 LYVE1 PLA2G2D,nucleolar chromatin organization|trans-Golgi network membrane organization|positive regulation of polyamine transmembrane transport|cellular response to bleomycin|response to bleomycin,0.0005824|0.0005824|0.0008735|0.0008735|0.0008735,1|1|1|1|1,3432|3432|1716|1716|1716
954,7,0.401,8.421,5894.0,0.001423,0.9992989999999999,BRINP3 CACNG6 CCDC89 CCK CD83 GPR12 RIMS1,regulation of system process|positive regulation of nervous system process|cardiac conduction|negative regulation of behavioral fear response|negative regulation of fear response,4.168e-05|0.0001021|0.000603|0.0007765|0.0007765,0.6574|0.8057|1|1|1,17.66|135.5|54.2|2574|2574
955,6,0.4291,6.437,4911.0,0.001306,0.998474,ACTR1B CCKAR CDK5R1 CORIN RFX2 TTC36,plasma membrane bounded cell projection organization|cell projection organization|cellular component morphogenesis|neuron migration|cell development,0.0001416|0.0001646|0.0004763|0.0004807|0.000501,1|1|1|1|1,11.78|11.33|17.05|59.18|8.502
956,6,0.4192,6.287000000000001,4927.0,0.001271,0.998474,CCL18 CD300A LRRC47 LRRN2 PDCD4 PLK2,"long-term synaptic potentiation|negative regulation of endocytosis|negative regulation of MAP kinase activity|negative regulation of activation of Janus kinase activity|negative regulation of phagocytosis, engulfment",0.0001108|0.0001155|0.0002861|0.0006794|0.0006794,1|0.9109|1|1|1,127.9|125.2|78.46|2942|2942
957,6,0.4168,6.252000000000001,4806.0,0.001296,0.998474,CCL3 CCL4 CMTM2 PCSK1 RIPOR2 TSPOAP1,regulation of lymphocyte migration|cellular response to chemokine|response to chemokine|positive regulation of leukocyte chemotaxis|positive regulation of natural killer cell chemotaxis,5.955e-07|1.707e-06|1.707e-06|1.941e-06|1.978e-06,0.009394|0.01346|0.008976|0.007656|0.00624,166.1|115.7|115.7|110.7|1144
958,12,0.4138,27.31,7649.0,0.003547,0.999986,CCNA2 CCNB1 CDC25B CUL1 DBF4 FBXO5 FOXM1 LIN37 LIN54 PKMYT1 SKP2 UBE2Q1,mitotic cell cycle phase transition|cell cycle phase transition|regulation of cell cycle|G2/M transition of mitotic cell cycle|cell cycle G2/M phase transition,4.594e-15|5.862e-15|3.029e-13|6.257e-13|6.888e-13,7.246e-11|4.624e-11|1.593e-09|2.467e-09|2.173e-09,54.2|52.72|15.78|85.81|84.6
959,5,0.4264,4.263999999999999,3975.0,0.0010689999999999999,0.996692,CACNG3 CCNDBP1 FGFRL1 PIGW SERPINB13,"negative regulation of keratinocyte apoptotic process|protein localization to cell periphery|regulation of keratinocyte apoptotic process|neurotransmitter receptor transport, postsynaptic endosome to lysosome|positive regulation of AMPA receptor activity",0.0004854|0.001278|0.001698|0.00194|0.002183,1|1|1|1|1,4119|35.21|686.5|588.4|514.9
960,14,0.4086,37.18,9809.0,0.003766,0.9999969999999999,HEXIM1 LARP7 LSM2 LSM3 LSM4 LSM5 LSM6 LSM7 LSM8 MEPCE METTL16 TMCO6 USB1 ZNF511,"exonucleolytic catabolism of deadenylated mRNA|nuclear-transcribed mRNA catabolic process, exonucleolytic|RNA splicing|nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay|RNA processing",9.113e-14|1.255e-13|9.349e-13|2.762e-12|2.927e-11,1.437e-09|9.899e-10|4.916e-09|1.089e-08|9.234e-08,267.5|252.2|32.53|144.7|15.94
961,6,0.4266,6.399,5009.0,0.001273,0.998474,CCNJL ENO2 HLA-DOA NCKIPSD PDE1B SIPA1L2,"negative regulation of antigen processing and presentation of peptide antigen via MHC class II|negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|regulation of antigen processing and presentation of peptide antigen via MHC class II|negative regulation of antigen processing and presentation of peptide antigen|regulation of vacuole fusion, non-autophagic",0.0008735|0.001165|0.001456|0.001456|0.001456,1|1|1|1|1,1716|1144|858.1|858.1|858.1
962,5,0.4159,4.159,3984.0,0.0010400000000000001,0.996692,CCNO DMPK PRR23B SALL4 SLC12A2,positive regulation of cell volume|regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction|regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction|inorganic anion import across plasma membrane|positive regulation of aspartate secretion,0.0004854|0.0004854|0.0004854|0.000728|0.000728,1|1|1|1|1,4119|4119|4119|2060|2060
963,7,0.4414,9.27,5888.0,0.001568,0.9992989999999999,C11orf24 DOK1 FAM107A FIGLA LOXL3 NPEPL1 NUDT2,fibronectin fibril organization|negative regulation of T-helper 17 cell lineage commitment|macrophage colony-stimulating factor signaling pathway|peptidyl-arginine ADP-ribosylation|peptidyl-lysine oxidation,0.0007765|0.001552|0.00194|0.00194|0.002328,1|1|1|1|1,2574|858.1|643.6|643.6|514.9
964,4,0.8411,5.046,2919.0,0.001721,0.9929309999999999,HLA-DQA1 HLA-DQB1 HLA-DRB1 HLA-DRB5,interferon-gamma-mediated signaling pathway|antigen processing and presentation of exogenous peptide antigen via MHC class II|antigen processing and presentation of peptide antigen via MHC class II|antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|cellular response to interferon-gamma,6.394e-13|2.976e-12|3.28e-12|3.441e-12|2.917e-11,1.009e-08|2.347e-08|1.724e-08|1.357e-08|9.202e-08,286|208|203.9|201.9|130.3
965,5,0.4294,4.294,4017.0,0.001065,0.996692,CAB39L CCR10 KIF27 NFAT5 UQCC1,calcium-mediated signaling|second-messenger-mediated signaling|chemokine-mediated signaling pathway|cellular response to chemokine|response to chemokine,7.153e-06|2.379e-05|0.0002267|0.0002862|0.0002862,0.1128|0.1876|1|1|0.9028,71.02|47.24|86.9|77.13|77.13
966,7,0.4252,8.929,5329.0,0.0016690000000000001,0.9992989999999999,BMPR1A CCR6 GPR31 HNF4A LPA TBXT ZBTB43,signal transduction involved in regulation of gene expression|transmembrane receptor protein serine/threonine kinase signaling pathway|response to organic substance|SMAD protein signal transduction|somitogenesis,2.76e-05|4.868e-05|0.0002041|0.0002628|0.0002628,0.4354|0.384|1|1|0.829,271|39.2|5.157|83.04|83.04
967,10,0.6653,29.94,6236.0,0.004763,0.999933,CYB5R4 LCMT1 PPME1 PPP4C PPP4R3A PPP4R3B PPP6C PPP6R3 PTPA TIPRL,regulation of phosphoprotein phosphatase activity|regulation of protein dephosphorylation|regulation of phosphatase activity|protein dephosphorylation|regulation of dephosphorylation,4.254e-07|8.33e-07|1.976e-06|3.934e-06|3.934e-06,0.006711|0.00657|0.01039|0.01551|0.01241,61.39|51.65|41.38|34.67|34.67
968,6,0.4314,6.472,4897.0,0.0013160000000000001,0.998474,ART1 CCSER1 GCKR INPP4B SCUBE2 SGCZ,peptidyl-arginine ADP-ribosylation|negative regulation of glucokinase activity|negative regulation of hexokinase activity|positive regulation of chondrocyte proliferation|response to fructose,0.001456|0.001746|0.001746|0.002037|0.002909,1|1|1|1|1,858.1|686.5|686.5|572.1|381.4
969,6,0.4386,6.579,4795.0,0.001367,0.998474,C1QL1 CCSER2 KIF19 LXN PGM2L1 TTYH2,axonemal microtubule depolymerization|plus-end specific microtubule depolymerization|cytoplasmic microtubule depolymerization|cilium disassembly|motor learning,0.0005824|0.0005824|0.0005824|0.0005824|0.002037,1|1|1|1|1,3432|3432|3432|3432|572.1
970,18,0.3355,51.33,12120.0,0.0042049999999999995,1.0,CCT3 CCT4 CCT5 CCT6A CCT8 MSTO1 PDCD5 PDCL3 PFDN1 PFDN4 SSSCA1 TBCA TCP1 TUBA1B TUBA1C TUBB TXNDC9 UBE2C,protein folding|positive regulation of establishment of protein localization to telomere|regulation of establishment of protein localization to telomere|positive regulation of protein localization to Cajal body|regulation of protein localization to Cajal body,6.316e-16|9.269e-16|1.432e-15|1.432e-15|1.432e-15,9.962e-12|7.311e-12|7.529e-12|5.647e-12|4.517e-12,53.13|726.9|660.8|660.8|660.8
971,6,0.406,6.09,4187.0,0.001448,0.998474,CCT7 CD46 CR1L GLB1L2 SPPL3 SREBF2,regulation of Notch signaling pathway|regulation of complement activation|regulation of humoral immune response|single fertilization|fertilization,0.0004029|0.0004889|0.000695|0.0008061|0.001213,1|1|1|1|1,64.76|58.68|49.04|45.46|36.91
972,5,0.4006,4.006,3908.0,0.001021,0.996692,C5orf24 CCT8L2 FAM155A FBXO45 TSHZ1,synapse assembly involved in innervation|soft palate development|anterior commissure morphogenesis|corticospinal tract morphogenesis|cerebral cortex tangential migration,0.0004854|0.001456|0.001698|0.001698|0.001698,1|1|1|1|1,4119|823.8|686.5|686.5|686.5
973,18,0.4108,62.85,11910.0,0.005233,1.0,APH1A BAMBI CNEP1R1 CTDNEP1 FKBP1A IPO8 LEMD3 MIB1 NCSTN PSEN1 PSENEN RGMB RNF111 SMAD7 SMURF1 TGFBR1 TGFBR2 TGFBR3,enzyme linked receptor protein signaling pathway|transmembrane receptor protein serine/threonine kinase signaling pathway|regulation of transforming growth factor beta receptor signaling pathway|regulation of cellular response to transforming growth factor beta stimulus|regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,1.059e-15|3.753e-14|7.841e-14|9.46e-14|3.099e-13,1.67e-11|2.96e-10|4.123e-10|3.731e-10|9.776e-10,20.49|52.27|75.65|73.82|41.03
974,5,0.4085,4.085,3924.0,0.001037,0.996692,CD163 GPR35 HORMAD2 TIGD5 WDR47,negative regulation of neuronal action potential|regulation of neuronal action potential|negative regulation of action potential|negative regulation of transmission of nerve impulse|meiosis II,0.0004854|0.001456|0.001698|0.001698|0.002425,1|1|1|1|1,4119|823.8|686.5|686.5|457.7
975,4,0.4525,2.715,3042.0,0.0008894,0.9929309999999999,CD164 EREG HM13 TRIM15,"primary follicle stage|negative regulation of intracellular transport of viral material|luteinizing hormone signaling pathway|membrane protein proteolysis involved in retrograde protein transport, ER to cytosol|ovarian cumulus expansion",0.0003883|0.0005825|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|2574|2574|2574|1716
976,6,0.4134,6.2010000000000005,4917.0,0.001256,0.998474,ANKZF1 C1orf116 CD200 FKRP GMPR PYCR2,positive regulation of arginase activity|regulation of arginase activity|negative regulation of matrix metallopeptidase secretion|positive regulation of protein-glutamine gamma-glutamyltransferase activity|regulation of protein-glutamine gamma-glutamyltransferase activity,0.0005824|0.0005824|0.0008735|0.0008735|0.0008735,1|1|1|1|1,3432|3432|1716|1716|1716
977,5,0.4398,4.398,3969.0,0.001104,0.996692,CA11 CD226 ELSPBP1 JAM2 SLC39A8,leukocyte adhesion to vascular endothelial cell|leukocyte cell-cell adhesion|mitochondrial manganese ion transmembrane transport|leukocyte adhesion to arterial endothelial cell|plasma membrane selenite transport,1.784e-05|0.000112|0.0005824|0.0005824|0.0005824,0.2814|0.8835|1|1|1,326.9|124.8|3432|3432|3432
978,12,0.4007,26.45,9669.0,0.002721,0.999986,C1orf105 CD244 FYTTD1 LAMC2 MFGE8 OR10Z1 PEBP4 SLC36A1 SPINK6 SPRR4 STMND1 SWT1,epidermis development|positive regulation of granzyme B production|regulation of granzyme B production|alkanesulfonate transport|taurine transport,0.001613|0.002327|0.002327|0.00407|0.00407,1|1|1|1|1,12.35|572.1|572.1|286|286
979,13,0.4083,31.85,10520.0,0.003012,0.999993,BSND C1orf123 C8A CC2D1B CYP4X1 GBP5 GPX7 GUCA2B MROH7 PCSK9 PLA2G12A TMEM53 ZYG11B,interleukin-18 production|negative regulation of low-density lipoprotein particle receptor binding|negative regulation of intracellular cholesterol transport|negative regulation of intracellular sterol transport|negative regulation of intracellular lipid transport,0.001164|0.001164|0.001746|0.001746|0.001746,1|1|1|1|1,1716|1716|858.1|858.1|858.1
980,6,0.4135,6.202000000000001,4938.0,0.001251,0.998474,CD27 FHIT GPR155 ICOS KCTD2 TTC26,diadenosine triphosphate catabolic process|diadenosine triphosphate metabolic process|T cell tolerance induction|intraciliary anterograde transport|manchette assembly,0.0005824|0.0005824|0.0008735|0.001165|0.001456,1|1|1|1|1,3432|3432|1716|1144|858.1
981,15,0.4036,42.38,9673.0,0.0043479999999999994,0.999999,CIP2A FEN1 H2AFX HUS1 LIG1 LIG3 MAD2L2 RAD1 RAD17 RAD9A RFC5 RHNO1 TOPBP1 TRAIP XRCC1,DNA repair|DNA replication|DNA metabolic process|cellular response to DNA damage stimulus|cellular response to stress,4.268e-20|2.069e-19|8.81e-18|9.788e-18|5.951e-13,6.732e-16|1.632e-15|4.632e-14|3.86e-14|1.878e-09,32|53.64|21.72|21.55|9.664
982,6,0.4118,6.176,4669.0,0.001318,0.998474,CD320 GREB1L LIN28B PHOX2B TPRG1L TRIM71,miRNA metabolic process|production of miRNAs involved in gene silencing by miRNA|production of small RNA involved in gene silencing by RNA|dsRNA processing|RNA destabilization,1.784e-05|3.493e-05|4.434e-05|4.434e-05|5.213e-05,0.2814|0.2755|0.2331|0.1749|0.1645,326.9|228.8|201.9|201.9|185.5
983,6,0.4123,6.184,4679.0,0.001317,0.998474,BACE1 CD33 GLB1L3 SMIM2 THYN1 TMEFF1,negative regulation of monocyte activation|positive regulation of protein tyrosine phosphatase activity|regulation of protein tyrosine phosphatase activity|amyloid-beta formation|immune response-inhibiting signal transduction,0.0008735|0.001165|0.002037|0.0032|0.0032,1|1|1|1|1,1716|1144|572.1|343.2|343.2
984,5,0.4468,4.468,3805.0,0.00117,0.996692,CD34 DEGS2 IFFO2 JAGN1 ZNF619,extracellular exosome assembly|cellular response to tunicamycin|response to tunicamycin|negative regulation of cellular response to heat|metanephric glomerular mesangial cell differentiation,0.0004854|0.0004854|0.0004854|0.0004854|0.000728,1|1|1|1|1,4119|4119|4119|4119|2060
985,8,0.4026,11.27,5661.0,0.001982,0.9996790000000001,AMOTL1 CD47 DLG5 KLHL7 LATS2 NF2 PKN2 TSPAN13,regulation of localization|regulation of hippo signaling|cell-cell junction organization|hippo signaling|positive regulation of stress fiber assembly,5.181e-06|3.036e-05|4.113e-05|5.708e-05|0.0002011,0.08173|0.2394|0.2163|0.2251|0.6343,6.591|257.4|41.52|183.9|95.35
986,6,0.404,6.059,4742.0,0.001273,0.998474,CAMP CD6 EOGT FAM19A4 OIT3 TMF1,positive regulation of cytokine production|cellular response to lipid|urate homeostasis|protein O-GlcNAcylation via threonine|regulation of cytokine production,0.0001882|0.00024|0.0005824|0.0005824|0.0007541,1|1|1|1|1,23.4|21.54|3432|3432|14.57
987,6,0.4044,6.066,4701.0,0.001285,0.998474,C6orf48 CD63 GPX1 IFNG KLK6 LY6G6C,"tissue regeneration|regulation of carbohydrate phosphatase activity|positive regulation of fructose 1,6-bisphosphate metabolic process|regulation of fructose 1,6-bisphosphate metabolic process|positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity",0.0001005|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,128.7|4119|4119|4119|4119
988,6,0.4256,6.3839999999999995,5000.0,0.0012720000000000001,0.998474,CD69 CRELD1 LRRC7 MINPP1 RPS6KB2 SPINK1,negative regulation of nitric oxide mediated signal transduction|polyphosphate metabolic process|negative regulation of serine-type peptidase activity|negative regulation of serine-type endopeptidase activity|regulation of serine-type peptidase activity,0.001165|0.002037|0.002328|0.002328|0.002909,1|1|1|1|1,1144|572.1|490.4|490.4|381.4
989,6,0.4042,6.063,4852.0,0.001245,0.998474,CD70 DAW1 EEF1D NEIL1 PDSS1 SCG3,protein localization to secretory granule|negative regulation of nuclease activity|depyrimidination|cerebrospinal fluid circulation|ubiquinone biosynthetic process,0.001165|0.002328|0.002619|0.0032|0.004942,1|1|1|1|1,1144|490.4|429.1|343.2|214.5
990,6,0.4189,6.2829999999999995,4863.0,0.001287,0.998474,CD72 DISC1 NQO1 OR6C74 RPS15 SLC17A9,response to electrical stimulus|guanine nucleotide transport|guanine nucleotide transmembrane transport|response to flavonoid|response to hydrogen sulfide,7.597e-05|0.0008735|0.0008735|0.001165|0.001165,1|1|1|1|1,152.6|1716|1716|1144|1144
991,5,0.8969,8.969,3501.0,0.002548,0.996692,YWHAB YWHAE YWHAG YWHAQ YWHAZ,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway|regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway|positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway|regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway|positive regulation of establishment of protein localization to mitochondrion,5.499e-15|5.499e-15|2.425e-14|7.602e-14|2.275e-13,8.674e-11|4.337e-11|1.275e-10|2.998e-10|7.176e-10,792.1|792.1|572.1|447.7|355.1
992,7,0.4193,8.805,5806.0,0.001511,0.9992989999999999,C9orf47 CD80 CHST12 DST GEM LRRC39 PEAR1,negative regulation of high voltage-gated calcium channel activity|positive regulation of T-helper 1 cell differentiation|recognition of apoptotic cell|regulation of T-helper 1 cell differentiation|hemidesmosome assembly,0.002037|0.002376|0.002715|0.003732|0.004409,1|1|1|1|1,588.4|490.4|420.3|294.2|245.2
993,45,0.3887,384.8,35960.0,0.01056,1.0,C5AR1 C5AR2 CABP5 CALM3 CEACAM4 CEACAM6 CRX CYP2A13 CYP2B6 CYP2S1 EML2 FFAR3 FGF21 FLT3LG FUT1 FUT2 GPR32 IGFL1 KIR2DL1 KIR2DL3 KLK11 KLK3 KLK6 LAIR2 PSG11 PSG2 PSG3 PSG4 PSG6 PSG8 SIGLEC5 SULT2A1 SULT2B1 VN1R4 ZNF155 ZNF222 ZNF225 ZNF230 ZNF284 ZNF285 ZNF45 ZNF571 ZNF665 ZNF780B ZNF880,female pregnancy|complement receptor mediated signaling pathway|multi-multicellular organism process|epoxygenase P450 pathway|exogenous drug catabolic process,4.849e-06|6.886e-06|1.115e-05|2.152e-05|3.144e-05,0.07648|0.05431|0.05865|0.08488|0.09919,14.09|96.99|12.12|63.05|54.82
994,6,0.4185,6.277,4975.0,0.001257,0.998474,ARHGAP39 CD8A KIAA0556 OTOA SCGN ZNF572,cytotoxic T cell differentiation|cerebrospinal fluid circulation|regulation of presynaptic cytosolic calcium ion concentration|T cell mediated immunity|neuron cellular homeostasis,0.0005824|0.0032|0.004942|0.008996|0.009863,1|1|1|1|1,3432|343.2|214.5|114.4|104
995,28,0.4006,151.4,22080.0,0.006794,1.0,ARHGAP11B BNIP2 C15orf53 CHRFAM7A CHRNA7 DEXI DUOXA1 DUOXA2 EPB42 FBXL22 GABRA5 GOLGA8M MYO5A MYO5C NIPA2 PIGH PLA2G4D PLA2G4E PLCB2 PLEKHO2 PPIB RAB8B SCAMP2 SNURF SNX22 TGM5 TMCO5A TYRO3,"synaptic transmission, cholinergic|regulation of postsynaptic membrane potential|positive regulation of hydrogen peroxide biosynthetic process|regulation of thyroid hormone generation|positive regulation of hydrogen peroxide metabolic process",8.912e-06|1.315e-05|3.992e-05|5.318e-05|6.831e-05,0.1406|0.1037|0.2099|0.2097|0.2155,81.94|28.41|284.1|236.7|202.9
996,6,0.4075,6.112,4170.0,0.001459,0.998474,ASCC2 CDC37 CHORDC1 ERBB2 ERBB3 LSM4,ERBB2 signaling pathway|ERBB signaling pathway|regulation of protein kinase activity|regulation of kinase activity|phosphatidylinositol 3-kinase signaling,8.953e-08|8.473e-07|3.196e-05|5.329e-05|5.487e-05,0.001412|0.006682|0.1681|0.2101|0.1731,321.8|147.1|17.23|15.12|180.7
997,15,0.4082,42.86,9771.0,0.004354,0.999999,ALG1 ALG2 BUB3 C1orf109 DAD1 DOLK DPAGT1 HYOU1 OST4 RFT1 RPN1 RPN2 SLC35B1 SLC39A7 TMEM258,protein N-linked glycosylation|protein glycosylation|macromolecule glycosylation|glycosylation|glycoprotein biosynthetic process,1.475e-23|3.173e-18|3.173e-18|5.55e-18|3.161e-17,2.327e-19|2.502e-14|1.668e-14|2.189e-14|9.973e-14,188.8|58.51|58.51|55.53|47.2
998,4,0.427,2.562,2987.0,0.0008545,0.9929309999999999,CDC42EP2 FCRL6 TTLL11 WDR54,microtubule severing|negative regulation of receptor internalization|protein polyglutamylation|positive regulation of pseudopodium assembly|regulation of pseudopodium assembly,0.002522|0.002716|0.002716|0.002716|0.00291,1|1|1|1|1,429.1|396.1|396.1|396.1|367.8
999,6,0.4107,6.1610000000000005,4813.0,0.001275,0.998474,C6orf10 CDC42EP3 DCDC2 PDE5A PTK6 TMEM144,regulation of plasma membrane bounded cell projection organization|regulation of cell projection organization|regulation of plasma membrane bounded cell projection assembly|regulation of cell projection assembly|cGMP catabolic process,0.0002643|0.0002862|0.000805|0.0008222|0.001456,1|1|1|1|1,19.9|19.37|44.53|44.05|823.8
1000,6,0.4344,6.515,4748.0,0.001367,0.998474,ARPIN CDC42EP4 HCAR2 MFSD4B RNF19A ZP4,neutrophil apoptotic process|negative regulation of lamellipodium morphogenesis|positive regulation of adiponectin secretion|regulation of actin filament polymerization|directional locomotion,0.0008735|0.0008735|0.0008735|0.001052|0.001165,1|1|1|1|1,1716|1716|1716|39.68|1144
1001,6,0.4252,6.377999999999999,4873.0,0.0013039999999999998,0.998474,CDC42EP5 CDH19 HIVEP2 RD3L SOAT2 TAAR6,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|adherens junction organization|cell-cell junction assembly|mitral valve formation|homophilic cell adhesion via plasma membrane adhesion molecules,9.298e-05|0.0001975|0.0008004|0.001358|0.001367,1|1|1|1|1,140.1|94.91|46.33|980.7|35.24
1002,6,0.406,6.09,4789.0,0.001267,0.998474,CDH11 KRT4 MMP19 PROX1 SEZ6L ZIC4,positive regulation of forebrain neuron differentiation|hepatocyte cell migration|acinar cell differentiation|otic placode formation|branching involved in pancreas morphogenesis,0.0005824|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,3432|3432|3432|3432|3432
1003,6,0.4146,6.22,4228.0,0.001465,0.998474,CDH15 DYNLRB1 NDE1 PAFAH1B1 ZNF154 ZNF256,regulation of microtubule motor activity|transport along microtubule|microtubule-based transport|cytoskeleton-dependent intracellular transport|neuroblast proliferation,5.506e-06|8.871e-06|1.611e-05|1.661e-05|2.86e-05,0.08685|0.06996|0.08469|0.0655|0.09023,624.1|66.01|53.91|53.35|254.3
1004,22,0.4005,92.52,14890.0,0.006156,1.0,ACTR10 ATP6V1D CCNK CINP DDX24 DICER1 DYNC1H1 EIF2B2 EIF2S1 EIF5 EXOC5 LRR1 NRDE2 POLE2 PSMA3 PSMC1 PSMC6 RBM25 SNAPC1 TRMT5 WARS WDR25,posttranscriptional regulation of gene expression|cellular macromolecule biosynthetic process|macromolecule biosynthetic process|antigen processing and presentation of exogenous peptide antigen|antigen processing and presentation of exogenous antigen,6.012e-08|2.837e-07|3.631e-07|1.215e-06|1.5e-06,0.0009484|0.002238|0.001909|0.004792|0.004733,13.69|6.222|6.072|26.3|25.16
1005,6,0.4244,6.3660000000000005,4832.0,0.001312,0.998474,CDH26 CPNE1 CRACR2B CTSB LRRCC1 UGGT2,UDP-glucosylation|UDP-glucose metabolic process|leukocyte activation|cell activation|store-operated calcium entry,0.0008735|0.001456|0.001697|0.002598|0.002619,1|1|1|1|1,1716|858.1|11.01|9.5|429.1
1006,4,0.4665,2.799,3121.0,0.0008937999999999999,0.9929309999999999,CDHR1 CLU DIRC2 GNG7,negative regulation of cellular response to tunicamycin|negative regulation of cellular response to thapsigargin|regulation of neuronal signal transduction|regulation of cellular response to tunicamycin|regulation of cellular response to thapsigargin,0.0004854|0.0004854|0.0004854|0.000728|0.000728,1|1|1|1|1,4119|4119|4119|2060|2060
1007,6,0.4052,6.077999999999999,4805.0,0.00126,0.998474,ATP5MD CDHR4 CUEDC2 HLA-DOA HLA-DOB IQCF6,negative regulation of antigen processing and presentation of peptide antigen via MHC class II|negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|regulation of antigen processing and presentation of peptide antigen via MHC class II|negative regulation of antigen processing and presentation of peptide antigen|regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,4.24e-07|7.066e-07|1.06e-06|1.06e-06|1.484e-06,0.006689|0.005573|0.005573|0.004179|0.00468,3432|2288|1716|1716|1373
1008,37,0.4036,268.8,21300.0,0.01242,1.0,ADSL ADSS AHCY ATIC CAD COASY CTPS1 DHFR DHODH DTYMK FPGS GART GMPS HMGCR HMGCS1 IMPDH2 MAT2A MTHFD1 MVD MVK NAMPT PAICS PFAS PGD PGM3 PMVK PPAT PPCDC RFK RPE RPIA SDHA SDHB TFRC TKT UMPS YRDC,small molecule metabolic process|nucleobase-containing small molecule metabolic process|organophosphate metabolic process|ribose phosphate metabolic process|nucleotide metabolic process,9.427e-33|1.947e-31|2.575e-30|3.754e-30|1.023e-29,1.487e-28|1.535e-27|1.354e-26|1.481e-26|3.228e-26,10.83|25.31|16.22|33.78|27.97
1009,5,0.422,4.22,3959.0,0.001062,0.996692,CDK14 FAM227B MYOT SIGLEC6 STRC,cell adhesion|biological adhesion|auditory receptor cell stereocilium organization|detection of mechanical stimulus involved in sensory perception of sound|cell morphogenesis involved in neuron differentiation,0.0009229|0.00094|0.00412|0.00412|0.004578,1|1|1|1|1,12.99|12.91|257.4|257.4|18.35
1010,15,0.4007,42.07,11560.0,0.003618,0.999999,AKR1C1 AKR1C3 ANKRD30A ARHGAP12 CCNY CREM FZD8 MTRNR2L7 NRP1 PRPF18 ZNF248 ZNF25 ZNF33A ZNF33B ZNF37A,cellular response to jasmonic acid stimulus|response to jasmonic acid|doxorubicin metabolic process|daunorubicin metabolic process|polyketide metabolic process,8.459e-06|8.459e-06|3.095e-05|3.095e-05|3.095e-05,0.1334|0.06672|0.1627|0.122|0.09763,643.6|643.6|286|286|286
1011,5,0.4543,4.543,4063.0,0.001114,0.996692,CDK5R2 HOXD11 NECTIN4 SLCO6A1 TTC32,superior olivary nucleus maturation|superior olivary nucleus development|pons maturation|hindbrain maturation|central nervous system maturation,0.000728|0.000728|0.000728|0.001456|0.00194,1|1|1|1|1,2060|2060|2060|823.8|588.4
1012,7,0.4037,8.478,6040.0,0.001398,0.9992989999999999,ASPSCR1 CAMKK2 CDH3 CDK5RAP1 EPHB4 NGFR SLPI,negative regulation of hair follicle development|regulation of hair follicle development|regulation of hair cycle|regulation of catalytic activity|adherens junction organization,2.768e-06|2.249e-05|4.962e-05|7.513e-05|0.0002628,0.04366|0.1773|0.2609|0.2963|0.829,1030|302.9|198|6.139|83.04
1013,59,0.3403,582.2,42000.0,0.013630000000000001,1.0,BTN2A1 BTN2A2 CDKAL1 GPX6 H2AFX HIST1H1A HIST1H1B HIST1H1C HIST1H1D HIST1H1E HIST1H1T HIST1H2AA HIST1H2AC HIST1H2AD HIST1H2AE HIST1H2AG HIST1H2AI HIST1H2AJ HIST1H2BA HIST1H2BB HIST1H2BC HIST1H2BD HIST1H2BE HIST1H2BF HIST1H2BG HIST1H2BH HIST1H2BI HIST1H2BJ HIST1H2BK HIST1H2BL HIST1H2BM HIST1H2BN HIST1H2BO HIST1H3A HIST1H3D HIST1H3I HIST1H3J HIST1H4A HIST1H4C HIST1H4I HIST1H4L HIST2H2AC HIST2H2BE HIST2H2BF OR14J1 OR2B6 OR2J2 OR2J3 OR2W1 SLC17A2 SLC17A4 TRIM10 TRIM26 ZKSCAN4 ZKSCAN8 ZNF165 ZNF184 ZSCAN16 ZSCAN31,"sialic acid transport|regulation of gene expression, epigenetic|chromatin organization involved in negative regulation of transcription|negative regulation of gene expression, epigenetic|chromatin organization involved in regulation of transcription",3.198e-05|6.475e-05|0.0001371|0.0001422|0.0002074,0.5044|0.5107|0.7207|0.5609|0.6544,316.8|18.53|30.86|30.47|26.7
1014,5,0.4185,4.185,4053.0,0.001029,0.996692,CDKL1 DUSP8 PRKAR2A RNF144A ZNF451,negative regulation of protein modification process|negative regulation of protein serine/threonine kinase activity|negative regulation of histone H3-K9 acetylation|regulation of cellular protein metabolic process|negative regulation of cellular protein metabolic process,0.0001838|0.0004397|0.0004854|0.0008905|0.00102,1|1|1|1|1,22.51|60.57|4119|6.761|12.56
1015,6,0.4256,6.385,4881.0,0.001303,0.998474,C20orf96 CBR4 CDKL2 CLDN24 KLHL2 KLRG1,doxorubicin metabolic process|daunorubicin metabolic process|polyketide metabolic process|aminoglycoside antibiotic metabolic process|tertiary alcohol metabolic process,0.002909|0.002909|0.002909|0.0032|0.004071,1|1|1|1|1,381.4|381.4|381.4|343.2|264
1016,6,0.4273,6.409,4876.0,0.001309,0.998474,CDON LRRC8E ORMDL1 RTN4RL1 USP2 WNT7A,forebrain development|lens development in camera-type eye|asymmetric protein localization involved in cell fate determination|positive regulation of protein localization to presynapse|regulation of protein localization to presynapse,0.0001223|0.0002102|0.0005824|0.0008735|0.0008735,1|1|1|1|1,27.1|90.33|3432|1716|1716
1017,20,0.4099,77.87,12790.0,0.006032,1.0,CKAP5 CLTC DHX9 DLGAP5 GAK GTSE1 HAUS1 HAUS2 HAUS3 HAUS4 HAUS5 HAUS6 HAUS8 KIF15 KIF18A KNTC1 MAD2L1BP TACC3 TUBGCP4 TUBGCP5,spindle organization|mitotic cell cycle|mitotic prometaphase|microtubule-based process|cell cycle,1.968e-23|5.528e-22|1.499e-20|1.395e-19|1.573e-19,3.104e-19|4.36e-18|7.884e-17|5.5e-16|4.963e-16,64.07|23|73.99|20.52|13.33
1018,6,0.4454,6.681,4979.0,0.0013369999999999999,0.998474,CDR2 FKBP5 NANOS1 POPDC3 RASGRF1 SLC35D1,UDP-glucuronate biosynthetic process|cerebellar neuron development|UDP-N-acetylgalactosamine transmembrane transport|UDP-glucuronic acid transmembrane transport|UDP-glucuronate metabolic process,0.001165|0.001165|0.001165|0.001165|0.001456,1|1|1|1|1,1144|1144|1144|1144|858.1
1019,5,0.4452,4.452,4042.0,0.001097,0.996692,ANGPT4 CDX1 GJA5 LRRC3B PDE1A,regulation of Purkinje myocyte action potential|vasomotion|Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling|bundle of His cell to Purkinje myocyte communication by electrical coupling|atrial cardiac muscle cell to AV node cell communication by electrical coupling,0.0004854|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,4119|4119|4119|4119|4119
1020,7,0.4094,8.597000000000001,5728.0,0.001495,0.9992989999999999,CDX2 DEPP1 MFRP RAB22A SRRM4 TPRA1 UNC119B,embryonic cleavage|regulation of somitogenesis|embryo development|regulation of vesicle size|lipoprotein transport,0.002376|0.002376|0.003195|0.004071|0.004748,1|1|1|1|1,490.4|490.4|9.09|267.5|226.3
1021,5,0.4383,4.383,3909.0,0.001117,0.996692,CEACAM16 FHL3 KNCN SLC31A2 WDR24,regulation of copper ion transmembrane transport|copper ion transmembrane transport|cellular copper ion homeostasis|copper ion transport|copper ion homeostasis,0.0004854|0.001698|0.003636|0.00412|0.004362,1|1|1|1|1,4119|686.5|294.2|257.4|242.3
1022,9,0.4175,15.03,6398.0,0.002337,0.9998530000000001,ADIPOR2 BCL2 CEBPA IRF8 MEF2D MYB SIK3 SLC5A3 ZFP64,positive regulation of cellular metabolic process|positive regulation of metabolic process|positive regulation of cellular process|regulation of biosynthetic process|positive regulation of biological process,2.917e-06|8.607e-06|8.938e-06|2.174e-05|2.175e-05,0.04601|0.06788|0.047|0.08573|0.06862,5.654|4.922|3.641|4.37|3.298
1023,5,0.4242,4.242,3794.0,0.001114,0.996692,ACTL7A CEL LCN1 PPDPF WFIKKN1,protein esterification|intestinal lipid catabolic process|negative regulation of endopeptidase activity|negative regulation of peptidase activity|pancreatic juice secretion,0.0004854|0.000728|0.001398|0.001512|0.00194,1|1|1|1|1,4119|2060|33.62|32.31|588.4
1024,12,0.4068,26.85,8412.0,0.003172,0.999986,CCDC86 CLNS1A INTS4 NUMA1 POLA2 POLD3 RPS3 SPCS2 THAP12 TMEM258 UVRAG ZNHIT2,"positive regulation of microtubule polymerization|positive regulation of microtubule polymerization or depolymerization|cell cycle process|telomere maintenance via semi-conservative replication|DNA damage response, detection of DNA damage",0.0001625|0.0002047|0.0002228|0.0002517|0.0002517,1|1|1|0.9926|0.7941,110.7|98.07|8.02|88.01|88.01
1025,7,0.4271,8.97,5680.0,0.001573,0.9992989999999999,APC2 C12orf40 CELSR2 PLPPR3 SNCB TMEM222 UBL4B,cell-cell signaling by wnt|Wnt signaling pathway|cell surface receptor signaling pathway involved in cell-cell signaling|cell-cell signaling|positive regulation of very-low-density lipoprotein particle remodeling,0.0005426|0.0005426|0.0009196|0.001442|0.001455,1|1|1|1|1,17.7|17.7|14.75|7.323|1030
1026,6,0.4148,6.221,4908.0,0.001263,0.998474,CEMP1 MUC7 PJVK SIGLEC5 ZAP70 ZNF35,T cell aggregation|stereocilium maintenance|beta selection|programmed cell death in response to reactive oxygen species|regulation of peroxisome organization,0.0008735|0.0008735|0.0008735|0.001165|0.001456,1|1|1|1|1,1716|1716|1716|1144|858.1
1027,5,0.405,4.05,3764.0,0.001072,0.996692,CEND1 DLX4 DNAJB1 DTX4 LCE3C,cerebellar granular layer maturation|radial glia guided migration of cerebellar granule cell|negative regulation of cerebellar granule cell precursor proliferation|cerebellar cortex maturation|cerebellum maturation,0.0004854|0.0004854|0.000728|0.0009706|0.0009706,1|1|1|1|1,4119|4119|2060|1373|1373
1028,10,0.4233,19.05,7195.0,0.002633,0.999933,ANAPC10 CENPE GAR1 HSPA13 NAF1 RPL34 SPATA5 SPCS3 TMA16 TRAPPC11,snoRNA guided rRNA pseudouridine synthesis|rRNA pseudouridine synthesis|pseudouridine synthesis|rRNA modification|rRNA processing,2.118e-06|1.396e-05|4.009e-05|0.0001806|0.0002309,0.03341|0.1101|0.2108|0.7124|0.7283,1373|411.9|228.8|103|23.76
1029,13,0.4163,32.47,8857.0,0.0036420000000000003,0.999993,ACTR10 ACTR1A CENPF DCTN4 DCTN5 DCTN6 DYNC1LI1 DYNC1LI2 DYNLRB1 NDE1 PAFAH1B1 SPDL1 VEZT,antigen processing and presentation of exogenous peptide antigen via MHC class II|antigen processing and presentation of peptide antigen via MHC class II|antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|mitotic spindle organization|mitotic prometaphase,1.303e-13|1.49e-13|1.592e-13|3.94e-12|4.456e-12,2.056e-09|1.175e-09|8.372e-10|1.554e-08|1.406e-08,112|109.8|108.7|67.62|66.4
1030,21,0.407,85.47,16540.0,0.005129,1.0,AKAP2 C9orf3 C9orf84 FAM206A FBP1 FBP2 GNA14 KIF12 NUTM2G OR1J4 OR1L1 OR1L8 OR1N2 PALM2 TRPM3 TRPM6 TXNDC8 ZBTB6 ZNF484 ZNF510 ZNF782,"sucrose biosynthetic process|sucrose metabolic process|disaccharide biosynthetic process|fructose 1,6-bisphosphate metabolic process|disaccharide metabolic process",5.359e-06|8.926e-06|1.872e-05|4.892e-05|6.93e-05,0.08453|0.0704|0.09845|0.1929|0.2186,1030|686.5|411.9|228.8|187.2
1031,6,0.4232,6.347,4795.0,0.0013189999999999999,0.998474,CEP128 FAM135B MYO1F TMEM132D ZGLP1 ZNF804A,positive regulation of dendritic spine maintenance|regulation of dendritic spine maintenance|vesicle transport along actin filament|actin filament-based transport|oocyte development,0.001456|0.003781|0.005812|0.006391|0.01102,1|1|1|1|1,858.1|286|180.7|163.5|92.77
1032,22,0.4076,94.16,15150.0,0.006157,1.0,CNIH4 DUX4 EIF2S1 FOXD4 HSPE1 NBEAL1 NUTF2 OR2A25 RPL11 RPL12 RPL13 RPL17 RPL18A RPL23 RPL23A RPL37 RPL4 RPLP2 RPS13 SNU13 ST20 TSPYL5,translational initiation|SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum,2.661e-20|5.565e-20|9.4e-20|2.5e-19|3.612e-19,4.197e-16|4.389e-16|4.942e-16|9.859e-16|1.139e-15,75.14|102.6|97.52|88.74|85.65
1033,5,0.4201,4.2010000000000005,3884.0,0.001078,0.996692,CEP170 EPHB4 GRID1 MIB2 TPH1,serotonin biosynthetic process|primary amino compound biosynthetic process|indole-containing compound biosynthetic process|indolalkylamine biosynthetic process|serotonin metabolic process,0.0009706|0.001456|0.001456|0.001456|0.002667,1|1|1|1|1,1373|823.8|823.8|823.8|411.9
1034,6,0.4251,6.376,4794.0,0.001325,0.998474,CEP290 FAM171B SLF1 SPR TAS2R42 USP40,positive regulation of maintenance of mitotic sister chromatid cohesion|positive regulation of maintenance of sister chromatid cohesion|protein localization to site of double-strand break|tetrahydrobiopterin biosynthetic process|regulation of maintenance of mitotic sister chromatid cohesion,0.002037|0.002037|0.002037|0.002715|0.003054,1|1|1|1|1,588.4|588.4|588.4|420.3|367.8
1035,19,0.706,120.7,12770.0,0.009335,1.0,CCP110 CENPJ CEP120 CEP135 CEP152 CEP295 CEP44 PCNT PLK4 PPP1R35 RTTN SASS6 SPICE1 STIL TEDC1 TEDC2 TUBD1 TUBE1 WRAP73,centrosome cycle|microtubule organizing center organization|centrosome duplication|microtubule cytoskeleton organization|centriole replication,4.202e-24|1.76e-23|7.628e-23|1.193e-22|1.387e-21,6.628e-20|1.388e-19|4.011e-19|4.703e-19|4.377e-18,147.8|130.1|309.7|30.64|424.2
1036,6,0.4133,6.2,4749.0,0.001301,0.998474,ANTXR1 CEP70 GKN1 KIF22 PURG TMEM135,negative regulation of extracellular matrix assembly|positive regulation of metallopeptidase activity|negative regulation of extracellular matrix organization|regulation of metallopeptidase activity|regulation of extracellular matrix assembly,0.0005824|0.002037|0.00349|0.004361|0.004651,1|1|1|1|1,3432|572.1|312|245.2|228.8
1037,14,0.4169,37.94,11100.0,0.003397,0.9999969999999999,C6orf203 ENPP1 ENPP3 FABP7 GABRR1 NKAIN2 RAET1G TAAR2 TAAR6 TAAR8 TCF21 ULBP3 VNN2 WISP3,nucleoside triphosphate catabolic process|natural killer cell mediated cytotoxicity|natural killer cell mediated immunity|leukocyte mediated cytotoxicity|negative regulation of hh target transcription factor activity,4.386e-05|0.0001184|0.0001376|0.0002971|0.001261,0.6919|0.9336|0.7234|1|1,226.3|132|121.9|81.24|1584
1038,5,0.4451,4.4510000000000005,3957.0,0.001121,0.996692,ANKRD10 AUNIP CEP89 NUPR1 TVP23A,negative regulation of type B pancreatic cell proliferation|positive regulation of oxidative phosphorylation|regulation of female gonad development|negative regulation of double-strand break repair via nonhomologous end joining|regulation of type B pancreatic cell proliferation,0.000728|0.0009706|0.001698|0.00194|0.003152,1|1|1|1|1,2060|1373|686.5|588.4|343.3
1039,5,0.4349,4.349,3930.0,0.001103,0.996692,CERK GJA8 RHO SCGB1A1 ZNF763,absorption of visible light|light absorption|thermotaxis|response to silicon dioxide|response to ozone,0.0004854|0.0004854|0.000728|0.0009706|0.001213,1|1|1|1|1,4119|4119|2060|1373|1030
1040,17,0.4043,54.99,11210.0,0.004866,1.0,ARMH3 CERS2 COG4 COG5 COG6 COG7 COL4A3BP ELOVL1 KDSR PI4KB PTAR1 SGMS1 SPTLC1 SPTLC2 SPTSSA TM9SF2 TMEM189,sphingolipid biosynthetic process|ceramide biosynthetic process|membrane lipid biosynthetic process|sphingolipid metabolic process|ceramide metabolic process,8.57e-13|3.684e-12|7.997e-12|2.364e-11|8.113e-11,1.352e-08|2.906e-08|4.205e-08|9.324e-08|2.559e-07,91.01|143|65.29|55.62|83.04
1041,6,0.4185,6.277,4722.0,0.001324,0.998474,CERS3 DTNA EDN3 LEP MTNR1B PMAIP1,regulation of hormone secretion|muscle system process|negative regulation of peptide hormone secretion|peptide hormone secretion|cell-cell signaling,4.769e-05|5.462e-05|7.275e-05|0.0001201|0.0001231,0.7522|0.4308|0.3825|0.4735|0.3884,37.31|35.63|156|120.4|12.2
1042,5,0.4555,4.555,4002.0,0.001134,0.996692,ARL6 CERS4 COTL1 SELENOK SPIRE1,protein polymerization|regulation of actin filament polymerization|regulation of actin polymerization or depolymerization|regulation of actin filament length|respiratory burst after phagocytosis,0.0002219|0.0007056|0.0008396|0.0008484|0.0009706,1|1|1|1|1,85.81|47.62|43.59|43.36|1373
1043,6,0.4006,6.007999999999999,4796.0,0.001248,0.998474,CERS5 MOB3C ORMDL2 PFN4 THTPA TMEM116,ceramide metabolic process|thiamine diphosphate metabolic process|sphingolipid metabolic process|thiamine metabolic process|membrane lipid metabolic process,0.0003119|0.0008735|0.0009252|0.001456|0.001539,1|1|1|1|1,73.82|1716|42.38|858.1|32.69
1044,15,0.4089,42.94,10100.0,0.004221,0.999999,ARMH3 CERS2 CERS6 COL4A3BP ELOVL1 FASN KDSR PI4KB SGMS1 SPTLC1 SPTLC2 SPTSSA TECR TM9SF2 TMEM189,lipid biosynthetic process|sphingolipid metabolic process|sphingolipid biosynthetic process|membrane lipid metabolic process|ceramide biosynthetic process,3.506e-17|2.913e-16|1.184e-15|2.801e-15|4.708e-15,5.531e-13|2.297e-12|6.223e-12|1.105e-11|1.485e-11,29.52|81.73|118.9|63.05|190.7
1045,6,0.406,6.0889999999999995,4831.0,0.001256,0.998474,ACSL6 CETN1 DOK4 EMILIN1 FDXACB1 GLI2,floor plate formation|floor plate morphogenesis|notochord regression|negative regulation of collagen fibril organization|smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,0.0005824|0.0008735|0.0008735|0.0008735|0.001165,1|1|1|1|1,3432|1716|1716|1716|1144
1046,9,0.4197,15.11,7315.0,0.0020570000000000002,0.9998530000000001,BTNL8 CBY3 EIF4E1B NSG2 RASGEF1C RUFY1 TBC1D19 ZNF454 ZNF879,small GTPase mediated signal transduction|clathrin coat assembly|dopamine receptor signaling pathway|multicellular organismal process|cellular response to dopamine,0.005549|0.00827|0.01389|0.03388|0.03526,1|1|1|1|1,17.47|127.1|73.82|0|28.25
1047,6,0.4268,6.401,5030.0,0.001268,0.998474,CFAP43 CYP17A1 FAM219A LINGO1 NQO2 RMND5B,mucociliary clearance|androgen biosynthetic process|cerebrospinal fluid circulation|glucocorticoid biosynthetic process|progesterone metabolic process,0.001746|0.0032|0.0032|0.00349|0.004361,1|1|1|1|1,686.5|343.2|343.2|312|245.2
1048,6,0.4536,6.805,4724.0,0.0014349999999999999,0.998474,APOBEC3D ARL6 CFAP44 LRBA SH2D3A TLR10,toll-like receptor 10 signaling pathway|DNA cytosine deamination|cytidine metabolic process|cytidine catabolic process|cytidine deamination,0.0005824|0.0032|0.003781|0.003781|0.003781,1|1|1|1|1,3432|343.2|286|286|286
1049,5,0.4507,4.507,3944.0,0.001139,0.996692,ARHGAP1 CFAP45 RAB11FIP5 TIE1 TMEM14C,negative regulation of endocytic recycling|branching involved in lymph vessel morphogenesis|regulation of tetrapyrrole biosynthetic process|regulation of heme biosynthetic process|regulation of tetrapyrrole metabolic process,0.0004854|0.0004854|0.0009706|0.0009706|0.001213,1|1|1|1|1,4119|4119|1373|1373|1030
1050,6,0.4245,6.367999999999999,5074.0,0.00125,0.998474,CFAP65 CHCHD6 CNMD FABP6 GRIA1 TPPP,microtubule bundle formation|cellular response to ammonium ion|microtubule nucleation by microtubule organizing center|response to ammonium ion|negative regulation of tubulin deacetylation,0.0004255|0.001746|0.001746|0.002037|0.002037,1|1|1|1|1,62.98|686.5|686.5|572.1|572.1
1051,7,0.4015,8.431000000000001,5893.0,0.001425,0.9992989999999999,CFAP73 FABP6 FHOD3 TMEM63B TREML4 TSPO2 ZMPSTE24,cortical actin cytoskeleton organization|cardiac muscle cell development|cortical cytoskeleton organization|cardiac cell development|cardiac muscle cell differentiation,0.0001021|0.0001939|0.0002309|0.0002309|0.0003904,1|1|1|0.9106|1,135.5|97.15|88.77|88.77|67.75
1052,6,0.4309,6.462999999999999,4990.0,0.0012900000000000001,0.998474,ANXA3 CFD FCER2 OGG1 OMD THAP6,Notch signaling pathway|negative regulation of double-strand break repair via single-strand annealing|carbohydrate derivative catabolic process|positive regulation of humoral immune response mediated by circulating immunoglobulin|depyrimidination,0.0004971|0.0005824|0.001344|0.002037|0.002619,1|1|1|1|1,58.18|3432|35.03|572.1|429.1
1053,5,0.4332,4.332,4006.0,0.001078,0.996692,CCDC58 CFH COL5A2 DCAF5 TM7SF2,"negative regulation of endodermal cell differentiation|regulation of endodermal cell differentiation|regulation of complement-dependent cytotoxicity|complement activation, alternative pathway|secondary alcohol biosynthetic process",0.0009706|0.001456|0.002183|0.003878|0.009913,1|1|1|1|1,1373|823.8|514.9|274.6|103
1054,6,0.4065,6.098,4653.0,0.0013050000000000002,0.998474,ARL4D C17orf99 CFHR1 CFHR3 KCND2 PDLIM7,positive regulation of immunoglobulin production in mucosal tissue|regulation of immunoglobulin production in mucosal tissue|cytolysis by host of symbiont cells|cytolysis in other organism involved in symbiotic interaction|locomotor rhythm,0.0008735|0.0008735|0.003781|0.003781|0.004071,1|1|1|1|1,1716|1716|286|286|264
1055,6,0.4358,6.537999999999999,4801.0,0.001356,0.998474,AGT CFL2 DRG1 MIEF2 TRMT2A WDR19,"positive regulation of cellular component organization|positive regulation of membrane hyperpolarization|glycine biosynthetic process, by transamination of glyoxylate|G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger|ciliary receptor clustering involved in smoothened signaling pathway",0.0005435|0.0007765|0.001164|0.001164|0.001164,1|1|1|1|1,9.073|2574|1287|1287|1287
1056,5,0.4563,4.563,3995.0,0.0011380000000000001,0.996692,ABHD3 CFTR FKBP15 PDE7B SERPINB3,small molecule biosynthetic process|positive regulation of cyclic nucleotide-gated ion channel activity|regulation of cyclic nucleotide-gated ion channel activity|positive regulation of voltage-gated chloride channel activity|regulation of voltage-gated chloride channel activity,0.0001928|0.0004854|0.000728|0.000728|0.000728,1|1|1|1|1,22.15|4119|2060|2060|2060
1057,10,0.4286,19.29,7859.0,0.002442,0.999933,CGGBP1 EOGT EPHA3 FAM19A4 HTR1F LMOD3 POU1F1 TMF1 VGLL3 ZNF654,cellular component assembly involved in morphogenesis|protein O-GlcNAcylation via threonine|positive regulation of testosterone secretion|regulation of testosterone secretion|fasciculation of motor neuron axon,0.0007261|0.0008734|0.00131|0.00131|0.00131,1|1|1|1|1,49.75|2288|1144|1144|1144
1058,4,0.468,2.8080000000000003,2970.0,0.0009419000000000001,0.9929309999999999,CGRRF1 EIF3J RBX1 ZFYVE19,negative regulation of cell cycle|negative regulation of G2/M transition of mitotic cell cycle|negative regulation of cell cycle G2/M phase transition|regulation of G2/M transition of mitotic cell cycle|regulation of cell cycle G2/M phase transition,8.344e-05|0.0001363|0.0001684|0.0005836|0.0006778,1|1|0.8853|1|1,27.15|106.2|95.35|50.73|47.02
1059,5,0.4421,4.421,4072.0,0.001082,0.996692,ADAMDEC1 CEP85 CHAC2 OSTN ZMYND12,negative regulation of dendrite extension|regulation of mitotic centrosome separation|glutathione catabolic process|negative regulation of glucose import|glutathione biosynthetic process,0.0009706|0.002425|0.00291|0.00291|0.003878,1|1|1|1|1,1373|457.7|374.5|374.5|274.6
1060,7,0.4076,8.56,5641.0,0.001511,0.9992989999999999,CHAD DGKZ GAST GUCY2D KRT31 KRTAP4-2 TMEM88,positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity|negative regulation of bone trabecula formation|regulation of bone trabecula formation|regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity|keratinization,0.0006794|0.001019|0.001019|0.001698|0.002469,1|1|1|1|1,2942|1471|1471|735.5|26.04
1061,17,0.4097,55.72,11560.0,0.004785,1.0,ATG9A BCL10 CHIC2 CYLD IKBKB N4BP1 NFKB2 NFKBIA NFKBIB RNF31 SPATA2 STUB1 TNFAIP3 TNIP1 TRAF2 TRAF3 TRAF6,pattern recognition receptor signaling pathway|regulation of DNA-binding transcription factor activity|regulation of I-kappaB kinase/NF-kappaB signaling|I-kappaB kinase/NF-kappaB signaling|positive regulation of NF-kappaB transcription factor activity,8.375e-16|1.138e-14|2.336e-13|2.363e-13|7.757e-13,1.321e-11|8.977e-11|1.228e-09|9.319e-10|2.447e-09,81.08|29.07|42.38|114.4|56.16
1062,6,0.44,6.601,4874.0,0.001349,0.998474,C12orf40 CHKB CPNE8 PAK5 PLPPR3 ZNF621,memory|stress-activated protein kinase signaling cascade|learning|locomotory behavior|phosphate-containing compound metabolic process,0.0006591|0.0007638|0.0009957|0.0016|0.002049,1|1|1|1|1,51.17|47.45|41.44|32.51|6.174
1063,6,0.4401,6.602,4902.0,0.001342,0.998474,CHML KLK3 NCKAP5L TECTB TERB2 TRPC6,zymogen activation|Factor XII activation|antibacterial peptide production|antimicrobial peptide production|plasma kallikrein-kinin cascade,0.0001155|0.001019|0.001019|0.001019|0.001358,1|1|1|1|1,125.2|1471|1471|1471|980.7
1064,21,0.41,86.1,13540.0,0.006301,1.0,CHMP1B CHMP3 CHMP4B CHMP5 CHMP6 CLTC HGS IST1 PTPN23 RNF11 SNF8 STAMBP TFG UBAP1 USP8 VPS25 VPS36 VPS37A VPS4A VPS4B VTA1,multivesicular body assembly|multivesicular body organization|endosome organization|endosomal transport|vesicle organization,4.628e-34|6.715e-34|8.858e-32|2.432e-27|2.004e-25,7.3e-30|5.297e-30|4.658e-28|9.591e-24|6.322e-22,457.7|442.9|191|67.35|50.62
1065,7,0.4094,8.597000000000001,5702.0,0.0015019999999999999,0.9992989999999999,CHPF ENOSF1 ETV3 HOXC6 LRP6 OR1N2 UBXN2A,canonical Wnt signaling pathway involved in neural crest cell differentiation|external genitalia morphogenesis|receptor-mediated endocytosis involved in cholesterol transport|axis elongation involved in somitogenesis|Wnt signaling pathway involved in somitogenesis,0.001019|0.001019|0.001358|0.001698|0.001698,1|1|1|1|1,1471|1471|980.7|735.5|735.5
1066,5,0.4194,4.194,4218.0,0.0009908999999999999,0.996692,CHPT1 MAS1 NYAP1 PPP1R27 SLCO5A1,platelet activating factor biosynthetic process|CDP-choline pathway|platelet activating factor metabolic process|ether lipid biosynthetic process|cellular lipid biosynthetic process,0.001213|0.00194|0.002183|0.00291|0.00291,1|1|1|1|1,1030|588.4|514.9|374.5|374.5
1067,7,0.4176,8.769,4953.0,0.0017620000000000001,0.9992989999999999,CHRD MAPK1 SERPINI1 WIZ ZBTB2 ZNF592 ZNF644,BMP signaling pathway involved in spinal cord dorsal/ventral patterning|cytosine metabolic process|diadenosine tetraphosphate biosynthetic process|diadenosine tetraphosphate metabolic process|diadenosine polyphosphate biosynthetic process,0.0006794|0.001019|0.001358|0.001358|0.001358,1|1|1|1|1,2942|1471|980.7|980.7|980.7
1068,6,0.4343,6.513999999999999,4905.0,0.001323,0.998474,CHRNA1 DCBLD1 EFCAB12 GALNT5 KLHDC9 RAB17,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor|immunoglobulin transcytosis in epithelial cells|skeletal muscle tissue growth|filopodium assembly|transcytosis,0.0008735|0.001165|0.001165|0.006101|0.006391,1|1|1|1|1,1716|1144|1144|171.6|163.5
1069,5,0.4475,4.475,3803.0,0.001172,0.996692,CDH26 CHRNA10 GPR21 MROH6 PLA2G5,positive regulation of phagosome maturation|positive regulation of antifungal innate immune response|positive regulation of opsonization|positive regulation of immune complex clearance by monocytes and macrophages|regulation of antifungal innate immune response,0.0004854|0.0004854|0.000728|0.000728|0.000728,1|1|1|1|1,4119|4119|2060|2060|2060
1070,6,0.4211,6.317,4828.0,0.001303,0.998474,CHRNA3 LALBA LIMA1 OR4K5 RABL2A TTC26,"synaptic transmission involved in micturition|regulation of acetylcholine secretion, neurotransmission|lactose biosynthetic process|lactose metabolic process|intraciliary anterograde transport",0.001165|0.001165|0.001165|0.001165|0.001165,1|1|1|1|1,1144|1144|1144|1144|1144
1071,6,0.4015,6.023,4979.0,0.0012050000000000001,0.998474,CHRNA4 ELFN1 FSCN1 FSCN3 GGA3 HOXD8,actin filament bundle assembly|actin filament bundle organization|supramolecular fiber organization|establishment or maintenance of cell polarity|microspike assembly,0.0001242|0.000137|0.0004604|0.001331|0.001456,1|1|1|1|1,118.4|112.5|17.25|35.21|858.1
1072,10,0.406,18.27,7281.0,0.002496,0.999933,CHRNB2 FCER1A IL6ST JAK1 LIFR RXFP4 SLC39A1 SOCS3 STAT3 TNN,interleukin-6-mediated signaling pathway|cellular response to interleukin-6|response to interleukin-6|interleukin-35-mediated signaling pathway|interleukin-27-mediated signaling pathway,2.037e-10|2.535e-09|3.761e-09|2.988e-08|2.988e-08,3.214e-06|1.999e-05|1.978e-05|0.0001178|9.426e-05,457.7|228.8|205.9|561.7|561.7
1073,6,0.4485,6.728,4825.0,0.001389,0.998474,ACSM6 CHRNB4 CIB2 KAZN NRG2 RAB32,synaptic transmission involved in micturition|melanosome assembly|micturition|pigment granule maturation|endosome to pigment granule transport,0.001165|0.001746|0.002037|0.0032|0.0032,1|1|1|1|1,1144|686.5|572.1|343.2|343.2
1074,6,0.4432,6.648,4858.0,0.001363,0.998474,CHST10 DUS1L GPRC5C PLEK2 STK39 ZACN,negative regulation of creatine transmembrane transporter activity|regulation of creatine transmembrane transporter activity|negative regulation of pancreatic juice secretion|chemokine (C-X-C motif) ligand 12 signaling pathway|maintenance of lens transparency,0.0008735|0.0008735|0.001165|0.001456|0.001456,1|1|1|1|1,1716|1716|1144|858.1|858.1
1075,6,0.4093,6.138999999999999,4608.0,0.001327,0.998474,CHST13 CRYL1 FAM162B PRAP1 PRPF38B RET,posterior midgut development|positive regulation of metanephric glomerulus development|regulation of metanephric glomerulus development|positive regulation of metanephros development|positive regulation of glomerulus development,0.0008735|0.0008735|0.0008735|0.0008735|0.001165,1|1|1|1|1,1716|1716|1716|1716|1144
1076,6,0.4214,6.321000000000001,4759.0,0.001323,0.998474,AMOTL1 CCDC138 CHST4 FAM241B LYPD6 PRSS23,establishment of cell polarity involved in ameboidal cell migration|protein sulfation|N-acetylglucosamine metabolic process|sulfation|glucosamine-containing compound metabolic process,0.001165|0.002619|0.005812|0.00726|0.007839,1|1|1|1|1,1144|429.1|180.7|143|132
1077,5,0.4198,4.198,3863.0,0.001083,0.996692,CHSY3 DNAJC22 GORASP2 TAS2R5 XCR1,chondroitin sulfate biosynthetic process|chondroitin sulfate proteoglycan biosynthetic process|chondroitin sulfate metabolic process|chondroitin sulfate proteoglycan metabolic process|proteoglycan biosynthetic process,2.473e-05|3.493e-05|5.487e-05|6.96e-05|0.0001326,0.3901|0.2755|0.2885|0.2745|0.4185,274.6|228.8|180.7|159.7|114.4
1078,5,0.4058,4.058,3983.0,0.001015,0.996692,C20orf141 CIB1 INPP1 SLC43A3 TOB2,negative regulation of myeloid cell differentiation|positive regulation of male germ cell proliferation|positive regulation of germ cell proliferation|endomitotic cell cycle|regulation of male germ cell proliferation,0.0001709|0.0004854|0.0004854|0.0009706|0.0009706,1|1|1|1|1,98.07|4119|4119|1373|1373
1079,7,0.4026,8.454,5890.0,0.00143,0.9992989999999999,C3orf20 CAMKV CCDC169 CIDEC ELF2 SYNJ2 TBC1D5,regulation of modification of postsynaptic structure|regulation of modification of synaptic structure|inositol phosphate dephosphorylation|inositol phosphate catabolic process|phosphorylated carbohydrate dephosphorylation,0.003393|0.004748|0.006101|0.006777|0.006777,1|1|1|1|1,326.9|226.3|173.1|154.8|154.8
1080,6,0.4019,6.029,4534.0,0.001324,0.998474,CDC20 CILP2 CTRL EBNA1BP2 RPS8 STIL,mitotic spindle organization|positive regulation of anaphase-promoting complex-dependent catabolic process|regulation of anaphase-promoting complex-dependent catabolic process|microtubule cytoskeleton organization involved in mitosis|spindle organization,0.0009477|0.001165|0.001165|0.0012|0.001761,1|1|1|1|1,41.86|1144|1144|37.11|30.51
1081,5,0.4444,4.444,3781.0,0.0011710000000000002,0.996692,CIPC CYP4F22 NGB OR52K2 WIZ,positive regulation of nuclear cell cycle DNA replication|positive regulation of DNA-dependent DNA replication|regulation of nuclear cell cycle DNA replication|oxygen transport|negative regulation of circadian rhythm,0.001698|0.003152|0.003636|0.003636|0.003878,1|1|1|1|1,686.5|343.3|294.2|294.2|274.6
1082,6,0.4254,6.381,5203.0,0.001222,0.998474,BAALC CELF4 CISD1 FLRT3 KIAA1328 PENK,"general adaptation syndrome, behavioral process|proepicardium cell migration involved in pericardium morphogenesis|regulation of retina development in camera-type eye|general adaptation syndrome|synaptic signaling via neuropeptide",0.0005824|0.0005824|0.0005824|0.0008735|0.0008735,1|1|1|1|1,3432|3432|3432|1716|1716
1083,5,0.4483,4.4830000000000005,3756.0,0.001189,0.996692,CKAP2 FAM200B MADD NUSAP1 SLC18B1,mitotic cytokinesis|cytoskeleton-dependent cytokinesis|cytokinesis|regulation of Rab protein signal transduction|cell division,0.0001131|0.0002219|0.0002796|0.00194|0.00547,1|1|1|1|1,121.1|85.81|76.28|588.4|16.74
1084,7,0.4111,8.633,5873.0,0.001464,0.9992989999999999,CHGA CKAP4 POPDC2 RTN4RL1 SLC16A8 SLC30A2 ZBTB8B,adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation|positive regulation of sequestering of zinc ion|positive regulation of dense core granule biogenesis|positive regulation of relaxation of cardiac muscle|mast cell cytokine production,0.0006794|0.0006794|0.001019|0.001019|0.001019,1|1|1|1|1,2942|2942|1471|1471|1471
1085,6,0.4444,6.665,4815.0,0.001379,0.998474,CKB COL7A1 HTR3E IGFBP6 RETREG1 UCHL1,sensory perception of pain|axon target recognition|phosphocreatine metabolic process|phosphagen metabolic process|phosphagen biosynthetic process,0.0002787|0.001358|0.001698|0.001698|0.001698,1|1|1|1|1,79.52|980.7|735.5|735.5|735.5
1086,5,0.4173,4.173,4050.0,0.001027,0.996692,CKM IGLON5 MEFV NPTX1 SLC28A1,cytidine transport|negative regulation of macrophage inflammatory protein 1 alpha production|phosphocreatine metabolic process|phosphagen metabolic process|purine nucleobase transmembrane transport,0.0004854|0.0009706|0.001213|0.001213|0.001213,1|1|1|1|1,4119|1373|1030|1030|1030
1087,8,0.4139,11.59,6241.0,0.001849,0.9996790000000001,ADAMTS15 ADAMTS8 CKMT2 NAB1 OR10G8 OR10G9 OR10S1 OR8B2,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,1.403e-05|1.77e-05|2.051e-05|2.71e-05|3.137e-05,0.2213|0.1396|0.1078|0.1069|0.09898,23.35|22|21.19|19.73|19
1088,5,0.4296,4.296,4066.0,0.001053,0.996692,CLCN2 MFSD4B RAB5B SHROOM1 ZIC4,cell differentiation involved in salivary gland development|regulation of aldosterone biosynthetic process|regulation of aldosterone metabolic process|plasma membrane to endosome transport|regulation of steroid hormone biosynthetic process,0.000728|0.00194|0.00194|0.002183|0.00291,1|1|1|1|1,2060|588.4|588.4|514.9|374.5
1089,16,0.4113,49.35,10060.0,0.004866,0.999999,ALDOA BSG GAPDH GPI HK2 PFKP PGAM1 PGD PGLS PGP PKM RPE RPIA SLC2A1 TKT TPI1,monosaccharide metabolic process|carbohydrate metabolic process|generation of precursor metabolites and energy|monosaccharide catabolic process|NADH regeneration,2.322e-23|2.623e-22|5.796e-19|9.521e-19|1.261e-18,3.662e-19|2.069e-18|3.048e-15|3.755e-15|3.978e-15,82.63|36.21|37|180.7|339
1090,6,0.4071,6.106,4694.0,0.001296,0.998474,CLDN11 COX7B2 IRF3 NUGGC SMR3B TBK1,positive regulation of type I interferon-mediated signaling pathway|positive regulation of interferon-alpha production|regulation of interferon-alpha production|TRIF-dependent toll-like receptor signaling pathway|MyD88-independent toll-like receptor signaling pathway,7.41e-06|2.29e-05|3.493e-05|3.493e-05|4.188e-05,0.1169|0.1806|0.1836|0.1377|0.1321,528.1|286|228.8|228.8|208
1091,6,0.4406,6.61,4776.0,0.001379,0.998474,BCAP29 CLDN16 NMUR1 PACS1 RAB40C WDR37,protein localization to plasma membrane|protein localization to cell periphery|protein localization to endoplasmic reticulum exit site|metal ion transport|magnesium ion transmembrane transport,0.001331|0.001902|0.002619|0.003591|0.004942,1|1|1|1|1,35.21|29.34|429.1|21.19|214.5
1092,6,0.4086,6.13,4466.0,0.001367,0.998474,CLDN18 CYB5B KLK2 PSKH2 SLIRP ZNF93,negative regulation of transposon integration|regulation of transposon integration|negative regulation of mitochondrial RNA catabolic process|TNFSF11-mediated signaling pathway|negative regulation of osteoclast development,0.0008735|0.0008735|0.0008735|0.001456|0.001746,1|1|1|1|1,1716|1716|1716|858.1|686.5
1093,6,0.4389,6.584,4887.0,0.001342,0.998474,CLDN20 HEXA PRSS3 SLC9C2 TNFSF18 TUBB4A,negative regulation of T-helper 17 cell lineage commitment|T cell proliferation involved in immune response|ganglioside catabolic process|regulation of T-helper 17 cell lineage commitment|regulation of dendritic cell chemotaxis,0.001165|0.001746|0.002328|0.002328|0.0032,1|1|1|1|1,1144|686.5|490.4|490.4|343.2
1094,5,0.432,4.32,3892.0,0.001106,0.996692,APBA3 C19orf38 CLDN23 IPCEF1 SLC10A5,oxygen transport|gas transport|calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules|bile acid and bile salt transport|bicellular tight junction assembly,0.003636|0.004845|0.005329|0.008467|0.01424,1|1|1|1|1,294.2|216.8|196.1|121.1|71.02
1095,9,0.4257,15.33,6848.0,0.002227,0.9998530000000001,JAG1 JAG2 KLHL42 LRP10 NRARP RBM47 SUSD6 TMEM127 WWP2,regulation of Notch signaling pathway|Notch signaling pathway|inner ear development|inner ear auditory receptor cell differentiation|ear development,1.575e-07|2.3e-05|9.393e-05|0.0001043|0.0001345,0.002485|0.1814|0.4939|0.4114|0.4243,77.72|52.36|32.35|137.3|28.6
1096,5,0.4078,4.078,3934.0,0.001033,0.996692,CLEC14A HEBP2 NEB PM20D2 SELENOS,vascular endothelial growth factor receptor-3 signaling pathway|cardiac muscle thin filament assembly|somatic muscle development|negative regulation of nitric-oxide synthase biosynthetic process|negative regulation of macrophage apoptotic process,0.0004854|0.0009706|0.0009706|0.001213|0.001213,1|1|1|1|1,4119|1373|1373|1030|1030
1097,5,0.427,4.27,3524.0,0.001207,0.996692,CCDC6 CDCA4 CLEC1A FAM122A HIST4H4,"chromatin organization involved in regulation of transcription|regulation of gene expression, epigenetic|negative regulation of megakaryocyte differentiation|DNA replication-dependent nucleosome assembly|DNA replication-dependent nucleosome organization",0.0001913|0.0006897|0.001456|0.002667|0.002667,1|1|1|1|1,92.56|48.18|823.8|411.9|411.9
1098,42,0.3126,269.1,29070.0,0.009147,1.0,DUX4 FAU HSPE1 RPL10A RPL11 RPL12 RPL13 RPL13A RPL14 RPL15 RPL17 RPL18 RPL18A RPL19 RPL23 RPL23A RPL27 RPL27A RPL3 RPL31 RPL32 RPL34 RPL35 RPL35A RPL37 RPL4 RPL5 RPL6 RPL7 RPL9 RPLP0 RPLP2 RPS11 RPS13 RPS15A RPS17 RPS20 RPS24 RPS27A RPS3A RPS6 RPS8,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,8.484e-88|4.628e-87|1.124e-85|3.758e-85|5.053e-85,1.338e-83|3.65e-83|5.908e-82|1.482e-81|1.594e-81,204.3|194.2|176.7|170.6|169.1
1099,5,0.4355,4.355,3994.0,0.0010869999999999999,0.996692,CELF5 CLEC3A NAV3 SLC22A16 ZNF594,carnitine transmembrane transport|carnitine transport|amino-acid betaine transport|amine transport|quaternary ammonium group transport,0.001213|0.001456|0.00194|0.002183|0.003394,1|1|1|1|1,1030|823.8|588.4|514.9|316.8
1100,5,0.4105,4.105,3922.0,0.0010429999999999999,0.996692,B4GALT2 CEACAM3 CLEC3B LYZL6 VWCE,positive regulation of plasminogen activation|regulation of plasminogen activation|fusion of sperm to egg plasma membrane involved in single fertilization|plasma membrane fusion|positive regulation of protein processing,0.001698|0.003394|0.005329|0.006295|0.006295,1|1|1|1|1,686.5|316.8|196.1|164.8|164.8
1101,6,0.429,6.435,4740.0,0.001352,0.998474,ABHD4 ACADVL CLEC4G CSF2 FAM81B SYPL1,response to silicon dioxide|positive regulation of interleukin-23 production|neutrophil differentiation|histamine secretion|regulation of interleukin-23 production,0.001165|0.001746|0.001746|0.002328|0.002619,1|1|1|1|1,1144|686.5|686.5|490.4|429.1
1102,5,0.4359,4.359,3861.0,0.001125,0.996692,ANTXRL CLEC4M FAM222A SMR3B STXBP2,peptide antigen transport|virion attachment to host cell|adhesion of symbiont to host cell|adhesion of symbiont to host|viral genome replication,0.0009706|0.002667|0.00291|0.003152|0.006778,1|1|1|1|1,1373|411.9|374.5|343.3|152.6
1103,7,0.4114,8.639,5860.0,0.001469,0.9992989999999999,ASB17 CLGN DBNDD1 EEF2K LNX1 MAGI3 MBOAT2,cellular response to anoxia|response to anoxia|response to prolactin|cellular response to brain-derived neurotrophic factor stimulus|GDP metabolic process,0.0006794|0.001358|0.001358|0.003732|0.004071,1|1|1|1|1,2942|980.7|980.7|294.2|267.5
1104,6,0.4125,6.188,4686.0,0.001315,0.998474,CLHC1 IQGAP2 LSAMP PECR TEAD2 TOP3B,fatty alcohol metabolic process|phytol metabolic process|fatty acid alpha-oxidation|DNA topological change|thrombin-activated receptor signaling pathway,0.0008735|0.0008735|0.002909|0.002909|0.002909,1|1|1|1|1,1716|1716|381.4|381.4|381.4
1105,8,0.4128,11.56,5700.0,0.002018,0.9996790000000001,CLIC4 EZR LZTR1 PPP1R18 RASA2 SHOC2 SOS1 STK10,regulation of small GTPase mediated signal transduction|regulation of Ras protein signal transduction|negative regulation of Ras protein signal transduction|endothelial cell development|leukocyte cell-cell adhesion,4.352e-06|4.941e-05|0.0001733|0.0001939|0.0002083,0.06865|0.3897|0.9109|0.7647|0.6572,31.49|39.01|103|97.15|93.61
1106,10,0.4091,18.41,8364.0,0.002191,0.999933,C16orf71 CLIP1 CYP2W1 GPER1 GPR146 MICALL2 RBAK RNF216 SCIN SLC38A10,"actin polymerization or depolymerization|protein catabolic process at synapse|protein catabolic process, modulating synaptic transmission|nuclear fragmentation involved in apoptotic nuclear change|positive regulation of cardiac vascular smooth muscle cell differentiation",0.0003947|0.0009704|0.0009704|0.0009704|0.001455,1|1|1|1|1,68.65|2060|2060|2060|1030
1107,5,0.4392,4.3919999999999995,3857.0,0.001134,0.996692,CLIP4 HPS5 HPS6 KIF1B TMEM74B,lysosome localization|pigmentation|response to rotenone|retrograde neuronal dense core vesicle transport|anterograde neuronal dense core vesicle transport,8.606e-05|0.0002799|0.0005824|0.001746|0.001746,1|1|1|1|1,143|78.01|3432|686.5|686.5
1108,6,0.4469,6.702999999999999,4683.0,0.001426,0.998474,CLK1 CLK3 CLK4 ELOVL3 NR1H4 PLEKHG7,peptidyl-tyrosine phosphorylation|regulation of RNA splicing|peptidyl-tyrosine modification|protein autophosphorylation|peptidyl-amino acid modification,7.447e-06|7.749e-06|7.903e-06|1.443e-05|4.609e-05,0.1175|0.06112|0.04156|0.0569|0.1454,70.05|69.11|68.65|55.96|15.69
1109,6,0.4339,6.5089999999999995,4950.0,0.00131,0.998474,AP3M1 CLPS FAM45A FBLIM1 FBXL20 TNFSF11,"positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling|positive regulation of fever generation by positive regulation of prostaglandin secretion|regulation of protein catabolic process at presynapse, modulating synaptic transmission|positive regulation of corticotropin-releasing hormone secretion|regulation of actin binding",0.000728|0.000728|0.000728|0.0009706|0.0009706,1|1|1|1|1,2060|2060|2060|1373|1373
1110,6,0.446,6.69,4917.0,0.001355,0.998474,CLPSL2 MCTP2 MPZ NMB RAB4A WNT16,cell-cell signaling|optic cup formation involved in camera-type eye development|oxidative stress-induced premature senescence|signaling|cell communication,0.0002747|0.001019|0.001698|0.001933|0.002114,1|1|1|1|1,10.46|1471|735.5|3.218|3.168
1111,5,0.4127,4.127,3760.0,0.001093,0.996692,CLPS CLPTM1 FAM45A FBLIM1 ZSCAN9,lipid digestion|regulation of integrin activation|response to food|regulation of T cell differentiation in thymus|retinoid metabolic process,0.003104|0.003491|0.004459|0.004846|0.021,1|1|1|1|1,343.2|302.9|234|214.5|47.67
1112,29,0.4062,164.9,22760.0,0.007175,1.0,ABHD14A ABHD14B APEH CACNA2D2 CCR2 CCR3 CCR5 CCR9 FAM107A FAM198A GNAT1 HYAL1 IQCF1 IQCF2 IQCF3 IQCF5 ITIH3 ITIH4 KLHDC8B KRBOX1 MUSTN1 NISCH NT5DC2 PFKFB4 SEMA3G TLR9 TOPAZ1 XCR1 ZNF502,chemokine-mediated signaling pathway|cellular response to chemokine|response to chemokine|cellular defense response|calcium-mediated signaling,9.073e-08|1.598e-07|1.598e-07|1.022e-06|1.635e-06,0.001431|0.00126|0.0008403|0.004029|0.005158,46.55|41.32|41.32|55.51|25.36
1113,7,0.4043,8.491,5906.0,0.0014320000000000001,0.9992989999999999,CCDC28B CD9 CLSTN1 KCNC2 MTHFR SLC43A2 SMIM1,response to vitamin B2|response to acid chemical|negative regulation of leucine import|regulation of leucine import|nitric oxide-cGMP-mediated signaling pathway,0.0006794|0.0008378|0.001019|0.001019|0.001019,1|1|1|1|1,2942|45.26|1471|1471|1471
1114,7,0.4003,8.406,5722.0,0.001463,0.9992989999999999,ARHGAP28 CLUL1 LRRC30 MC5R PTPRM SORCS3 STK25,intrinsic apoptotic signaling pathway in response to hydrogen peroxide|hydrogen peroxide-mediated programmed cell death|signal transduction|negative regulation of GTP binding|programmed cell death in response to reactive oxygen species,0.001019|0.001019|0.00133|0.001358|0.001358,1|1|1|1|1,1471|1471|3.436|980.7|980.7
1115,5,0.4537,4.537,3959.0,0.001142,0.996692,CHAC1 CMC2 CPNE7 GAL3ST4 PLEKHG6,response to calcium ion|malate-aspartate shuttle|aspartate transmembrane transport|glutathione catabolic process|L-aspartate transmembrane transport,0.0008061|0.001456|0.002909|0.00349|0.00349,1|1|1|1|1,45.46|858.1|381.4|312|312
1116,12,0.4033,26.62,9034.0,0.00293,0.999986,GATA3 HAND2 HDDC2 INSM2 ISL1 MEIS2 PBX1 PBX2 PBX3 PHOX2B SOX11 TFAP2B,sensory system development|sensory organ development|sympathetic nervous system development|positive regulation of transcription by RNA polymerase II|autonomic nervous system development,5.293e-14|1.655e-12|1.673e-12|2.925e-11|6.562e-11,8.349e-10|1.305e-08|8.798e-09|1.153e-07|2.07e-07,41.08|27.83|408.6|14.23|182.6
1117,6,0.4325,6.487,5003.0,0.001292,0.998474,CACFD1 CMSS1 FUT7 KNCN LCLAT1 PACRG,"leukocyte migration involved in immune response|regulation of type IV hypersensitivity|CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation|regulatory T cell differentiation|lymphocyte migration into lymphoid organs",0.0008735|0.001165|0.001456|0.002037|0.002328,1|1|1|1|1,1716|1144|858.1|572.1|490.4
1118,7,0.4113,8.637,5716.0,0.001505,0.9992989999999999,C12orf29 CD22 CMTM4 EVL NAPSA TGM2 TIE1,tissue remodeling|branching involved in lymph vessel morphogenesis|isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine|morphogenesis of a branching epithelium|morphogenesis of a branching structure,0.0005015|0.0006794|0.001019|0.001197|0.001335,1|1|1|1|1,58.84|2942|1471|37.72|35.66
1119,44,0.3784,358.0,35280.0,0.010020000000000001,1.0,ABCA13 ABCB5 ADCYAP1R1 AEBP1 AGR2 AGR3 CALM1 EGR3 FKBP9 GCK GHRHR GPCPD1 INMT KIAA0895 LANCL2 MTURN MYL7 MYO1G NIPSNAP2 NME8 NPC1L1 NPY NUPR2 PHKG1 PKD1L1 POM121L12 PSPH RNASET2 SEPT14 SLC29A4 SPATA48 SUGCT SUMF2 UBE2D4 UPP1 URGCP VSTM2A VWC2 WIPF3 ZNF479 ZNF679 ZNF713 ZNF716 ZNF736,carbohydrate catabolic process|negative regulation of ryanodine-sensitive calcium-release channel activity|negative regulation of release of sequestered calcium ion into cytosol|regulation of high voltage-gated calcium channel activity|positive regulation of sequestering of calcium ion,0.0001468|0.0003731|0.0005008|0.0005716|0.0006469,1|1|1|1|1,15.44|81.4|68.88|63.96|59.7
1120,5,0.4392,4.3919999999999995,3415.0,0.001281,0.996692,CMTR2 ECT2 GAN KIF20A SACS,"mitotic cytokinesis|regulation of cytokinesis|cytoskeleton-dependent cytokinesis|cytokinesis|regulation of cytokinesis, actomyosin contractile ring assembly",0.0001131|0.0001913|0.0002219|0.0002796|0.0004854,1|1|1|1|1,121.1|92.56|85.81|76.28|4119
1121,7,0.4082,8.572000000000001,5921.0,0.001442,0.9992989999999999,AATK CMYA5 EVI5 PLPP7 RAB37 SLC25A10 ZNF620,oxaloacetate(2-) transmembrane transport|malate transmembrane transport|malate transport|oxaloacetate transport|thiosulfate transport,0.001698|0.001698|0.001698|0.001698|0.001698,1|1|1|1|1,735.5|735.5|735.5|735.5|735.5
1122,5,0.418,4.18,3835.0,0.001086,0.996692,CNBD1 GALNT6 NFXL1 PANK2 PFKM,glycolysis from storage polysaccharide through glucose-1-phosphate|glycolytic process through glucose-1-phosphate|carbohydrate derivative metabolic process|energy derivation by oxidation of organic compounds|pantothenate metabolic process,0.0004854|0.000728|0.001088|0.001204|0.00194,1|1|1|1|1,4119|2060|12.28|36.29|588.4
1123,6,0.4551,6.827000000000001,3728.0,0.0018219999999999998,0.998474,CCND2 CCND3 CDK6 CNBP MSI2 NFE2L2,regulation of G1/S transition of mitotic cell cycle|regulation of cell cycle G1/S phase transition|positive regulation of cyclin-dependent protein serine/threonine kinase activity|positive regulation of G1/S transition of mitotic cell cycle|positive regulation of cyclin-dependent protein kinase activity,8.218e-06|1.183e-05|3.949e-05|4.434e-05|4.946e-05,0.1296|0.09328|0.2077|0.1749|0.1561,67.75|59.87|214.5|201.9|190.7
1124,5,0.4204,4.204,3994.0,0.001049,0.996692,ANGPTL3 CCDC122 CNDP1 DBNDD2 ZNF786,negative regulation of lipoprotein lipase activity|negative regulation of phospholipase activity|phospholipid homeostasis|negative regulation of lipase activity|glycerol metabolic process,0.001698|0.002183|0.00412|0.004362|0.005329,1|1|1|1|1,686.5|514.9|257.4|242.3|196.1
1125,5,0.4448,4.448,3917.0,0.001131,0.996692,CNFN GSTA3 SLC39A2 ST8SIA4 VASP,ganglioside biosynthetic process|N-glycan processing|sialylation|glutathione derivative biosynthetic process|glutathione derivative metabolic process,0.00412|0.004845|0.005087|0.005571|0.005571,1|1|1|1|1,257.4|216.8|205.9|187.2|187.2
1126,6,0.4097,6.145,4833.0,0.001267,0.998474,CDHR3 CNGA4 LY86 PCSK1 TEX2 TNRC6C,"positive regulation of lipopolysaccharide-mediated signaling pathway|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation|regulation of translation, ncRNA-mediated|positive regulation of nuclear-transcribed mRNA poly(A) tail shortening",0.002619|0.004071|0.004071|0.004071|0.004361,1|1|1|1|1,429.1|264|264|264|245.2
1127,6,0.4102,6.153,4875.0,0.001258,0.998474,ATP12A CNKSR1 CNTN5 NEUROG2 NOTCH4 STK19,negative regulation of cell adhesion molecule production|negative regulation of endothelial cell differentiation|regulation of cell adhesion molecule production|negative regulation of cell-cell adhesion mediated by cadherin|miRNA mediated inhibition of translation,0.001746|0.002909|0.0032|0.0032|0.004071,1|1|1|1|1,686.5|381.4|343.2|343.2|264
1128,5,0.421,4.21,3815.0,0.001099,0.996692,CLEC2A CNKSR3 FXR1 TSR3 ZMYM1,enzyme-directed rRNA pseudouridine synthesis|rRNA pseudouridine synthesis|pseudouridine synthesis|natural killer cell mediated cytotoxicity|natural killer cell mediated immunity,0.001698|0.002667|0.004604|0.006054|0.006537,1|1|1|1|1,686.5|411.9|228.8|171.6|158.4
1129,7,0.4045,8.494,5830.0,0.001451,0.9992989999999999,CNN3 FLAD1 LARP6 LRP2 MEGF8 RAB27B SLC5A9,coronary vasculature development|flavin adenine dinucleotide biosynthetic process|FAD biosynthetic process|epiboly involved in gastrulation with mouth forming second|FAD metabolic process,9.729e-05|0.0006794|0.0006794|0.0006794|0.0006794,1|1|1|1|1,136.8|2942|2942|2942|2942
1130,6,0.4241,6.361000000000001,4784.0,0.001325,0.998474,ABCC1 AKR1B10 CNNM1 MXRA7 NSUN6 ZNF746,farnesol catabolic process|farnesol metabolic process|sesquiterpenoid catabolic process|tRNA C5-cytosine methylation|sesquiterpenoid metabolic process,0.0008735|0.0008735|0.0008735|0.0008735|0.001165,1|1|1|1|1,1716|1716|1716|1716|1144
1131,21,0.4056,85.17,16580.0,0.005098,1.0,ASTL C2orf49 CCDC74B CFC1 CFC1B CNNM3 CNNM4 FAHD2A FAHD2B FAM178B IL1F10 IL1RN IL36G LYG1 MGAT4A MRPL30 POTEI SLC9A2 SULT1C2 TRIM43 TUBA3D,inflammatory response to antigenic stimulus|nodal signaling pathway|sulfation|purine ribonucleoside bisphosphate metabolic process|3'-phosphoadenosine 5'-phosphosulfate metabolic process,8.683e-06|9.815e-05|0.0003478|0.0003754|0.0003754,0.137|0.7741|1|1|1,80.24|156|78.01|74.89|74.89
1132,6,0.4111,6.166,4857.0,0.001265,0.998474,CALU CNPPD1 CSGALNACT2 KCNB1 KNOP1 TMEM9B,"dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process|chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process|positive regulation of norepinephrine secretion|regulation of motor neuron apoptotic process|positive regulation of long-term synaptic depression",0.0005824|0.0008735|0.001456|0.001746|0.002037,1|1|1|1|1,3432|1716|858.1|686.5|572.1
1133,6,0.4031,6.047000000000001,4763.0,0.001265,0.998474,BRMS1L CNRIP1 FAM71E1 IGDCC4 OC90 RASSF3,otolith mineralization|otolith development|arachidonic acid secretion|arachidonate transport|icosanoid secretion,0.0008735|0.002619|0.00726|0.00726|0.008128,1|1|1|1|1,1716|429.1|143|143|127.1
1134,6,0.4245,6.367000000000001,5014.0,0.001265,0.998474,CNST DDI1 FOXI2 GRM6 HIST1H4F TOGARAM2,regulation of DNA stability|mitotic nuclear division|negative regulation of megakaryocyte differentiation|positive regulation of Golgi to plasma membrane protein transport|adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway,0.001456|0.001524|0.001746|0.001746|0.002328,1|1|1|1|1,858.1|32.85|686.5|686.5|490.4
1135,7,0.4022,8.446,5460.0,0.0015400000000000001,0.9992989999999999,CIB3 CNTD1 GMIP PALMD S1PR5 ZNF682 ZNF98,sphingosine-1-phosphate receptor signaling pathway|sphingolipid mediated signaling pathway|negative regulation of GTPase activity|reciprocal meiotic recombination|reciprocal homologous recombination,0.005086|0.005425|0.01586|0.01921|0.01921,1|1|1|1|1,210.2|196.1|63.96|52.54|52.54
1136,6,0.4362,6.542999999999999,4949.0,0.001317,0.998474,CD164L2 CNTF HOMER3 MBP SIGLEC15 TBC1D9,positive regulation of metalloendopeptidase activity|regulation of retinal cell programmed cell death|ciliary neurotrophic factor-mediated signaling pathway|regulation of metalloendopeptidase activity|positive regulation of metallopeptidase activity,0.001019|0.001358|0.002037|0.002376|0.002376,1|1|1|1|1,1471|980.7|588.4|490.4|490.4
1137,12,0.4008,26.45,9356.0,0.0028120000000000003,0.999986,CDK18 CHIT1 CNTN2 HHAT NFASC REN RGS18 RGS2 RGS21 TMEM206 TMEM81 TROVE2,regulation of G protein-coupled receptor signaling pathway|regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway|establishment of protein localization to juxtaparanode region of axon|negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process|regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,5.859e-05|0.001067|0.001067|0.001067|0.001067,0.9242|1|1|1|1,38.47|1872|1872|1872|1872
1138,6,0.4521,6.781000000000001,4943.0,0.001367,0.998474,B3GALT4 CNTN4 GPR31 LEPROTL1 NECAP1 ZFPL1,negative regulation of protein localization to cell surface|ganglioside biosynthetic process|neuron cell-cell adhesion|late endosome to vacuole transport via multivesicular body sorting pathway|dendrite self-avoidance,0.004071|0.004942|0.005232|0.005232|0.005232,1|1|1|1|1,264|214.5|201.9|201.9|201.9
1139,6,0.4025,6.037999999999999,4935.0,0.001219,0.998474,ACOX2 AXDND1 COA1 PROK2 SLC12A3 TSN,positive regulation of response to oxidative stress|chemical homeostasis|production of siRNA involved in RNA interference|RNA interference|fatty acid beta-oxidation using acyl-CoA oxidase,0.002328|0.002882|0.0032|0.004361|0.004651,1|1|1|1|1,490.4|9.161|343.2|245.2|228.8
1140,13,0.4063,31.69,8796.0,0.00358,0.999993,C12orf45 C16orf72 C1D DDX21 HSPA14 NCL NOLC1 PINX1 RPF1 TENT4B ZCCHC7 ZNHIT3 ZNHIT6,rRNA processing|rRNA metabolic process|ribosome biogenesis|ncRNA processing|ribonucleoprotein complex biogenesis,8.659e-12|1.161e-11|5.795e-11|4.486e-10|7.944e-10,1.366e-07|9.158e-08|3.047e-07|1.769e-06|2.506e-06,39.61|38.14|31.02|23.84|22.15
1141,5,0.4401,4.401,4061.0,0.00108,0.996692,COL10A1 PROKR2 RFPL1 SRPK2 UBXN11,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis|nuclear speck organization|regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis|R-loop disassembly|negative regulation of cell division,0.000728|0.001213|0.001456|0.001456|0.00412,1|1|1|1|1,2060|1030|823.8|823.8|257.4
1142,5,0.4257,4.257,4104.0,0.001034,0.996692,COL11A1 LIMK1 LRRC6 SEMA3D SUMO3,regulation of axon extension|regulation of extent of cell growth|regulation of axonogenesis|regulation of cell size|tendon development,0.0002219|0.0002847|0.0005904|0.0007712|0.001698,1|1|1|1|1,85.81|75.58|52.14|45.51|686.5
1143,5,0.4141,4.141,3723.0,0.001108,0.996692,COL11A2 EXOC8 LRRC57 OR11L1 SEMA4D,positive regulation of inhibitory synapse assembly|semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis|negative regulation of alkaline phosphatase activity|regulation of inhibitory synapse assembly|soft palate development,0.000728|0.000728|0.0009706|0.001213|0.001456,1|1|1|1|1,2060|2060|1373|1030|823.8
1144,7,0.4209,8.838,5825.0,0.001511,0.9992989999999999,ANXA4 C17orf47 COL15A1 CTNNBIP1 DLL4 KCNA2 RCAN3,epithelium development|endothelium development|Notch signaling pathway|branching morphogenesis of an epithelial tube|tube morphogenesis,0.0002493|0.0004631|0.0006932|0.0008127|0.0009861,1|1|1|1|1,10.73|61.29|49.87|45.97|13.68
1145,6,0.4186,6.279,4771.0,0.0013109999999999999,0.998474,APLNR COL1A1 DNAJB13 PUM3 SAMD14 SLC25A31,cellular response to fluoride|positive regulation of inhibitory G protein-coupled receptor phosphorylation|regulation of inhibitory G protein-coupled receptor phosphorylation|cellular response to vitamin E|apelin receptor signaling pathway,0.0005824|0.0005824|0.0005824|0.0008735|0.001165,1|1|1|1|1,3432|3432|3432|1716|1144
1146,6,0.4082,6.122999999999999,4914.0,0.001241,0.998474,BMP1 CIZ1 COL1A2 IL1F10 MLYCD SLC37A2,collagen fibril organization|malonyl-CoA catabolic process|protein heterotrimerization|positive regulation of DNA-dependent DNA replication initiation|malonyl-CoA metabolic process,0.0003809|0.0005824|0.0005824|0.0008735|0.001165,1|1|1|1|1,66.65|3432|3432|1716|1144
1147,5,0.4188,4.188,4027.0,0.001036,0.996692,ANKRD30B COL25A1 FNDC7 GLP2R HSPA4L,cellular response to glucagon stimulus|response to glucagon|collagen fibril organization|response to unfolded protein|response to topologically incorrect protein,0.00702|0.009672|0.02499|0.04012|0.04504,1|1|1|1|1,147.1|105.6|39.99|24.66|21.91
1148,5,0.4332,4.332,4039.0,0.0010689999999999999,0.996692,COL28A1 CTSV DEFB131A ENO3 KIAA1328,"regulation of vacuole fusion, non-autophagic|cellular response to lipoteichoic acid|response to lipoteichoic acid|extracellular matrix organization|extracellular structure organization",0.001213|0.00291|0.00291|0.003339|0.003356,1|1|1|1|1,1030|374.5|374.5|21.57|21.51
1149,6,0.4326,6.489,4813.0,0.001343,0.998474,COL2A1 DYDC1 EHD3 KRT84 PLEK VTI1B,"Golgi to vacuole transport|vesicle docking involved in exocytosis|vesicle docking|exocytic process|retrograde transport, endosome to Golgi",1.481e-05|6.96e-05|0.0001504|0.0001644|0.0002925,0.2336|0.5489|0.7907|0.6483|0.9227,361.3|159.7|107.3|102.5|76.28
1150,6,0.4155,6.232,4772.0,0.001301,0.998474,CD34 COL3A1 IFFO2 JAGN1 PPP1R32 VAMP3,cell-substrate adhesion|cell-matrix adhesion|extracellular exosome assembly|cellular response to tunicamycin|response to tunicamycin,1.466e-05|0.0005653|0.0005824|0.0005824|0.0005824,0.2312|1|1|1|1,55.66|54.48|3432|3432|3432
1151,11,0.4211,23.16,8913.0,0.0025859999999999998,0.999969,CHRND COL4A3 COL4A4 CRYGA CRYGB CRYGC CRYGD ILKAP PRLH SLC11A1 SNORC,lens development in camera-type eye|visual perception|sensory perception of light stimulus|camera-type eye development|glomerular basement membrane development,6.807e-08|3.934e-06|4.226e-06|1.771e-05|2.014e-05,0.001074|0.03103|0.02222|0.06984|0.06355,98.54|34.67|34.04|23.55|340.4
1152,7,0.4134,8.682,5750.0,0.001504,0.9992989999999999,COL6A3 FDCSP HECA PPFIBP2 SLAMF8 SPSB1 TNS1,B-1 B cell lineage commitment|negative regulation of dendritic cell chemotaxis|negative regulation of neutrophil migration|B-1 B cell differentiation|negative regulation of respiratory burst,0.0006794|0.0006794|0.001698|0.002037|0.002037,1|1|1|1|1,2942|2942|735.5|588.4|588.4
1153,13,0.4112,32.07,7889.0,0.004036,0.999993,BRAF DUSP4 ELAVL1 GRB2 MAFF MAP2K1 MAPK1 MITF PEA15 PTPN11 SHOC2 SOX10 SOX9,ERBB signaling pathway|MAPK cascade|face development|epidermal growth factor receptor signaling pathway|Bergmann glial cell differentiation,7.014e-10|2.008e-09|2.34e-08|2.958e-08|3.226e-08,1.106e-05|1.583e-05|0.000123|0.0001166|0.0001018,113.2|27.11|134.8|126.7|594.1
1154,9,0.4077,14.68,7676.0,0.0019039999999999999,0.9998530000000001,BSND C1orf123 COL8A2 ELOVL3 GPX7 HTR6 PCSK9 PLAU SLC44A3,negative regulation of low-density lipoprotein particle receptor binding|negative regulation of intracellular cholesterol transport|negative regulation of intracellular sterol transport|negative regulation of intracellular lipid transport|negative regulation of receptor-mediated endocytosis involved in cholesterol transport,0.0007765|0.001164|0.001164|0.001164|0.001164,1|1|1|1|1,2574|1287|1287|1287|1287
1155,11,0.4091,22.5,7715.0,0.0029,0.999969,C11orf53 CKS1B COLCA2 E2F3 IDE POU2F3 SKP2 SOX4 STAM2 TFAP2B TP73,G1 phase|mitotic G1 phase|mitotic interphase|interphase|positive regulation of nitrogen compound metabolic process,2.277e-07|2.277e-07|9.794e-06|9.794e-06|2.575e-05,0.003591|0.001795|0.0515|0.03862|0.08122,267.5|267.5|71.1|71.1|4.898
1156,6,0.4161,6.242000000000001,4609.0,0.001349,0.998474,COLGALT2 EFR3B KIRREL3 PAX2 TBCEL TBX5,cell fate specification|nephron development|optic nerve structural organization|positive regulation of optic nerve formation|regulation of optic nerve formation,0.0002381|0.0005478|0.0005824|0.0005824|0.0005824,1|1|1|1|1,84.75|55.36|3432|3432|3432
1157,6,0.408,6.121,4971.0,0.001227,0.998474,COLQ EPN3 EPS15 INPP4A PCSK9 PTGR1,regulation of receptor recycling|organic hydroxy compound metabolic process|receptor metabolic process|negative regulation of low-density lipoprotein particle receptor binding|regulation of low-density lipoprotein particle receptor binding,2.114e-05|0.000249|0.0003955|0.0005824|0.0008735,0.3335|1|1|1|1,298.5|21.28|65.38|3432|1716
1158,6,0.4105,6.157,4687.0,0.001309,0.998474,COMP GALK1 NME2 NPHP4 TOM1 UBE2O,nucleoside diphosphate phosphorylation|nucleotide phosphorylation|nucleoside diphosphate metabolic process|galactitol metabolic process|peptidyl-histidine phosphorylation,0.0001326|0.000137|0.0002556|0.0005824|0.0005824,1|1|1|1|1,114.4|112.5|81.73|3432|3432
1159,29,0.3908,158.6,20130.0,0.007798,1.0,ABCE1 CCT3 COPA COPB2 EIF2S1 ETF1 ISY1 NARS NEDD8 NUTF2 PSMA1 PSMA2 PSMA3 PSMA4 PSMA5 PSMA6 PSMB3 PSMB4 RPL17 SARS SF3A1 SMU1 SNRNP200 SNRPD1 SNU13 SRP54 VCP XAB2 YARS,proteasomal ubiquitin-independent protein catabolic process|protein-containing complex subunit organization|regulation of cellular amino acid metabolic process|S phase|pre-replicative complex assembly,4.137e-17|1.73e-14|9.12e-14|9.12e-14|9.12e-14,6.525e-13|1.364e-10|4.795e-10|3.596e-10|2.877e-10,249.6|8.25|84.49|84.49|84.49
1160,5,0.4156,4.156000000000001,3937.0,0.001052,0.996692,AGAP1 ANKRD18A C8orf34 COQ10A SOX17,cardiogenic plate morphogenesis|endodermal cell fate determination|inner cell mass cellular morphogenesis|regulation of cardiac cell fate specification|endodermal digestive tract morphogenesis,0.0004854|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,4119|2060|2060|2060|2060
1161,5,0.4233,4.2330000000000005,3888.0,0.001085,0.996692,CAPN10 COQ9 FAM210B MCTP2 UMOD,citric acid secretion|metanephric thick ascending limb development|juxtaglomerular apparatus development|thick ascending limb development|creatinine homeostasis,0.0004854|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,4119|2060|2060|2060|2060
1162,5,0.4046,4.046,3623.0,0.001112,0.996692,ANAPC13 CORO1B FZR1 GNS ZDHHC22,protein K11-linked ubiquitination|protein localization to cell leading edge|positive regulation of anaphase-promoting complex-dependent catabolic process|regulation of anaphase-promoting complex-dependent catabolic process|actin filament branching,2.185e-05|0.000728|0.0009706|0.0009706|0.0009706,0.3447|1|1|1|1,284.1|2060|1373|1373|1373
1163,6,0.4246,6.369,4924.0,0.001289,0.998474,COX6B2 ETV2 GRB14 HAPLN1 RBM24 ZNF414,BMP signaling pathway involved in mesodermal cell fate specification|positive regulation of mesoderm development|positive regulation of skeletal muscle fiber differentiation|regulation of skeletal muscle fiber differentiation|positive regulation of 3'-UTR-mediated mRNA stabilization,0.0005824|0.0008735|0.001165|0.001456|0.001746,1|1|1|1|1,3432|1716|1144|858.1|686.5
1164,5,0.403,4.03,3722.0,0.0010789999999999999,0.996692,COX7A2 DAZAP1 HNRNPL S1PR4 VSIR,"regulation of mRNA splicing, via spliceosome|regulation of mRNA processing|negative regulation of CD8-positive, alpha-beta T cell proliferation|positive regulation of collagen catabolic process|regulation of RNA splicing",0.0002499|0.000472|0.0004854|0.0004854|0.0005261,1|1|1|1|1,80.76|58.43|4119|4119|55.29
1165,61,0.382,699.0,43420.0,0.0158,1.0,ACAD9 ATPAF2 C12orf65 CARS2 CLPP CLPX COA7 COQ7 DARS2 DDX28 FASTKD2 FOXRED1 GFM2 GRSF1 GTPBP10 GTPBP8 MALSU1 MCAT METTL17 MPV17L2 MRM2 MRM3 MRPL1 MRPL18 MRPL41 MRPL44 MRPL50 MRPL58 MRPL9 MRRF MTERF3 MTERF4 MTFMT MTG1 MTG2 MTIF2 MTIF3 MTO1 MTRF1L NDUFAF1 NDUFAF3 NDUFAF6 NDUFAF7 NDUFB9 NGRN NOA1 NSUN4 NUBPL PDE12 PTCD1 REXO2 RMND1 RPUSD3 RPUSD4 RTN4IP1 SLC30A9 SSBP1 TFB1M TIMMDC1 TRUB2 YBEY,mitochondrial gene expression|mitochondrial translation|translation|regulation of mitochondrial translation|peptide biosynthetic process,2.139e-22|9.509e-19|4.261e-18|6.619e-18|1.304e-17,3.374e-18|7.5e-15|2.241e-14|2.61e-14|4.115e-14,40.34|41.9|16.44|127.8|15.43
1166,6,0.4099,6.148,4761.0,0.001286,0.998474,CP DENND2A DIRC2 HACD2 ROPN1B SLC9C1,sperm motility|flagellated sperm motility|cilium movement involved in cell motility|cilium-dependent cell motility|cilium or flagellum-dependent cell motility,0.0002925|0.0002925|0.0003455|0.0004409|0.0004409,1|1|1|1|1,76.28|76.28|70.05|61.85|61.85
1167,5,0.4289,4.289,3835.0,0.001114,0.996692,C16orf96 CPAMD8 CPLANE2 MC4R TMX3,peptidyl-cysteine oxidation|regulation of grooming behavior|negative regulation of feeding behavior|diet induced thermogenesis|protein oxidation,0.0009706|0.001456|0.002425|0.00291|0.003152,1|1|1|1|1,1373|823.8|457.7|374.5|343.3
1168,5,0.4466,4.466,3953.0,0.001125,0.996692,CPEB1 FZD10 HIP1 STATH STXBP5,positive regulation of hydrolase activity|positive regulation of platelet-derived growth factor receptor-beta signaling pathway|positive regulation of mRNA polyadenylation|non-canonical Wnt signaling pathway via JNK cascade|positive regulation of platelet-derived growth factor receptor signaling pathway,0.0005107|0.0009706|0.001213|0.001456|0.001456,1|1|1|1|1,15.9|1373|1030|823.8|823.8
1169,8,0.4006,11.22,6491.0,0.001721,0.9996790000000001,B4GALNT3 CPEB3 ERC1 KLRC1 KLRC4 NRIP2 SLC6A12 WNT5B,"negative regulation of cytoplasmic translational elongation|positive regulation of convergent extension involved in gastrulation|regulation of convergent extension involved in gastrulation|CD8-positive, gamma-delta intraepithelial T cell differentiation|gamma-delta intraepithelial T cell differentiation",0.001164|0.001164|0.001164|0.001552|0.001552,1|1|1|1|1,1287|1287|1287|858.1|858.1
1170,6,0.4019,6.029,4839.0,0.001241,0.998474,CPLX2 GAD2 ITGA6 NKX2-5 RELN ZBTB5,neurotransmitter secretion|signal release from synapse|positive regulation of lateral motor column neuron migration|regulation of lateral motor column neuron migration|positive regulation of motor neuron migration,0.0003119|0.0003119|0.0005824|0.0005824|0.0005824,1|1|1|1|1,73.82|73.82|3432|3432|3432
1171,6,0.4228,6.343,4864.0,0.001299,0.998474,CASC10 CPN1 MOS MSRB2 PTF1A SPAG6,establishment of meiotic spindle orientation|negative regulation of metaphase/anaphase transition of meiotic cell cycle|negative regulation of meiotic chromosome separation|regulation of neural retina development|negative regulation of meiotic cell cycle phase transition,0.0005824|0.001165|0.001165|0.001165|0.001456,1|1|1|1|1,3432|1144|1144|1144|858.1
1172,6,0.4358,6.537000000000001,4883.0,0.001334,0.998474,CPNE5 PPP4C SCUBE3 SRCIN1 UGT1A5 WDR76,regulation of response to DNA damage stimulus|flavonoid glucuronidation|xenobiotic glucuronidation|flavonoid metabolic process|regulation of DNA damage checkpoint,0.001746|0.002909|0.00349|0.004651|0.005232,1|1|1|1|1,30.65|381.4|312|228.8|201.9
1173,8,0.4293,12.02,6776.0,0.0017670000000000001,0.9996790000000001,ATP2B2 CAMK1G CPNE9 LHFPL4 PLCD4 SLC6A1 SLC6A11 TATDN2,gamma-aminobutyric acid reuptake|amino acid neurotransmitter reuptake|gamma-aminobutyric acid transport|neurotransmitter reuptake|import into cell,2.542e-06|4.743e-06|9.31e-06|4.658e-05|5.842e-05,0.04009|0.03741|0.04895|0.1837|0.1843,1144|762.8|508.5|208|37.51
1174,6,0.4191,6.287000000000001,4787.0,0.001308,0.998474,CPPED1 CRADD DPYSL3 GPC2 PARVB SLC8A3,positive regulation of neuron projection development|establishment or maintenance of cell polarity regulating cell shape|calcium ion export across plasma membrane|calcium ion export|regulation of postsynaptic cytosolic calcium ion concentration,0.0008701|0.0008735|0.001746|0.002909|0.00349,1|1|1|1|1,43.73|1716|686.5|381.4|312
1175,5,0.4185,4.185,3861.0,0.00108,0.996692,CPQ CYBRD1 GPD1L LEMD1 RNGTT,glycerol-3-phosphate catabolic process|polynucleotide 5' dephosphorylation|negative regulation of protein kinase C signaling|regulation of ventricular cardiac muscle cell membrane depolarization|glycerol-3-phosphate metabolic process,0.000728|0.000728|0.001213|0.001456|0.002667,1|1|1|1|1,2060|2060|1030|823.8|411.9
1176,6,0.4528,6.791,4962.0,0.001363,0.998474,CD8B CPS1 CRB2 CYP17A1 LVRN RIPK1,regulation of ATP:ADP antiporter activity|carbamoyl phosphate biosynthetic process|carbamoyl phosphate metabolic process|ingression involved in gastrulation with mouth forming second|ripoptosome assembly,0.0005824|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,3432|3432|3432|3432|3432
1177,9,0.42,15.12,6111.0,0.002461,0.9998530000000001,HNRNPD NKTR NUP50 NUP54 NUP58 NUP62 SFSWAP TMEM209 USP14,tRNA-containing ribonucleoprotein complex export from nucleus|tRNA export from nucleus|tRNA transport|ncRNA export from nucleus|intracellular transport of virus,1.231e-09|1.231e-09|1.688e-09|1.865e-09|7.047e-09,1.941e-05|9.707e-06|8.873e-06|7.354e-06|2.223e-05,269.2|269.2|247.4|240.9|169.5
1178,5,0.4421,4.421,4005.0,0.0011,0.996692,C19orf44 CPT2 RHOU SLC2A8 ZNF620,fructose transmembrane transport|dehydroascorbic acid transport|Cdc42 protein signal transduction|carnitine shuttle|carnitine metabolic process,0.001456|0.00194|0.00194|0.00291|0.003636,1|1|1|1|1,823.8|588.4|588.4|374.5|294.2
1179,6,0.4069,6.103,4941.0,0.001231,0.998474,CPVL HMBOX1 KCNG1 MOV10 OPRPN SYT11,negative regulation of clathrin-coated pit assembly|regulation of clathrin-coated pit assembly|negative regulation of synaptic vesicle endocytosis|negative regulation of membrane invagination|regulation of protein localization to phagocytic vesicle,0.0005824|0.0005824|0.0005824|0.0008735|0.0008735,1|1|1|1|1,3432|3432|3432|1716|1716
1180,5,0.4468,4.468,3947.0,0.0011279999999999999,0.996692,AAED1 BICD2 C9orf47 CPXM1 GPR139,minus-end-directed organelle transport along microtubule|microtubule anchoring at microtubule organizing center|microtubule anchoring|protein localization to Golgi apparatus|centrosome localization,0.001165|0.002522|0.005233|0.005813|0.0062,1|1|1|1|1,1030|429.1|198|177.5|166.1
1181,7,0.4095,8.599,5736.0,0.001493,0.9992989999999999,BCL2L10 CRABP1 CYP1B1 DGKQ HSPA1B LIPG LRRC37A,lipid catabolic process|acylglycerol metabolic process|neutral lipid metabolic process|cellular lipid metabolic process|lipid metabolic process,3.27e-06|7.696e-06|7.912e-06|1.197e-05|3.577e-05,0.05159|0.0607|0.0416|0.0472|0.1128,33.87|73.55|72.86|13.2|10.53
1182,6,0.4016,6.024,4853.0,0.0012369999999999998,0.998474,CACNG8 CRABP2 HPCAL4 NLRP3 RIMS3 TCTEX1D1,"positive regulation of synaptic transmission|positive regulation of T-helper 2 cell differentiation|positive regulation of T-helper 2 cell cytokine production|neurotransmitter receptor transport, postsynaptic endosome to lysosome|neurotransmitter receptor diffusion trapping",0.000601|0.002328|0.002328|0.002328|0.002909,1|1|1|1|1,52.81|490.4|490.4|490.4|381.4
1183,6,0.4132,6.1979999999999995,4920.0,0.001255,0.998474,BVES CRBN KCTD20 MPP7 PGPEP1L SLC22A23,negative regulation of large conductance calcium-activated potassium channel activity|regulation of large conductance calcium-activated potassium channel activity|protein localization to adherens junction|sinoatrial node cell development|cardiac pacemaker cell development,0.0006794|0.001358|0.002037|0.002037|0.002376,1|1|1|1|1,2942|980.7|588.4|588.4|490.4
1184,10,0.4025,18.11,6210.0,0.0028989999999999997,0.999933,KRAS MAPK1 NRAS RAF1 RCE1 SHOC2 WIZ ZBTB2 ZNF592 ZNF644,MAPK cascade|stimulatory C-type lectin receptor signaling pathway|innate immune response activating cell surface receptor signaling pathway|innate immune response-activating signal transduction|intracellular signal transduction,1.263e-08|2.134e-05|2.358e-05|2.416e-05|3.241e-05,0.0001992|0.1683|0.124|0.09527|0.1022,30.21|53.73|51.92|51.49|7.846
1185,5,0.4339,4.3389999999999995,3788.0,0.001141,0.996692,CREB3L2 IRX1 RALGAPA2 SYT5 XKR8,proximal/distal pattern formation involved in metanephric nephron development|pattern specification involved in metanephros development|specification of loop of Henle identity|specification of nephron tubule identity|proximal/distal pattern formation involved in nephron development,0.000728|0.001213|0.001213|0.001456|0.001456,1|1|1|1|1,2060|1030|1030|823.8|823.8
1186,13,0.4088,31.89,7717.0,0.004101,0.999993,BRAF DUSP4 DUSP5 ELAVL1 GRB2 MAP2K1 MAPK1 NRAS PEA15 PTPN11 SHOC2 SOX10 SOX9,MAPK cascade|ERBB signaling pathway|positive regulation of intracellular signal transduction|regulation of MAPK cascade|regulation of intracellular signal transduction,3.551e-13|7.014e-10|1.065e-09|1.929e-09|5.006e-09,5.601e-09|5.532e-06|5.6e-06|7.605e-06|1.579e-05,34.86|113.2|14.05|18.26|8.961
1187,5,0.423,4.23,3916.0,0.001076,0.996692,C1QTNF8 CREB3L4 FAM173A UBE2Q2 WNT11,positive regulation of transforming growth factor beta2 production|mediolateral intercalation|negative regulation of fibroblast growth factor production|planar cell polarity pathway involved in gastrula mediolateral intercalation|cloacal septation,0.0005825|0.0005825|0.0005825|0.0005825|0.0007766,1|1|1|1|1,2574|2574|2574|2574|1716
1188,34,0.4033,226.3,27390.0,0.008173,1.0,ADA BCAS4 BPIFB4 CNBD2 CPNE1 DEFB115 DEFB116 DUSP15 EPPIN FAM209A FAM209B FAM83C FOXS1 GGT7 GHRH HCK LBP MAP1LC3A MYH7B MYLK2 NOL4L OCSTAMP R3HDML RBPJL SDC4 SLC12A5 SLC13A3 TLDC2 TM9SF4 WFDC11 WFDC6 WFDC8 WISP2 XKR7,"response to bacterium|defense response to bacterium|regulation of circadian sleep/wake cycle, sleep|regulation of circadian sleep/wake cycle|negative regulation of peptidase activity",0.0001237|0.0002194|0.0004172|0.0006148|0.0007461,1|1|1|1|1,6.084|9.045|73.42|59.44|9.79
1189,16,0.4103,49.24,12030.0,0.004064,0.999999,CCDC89 CREBZF FCHSD2 FOLR1 FOLR2 KCTD21 KRTAP5-1 KRTAP5-10 KRTAP5-11 KRTAP5-9 P2RY2 P2RY6 PLEKHB1 TRIM49D1 UCP2 UCP3,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,2.127e-08|5.718e-08|1.485e-07|4.513e-07|7.367e-07,0.0003355|0.000451|0.000781|0.00178|0.002324,32.16|27.12|23|18.98|17.43
1190,6,0.4045,6.067,4963.0,0.001218,0.998474,CEP162 CRHBP SEC22C SLC15A2 SVEP1 TMEM25,negative regulation of corticotropin secretion|negative regulation of corticotropin-releasing hormone receptor activity|regulation of corticotropin-releasing hormone receptor activity|lymph circulation|peptidoglycan transport,0.0005824|0.0005824|0.0005824|0.0008735|0.001165,1|1|1|1|1,3432|3432|3432|1716|1144
1191,6,0.4004,6.005,4583.0,0.0013050000000000002,0.998474,C16orf54 CRHR2 FSD1 HMSD MMD2 PRR4,cellular response to corticotropin-releasing hormone stimulus|response to corticotropin-releasing hormone|cytolysis|regulation of mitotic spindle organization|regulation of spindle organization,0.002037|0.002037|0.0115|0.01251|0.01385,1|1|1|1|1,588.4|588.4|89.16|81.73|73.55
1192,7,0.4023,8.449,5150.0,0.001633,0.9992989999999999,CRIP2 NFIA PLAT POLQ RIPK4 UBE3A VPS36,positive regulation of Golgi lumen acidification|sperm entry|regulation of Golgi lumen acidification|cellular macromolecule metabolic process|double-strand break repair via alternative nonhomologous end joining,0.0006794|0.0006794|0.001019|0.001091|0.001698,1|1|1|1|1,2942|2942|1471|3.557|735.5
1193,21,0.4053,85.11,16080.0,0.00525,1.0,AIF1 C6orf48 HLA-DMB HLA-F HSPA1L LY6G6F MICB MPIG6B MSH5 NCR3 NEU1 NUDT3 OR14J1 OR2J3 PPT2 PSORS1C2 STK19 TAPBP TNXB TRIM10 TRIM26,MHC protein complex assembly|immune response|antigen processing and presentation of endogenous peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen|immune system process,3.542e-05|6.893e-05|0.0001672|0.0002051|0.0002109,0.5588|0.5437|0.8793|0.8089|0.6655,280.2|4.476|115.4|103.2|3.442
1194,5,0.4298,4.298,4021.0,0.001065,0.996692,ATP9B CASP6 CRISPLD1 OXTR PPP1R36,response to alkaloid|response to anoxia|positive regulation of norepinephrine secretion|positive regulation of penile erection|regulation of systemic arterial blood pressure by vasopressin,0.0002951|0.0009706|0.001213|0.001456|0.001456,1|1|1|1|1,74.22|1373|1030|823.8|823.8
1195,6,0.4227,6.34,5068.0,0.001247,0.998474,CGA CRLF1 GNAZ PEX11G SLC39A3 TSN,adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation|positive regulation of dense core granule biogenesis|positive regulation of relaxation of cardiac muscle|mast cell cytokine production|regulation of dense core granule biogenesis,0.0006794|0.001019|0.001019|0.001019|0.001358,1|1|1|1|1,2942|1471|1471|1471|980.7
1196,7,0.4133,8.68,5685.0,0.001521,0.9992989999999999,CRMP1 HS6ST3 KCNH5 NOVA1 RIIAD1 SLC35E1 TRIM36,"negative regulation of actin binding|negative regulation of actin filament binding|regulation of actin filament binding|regulation of actin binding|heparan sulfate proteoglycan biosynthetic process, enzymatic modification",0.0006794|0.0006794|0.001019|0.001358|0.002376,1|1|1|1|1,2942|2942|1471|980.7|490.4
1197,12,0.392,25.88,8692.0,0.00296,0.999986,ARHGAP45 ECHS1 EXOC6 JAK3 LDLR LDLRAP1 LRP8 MCEMP1 PYCR2 REEP4 SH2B1 TOP2A,receptor-mediated endocytosis involved in cholesterol transport|intracellular cholesterol transport|intracellular sterol transport|low-density lipoprotein particle clearance|plasma lipoprotein particle clearance,3.106e-06|6.488e-05|7.135e-05|0.0001002|0.0002517,0.04899|0.5117|0.3751|0.3953|0.7941,1144|180.7|171.6|143|88.01
1198,13,0.4063,31.69,9100.0,0.003461,0.999993,ATR EIF2B5 GFM1 LSG1 MRPL47 NMD3 OPA1 PDCD6 PSMD2 RFC4 RPL35A TRA2A U2SURP,ribosome localization|ribosomal subunit export from nucleus|rRNA-containing ribonucleoprotein complex export from nucleus|cellular macromolecule biosynthetic process|macromolecule biosynthetic process,5.163e-05|5.163e-05|5.898e-05|7.893e-05|9.226e-05,0.8144|0.4072|0.3101|0.3113|0.2911,211.2|211.2|196.1|5.807|5.667
1199,12,0.408,26.93,7780.0,0.003439,0.999986,BRAF CRTC2 CRTC3 DUSP4 MAFF MAP2K1 MAPK1 MITF SOX10 SOX9 TFAP2A ZEB2,"positive regulation of nucleic acid-templated transcription|positive regulation of transcription, DNA-templated|positive regulation of RNA biosynthetic process|positive regulation of RNA metabolic process|positive regulation of macromolecule biosynthetic process",5.383e-10|5.383e-10|5.416e-10|9.462e-10|1.986e-09,8.492e-06|4.246e-06|2.848e-06|3.731e-06|6.264e-06,10.58|10.58|10.57|9.99|9.262
1200,6,0.4343,6.515,4919.0,0.00132,0.998474,ABTB1 CLDN11 CRY1 FADS6 GALK1 SLC38A8,galactitol metabolic process|glycolytic process from galactose|hexose metabolic process|cellular response to blue light|blue light signaling pathway,0.0005824|0.0005824|0.0008592|0.0008735|0.0008735,1|1|1|1|1,3432|3432|44.01|1716|1716
1201,5,0.4526,4.526,3977.0,0.001134,0.996692,ARMH4 CRYBB2 GCAT KIAA1671 SLC35E4,threonine catabolic process|L-threonine catabolic process to glycine|threonine metabolic process|glycine metabolic process|aspartate family amino acid catabolic process,0.001456|0.001456|0.001698|0.004845|0.005812,1|1|1|1|1,823.8|823.8|686.5|216.8|179.1
1202,9,0.838,30.17,5891.0,0.0050799999999999994,0.9998530000000001,CS DLAT LIPT1 MDH2 MPC1 MPC2 PDHB PDHX SLC25A1,acetyl-CoA biosynthetic process from pyruvate|acyl-CoA biosynthetic process|thioester biosynthetic process|purine nucleoside bisphosphate biosynthetic process|ribonucleoside bisphosphate biosynthetic process,5.531e-12|8.569e-12|8.569e-12|3.332e-11|3.332e-11,8.725e-08|6.758e-08|4.505e-08|1.314e-07|1.051e-07,1308|254.3|254.3|190.7|190.7
1203,6,0.5545,8.317,3479.0,0.0023769999999999998,0.998474,CSDE1 DHX29 EIF4A1 EIF4G2 STRAP XRN1,regulation of translational initiation|cellular nitrogen compound metabolic process|regulation of translation|regulation of cellular amide metabolic process|translational initiation,2.344e-06|3.414e-06|3.507e-06|6.584e-06|1.195e-05,0.03698|0.02693|0.01844|0.02596|0.0377,107.6|6.045|31.98|27.24|61.72
1204,7,0.4041,8.487,5536.0,0.001527,0.9992989999999999,BTLA CSF1R DERL3 HOXC6 LRRC27 SLC2A2 TMEM41A,macrophage colony-stimulating factor signaling pathway|positive regulation of macrophage proliferation|fructose transmembrane transport|intestinal hexose absorption|regulation of macrophage proliferation,0.001698|0.002037|0.002037|0.002376|0.002376,1|1|1|1|1,735.5|588.4|588.4|490.4|490.4
1205,11,0.4148,22.82,7474.0,0.003034,0.999969,ABL1 BCR CSF2RB ETV6 GAB2 GSE1 LMO2 MYB PTPN11 RUNX1 SOS1,regulation of hematopoietic progenitor cell differentiation|regulation of hematopoietic stem cell differentiation|regulation of leukocyte activation|regulation of stem cell differentiation|regulation of cell activation,8.463e-10|6.469e-08|2.999e-07|3.159e-07|4.405e-07,1.335e-05|0.0005102|0.001577|0.001246|0.00139,104|99.85|18.24|66.28|17.07
1206,7,0.4011,8.424,5124.0,0.001637,0.9992989999999999,C1orf43 CSK FAM102A KIAA0100 KIAA1109 TMCC1 VAPA,endoplasmic reticulum organization|endosome membrane tubulation|endosome fission|membrane tubulation|positive regulation by host of viral release from host cell,0.0005015|0.001019|0.001358|0.001698|0.002037,1|1|1|1|1,58.84|1471|980.7|735.5|588.4
1207,6,0.4,6.0,4951.0,0.001208,0.998474,CSMD1 CSTL1 GJD4 GPR6 MT1HL1 SPOCK3,conditioned place preference|oviduct epithelium development|oviduct development|peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|negative regulation of endopeptidase activity,0.001165|0.001165|0.001746|0.002037|0.00208,1|1|1|1|1,1144|1144|686.5|572.1|28.02
1208,6,0.4354,6.531000000000001,4787.0,0.001359,0.998474,CSNK1G3 GFY OCM2 SLFN11 ZNF154 ZNF77,replication fork arrest|negative regulation of DNA-dependent DNA replication|negative regulation of DNA replication|DNA-dependent DNA replication maintenance of fidelity|regulation of DNA-dependent DNA replication,0.001456|0.005232|0.01015|0.01419|0.01448,1|1|1|1|1,858.1|201.9|101|71.51|70.05
1209,6,0.4224,6.336,4431.0,0.001424,0.998474,ACOT2 CDKN3 CSPG5 LRIF1 MKLN1 SMCHD1,dosage compensation by inactivation of X chromosome|dosage compensation|peptidyl-tyrosine dephosphorylation|G0 to G1 transition|inactivation of X chromosome by DNA methylation,1.51e-05|1.875e-05|0.000562|0.0006794|0.0006794,0.2382|0.1479|1|1|1,367.8|326.9|55.51|2942|2942
1210,14,0.3896,35.45,10140.0,0.003475,0.9999969999999999,APH1A ATP6V0A2 HMGCL KCNK5 MSI2 NCSTN NOTCH1 PRSS42 PSEN1 PSENEN RHOH SLC25A19 SUCLA2 SUCLG1,"Notch receptor processing, ligand-dependent|amyloid-beta formation|Notch receptor processing|amyloid precursor protein catabolic process|membrane protein ectodomain proteolysis",3.133e-11|9.493e-11|9.493e-11|4.585e-10|1.004e-09,4.942e-07|7.487e-07|4.992e-07|1.808e-06|3.168e-06,905.3|633.7|633.7|396.1|316.8
1211,6,0.4479,6.718,4884.0,0.00137,0.998474,CSRNP3 GPR176 GPR20 LGMN PDK2 TTN,response to calcium ion|vacuolar protein processing|striated muscle myosin thick filament assembly|sarcomerogenesis|skeletal muscle myosin thick filament assembly,0.0008061|0.0008735|0.001165|0.001165|0.001165,1|1|1|1|1,45.46|1716|1144|1144|1144
1212,6,0.4061,6.0920000000000005,4880.0,0.0012439999999999999,0.998474,BATF CD8B CSRP1 DFFA SHMT2 SPATC1,glycine biosynthetic process from serine|negative regulation of deoxyribonuclease activity|negative regulation of apoptotic DNA fragmentation|L-serine catabolic process|T-helper 2 cell differentiation,0.0008735|0.0008735|0.001165|0.001456|0.001456,1|1|1|1|1,1716|1716|1144|858.1|858.1
1213,8,0.4025,11.27,6561.0,0.0017109999999999998,0.9996790000000001,ARHGAP9 CHRM1 CST6 FRZB GAL3ST3 HRASLS2 PRSS8 ZRANB3,negative regulation of hepatocyte differentiation|DNA rewinding|regulation of hepatocyte differentiation|phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway|convergent extension involved in organogenesis,0.0008734|0.0008734|0.00131|0.001746|0.002618,1|1|1|1|1,2288|2288|1144|762.8|457.7
1214,5,0.4259,4.2589999999999995,3733.0,0.001137,0.996692,CSTB HSPA4 IP6K1 PTGES3 SLCO6A1,chaperone-mediated protein complex assembly|outer mitochondrial membrane organization|protein insertion into mitochondrial outer membrane|telomerase holoenzyme complex assembly|glucocorticoid receptor signaling pathway,1.19e-05|0.001213|0.001213|0.001213|0.001698,0.1877|1|1|1|1,392.3|1030|1030|1030|686.5
1215,11,0.4016,22.09,7310.0,0.003003,0.999969,ASNS ATF4 C2orf69 EIF2AK4 GCN1 GLUL QARS SLC1A5 SLC38A2 SLC7A11 WSB1,cellular response to starvation|response to starvation|cellular response to nutrient levels|cellular response to extracellular stimulus|cellular response to external stimulus,6.424e-10|1.993e-09|2.37e-09|4.621e-09|1.885e-08,1.013e-05|1.572e-05|1.246e-05|1.822e-05|5.946e-05,53.63|44.2|42.91|38.28|30.11
1216,15,0.4042,42.44,10620.0,0.0039700000000000004,0.999999,ACR ANHX C8orf33 CHAMP1 CTC1 DCLRE1B MZF1 PARD6G PGBD2 RABL2B SLC27A5 STN1 TEN1 ZBTB45 ZNF672,telomere capping|negative regulation of telomere maintenance via telomerase|telomere maintenance|telomere organization|negative regulation of telomere maintenance via telomere lengthening,2.776e-09|9.331e-07|1.551e-06|1.732e-06|2.065e-06,4.379e-05|0.007359|0.008154|0.006831|0.006514,255|173.1|47.05|45.72|129.8
1217,10,0.4076,18.34,7978.0,0.002288,0.999933,CDH12 CTDSP2 DAP DNAH5 FAM173B LGR5 OR2T5 OTULINL PRLR ROPN1L,epithelial cilium movement involved in extracellular fluid movement|extracellular transport|sperm motility|flagellated sperm motility|prolactin signaling pathway,0.0001616|0.0001899|0.001056|0.001056|0.001067,1|1|1|1|1,110.1|101.2|41.61|41.61|1872
1218,5,0.4372,4.372,3480.0,0.001251,0.996692,CTDSPL2 DMTF1 PCBP1 STK35 USP42,viral RNA genome replication|positive regulation of protein export from nucleus|viral genome replication|regulation of protein export from nucleus|negative regulation of BMP signaling pathway,0.003394|0.005329|0.006778|0.008467|0.01544,1|1|1|1|1,316.8|196.1|152.6|121.1|65.38
1219,7,0.4141,8.697000000000001,5015.0,0.001727,0.9992989999999999,CTF1 KRAS MAP2K5 MAP3K2 MAPK7 OTUD3 RNF125,regulation of intracellular signal transduction|cellular response to laminar fluid shear stress|MAPK cascade|negative regulation of heterotypic cell-cell adhesion|regulation of cell-cell adhesion involved in gastrulation,2.623e-06|4.447e-06|5.311e-06|6.521e-06|6.521e-06,0.04138|0.03508|0.02793|0.02571|0.02057,9.985|735.5|28.77|588.4|588.4
1220,17,0.4018,54.64,13490.0,0.004024,1.0,AGO4 ATG4C BMP8B BSND C1orf123 CFAP57 CTH CYP4X1 FAAH GJB3 GJB5 PCSK9 RAB3B TMEM53 ZFP69 ZFP69B ZNF684,protein sulfhydration|protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine|negative regulation of low-density lipoprotein particle receptor binding|regulation of aortic smooth muscle cell differentiation|positive regulation of aortic smooth muscle cell differentiation,0.001746|0.001746|0.001746|0.002618|0.002618,1|1|1|1|1,1144|1144|1144|572.1|572.1
1221,14,0.3882,35.32,10980.0,0.003198,0.9999969999999999,FSHR GNLY LHCGR NAT8 OXER1 REG3G SEMA4F SFTPB SIX3 STON1 TEX261 TRABD2A WBP1 WDR54,cellular response to gonadotropin stimulus|response to gonadotropin|activation of adenylate cyclase activity|ovulation cycle process|adenylate cyclase-modulating G protein-coupled receptor signaling pathway,7.28e-05|0.0001604|0.0003809|0.0003809|0.0004166,1|1|1|1|1,173.1|113.2|71.76|71.76|20.06
1222,6,0.4103,6.155,4866.0,0.00126,0.998474,B3GALT1 CTNNA3 NUB1 PDIA4 TCAF2 UPB1,beta-alanine biosynthetic process via 3-ureidopropionate|beta-alanine biosynthetic process|beta-alanine metabolic process|negative regulation of anion channel activity|dUMP catabolic process,0.0005824|0.0008735|0.001456|0.001456|0.001746,1|1|1|1|1,3432|1716|858.1|858.1|686.5
1223,6,0.401,6.015,5068.0,0.001183,0.998474,CALY CTNNAL1 MAB21L1 OR5B17 RETN TTC23,positive regulation of progesterone secretion|positive regulation of retrograde axon cargo transport|regulation of retrograde axon cargo transport|positive regulation of female gonad development|regulation of progesterone secretion,0.0005824|0.0005824|0.0005824|0.0005824|0.0008735,1|1|1|1|1,3432|3432|3432|3432|1716
1224,5,0.4295,4.295,4134.0,0.001035,0.996692,BLOC1S6 CRLF3 CTNS GFAP SLC17A5,amino acid transport|carboxylic acid transport|organic acid transport|organic anion transport|nitrogen compound transport,2.726e-06|1.777e-05|2.54e-05|4.464e-05|0.0002733,0.043|0.1401|0.1336|0.176|0.8621,93.61|49.63|43.98|36.34|9.148
1225,6,0.4002,6.002999999999999,4806.0,0.001245,0.998474,CAMK2N1 CSGALNACT2 CTSD OR10R2 PDGFC STAR,"intermembrane lipid transfer|sterol transport|dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process|cholesterol metabolic process|steroid biosynthetic process",0.0001203|0.0002935|0.0006794|0.0007518|0.0007881,1|1|1|1|1,122.6|77.42|2942|47.84|46.7
1226,5,0.4374,4.374,4007.0,0.001088,0.996692,CTSF IGF2BP3 PPP2R5B SLAMF1 ZNF2,negative regulation of CD40 signaling pathway|myeloid dendritic cell activation involved in immune response|regulation of CD40 signaling pathway|positive regulation of neurotrophin TRK receptor signaling pathway|regulation of neurotrophin TRK receptor signaling pathway,0.000728|0.0009706|0.001698|0.001698|0.003152,1|1|1|1|1,2060|1373|686.5|686.5|343.3
1227,5,0.4481,4.481,3985.0,0.001121,0.996692,C1orf100 CTSH NAT14 POMT1 ZBTB20,dichotomous subdivision of terminal units involved in lung branching|neuropeptide catabolic process|positive regulation of protein O-linked glycosylation|regulation of protein O-linked glycosylation|bradykinin catabolic process,0.000728|0.000728|0.0009706|0.0009706|0.001456,1|1|1|1|1,2060|2060|1373|1373|823.8
1228,6,0.4178,6.267,4870.0,0.001282,0.998474,CARNS1 CTTNBP2NL DSP KRTAP22-2 PRR18 ZDHHC3,lipoprotein localization to membrane|carnosine biosynthetic process|carnosine metabolic process|odontoblast differentiation|positive regulation of receptor localization to synapse,0.0006794|0.0006794|0.001019|0.001358|0.001698,1|1|1|1|1,2942|2942|1471|980.7|735.5
1229,6,0.4008,6.0120000000000005,4760.0,0.001258,0.998474,AIPL1 ANKRD24 CTXN2 PRAMEF12 PRAMEF14 SPOCD1,protein farnesylation|negative regulation of apoptotic process|negative regulation of programmed cell death|negative regulation of cell death|protein prenylation,0.001165|0.001462|0.001554|0.002048|0.0032,1|1|1|1|1,1144|11.6|11.35|10.32|343.2
1230,5,0.4354,4.354,4033.0,0.001076,0.996692,ARMC3 CTXN3 FBXO48 PHOSPHO1 TBC1D32,retinal pigment epithelium development|smoothened signaling pathway involved in dorsal/ventral neural tube patterning|bone mineralization involved in bone maturation|phosphatidylethanolamine biosynthetic process|ossification involved in bone maturation,0.001456|0.001698|0.00194|0.003878|0.003878,1|1|1|1|1,823.8|686.5|588.4|274.6|274.6
1231,5,0.4393,4.393,3697.0,0.001183,0.996692,C16orf96 CUEDC1 HMGCLL1 KRTAP10-9 OR4Q3,leucine catabolic process|leucine metabolic process|ketone body biosynthetic process|cellular ketone body metabolic process|ketone body metabolic process,0.001698|0.002183|0.002425|0.00291|0.003152,1|1|1|1|1,686.5|514.9|457.7|374.5|343.3
1232,6,0.4112,6.167999999999999,4002.0,0.001534,0.998474,CAND1 CUL4A GLMN RBX1 UBE2G1 UBE2M,protein modification by small protein conjugation|post-translational protein modification|protein modification by small protein conjugation or removal|SCF complex assembly|protein neddylation,5.941e-07|1.414e-06|1.832e-06|1.978e-06|7.41e-06,0.009372|0.01115|0.009635|0.0078|0.02338,20.9|38.03|16.65|1144|528.1
1233,17,0.4032,54.84,11730.0,0.00464,1.0,AK6 CCDC59 DDX49 DHX33 EXOSC1 EXOSC10 HEATR1 IMP3 IMP4 KRR1 NOL6 NOP9 POP5 RBM19 SRFBP1 UTP4 WDR43,rRNA processing|rRNA metabolic process|ribosome biogenesis|ncRNA processing|ribonucleoprotein complex biogenesis,2.065e-20|3.32e-20|4.499e-19|1.255e-17|3.187e-17,3.257e-16|2.619e-16|2.365e-15|4.95e-14|1.005e-13,51.49|49.58|40.32|30.99|28.79
1234,5,0.4015,4.015,3900.0,0.001026,0.996692,CDK2AP2 CUL9 ERO1B MANBA ZNF438,regulation of stem cell division|protein folding in endoplasmic reticulum|oligosaccharide catabolic process|glycoprotein catabolic process|regulation of mitotic cell cycle,0.002667|0.00291|0.003394|0.006537|0.007732,1|1|1|1|1,411.9|374.5|316.8|158.4|14.01
1235,15,0.4147,43.54,10190.0,0.004242,0.999999,FBXO5 LTV1 MRPL18 MTRF1L NUP43 NUS1 PDCD5 PPIL4 PSMB1 REV3L RPS12 SF3B5 TCP1 TMEM242 WTAP,RNA localization|RNA transport|nucleic acid transport|establishment of RNA localization|cellular macromolecule metabolic process,1.748e-05|0.0003982|0.0003982|0.0004098|0.0005835,0.2757|1|1|1|1,24.74|20.49|20.49|20.29|2.766
1236,5,0.4474,4.474,4218.0,0.001057,0.996692,COL3A1 CUTC EMX2 PAFAH1B3 WFS1,cerebral cortex development|brain development|head development|pallium development|negative regulation of ATF6-mediated unfolded protein response,0.0003217|0.0004514|0.0005322|0.0006739|0.000728,1|1|1|1|1,71.02|16.59|15.68|48.75|2060
1237,6,0.4127,6.19,4932.0,0.00125,0.998474,CUX2 FAM89B KHK PIP4K2A SPDYA ZNF324B,"1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process|1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate metabolic process|negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity|vesicle-mediated cholesterol transport|regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity",0.001165|0.001165|0.001165|0.001165|0.001456,1|1|1|1|1,1144|1144|1144|1144|858.1
1238,34,0.3501,196.4,23710.0,0.008192,1.0,ABCE1 COPB2 CWC22 EIF2S1 ETF1 ISY1 NBEAL1 NEDD8 NUTF2 PSMA1 PSMA2 PSMA3 PSMA4 PSMA5 PSMA6 PSMB3 PSMD7 PUF60 RPL17 RPL18 RPS17 SARS SF3A1 SF3B1 SF3B3 SMU1 SNRNP200 SNRPD1 SNU13 SRP54 UBL5 VCP XAB2 ZNF830,"mRNA metabolic process|RNA processing|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions",1.024e-17|1.358e-15|2.092e-15|2.092e-15|2.365e-15,1.615e-13|1.071e-11|1.1e-11|8.25e-12|7.461e-12,15.26|11.48|25.33|25.33|25.08
1239,6,0.4067,6.1,4824.0,0.00126,0.998474,AP4B1 CX3CL1 IGF2BP3 MIEF1 TOP3B TRPV4,positive regulation of organelle organization|positive regulation of calcium-independent cell-cell adhesion|negative regulation of glutamate receptor signaling pathway|blood vessel endothelial cell delamination|negative regulation of hippocampal neuron apoptotic process,0.0004448|0.0005824|0.0005824|0.0005824|0.0008735,1|1|1|1|1,17.45|3432|3432|3432|1716
1240,6,0.4389,6.582999999999999,5120.0,0.001281,0.998474,CXCL11 GLT6D1 GOLGA7B KDR KIFC2 LITAF,cellular response to hydrogen sulfide|cellular response to lipopolysaccharide|response to hydrogen sulfide|cellular response to molecule of bacterial origin|cellular response to biotic stimulus,0.0008735|0.00115|0.001165|0.001278|0.001611,1|1|1|1|1,1716|37.93|1144|35.94|31.93
1241,5,0.4452,4.452,4070.0,0.00109,0.996692,APOA4 CXCL16 DOCK8 LRCH3 RDH12,mononuclear cell migration|cellular detoxification|retinoid metabolic process|diterpenoid metabolic process|cellular response to toxic substance,0.0002646|0.0002796|0.0002796|0.0003109|0.0003163,1|1|1|1|0.9978,78.46|76.28|76.28|72.26|71.63
1242,5,0.4181,4.181,3985.0,0.001046,0.996692,CPAMD8 CPLANE2 CXXC4 IL27RA SRI,negative regulation of T cell extravasation|zygotic specification of dorsal/ventral axis|negative regulation of cardiac muscle contraction|regulation of T cell extravasation|intracellular sequestering of iron ion,0.0004854|0.0009706|0.001213|0.001456|0.001698,1|1|1|1|1,4119|1373|1030|823.8|686.5
1243,26,0.3592,116.8,20740.0,0.005584,1.0,AK4 ALG10 BICD1 CBLB CLEC6A ERGIC2 ETFBKMT FAR2 GYS2 IAPP IL17RE ITPR2 KCNJ8 KIAA1551 KLHL42 LMNTD1 MANSC4 PKP2 PTHLH RASSF8 SLCO1B3 SLCO1C1 SYT10 TM7SF3 TMTC1 TSPAN11,sodium-independent organic anion transport|ventricular cardiac muscle cell action potential|bile acid and bile salt transport|cardiac muscle cell action potential involved in contraction|cardiac muscle cell contraction,0.000231|0.0003805|0.000938|0.001158|0.0014,1|1|1|1|1,99.01|75.44|46.6|41.69|37.72
1244,14,0.4101,37.32,9657.0,0.003839,0.9999969999999999,ARIH2 ARIH2OS CUL1 CUL5 CYB5A CYB5R3 DCUN1D1 DCUN1D3 NAE1 RNF7 SENP8 SOCS6 UBE2F UBE2R2,protein modification by small protein conjugation or removal|protein modification by small protein conjugation|post-translational protein modification|protein neddylation|cellular protein modification process,1.049e-13|5.121e-13|8.004e-13|8.263e-13|2.957e-08,1.654e-09|4.039e-09|4.208e-09|3.259e-09|9.328e-05,15.98|18.4|34.23|528.1|5.457
1245,6,0.4166,6.249,4711.0,0.001322,0.998474,COPS7B CYB5D2 EFL1 FERMT3 SBDS TMEM63B,mature ribosome assembly|ribosome assembly|COP9 signalosome assembly|cellular component assembly|integrin activation,1.484e-06|0.0001504|0.001746|0.002423|0.002909,0.0234|1|1|1|1,1373|107.3|686.5|5.632|381.4
1246,36,0.4004,252.2,29150.0,0.008558,1.0,ERVV-2 FPR1 GPR32 KIR2DL1 KIR2DL3 KLK11 KLK3 LAIR2 LILRA4 LILRB2 LILRB5 NLRP11 NLRP12 SIGLEC12 SIGLEC5 VN1R4 ZFP28 ZNF175 ZNF28 ZNF320 ZNF415 ZNF432 ZNF528 ZNF534 ZNF571 ZNF578 ZNF610 ZNF613 ZNF615 ZNF665 ZNF677 ZNF701 ZNF765 ZNF808 ZNF841 ZNF880,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|cellular process",3.423e-09|8.534e-08|8.577e-08|8.799e-08|1.195e-07,5.399e-05|0.0006731|0.000451|0.000347|0.0003771,4.192|3.286|3.285|3.28|0.4549
1247,5,0.4339,4.3389999999999995,3959.0,0.001092,0.996692,AIMP2 CYB5R2 DNAH7 OSBPL11 TMPRSS5,positive regulation of aminoacyl-tRNA ligase activity|regulation of aminoacyl-tRNA ligase activity|type II pneumocyte differentiation|positive regulation of sequestering of triglyceride|lung secretory cell differentiation,0.0004854|0.000728|0.001456|0.002425|0.002425,1|1|1|1|1,4119|2060|823.8|457.7|457.7
1248,5,0.7955,7.955,3102.0,0.00255,0.996692,CAB39 NRBP1 OXSR1 TSC22D2 WNK1,response to osmotic stress|chemokine (C-C motif) ligand 21 signaling pathway|regulation of potassium ion transmembrane transport|regulation of potassium ion transport|cellular hypotonic response,5.194e-07|7.067e-07|1.391e-06|2.059e-06|2.119e-06,0.008193|0.005574|0.007313|0.008121|0.006686,164.8|2060|117.7|103|1030
1249,6,0.4322,6.483,5061.0,0.001276,0.998474,CAMKV COL5A1 CYP1A2 IL17RD PSME2 ZBTB8A,integrin biosynthetic process|toxin biosynthetic process|negative regulation of endodermal cell differentiation|dibenzo-p-dioxin metabolic process|regulation of endodermal cell differentiation,0.0005824|0.0005824|0.001165|0.001165|0.001746,1|1|1|1|1,3432|3432|1144|1144|686.5
1250,7,0.4009,8.419,5851.0,0.001434,0.9992989999999999,CYP20A1 EDN1 EPGN EPHA5 NQO2 STC2 ZNF311,positive regulation of vascular associated smooth muscle cell proliferation|positive regulation of mitotic nuclear division|positive regulation of signaling receptor activity|regulation of vascular associated smooth muscle cell proliferation|positive regulation of nuclear division,6.2e-05|9.729e-05|0.0001062|0.0001457|0.0001678,0.978|0.7673|0.5584|0.5746|0.5293,173.1|136.8|130.8|111|103.2
1251,19,0.4052,69.29,15230.0,0.004517,1.0,ATP9A BCAS1 BMP7 CASS4 CTSZ CYP24A1 FAM209A FAM209B MTRNR2L3 NPBWR2 OPRL1 PMEPA1 PPDPF RBM38 SLC2A4RG STX16 TFAP2C ZGPAT ZNF831,opioid receptor signaling pathway|response to vitamin D|regulation of pathway-restricted SMAD protein phosphorylation|negative regulation of signaling receptor activity|steroid hormone mediated signaling pathway,5.283e-05|0.0003448|0.001568|0.001768|0.00209,0.8333|1|1|1|1,216.8|77.42|34.97|32.85|30.11
1252,6,0.4074,6.111000000000001,4887.0,0.0012460000000000001,0.998474,ADGRG7 CDKL2 CYP2E1 RAB31 SLC35F1 SOWAHA,4-nitrophenol metabolic process|benzene metabolic process|carbon tetrachloride metabolic process|halogenated hydrocarbon metabolic process|response to ozone,0.0005824|0.0005824|0.0005824|0.0008735|0.001456,1|1|1|1|1,3432|3432|3432|1716|858.1
1253,6,0.4095,6.143,4845.0,0.001263,0.998474,BFAR CTNNBIP1 CYP2J2 GDPD3 LRRC42 RSBN1L,"regulation of vascular permeability involved in acute inflammatory response|N-acylethanolamine metabolic process|negative regulation of IRE1-mediated unfolded protein response|negative regulation of transcription initiation from RNA polymerase II promoter|negative regulation of DNA-templated transcription, initiation",0.001456|0.001746|0.001746|0.001746|0.002037,1|1|1|1|1,858.1|686.5|686.5|686.5|572.1
1254,7,0.4132,8.677,5587.0,0.001547,0.9992989999999999,CTSH CYP2R1 HSBP1L1 KCNIP2 NAT14 OTX2 SFTPA2,response to cesium ion|dichotomous subdivision of terminal units involved in lung branching|neuropeptide catabolic process|clustering of voltage-gated potassium channels|positive regulation of potassium ion export across plasma membrane,0.0006794|0.001019|0.001019|0.001358|0.001358,1|1|1|1|1,2942|1471|1471|980.7|980.7
1255,5,0.436,4.36,3896.0,0.001115,0.996692,CYP2U1 DEFB118 NHLH2 OSMR PHLDA3,male mating behavior|oncostatin-M-mediated signaling pathway|leukemia inhibitory factor signaling pathway|omega-hydroxylase P450 pathway|membrane disruption in other organism,0.00194|0.00194|0.002425|0.002425|0.002667,1|1|1|1|1,588.4|588.4|457.7|457.7|411.9
1256,5,0.432,4.32,4038.0,0.001066,0.996692,CHRNA3 CYP39A1 FREM3 GPBP1L1 ICAM4,"synaptic transmission involved in micturition|regulation of acetylcholine secretion, neurotransmission|micturition|regulation of synaptic transmission, cholinergic|behavioral response to nicotine",0.0009706|0.0009706|0.001698|0.001698|0.001698,1|1|1|1|1,1373|1373|686.5|686.5|686.5
1257,24,0.4013,110.7,17190.0,0.006384,1.0,CYP4F11 CYP4F12 CYP4F2 GMIP MEF2B OR10H2 OR7C1 OR7C2 ZNF100 ZNF101 ZNF14 ZNF195 ZNF253 ZNF43 ZNF443 ZNF486 ZNF492 ZNF682 ZNF69 ZNF714 ZNF737 ZNF91 ZNF98 ZNF99,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",7.19e-11|7.358e-09|7.391e-09|7.56e-09|2.409e-08,1.134e-06|5.803e-05|3.886e-05|2.981e-05|7.6e-05,5.641|4.211|4.21|4.204|3.903
1258,23,0.4055,102.6,16450.0,0.006179,1.0,CYP4F11 CYP4F12 CYP4F2 CYP4F22 CYP4F3 MEF2B OR10H2 OR7A5 OR7C1 OR7C2 ZNF14 ZNF195 ZNF253 ZNF43 ZNF486 ZNF492 ZNF625 ZNF682 ZNF714 ZNF737 ZNF91 ZNF98 ZNF99,vitamin K catabolic process|menaquinone catabolic process|quinone catabolic process|leukotriene B4 catabolic process|leukotriene catabolic process,8.21e-11|8.21e-11|1.477e-10|1.477e-10|1.477e-10,1.295e-06|6.475e-07|7.765e-07|5.824e-07|4.659e-07,895.4|895.4|716.3|716.3|716.3
1259,5,0.4322,4.322,3914.0,0.0011,0.996692,CYP4V2 ESYT2 GOLGA8N NLRP11 SWI5,fatty acid omega-oxidation|endoplasmic reticulum-plasma membrane tethering|endoplasmic reticulum localization|endomembrane system organization|biological regulation,0.001456|0.001698|0.002667|0.005384|0.008988,1|1|1|1|1,823.8|686.5|411.9|16.88|0
1260,6,0.4038,6.056,4744.0,0.0012720000000000001,0.998474,AUH CYP7B1 FBXL22 RBBP6 USP29 ZNF177,"organonitrogen compound catabolic process|ubiquitin-dependent protein catabolic process|modification-dependent protein catabolic process|modification-dependent macromolecule catabolic process|putrescine biosynthetic process from arginine, using agmatinase",0.0002347|0.0005669|0.0005888|0.0006244|0.0006794,1|1|1|1|1,10.9|16.56|16.35|16.02|2942
1261,30,0.4026,175.1,23520.0,0.007373,1.0,ABHD14A ABHD14B CCR2 CCR3 CCR5 CCR8 CCR9 CYP8B1 FAM198A GLYCTK GNAT1 HYAL1 IQCF1 IQCF2 IQCF3 IQCF5 ITIH3 ITIH4 KLHDC8B KRBOX1 LTF MUSTN1 PFKFB4 SCN10A SCN11A SEMA3G TLR9 VILL XCR1 ZNF502,chemokine-mediated signaling pathway|cellular response to chemokine|response to chemokine|calcium-mediated signaling|cell chemotaxis,1.803e-09|3.55e-09|3.55e-09|5.763e-08|3.832e-07,2.845e-05|2.8e-05|1.866e-05|0.0002273|0.001209,53.94|47.88|47.88|29.39|21.09
1262,5,0.4209,4.209,3912.0,0.001072,0.996692,ABHD10 CYR61 NRG4 PTX3 WRN,positive regulation of cell proliferation in midbrain|positive regulation of strand invasion|regulation of strand invasion|regulation of cell proliferation in midbrain|response to glial cell derived neurotrophic factor,0.0004854|0.0004854|0.0004854|0.000728|0.000728,1|1|1|0.8834|0.957,4119|4119|4119|2060|2060
1263,5,0.4505,4.505,3943.0,0.001139,0.996692,BCL7C CELA2A CGREF1 CYSRT1 LRRC49,insulin catabolic process|insulin metabolic process|regulation of platelet aggregation|outer dynein arm assembly|regulation of homotypic cell-cell adhesion,0.0009706|0.001456|0.005329|0.005329|0.007261,1|1|1|1|1,1373|823.8|196.1|196.1|142
1264,6,0.4107,6.16,4713.0,0.001302,0.998474,BCL6B CYTH1 IL1RN LGALS3BP PKP3 PPRC1,desmosome assembly|negative regulation of interleukin-1-mediated signaling pathway|regulation of interleukin-1-mediated signaling pathway|type 2 immune response|negative regulation of heterotypic cell-cell adhesion,0.001456|0.001746|0.002619|0.002909|0.0032,1|1|1|1|1,858.1|686.5|429.1|381.4|343.2
1265,6,0.4321,6.481,4869.0,0.001326,0.998474,D2HGDH HSPH1 IL20RA RBM24 SMAD9 VLDLR,glycoprotein transport|positive regulation of skeletal muscle fiber differentiation|regulation of skeletal muscle fiber differentiation|positive regulation of 3'-UTR-mediated mRNA stabilization|positive regulation of MHC class I biosynthetic process,0.001165|0.001165|0.001456|0.001746|0.002037,1|1|1|1|1,1144|1144|858.1|686.5|572.1
1266,7,0.4411,9.262,5651.0,0.001632,0.9992989999999999,BBS9 CRYZ CUL4A DAAM1 S100A11 SPATA18 ZUP1,mitophagy by induced vacuole formation|regulation of nucleotide-excision repair|mitochondrial protein catabolic process|visual perception|sensory perception of light stimulus,0.0006794|0.001698|0.002037|0.00226|0.002342,1|1|1|1|1,2942|735.5|588.4|27.24|26.75
1267,6,0.4409,6.614,4708.0,0.001399,0.998474,ANKRD13B CHRDL2 DAAM2 EGFLAM SIAE TEX19,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|negative regulation of oligodendrocyte differentiation|negative regulation of receptor internalization|dorsal spinal cord development|animal organ development,0.002037|0.00349|0.004071|0.006101|0.006624,1|1|1|1|1,572.1|312|264|171.6|4.308
1268,5,0.4407,4.407,4045.0,0.001086,0.996692,CPO DACT2 DOK6 LMAN2L OSTM1,inner medullary collecting duct development|negative regulation of nodal signaling pathway|regulation of nodal signaling pathway|protoporphyrinogen IX biosynthetic process|negative regulation of activin receptor signaling pathway,0.001165|0.001456|0.002619|0.002909|0.00349,1|1|1|1|1,1144|858.1|429.1|381.4|312
1269,6,0.4047,6.07,4931.0,0.0012259999999999999,0.998474,C4orf51 CLCA2 DALRD3 NCEH1 SLC22A3 UTRN,epinephrine uptake|arginyl-tRNA aminoacylation|histamine uptake|epinephrine transport|imidazole-containing compound metabolic process,0.0008735|0.001165|0.001165|0.001456|0.002037,1|1|1|1|1,1716|1144|1144|858.1|572.1
1270,4,0.4493,2.696,2819.0,0.0009529,0.9929309999999999,CEP112 DAPK1 DTL GMNN,DNA replication preinitiation complex assembly|DNA replication|cellular response to hydroperoxide|signal transduction involved in G2 DNA damage checkpoint|positive regulation of chromatin binding,0.0007766|0.001032|0.001747|0.002522|0.00291,1|1|1|1|1,1716|38|643.6|429.1|367.8
1271,8,0.4012,11.23,5995.0,0.001865,0.9996790000000001,ADCY6 ANKMY2 CMIP DAPP1 GPR3 PDE7A PTGES3 RIC8B,cAMP metabolic process|cyclic nucleotide metabolic process|G protein-coupled receptor signaling pathway|adenylate cyclase-activating G protein-coupled receptor signaling pathway|cellular response to vasopressin,3.626e-05|0.0001182|0.0009888|0.00118|0.001552,0.5719|0.9322|1|1|1,234|125.6|7.748|38.42|858.1
1272,24,0.4041,111.5,17170.0,0.006436,1.0,CLEC17A CYP4F11 CYP4F12 CYP4F2 MEF2B OR10H1 OR10H2 OR10H5 OR7C1 OR7C2 ZNF195 ZNF253 ZNF43 ZNF486 ZNF492 ZNF625 ZNF682 ZNF69 ZNF714 ZNF737 ZNF763 ZNF91 ZNF98 ZNF99,regulation of transcription by RNA polymerase II|vitamin K catabolic process|menaquinone catabolic process|phylloquinone catabolic process|menaquinone metabolic process,1.336e-08|4.835e-08|4.835e-08|7.729e-08|7.729e-08,0.0002108|0.0003813|0.0002542|0.0001524|0.0001742,4.978|643.6|643.6|514.9|514.9
1273,4,0.4464,2.678,3143.0,0.0008493,0.9929309999999999,DBF4B ELMO1 MEST UCMA,positive regulation of nuclear cell cycle DNA replication|negative regulation of SMAD protein signal transduction|positive regulation of DNA-dependent DNA replication|regulation of nuclear cell cycle DNA replication|Rac protein signal transduction,0.001359|0.001553|0.002522|0.00291|0.004266,1|1|1|1|1,858.1|735.5|429.1|367.8|245.2
1274,5,0.4359,4.359,3940.0,0.001102,0.996692,DBN1 FETUB IVD PRR30 RECQL5,cell communication by chemical coupling|positive regulation of receptor localization to synapse|cellular response to camptothecin|response to camptothecin|leucine catabolic process,0.000728|0.001213|0.001213|0.001456|0.001698,1|1|1|1|1,2060|1030|1030|823.8|686.5
1275,6,0.4136,6.205,4920.0,0.001257,0.998474,ASB5 DBP IBSP LAMP3 PP2D1 UBASH3A,vitamin D metabolic process|vitamin transmembrane transport|regulation of protein catabolic process|negative regulation of T cell receptor signaling pathway|response to interferon-alpha,0.005763|0.006101|0.007367|0.008127|0.008465,1|1|1|1|1,183.9|173.1|14.82|127.9|122.6
1276,6,0.4145,6.218,4776.0,0.001297,0.998474,AKR1B10 CCDC150 DBT RARB STPG1 TMEM51,farnesol catabolic process|farnesol metabolic process|sesquiterpenoid catabolic process|sesquiterpenoid metabolic process|polyprenol catabolic process,0.0008735|0.0008735|0.0008735|0.001165|0.001165,1|1|1|1|1,1716|1716|1716|1144|1144
1277,6,0.4256,6.3839999999999995,4794.0,0.001327,0.998474,AFM ATF7 C18orf54 DBX2 DNAJC5B VDAC1,negative regulation of calcium import into the mitochondrion|protein transport within extracellular region|regulation of calcium import into the mitochondrion|positive regulation of mitophagy|neuron-neuron synaptic transmission,0.0005824|0.0005824|0.0008735|0.0008735|0.002037,1|1|1|1|1,3432|3432|1716|1716|572.1
1278,5,0.4475,4.475,4014.0,0.001111,0.996692,CACNA2D1 DCAF12 LCN12 OR2M5 POLK,membrane depolarization during bundle of His cell action potential|calcium ion transmembrane transport via high voltage-gated calcium channel|positive regulation of high voltage-gated calcium channel activity|bundle of His cell action potential|bundle of His cell to Purkinje myocyte signaling,0.0009706|0.0009706|0.001456|0.001456|0.001456,1|1|1|1|1,1373|1373|823.8|823.8|823.8
1279,24,0.4017,110.9,19000.0,0.005786,1.0,APBB2 CHRNA9 CNGA1 CORIN CWH43 GABRA2 GABRA4 GABRB1 GABRG1 MRFAP1L1 NIPAL1 OCIAD1 OCIAD2 SLC10A4 TEC TLR1 TLR10 TLR6 TXK USP17L10 USP17L13 USP17L5 WDR19 ZAR1,"gamma-aminobutyric acid signaling pathway|regulation of postsynaptic membrane potential|synaptic transmission, GABAergic|chloride transmembrane transport|chloride transport",5.171e-08|1.524e-07|1.269e-06|6.337e-06|7.971e-06,0.0008156|0.001202|0.006674|0.02499|0.02515,122|41.19|164.8|33.97|31.99
1280,5,0.443,4.43,3797.0,0.0011619999999999998,0.996692,DCAF4 FKBP15 KIAA1671 NR1D1 PIWIL3,negative regulation of astrocyte activation|circadian temperature homeostasis|positive regulation of bile acid biosynthetic process|positive regulation of bile acid metabolic process|regulation of astrocyte activation,0.000728|0.0009706|0.0009706|0.0009706|0.001213,1|1|1|1|1,2060|1373|1373|1373|1030
1281,5,0.4209,4.209,3845.0,0.001091,0.996692,CNDP2 DCC NPPA PDLIM1 POMGNT2,neuron migration|negative regulation of collecting lymphatic vessel constriction|regulation of collecting lymphatic vessel constriction|negative regulation of cell growth|cell migration,0.0003217|0.0004854|0.0004854|0.0008222|0.0009632,1|1|1|1|1,71.02|4119|4119|44.05|12.81
1282,7,0.4071,8.549,5709.0,0.001492,0.9992989999999999,CCL21 DCD GHRHR HSD17B1 RAB3C RADIL VWC2,killing of cells of other organism|antimicrobial humoral immune response mediated by antimicrobial peptide|somatotropin secreting cell development|negative regulation of dendritic cell dendrite assembly|positive regulation of myeloid dendritic cell chemotaxis,0.0003568|0.0005314|0.0006794|0.0006794|0.0006794,1|1|1|1|1,70.05|57.13|2942|2942|2942
1283,6,0.4046,6.069,4880.0,0.001239,0.998474,DCHS2 DDO RGS22 TCF15 TELO2 TTI1,regulation of TOR signaling|D-amino acid catabolic process|positive regulation of TORC2 signaling|regulation of TORC2 signaling|D-amino acid metabolic process,0.0003524|0.0008735|0.0008735|0.0008735|0.001165,1|1|1|1|1,69.34|1716|1716|1716|1144
1284,6,0.4042,6.063,4939.0,0.0012230000000000001,0.998474,CPPED1 DCK EFCAB13 FAM118A HMBS NUGGC,peptidyl-pyrromethane cofactor linkage|dAMP biosynthetic process|purine deoxyribonucleoside monophosphate biosynthetic process|dAMP metabolic process|purine deoxyribonucleoside monophosphate metabolic process,0.0005824|0.0008735|0.0008735|0.001165|0.001746,1|1|1|1|1,3432|1716|1716|1144|686.5
1285,14,0.4067,37.01,11140.0,0.003303,0.9999969999999999,ATP12A C1QTNF9 C1QTNF9B CKAP2 DCLK1 GJB2 GJB6 HTR2A POSTN RNF6 RXFP2 SOHLH2 SPATA13 ZAR1L,gap junction-mediated intercellular transport|intercellular transport|gap junction assembly|cell communication by electrical coupling|sensory perception of mechanical stimulus,1.197e-05|1.539e-05|1.922e-05|9.822e-05|0.000208,0.1888|0.1213|0.1011|0.3873|0.6561,490.4|420.3|367.8|147.1|25.51
1286,6,0.4028,6.042000000000001,4815.0,0.00125,0.998474,DCLK3 OR2T35 PCDHB15 RETREG2 SCN8A ZC3H14,negative regulation of mRNA polyadenylation|negative regulation of mRNA 3'-end processing|regulation of mRNA polyadenylation|neuronal action potential|regulation of mRNA 3'-end processing,0.002619|0.002909|0.005232|0.008418|0.008418,1|1|1|1|1,429.1|381.4|201.9|122.6|122.6
1287,25,0.3859,115.8,18670.0,0.006146,1.0,BCL6 CD19 CD79A CD79B CD81 CYB561A3 DCLRE1A DOCK2 EBF1 ELMO1 GNAI2 KLHL6 LDLRAP1 LRP10 MEF2B ODC1 PAX5 POU2AF1 POU2F2 RAC2 RHOH RNF121 SRM SYK TOX,leukocyte differentiation|lymphocyte differentiation|lymphocyte activation|mononuclear cell differentiation|hemopoiesis,4.515e-13|5.522e-13|1.329e-12|2.243e-12|7.261e-11,7.122e-09|4.355e-09|6.987e-09|8.845e-09|2.291e-07,23.77|30.76|21.46|26.58|14.67
1288,8,0.4069,11.39,6422.0,0.0017670000000000001,0.9996790000000001,B4GALNT3 DCP1B ERC1 NRIP2 SLC6A12 SLCO1B1 SLCO1C1 WNT5B,sodium-independent organic anion transport|monocarboxylic acid transport|bile acid and bile salt transport|carboxylic acid transport|organic acid transport,2.012e-05|2.275e-05|8.257e-05|9.677e-05|0.0001379,0.3174|0.1794|0.4342|0.3816|0.435,321.8|50.81|151.4|31.02|27.48
1289,8,0.7068,19.79,5644.0,0.0034840000000000006,0.9996790000000001,DCP2 DDX6 EDC3 EDC4 EIF4ENIF1 LSM14A PNRC2 XRN1,methylguanosine-cap decapping|nuclear-transcribed mRNA catabolic process|negative regulation of gene expression|RNA decapping|P-body assembly,1.694e-11|2.272e-11|2.387e-11|2.848e-11|2.848e-11,2.672e-07|1.792e-07|1.255e-07|1.123e-07|8.984e-08,858.1|78.81|21.36|735.5|735.5
1290,6,0.4232,6.348,4858.0,0.001302,0.998474,B3GNT7 DCSTAMP PAX9 PGPEP1L UPK3A USH2A,urinary bladder development|anatomical structure morphogenesis|maintenance of animal organ identity|positive regulation of macrophage fusion|regulation of macrophage fusion,0.001456|0.001463|0.001746|0.001746|0.001746,1|1|1|1|1,858.1|6.431|686.5|686.5|686.5
1291,14,0.4077,37.1,9698.0,0.0038,0.9999969999999999,ACTR10 ACTR1A DCTN1 DCTN2 DCTN3 DCTN4 DCTN5 DCTN6 DYNC1LI2 DYNLRB1 NDE1 SGO1 SPDL1 VEZT,antigen processing and presentation of exogenous peptide antigen via MHC class II|antigen processing and presentation of peptide antigen via MHC class II|antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|antigen processing and presentation of exogenous peptide antigen|antigen processing and presentation of exogenous antigen,4.153e-18|4.928e-18|5.362e-18|6.613e-16|9.704e-16,6.551e-14|3.887e-14|2.819e-14|2.608e-12|3.061e-12,133.7|131.1|129.8|74.38|71.18
1292,11,0.4045,22.25,8754.0,0.002529,0.999969,BIVM CLYBL COL4A1 DCUN1D2 F10 F7 KDELC1 SLITRK5 TMCO3 ZIC2 ZIC5,"negative regulation of blood coagulation, extrinsic pathway|regulation of blood coagulation, extrinsic pathway|blood coagulation, extrinsic pathway|negative regulation of protein activation cascade|regulation of protein activation cascade",3.882e-06|3.882e-06|3.882e-06|1.705e-05|2.014e-05,0.06123|0.03061|0.02041|0.06723|0.06355,936.1|936.1|936.1|374.5|340.4
1293,7,0.4105,8.62,5603.0,0.001532,0.9992989999999999,DDAH2 ENPP4 FRS3 GUCA1A PRICKLE4 PRR3 WNT9B,mesonephric duct formation|establishment of planar polarity involved in nephron morphogenesis|mesenchymal stem cell maintenance involved in nephron morphogenesis|non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation|mesonephric duct morphogenesis,0.0007765|0.0007765|0.001164|0.001164|0.001552,1|1|1|1|1,2574|2574|1287|1287|858.1
1294,12,0.4163,27.48,9874.0,0.002768,0.999986,ARSB BHMT CD180 F2R F2RL2 FST GAPT GPBP1 ITGA2 NDUFS4 PLK2 RAB3C,B cell proliferation involved in immune response|thrombin-activated receptor signaling pathway|cell population proliferation|positive regulation of collagen biosynthetic process|positive regulation of collagen metabolic process,8.687e-06|1.705e-05|0.000125|0.0001251|0.000134,0.137|0.1345|0.6574|0.4934|0.4228,572.1|381.4|14.39|127.1|122.6
1295,11,0.4045,22.25,7103.0,0.003113,0.999969,ACTR1A DDX11 DYNC1LI1 DYNC1LI2 DYNLRB1 ESCO2 NDE1 PAFAH1B1 SGO1 SRSF10 ZWINT,biological phase|mitotic cell cycle phase|cell cycle phase|mitotic prometaphase|anaphase,1.075e-13|1.075e-13|1.075e-13|8.698e-13|9.988e-11,1.695e-09|8.475e-10|5.65e-10|3.43e-09|3.151e-07,58.28|58.28|58.28|78.48|71.55
1296,9,0.407,14.65,7103.0,0.002053,0.9998530000000001,A1BG DDX25 MZF1 PCMTD2 PPP2R1B SLC27A5 TTC39B ZBTB45 ZNF324,triglyceride mobilization|long-chain fatty acid import across plasma membrane|positive regulation of extrinsic apoptotic signaling pathway in absence of ligand|ketone body biosynthetic process|negative regulation of cholesterol storage,0.002182|0.002182|0.00436|0.00436|0.00436,1|1|1|1|1,572.1|572.1|254.3|254.3|254.3
1297,5,0.4049,4.0489999999999995,3830.0,0.001053,0.996692,CLDND2 DDX27 FGB IL26 NAGLU,positive regulation of ERK1 and ERK2 cascade|induction of bacterial agglutination|regulation of ERK1 and ERK2 cascade|retinal rod cell development|plasminogen activation,0.000985|0.001456|0.00196|0.002667|0.00291,1|1|1|1|1,40.19|823.8|28.31|411.9|374.5
1298,10,0.4014,18.06,6816.0,0.002635,0.999933,API5 CHTOP DDX39A DDX39B RBM33 SARNP THOC5 THOC6 THOC7 XPO4,protein export from nucleus|nuclear export|mRNA 3'-end processing|mRNA export from nucleus|mRNA-containing ribonucleoprotein complex export from nucleus,4.921e-16|9.756e-16|4.195e-15|1.996e-14|1.996e-14,7.762e-12|7.694e-12|2.206e-11|7.87e-11|6.296e-11,108.4|99.25|163.8|129.9|129.9
1299,23,0.3892,98.47,16220.0,0.006017,1.0,ANLN CCT6A DDX56 EIF3B GARS HUS1 INTS1 LSM5 MALSU1 MRPL32 MRPS24 NUDCD3 POLD2 PSMA2 PSMG1 PSMG2 PSMG3 RPA3 SEC61G TRA2B TWISTNB YAE1 YKT6,chaperone-mediated protein complex assembly|protein-containing complex subunit organization|cellular macromolecule biosynthetic process|mitochondrial translation|macromolecule biosynthetic process,2.76e-06|5.217e-06|7.839e-06|8.951e-06|9.737e-06,0.04353|0.04115|0.04122|0.0353|0.03072,122.6|5.428|5.185|30.92|5.06
1300,19,0.3857,65.95,14490.0,0.004520000000000001,1.0,CHRM1 FERMT3 HRASLS2 HRASLS5 NUDT22 OCM2 PLA2G16 RARRES3 RASGRP2 SCGB1D1 SCGB1D2 SCGB1D4 SCGB2A1 SCGB2A2 SLC22A10 SLC22A9 SLC25A45 SYT7 TIGD3,N-acylphosphatidylethanolamine metabolic process|phosphatidylethanolamine metabolic process|androgen receptor signaling pathway|phosphatidylethanolamine acyl-chain remodeling|intracellular steroid hormone receptor signaling pathway,1.224e-07|3.289e-06|0.0001356|0.0002686|0.0009666,0.001931|0.02594|0.7128|1|1,381.4|110.7|127.1|88.01|44.87
1301,6,0.4048,6.072,4740.0,0.001276,0.998474,DDX60L FBXL3 FYB1 HIBADH MPPED2 ZNF845,valine catabolic process|valine metabolic process|branched-chain amino acid catabolic process|branched-chain amino acid metabolic process|entrainment of circadian clock by photoperiod,0.001456|0.002328|0.006391|0.00726|0.008707,1|1|1|1|1,858.1|490.4|163.5|143|118.4
1302,12,0.4,26.4,9593.0,0.002738,0.999986,C22orf46 CERK CSDC2 DESI1 MEI1 PARVB PMM1 PNPLA5 SEPT3 SMDT1 SULT4A1 TTLL12,establishment or maintenance of cell polarity regulating cell shape|GDP-mannose biosynthetic process|protein desumoylation|GDP-mannose metabolic process|mannose metabolic process,0.001746|0.003489|0.00523|0.00523|0.005809,1|1|1|1|1,858.1|343.2|214.5|214.5|190.7
1303,6,0.4235,6.352,5014.0,0.0012619999999999999,0.998474,AP4M1 CD74 DECR1 EMX2 FAM166B TRAM1,macrophage migration inhibitory factor signaling pathway|positive regulation of macrophage migration inhibitory factor signaling pathway|regulation of macrophage migration inhibitory factor signaling pathway|negative regulation of mature B cell apoptotic process|regulation of mature B cell apoptotic process,0.0006794|0.001019|0.001358|0.001358|0.001358,1|1|1|1|1,2942|1471|980.7|980.7|980.7
1304,5,0.424,4.24,3884.0,0.001088,0.996692,CCL16 DEFB1 PPFIA2 RARS ZNF385D,positive regulation of flagellated sperm motility involved in capacitation|arginyl-tRNA aminoacylation|dense core granule transport|dense core granule cytoskeletal transport|dense core granule localization,0.0009706|0.0009706|0.002425|0.002425|0.002425,1|1|1|1|1,1373|1373|457.7|457.7|457.7
1305,5,0.4112,4.112,3894.0,0.001052,0.996692,CC2D1B DEFB110 KIFC2 KIR3DL3 TMEM163,zinc ion import into synaptic vesicle|zinc ion import into organelle|mitotic nuclear division|nuclear division|organelle fission,0.000728|0.000728|0.001023|0.002659|0.003137,1|1|1|1|1,2060|2060|39.42|24.23|22.26
1306,6,0.4046,6.069,4790.0,0.0012619999999999999,0.998474,DEFB113 GRM5 MEIG1 OR6T1 SEC31B TYR,"phospholipase C-activating G protein-coupled glutamate receptor signaling pathway|melanin biosynthetic process from tyrosine|eye pigment biosynthetic process|trans-synaptic signaling by endocannabinoid, modulating synaptic transmission|trans-synaptic signaling by lipid, modulating synaptic transmission",0.0008735|0.0008735|0.001165|0.001165|0.001165,1|1|1|1|1,1716|1716|1144|1144|1144
1307,6,0.4315,6.473,4936.0,0.001306,0.998474,CTGF DEFB114 DPYSL3 SLC39A3 ZNF429 ZNF480,antifungal innate immune response|negative regulation of lipopolysaccharide-mediated signaling pathway|actin crosslink formation|negative regulation of multi-organism process|zinc ion transmembrane transport,0.001456|0.003394|0.003636|0.005087|0.006054,1|1|1|1|1,823.8|316.8|294.2|205.9|171.6
1308,21,0.4007,84.15,16310.0,0.005118,1.0,BPIFB4 CCM2L COX4I2 CPNE1 DEFB115 DEFB116 DEFB118 DEFB119 DEFB121 DEFB123 DEFB124 DUSP15 FOXS1 HCK HM13 MYLK2 NECAB3 NOL4L REM1 TM9SF4 XKR7,defense response to bacterium|response to bacterium|innate immune response|defense response to other organism|defense response,3.773e-08|3.083e-07|1.001e-06|4.611e-06|4.581e-05,0.0005951|0.002432|0.005264|0.01819|0.1445,19.9|10.93|9.34|7.602|5.541
1309,7,0.4157,8.73,6094.0,0.0014269999999999999,0.9992989999999999,ACAD10 C10orf113 CD52 DEFB125 ENTHD1 NTRK2 SLC17A8,"acidic amino acid transport|neural retina development|dicarboxylic acid transport|fatty acid transport|trans-synaptic signaling by neuropeptide, modulating synaptic transmission",0.0001457|0.0002432|0.0003244|0.000648|0.0006794,1|1|1|1|1,111|85.28|73.55|51.62|2942
1310,5,0.4272,4.272,3917.0,0.0010869999999999999,0.996692,C12orf57 DEFB126 GCDH GRXCR2 RNF157,third ventricle development|psychomotor behavior|corpus callosum morphogenesis|sensory organ morphogenesis|fatty acid beta-oxidation using acyl-CoA dehydrogenase,0.001213|0.001213|0.001456|0.001548|0.002667,1|1|1|1|1,1030|1030|823.8|31.93|411.9
1311,19,0.4013,68.63,14280.0,0.00477,1.0,AIF1 BTN2A1 BTN2A2 C6orf48 HLA-A HLA-B HLA-C HLA-F HLA-G MICB MSH5 OR14J1 OR2J2 OR2J3 PSORS1C2 TAPBP TCF19 TRIM10 TRIM26,"antigen processing and presentation of endogenous peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen|antigen processing and presentation of endogenous antigen|antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent|antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway",1.745e-14|3.059e-14|1.56e-13|3.543e-13|3.543e-13,2.753e-10|2.413e-10|8.201e-10|1.397e-09|1.118e-09,403.8|361.3|264|715.1|715.1
1312,12,0.4029,26.59,8470.0,0.00312,0.999986,BIRC6 DELE1 DNAJC7 EIF2AK1 HECTD1 KCMF1 OMA1 OPA3 PPP1R15B TDGF1 UBA6 UBR4,HRI-mediated signaling|integrated stress response signaling|cellular protein metabolic process|protein ubiquitination|cellular protein modification process,5.273e-09|1.995e-07|2.239e-05|3.931e-05|6.101e-05,8.318e-05|0.001573|0.1177|0.155|0.1925,1287|286|4.24|11.58|4.548
1313,6,0.4277,6.415,4920.0,0.001299,0.998474,CEP131 DENND1B MPP3 RHOJ TMEM131L ZNF480,"intramanchette transport|T-helper 2 cell cytokine production|T cell cytokine production|CD4-positive, alpha-beta T cell cytokine production|manchette assembly",0.0005824|0.0008735|0.001165|0.001165|0.001456,1|1|1|1|1,3432|1716|1144|1144|858.1
1314,5,0.4211,4.211,3803.0,0.001103,0.996692,ANKHD1 C1orf74 DENR EIF4EBP3 KY,translation reinitiation|ribosome disassembly|formation of translation preinitiation complex|IRES-dependent viral translational initiation|viral translation,0.001213|0.002183|0.00291|0.00291|0.004845,1|1|1|1|1,1030|514.9|374.5|374.5|216.8
1315,5,0.4271,4.271,3955.0,0.001076,0.996692,AGMAT COL12A1 DEPDC1B INTU OR1D2,"putrescine biosynthetic process from arginine, using agmatinase|putrescine biosynthetic process from arginine|agmatine biosynthetic process|spermidine biosynthetic process|primary amino compound biosynthetic process",0.0004854|0.0004854|0.000728|0.0009706|0.001456,1|1|1|1|1,4119|4119|2060|1373|823.8
1316,6,0.4107,6.16,4784.0,0.001283,0.998474,C17orf78 CCDC14 DEPTOR HRCT1 IFRD2 SLC2A10,negative regulation of proteoglycan biosynthetic process|negative regulation of connective tissue growth factor production|galactose transmembrane transport|negative regulation of integrin-mediated signaling pathway|regulation of connective tissue growth factor production,0.0005824|0.0005824|0.0008735|0.001165|0.001165,1|1|1|1|1,3432|3432|1716|1144|1144
1317,7,0.401,8.42,5192.0,0.001615,0.9992989999999999,DERA LINS1 METTL23 NOSIP PPIH RTP4 SCNM1,"deoxyribonucleoside catabolic process|negative regulation of nitric-oxide synthase activity|deoxyribonucleoside metabolic process|cognition|mRNA splicing, via spliceosome",0.001358|0.003054|0.003054|0.004119|0.00434,1|1|1|1|1,980.7|367.8|367.8|20.01|19.48
1318,5,0.4592,4.592,4205.0,0.001088,0.996692,DES EPS8L2 FBXL20 FHDC1 ORMDL3,"negative regulation of serine C-palmitoyltransferase activity|regulation of protein catabolic process at presynapse, modulating synaptic transmission|cellular sphingolipid homeostasis|negative regulation of ceramide biosynthetic process|regulation of serine C-palmitoyltransferase activity",0.0004854|0.000728|0.001456|0.001456|0.001456,1|1|1|1|1,4119|2060|823.8|823.8|823.8
1319,6,0.4119,6.178,5020.0,0.0012259999999999999,0.998474,DESI2 FAM20C NEU4 OC90 SCARA3 ZDHHC18,biomineralization|biomineral tissue development|otolith mineralization|odontoblast differentiation|ganglioside catabolic process,0.0003053|0.0003053|0.0008735|0.001165|0.002328,1|1|1|1|1,74.62|74.62|1716|1144|490.4
1320,5,0.4464,4.4639999999999995,4048.0,0.001099,0.996692,DEUP1 FAM81B PDIA6 PROB1 TOPORS,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation|de novo centriole assembly|multi-ciliated epithelial cell differentiation|retinal rod cell development|retinal cone cell differentiation,0.001456|0.001456|0.002425|0.002667|0.00291,1|1|1|1|1,823.8|823.8|457.7|411.9|374.5
1321,27,0.4027,141.3,22910.0,0.006116,1.0,AARD C8orf44 C8orf76 CA1 CA13 CA2 CA3 CA8 CNGB3 COL14A1 CPA6 CYP7A1 FABP12 FABP4 KLHL38 MCMDC2 MTSS1 NOV PKIA PMP2 PPDPFL RNF139 SGK3 SLC30A8 TMEM69 TRIM55 UBE2W,one-carbon metabolic process|bicarbonate transport|organic anion transport|cellular response to fluid shear stress|triglyceride catabolic process,3.995e-09|4.938e-07|0.0001086|0.0003571|0.0007571,6.302e-05|0.003894|0.571|1|1,91.05|67.64|10.44|78.91|52.61
1322,7,0.401,8.421,5755.0,0.001458,0.9992989999999999,AGBL3 ATP6V0A4 DGCR2 DLL3 FAM200A NSG2 THAP5,compartment pattern specification|protein side chain deglutamylation|protein deglutamylation|paraxial mesoderm development|clathrin coat assembly,0.001698|0.002037|0.003054|0.006439|0.006439,1|1|1|1|1,735.5|588.4|367.8|163.5|163.5
1323,5,0.4305,4.305,3955.0,0.001084,0.996692,DGKB NLRP1 OPRM1 PANX1 ZNF235,positive regulation of interleukin-1 beta production|positive regulation of interleukin-1 production|regulation of interleukin-1 beta production|regulation of interleukin-1 production|response to bacterium,7.22e-05|9.744e-05|0.000183|0.0002499|0.000405,1|0.7685|0.9623|0.9857|1,152.6|130.8|94.69|80.76|17.21
1324,40,0.399,311.2,32050.0,0.009592,1.0,ERVV-2 FFAR3 GP6 GPR32 KIR2DL1 KIR2DL3 KLK11 KLK3 LAIR1 LAIR2 LILRA1 LILRA4 LILRB2 LILRB4 LILRB5 NLRP11 NLRP4 NLRP9 SHISA7 SIGLEC12 SPIB SULT2B1 VN1R4 ZFP28 ZNF28 ZNF304 ZNF415 ZNF524 ZNF528 ZNF534 ZNF581 ZNF587 ZNF610 ZNF665 ZNF667 ZNF701 ZNF772 ZNF773 ZNF880 ZSCAN5B,regulation of transcription by RNA polymerase II|regulation of gene expression|immune response-inhibiting cell surface receptor signaling pathway|immune response-inhibiting signal transduction|cellular metabolic process,1.926e-07|7.443e-07|1.279e-06|2.21e-06|1.645e-05,0.003038|0.00587|0.006723|0.008716|0.0519,3.603|2.516|183.9|147.1|0.1943
1325,5,0.4486,4.486000000000001,3943.0,0.001134,0.996692,DGKE ETNK2 MXRA8 TSTD2 TTLL6,establishment of glial blood-brain barrier|glycerophospholipid biosynthetic process|glycerolipid biosynthetic process|phospholipid biosynthetic process|glycerophospholipid metabolic process,0.000728|0.001122|0.001332|0.001524|0.002523,1|1|1|1|1,2060|37.62|34.47|32.18|24.89
1326,7,0.401,8.42,5836.0,0.001437,0.9992989999999999,ACOD1 COMMD6 DDO DGKH KATNAL1 PDX1 SIAH3,negative regulation of NF-kappaB transcription factor activity|organophosphate biosynthetic process|D-amino acid catabolic process|response to chlorate|tolerance induction to lipopolysaccharide,0.000508|0.0008655|0.001164|0.001164|0.001164,1|1|1|1|1,59.18|14.63|1287|1287|1287
1327,5,0.4547,4.547,4168.0,0.0010869999999999999,0.996692,DHCR24 GJD2 PCDHAC2 RXFP2 YIF1B,male sex differentiation|cholesterol biosynthetic process via lathosterol|cholesterol biosynthetic process via desmosterol|sex differentiation|plasminogen activation,0.0005614|0.001213|0.001213|0.001619|0.00291,1|1|1|1|1,53.49|1030|1030|31.2|374.5
1328,25,0.3612,108.4,18620.0,0.005772,1.0,ANO1 BBS1 CARNS1 CCDC36 CTTN FADD FGF19 FGF4 FOLR1 FOLR2 GSTP1 KRTAP5-1 KRTAP5-10 KRTAP5-11 KRTAP5-3 KRTAP5-9 MRGPRD MRGPRF MYEOV P2RY6 PLEKHB1 POLD4 TBX10 TESMIN TRIM49D1,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|cell differentiation,2.161e-07|5.739e-07|1.47e-06|4.38e-06|6.189e-06,0.003409|0.004526|0.00773|0.01727|0.01953,22.78|19.21|16.29|13.44|3.424
1329,8,0.4149,11.62,5505.0,0.0021,0.9996790000000001,CDK11A DDOST DHDDS GPN2 NUDC RPA2 SYF2 VPS13D,mitotic cell cycle|protein N-linked glycosylation|mitotic DNA damage checkpoint|mitotic DNA integrity checkpoint|positive regulation of mitophagy,0.0002046|0.0004879|0.0008877|0.0009567|0.00131,1|1|1|1|1,12.03|61.02|44.87|43.18|1144
1330,8,0.4112,11.51,5978.0,0.001917,0.9996790000000001,CCDC51 CDC42BPB DHH DNM1L KLHL12 MIEF1 SLC25A46 STARD7,mitochondrial fission|mitochondrial membrane fission|membrane fission|positive regulation of mitochondrial fission|regulation of mitochondrial fission,7.747e-08|7.913e-07|1.789e-05|2.249e-05|5.328e-05,0.001222|0.006241|0.09407|0.08867|0.1681,367.8|2574|343.2|302.9|190.7
1331,11,0.406,22.33,7199.0,0.003083,0.999969,ADAT2 CDIPT DHPS DOHH EIF5A EIF5AL1 FAM98B PYROXD1 RTCB RTRAF TTC4,"tRNA splicing, via endonucleolytic cleavage and ligation|RNA splicing, via endonucleolytic cleavage and ligation|tRNA processing|peptidyl-lysine modification to peptidyl-hypusine|tRNA metabolic process",9.194e-08|1.091e-07|5.779e-07|1.554e-06|1.976e-06,0.00145|0.0008609|0.003039|0.006126|0.006233,374.5|351.1|56.74|1872|41.38
1332,6,0.4345,6.518,4699.0,0.001382,0.998474,ALPK1 DHRS3 MAP2K2 RARG RPTN RXRA,retinoic acid receptor signaling pathway|intracellular receptor signaling pathway|bone morphogenesis|response to retinoic acid|hormone-mediated signaling pathway,1.481e-05|1.738e-05|0.0003524|0.0004179|0.0006101,0.2336|0.1371|1|1|1,361.3|52.54|69.34|63.56|52.4
1333,7,0.4009,8.419,5694.0,0.0014730000000000001,0.9992989999999999,CNTD2 DHRS7 HDDC3 LYPD5 MCTP2 MPZ WNT16,optic cup formation involved in camera-type eye development|oxidative stress-induced premature senescence|optic cup morphogenesis involved in camera-type eye development|stress-induced premature senescence|keratinocyte proliferation,0.001019|0.001698|0.002715|0.003054|0.004071,1|1|1|1|1,1471|735.5|420.3|367.8|267.5
1334,4,0.4605,2.763,3059.0,0.0009002000000000001,0.9929309999999999,C18orf63 CFHR2 DHRS7C IRF7,interferon-alpha production|interferon-beta production|MDA-5 signaling pathway|regulation of MyD88-dependent toll-like receptor signaling pathway|negative regulation of macrophage apoptotic process,0.0003883|0.0007766|0.0007766|0.0009706|0.0009706,1|1|1|1|1,5149|1716|1716|1287|1287
1335,6,0.4329,6.494,4496.0,0.001439,0.998474,ANAPC5 CLDN7 DHX37 KCNIP2 RSRC2 SBNO1,clustering of voltage-gated potassium channels|positive regulation of potassium ion export across plasma membrane|regulation of potassium ion export across plasma membrane|positive regulation of male gonad development|positive regulation of gonad development,0.001165|0.001165|0.002328|0.002909|0.0032,1|1|1|1|1,1144|1144|490.4|381.4|343.2
1336,27,0.4044,141.9,21560.0,0.006525,1.0,ACSF2 ADAM11 C17orf47 C17orf67 CSHL1 EPX HOXB5 HOXB6 HOXB7 HOXB9 LPO LRRC46 MKS1 MPO MYCBPAP NME1 NME2 OR4D1 OR4D2 OSBPL7 PLEKHM1 RSAD1 SCPEP1 SCRN2 SEPT4 TBKBP1 TBX21,embryonic skeletal system morphogenesis|hydrogen peroxide catabolic process|embryonic skeletal system development|hydrogen peroxide metabolic process|embryonic organ morphogenesis,7.738e-06|9.679e-06|2.091e-05|2.558e-05|3.611e-05,0.1221|0.07634|0.11|0.1009|0.1139,32.46|78.91|25.01|55.81|13.15
1337,7,0.4008,8.416,5904.0,0.0014199999999999998,0.9992989999999999,ASAP2 CH25H DHX58 DMRT1 DYSF HEPACAM2 TSN,monocyte activation involved in immune response|male germ cell proliferation|germ cell proliferation|positive regulation of meiosis I|positive regulation of MDA-5 signaling pathway,0.001019|0.001019|0.001019|0.001019|0.001698,1|1|1|1|1,1471|1471|1471|1471|735.5
1338,21,0.4073,85.52,14270.0,0.00594,1.0,AK6 C18orf21 C1D EXOSC1 EXOSC10 HEATR1 METAP1 NEPRO NOC4L NOL6 NOP9 PDCD11 POP1 POP4 POP5 POP7 RPP14 RPP30 RPP38 RPP40 RRP12,ncRNA processing|rRNA processing|rRNA metabolic process|ncRNA metabolic process|ribosome biogenesis,9.843e-25|8.047e-24|1.39e-23|1.932e-23|2.793e-22,1.553e-20|6.347e-20|7.308e-20|7.617e-20|8.811e-19,36.84|54.01|52.01|30.78|42.3
1339,15,0.4223,44.34,10050.0,0.004381,0.999999,DIAPH1 DIAPH3 FLII GNA13 LRRFIP2 LUZP1 MYH9 MYL12A MYL12B MYL6 PFN1 ROCK1 ROCK2 SIAH1 TMOD3,actin filament-based process|actin cytoskeleton organization|actomyosin structure organization|muscle contraction|muscle system process,6.72e-11|1.027e-09|1.086e-08|1.338e-08|3.671e-08,1.06e-06|8.096e-06|5.71e-05|5.276e-05|0.0001158,20.66|20.96|66.01|33.9|28.51
1340,16,0.4065,48.77,11260.0,0.0043,0.999999,AK6 C18orf21 C1D DIMT1 EXOSC1 EXOSC10 HEATR1 MTREX NOP9 POP4 PPWD1 RPS23 SRFBP1 UTP15 WDR43 ZCCHC9,rRNA processing|rRNA metabolic process|ribosome biogenesis|ncRNA processing|ribonucleoprotein complex biogenesis,1.912e-17|2.862e-17|2.615e-16|4.405e-15|9.707e-15,3.016e-13|2.257e-13|1.375e-12|1.737e-11|3.062e-11,51.25|49.36|40.14|30.85|28.66
1341,6,0.4246,6.369,4699.0,0.00135,0.998474,ALPG ATP13A1 C2orf40 DIO1 FZD5 WFDC1,negative regulation of cell population proliferation|vasopressin secretion|syncytiotrophoblast cell differentiation involved in labyrinthine layer development|positive regulation of corticosterone secretion|positive regulation of corticotropin-releasing hormone secretion,0.0006995|0.0008735|0.0008735|0.001165|0.001165,1|1|1|1|1,14.95|1716|1716|1144|1144
1342,5,0.4473,4.473,4192.0,0.0010630000000000001,0.996692,ACTG2 DIRAS1 GCM1 GPX8 PLSCR5,astrocyte fate commitment|regulation of cell differentiation involved in embryonic placenta development|mesenchyme migration|branching involved in labyrinthine layer morphogenesis|glial cell fate commitment,0.001213|0.001213|0.001456|0.003152|0.003394,1|1|1|1|1,1030|1030|823.8|343.3|316.8
1343,5,0.4439,4.439,4054.0,0.001091,0.996692,DGAT1 DIRC1 IYD NOTUM SLC15A3,protein depalmitoleylation|hormone metabolic process|peptidoglycan transport|dipeptide import across plasma membrane|oligopeptide import across plasma membrane,0.0004854|0.0008838|0.0009706|0.001456|0.001456,1|1|1|1|1,4119|42.46|1373|823.8|823.8
1344,8,0.4166,11.66,5924.0,0.00196,0.9996790000000001,DISP3 PRAMEF1 PRAMEF11 PRAMEF12 PRAMEF14 PRAMEF18 PRAMEF20 PRKACB,negative regulation of cell differentiation|negative regulation of developmental process|positive regulation of cell population proliferation|regulation of cell differentiation|regulation of cell population proliferation,2.222e-10|1.906e-09|3.072e-09|1.166e-07|1.534e-07,3.506e-06|1.504e-05|1.615e-05|0.0004596|0.0004841,28.25|20.71|19.34|11.43|10.99
1345,11,0.8778,48.28,7035.0,0.006795000000000001,0.999969,ALKBH8 CTU1 CTU2 DPH3 ELP5 ELP6 MOCS3 NR2C2AP PUS3 RNF25 URM1,tRNA wobble uridine modification|tRNA wobble base modification|tRNA modification|tRNA processing|RNA modification,3.194e-22|8.773e-22|5.127e-20|1.38e-18|1.246e-17,5.039e-18|6.919e-18|2.696e-16|5.443e-15|3.932e-14,832.1|713.2|187.2|127.7|99.12
1346,6,0.4071,6.107,4757.0,0.001279,0.998474,AARS DKK3 DNASE1L2 DZIP1 TANGO6 TCAP,negative regulation of anti-Mullerian hormone signaling pathway|regulation of anti-Mullerian hormone signaling pathway|corneocyte development|striated muscle myosin thick filament assembly|sarcomerogenesis,0.0004854|0.0004854|0.000728|0.0009706|0.0009706,1|1|1|1|1,4119|4119|2060|1373|1373
1347,32,0.3951,196.0,26560.0,0.007305,1.0,C5AR1 C5AR2 CABP5 CALM3 CBLC CCDC61 CRX DKKL1 EML2 FFAR3 FLT3LG FUT1 FUT2 GPR32 IGFL1 IGFL2 IGFL3 IGFL4 KIR2DL1 KLK11 KLK3 SIGLEC11 SIGLEC5 SPACA4 SULT2A1 SULT2B1 TPRX1 VN1R4 ZNF155 ZNF45 ZNF665 ZNF880,complement receptor mediated signaling pathway|complement component C5a signaling pathway|fucose catabolic process|L-fucose catabolic process|L-fucose metabolic process,2.257e-06|1.579e-05|0.0001437|0.0001437|0.0001437,0.03561|0.1245|0.7554|0.5666|0.4533,139.8|605.7|134.6|134.6|134.6
1348,7,0.4025,8.452,5641.0,0.001492,0.9992989999999999,DLG4 KIAA1324L LMO1 NXPH2 PACS1 PNKD UPP2,neuromuscular process|uridine metabolic process|uridine catabolic process|regulation of T cell homeostatic proliferation|methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,0.0005114|0.001019|0.001019|0.001358|0.001358,1|1|1|1|1,58.26|1471|1471|980.7|980.7
1349,4,0.438,2.628,2921.0,0.0008964999999999999,0.9929309999999999,DLGAP3 KCTD8 KIAA1143 KIF15,"modification of synaptic structure|regulation of postsynaptic neurotransmitter receptor activity|retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum|regulation of neurotransmitter receptor activity|antigen processing and presentation of exogenous peptide antigen via MHC class II",0.002522|0.003878|0.0166|0.01698|0.01928,1|1|1|1|1,429.1|271|60.57|59.18|52.01
1350,6,0.4146,6.218999999999999,4841.0,0.00128,0.998474,CIZ1 DLK1 GPR35 MGAT5B MLYCD RGL3,malonyl-CoA catabolic process|negative regulation of neuronal action potential|positive regulation of DNA-dependent DNA replication initiation|malonyl-CoA metabolic process|regulation of neuronal action potential,0.0005824|0.0005824|0.0008735|0.001165|0.001746,1|1|1|1|1,3432|3432|1716|1144|686.5
1351,6,0.4171,6.256,5035.0,0.0012380000000000002,0.998474,DLX1 HTR1E KCNK6 RTP4 SYNGR3 VWA3A,cerebral cortex GABAergic interneuron fate commitment|positive regulation of amacrine cell differentiation|negative regulation of cellular response to transforming growth factor beta stimulus|regulation of amacrine cell differentiation|negative regulation of photoreceptor cell differentiation,0.0008735|0.0008735|0.001165|0.001165|0.002037,1|1|1|1|1,1716|1716|1144|1144|572.1
1352,6,0.428,6.419,4963.0,0.001289,0.998474,DLX2 DNAJC5G HOXB4 INHBC SNX11 TBKBP1,embryonic skeletal system morphogenesis|embryonic skeletal system development|cerebral cortex GABAergic interneuron fate commitment|positive regulation of amacrine cell differentiation|regulation of amacrine cell differentiation,0.0003184|0.0005306|0.0008735|0.0008735|0.001165,1|1|1|1|1,73.03|56.27|1716|1716|1144
1353,7,0.407,8.547,5710.0,0.001491,0.9992989999999999,ABCC10 DEFB1 DMBX1 MMP20 SMIM2 SPATA25 WFDC6,collagen catabolic process|collagen metabolic process|positive regulation of flagellated sperm motility involved in capacitation|regulation of enamel mineralization|leukotriene transport,9.729e-05|0.0001914|0.001358|0.002037|0.002715,1|1|1|1|1,136.8|96.46|980.7|588.4|420.3
1354,5,0.4369,4.369,4139.0,0.001052,0.996692,DMRTA1 FLRT3 PENK SSTR3 TMEM130,"neuropeptide signaling pathway|response to estradiol|general adaptation syndrome, behavioral process|proepicardium cell migration involved in pericardium morphogenesis|general adaptation syndrome",0.0002847|0.0004525|0.0004854|0.0004854|0.000728,1|1|1|1|1,75.58|59.7|4119|4119|2060
1355,5,0.4381,4.381,3903.0,0.001118,0.996692,DMWD FOXP1 FOXP4 INSIG1 LRRC32,roof of mouth development|regulation of transforming growth factor beta3 activation|negative regulation of cargo loading into COPII-coated vesicle|interleukin-21 production|regulation of cargo loading into COPII-coated vesicle,0.0001872|0.0004854|0.0004854|0.000728|0.000728,1|1|1|1|1,93.61|4119|4119|2060|2060
1356,5,0.4315,4.315,3954.0,0.0010869999999999999,0.996692,CXCL14 CXCL5 DNAAF2 GATM HKDC1,antimicrobial humoral immune response mediated by antimicrobial peptide|antimicrobial humoral response|creatine biosynthetic process|cell chemotaxis|establishment of left/right asymmetry,0.0002548|0.0005758|0.000728|0.0009569|0.0009706,1|1|1|1|1,79.98|52.81|2060|40.78|1373
1357,9,0.4043,14.55,5953.0,0.002432,0.9998530000000001,DNAAF5 ICE2 INTS10 INTS14 PIH1D1 POLR2M RPAP3 WDCP ZNHIT3,RNA biosynthetic process|snRNA transcription by RNA polymerase II|snoRNA localization|snRNA transcription|box C/D snoRNP assembly,1.846e-06|3.53e-06|3.558e-06|3.678e-06|7.619e-06,0.02912|0.02784|0.01871|0.0145|0.02404,20.21|98.07|915.3|96.69|572.1
1358,8,0.4063,11.38,6271.0,0.0018059999999999999,0.9996790000000001,DNAH10 HCAR2 HCAR3 OASL P2RX4 PITPNM2 TMEM132B TMEM233,neutrophil apoptotic process|positive regulation of adiponectin secretion|microglial cell migration|sensory perception of touch|positive regulation of neutrophil apoptotic process,0.001164|0.001164|0.001164|0.00194|0.002328,1|1|1|1|1,1287|1287|1287|643.6|514.9
1359,6,0.4107,6.16,4247.0,0.001444,0.998474,ANP32A DNAH12 FOSL1 HIVEP1 JUN MORN3,"positive regulation of DNA-templated transcription, initiation|positive regulation of pri-miRNA transcription by RNA polymerase II|regulation of pri-miRNA transcription by RNA polymerase II|regulation of DNA-templated transcription, initiation|response to cAMP",5.213e-05|6.35e-05|0.0001043|0.0002737|0.0003455,0.8223|0.5008|0.5482|1|1,185.5|167.4|129.5|78.91|70.05
1360,5,0.446,4.46,4035.0,0.001101,0.996692,DNAH6 DOK3 FGF7 MKNK1 ZDHHC18,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling|secretion by lung epithelial cell involved in lung growth|positive regulation of epithelial cell proliferation involved in lung morphogenesis|lung growth|regulation of epithelial cell proliferation involved in lung morphogenesis,0.0009706|0.0009706|0.001456|0.001698|0.00194,1|1|1|1|1,1373|1373|823.8|686.5|588.4
1361,6,0.407,6.104,4950.0,0.0012289999999999998,0.998474,DNAJB14 GPR1 GUCY2C HNRNPDL TMEM150C UGT2B11,cellular response to stimulus|proprioception|steroid metabolic process|receptor guanylyl cyclase signaling pathway|xenobiotic glucuronidation,0.001264|0.001746|0.002372|0.0032|0.00349,1|1|1|1|1,3.042|686.5|26.2|343.2|312
1362,6,0.4266,6.399,4866.0,0.00131,0.998474,BET1L CDX1 DNAJB7 HK3 NEU4 UNC5A,"carbohydrate catabolic process|regulation of retrograde vesicle-mediated transport, Golgi to ER|regulation of somitogenesis|anterior/posterior axon guidance|ganglioside catabolic process",0.0004807|0.0008735|0.002037|0.002328|0.002328,1|1|1|1|1,59.18|1716|572.1|490.4|490.4
1363,6,0.4075,6.1129999999999995,4956.0,0.0012289999999999998,0.998474,DNAJB8 EVI2B GFOD1 KLHL33 KRTAP29-1 RXFP4,positive regulation of neutrophil differentiation|regulation of neutrophil differentiation|positive regulation of granulocyte differentiation|positive regulation of feeding behavior|regulation of stem cell division,0.0005824|0.001165|0.002619|0.0032|0.0032,1|1|1|1|1,3432|1144|429.1|343.2|343.2
1364,4,0.4886,2.932,3014.0,0.0009693,0.9929309999999999,DNAJC15 LDHC PDP1 RANBP10,"lactate biosynthetic process from pyruvate|lactate oxidation|negative regulation of mitochondrial ATP synthesis coupled electron transport|positive regulation of pyruvate dehydrogenase activity|negative regulation of mitochondrial electron transport, NADH to ubiquinone",0.0003883|0.0003883|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|5149|2574|2574|2574
1365,13,0.4145,32.33,8688.0,0.003696,0.999993,AQR BUB1B DNAJC17 HAUS2 HYPK MFAP1 RPAP1 RTF1 TUBGCP4 TUBGCP5 USP8 VPS18 VPS39,mitotic prometaphase|spindle organization|biological phase|mitotic cell cycle phase|cell cycle phase,3.087e-06|9.816e-06|1.643e-05|1.643e-05|1.643e-05,0.04869|0.07742|0.0864|0.0648|0.05184,37.95|28.16|24.66|24.66|24.66
1366,6,0.42,6.301,4902.0,0.001281,0.998474,CCL18 DNAJC18 IGDCC4 LRRN2 PDCD4 RASSF3,epithelial to mesenchymal transition involved in cardiac fibroblast development|epicardium-derived cardiac fibroblast cell development|epicardium-derived cardiac fibroblast cell differentiation|cardiac fibroblast cell development|cardiac fibroblast cell differentiation,0.001019|0.001358|0.001358|0.001358|0.001358,1|1|1|1|1,1471|980.7|980.7|980.7|980.7
1367,15,0.4078,42.82,10020.0,0.0042439999999999995,0.999999,ADAT2 DNAJC24 DOHH DPH1 DPH2 DPH3 DPH5 DPH6 DPH7 N6AMT1 RTCB RTRAF TPT1 TRMT61A TTC4,peptidyl-diphthamide biosynthetic process from peptidyl-histidine|peptidyl-diphthamide metabolic process|regulation of cytoplasmic translational elongation|peptidyl-histidine modification|regulation of translational elongation,1.319e-19|1.319e-19|6.516e-19|1.586e-18|2.416e-17,2.081e-15|1.04e-15|3.426e-15|6.255e-15|7.623e-14,1201|1201|873.7|739.3|457.7
1368,5,0.4058,4.058,3935.0,0.0010279999999999998,0.996692,AKR1B10 CSRP1 DFFA DNAJC25 TMEM190,negative regulation of deoxyribonuclease activity|farnesol catabolic process|farnesol metabolic process|sesquiterpenoid catabolic process|negative regulation of apoptotic DNA fragmentation,0.000728|0.000728|0.000728|0.000728|0.0009706,1|1|1|1|1,2060|2060|2060|2060|1373
1369,5,0.4268,4.268,3868.0,0.0011,0.996692,DERL3 DNALI1 EPM2AIP1 MMD TTC33,"positive regulation of glycogen (starch) synthase activity|regulation of glycogen (starch) synthase activity|negative regulation of retrograde protein transport, ER to cytosol|negative regulation of protein exit from endoplasmic reticulum|regulation of retrograde protein transport, ER to cytosol",0.001456|0.002425|0.002425|0.002667|0.003394,1|1|1|1|1,823.8|457.7|457.7|411.9|316.8
1370,7,0.4256,8.937000000000001,5959.0,0.0014939999999999999,0.9992989999999999,CXCR6 DNASE1L3 LYPD3 MYL7 SLC38A10 TNS4 TOGARAM1,"regulation of neutrophil mediated cytotoxicity|programmed cell death involved in cell development|apoptotic DNA fragmentation|DNA catabolic process, endonucleolytic|apoptotic nuclear changes",0.002376|0.003393|0.005763|0.008127|0.008802,1|1|1|1|1,490.4|326.9|183.9|127.9|117.7
1371,4,0.4515,2.7089999999999996,3020.0,0.0008937000000000001,0.9929309999999999,AKT3 DNASE2B PDK1 ZNF558,positive regulation of vascular endothelial cell proliferation|regulation of vascular endothelial cell proliferation|positive regulation of blood vessel endothelial cell migration|regulation of blood vessel endothelial cell migration|positive regulation of endothelial cell proliferation,6.401e-06|1.087e-05|7.22e-05|0.0001999|0.0002042,0.101|0.0857|0.3796|0.7881|0.6441,549.2|411.9|152.6|90.53|89.54
1372,4,0.4806,2.884,3117.0,0.0009220000000000001,0.9929309999999999,DLGAP2 DNHD1 ITPR1 OSBPL8,protein localization to nuclear pore|negative regulation of sequestering of triglyceride|neuron-neuron synaptic transmission|voluntary musculoskeletal movement|protein localization to nuclear envelope,0.0007766|0.001165|0.001359|0.001359|0.002134,1|1|1|1|1,1716|1030|858.1|858.1|514.9
1373,5,0.4258,4.258,4027.0,0.0010539999999999998,0.996692,DNM1 LHX2 REEP1 ZNF414 ZNF76,synaptic vesicle budding from presynaptic endocytic zone membrane|positive regulation of synaptic vesicle endocytosis|dynamin family protein polymerization involved in mitochondrial fission|dynamin family protein polymerization involved in membrane fission|postsynaptic endocytosis,0.00194|0.002183|0.002183|0.002183|0.002425,1|1|1|1|1,588.4|514.9|514.9|514.9|457.7
1374,6,0.413,6.195,4827.0,0.001279,0.998474,CARF DNMBP MC1R NAB1 RXRG USP48,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion|positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus|positive regulation of transcription by RNA polymerase II|cellular response to calcium ion|positive regulation of nucleic acid-templated transcription,5.936e-07|2.958e-05|0.0003591|0.0003651|0.001114,0.009363|0.2333|1|1|1,2942|255.8|9.758|69.23|7.256
1375,12,0.4108,27.11,8189.0,0.00329,0.999986,ARMC7 CCDC84 DDX59 DHX9 LINS1 METTL23 NOSIP PHAX PPIH RBM48 SCNM1 TXNL4B,"mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|RNA splicing|alternative mRNA splicing, via spliceosome",2.148e-05|2.148e-05|2.232e-05|6.799e-05|7.812e-05,0.3389|0.1694|0.1174|0.2681|0.2464,22.73|22.73|22.51|16.87|163.5
1376,5,0.4558,4.558,3653.0,0.001243,0.996692,DNTTIP1 ELMSAN1 NAT2 PLEKHG6 TEAD4,trophectodermal cell fate commitment|female pregnancy|multi-multicellular organism process|N-terminal peptidyl-methionine acetylation|glutamine transport,0.0005824|0.001125|0.00151|0.002328|0.002619,1|1|1|1|1,3432|38.35|33|490.4|429.1
1377,7,0.4011,8.423,5310.0,0.00158,0.9992989999999999,ACBD3 DDHD2 DENND4A DOCK10 FLT3 SPN ZFP64,lymphocyte differentiation|mononuclear cell differentiation|leukocyte differentiation|lymphocyte activation|leukocyte homeostasis,6.032e-05|9.265e-05|0.0001701|0.0002295|0.0002432,0.9515|0.7308|0.8943|0.9049|0.7672,35.59|30.75|25|22.57|85.28
1378,5,0.4098,4.098,3810.0,0.001072,0.996692,DOCK4 MMP16 RPL26L1 SSH3 ZMYM6,negative regulation of vascular associated smooth muscle contraction|negative regulation of vasoconstriction|regulation of vascular associated smooth muscle contraction|chondrocyte proliferation|negative regulation of smooth muscle contraction,0.0009706|0.00194|0.002183|0.00291|0.003394,1|1|1|1|1,1373|588.4|514.9|374.5|316.8
1379,13,0.41,31.98,10190.0,0.0031190000000000002,0.999993,FAM131A HRASLS HTR3D KLHL6 MUC20 MUC4 PDCD6 RTP1 RTP2 SERPINI1 SLC51A TCTEX1D2 TM4SF19,detection of chemical stimulus involved in sensory perception of bitter taste|sensory perception of bitter taste|detection of chemical stimulus involved in sensory perception of taste|O-glycan processing|sensory perception of taste,0.000255|0.0003269|0.0003424|0.000702|0.0008659,1|1|1|1|1,88.01|77.28|75.44|51.94|46.6
1380,8,0.4018,11.25,6037.0,0.001855,0.9996790000000001,AMDHD2 DOCK7 FOXN2 ITPRIPL2 LRCH1 MOB1A STK4 TAOK2,hippo signaling|regulation of protein autophosphorylation|intracellular signal transduction|positive regulation of phosphorylation|positive regulation of phosphorus metabolic process,2.575e-07|0.0002055|0.0002555|0.0004104|0.000556,0.004061|1|1|1|1,245.2|95.35|7.265|10.03|9.255
1381,6,0.4107,6.1610000000000005,5017.0,0.001224,0.998474,AMIGO1 CLCA2 DOK5 KCNQ2 MCCC1 TKTL2,cellular response to L-glutamate|leucine catabolic process|leucine metabolic process|biotin metabolic process|response to L-glutamate,0.001746|0.002037|0.002619|0.002909|0.0032,1|1|1|1|1,686.5|572.1|429.1|381.4|343.2
1382,5,0.4404,4.404,3997.0,0.001098,0.996692,DOPEY2 HEPACAM IFT80 PEAR1 TMPRSS11A,articular cartilage development|osteoblast proliferation|receptor localization to non-motile cilium|negative regulation of non-canonical Wnt signaling pathway|recognition of apoptotic cell,0.0007766|0.001165|0.001165|0.001359|0.001553,1|1|1|1|1,1716|1030|1030|858.1|735.5
1383,5,0.4249,4.249,3938.0,0.001075,0.996692,CBR3 CFAP57 DPP10 H1FOO RHOT1,microtubule polymerization based movement|establishment of mitochondrion localization by microtubule attachment|quinone catabolic process|phylloquinone catabolic process|phylloquinone metabolic process,0.0003883|0.0003883|0.001165|0.001165|0.001165,1|1|1|1|1,5149|5149|1030|1030|1030
1384,5,0.4212,4.212,3885.0,0.00108,0.996692,CD5 DPP4 RASSF3 TAOK2 ULK4,T cell costimulation|lymphocyte costimulation|regulation of JNK cascade|regulation of stress-activated MAPK cascade|regulation of stress-activated protein kinase signaling cascade,6.963e-05|7.482e-05|0.0003963|0.0007463|0.0007712,1|0.5901|1|1|1,155.4|149.8|63.86|46.28|45.51
1385,10,0.4104,18.47,7853.0,0.00234,0.999933,BIVM CLYBL COMMD6 DPP8 GAS6 GPR183 SLITRK5 UCHL3 ZIC2 ZIC5,lymphocyte chemotaxis|lymphocyte migration|negative regulation of renal albumin absorption|positive regulation of cobalamin metabolic process|regulation of cobalamin metabolic process,0.0002669|0.0005927|0.0009704|0.0009704|0.0009704,1|1|1|1|1,84.06|55.66|2060|2060|2060
1386,7,0.4253,8.932,5986.0,0.0014869999999999998,0.9992989999999999,C1orf141 DPP9 GPR141 OARD1 PEPD RETSAT SMIM29,peptidyl-glutamate ADP-deribosylation|protein de-ADP-ribosylation|small molecule metabolic process|collagen catabolic process|retinol metabolic process,0.001358|0.002376|0.01348|0.01486|0.01653,1|1|1|1|1,980.7|490.4|5.438|68.42|61.29
1387,5,0.4196,4.196000000000001,3926.0,0.001065,0.996692,ADRB1 COMTD1 DPYD MAPK10 MCU,regulation of circadian rhythm|pyrimidine deoxyribonucleoside catabolic process|thymidine catabolic process|beta-alanine biosynthetic process|positive regulation of the force of heart contraction by epinephrine-norepinephrine,0.0003382|0.0004854|0.0004854|0.000728|0.000728,1|1|1|1|1,69.23|4119|4119|2060|2060
1388,6,0.4201,6.301,4599.0,0.0013650000000000001,0.998474,CD6 DPYS HSD17B8 MYLIP PTBP3 SREBF1,uracil catabolic process|thymine catabolic process|pyrimidine nucleobase catabolic process|uracil metabolic process|thymine metabolic process,0.0008735|0.001165|0.001165|0.001165|0.001165,1|1|1|1|1,1716|1144|1144|1144|1144
1389,5,0.4259,4.2589999999999995,3939.0,0.001077,0.996692,C12orf40 CPNE8 DRAM1 OAS1 PLPPR3,regulation of ribonuclease activity|cellular response to interferon-alpha|regulation of nuclease activity|response to interferon-alpha|phospholipid dephosphorylation,0.002425|0.003394|0.005571|0.006054|0.01112,1|1|1|1|1,457.7|316.8|187.2|171.6|91.53
1390,5,0.4181,4.181,4102.0,0.001016,0.996692,DRAM2 LCN9 REG1A RTL10 ZNF766,cellular response to gastrin|response to gastrin|response to growth hormone-releasing hormone|pancreas regeneration|positive regulation of acinar cell proliferation,0.0004854|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,4119|4119|4119|4119|4119
1391,11,0.3833,21.08,8507.0,0.0024649999999999997,0.999969,C1QB CCDC28B CLCNKA GPR153 HNRNPCL1 MST1 PRAMEF11 PRAMEF12 PRAMEF14 PRAMEF18 PRAMEF20,positive regulation of cell population proliferation|negative regulation of developmental process|negative regulation of apoptotic process|negative regulation of programmed cell death|negative regulation of cell death,2.585e-07|4.301e-06|4.839e-06|5.464e-06|9.452e-06,0.004077|0.03392|0.02544|0.02155|0.02982,12.89|11.84|11.6|11.35|10.32
1392,5,0.4493,4.493,3949.0,0.001134,0.996692,ASB10 CAPN11 DRD4 PATE2 TBC1D24,positive regulation of catecholamine uptake involved in synaptic transmission|positive regulation of dopamine uptake involved in synaptic transmission|positive regulation of sodium:proton antiporter activity|neuron death in response to oxidative stress|adenylate cyclase-inhibiting dopamine receptor signaling pathway,0.0009706|0.0009706|0.001213|0.001213|0.001456,1|1|1|1|1,1373|1373|1030|1030|823.8
1393,17,0.4099,55.75,12210.0,0.004533,1.0,DCTN4 DDX41 DDX46 GEMIN5 IK ISY1 LARS NHP2 RACK1 RBM22 RPS14 SLU7 SPDL1 THOC3 TTC1 U2SURP ZMAT2,"RNA splicing|RNA processing|mRNA metabolic process|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile",1.769e-13|3.554e-13|7.124e-13|7.897e-13|7.897e-13,2.79e-09|2.803e-09|3.746e-09|3.114e-09|2.491e-09,29.77|15.75|19.2|36.1|36.1
1394,22,0.3832,88.52,14800.0,0.005929,1.0,ALG12 ALG9 ARHGAP45 CCND2 DPM1 HERPUD1 IKBKB IKZF3 IRF4 MAF MANF MEF2C NFKB1 POU2AF1 PRDM1 RELA RELB SMAD7 SYVN1 TCF3 UBE2G2 UBE2J1,lymphocyte activation|positive regulation of transcription by RNA polymerase II|leukocyte activation|regulation of transcription by RNA polymerase II|B cell activation,1.779e-07|2.769e-07|3.892e-07|6.575e-07|1.041e-06,0.002806|0.002184|0.002047|0.002593|0.003285,16.03|7.425|8.619|4.501|27.3
1395,5,0.43,4.3,3842.0,0.001115,0.996692,DSTN EBI3 FBXW9 IPP TMCO4,actin filament fragmentation|leptin-mediated signaling pathway|interleukin-35-mediated signaling pathway|interleukin-27-mediated signaling pathway|actin filament depolymerization,0.001456|0.00349|0.00349|0.00349|0.003781,1|1|1|1|1,858.1|312|312|312|286
1396,8,0.4299,12.04,6480.0,0.00185,0.9996790000000001,BBS5 DTD2 G6PC2 GP2 SCN1A SCN2A SCN3A SCN7A,neuronal action potential|membrane depolarization during action potential|transmission of nerve impulse|membrane depolarization|action potential,3.339e-10|4.305e-10|3.398e-09|3.398e-09|3.054e-08,5.267e-06|3.395e-06|1.787e-05|1.34e-05|9.635e-05,367.8|343.2|198|198|111.9
1397,6,0.4375,6.562,5055.0,0.0012929999999999999,0.998474,ACTRT2 CBY3 DTWD2 HMHB1 IRF7 TBC1D19,interferon-alpha production|interferon-beta production|MDA-5 signaling pathway|regulation of MyD88-dependent toll-like receptor signaling pathway|negative regulation of macrophage apoptotic process,0.0005824|0.001165|0.001165|0.001456|0.001456,1|1|1|1|1,3432|1144|1144|858.1|858.1
1398,5,0.4025,4.025,4027.0,0.0009962,0.996692,ACOT4 DHRS3 DUOX1 FBN1 NPAS1,unsaturated monocarboxylic acid metabolic process|saturated monocarboxylic acid metabolic process|hormone metabolic process|cuticle development|sequestering of TGFbeta in extracellular matrix,0.0004854|0.0004854|0.0008838|0.0009706|0.001213,1|1|1|1|1,4119|4119|42.46|1373|1030
1399,6,0.4314,6.471,5001.0,0.001289,0.998474,ASIC4 CFAP44 CLSTN1 DUS3L HDHD3 SSFA2,tRNA dihydrouridine synthesis|neurotransmitter receptor transport to postsynaptic membrane|regulation of synapse maturation|establishment of protein localization to postsynaptic membrane|neurotransmitter receptor transport to plasma membrane,0.001456|0.003636|0.003636|0.003878|0.00412,1|1|1|1|1,823.8|294.2|294.2|274.6|257.4
1400,6,0.4123,6.185,4782.0,0.001289,0.998474,DUSP16 RNF220 SLC30A3 TFEB TNFRSF11A TREM2,osteoclast differentiation|myeloid leukocyte differentiation|positive regulation of inflammatory response|positive regulation of C-C chemokine receptor CCR7 signaling pathway|regulation of C-C chemokine receptor CCR7 signaling pathway,6.055e-05|0.0005221|0.0005741|0.0005824|0.0005824,0.9551|1|1|1|1,171.6|56.74|54.06|3432|3432
1401,5,0.4483,4.4830000000000005,4026.0,0.001109,0.996692,DEPTOR DUSP26 GABARAPL2 MC2R MEDAG,positive regulation of peptidyl-serine dephosphorylation|negative regulation of cellular protein metabolic process|negative regulation of protein metabolic process|negative regulation of protein kinase activity|regulation of peptidyl-serine dephosphorylation,0.000728|0.00102|0.001253|0.001321|0.001456,1|1|1|1|1,2060|12.56|11.7|34.61|823.8
1402,6,0.4277,6.416,4877.0,0.0013109999999999999,0.998474,ABI3BP APOF DUSP27 HAL LSR RABAC1,tricellular tight junction assembly|protein localization to tricellular tight junction|formamide metabolic process|histidine catabolic process to glutamate and formate|histidine catabolic process to glutamate and formamide,0.0005824|0.0008735|0.001456|0.001456|0.001456,1|1|1|1|1,3432|1716|858.1|858.1|858.1
1403,20,0.4043,76.82,13300.0,0.005727,1.0,BUB3 C1orf109 DAD1 DHX33 DPAGT1 FARSB IMP3 MYBBP1A NOL9 OSGEP PAK1IP1 POP5 RPP21 RPP30 RPP40 SPATA5L1 TIMM10 TRMT112 UTP4 WDR18,ribosome biogenesis|ncRNA metabolic process|ncRNA processing|ribonucleoprotein complex biogenesis|rRNA processing,4.154e-13|7.848e-13|5.298e-12|1.079e-11|1.292e-10,6.552e-09|6.19e-09|2.786e-08|4.254e-08|4.075e-07,29.54|20.87|22.7|21.09|30.18
1404,6,0.4125,6.188,4799.0,0.001285,0.998474,CLCN1 DUSP3 FAP HDGFL3 MUSK OR4L1,positive regulation of protein geranylgeranylation|regulation of protein geranylgeranylation|melanocyte apoptotic process|negative regulation of T cell activation|negative regulation of leukocyte cell-cell adhesion,0.0006794|0.0006794|0.0006794|0.0006932|0.0008252,1|1|1|1|1,2942|2942|2942|49.87|45.61
1405,15,0.4,42.0,9143.0,0.0045579999999999996,0.999999,GRB2 KRAS LZTR1 MAP2K1 MAPK1 NF1 NRAS PTPN11 RAF1 RCE1 SHOC2 SOS1 SOS2 SPRED1 SPRED2,MAPK cascade|regulation of intracellular signal transduction|intracellular signal transduction|fibroblast growth factor receptor signaling pathway|cellular response to fibroblast growth factor stimulus,2.805e-16|1.28e-12|1.527e-11|2.305e-11|1.487e-10,4.424e-12|1.01e-08|8.031e-08|9.09e-08|4.69e-07,36.93|10.1|10.46|101.7|73.55
1406,6,0.4214,6.321000000000001,4800.0,0.001312,0.998474,APBA3 DYDC2 GSTZ1 SLC50A1 SPRN TBC1D26,glucoside transport|tyrosine catabolic process|glycoside transport|regulation of acetyl-CoA biosynthetic process from pyruvate|organic substance transport,0.001358|0.002037|0.002037|0.003054|0.003328,1|1|1|1|1,980.7|588.4|588.4|367.8|5.423
1407,5,0.4154,4.154,3957.0,0.001046,0.996692,C3orf70 CCDC91 CHL1 DYNAP LCTL,nucleolar chromatin organization|cellular response to ergosterol|cellular response to bleomycin|response to bleomycin|positive regulation of endodeoxyribonuclease activity,0.0005824|0.0005824|0.0008735|0.0008735|0.001456,1|1|1|1|1,3432|3432|1716|1716|858.1
1408,6,0.4066,6.099,4722.0,0.001287,0.998474,DDAH2 DYNC1I1 ENPP4 PRICKLE4 PRR3 WNT9B,mesonephric duct formation|establishment of planar polarity involved in nephron morphogenesis|mesenchymal stem cell maintenance involved in nephron morphogenesis|non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation|mesonephric duct morphogenesis,0.0006794|0.0006794|0.001019|0.001019|0.001358,1|1|1|1|1,2942|2942|1471|1471|980.7
1409,6,0.4362,6.544,4923.0,0.001324,0.998474,CAMKK1 DYNC2LI1 FBLN2 FBXO41 RBP7 TMEM184B,intraciliary retrograde transport|intraciliary transport involved in cilium assembly|intraciliary transport|regulation of cilium assembly|protein transport along microtubule,0.004361|0.01188|0.01563|0.01735|0.01993,1|1|1|1|1,245.2|85.81|64.76|58.18|50.48
1410,6,0.4377,6.565,4934.0,0.001326,0.998474,CLDN10 DYRK3 IL22RA1 MEI4 PATE1 SFN,regulation of epidermal cell division|nuclear speck organization|stress granule disassembly|ribonucleoprotein complex disassembly|meiotic DNA double-strand break formation,0.001358|0.001698|0.002037|0.002715|0.002715,1|1|1|1|1,980.7|735.5|588.4|420.3|420.3
1411,5,0.425,4.25,4057.0,0.001044,0.996692,E2F2 FOXQ1 MCCC2 STOM TMEM143,regulation of acid-sensing ion channel activity|lens fiber cell apoptotic process|leucine catabolic process|positive regulation by host of viral genome replication|leucine metabolic process,0.0004854|0.001213|0.001698|0.002183|0.002183,1|1|1|1|1,4119|1030|686.5|514.9|514.9
1412,6,0.4215,6.3229999999999995,4647.0,0.001355,0.998474,CABP5 E2F4 PISD PTDSS1 SYNRG ZNF628,phosphatidylserine biosynthetic process|glycerophospholipid biosynthetic process|glycerolipid biosynthetic process|phospholipid biosynthetic process|multi-ciliated epithelial cell differentiation,0.001456|0.00167|0.001982|0.002267|0.002909,1|1|1|1|1,858.1|31.35|28.72|26.82|381.4
1413,6,0.4428,6.643,4895.0,0.001352,0.998474,EAF2 HAVCR2 PLPP7 ZBED8 ZDHHC12 ZNF189,negative regulation of granulocyte colony-stimulating factor production|negative regulation of interleukin-3 production|negative regulation of macrophage colony-stimulating factor production|negative regulation of immune response to tumor cell|negative regulation of natural killer cell mediated immune response to tumor cell,0.0005824|0.0005824|0.0005824|0.0008735|0.0008735,1|1|1|1|1,3432|3432|3432|1716|1716
1414,8,0.4311,12.07,7157.0,0.00168,0.9996790000000001,EBLN2 FLRT3 IL4 TGM4 TMEM104 TOMM34 TTC39B ZFAND4,proepicardium cell migration involved in pericardium morphogenesis|positive regulation of eosinophil chemotaxis|regulation of eosinophil chemotaxis|T-helper 2 cell cytokine production|T cell cytokine production,0.0007765|0.001164|0.001164|0.001164|0.001552,1|1|1|1|1,2574|1287|1287|1287|858.1
1415,6,0.433,6.494,4799.0,0.001348,0.998474,B3GAT1 ECEL1 ENTPD4 MYO1D OBSL1 XKR7,UDP catabolic process|pyrimidine ribonucleoside diphosphate catabolic process|pyrimidine nucleoside diphosphate catabolic process|early endosome to recycling endosome transport|GDP catabolic process,0.0008735|0.0008735|0.0008735|0.0008735|0.0008735,1|1|1|1|1,1716|1716|1716|1716|1716
1416,19,0.4082,69.81,14630.0,0.0047350000000000005,1.0,AKAP2 ASB6 C9orf16 C9orf84 ECPAS FAM129B GBGT1 KIF12 OR1J1 OR1J2 OR1J4 OR1L1 OR1L8 OR1N2 OR1Q1 PALM2 TOR1B TXNDC8 ZBTB6,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,3.523e-08|5.26e-08|6.782e-08|1.097e-07|1.412e-07,0.0005558|0.0004148|0.0003566|0.0004325|0.0004455,19.23|18.12|17.45|16.25|15.65
1417,7,0.4047,8.499,5835.0,0.001451,0.9992989999999999,CXCL5 EDARADD GPM6A HS3ST1 NID2 SLC34A2 SORCS2,sodium-dependent phosphate transport|cellular phosphate ion homeostasis|cellular trivalent inorganic anion homeostasis|phosphate ion homeostasis|trivalent inorganic anion homeostasis,0.001358|0.003393|0.003393|0.004748|0.004748,1|1|1|1|1,980.7|326.9|326.9|226.3|226.3
1418,6,0.4199,6.297999999999999,4866.0,0.001289,0.998474,EDIL3 HOGA1 IQCF3 MYL3 NDFIP1 PLIN5,oxalate metabolic process|negative regulation of isotype switching to IgE isotypes|glyoxylate catabolic process|negative regulation of peroxisome proliferator activated receptor signaling pathway|4-hydroxyproline metabolic process,0.0005824|0.001165|0.001165|0.001165|0.001456,1|1|1|1|1,3432|1144|1144|1144|858.1
1419,7,0.403,8.463,5751.0,0.001466,0.9992989999999999,EDNRA METTL22 MUC16 NAGPA NTMT1 RFNG RNF150,peptidyl-alanine modification|N-terminal peptidyl-proline dimethylation|N-terminal peptidyl-glycine methylation|N-terminal peptidyl-alanine trimethylation|N-terminal peptidyl-alanine methylation,0.0006794|0.0006794|0.0006794|0.0006794|0.0006794,1|1|1|1|1,2942|2942|2942|2942|2942
1420,20,0.4083,77.57,15870.0,0.004852,1.0,BCAS4 BMP7 CASS4 CTSZ EEF1A2 FAM209A FAM209B MTRNR2L3 NDFIP1 NPBWR2 OPRL1 PMEPA1 PPDPF RBM38 SLC2A4RG STX16 TFAP2C WFDC11 ZGPAT ZNF831,opioid receptor signaling pathway|negative regulation of molecular function|negative regulation of nitrogen compound metabolic process|regulation of molecular function|regulation of pathway-restricted SMAD protein phosphorylation,5.868e-05|7.841e-05|0.001145|0.001646|0.001739,0.9255|0.6184|1|1|1,205.9|6.156|3.447|2.916|33.22
1421,8,0.409,11.45,7095.0,0.0016079999999999998,0.9996790000000001,DCDC2B EBLN2 EEF1AKMT1 FRMD5 LIX1 TGM4 TNFRSF17 ZNF660,autophagosome maturation|lymphocyte homeostasis|leukocyte homeostasis|peptidyl-lysine methylation|peptide cross-linking,0.01159|0.02002|0.02686|0.03254|0.03931,1|1|1|1|1,88.77|50.48|37.31|30.65|25.24
1422,20,0.4053,77.0,14230.0,0.005365999999999999,1.0,ANAPC11 CDC27 CHMP6 EIF4A3 FTSJ3 GOSR2 GPS1 HGS INTS2 NPLOC4 NSF NUP85 PSMC5 PSMD12 RPL38 SAP30BP SRP68 TBCD USP36 UTP18,anaphase|mitotic anaphase|M phase|mitotic M phase|cellular component biogenesis,3.97e-07|3.97e-07|4.349e-07|4.349e-07|1.19e-06,0.006263|0.003131|0.002287|0.001715|0.003754,32.79|32.79|32.18|32.18|4.575
1423,23,0.4041,102.2,15760.0,0.0064269999999999996,1.0,ABCG1 BUB3 CNIH4 DUX4 EIF2S1 HSPE1 NBEAL1 NUTF2 OR2A25 RPL11 RPL12 RPL13 RPL17 RPL18A RPL23 RPL23A RPL37 RPL4 RPLP2 RPS13 SARS SNU13 ST20,translational initiation|SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum,5.285e-20|1.022e-19|1.727e-19|4.59e-19|6.63e-19,8.336e-16|8.064e-16|9.079e-16|1.81e-15|2.092e-15,72.01|98.33|93.46|85.04|82.08
1424,7,0.8885,18.66,3795.0,0.004875,0.9992989999999999,EEFSEC GPX4 PSTK SECISBP2 SEPHS2 SEPSECS TXNRD1,translational readthrough|selenocysteine incorporation|translational elongation|peptide metabolic process|selenocysteinyl-tRNA(Sec) biosynthetic process,2.307e-12|2.307e-12|5.06e-08|2.488e-07|1.483e-06,3.638e-08|1.819e-08|0.0002661|0.000981|0.00468,1471|1471|94.15|27.39|1471
1425,5,0.4265,4.265,3747.0,0.001134,0.996692,CDCA4 CLEC1A EEPD1 FAM122A HIST4H4,"chromatin organization involved in regulation of transcription|regulation of gene expression, epigenetic|negative regulation of megakaryocyte differentiation|DNA replication-dependent nucleosome assembly|DNA replication-dependent nucleosome organization",0.0001913|0.0006897|0.001456|0.002667|0.002667,1|1|1|1|1,92.56|48.18|823.8|411.9|411.9
1426,12,0.4003,26.42,10090.0,0.002605,0.999986,AFAP1L2 C2orf15 CALHM3 EFCAB5 IFIT1B LIPA LIPK LIPM MRC1 NUTM2B SFXN5 ZFYVE27,lipid catabolic process|cornification|endoplasmic reticulum tubular network formation|tricarboxylic acid transport|citrate transport,0.000652|0.001965|0.002909|0.003489|0.003489,1|1|1|1|1,16.94|30.38|429.1|343.2|343.2
1427,6,0.4191,6.2860000000000005,4908.0,0.001276,0.998474,ABCG5 EFCAB6 JPH2 MAB21L3 PITPNC1 RAPGEF5,intermembrane lipid transfer|negative regulation of intestinal cholesterol absorption|negative regulation of intestinal lipid absorption|negative regulation of intestinal phytosterol absorption|negative regulation of intestinal absorption,8.606e-05|0.0008735|0.0008735|0.0008735|0.001165,1|1|1|1|1,143|1716|1716|1716|1144
1428,5,0.4502,4.502,3887.0,0.0011539999999999999,0.996692,ACSBG2 EFCAB7 IRX4 MTFP1 PPP3CA,positive regulation of protein localization to ciliary membrane|positive regulation of cardiac muscle hypertrophy in response to stress|establishment of animal organ orientation|positive regulation of cardiac muscle adaptation|regulation of protein localization to ciliary membrane,0.0004854|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,4119|2060|2060|2060|2060
1429,5,0.4239,4.239,3897.0,0.001084,0.996692,BSPRY EFCC1 LRRC66 TRPM6 ZNF79,calcium ion transport|metal ion transport|cation transport|protein tetramerization|cellular response to leukemia inhibitory factor,0.001387|0.002419|0.01488|0.0207|0.02142,1|1|1|1|1,33.76|25.43|9.973|48.46|46.81
1430,8,0.4163,11.66,6785.0,0.0017109999999999998,0.9996790000000001,CNTNAP1 EFEMP1 PHTF1 PRB4 PRH2 RAB31 TAS2R30 TAS2R46,detection of chemical stimulus involved in sensory perception of bitter taste|sensory perception of bitter taste|detection of chemical stimulus involved in sensory perception of taste|sensory perception of taste|nervous system process,9.21e-05|0.0001182|0.0001238|0.0003144|0.00114,1|0.9322|0.6509|1|1,143|125.6|122.6|75.72|7.462
1431,16,0.3904,46.85,11260.0,0.004132,0.999999,CHMP2A CLASRP GRWD1 LENG1 LENG8 NUP62 PNKP POLD1 RBM42 RPL18 RPS19 SNRNP70 SNRPD2 SYMPK TOMM40 TSEN34,mRNA metabolic process|RNA processing|RNA splicing|nucleic acid metabolic process|mRNA processing,4.471e-07|2.977e-06|1.134e-05|1.171e-05|2.591e-05,0.007053|0.02348|0.05965|0.04617|0.08174,12.98|9.762|15.81|5.19|13.3
1432,5,0.4523,4.523,4020.0,0.001121,0.996692,CD37 DSTYK EFNA2 ESM1 GON7,positive regulation of hepatocyte growth factor receptor signaling pathway|regulation of hepatocyte growth factor receptor signaling pathway|positive regulation of fibroblast growth factor receptor signaling pathway|olfactory bulb development|regulation of fibroblast growth factor receptor signaling pathway,0.0004854|0.001213|0.002183|0.007502|0.007744,1|1|1|1|1,4119|1030|514.9|137.3|132.9
1433,7,0.4053,8.511000000000001,5676.0,0.0014939999999999999,0.9992989999999999,CFAP97D1 EFNB3 GRIN2D NME1 NPTN PCDHGA4 PCDHGA8,"trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission|trans-synaptic signaling, modulating synaptic transmission|trans-synaptic signaling by trans-synaptic complex|homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules",9.891e-07|6.521e-06|6.521e-06|1.886e-05|6.853e-05,0.0156|0.05143|0.03429|0.07436|0.2162,1961|588.4|588.4|52.85|34.08
1434,28,0.4021,152.0,19460.0,0.0077280000000000005,1.0,ABCE1 COPB2 EFTUD2 EIF2S1 EIF4A3 ETF1 ISY1 KPNB1 NBEAL1 NEDD8 NUTF2 PSMA1 PSMA2 PSMA3 PSMA4 PSMA5 PSMA6 PSMB3 RPL17 SARS SF3A1 SMU1 SNRNP200 SNRPD1 SNU13 SRP54 VCP XAB2,proteasomal ubiquitin-independent protein catabolic process|cellular component biogenesis|cellular protein-containing complex assembly|protein-containing complex subunit organization|regulation of cellular amino acid metabolic process,7.586e-15|4.68e-13|2.295e-12|2.546e-12|6.878e-12,1.197e-10|3.691e-09|1.207e-08|1.004e-08|2.17e-08,226|5.522|11.57|7.636|76.48
1435,7,0.4173,8.763,5964.0,0.001464,0.9992989999999999,CCDC159 EGF FAT4 HOGA1 INPP4B MARK4 POMGNT1,oxalate metabolic process|epidermal growth factor receptor signaling pathway via MAPK cascade|branching morphogenesis of an epithelial tube|morphogenesis of a branching epithelium|morphogenesis of a branching structure,0.0006794|0.0006794|0.0008127|0.001197|0.001335,1|1|1|1|1,2942|2942|45.97|37.72|35.66
1436,5,0.4182,4.1819999999999995,3938.0,0.001058,0.996692,ANKRD27 CTSO EGR2 GCFC2 TCF25,rhombomere 5 formation|rhombomere 5 structural organization|rhombomere 5 morphogenesis|rhombomere 3 formation|rhombomere 3 structural organization,0.0005824|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,3432|3432|3432|3432|3432
1437,4,0.4525,2.715,3194.0,0.0008472000000000001,0.9929309999999999,C8orf86 EHD4 FSCN3 RNF130,pinocytosis|endocytic recycling|actin filament bundle assembly|actin filament bundle organization|spermatid development,0.002328|0.008131|0.01141|0.01199|0.02995,1|1|1|1|1,468.1|125.6|88.77|84.41|33.22
1438,7,0.4128,8.669,5625.0,0.001535,0.9992989999999999,EHHADH JUND MAIP1 PCDH15 SLC2A13 TIMD4 ZFAND2A,response to calcium ion|protein insertion into mitochondrial inner membrane from matrix|protein insertion into membrane from inner side|myo-inositol transport|equilibrioception,0.001123|0.001698|0.001698|0.001698|0.003054,1|1|1|1|1,38.97|735.5|735.5|735.5|367.8
1439,5,0.4084,4.084,3890.0,0.001046,0.996692,ACOT7 DQX1 EIF2B3 LRRC52 ZNF311,long-chain fatty-acyl-CoA catabolic process|palmitic acid biosynthetic process|palmitic acid metabolic process|medium-chain fatty-acyl-CoA catabolic process|fatty-acyl-CoA catabolic process,0.0004854|0.000728|0.000728|0.000728|0.001213,1|1|1|1|1,4119|2060|2060|2060|1030
1440,15,0.6,63.0,9453.0,0.0066,0.999999,ALKBH8 CTU1 CTU2 DPH3 EIF1 EIF2AK4 ELP5 ELP6 MOCS3 NR2C2AP PDAP1 PPP1R15B PUS3 RNF25 URM1,tRNA wobble uridine modification|tRNA wobble base modification|tRNA modification|tRNA processing|RNA modification,1.24e-20|3.404e-20|4.584e-18|1.225e-16|1.099e-15,1.956e-16|2.685e-16|2.41e-14|4.831e-13|3.467e-12,610.2|523|137.3|93.61|72.69
1441,27,0.3892,136.6,18920.0,0.007147,1.0,ABCE1 CNIH4 COPB2 DUX4 EIF2S1 FOXD4 NBEAL1 NEDD8 NUTF2 POGZ PSMA1 PSMA2 PSMA3 PSMA4 PSMA6 RPL17 RPL18 RPL18A RPS17 SMU1 SNRPD1 SNU13 SRP54 ST20 TSPYL5 UQCRH VCP,proteasomal ubiquitin-independent protein catabolic process|cellular component biogenesis|cellular macromolecule catabolic process|regulation of cellular amino acid metabolic process|S phase,2.502e-10|4.819e-10|1.45e-08|3.604e-08|3.604e-08,3.946e-06|3.8e-06|7.625e-05|0.0001421|0.0001137,167.2|4.902|8.872|56.58|56.58
1442,9,0.4046,14.57,6271.0,0.002311,0.9998530000000001,EIF2B5 EIF4A1 EIF4B EIF4E EIF4G1 LSG1 NMD3 PSMD2 RFC4,translational initiation|translation|cytoplasmic translational initiation|peptide biosynthetic process|cellular macromolecule biosynthetic process,2.2e-09|2.768e-07|3.124e-07|3.77e-07|6.835e-07,3.47e-05|0.002183|0.001642|0.001487|0.002156,80.01|29.8|228.8|27.97|9.679
1443,6,0.4077,6.115,4705.0,0.001295,0.998474,EIF4H OR51I1 OR52D1 PDCD4 PDE5A TRIM34,epithelial to mesenchymal transition involved in cardiac fibroblast development|eukaryotic translation initiation factor 4F complex assembly|epicardium-derived cardiac fibroblast cell development|epicardium-derived cardiac fibroblast cell differentiation|cardiac fibroblast cell development,0.0008735|0.0008735|0.001165|0.001165|0.001165,1|1|1|1|1,1716|1716|1144|1144|1144
1444,6,0.4304,6.456,5081.0,0.001266,0.998474,ADH7 C4orf17 EIF5A2 ORMDL1 RTN4RL1 TMEM101,polyamine homeostasis|positive regulation of translational termination|cellular sphingolipid homeostasis|negative regulation of ceramide biosynthetic process|fatty acid omega-oxidation,0.0005824|0.001456|0.001746|0.001746|0.001746,1|1|1|1|1,3432|858.1|686.5|686.5|686.5
1445,6,0.4302,6.452999999999999,4892.0,0.001314,0.998474,APEH ELAVL2 TCAIM TNFSF8 ZNF620 ZNF90,"CD8-positive, alpha-beta T cell differentiation|CD8-positive, alpha-beta T cell activation|amyloid-beta metabolic process|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription",0.002619|0.003781|0.006101|0.009019|0.009029,1|1|1|1|1,429.1|286|171.6|3.964|3.962
1446,7,0.4322,9.077,5259.0,0.001718,0.9992989999999999,DCD ELAVL4 OR1M1 OR7D4 OR7G1 OR7G3 ZNF266,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,7.139e-06|9.014e-06|1.045e-05|1.383e-05|1.603e-05,0.1126|0.07109|0.05496|0.05454|0.05056,26.69|25.15|24.22|22.55|21.71
1447,6,0.4472,6.707999999999999,4901.0,0.001363,0.998474,CTSA ELFN2 KLHL5 SLC25A17 WFDC2 ZNF562,"adenosine 3',5'-bisphosphate transmembrane transport|FAD transport|coenzyme A transport|FAD transmembrane transport|coenzyme A transmembrane transport",0.0008735|0.0008735|0.0008735|0.0008735|0.0008735,1|1|1|1|1,1716|1716|1716|1716|1716
1448,5,0.4599,4.599,4021.0,0.00114,0.996692,CARD17 ELK3 GSDME MX2 RMDN1,synaptic vesicle budding from presynaptic endocytic zone membrane|granzyme-mediated programmed cell death signaling pathway|dynamin family protein polymerization involved in mitochondrial fission|dynamin family protein polymerization involved in membrane fission|postsynaptic endocytosis,0.002328|0.002619|0.002619|0.002619|0.002909,1|1|1|1|1,490.4|429.1|429.1|429.1|381.4
1449,5,0.446,4.46,4062.0,0.001094,0.996692,CXCL8 DTHD1 ELMOD1 S100A10 TEX12,meiotic DNA repair synthesis|negative regulation of cell adhesion molecule production|regulation of entry of bacterium into host cell|regulation of cell adhesion molecule production|membrane raft assembly,0.0009706|0.001456|0.00194|0.002667|0.002667,1|1|1|1|1,1373|823.8|588.4|411.9|411.9
1450,4,0.4635,2.781,3032.0,0.0009138999999999999,0.9929309999999999,CD3E ELOA3D INF2 SLC36A3,positive regulation of T cell anergy|positive regulation of lymphocyte anergy|positive regulation of cell-cell adhesion mediated by integrin|regulation of T cell anergy|regulation of lymphocyte anergy,0.0009706|0.0009706|0.001359|0.001553|0.001553,1|1|1|1|1,1287|1287|858.1|735.5|735.5
1451,6,0.4083,6.125,4670.0,0.001306,0.998474,DYNLRB2 ELOVL4 FOXF1 HOXC5 MSRB3 MYOM2,right lung morphogenesis|embryonic ectodermal digestive tract morphogenesis|ectodermal digestive tract morphogenesis|lateral mesodermal cell differentiation|detection of wounding,0.0005824|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,3432|3432|3432|3432|3432
1452,5,0.454,4.54,3994.0,0.0011330000000000001,0.996692,ELOVL5 HCN3 MX1 SIGLECL1 ZNF668,"fatty acid elongation, unsaturated fatty acid|fatty acid elongation, saturated fatty acid|synaptic vesicle budding from presynaptic endocytic zone membrane|fatty acid elongation, polyunsaturated fatty acid|fatty acid elongation, monounsaturated fatty acid",0.002328|0.002328|0.002328|0.002328|0.002328,1|1|1|1|1,490.4|490.4|490.4|490.4|490.4
1453,7,0.4023,8.447000000000001,5789.0,0.001454,0.9992989999999999,CBS ELOVL7 LARGE2 NYAP1 PTH SPSB4 ZNF648,cysteine biosynthetic process from serine|positive regulation of osteoclast proliferation|cysteine biosynthetic process via cystathionine|homocysteine catabolic process|L-cysteine metabolic process,0.001164|0.001164|0.001552|0.001552|0.00194,1|1|1|1|1,1287|1287|858.1|858.1|643.6
1454,20,0.4116,78.2,13140.0,0.005899000000000001,1.0,ARHGEF12 CCDC115 CCDC47 EMC1 EMC2 EMC3 EMC4 EMC6 EMC7 EMC8 GNA13 LPAR1 LPAR2 MYO9B NCLN PDCL RAB5IF RHOA RIC8A TMEM147,protein insertion into ER membrane by stop-transfer membrane-anchor sequence|tail-anchored membrane protein insertion into ER membrane|protein insertion into ER membrane|endoplasmic reticulum organization|protein insertion into membrane,4.781e-18|6.006e-17|5.454e-15|5.211e-14|4.725e-13,7.541e-14|4.737e-13|2.867e-11|2.055e-10|1.491e-09,720.8|450.5|212|82.38|106
1455,7,0.4167,8.75,5334.0,0.001634,0.9992989999999999,ARHGAP9 EMCN INHBE KIF5A KRT81 SLC35B4 ZNF93,UDP-xylose transmembrane transport|negative regulation of transposon integration|regulation of transposon integration|anterograde dendritic transport of neurotransmitter receptor complex|UDP-N-acetylglucosamine transmembrane transport,0.0006794|0.001019|0.001019|0.001698|0.002037,1|1|1|1|1,2942|1471|1471|735.5|588.4
1456,8,0.4022,11.26,6411.0,0.001749,0.9996790000000001,ABCG4 ADAMTS15 ADAMTS8 EML1 KCNJ1 OR8D1 SMIM6 TMEM136,phosphate ion transmembrane transport|phosphate ion transport|extracellular matrix organization|extracellular structure organization|external encapsulating structure organization,0.006197|0.008126|0.009007|0.009052|0.009143,1|1|1|1|1,171.6|128.7|13.48|13.44|13.37
1457,6,0.4265,6.397,5076.0,0.001256,0.998474,DYNC2LI1 EML4 FBLN2 KLKB1 PROZ WDR54,"Factor XII activation|plasma kallikrein-kinin cascade|kinin cascade|positive regulation of fibrinolysis|negative regulation of blood coagulation, intrinsic pathway",0.0008735|0.001165|0.001165|0.001456|0.001746,1|1|1|1|1,1716|1144|1144|858.1|686.5
1458,6,0.45,6.751,4956.0,0.0013570000000000001,0.998474,DRC7 EML5 LHFPL4 PPP1R14A RAB3IL1 TEPP,regulation of inhibitory synapse assembly|gamma-aminobutyric acid receptor clustering|neurotransmitter-gated ion channel clustering|postsynaptic membrane organization|receptor clustering,0.001456|0.001746|0.0032|0.008418|0.01332,1|1|1|1|1,858.1|686.5|343.2|122.6|76.28
1459,8,0.4064,11.38,6249.0,0.001813,0.9996790000000001,ENAM FAM208A LIG4 MORC2 NHEJ1 PPHLN1 RYR1 XRCC4,double-strand break repair via nonhomologous end joining|non-recombinational repair|immunoglobulin V(D)J recombination|DNA ligation involved in DNA repair|establishment of integrated proviral latency,1.089e-06|1.418e-06|2.768e-06|3.558e-06|4.447e-06,0.01718|0.01118|0.01455|0.01403|0.01403,140.1|127.9|980.7|840.6|735.5
1460,7,0.401,8.42,5726.0,0.001465,0.9992989999999999,ENDOD1 ERBB4 GPR22 LBHD1 NAPEPLD PVRIG SPAG6,central nervous system morphogenesis|host-mediated regulation of intestinal microbiota composition|negative regulation of eating behavior|cardiac muscle tissue regeneration|N-acylethanolamine metabolic process,0.001019|0.001019|0.001358|0.001698|0.002037,1|1|1|1|1,1471|1471|980.7|735.5|588.4
1461,5,0.4514,4.513999999999999,4148.0,0.001084,0.996692,DNAH3 ENDOU JPT2 MANBA SLC30A3,zinc ion import into synaptic vesicle|zinc ion import into organelle|regulation of sequestering of zinc ion|oligosaccharide catabolic process|zinc ion transmembrane transport,0.000728|0.000728|0.001456|0.003394|0.006054,1|1|1|1|1,2060|2060|823.8|316.8|171.6
1462,8,0.4097,11.47,6446.0,0.001772,0.9996790000000001,CRYL1 ENGASE IFT88 PSPC1 RASL11A RNF6 ZMYM2 ZMYM5,cellular response to gibberellin stimulus|gibberellic acid mediated signaling pathway|response to gibberellin|gibberellin mediated signaling pathway|protein K27-linked ubiquitination,0.0007765|0.0007765|0.0007765|0.0007765|0.002328,1|1|1|1|1,2574|2574|2574|2574|514.9
1463,4,0.479,2.8739999999999997,3077.0,0.0009308,0.9929309999999999,ENHO METTL7A SFTA2 TRIM68,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding|regulation of RNA polymerase II regulatory region sequence-specific DNA binding|negative regulation of transcription regulatory region DNA binding|negative regulation of insulin receptor signaling pathway|regulation of androgen receptor signaling pathway,0.001553|0.003104|0.004459|0.007166|0.007166,1|1|1|1|1,735.5|343.2|234|143|143
1464,5,0.434,4.34,3886.0,0.001113,0.996692,BMP8A ENKUR HSPG2 MAPK8IP3 PIGQ,establishment of left/right asymmetry|anterograde axonal protein transport|protein localization to presynapse|microtubule-based movement|diet induced thermogenesis,0.0009706|0.002425|0.002425|0.002814|0.00291,1|1|1|1|1,1373|457.7|457.7|23.54|374.5
1465,6,0.4259,6.388999999999999,4807.0,0.001324,0.998474,CLCN3 ENPEP LAX1 PIFO SFRP2 SLCO4C1,negative regulation of MAP kinase activity|synaptic vesicle lumen acidification|negative regulation of dermatome development|negative regulation of protein serine/threonine kinase activity|negative regulation of planar cell polarity pathway involved in axis elongation,0.0002048|0.0005824|0.0005824|0.0006566|0.0008735,1|1|1|1|1,91.53|3432|3432|50.48|1716
1466,5,0.4437,4.437,3871.0,0.001142,0.996692,BGLAP BTBD9 ENPP6 RTN1 SLC2A6,"ammonium ion metabolic process|circadian sleep/wake cycle, non-REM sleep|circadian sleep/wake cycle, sleep|response to hydroxyisoflavone|response to vitamin K",1.65e-05|0.0004854|0.0009706|0.001213|0.001213,0.2603|1|1|1|1,329.5|4119|1373|1030|1030
1467,5,0.435,4.35,4016.0,0.0010789999999999999,0.996692,C10orf67 ENTPD1 INHA TRMT44 ZIC2,negative regulation of follicle-stimulating hormone secretion|negative regulation of B cell differentiation|positive regulation of gonadotropin secretion|positive regulation of follicle-stimulating hormone secretion|regulation of follicle-stimulating hormone secretion,0.0009706|0.001456|0.001456|0.001456|0.001456,1|1|1|1|1,1373|823.8|823.8|823.8|823.8
1468,5,0.4443,4.4430000000000005,3971.0,0.001115,0.996692,ATG4B ENTPD3 RLF TRAF3IP1 UBQLN4,protein delipidation|negative regulation of autophagosome maturation|histone H3-K4 monomethylation|autophagy|process utilizing autophagic mechanism,0.0005824|0.002037|0.002619|0.003212|0.003212,1|1|1|1|1,3432|572.1|429.1|22.43|22.43
1469,25,0.4011,120.3,17870.0,0.006670999999999999,1.0,CYP4F11 CYP4F12 CYP4F2 MEF2B OR10H2 OR7A5 OR7C1 OR7C2 ZNF14 ZNF195 ZNF253 ZNF43 ZNF443 ZNF486 ZNF492 ZNF625 ZNF682 ZNF69 ZNF714 ZNF737 ZNF763 ZNF844 ZNF91 ZNF98 ZNF99,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",1.257e-11|1.718e-09|1.727e-09|1.768e-09|6.066e-09,1.983e-07|1.355e-05|9.078e-06|6.974e-06|1.914e-05,5.734|4.281|4.279|4.273|3.967
1470,5,0.4429,4.428999999999999,3949.0,0.001118,0.996692,CAPNS1 CASC10 COPS9 EOMES SCN3B,"CD8-positive, alpha-beta T cell differentiation involved in immune response|mesodermal to mesenchymal transition involved in gastrulation|regulation of ventricular cardiac muscle cell membrane depolarization|endodermal cell fate specification|negative regulation of protein neddylation",0.0003883|0.0007766|0.001165|0.001165|0.001165,1|1|1|1|1,5149|1716|1030|1030|1030
1471,6,0.4539,6.808,3854.0,0.0017579999999999998,0.998474,ARNT CUL2 EPAS1 HIF1A TNFSF10 VHL,regulation of transcription from RNA polymerase II promoter in response to hypoxia|regulation of transcription from RNA polymerase II promoter in response to stress|regulation of DNA-templated transcription in response to stress|cellular response to hypoxia|cellular response to decreased oxygen levels,5.619e-12|3.238e-11|4.175e-11|4.298e-10|5.397e-10,8.863e-08|2.554e-07|2.195e-07|1.695e-06|1.702e-06,220|153.2|145.4|90.33|86.24
1472,5,0.4206,4.206,3932.0,0.001066,0.996692,A4GNT DRD1 EPB41L4A KATNAL2 SLC10A5,cerebral cortex GABAergic interneuron migration|cerebral cortex GABAergic interneuron development|phospholipase C-activating dopamine receptor signaling pathway|regulation of catecholamine uptake involved in synaptic transmission|regulation of dopamine uptake involved in synaptic transmission,0.001698|0.00194|0.002183|0.002183|0.002183,1|1|1|1|1,686.5|588.4|514.9|514.9|514.9
1473,24,0.4016,110.9,20230.0,0.005437,1.0,C8orf44 C8orf76 CA1 CA13 CA2 CA3 CA8 CNGB3 CPA6 CYP7A1 EPB41L5 ESRP1 FABP12 KLHL38 MCMDC2 MTSS1 NOV PKIA PMP2 PPDPFL SGK3 TMEM69 TRIM55 UBE2W,one-carbon metabolic process|bicarbonate transport|organic anion transport|cellular response to fluid shear stress|response to fluid shear stress,2.225e-09|3.125e-07|6.273e-05|0.0002864|0.0008366,3.51e-05|0.002465|0.3298|1|1,101.6|75.44|11.65|88.01|49.51
1474,5,0.4061,4.061,3976.0,0.001018,0.996692,BBS2 EPCAM MAMDC2 PRKD3 ZNF507,protein kinase D signaling|negative regulation of appetite by leptin-mediated signaling pathway|regulation of cilium beat frequency involved in ciliary motility|artery smooth muscle contraction|negative regulation of cell-cell adhesion mediated by cadherin,0.0009706|0.001213|0.00194|0.002425|0.002667,1|1|1|1|1,1373|1030|588.4|457.7|411.9
1475,6,0.4022,6.0329999999999995,4851.0,0.001239,0.998474,CA13 EPHA1 FGD4 KCNE2 PPP3R1 ZNF280A,regulation of cyclic nucleotide-gated ion channel activity|regulation of inward rectifier potassium channel activity|negative regulation of delayed rectifier potassium channel activity|calcineurin-NFAT signaling cascade|ventricular cardiac muscle cell membrane repolarization,0.0008735|0.001746|0.003781|0.003781|0.003781,1|1|1|1|1,1716|686.5|286|286|286
1476,5,0.4502,4.502,3869.0,0.001159,0.996692,EPHA6 EVI2B MUM1 PTH SERINC1,positive regulation of neutrophil differentiation|positive regulation of molecular function|positive regulation of osteoclast proliferation|regulation of neutrophil differentiation|positive regulation of serine C-palmitoyltransferase activity,0.0005824|0.0007071|0.0008735|0.001165|0.001165,1|1|1|1|1,3432|7.775|1716|1144|1144
1477,6,0.4171,6.256,4556.0,0.001368,0.998474,CTSO EPHA8 ITPKA PTRH1 TRAPPC6B UBB,toll-like receptor signaling pathway|proteolysis involved in cellular protein catabolic process|pattern recognition receptor signaling pathway|cellular protein catabolic process|protein catabolic process,0.0005114|0.0007843|0.0008004|0.0009169|0.001164,1|1|1|1|1,58.26|14.81|46.33|14.03|12.92
1478,5,0.4439,4.439,4089.0,0.001082,0.996692,EFCAB9 EPHB1 LIMK1 RUFY1 SUMO3,negative regulation of satellite cell differentiation|negative regulation of skeletal muscle satellite cell proliferation|negative regulation of skeletal muscle cell proliferation|optic nerve morphogenesis|negative regulation of skeletal muscle cell differentiation,0.001213|0.001213|0.001213|0.001456|0.001456,1|1|1|1|1,1030|1030|1030|823.8|823.8
1479,5,0.4036,4.0360000000000005,3966.0,0.0010140000000000001,0.996692,DCTN3 EPHX1 KIAA0930 MNS1 PLEKHN1,epoxide metabolic process|left/right axis specification|cilium organization|3'-UTR-mediated mRNA destabilization|left/right pattern formation,0.001456|0.003152|0.003689|0.004604|0.004845,1|1|1|1|1,823.8|343.3|20.49|228.8|216.8
1480,6,0.4226,6.34,4904.0,0.001288,0.998474,ATP11A DLEC1 EPHX3 HLA-DQB2 ZNF19 ZNF23,B cell affinity maturation|peripheral B cell selection|B cell selection|epoxide metabolic process|aminophospholipid translocation,0.0008735|0.0008735|0.001456|0.001746|0.002328,1|1|1|1|1,1716|1716|858.1|686.5|490.4
1481,7,0.4055,8.516,5706.0,0.0014869999999999998,0.9992989999999999,BTBD2 CYBC1 EPHX4 FRZB NCK2 SEPT10 YPEL2,negative regulation of hepatocyte differentiation|regulation of hepatocyte differentiation|respiratory burst after phagocytosis|negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress|convergent extension involved in organogenesis,0.0006794|0.001019|0.001358|0.001698|0.002037,1|1|1|1|1,2942|1471|980.7|735.5|588.4
1482,5,0.4296,4.296,3880.0,0.001103,0.996692,ALKBH4 BBS4 CTNNBIP1 EPM2A ZNF521,cytoskeleton-dependent cytokinesis|cytokinesis|cleavage furrow ingression|regulation of cellular component organization|regulation of vascular permeability involved in acute inflammatory response,0.0002219|0.0002796|0.000728|0.0007859|0.001213,1|1|1|1|1,85.81|76.28|2060|6.981|1030
1483,7,0.4185,8.788,5876.0,0.00149,0.9992989999999999,CAPG EPN1 GNLY STON1 TLX2 TRABD2A TRIM56,positive regulation of protein oxidation|regulation of protein oxidation|interferon-beta production|type I interferon production|negative regulation of dendrite morphogenesis,0.001164|0.001164|0.001552|0.002328|0.003877,1|1|1|1|1,1287|1287|858.1|514.9|286
1484,9,0.4122,14.84,7170.0,0.00206,0.9998530000000001,ACACB ARL6IP4 HCAR2 HCAR3 OASL P2RX4 PITPNM2 TMEM132B TMEM233,negative regulation of lipid catabolic process|regulation of lipid catabolic process|negative regulation of lipid metabolic process|positive regulation of lipid localization|malonyl-CoA biosynthetic process,5.92e-05|0.0003164|0.0008211|0.001065|0.00131,0.9338|1|1|1|1,183.1|76.28|46.7|40.86|1144
1485,6,0.4047,6.071000000000001,4731.0,0.0012779999999999998,0.998474,EPYC PEX5L PTPN3 TTC9 WNT5A ZNF280B,chemoattraction of serotonergic neuron axon|planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation|negative regulation of cell proliferation in midbrain|planar cell polarity pathway involved in pericardium morphogenesis|planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,0.0005824|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,3432|3432|3432|3432|3432
1486,6,0.425,6.375,4725.0,0.001344,0.998474,ERAP1 IPCEF1 MAGI2 SYNC TNIK ZP1,asparaginyl-tRNA aminoacylation|planar cell polarity pathway involved in axis elongation|activation of JNKK activity|negative regulation of activin receptor signaling pathway|glomerular visceral epithelial cell development,0.001358|0.001358|0.003732|0.004071|0.004071,1|1|1|1|1,980.7|980.7|294.2|267.5|267.5
1487,5,0.4304,4.303999999999999,4274.0,0.001004,0.996692,C15orf39 CYP27A1 ERAP2 GEM IL13,positive regulation of pancreatic stellate cell proliferation|positive regulation of lung goblet cell differentiation|regulation of lung goblet cell differentiation|negative regulation of lung ciliated cell differentiation|regulation of calcium ion transmembrane transport,0.0004854|0.0004854|0.0004854|0.0004854|0.0005471,1|1|1|1|1,4119|4119|4119|4119|54.2
1488,7,0.4108,8.627,5936.0,0.001448,0.9992989999999999,ERBIN EVA1B HPCAL4 TCTEX1D1 TEKT2 TMEM171 TRIM23,basal protein localization|negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway|negative regulation of nucleotide-binding oligomerization domain containing signaling pathway|negative regulation of monocyte chemotactic protein-1 production|regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,0.0006794|0.001358|0.001358|0.002376|0.003054,1|1|1|1|1,2942|980.7|980.7|490.4|367.8
1489,6,0.4043,6.064,4930.0,0.0012259999999999999,0.998474,BEST2 ERF IRGC PDE6A RIMS3 ZNF568,"rhodopsin mediated signaling pathway|calcium ion-regulated exocytosis of neurotransmitter|phototransduction, visible light|regulation of membrane potential|cellular response to interferon-beta",0.003781|0.004651|0.005522|0.006392|0.006681,1|1|1|1|1,286|228.8|190.7|15.75|156
1490,6,0.4008,6.013,5061.0,0.001184,0.998474,ARMH1 CLCN2 ERICH1 GRK4 KCNMB3 PAH,"tyrosine biosynthetic process|aromatic amino acid family biosynthetic process, prephenate pathway|aromatic amino acid family biosynthetic process|cell differentiation involved in salivary gland development|regulation of aldosterone biosynthetic process",0.0005824|0.0005824|0.0005824|0.0008735|0.002328,1|1|1|1|1,3432|3432|3432|1716|490.4
1491,6,0.4327,6.4910000000000005,4883.0,0.001324,0.998474,EBPL ERICH6B HRC IQUB MYLK3 SLC2A8,positive regulation of relaxation of cardiac muscle|sarcomerogenesis|positive regulation of relaxation of muscle|regulation of vascular permeability involved in acute inflammatory response|positive regulation of sarcomere organization,0.0008735|0.001165|0.001165|0.001456|0.001456,1|1|1|1|1,1716|1144|1144|858.1|858.1
1492,5,0.4613,4.613,4064.0,0.001131,0.996692,BLNK ERLIN1 LRRC29 LRRC8E VEGFC,positive regulation of lymphangiogenesis|negative regulation of cholesterol biosynthetic process|positive regulation of mesenchymal stem cell proliferation|regulation of mesenchymal stem cell proliferation|regulation of lymphangiogenesis,0.000728|0.001456|0.001456|0.001456|0.001456,1|1|1|1|1,2060|823.8|823.8|823.8|823.8
1493,5,0.4525,4.525,4138.0,0.00109,0.996692,CDKN2D ERN2 LYZL6 SLC28A1 SUGCT,cytidine transport|cell cycle arrest|purine nucleobase transmembrane transport|pyrimidine nucleoside transport|uridine transport,0.0004854|0.000492|0.001213|0.001456|0.001456,1|1|1|1|1,4119|57.21|1030|823.8|823.8
1494,21,0.4006,84.13,14710.0,0.005671,1.0,CNIH4 DUX4 EIF2S1 EIF4B NBEAL1 NEDD8 NUTF2 POGZ PSMA1 PSMA2 PSMA4 PSMA6 RPL17 SMU1 SNRPD1 SNU13 SRP54 ST20 TBC1D3B TSPYL5 UQCRH,cellular protein-containing complex assembly|proteasomal ubiquitin-independent protein catabolic process|protein-DNA complex assembly|protein-containing complex assembly|cellular component biogenesis,6.855e-09|1.431e-08|2.392e-07|4.291e-07|5.395e-07,0.0001081|0.0001129|0.001258|0.001692|0.001702,10.9|170.2|22.11|7.002|4.506
1495,6,0.4022,6.032,4798.0,0.001253,0.998474,ESAM FABP6 REC114 REM2 TM4SF5 ZNF480,triglyceride catabolic process|maintenance of blood-brain barrier|acylglycerol catabolic process|neutral lipid catabolic process|regulation of actin cytoskeleton reorganization,0.008128|0.01015|0.01102|0.01102|0.01159,1|1|1|1|1,127.1|101|92.77|92.77|88.01
1496,7,0.4163,8.742,5869.0,0.001484,0.9992989999999999,C20orf194 CATIP ESCO1 FAM81A MGAT4D MTTP OTUD7A,negative regulation of protein glycosylation|post-translational protein acetylation|triglyceride transport|acylglycerol transport|protein deubiquitination involved in ubiquitin-dependent protein catabolic process,0.001358|0.001358|0.002037|0.002037|0.002715,1|1|1|1|1,980.7|980.7|588.4|588.4|420.3
1497,6,0.4208,6.312,4914.0,0.00128,0.998474,ADAL ESD GPR176 KLHL23 MAST3 RNF6,inosine biosynthetic process|adenosine catabolic process|formaldehyde catabolic process|inosine metabolic process|formaldehyde metabolic process,0.001165|0.001165|0.001165|0.001456|0.001456,1|1|1|1|1,1144|1144|1144|858.1|858.1
1498,9,0.4093,14.74,7168.0,0.002046,0.9998530000000001,C1QB C1QC CELA3A CLCNKA CLCNKB ESPN MST1 NBL1 WDR38,positive regulation of mammary gland epithelial cell proliferation|synapse pruning|cell junction disassembly|regulation of leukocyte chemotaxis|regulation of mammary gland epithelial cell proliferation,1.396e-05|1.649e-05|1.923e-05|2.475e-05|4.43e-05,0.2201|0.13|0.1011|0.09761|0.1398,411.9|374.5|343.3|51.06|216.8
1499,5,0.4387,4.387,3985.0,0.001097,0.996692,CNTF ESRRA HOMER3 MBP TBC1D9,positive regulation of metalloendopeptidase activity|regulation of retinal cell programmed cell death|ciliary neurotrophic factor-mediated signaling pathway|regulation of metalloendopeptidase activity|positive regulation of metallopeptidase activity,0.0008735|0.001165|0.001746|0.002037|0.002037,1|1|1|1|1,1716|1144|686.5|572.1|572.1
1500,6,0.4,6.001,4982.0,0.0012,0.998474,ANKRD46 C3orf30 DLG1 ERICH5 ESRRB FILIP1L,positive regulation of transcription involved in G2/M transition of mitotic cell cycle|regulation of transcription involved in G2/M transition of mitotic cell cycle|positive regulation of transcription involved in G1/S transition of mitotic cell cycle|cortical microtubule organization|regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,0.0005824|0.0008735|0.001165|0.001165|0.001165,1|1|1|1|1,3432|1716|1144|1144|1144
1501,4,0.422,2.532,3066.0,0.0008231,0.9929309999999999,ESYT1 LRRTM2 S100A1 TSPEAR,endoplasmic reticulum-plasma membrane tethering|endoplasmic reticulum localization|regulation of postsynaptic density assembly|regulation of postsynaptic specialization assembly|negative regulation of receptor internalization,0.001359|0.002134|0.002328|0.002522|0.002716,1|1|1|1|1,858.1|514.9|468.1|429.1|396.1
1502,7,0.4143,8.701,5790.0,0.001497,0.9992989999999999,COL4A2 ESYT3 FMN2 KDELC1 PLXND1 PROZ PYGB,homologous chromosome movement towards spindle pole in meiosis I anaphase|formin-nucleated actin cable organization|formin-nucleated actin cable assembly|meiotic chromosome movement towards spindle pole|polar body extrusion after meiotic divisions,0.0005824|0.001165|0.001165|0.001165|0.001456,1|1|1|1|1,3432|1144|1144|1144|858.1
1503,7,0.4457,9.36,5559.0,0.0016769999999999999,0.9992989999999999,ETFA ETFB ETFDH GBP7 KCNK7 PRKCD RAB1B,fatty acid beta-oxidation using acyl-CoA dehydrogenase|fatty acid beta-oxidation|fatty acid oxidation|lipid oxidation|fatty acid catabolic process,6.859e-09|9.006e-07|2.515e-06|2.881e-06|3.076e-06,0.0001082|0.007103|0.01322|0.01136|0.009705,882.6|149.6|105.1|100.3|98.07
1504,8,0.4189,11.73,5620.0,0.002077,0.9996790000000001,DCAKD ETNPPL PFDN1 TBCA TUBA1B TUBA1C TUBB UBQLN4,cytoskeleton-dependent intracellular transport|cell division|microtubule cytoskeleton organization|post-chaperonin tubulin folding pathway|mitotic cell cycle,4.584e-05|0.0007055|0.001058|0.002328|0.002473,0.7231|1|1|1|1,40.02|15.7|13.65|514.9|10.15
1505,6,0.4113,6.17,5170.0,0.001189,0.998474,ARRDC2 ENPEP ETV1 PPFIA1 RIPOR1 TMBIM1,negative regulation of protein localization to plasma membrane|negative regulation of protein localization to cell periphery|negative regulation of protein localization to membrane|regulation of protein localization to plasma membrane|regulation of cellular protein localization,2.29e-05|2.663e-05|3.949e-05|0.0003881|0.0003898,0.3613|0.21|0.2077|1|1,286|264|214.5|66.01|18.26
1506,6,0.4043,6.065,4112.0,0.001468,0.998474,ETV4 ETV5 ITPA KLHL11 MAPK1 RAF1,thyroid gland development|face development|thymus development|activation of MAPKK activity|regulation of cell differentiation,2.29e-05|8.263e-05|8.606e-05|0.000116|0.0004559,0.3613|0.6517|0.4525|0.4575|1,286|146.1|143|122.6|8.712
1507,5,0.4382,4.382,4106.0,0.0010630000000000001,0.996692,BTBD6 ETV7 H6PD LMBR1 TMEM150A,"pentose-phosphate shunt, oxidative branch|regulation of cortisol biosynthetic process|regulation of glucocorticoid biosynthetic process|regulation of glucocorticoid metabolic process|regulation of steroid hormone biosynthetic process",0.001213|0.00194|0.002183|0.002667|0.00291,1|1|1|1|1,1030|588.4|514.9|411.9|374.5
1508,5,0.4212,4.212,3724.0,0.001127,0.996692,EVX2 TGIF1 UBE4B UBL7 ZSWIM6,granzyme-mediated apoptotic signaling pathway|striatal medium spiny neuron differentiation|granzyme-mediated programmed cell death signaling pathway|regulation of axon guidance|striatum development,0.0004854|0.001213|0.002183|0.003636|0.004604,1|1|1|1|1,4119|1030|514.9|294.2|228.8
1509,5,0.4485,4.485,3935.0,0.0011359999999999999,0.996692,APC2 ATRAID EXD1 GAA TMBIM4,vacuolar sequestering|organophosphate ester transport|diaphragm contraction|positive regulation of very-low-density lipoprotein particle remodeling|urea homeostasis,0.0007765|0.001146|0.001164|0.001164|0.001164,1|1|1|1|1,2574|39.01|1287|1287|1287
1510,7,0.4206,8.834,4357.0,0.002017,0.9992989999999999,AHR ARNT CUL2 EPAS1 HIF1A TIPARP VHL,regulation of transcription from RNA polymerase II promoter in response to hypoxia|regulation of transcription from RNA polymerase II promoter in response to stress|regulation of DNA-templated transcription in response to stress|cellular response to hypoxia|cellular response to decreased oxygen levels,1.96e-11|1.128e-10|1.454e-10|1.492e-09|1.873e-09,3.092e-07|8.896e-07|7.644e-07|5.886e-06|5.909e-06,188.6|131.3|124.7|77.42|73.92
1511,5,0.4385,4.385,3872.0,0.0011279999999999999,0.996692,AVIL EXD3 KIAA0895L NR2F6 OR56B1,regulation of diacylglycerol biosynthetic process|actin filament severing|detection of temperature stimulus involved in sensory perception of pain|detection of temperature stimulus involved in sensory perception|barbed-end actin filament capping,0.0004854|0.003878|0.004604|0.005329|0.005571,1|1|1|1|1,4119|274.6|228.8|196.1|187.2
1512,6,0.4415,6.622000000000001,4781.0,0.0013800000000000002,0.998474,ATP7B EXOC3L1 FGF23 MYO9A SPACA9 SYTL2,copper ion export|positive regulation of vitamin D 24-hydroxylase activity|regulation of vitamin D 24-hydroxylase activity|response to sodium phosphate|vitamin D catabolic process,0.001165|0.001165|0.001165|0.001165|0.001165,1|1|1|1|1,1144|1144|1144|1144|1144
1513,6,0.4058,6.087000000000001,4891.0,0.00124,0.998474,C1orf115 EXOC3L2 LCT RNLS TMED9 TSNAX,exocyst localization|polysaccharide digestion|COPI-coated vesicle budding|COPI coating of Golgi vesicle|Golgi transport vesicle coating,0.001746|0.002037|0.002037|0.002037|0.002037,1|1|1|1|1,686.5|572.1|572.1|572.1|572.1
1514,5,0.4468,4.468,4114.0,0.001082,0.996692,CCDC58 EXPH5 NDRG2 RAB31 TAAR1,"regulation of platelet-derived growth factor production|keratinocyte development|positive regulation of phagocytosis, engulfment|positive regulation of membrane invagination|regulation of phagocytosis, engulfment",0.0009706|0.002667|0.003394|0.003394|0.003878,1|1|1|1|1,1373|411.9|316.8|316.8|274.6
1515,5,0.4251,4.251,3887.0,0.00109,0.996692,BTBD7 EXTL1 FNDC5 KLHL20 LRRC14B,protein K33-linked ubiquitination|regulation of branching involved in salivary gland morphogenesis|positive regulation of brown fat cell differentiation|Golgi to endosome transport|regulation of brown fat cell differentiation,0.0004854|0.00194|0.00412|0.004362|0.005571,1|1|1|1|1,4119|588.4|257.4|242.3|187.2
1516,5,0.4017,4.0169999999999995,4126.0,0.0009704000000000001,0.996692,ERAP2 F12 GUSB HAPLN3 PKP1,immune response|Factor XII activation|plasma kallikrein-kinin cascade|kinin cascade|glucuronoside catabolic process,0.0003898|0.000728|0.0009706|0.0009706|0.001213,1|1|1|1|1,8.355|2060|1373|1373|1030
1517,5,0.4501,4.501,3960.0,0.001132,0.996692,CREB5 F3 INF2 LMAN1 NOXRED1,"activation of plasma proteins involved in acute inflammatory response|activation of blood coagulation via clotting cascade|negative regulation of blood coagulation, extrinsic pathway|regulation of blood coagulation, extrinsic pathway|blood coagulation, extrinsic pathway",0.0004854|0.000728|0.001213|0.001213|0.001213,1|1|1|1|1,4119|2060|1030|1030|1030
1518,6,0.4354,6.531000000000001,4971.0,0.001309,0.998474,ADCY1 CHGA FABP1 SLC16A8 SLC30A2 TRAT1,response to inorganic substance|adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation|positive regulation of sequestering of zinc ion|adenylate cyclase-activating G protein-coupled receptor signaling pathway|positive regulation of dense core granule biogenesis,0.000347|0.0005824|0.0005824|0.0006378|0.0008735,1|1|1|1|1,19|3432|3432|51.23|1716
1519,8,0.4125,11.55,7144.0,0.001611,0.9996790000000001,CD180 CPT1C FABP2 LMBR1L MATN2 SMCO1 SUN2 ZNF202,lymphocyte proliferation|mononuclear cell proliferation|leukocyte proliferation|nuclear migration along microfilament|nuclear matrix anchoring at nuclear membrane,0.0004209|0.000442|0.0005907|0.001164|0.001552,1|1|1|1|1,65.17|63.56|54.77|1287|858.1
1520,18,0.405,61.97,14990.0,0.004107,1.0,AGO1 AGO3 AGO4 AZIN2 BSDC1 C1QB C1QC CTRC FABP3 GJA4 GJB4 KIAA0319L SCMH1 TSSK3 ZBTB8A ZFP69 ZFP69B ZNF684,"miRNA loading onto RISC involved in gene silencing by miRNA|RNA secondary structure unwinding|small RNA loading onto RISC|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation",6.683e-08|9.185e-08|1.224e-07|3.109e-07|3.109e-07,0.001054|0.0007244|0.0006436|0.001226|0.0009807,490.4|429.1|381.4|264|264
1521,7,0.4309,9.05,5813.0,0.001551,0.9992989999999999,C10orf62 FADS3 FAM81B IL17B MAP4K2 PATL2 PCK1,pyruvate metabolic process|cellular glucose homeostasis|monocarboxylic acid metabolic process|glucose metabolic process|positive regulation of transcription from RNA polymerase II promoter in response to acidic pH,0.0002432|0.0004172|0.00051|0.0006591|0.001019,1|1|1|1|1,85.28|64.66|17.17|51.17|1471
1522,4,0.4578,2.747,2984.0,0.0009172000000000001,0.9929309999999999,CNIH3 CSN2 FAF1 RPL36AL,cytoplasmic sequestering of NF-kappaB|protein deneddylation|positive regulation of extrinsic apoptotic signaling pathway via death domain receptors|inner cell mass cell proliferation|cytoplasmic sequestering of transcription factor,0.002183|0.002667|0.003394|0.003636|0.00412,1|1|1|1|1,514.9|411.9|316.8|294.2|257.4
1523,5,0.4461,4.461,3970.0,0.001119,0.996692,FAH HS3ST3A1 LAMA2 SGPP1 SYT1,positive regulation of synaptic transmission|positive regulation of calcium ion-dependent exocytosis of neurotransmitter|synchronous neurotransmitter secretion|homogentisate metabolic process|homogentisate catabolic process,0.0004024|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,63.37|4119|4119|4119|4119
1524,5,0.4521,4.521,4024.0,0.001119,0.996692,ABHD17A FAHD1 LOXL4 RUSC2 SF3A3,U2-type prespliceosome assembly|peptidyl-lysine oxidation|negative regulation of protein localization to microtubule|regulation of protein localization to microtubule|mRNA 3'-splice site recognition,0.0009706|0.001456|0.001456|0.001456|0.001698,1|1|1|1|1,1373|823.8|823.8|823.8|686.5
1525,23,0.405,102.5,17910.0,0.005673,1.0,ADCY10 ATXN7L3B C8orf44 CARNS1 CCDC25 CCNB1IP1 FAIM FEZF2 KIF26B KLK10 LRRC40 LYRM1 MAP3K7CL NDRG3 NECAP2 NIPSNAP3B PCDHB12 PCDHGA9 RNF114 SDR39U1 SLC25A36 TEX12 ZNF286A,homologous chromosome pairing at meiosis|carnosine biosynthetic process|homologous chromosome segregation|chromosome organization involved in meiotic cell cycle|spermatogenesis,0.001585|0.00223|0.002301|0.002745|0.003002,1|1|1|1|1,35.12|895.4|28.88|26.34|6.536
1526,6,0.4199,6.2989999999999995,4919.0,0.001276,0.998474,DRICH1 FAM110A KCNG3 LSR PDE4D RAB24,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate|adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate|tricellular tight junction assembly|regulation of ion transmembrane transport|regulation of transmembrane transport,0.0006794|0.0006794|0.0006794|0.0007247|0.000743,1|1|1|1|1,2942|2942|2942|15.22|15.09
1527,5,0.4251,4.251,3963.0,0.0010689999999999999,0.996692,CALB2 CLMN FAM110C HSF4 TMEM200B,histone H3-K9 demethylation|regulation of presynaptic cytosolic calcium ion concentration|nuclear migration|nucleus localization|histone lysine demethylation,0.003878|0.00412|0.005087|0.006537|0.007502,1|1|1|1|1,274.6|257.4|205.9|158.4|137.3
1528,5,0.409,4.09,3897.0,0.001046,0.996692,ARL6 CERS4 COTL1 FAM110D SELENOK,respiratory burst after phagocytosis|respiratory burst involved in defense response|foam cell differentiation|macrophage derived foam cell differentiation|positive regulation of monocyte chemotactic protein-1 production,0.0009706|0.00194|0.00194|0.00194|0.00291,1|1|1|1|1,1373|588.4|588.4|588.4|374.5
1529,6,0.4184,6.276,4411.0,0.001417,0.998474,FAM114A1 FAM162A OR10H5 OR5K3 POLQ WDR5B,double-strand break repair via alternative nonhomologous end joining|somatic hypermutation of immunoglobulin genes|somatic diversification of immune receptors via somatic mutation|negative regulation of double-strand break repair via homologous recombination|detection of chemical stimulus involved in sensory perception of smell,0.001456|0.004651|0.004942|0.005812|0.006535,1|1|1|1|1,858.1|228.8|214.5|180.7|15.57
1530,5,0.4295,4.295,3860.0,0.001109,0.996692,COX7B2 FAM117A NUDT16L1 PTK2B TMEM202,positive regulation of B cell chemotaxis|regulation of B cell chemotaxis|regulation of inositol trisphosphate biosynthetic process|activation of Janus kinase activity|negative regulation of double-strand break repair via nonhomologous end joining,0.000728|0.000728|0.001698|0.001698|0.00194,1|1|1|1|1,2060|2060|686.5|686.5|588.4
1531,14,0.4015,36.54,10750.0,0.003378,0.9999969999999999,ADAMTS15 ADAMTS8 CCDC153 DSCAML1 FAM118B KCNJ1 OR10G9 OR4D5 OR6M1 OR6X1 OR8B4 OR8D4 PDZD3 TMEM136,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,2.609e-07|3.683e-07|4.583e-07|6.931e-07|8.613e-07,0.004116|0.002905|0.00241|0.002733|0.002717,20.01|18.86|18.16|16.91|16.28
1532,15,0.4105,43.1,9736.0,0.0043939999999999995,0.999999,BUB1B CKAP5 CLTC DLGAP5 DSN1 GTSE1 KIF15 KNTC1 MAD1L1 MAD2L1BP MAPRE1 TACC3 TRIP13 ZWILCH ZWINT,mitotic cell cycle|mitotic spindle organization|microtubule cytoskeleton organization involved in mitosis|spindle organization|regulation of mitotic sister chromatid separation,1.461e-19|4.102e-18|1.313e-17|8.758e-17|1.052e-16,2.304e-15|3.235e-14|6.906e-14|3.454e-13|3.318e-13,25.26|83.72|74.22|61.02|169
1533,21,0.4064,85.35,17260.0,0.004907,1.0,AARD C8orf76 COL14A1 COLEC10 DCDC2 ENPP2 FBXO32 GNPNAT1 KLHL38 MTBP MTSS1 NETO2 NOV RNF139 SLC22A4 SLC30A8 STMN2 TRMT12 WDYHV1 ZFHX4 ZHX2,chemotaxis|taxis|nephron tubule epithelial cell differentiation|smooth muscle cell proliferation|regulation of kainate selective glutamate receptor activity,0.002963|0.003022|0.003343|0.003343|0.004455,1|1|1|1|1,6.56|6.524|447.7|447.7|298.5
1534,6,0.4357,6.5360000000000005,4951.0,0.001315,0.998474,APOF FAM126A IZUMO2 KCTD12 LRRC26 MTNR1B,"regulation of potassium ion transmembrane transporter activity|regulation of potassium ion transmembrane transport|regulation of potassium ion transport|regulation of cation channel activity|positive regulation of circadian sleep/wake cycle, non-REM sleep",0.000137|0.0003955|0.0005137|0.0012|0.001456,1|1|1|1|1,112.5|65.38|57.21|37.11|858.1
1535,6,0.431,6.465,4693.0,0.001372,0.998474,CYP26B1 FAM129C PRX SSBP4 TM6SF2 ZNF140,positive regulation of tongue muscle cell differentiation|regulation of tongue muscle cell differentiation|positive regulation of skeletal muscle fiber differentiation|regulation of skeletal muscle fiber differentiation|diterpenoid catabolic process,0.0008735|0.0008735|0.001165|0.001456|0.001746,1|1|1|1|1,1716|1716|1144|858.1|686.5
1536,6,0.4272,6.4079999999999995,4912.0,0.0013,0.998474,CPA3 FAM13A HOXC13 LONP2 RXYLT1 ZC3HAV1,protein processing|protein maturation|nail development|tongue morphogenesis|positive regulation of RIG-I signaling pathway,0.001498|0.002821|0.003393|0.003732|0.003732,1|1|1|1|1,33.62|24.32|326.9|294.2|294.2
1537,6,0.4251,6.377000000000001,4510.0,0.001408,0.998474,FAM13C LVRN OR56B1 RALGPS1 TRIM34 TRIM5,regulation of viral entry into host cell|modulation by symbiont of entry into host|interferon-gamma-mediated signaling pathway|positive regulation of autophagy|regulation of viral life cycle,6.96e-05|9.313e-05|0.0001892|0.0005306|0.0007853,1|0.7345|0.9946|1|1,159.7|137.3|95.35|56.27|46.07
1538,5,0.4215,4.215,4075.0,0.001031,0.996692,ADPRM CUTA FAM151A NGB SPATA24,oxygen transport|gas transport|biological regulation|nucleobase-containing small molecule catabolic process|regulation of biological process,0.003636|0.004845|0.008988|0.01208|0.01377,1|1|1|1|1,294.2|216.8|0|84.06|0
1539,8,0.4041,11.31,6695.0,0.0016829999999999998,0.9996790000000001,ACOT12 ADGRV1 ANKRD31 FAM151B FAM169A GUCA1C IFT172 IHH,embryonic camera-type eye morphogenesis|embryonic eye morphogenesis|embryonic camera-type eye development|positive regulation of smoothened signaling pathway|regulation of cyclase activity,4.962e-05|8.257e-05|9.21e-05|9.706e-05|0.0001601,0.7827|0.6512|0.4843|0.3828|0.5051,198|151.4|143|139.2|107.3
1540,6,0.4113,6.17,4973.0,0.001236,0.998474,EPS8L1 FAM160A1 PTPN3 RNF13 SLC14A2 TMOD1,regulation of membrane depolarization during action potential|pointed-end actin filament capping|urea transmembrane transport|negative regulation of membrane protein ectodomain proteolysis|urea transport,0.001746|0.002328|0.002619|0.002619|0.002909,1|1|1|1|1,686.5|490.4|429.1|429.1|381.4
1541,9,0.4046,14.57,7239.0,0.002003,0.9998530000000001,CD244 FAM160B2 FBXO25 MFGE8 OR10Z1 SLC36A1 SPRR4 SWT1 TSGA10,positive regulation of granzyme B production|regulation of granzyme B production|alkanesulfonate transport|taurine transport|proline transmembrane transport,0.001746|0.001746|0.003054|0.003054|0.003925,1|1|1|1|1,762.8|762.8|381.4|381.4|286
1542,13,0.3861,30.12,10360.0,0.002892,0.999993,ACBD3 FAM131A HRASLS HTR3D HTR3E MUC20 MUC4 PDCD6 SERP1 SERPINI1 SLC51A TCTEX1D2 TM4SF19,serotonin receptor signaling pathway|protein glycosylation|macromolecule glycosylation|glycosylation|O-glycan processing,0.0002971|0.0004347|0.0004347|0.0005055|0.000702,1|1|1|1|1,81.24|19.64|19.64|18.64|51.94
1543,6,0.4202,6.303,4840.0,0.001297,0.998474,C9orf50 FAM163B FAM241A HACL1 RFLNA SLC39A8,mitochondrial manganese ion transmembrane transport|leukocyte adhesion to arterial endothelial cell|phytanic acid metabolic process|plasma membrane selenite transport|cellular cadmium ion homeostasis,0.0005824|0.0005824|0.0005824|0.0005824|0.0008735,1|1|1|1|1,3432|3432|3432|3432|1716
1544,5,0.4316,4.316,3819.0,0.001126,0.996692,BNC2 FAM166A GNRH1 HAND1 SERPINB6,embryonic heart tube formation|cardiac left ventricle formation|response to prolactin|mesenchyme development|cardiac right ventricle formation,0.0004854|0.000728|0.0009706|0.001112|0.001213,1|1|1|1|1,4119|2060|1373|37.79|1030
1545,6,0.427,6.405,4806.0,0.001328,0.998474,ADGRF4 FAM169B GRB14 MT4 NT5C1B TBX5,cell migration involved in coronary vasculogenesis|cardiac left ventricle formation|bundle of His development|His-Purkinje system development|positive regulation of secondary heart field cardioblast proliferation,0.0005824|0.0008735|0.0008735|0.001165|0.001165,1|1|1|1|1,3432|1716|1716|1144|1144
1546,9,0.4139,14.9,7038.0,0.002107,0.9998530000000001,AKR1C1 AKR1C3 AKR1E2 CALML3 CALML5 FAM171A1 ITIH2 PDGFD PRTFDC1,cellular response to jasmonic acid stimulus|response to jasmonic acid|doxorubicin metabolic process|daunorubicin metabolic process|polyketide metabolic process,2.542e-06|2.542e-06|9.31e-06|9.31e-06|9.31e-06,0.04009|0.02005|0.04895|0.03671|0.02937,1144|1144|508.5|508.5|508.5
1547,5,0.4366,4.3660000000000005,3965.0,0.001097,0.996692,ABHD1 FAM171A2 GNAO1 NR2C1 RBP4,retinol transport|female genitalia morphogenesis|terpenoid transport|isoprenoid transport|urinary bladder development,0.000728|0.0009706|0.0009706|0.0009706|0.001213,1|1|1|1|1,2060|1373|1373|1373|1030
1548,7,0.4191,8.802,6094.0,0.001439,0.9992989999999999,C14orf39 FAM172A IFFO1 MFAP3L MFSD6 NSG2 ZBTB25,DNA double-strand break attachment to nuclear envelope|meiotic DNA double-strand break processing involved in reciprocal meiotic recombination|meiotic DNA double-strand break processing|heterochromatin assembly by small RNA|double-strand break repair,0.001019|0.001019|0.001698|0.001698|0.001983,1|1|1|1|1,1471|1471|735.5|735.5|29.13
1549,6,0.4134,6.2010000000000005,4925.0,0.001254,0.998474,BAIAP2L2 CDCA4 FAM181A MGAT3 PIH1D2 SLC16A8,negative regulation of lysosomal protein catabolic process|negative regulation of protein catabolic process in the vacuole|lactate transmembrane transport|lactate transport|box C/D snoRNP assembly,0.001165|0.001165|0.002328|0.002328|0.002619,1|1|1|1|1,1144|1144|490.4|490.4|429.1
1550,6,0.4075,6.1129999999999995,4820.0,0.0012640000000000001,0.998474,A1BG CLDN25 FAM184A LBH SLC17A6 ZBTB45,positive regulation of mammary stem cell proliferation|regulation of mammary stem cell proliferation|positive regulation of somatic stem cell division|regulation of somatic stem cell division|positive regulation of somatic stem cell population maintenance,0.0005824|0.0005824|0.0005824|0.0005824|0.0008735,1|1|1|1|1,3432|3432|3432|3432|1716
1551,5,0.4159,4.159,3799.0,0.001091,0.996692,FAM186B FCN1 GABBR2 PXK SNX1,cell surface pattern recognition receptor signaling pathway|neuron-glial cell signaling|lamellipodium morphogenesis|recognition of apoptotic cell|early endosome to Golgi transport,0.000728|0.001456|0.001456|0.00194|0.002425,1|1|1|1|1,2060|823.8|823.8|588.4|457.7
1552,7,0.4051,8.507,6065.0,0.001397,0.9992989999999999,AMIGO3 ERICH6B FAM189A1 ITGB7 NFATC1 RETREG2 TRAFD1,cell-matrix adhesion involved in ameboidal cell migration|negative regulation of vascular associated smooth muscle cell differentiation|calcineurin-NFAT signaling cascade|regulation of immune response|regulation of vascular associated smooth muscle cell differentiation,0.001019|0.003054|0.004409|0.0049|0.005425,1|1|1|1|1,1471|367.8|245.2|7.818|196.1
1553,6,0.4475,6.712000000000001,4934.0,0.001355,0.998474,CFAP44 FAM192A HMBOX1 LRBA SH2D3A TLR10,toll-like receptor 10 signaling pathway|positive regulation of chromatin binding|regulation of binding|sperm axoneme assembly|regulation of chromatin binding,0.0005824|0.004361|0.004552|0.006681|0.00726,1|1|1|1|1,3432|245.2|18.76|156|143
1554,5,0.4328,4.328,3959.0,0.0010890000000000001,0.996692,ANKK1 FAM198B LDLRAD4 OR2B11 UGT8,protein localization to paranode region of axon|negative regulation of SMAD protein complex assembly|galactolipid biosynthetic process|galactosylceramide biosynthetic process|paranodal junction assembly,0.0009706|0.001456|0.001698|0.001698|0.001698,1|1|1|1|1,1373|823.8|686.5|686.5|686.5
1555,5,0.4059,4.059,3948.0,0.001024,0.996692,FAM19A1 GGT7 POMZP3 R3HDML STXBP4,egg coat formation|leukotriene D4 biosynthetic process|leukotriene D4 metabolic process|glutathione catabolic process|positive regulation of acrosome reaction,0.0007766|0.002134|0.002134|0.002328|0.002522,1|1|1|1|1,1716|514.9|514.9|468.1|429.1
1556,14,0.4058,36.93,9479.0,0.0038689999999999996,0.9999969999999999,ARMC7 CCDC84 DDX59 DHX9 FAM204A PDCD7 PPIH RBM48 RNPC3 SCNM1 SNRNP25 TXNL4B WDR25 ZMAT5,"mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|RNA splicing|mRNA processing",6.651e-12|6.651e-12|7.184e-12|6.83e-11|2.64e-10,1.049e-07|5.245e-08|3.777e-08|2.694e-07|8.329e-07,38.97|38.97|38.59|28.92|24.32
1557,6,0.4001,6.001,4928.0,0.001213,0.998474,FAM214A GPSM3 MOB1B PPP1R14D SAMSN1 TEX26,negative regulation of protein serine/threonine phosphatase activity|positive regulation of protein serine/threonine phosphatase activity|cellular process|regulation of phosphorylation|positive regulation of phosphoprotein phosphatase activity,0.0005824|0.0008735|0.004476|0.005392|0.006391,1|1|1|1|1,3432|1716|0.2216|7.355|163.5
1558,6,0.4073,6.11,4724.0,0.001288,0.998474,AIG1 FAM216B GBE1 IL22 IP6K2 RAD21L1,cellular response to flavonoid|response to flavonoid|meiotic telomere tethering at nuclear periphery|meiotic attachment of telomere to nuclear envelope|long-chain fatty acid catabolic process,0.0005824|0.001165|0.001746|0.001746|0.001746,1|1|1|1|1,3432|1144|686.5|686.5|686.5
1559,5,0.4233,4.2330000000000005,3765.0,0.00112,0.996692,ACOT2 FAM218A OR10J1 SLC4A4 TNN,negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation|regulation of canonical Wnt signaling pathway involved in osteoblast differentiation|negative regulation of osteoblast proliferation|negative regulation of neuron migration|sodium ion export across plasma membrane,0.0004854|0.0004854|0.002667|0.00291|0.003636,1|1|1|1|1,4119|4119|411.9|374.5|294.2
1560,6,0.406,6.091,4992.0,0.001216,0.998474,CCPG1 CRYZ FAM219B PANK3 SLC35A3 TMEM91,regulation of Rho guanyl-nucleotide exchange factor activity|UDP-galactose transmembrane transport|UDP-N-acetylglucosamine transmembrane transport|regulation of guanyl-nucleotide exchange factor activity|pyrimidine nucleotide-sugar transmembrane transport,0.0008735|0.001456|0.001746|0.002909|0.00349,1|1|1|1|1,1716|858.1|686.5|381.4|312
1561,6,0.4015,6.022,4800.0,0.00125,0.998474,ANGPTL4 FAM222B KCNJ10 PXK RWDD2A SYNGR2,glutamate reuptake|protein unfolding|synaptic vesicle membrane organization|amino acid neurotransmitter reuptake|negative regulation of lipoprotein lipase activity,0.0008735|0.001165|0.001456|0.002037|0.002037,1|1|1|1|1,1716|1144|858.1|572.1|572.1
1562,21,0.4046,84.97,16960.0,0.004972,1.0,C1orf123 C1orf50 CCDC30 CFAP57 CYP4A11 CYP4A22 CYP4Z1 ERMAP EXO5 FST GAPT LURAP1 MFSD2A PLK2 PPT1 RAB3C ZFP69 ZFP69B ZNF248 ZNF684 ZNF691,lauric acid metabolic process|medium-chain fatty acid metabolic process|linoleic acid metabolic process|icosanoid biosynthetic process|negative regulation of transcription by RNA polymerase II,5.359e-06|0.0001064|0.0002235|0.0009417|0.001455,0.08453|0.8394|1|1|1,1030|147.1|98.07|45.77|5.708
1563,6,0.4157,6.236000000000001,4918.0,0.001263,0.998474,ACKR3 FAM229A IL25 PNPLA7 SYNE2 TTLL5,nuclear migration along microfilament|response to nematode|positive regulation of mesenchymal stem cell migration|regulation of mesenchymal stem cell migration|eosinophil differentiation,0.0008735|0.001165|0.001165|0.001165|0.001165,1|1|1|1|1,1716|1144|1144|1144|1144
1564,6,0.438,6.57,4910.0,0.001333,0.998474,AFAP1L1 ARHGDIG FAM234A GRIN1 IL32 RHBDD1,ionotropic glutamate receptor signaling pathway|glutamate receptor signaling pathway|propylene metabolic process|response to glycine|cellular alkene metabolic process,4e-05|0.0001155|0.0006794|0.001019|0.001019,0.631|0.9109|1|1|1,217.9|125.2|2942|1471|1471
1565,6,0.4154,6.231,4922.0,0.001261,0.998474,EMX2 FAM24B GH1 GNMT LRRC70 RAC3,response to estradiol|sarcosine metabolic process|S-adenosylhomocysteine metabolic process|receptor transactivation|cerebral cortex regionalization,0.0009416|0.001019|0.001358|0.002037|0.002376,1|1|1|1|1,42.64|1471|980.7|588.4|490.4
1566,12,0.4118,27.18,8523.0,0.00317,0.999986,CHERP DDX39B FAM32A GADD45GIP1 HAUS8 LSM4 MRPL34 MRPL4 RPL18A SUGP1 TIMM29 UBA52,gene expression|mRNA metabolic process|translation|peptide biosynthetic process|RNA processing,2.833e-07|1.167e-06|1.659e-06|2.253e-06|6.041e-06,0.004468|0.009201|0.008724|0.008883|0.01906,7.066|14.84|22.35|20.98|11.16
1567,6,0.4221,6.332000000000001,4712.0,0.0013390000000000001,0.998474,ACO1 DBNDD2 FAM3D ITPKB OR11A1 ZFYVE1,negative regulation of neutrophil apoptotic process|negative regulation of glucagon secretion|response to iron(II) ion|citrate metabolic process|inositol trisphosphate metabolic process,0.0005824|0.001456|0.001746|0.001746|0.002037,1|1|1|1|1,3432|858.1|686.5|686.5|572.1
1568,8,0.4035,11.3,6197.0,0.0018149999999999998,0.9996790000000001,FAM43A HTR3A HTR3B KIF3B NXPE1 NXPE2 NXPE4 SPTBN1,serotonin receptor signaling pathway|cellular response to dopamine|response to dopamine|cellular response to catecholamine stimulus|cellular response to monoamine stimulus,0.0001074|0.000442|0.0004526|0.0006281|0.0006281,1|1|1|1|1,132|63.56|62.79|53.08|53.08
1569,6,0.4293,6.44,4739.0,0.001354,0.998474,BHLHA9 FAM53A KLB NR5A2 THAP9 TSSK1B,"transposition, DNA-mediated|positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway|pancreas morphogenesis|transposition|calcineurin-mediated signaling",0.001165|0.001456|0.001456|0.002328|0.004651,1|1|1|1|1,1144|858.1|858.1|490.4|228.8
1570,6,0.4048,6.072,4917.0,0.00123,0.998474,C1orf105 FAM71D KDELR3 MIA2 TEX43 ZNF614,protein localization to endoplasmic reticulum|endoplasmic reticulum to Golgi vesicle-mediated transport|protein localization to endoplasmic reticulum exit site|protein retention in ER lumen|lipoprotein transport,0.0007146|0.001344|0.002619|0.002909|0.004071,1|1|1|1|1,48.35|35.03|429.1|381.4|264
1571,6,0.443,6.645,4764.0,0.001389,0.998474,FAM83B HIP1 HSD17B11 SMIM21 STATH STXBP5,positive regulation of platelet-derived growth factor receptor-beta signaling pathway|androgen catabolic process|positive regulation of platelet-derived growth factor receptor signaling pathway|saliva secretion|regulation of platelet-derived growth factor receptor-beta signaling pathway,0.001165|0.001746|0.001746|0.001746|0.002619,1|1|1|1|1,1144|686.5|686.5|686.5|429.1
1572,5,0.4143,4.143,3894.0,0.00106,0.996692,FAM83E GCA RABAC1 ULBP3 ZNF283,natural killer cell mediated cytotoxicity|natural killer cell mediated immunity|leukocyte mediated cytotoxicity|leukocyte mediated immunity|natural killer cell activation,0.006054|0.006537|0.009672|0.01252|0.01352,1|1|1|1|1,171.6|158.4|105.6|10.91|74.89
1573,5,0.462,4.62,3880.0,0.001186,0.996692,ARHGAP28 ATP1B1 FAM8A1 IBTK SIGLEC6,protein transport into plasma membrane raft|positive regulation of calcium:sodium antiporter activity|regulation of calcium:sodium antiporter activity|protein localization to plasma membrane raft|negative regulation of GTP binding,0.0004854|0.000728|0.0009706|0.0009706|0.0009706,1|1|1|1|1,4119|2060|1373|1373|1373
1574,6,0.409,6.135,4984.0,0.0012259999999999999,0.998474,FAM92A GDF9 OR4D11 SCRN1 SOSTDC1 SPRR1A,BMP signaling pathway|cellular response to BMP stimulus|response to BMP|regulation of progesterone secretion|oocyte growth,0.0002737|0.0003737|0.0003737|0.0008735|0.0008735,1|1|1|1|1,78.91|67.3|67.3|1716|1716
1575,6,0.4206,6.309,4909.0,0.001281,0.998474,ATRAID FAM98A FGL2 SLC37A3 SLC43A1 VPS50,negative regulation of macrophage antigen processing and presentation|regulation of macrophage antigen processing and presentation|negative regulation of leucine import|regulation of leucine import|negative regulation of leucine import across plasma membrane,0.0005824|0.0005824|0.0008735|0.0008735|0.0008735,1|1|1|1|1,3432|3432|1716|1716|1716
1576,6,0.4112,6.169,4909.0,0.0012519999999999999,0.998474,CBARP CGAS FAN1 IFT46 NDST4 THAP9,"transposition, DNA-mediated|microspike assembly|DNA metabolic process|regulation of microvillus assembly|DNA recombination",0.001358|0.001698|0.001713|0.002376|0.002426,1|1|1|1|1,980.7|735.5|11.3|490.4|26.27
1577,7,0.4272,8.972000000000001,5670.0,0.001576,0.9992989999999999,ABCA9 CALY FANK1 MAP1LC3C OR10Z1 PEBP4 TSN,positive regulation of retrograde axon cargo transport|regulation of retrograde axon cargo transport|positive regulation of clathrin coat assembly|regulation of clathrin coat assembly|postsynaptic endocytosis,0.0006794|0.0006794|0.001019|0.001019|0.003393,1|1|1|1|1,2942|2942|1471|1471|326.9
1578,6,0.4379,6.569,4822.0,0.0013570000000000001,0.998474,CAMTA2 FASLG GLIPR2 OR1J2 OR56B4 PUS7L,positive regulation of phosphatidylserine exposure on apoptotic cell surface|regulation of phosphatidylserine exposure on apoptotic cell surface|retinal cell programmed cell death|endosomal lumen acidification|positive regulation of phospholipid translocation,0.0005824|0.0005824|0.0008735|0.001456|0.001746,1|1|1|1|1,3432|3432|1716|858.1|686.5
1579,6,0.4379,6.569,4839.0,0.001352,0.998474,ABLIM1 CACNG3 FASTK KIAA1841 PDCL2 RPL15,"regulation of mitochondrial mRNA stability|neurotransmitter receptor transport, postsynaptic endosome to lysosome|positive regulation of AMPA receptor activity|neurotransmitter receptor diffusion trapping|postsynaptic neurotransmitter receptor diffusion trapping",0.002328|0.002328|0.002619|0.002909|0.002909,1|1|1|1|1,490.4|490.4|429.1|381.4|381.4
1580,15,0.4424,46.45,10280.0,0.004484,0.999999,ATP6V1E1 CDC45 CRK DGCR8 ESS2 GNB1L MRPL40 PI4KA PPIL2 SNAP23 TELO2 TFIP11 TTI1 TTI2 UFD1,cellular response to endothelin|negative regulation of DNA ligation|negative regulation of DNA ligase activity|viral replication complex formation and maintenance|mitotic DNA replication preinitiation complex assembly,0.001455|0.001455|0.001455|0.001455|0.001455,1|1|1|1|1,1373|1373|1373|1373|1373
1581,7,0.414,8.693,6124.0,0.0014140000000000001,0.9992989999999999,CPLANE1 DAW1 DYNLL2 FAXDC2 FRMD5 SCG3 SLC45A2,cilium assembly|cilium organization|plasma membrane bounded cell projection assembly|cell projection assembly|protein localization to secretory granule,0.0002078|0.0002489|0.0003905|0.0004306|0.001358,1|1|1|1|1,23.35|21.96|18.82|18.2|980.7
1582,22,0.405,93.55,17530.0,0.005294,1.0,CD300C COL1A1 CSHL1 EPX FBF1 HOXB5 HOXB9 LPO MIF4GD MKS1 MPO NME1 NME2 OR4D1 OR4D2 PLEKHM1 RSAD1 SAMD14 SCPEP1 SEPT4 SGCA UBE2O,hydrogen peroxide catabolic process|hydrogen peroxide metabolic process|response to oxidative stress|UTP biosynthetic process|GTP biosynthetic process,5.127e-06|1.358e-05|5.441e-05|7.128e-05|8.418e-05,0.08087|0.1071|0.2861|0.2811|0.2656,96.84|68.5|11.82|187.2|170.2
1583,5,0.4512,4.512,4143.0,0.001085,0.996692,ELFN1 FBH1 GPC6 OLIG2 WFDC13,negative regulation of nitrogen compound metabolic process|spinal cord oligodendrocyte cell fate specification|negative regulation of cellular metabolic process|glial cell fate specification|oligodendrocyte cell fate commitment,0.0008255|0.0009706|0.001112|0.001213|0.001213,1|1|1|1|1,6.894|1373|6.386|1030|1030
1584,23,0.4016,101.6,16810.0,0.00599,1.0,C19orf66 CNN1 FBN3 ICAM1 ICAM3 OR1M1 OR7G1 OR7G3 P2RY11 QTRT1 ZNF121 ZNF266 ZNF433 ZNF441 ZNF443 ZNF490 ZNF564 ZNF625 ZNF627 ZNF69 ZNF700 ZNF709 ZNF878,"regulation of transcription by RNA polymerase II|regulation of cellular macromolecule biosynthetic process|regulation of macromolecule biosynthetic process|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription",6.575e-07|1.588e-06|1.763e-06|2.614e-06|2.623e-06,0.01037|0.01253|0.009271|0.01031|0.008275,4.501|3.433|3.406|3.619|3.618
1585,7,0.4304,9.039,5575.0,0.001615,0.9992989999999999,DECR2 FBXL16 HAGHL HBQ1 MSLN TUB UNKL,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione|cellular catabolic process|methylglyoxal catabolic process|methylglyoxal catabolic process to lactate|receptor localization to non-motile cilium,0.001358|0.001641|0.001698|0.001698|0.002037,1|1|1|1|1,980.7|6.549|735.5|735.5|588.4
1586,7,0.4089,8.587,5432.0,0.001574,0.9992989999999999,ANKRD13B CHRDL2 EGFLAM FBXL2 RHOG SIAE TOMM20L,tRNA import into mitochondrion|modulation by host of viral RNA genome replication|RNA import into mitochondrion|peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|negative regulation of receptor internalization,0.001019|0.001698|0.002037|0.002376|0.004748,1|1|1|1|1,1471|735.5|588.4|490.4|226.3
1587,18,0.4046,61.9,14480.0,0.0042450000000000005,1.0,ADAMTS16 CCDC127 CDH12 CDH18 CEP72 DNAH5 FAM173B FBXL7 NKD2 OTULIN OTULINL PRLR SLC6A18 SLC6A19 SLC6A3 TPPP TRIO ZDHHC11,sodium ion transmembrane transport|sodium ion transport|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|lactation|anatomical structure morphogenesis,0.0001326|0.0003874|0.0005935|0.0006772|0.0009825,1|1|1|1|1,30.29|20.89|57.69|53.84|3.972
1588,6,0.4061,6.091,4993.0,0.001215,0.998474,CCDC151 FBXL8 ITGAM NPY2R SEC24D SLC1A7,regulation of circadian rhythm|positive regulation of hippocampal neuron apoptotic process|positive regulation of prostaglandin-E synthase activity|regulation of prostaglandin-E synthase activity|vertebrate eye-specific patterning,0.0005054|0.0008735|0.001165|0.001165|0.001165,1|1|1|1|1,57.69|1716|1144|1144|1144
1589,8,0.7613,21.32,5538.0,0.003824,0.9996790000000001,FOXK1 FOXK2 GSK3A GSK3B GSKIP RANBP3 UBALD1 UBALD2,regulation of glucose metabolic process|regulation of cellular carbohydrate metabolic process|negative regulation of type B pancreatic cell development|regulation of carbohydrate metabolic process|negative regulation of glycogen (starch) synthase activity,8.043e-08|2.162e-07|7.913e-07|8.257e-07|1.319e-06,0.001269|0.001705|0.004161|0.003256|0.00416,87.27|67.75|2574|48.12|1716
1590,6,0.4255,6.382000000000001,4913.0,0.001294,0.998474,COL6A3 F13B FBXO16 RIT1 RSPO4 SLC49A3,olfactory bulb axon guidance|lymphoid lineage cell migration into thymus|lymphoid lineage cell migration|striatal medium spiny neuron differentiation|somatic diversification of T cell receptor genes,0.0006794|0.001019|0.001019|0.001698|0.002037,1|1|1|1|1,2942|1471|1471|735.5|588.4
1591,5,0.4425,4.425,3992.0,0.001105,0.996692,FBXO17 METTL9 NAALADL1 TTC9 ZNF843,glycoprotein catabolic process|peptide catabolic process|biological regulation|regulation of biological process|ubiquitin-dependent ERAD pathway,0.006537|0.007744|0.008988|0.01377|0.01831,1|1|1|1|1,158.4|132.9|0|0|54.92
1592,5,0.4252,4.252,4048.0,0.001047,0.996692,FBXO2 GPR141 NXN PLEKHJ1 SPSB1,regulation of protein ubiquitination|regulation of protein modification by small protein conjugation or removal|protein polyubiquitination|proteasome-mediated ubiquitin-dependent protein catabolic process|receptor recycling,0.001014|0.001343|0.00239|0.002405|0.002667,1|1|1|1|1,39.61|34.33|25.58|25.5|411.9
1593,6,0.406,6.09,4297.0,0.001411,0.998474,DRAP1 FBXO22 KIF13B SP1 SP3 WBP4,sequestering of nodal from receptor via nodal binding|positive regulation of hydrogen sulfide biosynthetic process|regulation of hydrogen sulfide biosynthetic process|positive regulation of sulfur metabolic process|negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,0.0006794|0.0006794|0.0006794|0.001019|0.001019,1|1|1|1|1,2942|2942|2942|1471|1471
1594,6,0.4125,6.188,4913.0,0.001255,0.998474,DUSP2 FAM83E FBXO30 NKG7 ZNF740 ZP2,prevention of polyspermy|negative regulation of fertilization|egg activation|tRNA dihydrouridine synthesis|regulation of fertilization,0.0008735|0.0008735|0.001746|0.001746|0.003781,1|1|1|1|1,1716|1716|686.5|686.5|286
1595,6,0.4097,6.145,5086.0,0.001204,0.998474,DLGAP1 FBXO31 GPX3 PAFAH1B3 TAS1R1 WFS1,negative regulation of ATF6-mediated unfolded protein response|response to lipid hydroperoxide|catabolic process|regulation of ATF6-mediated unfolded protein response|negative regulation of type B pancreatic cell apoptotic process,0.0008735|0.001165|0.001334|0.001456|0.002037,1|1|1|1|1,1716|1144|6.588|858.1|572.1
1596,5,0.4436,4.436,4123.0,0.001072,0.996692,CD74 FBXO33 SLC9A3R2 SPHK2 XDH,small molecule biosynthetic process|positive regulation of lipid biosynthetic process|small molecule metabolic process|polyol metabolic process|pentitol metabolic process,7.869e-06|0.0002616|0.0005107|0.0005392|0.0005824,0.1241|1|1|1|0.6125,24.61|80.76|8.46|55.81|3432
1597,5,0.4488,4.488,3975.0,0.001125,0.996692,EPS8L2 FBXO36 KISS1 SLC16A14 TMEM230,positive regulation of ruffle assembly|regulation of ruffle assembly|synaptic vesicle transport|synaptic vesicle localization|Rho protein signal transduction,0.003878|0.007261|0.009672|0.01112|0.01496,1|1|1|1|1,274.6|142|105.6|91.53|67.52
1598,7,0.4143,8.7,4887.0,0.001772,0.9992989999999999,BCL11B DEDD FBXO38 MAU2 PRR12 STAG1 ZNF644,sister chromatid cohesion|cytokinesis|olfactory bulb axon guidance|cohesin loading|lymphoid lineage cell migration into thymus,0.0001601|0.0007745|0.0007765|0.001164|0.001164,1|1|1|1|1,107.3|47.67|2574|1287|1287
1599,7,0.4064,8.533999999999999,6056.0,0.0014039999999999999,0.9992989999999999,C16orf95 C17orf97 FBXO44 KIAA0556 OSCP1 PGAP1 POU4F3,sensory perception of sound|sensory perception of mechanical stimulus|positive regulation of ER to Golgi vesicle-mediated transport|attachment of GPI anchor to protein|xenobiotic detoxification by transmembrane export across the plasma membrane,0.0008166|0.001052|0.001746|0.002037|0.002619,1|1|1|1|1,45.16|39.68|686.5|572.1|429.1
1600,5,0.4453,4.453,3835.0,0.001157,0.996692,AADACL3 C11orf52 C1orf127 FBXO6 PRAMEF1,glycoprotein catabolic process|cellular process|ubiquitin-dependent ERAD pathway|ERAD pathway|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,0.006537|0.01519|0.01831|0.0219|0.02261,1|1|1|1|1,158.4|0.266|54.92|45.77|44.29
1601,6,0.6573,9.86,3989.0,0.0024579999999999997,0.998474,HNRNPF PCBP1 PRPF40A PSMF1 SON SRRM2,"RNA splicing|mRNA processing|mRNA metabolic process|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile",1.843e-08|4.345e-08|2.586e-07|6.994e-07|6.994e-07,0.0002908|0.0003427|0.00136|0.002758|0.002207,42.17|35.46|24.73|45.46|45.46
1602,6,0.4266,6.398,4900.0,0.001301,0.998474,DEFB134 FBXW2 JPH2 KLK1 MIEF1 SETX,"positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled|positive regulation of termination of RNA polymerase II transcription|positive regulation of DNA-templated transcription, termination|regulation of termination of RNA polymerase II transcription, poly(A)-coupled|regulation of termination of RNA polymerase II transcription",0.0005824|0.0005824|0.0005824|0.001165|0.001165,1|1|1|1|1,3432|3432|3432|1144|1144
1603,5,0.4325,4.325,3940.0,0.001094,0.996692,CHRND FBXW4 NIPAL4 NRXN2 ZBTB34,skeletal muscle tissue growth|neuroligin clustering involved in postsynaptic membrane assembly|gephyrin clustering involved in postsynaptic density assembly|cell-cell signaling|observational learning,0.0009706|0.0009706|0.001213|0.001506|0.001698,1|1|1|1|1,1373|1373|1030|10.98|686.5
1604,5,0.4164,4.164,3843.0,0.0010789999999999999,0.996692,C4orf17 DMP1 FCGR3B PURA TMEM260,dendritic transport of messenger ribonucleoprotein complex|dendritic transport of ribonucleoprotein complex|regulation of enamel mineralization|dendritic transport|regulation of tooth mineralization,0.001165|0.001165|0.001746|0.0032|0.0032,1|1|1|1|1,1144|1144|686.5|343.2|343.2
1605,6,0.4061,6.0920000000000005,4780.0,0.0012699999999999999,0.998474,FCHSD1 IQGAP2 LRRC8D PIPOX VTN ZBTB7B,positive regulation of cellular component organization|positive regulation of actin filament polymerization|positive regulation of organelle organization|positive regulation of protein polymerization|L-lysine catabolic process to acetyl-CoA via L-pipecolate,0.0001275|0.0002799|0.0004448|0.0005565|0.0005824,1|1|1|1|1,12.1|78.01|17.45|54.92|3432
1606,8,0.414,11.59,6608.0,0.0017469999999999999,0.9996790000000001,C21orf91 DOC2A FEM1A HUNK LIPC RBM11 SAMSN1 TRIM69,intermediate-density lipoprotein particle remodeling|spontaneous neurotransmitter secretion|triglyceride-rich lipoprotein particle clearance|spontaneous synaptic transmission|chylomicron remnant clearance,0.0006794|0.002037|0.002715|0.002715|0.002715,1|1|1|1|1,2942|588.4|420.3|420.3|420.3
1607,6,0.4154,6.23,4819.0,0.001288,0.998474,BVES FERD3L KCTD20 NSG1 PTPRN2 TLR5,positive regulation of receptor recycling|regulation of receptor recycling|toll-like receptor 5 signaling pathway|postsynaptic neurotransmitter receptor cycle|neurotransmitter receptor cycle,8.468e-06|2.114e-05|0.0005824|0.0005824|0.0005824,0.1336|0.1668|1|1|1,490.4|298.5|3432|3432|3432
1608,6,0.4133,6.2,4591.0,0.0013449999999999998,0.998474,ARL6 EPHA6 FEV LRRC14 MAPK15 TSTA3,protein localization to cilium|positive regulation of metaphase/anaphase transition of meiotic cell cycle|positive regulation of metaphase/anaphase transition of meiosis I|regulation of metaphase/anaphase transition of meiosis I|positive regulation of meiotic chromosome separation,0.000112|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,124.8|3432|3432|3432|3432
1609,5,0.4185,4.185,3916.0,0.001065,0.996692,DPY19L1 FEZ1 GCM2 GRIN3B PAPSS2,negative regulation of macroautophagy|negative regulation of autophagy|positive regulation of anterograde axonal transport of mitochondrion|regulation of anterograde axonal transport of mitochondrion|sulfate assimilation,4.946e-05|0.0002556|0.0005824|0.0005824|0.0008735,0.7803|1|1|1|1,190.7|81.73|3432|3432|1716
1610,6,0.438,6.57,4702.0,0.001392,0.998474,ABLIM2 FEZF1 MIOX PTF1A QDPR TMCO4,polyol metabolic process|inositol catabolic process|dihydrobiopterin metabolic process|forebrain anterior/posterior pattern specification|regulation of neural retina development,0.0005392|0.0005824|0.0008735|0.001165|0.001165,1|1|1|1|1,55.81|3432|1716|1144|1144
1611,5,0.4297,4.297,3883.0,0.001102,0.996692,BTBD1 FGD2 IDI1 MBOAT4 OR8D1,peptidyl-serine octanoylation|protein octanoylation|dimethylallyl diphosphate metabolic process|dimethylallyl diphosphate biosynthetic process|isopentenyl diphosphate biosynthetic process,0.0004854|0.0004854|0.000728|0.000728|0.001456,1|1|1|1|1,4119|4119|2060|2060|823.8
1612,7,0.4302,9.033999999999999,5404.0,0.0016649999999999998,0.9992989999999999,ARL8B FGD6 HAO1 MACO1 TMEM131 TMEM131L TMEM39A,glycolate catabolic process|glycolate metabolic process|negative regulation of immature T cell proliferation in thymus|negative regulation of immature T cell proliferation|negative regulation of autophagosome maturation,0.0006794|0.001358|0.002037|0.002376|0.002376,1|1|1|1|1,2942|980.7|588.4|490.4|490.4
1613,5,0.4072,4.072,3926.0,0.001033,0.996692,CACHD1 ERICH1 FGF1 IGHMBP2 UGT1A7,branch elongation involved in ureteric bud branching|ureteric bud elongation|regulation of endothelial tube morphogenesis|flavone metabolic process|regulation of endothelial cell chemotaxis to fibroblast growth factor,0.0004854|0.001456|0.001698|0.001698|0.00194,1|1|1|1|1,4119|823.8|686.5|686.5|588.4
1614,6,0.4285,6.4270000000000005,4867.0,0.001315,0.998474,ACOT7 FGF14 PPP6R2 RELN RYR2 SLC7A6,positive regulation of ion transmembrane transporter activity|positive regulation of transporter activity|positive regulation of cation transmembrane transport|positive regulation of ion transmembrane transport|positive regulation of transmembrane transport,2.928e-06|3.711e-06|1.084e-05|2.894e-05|2.894e-05,0.04619|0.02927|0.05701|0.1141|0.09131,96.24|88.77|61.66|44.2|44.2
1615,4,0.43,2.58,2879.0,0.000893,0.9929309999999999,FGF20 MAPK12 PLCG1 RASA2,MAPK cascade|intracellular signal transduction|positive regulation of hydrolase activity|positive regulation of dopaminergic neuron differentiation|positive regulation of developmental process,3.13e-05|3.44e-05|0.0002102|0.0007766|0.0008757,0.4938|0.2714|1|1|1,37.77|13.08|19.88|1716|12.27
1616,7,0.4079,8.567,5829.0,0.001464,0.9992989999999999,EFNA2 FGF22 KCNC3 MIDN RAPGEF5 RNF126 SOSTDC1,cytoplasm protein quality control by the ubiquitin-proteasome system|cytoplasm protein quality control|negative regulation of determination of dorsal identity|mammary gland bud morphogenesis|enzyme linked receptor protein signaling pathway,0.0006794|0.0006794|0.001019|0.001358|0.001388,1|1|1|1|1,2942|2942|1471|980.7|12.16
1617,6,0.4022,6.034,4764.0,0.0012619999999999999,0.998474,FGF6 GPR17 LRRC10 PNPLA6 SHH SRR,myoblast differentiation|oligodendrocyte differentiation|muscle structure development|positive regulation of cell division|regulation of sclerotome development,4.687e-05|0.0001892|0.0002145|0.0002737|0.0005824,0.7393|1|1|1|0.5742,196.1|95.35|22.39|78.91|3432
1618,6,0.4055,6.082000000000001,4776.0,0.001269,0.998474,COX6A2 CXCL6 FGF9 SIGMAR1 TRIM55 UBE2G1,myeloid leukocyte migration|regulation of neutrophil mediated killing of gram-negative bacterium|regulation of neutrophil mediated killing of bacterium|negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching|negative regulation of cell differentiation involved in phenotypic switching,0.0005565|0.0008735|0.0008735|0.0008735|0.0008735,1|1|1|1|1,54.92|1716|1716|1716|1716
1619,6,0.4081,6.121,4903.0,0.0012439999999999999,0.998474,BCL6B CMSS1 FGF19 FGFBP1 HHIPL1 TRIML2,fibroblast growth factor receptor signaling pathway|cellular response to fibroblast growth factor stimulus|response to fibroblast growth factor|negative regulation of bile acid biosynthetic process|negative regulation of bile acid metabolic process,0.0002381|0.0004488|0.0004971|0.001165|0.001165,1|1|1|1|1,84.75|61.29|58.18|1144|1144
1620,29,0.4008,162.7,21660.0,0.007439,1.0,BTN2A1 BTN2A2 GPX6 HIST1H1T HIST1H2AC HIST1H2AD HIST1H2BD HIST1H4C HLA-F HLA-G OR14J1 OR2B2 OR2B3 OR2B6 OR2J2 OR2J3 OR2W1 SLC17A1 SLC17A2 SLC17A4 TMEM14B TRIM10 TRIM26 ZKSCAN4 ZKSCAN8 ZNF165 ZNF184 ZSCAN16 ZSCAN31,sialic acid transport|detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus,1.116e-07|1.328e-06|1.96e-06|2.508e-06|3.994e-06,0.00176|0.01048|0.01031|0.009891|0.0126,457.7|12.11|11.41|10.99|10.23
1621,7,0.4072,8.551,5942.0,0.001434,0.9992989999999999,CEP290 FGG FICD KBTBD3 MRC1 S100A10 ZFYVE27,positive regulation of substrate adhesion-dependent cell spreading|positive regulation of cell development|vesicle-mediated transport|regulation of substrate adhesion-dependent cell spreading|positive regulation of cell morphogenesis involved in differentiation,9.298e-05|9.945e-05|0.0001392|0.0001735|0.0003165,1|0.7843|0.732|0.6843|0.9986,140.1|30.02|7.513|101.5|74.48
1622,7,0.408,8.568999999999999,5690.0,0.0015,0.9992989999999999,B4GALNT1 FHL5 GNLY PCSK1 SIRPD TLX2 TMEM198,negative regulation of dendrite morphogenesis|lipid glycosylation|enteric nervous system development|ganglioside biosynthetic process|ganglioside metabolic process,0.003393|0.004409|0.005425|0.005763|0.009139,1|1|1|1|1,326.9|245.2|196.1|183.9|113.2
1623,5,0.4529,4.529,3978.0,0.001134,0.996692,FIGN SYNPO TNS2 VCAN VWC2L,spine apparatus assembly|modification of dendritic spine|modification of postsynaptic structure|modification of synaptic structure|microtubule severing,0.0004854|0.000728|0.00194|0.003152|0.003152,1|1|1|1|1,4119|2060|588.4|343.3|343.3
1624,5,0.4244,4.244,4037.0,0.001048,0.996692,ABCG2 CPA1 FIP1L1 PAX4 RAB11FIP5,urate salt excretion|biotin transport|negative regulation of adiponectin secretion|xenobiotic transport across blood-brain barrier|riboflavin transport,0.0004854|0.0009706|0.001213|0.001456|0.001456,1|1|1|1|1,4119|1373|1030|823.8|823.8
1625,4,0.4582,2.7489999999999997,2906.0,0.0009427999999999999,0.9929309999999999,FIS1 LDLRAD3 PROX1 STRA8,positive regulation of organelle organization|positive regulation of forebrain neuron differentiation|hepatocyte cell migration|acinar cell differentiation|otic placode formation,9.292e-05|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,26.18|5149|5149|5149|5149
1626,6,0.405,6.075,4737.0,0.0012779999999999998,0.998474,ELOVL6 FIZ1 FOXJ1 PCDHB2 PDGFB RUNX1T1,epithelial cell differentiation involved in kidney development|cell differentiation involved in kidney development|glomerulus development|metanephros development|nephron development,4.434e-05|7.597e-05|0.0001005|0.0002211|0.0005478,0.6994|0.5992|0.5283|0.8721|1,201.9|152.6|132|88.01|55.36
1627,6,0.4241,6.361000000000001,4918.0,0.001289,0.998474,AXL C5orf52 CD28 FJX1 TMEM139 ZNF780B,positive regulation of viral process|regulation of viral life cycle|regulation of lymphocyte differentiation|positive regulation of protein kinase B signaling|regulation of viral process,0.0003053|0.0007853|0.001088|0.00115|0.001252,1|1|1|1|1,74.62|46.07|39.01|37.93|36.32
1628,5,0.4273,4.273,3991.0,0.001067,0.996692,ADIPOQ DYNAP FKBP11 HHIPL1 PLXNA4,chemorepulsion of branchiomotor axon|negative regulation of metanephros development|negative regulation of metanephric mesenchymal cell migration|positive regulation of renal albumin absorption|positive regulation of metanephric glomerular visceral epithelial cell development,0.0004854|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,4119|4119|4119|4119|4119
1629,6,0.4352,6.527,4868.0,0.001336,0.998474,FKBP1B KCTD6 PBX2 RNF24 UBXN7 ZNF766,neuronal action potential propagation|action potential propagation|protein maturation by protein folding|negative regulation of insulin secretion involved in cellular response to glucose stimulus|positive regulation of axon regeneration,0.002037|0.002037|0.002619|0.002619|0.002909,1|1|1|1|1,572.1|572.1|429.1|429.1|381.4
1630,6,0.421,6.315,4673.0,0.0013460000000000002,0.998474,ENTPD7 FKBP3 GDNF KCNMB4 TOMM40 ZDHHC4,regulation of neurotransmitter transport|UTP catabolic process|CTP catabolic process|pyrimidine ribonucleoside triphosphate catabolic process|postganglionic parasympathetic fiber development,0.0003955|0.0005824|0.0005824|0.0005824|0.0008735,1|1|1|1|1,65.38|3432|3432|3432|1716
1631,5,0.446,4.46,4013.0,0.0011070000000000001,0.996692,CAPG DDX20 FKBP4 PROSER2 RBMXL1,negative regulation of protein polymerization|negative regulation of protein-containing complex assembly|negative regulation of cytoskeleton organization|negative regulation of supramolecular fiber organization|regulation of protein polymerization,0.0001995|0.0006756|0.0008166|0.0008378|0.00187,1|1|1|1|1,92.77|49.75|45.16|44.58|29.59
1632,6,0.4009,6.013999999999999,4878.0,0.001228,0.998474,CD68 EVPLL FKBP8 MATN4 PPARA TMEM25,negative regulation of hepatocyte apoptotic process|regulation of hepatocyte apoptotic process|negative regulation of dendritic cell antigen processing and presentation|negative regulation of sequestering of triglyceride|cellular response to nutrient levels,0.0008735|0.0008735|0.001456|0.001746|0.001998,1|1|1|1|1,1716|1716|858.1|686.5|28.6
1633,7,0.4306,9.043,5646.0,0.0015949999999999998,0.9992989999999999,CNTN2 FLG HHAT ODF1 REN TMEM81 ZNF76,establishment of protein localization to juxtaparanode region of axon|cell maturation|positive regulation of adenosine receptor signaling pathway|clustering of voltage-gated potassium channels|regulation of adenosine receptor signaling pathway,0.0007765|0.001471|0.001552|0.001552|0.00194,1|1|1|1|1,2574|34.33|858.1|858.1|643.6
1634,6,0.4444,6.666,4850.0,0.001369,0.998474,ACBD4 FLNB HSPBP1 LBX2 SCUBE3 SMCO3,positive regulation of convergent extension involved in gastrulation|regulation of convergent extension involved in gastrulation|positive regulation of non-canonical Wnt signaling pathway|muscle structure development|regulation of non-canonical Wnt signaling pathway,0.0008735|0.0008735|0.004651|0.007091|0.00755,1|1|1|1|1,1716|1716|228.8|14.92|137.3
1635,6,0.4563,6.845,4960.0,0.001375,0.998474,DAGLA FBXO36 FLRT1 GRK4 MS4A15 SH3BP2,endocannabinoid signaling pathway|retrograde trans-synaptic signaling by endocannabinoid|retrograde trans-synaptic signaling by lipid|diacylglycerol catabolic process|trans-synaptic signaling by endocannabinoid,0.001358|0.001358|0.001358|0.001358|0.002037,1|1|1|1|1,980.7|980.7|980.7|980.7|588.4
1636,6,0.4158,6.237,4597.0,0.001351,0.998474,FLT4 GHITM KCTD16 OCIAD1 SLC38A11 XRCC6,cellular hyperosmotic salinity response|positive regulation of mitochondrial ATP synthesis coupled electron transport|negative regulation of hematopoietic stem cell differentiation|regulation of response to stimulus|regulation of blood vessel remodeling,0.001165|0.001456|0.001746|0.001843|0.002037,1|1|1|1|1,1144|858.1|686.5|4.048|572.1
1637,6,0.4322,6.482,4988.0,0.001295,0.998474,FLVCR2 GAS6 KCNIP1 SLC2A10 SLC36A4 VWF,cation transport|transmembrane transport|cation transmembrane transport|ion transmembrane transport|transport,6.122e-07|5.584e-06|1.325e-05|9.441e-05|0.0001094,0.009658|0.04404|0.06968|0.3723|0.345,20.78|13.28|21.55|13.06|4.576
1638,6,0.4303,6.455,4887.0,0.0013160000000000001,0.998474,FAM129A FMN1 IGFN1 SLC30A2 TBC1D15 ZC3H12C,positive regulation of sequestering of zinc ion|ureteric bud invasion|metanephric renal vesicle formation|ureteric bud elongation|regulation of sequestering of zinc ion,0.0005824|0.001165|0.001456|0.001746|0.001746,1|1|1|1|1,3432|1144|858.1|686.5|686.5
1639,5,0.4559,4.559,3986.0,0.00114,0.996692,ERICH6B FBXW4 FMNL2 MYBPC1 PIP4P2,positive regulation of mesenchymal cell proliferation|negative regulation of phagocytosis|regulation of mesenchymal cell proliferation|phosphatidylinositol dephosphorylation|actin filament-based process,0.005812|0.005812|0.007261|0.007744|0.007988,1|1|1|1|1,179.1|179.1|142|132.9|13.78
1640,11,0.4128,22.71,8676.0,0.002604,0.999969,CDK18 CHI3L1 FMO3 FMOD NECTIN4 NMNAT2 PRELP RGS18 RGS2 RGS21 TROVE2,aminoglycan catabolic process|keratan sulfate catabolic process|aminoglycan metabolic process|keratan sulfate biosynthetic process|carbohydrate derivative catabolic process,4.624e-06|1.923e-05|6.235e-05|9.155e-05|0.0001013,0.07294|0.1517|0.3278|0.361|0.3196,90.86|343.3|37.22|147.1|31.52
1641,7,0.4092,8.592,5646.0,0.001516,0.9992989999999999,FLG FN1 HHAT ODF1 REN TMEM81 ZNF76,"peptide cross-linking|positive regulation of substrate-dependent cell migration, cell attachment to substrate|regulation of substrate-dependent cell migration, cell attachment to substrate|calcium-independent cell-matrix adhesion|renin-angiotensin regulation of aldosterone production",0.0006928|0.001552|0.001552|0.00194|0.00194,1|1|1|1|1,50.48|858.1|858.1|643.6|643.6
1642,6,0.4111,6.166,4841.0,0.001269,0.998474,ANO7 AZI2 CLDN5 FN3K MARCH1 TLL2,establishment of blood-retinal barrier|fructoselysine metabolic process|dendritic cell proliferation|negative regulation of skeletal muscle tissue growth|protein deglycation,0.0005824|0.0005824|0.0008735|0.0008735|0.0008735,1|1|1|1|1,3432|3432|1716|1716|1716
1643,6,0.4104,6.157,4985.0,0.00123,0.998474,ABTB1 CAPN7 CRY1 FNBP1 GPR158 HMX3,cellular response to blue light|blue light signaling pathway|negative regulation of glucocorticoid secretion|negative regulation of corticosteroid hormone secretion|negative regulation of steroid hormone secretion,0.001019|0.001019|0.001358|0.001358|0.001358,1|1|1|1|1,1471|1471|980.7|980.7|980.7
1644,4,0.4549,2.7289999999999996,3009.0,0.0009039,0.9929309999999999,FNBP1L INA LCN2 RSRC2,postsynaptic intermediate filament cytoskeleton organization|siderophore transport|response to mycotoxin|response to herbicide|sequestering of iron ion,0.0007766|0.0007766|0.0009706|0.001553|0.001553,1|1|1|1|1,1716|1716|1287|735.5|735.5
1645,10,0.4009,18.04,6862.0,0.0026149999999999997,0.999933,ARGLU1 CENPJ CFAP20 DAZAP1 FNBP4 MZT1 NKTR NUP58 SFSWAP USPL1,microtubule nucleation by microtubule organizing center|microtubule nucleation|microtubule polymerization|microtubule polymerization or depolymerization|peptidyl-amino acid modification,4.446e-06|6.847e-05|0.0001399|0.0002993|0.0005619,0.07013|0.54|0.7357|1|1,823.8|171.6|117.7|79.21|9.415
1646,8,0.4205,11.77,6294.0,0.0018620000000000002,0.9996790000000001,CCR6 FNDC1 FUCA2 LPA OPRM1 PHACTR2 TAAR2 TPD52L1,positive regulation of cytosolic calcium ion concentration|regulation of cytosolic calcium ion concentration|chemokine-mediated signaling pathway|cellular response to chemokine|response to chemokine,0.000209|0.0003044|0.0005398|0.0006807|0.0006807,1|1|1|1|1,24.26|21.32|57.93|51.42|51.42
1647,6,0.4293,6.439,5036.0,0.001274,0.998474,C5orf22 CNGB3 FNIP2 MMP16 TOR3A VCPKMT,chondrocyte proliferation|negative regulation of ATPase activity|craniofacial suture morphogenesis|endochondral ossification|replacement ossification,0.00349|0.005522|0.005812|0.008996|0.008996,1|1|1|1|1,312|190.7|180.7|114.4|114.4
1648,21,0.4049,85.03,15790.0,0.005342,1.0,ANO1 BBS1 CCDC36 CTTN FCHSD2 FGF19 FGF4 FOLR1 FOLR2 KCTD21 KRTAP5-10 KRTAP5-9 MRGPRD MRGPRF MYEOV P2RY2 P2RY6 PLEKHB1 POLD4 TESMIN UCP3,cellular response to folic acid|cellular response to endogenous stimulus|folate import across plasma membrane|folate transmembrane transport|folic acid transport,5.922e-06|9.942e-06|2.069e-05|2.757e-05|4.425e-05,0.09342|0.07841|0.1088|0.1087|0.1396,980.7|6.846|392.3|326.9|245.2
1649,18,0.3951,60.45,13620.0,0.004407,1.0,AKAP2 C9orf84 FAM129B OR13C3 OR13C4 OR13C8 OR13D1 OR1J1 OR1J4 OR1L1 OR1L8 OR1N2 OR2K2 PALM2 RALGAPA1 TXNDC8 ZBTB6 ZNF483,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,1.623e-13|2.899e-13|4.19e-13|8.413e-13|1.214e-12,2.561e-09|2.286e-09|2.203e-09|3.318e-09|3.83e-09,29.19|27.5|26.49|24.66|23.75
1650,5,0.4481,4.481,3932.0,0.001135,0.996692,ACAD8 C1QTNF5 FAP FOXC2 TEKT4,blood vessel morphogenesis|blood vessel development|vasculature development|tube morphogenesis|melanocyte apoptotic process,0.0001486|0.0002566|0.0002936|0.0005771|0.0005824,1|1|1|1|1,25.36|21.06|20.11|15.97|3432
1651,11,0.4036,22.2,7883.0,0.0028,0.999969,HERC1 KDELR1 LMO2 LYL1 MYB PIK3R5 PREX1 PTPN6 SOS1 SPAST ULK3,cellular developmental process|cell activation|regulation of hematopoietic progenitor cell differentiation|developmental process|cell differentiation,5.484e-06|7.935e-06|1.43e-05|2.295e-05|7.221e-05,0.08651|0.06258|0.07522|0.0905|0.2278,4.731|10.36|62.41|3.268|4.269
1652,6,0.423,6.345,4306.0,0.001467,0.998474,CD46 CR1L FOXE1 GLB1L2 GORASP2 SPPL3,regulation of complement activation|regulation of humoral immune response|pharynx development|interleukin-10 production|soft palate development,0.0004889|0.000695|0.001165|0.001456|0.001746,1|1|1|1|1,58.68|49.04|1144|858.1|686.5
1653,6,0.4294,6.441,5116.0,0.001255,0.998474,ABHD17A FLAD1 FOXE3 GAS1 S100A10 TMCC3,flavin adenine dinucleotide biosynthetic process|FAD biosynthetic process|FAD metabolic process|flavin adenine dinucleotide metabolic process|positive regulation of lens epithelial cell proliferation,0.0005824|0.0005824|0.0005824|0.0008735|0.0008735,1|1|1|1|1,3432|3432|3432|1716|1716
1654,6,0.4485,6.727,4859.0,0.001379,0.998474,CFAP57 CRK FOXN3 OARD1 PDF RNF150,cellular response to endothelin|negative regulation of growth hormone receptor signaling pathway|response to endothelin|helper T cell diapedesis|response to cholecystokinin,0.0006794|0.001019|0.001019|0.001019|0.001019,1|1|1|1|1,2942|1471|1471|1471|1471
1655,5,0.4436,4.436,4036.0,0.0010949999999999998,0.996692,ANGPTL5 CATSPER4 FOXP2 LRRC59 PRLHR,putamen development|caudate nucleus development|innate vocalization behavior|response to ketone|striatum development,0.0004854|0.0004854|0.0004854|0.0009292|0.004604,1|1|1|1|1,4119|4119|4119|41.4|228.8
1656,7,0.4237,8.898,6034.0,0.001469,0.9992989999999999,FRAS1 GPAT3 GPR135 NLRC4 REG1B TCTEX1D1 UBE2L6,cell wall disruption in other organism|ISG15-protein conjugation|glycerol-3-phosphate metabolic process|alditol phosphate metabolic process|CDP-diacylglycerol biosynthetic process,0.001698|0.002376|0.003732|0.004409|0.004748,1|1|1|1|1,735.5|490.4|294.2|245.2|226.3
1657,6,0.4162,6.242999999999999,4677.0,0.00133,0.998474,ACTL7A FRAT2 MFSD14B MSLN TRPM5 WFIKKN1,beta-catenin destruction complex disassembly|muscle fiber development|negative regulation of DNA binding|negative regulation of signaling receptor activity|sensory perception of taste,0.006391|0.01361|0.0162|0.01936|0.01993,1|1|1|1|1,163.5|74.62|62.41|52.01|50.48
1658,5,0.4461,4.461,3842.0,0.001157,0.996692,FREM1 IGSF9 RNF130 SRM SUMO4,spermidine biosynthetic process|spermidine metabolic process|polyamine biosynthetic process|dendrite self-avoidance|polyamine metabolic process,0.0009706|0.002183|0.003636|0.004362|0.004845,1|1|1|1|1,1373|514.9|294.2|242.3|216.8
1659,5,0.4137,4.137,3879.0,0.0010630000000000001,0.996692,FREM2 GOLGA8H RCN1 SPINT4 ZNF547,eye development|visual system development|sensory system development|sensory organ development|embryonic digit morphogenesis,0.003071|0.003137|0.003237|0.006913|0.014,1|1|1|1|1,22.51|22.26|21.91|14.84|72.26
1660,6,0.4129,6.193,4607.0,0.0013390000000000001,0.998474,DEFB126 FRG1 FRG2B GRXCR2 PPIG SAMD11,auditory receptor cell stereocilium organization|auditory receptor cell morphogenesis|RNA splicing|auditory receptor cell development|inner ear auditory receptor cell differentiation,0.004942|0.005522|0.005594|0.006391|0.008996,1|1|1|1|1,214.5|190.7|16.87|163.5|114.4
1661,6,0.4037,6.055,4894.0,0.001233,0.998474,CC2D2A CYTH3 FEZ2 FRMD3 IQSEC1 TMEM80,regulation of ARF protein signal transduction|non-motile cilium assembly|plasma membrane bounded cell projection organization|cell projection organization|regulation of Ras protein signal transduction,1.481e-05|7.597e-05|0.0001416|0.0001646|0.001371,0.2336|0.5992|0.7444|0.6491|1,361.3|152.6|11.78|11.33|34.67
1662,7,0.4048,8.501,5611.0,0.001509,0.9992989999999999,CYB5RL EPS15 FRMD4B IL17D ONECUT3 SMPD2 TMEM158,sphingomyelin catabolic process|receptor-mediated endocytosis of virus by host cell|endocytosis involved in viral entry into host cell|postsynaptic endocytosis|postsynaptic neurotransmitter receptor internalization,0.002376|0.002715|0.002715|0.003393|0.003393,1|1|1|1|1,490.4|420.3|420.3|326.9|326.9
1663,6,0.4097,6.145,4838.0,0.001265,0.998474,FRMPD2 GJD2 PARP6 PCDHAC2 TMOD3 TRDN,positive regulation of cell communication by electrical coupling involved in cardiac conduction|positive regulation of cell communication by electrical coupling|endoplasmic reticulum membrane organization|muscle contraction|pointed-end actin filament capping,0.0005824|0.0008735|0.002037|0.002047|0.002328,1|1|1|1|1,3432|1716|572.1|28.25|490.4
1664,9,0.4029,14.5,7512.0,0.001923,0.9998530000000001,FRY GKN2 GPC5 HEPN1 LRRC28 PAEP RAB17 RABL2B ZNF584,negative regulation of sperm capacitation|immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor|immunoglobulin transcytosis in epithelial cells|regulation of sperm capacitation|regulation of binding of sperm to zona pellucida,0.0008734|0.00131|0.001746|0.002182|0.002618,1|1|1|1|1,2288|1144|762.8|572.1|457.7
1665,5,0.403,4.03,3856.0,0.001041,0.996692,CAPN2 FSBP HIST3H3 LAX1 LGALS9C,negative regulation of T cell activation|negative regulation of leukocyte cell-cell adhesion|negative regulation of lymphocyte activation|negative regulation of leukocyte activation|negative regulation of cell-cell adhesion,0.0002004|0.0002388|0.0003299|0.0004554|0.0004808,1|1|1|1|1,87.27|79.83|67.75|57.53|55.96
1666,7,0.4074,8.555,5692.0,0.001497,0.9992989999999999,CHST5 FSCN2 HACE1 HOGA1 PHLDA3 SLC12A4 TOR3A,oxalate metabolic process|ammonium import across plasma membrane|glyoxylate catabolic process|4-hydroxyproline metabolic process|4-hydroxyproline catabolic process,0.0006794|0.001358|0.001358|0.001698|0.001698,1|1|1|1|1,2942|980.7|980.7|735.5|735.5
1667,33,0.4014,211.9,26790.0,0.007831,1.0,C5AR1 C5AR2 CABP5 CCDC61 CCDC9 CRX CYP2A13 CYP2S1 EML2 FFAR3 FLT3LG FUT1 FUT2 GPR32 IGFL1 IGFL2 IGFL3 IGFL4 KLK11 KLK3 PSG6 PSG8 SIGLEC11 SPACA4 SULT2A1 SULT2B1 TPRX1 ZNF155 ZNF222 ZNF284 ZNF45 ZNF665 ZNF780B,complement receptor mediated signaling pathway|complement component C5a signaling pathway|fucose catabolic process|L-fucose catabolic process|L-fucose metabolic process,2.257e-06|1.579e-05|0.0001437|0.0001437|0.0001437,0.03561|0.1245|0.7554|0.5666|0.4533,139.8|605.7|134.6|134.6|134.6
1668,5,0.4252,4.252,3638.0,0.001164,0.996692,AMBRA1 CDKN1B ENTPD3 FSTL1 TEX264,selective autophagy|organelle disassembly|negative regulation of cardiac muscle tissue regeneration|regulation of cardiac muscle tissue regeneration|negative regulation of apoptotic process,8.576e-05|0.0001299|0.000728|0.000728|0.0007553,1|1|1|1|1,139.6|112.8|2060|2060|13.92
1669,21,0.3829,80.42,14710.0,0.0054210000000000005,1.0,AK6 C18orf21 C1D DIMT1 EXOSC1 EXOSC10 HEATR1 IMP4 NAT10 NOC4L NOL10 NOL6 NOP9 PARN PDCD11 POP4 RPS7 SRFBP1 UTP25 WDR43 WDR75,rRNA processing|rRNA metabolic process|ncRNA processing|ribosome biogenesis|ncRNA metabolic process,2.291e-28|4.252e-28|6.092e-27|1.271e-26|1.427e-25,3.614e-24|3.354e-24|3.203e-23|5.014e-23|4.501e-22,61.21|58.94|39.01|47.93|32.59
1670,7,0.4073,8.552999999999999,5897.0,0.0014449999999999999,0.9992989999999999,DUS4L FAM198A FSTL5 PSEN2 SH2D1B TTC23L ZNF860,"regulation of calcium import into the mitochondrion|mitochondrion-endoplasmic reticulum membrane tethering|tRNA dihydrouridine synthesis|Notch receptor processing, ligand-dependent|amyloid-beta formation",0.0008735|0.001456|0.001746|0.002328|0.0032,1|1|1|1|1,1716|858.1|686.5|490.4|343.2
1671,6,0.4304,6.456,4860.0,0.001324,0.998474,ACOD1 BIVM COL4A1 FTH1 GPD2 TNFSF11,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling|positive regulation of fever generation by positive regulation of prostaglandin secretion|glycerophosphate shuttle|tolerance induction to lipopolysaccharide|positive regulation of corticotropin-releasing hormone secretion,0.0008735|0.0008735|0.0008735|0.0008735|0.001165,1|1|1|1|1,1716|1716|1716|1716|1144
1672,5,0.4242,4.242,3931.0,0.001075,0.996692,FTMT KIAA0319L NCALD PDE4DIP PPIAL4A,positive regulation of succinate dehydrogenase activity|regulation of succinate dehydrogenase activity|positive regulation of aconitate hydratase activity|regulation of aconitate hydratase activity|intracellular sequestering of iron ion,0.000728|0.000728|0.0009706|0.0009706|0.001698,1|1|1|1|1,2060|2060|1373|1373|686.5
1673,7,0.4192,8.802999999999999,4666.0,0.0018780000000000001,0.9992989999999999,CFAP20 FUBP1 HNRNPAB HNRNPD HNRNPUL1 KHSRP RBM5,"RNA splicing, via transesterification reactions|RNA splicing|mRNA processing|3'-UTR-mediated mRNA destabilization|mRNA metabolic process",1.677e-06|5.21e-06|1.028e-05|1.875e-05|4.214e-05,0.02645|0.04109|0.05408|0.07393|0.1329,38.59|28.92|24.32|326.9|16.96
1674,6,0.4108,6.162000000000001,4789.0,0.001282,0.998474,ANTXRL FUCA1 GPR152 KIAA0408 PDIA5 PPFIA1,glycoside catabolic process|glycolipid catabolic process|fucose metabolic process|glycoside metabolic process|negative regulation of protein localization to plasma membrane,0.00349|0.004651|0.004942|0.006681|0.00726,1|1|1|1|1,312|228.8|214.5|156|143
1675,6,0.413,6.194,4744.0,0.001301,0.998474,AP4B1 CXCL12 DCBLD2 FLG FUOM ZNF22,response to ultrasound|negative regulation of leukocyte tethering or rolling|chemokine (C-X-C motif) ligand 12 signaling pathway|negative regulation of leukocyte adhesion to vascular endothelial cell|positive regulation of dopamine secretion,0.0008735|0.001456|0.001456|0.001746|0.002328,1|1|1|1|1,1716|858.1|858.1|686.5|490.4
1676,5,0.4271,4.271,3737.0,0.001139,0.996692,C19orf67 CMTR1 DST FUS PHAX,snRNA export from nucleus|cap mRNA methylation|cap1 mRNA methylation|snRNA transport|hemidesmosome assembly,0.000728|0.000728|0.000728|0.001213|0.003152,1|1|1|1|1,2060|2060|2060|1030|343.3
1677,5,0.4259,4.2589999999999995,3877.0,0.001094,0.996692,FLYWCH1 FUT9 OR5F1 RANBP17 TMEM179B,fucose catabolic process|L-fucose catabolic process|L-fucose metabolic process|regulation of leukocyte tethering or rolling|fucose metabolic process,0.002425|0.002425|0.002425|0.003394|0.00412,1|1|1|1|1,457.7|457.7|457.7|316.8|257.4
1678,6,0.4048,6.072,4786.0,0.0012640000000000001,0.998474,ADM5 CSKMT FKBP2 FXYD4 PLA2G16 TM7SF2,peptidyl-lysine monomethylation|peptidyl-lysine dimethylation|peptidyl-lysine trimethylation|secondary alcohol biosynthetic process|cholesterol biosynthetic process,0.002667|0.004845|0.008226|0.009913|0.009913,1|1|1|1|1,411.9|216.8|124.8|103|103
1679,5,0.4244,4.244,4066.0,0.0010400000000000001,0.996692,CNKSR1 FYCO1 MIXL1 NPDC1 TOR2A,positive regulation of mesoderm development|plus-end-directed vesicle transport along microtubule|regulation of mesoderm development|positive regulation of autophagosome maturation|plus-end-directed organelle transport along microtubule,0.000728|0.001698|0.001698|0.001698|0.00194,1|1|1|1|1,2060|686.5|686.5|686.5|588.4
1680,7,0.4082,8.572000000000001,5916.0,0.001443,0.9992989999999999,ASAP2 G6PC3 HAS3 IFT140 PLCH2 TRABD2A TREML1,carbohydrate biosynthetic process|positive regulation of protein oxidation|regulation of protein oxidation|extracellular polysaccharide biosynthetic process|positive regulation of hyaluranon cable assembly,0.0009151|0.001019|0.001019|0.001358|0.001358,1|1|1|1|1,43.27|1471|1471|980.7|980.7
1681,5,0.4096,4.096,3979.0,0.001026,0.996692,FAM45A GAB4 OR51V1 SLC22A1 TLR2,positive regulation of cellular response to macrophage colony-stimulating factor stimulus|positive regulation of response to macrophage colony-stimulating factor|detection of diacyl bacterial lipopeptide|detection of triacyl bacterial lipopeptide|cellular response to triacyl bacterial lipopeptide,0.0005825|0.0005825|0.0005825|0.0005825|0.0007766,1|1|1|1|1,2574|2574|2574|2574|1716
1682,6,0.4096,6.145,4166.0,0.001468,0.998474,GABPA GABPB1 H2AFZ NUDCD3 RSL24D1 TRA2B,protein localization to pericentriolar material|assembly of large subunit precursor of preribosome|negative regulation of megakaryocyte differentiation|cerebral cortex regionalization|embryonic brain development,0.000728|0.0009706|0.001456|0.001698|0.003152,1|1|1|1|1,2060|1373|823.8|686.5|343.3
1683,16,0.4087,49.04,10420.0,0.004671,0.999999,AASDHPPT ADAT2 ADAT3 CDIPT DNLZ DOLK FAM98B FDXR MRE11 PGS1 PTPMT1 PYROXD1 RTCB RTRAF TRMT6 TRMT61A,tRNA processing|tRNA metabolic process|ncRNA processing|cardiolipin biosynthetic process|ncRNA metabolic process,1.629e-11|1.372e-10|4.923e-08|1.224e-07|1.645e-07,2.569e-07|1.082e-06|0.0002589|0.0004827|0.000519,60.68|44.25|18.54|381.4|15.49
1684,5,0.4298,4.298,3808.0,0.001124,0.996692,DHRS3 GABRP RARG RXRA XRCC6,retinoic acid receptor signaling pathway|bone morphogenesis|response to retinoic acid|hormone-mediated signaling pathway|transcription initiation from RNA polymerase II promoter,9.879e-06|0.0002357|0.0002796|0.0004085|0.0007796,0.1558|1|1|1|1,433.6|83.21|76.28|62.89|45.26
1685,7,0.4037,8.477,5973.0,0.0014140000000000001,0.9992989999999999,DNAJB4 GADD45A GPR4 LNPK LRRC58 SAMD13 SPOPL,negative regulation of angiogenesis|negative regulation of blood vessel morphogenesis|negative regulation of vasculature development|endoplasmic reticulum tubular network maintenance|negative regulation of peptidyl-serine phosphorylation of STAT protein,0.0005213|0.0005314|0.0005415|0.0006794|0.001358,1|1|1|1|1,57.69|57.13|56.58|2942|980.7
1686,16,0.4143,49.71,10160.0,0.004854,0.999999,ANKRD52 CCDC6 CYB5R4 DUSP6 LCMT1 PPM1A PPME1 PPP2CA PPP4C PPP4R3A PPP4R3B PPP6C PPP6R1 PPP6R3 PTPA TIPRL,protein dephosphorylation|dephosphorylation|regulation of phosphoprotein phosphatase activity|regulation of protein dephosphorylation|regulation of phosphatase activity,2.801e-10|4.026e-09|4.784e-08|1.101e-07|3.213e-07,4.418e-06|3.175e-05|0.0002516|0.0004341|0.001014,39.26|26.5|49.65|41.77|33.47
1687,7,0.4432,9.308,5772.0,0.0016059999999999998,0.9992989999999999,EHD4 GADD45G MCTP2 PLEKHG3 RMDN1 SI TMEM129,"polysaccharide digestion|pinocytosis|attachment of mitotic spindle microtubules to kinetochore|activation of MAPKKK activity|retrograde protein transport, ER to cytosol",0.002376|0.004071|0.004409|0.004748|0.006101,1|1|1|1|1,490.4|267.5|245.2|226.3|173.1
1688,5,0.4514,4.513999999999999,4057.0,0.001109,0.996692,GAL3ST2 KLHL30 PCLO SLC25A47 UST,presynapse to nucleus signaling pathway|presynaptic signal transduction|presynaptic active zone assembly|acyl carnitine transmembrane transport|acyl carnitine transport,0.000728|0.000728|0.0009706|0.001213|0.001456,1|1|1|1|1,2060|2060|1373|1030|823.8
1689,6,0.4011,6.016,4954.0,0.00121,0.998474,CXCR6 ESD GALK2 HESX1 LZTFL1 PHOSPHO2,negative regulation of protein localization to ciliary membrane|regulation of protein localization to ciliary membrane|negative regulation of protein localization to cilium|formaldehyde catabolic process|formaldehyde metabolic process,0.0005824|0.0008735|0.0008735|0.001165|0.001456,1|1|1|1|1,3432|1716|1716|1144|858.1
1690,7,0.4029,8.462,6137.0,0.001374,0.9992989999999999,ABCG5 CCDC80 CDC14A DCAF4L2 FCGRT GALM THBS1,negative regulation of lipid transport|negative regulation of lipid localization|IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor|negative regulation of intestinal cholesterol absorption|negative regulation of intestinal lipid absorption,7.289e-05|0.0001511|0.0006794|0.001019|0.001019,1|1|1|1|1,159|109|2942|1471|1471
1691,7,0.4062,8.53,5885.0,0.001444,0.9992989999999999,GALNS MCHR1 SARDH SLC5A1 SUN2 TEX33 TNNI1,sarcosine catabolic process|actin filament-based movement|sarcosine metabolic process|alpha-glucoside transport|nuclear migration along microfilament,0.0006794|0.0007047|0.001019|0.001019|0.001019,1|1|1|1|1,2942|49.45|1471|1471|1471
1692,4,0.448,2.688,3160.0,0.0008477000000000001,0.9929309999999999,GALNT10 HRH3 SCGB3A1 TRIM41,negative regulation of serotonin secretion|negative regulation of glutamate secretion|adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway|regulation of serotonin secretion|cellular response to muramyl dipeptide,0.001165|0.001165|0.001747|0.001747|0.001941,1|1|1|1|1,1030|1030|643.6|643.6|572.1
1693,5,0.449,4.49,4051.0,0.001104,0.996692,GALNT12 LRRN3 PANK1 PRM1 TMPRSS4,negative regulation of growth rate|regulation of growth rate|coenzyme A biosynthetic process|positive regulation by symbiont of entry into host|positive regulation of viral entry into host cell,0.001165|0.002619|0.00349|0.003781|0.003781,1|1|1|1|1,1144|429.1|312|286|286
1694,6,0.4083,6.124,4856.0,0.001256,0.998474,ACACB B3GLCT DCT EDNRB GALNT14 RCBTB2,developmental pigmentation|pigmentation|protein O-linked glycosylation|carbohydrate derivative biosynthetic process|enteric smooth muscle cell differentiation,5.487e-05|0.0002799|0.0003881|0.0004763|0.0005824,0.8655|1|1|1|1,180.7|78.01|66.01|17.05|3432
1695,5,0.4199,4.199,3849.0,0.0010869999999999999,0.996692,GALNT15 HEPHL1 HIST3H2BB IL17REL OLAH,medium-chain fatty acid biosynthetic process|medium-chain fatty acid metabolic process|copper ion transport|O-glycan processing|cellular iron ion homeostasis,0.001698|0.003636|0.00412|0.01496|0.0164,1|1|1|1|1,686.5|294.2|257.4|67.52|61.48
1696,7,0.4216,8.853,5856.0,0.001506,0.9992989999999999,ADAM15 CLDN15 CTSB GALNT7 PPID RPS6KB2 SYNPO2,collagen catabolic process|collagen metabolic process|protein metabolic process|movement in host environment|response to hypobaric hypoxia,9.729e-05|0.0001914|0.0004275|0.0006591|0.001358,1|1|1|1|1,136.8|96.46|4.185|51.17|980.7
1697,5,0.4613,4.613,3845.0,0.0011949999999999999,0.996692,ANO2 GALP RND1 SLC6A13 TRMT61B,behavioral response to starvation|creatine transmembrane transport|gamma-aminobutyric acid import|gamma-aminobutyric acid reuptake|mitochondrial tRNA methylation,0.000728|0.0009706|0.001213|0.001213|0.001456,1|1|1|1|1,2060|1373|1030|1030|823.8
1698,6,0.4061,6.0920000000000005,4869.0,0.001247,0.998474,GALR1 HIST1H3J LAG3 NCK2 NCKIPSD ROBO1,positive regulation of response to stimulus|negative regulation of negative chemotaxis|chemorepulsion involved in postnatal olfactory bulb interneuron migration|postnatal olfactory bulb interneuron migration|substrate-dependent cerebral cortex tangential migration,0.0006847|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,7.233|2060|2060|2060|2060
1699,5,0.435,4.35,3946.0,0.001098,0.996692,CRYL1 FAM162B GALR2 RET WHRN,neuron projection development|paranodal junction maintenance|neuron development|positive regulation of metanephros development|regulation of metanephric glomerulus development,0.0003497|0.0004854|0.0006263|0.000728|0.000728,1|1|1|1|1,18.09|4119|14.83|2060|2060
1700,15,0.4001,42.01,11920.0,0.0035039999999999997,0.999999,ATP12A C1QTNF9 C1QTNF9B CBLB GAREM1 GJB2 GJB6 HTR2A PCDH8 RCBTB2 RNF6 SIAH3 SLC25A30 SOHLH2 SPATA13,gap junction-mediated intercellular transport|intercellular transport|gap junction assembly|cell communication by electrical coupling|sensory perception of mechanical stimulus,1.381e-05|1.775e-05|2.217e-05|0.0001133|0.0002583,0.2178|0.14|0.1166|0.4466|0.8148,457.7|392.3|343.2|137.3|23.81
1701,5,0.4443,4.4430000000000005,4074.0,0.0010869999999999999,0.996692,CPED1 GAS7 LTK PPP1R3C SLC6A7,proline transmembrane transport|proline transport|positive regulation of cardiac muscle cell apoptotic process|positive regulation of striated muscle cell apoptotic process|glycogen biosynthetic process,0.002183|0.002183|0.002667|0.002667|0.005571,1|1|1|1|1,514.9|514.9|411.9|411.9|187.2
1702,5,0.4221,4.221,3911.0,0.001076,0.996692,FGF7 GATD1 OR5AK2 SOCS4 ZNF382,phosphatidylinositol phosphorylation|regulation of phosphatidylinositol 3-kinase activity|regulation of lipid kinase activity|lipid phosphorylation|regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,0.0001678|0.0001735|0.0002501|0.0002642|0.001358,1|1|1|1|1,103.2|101.5|84.06|81.73|980.7
1703,36,0.3936,248.0,26040.0,0.009406999999999999,1.0,BTN2A1 BTN2A2 GPX6 HIST1H1B HIST1H1C HIST1H1D HIST1H1E HIST1H1T HIST1H2AC HIST1H2AD HIST1H2AG HIST1H2BC HIST1H2BD HIST1H2BG HIST1H2BJ HIST1H2BK HIST1H2BL HIST1H2BN HIST1H4A HIST1H4C OR14J1 OR2B3 OR2B6 OR2J2 OR2J3 OR2W1 SLC17A2 SLC17A4 TRIM10 TRIM26 ZKSCAN4 ZKSCAN8 ZNF165 ZNF184 ZSCAN16 ZSCAN31,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sialic acid transport,9.699e-06|1.354e-05|1.672e-05|2.49e-05|2.717e-05,0.153|0.1068|0.0879|0.0982|0.08572,11.68|11|10.59|9.864|343.2
1704,6,0.4121,6.182,4830.0,0.001275,0.998474,C9orf47 CD80 GCG GEM HPX PEAR1,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains|regulation of adaptive immune response|positive regulation of protein phosphorylation|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of phosphorylation,0.0008592|0.001029|0.001194|0.001331|0.001584,1|1|1|1|1,44.01|40.15|12.44|35.21|11.28
1705,5,0.4396,4.396,3992.0,0.001097,0.996692,C12orf54 FBXO43 FMNL3 GCNT3 MAB21L2,embryonic body morphogenesis|negative regulation of meiotic nuclear division|negative regulation of meiotic cell cycle|regulation of meiotic nuclear division|intestinal absorption,0.001698|0.002425|0.004362|0.007744|0.007985,1|1|1|1|1,686.5|457.7|242.3|132.9|128.7
1706,6,0.4006,6.0089999999999995,4913.0,0.001219,0.998474,C6orf48 CD63 FAM78A GCSAM KIF5A SNAI3,anterograde dendritic transport of neurotransmitter receptor complex|retrograde neuronal dense core vesicle transport|anterograde dendritic transport|positive regulation of integrin-mediated signaling pathway|dense core granule transport,0.001213|0.001456|0.001698|0.00194|0.002425,1|1|1|1|1,1030|823.8|686.5|588.4|457.7
1707,32,0.4001,198.4,25930.0,0.0075769999999999995,1.0,ADA BCAS4 BPIFB4 CNBD2 CPNE1 DUSP15 EPPIN FAM209A FAM209B FAM83C GDAP1L1 GGT7 GHRH HCK LBP MAP1LC3A MYH7B MYLK2 OCSTAMP R3HDML RALY RBPJL SLC12A5 SLC13A3 TFAP2C TLDC2 TM9SF4 WFDC11 WFDC6 WFDC8 WISP2 XKR7,"regulation of circadian sleep/wake cycle, sleep|regulation of circadian sleep/wake cycle|negative regulation of peptidase activity|response to isoquinoline alkaloid|lipopolysaccharide-mediated signaling pathway",0.0003679|0.0005423|0.0005853|0.001334|0.001334,1|1|1|1|1,78.16|63.27|10.42|39.08|39.08
1708,6,0.4152,6.228,4887.0,0.0012699999999999999,0.998474,GDF10 IQCJ LCP1 PELI3 RHOBTB1 STOML1,cortical cytoskeleton organization|regulation of Toll signaling pathway|Toll signaling pathway|actin filament organization|positive regulation of podosome assembly,0.0001242|0.001456|0.002037|0.002516|0.002909,1|1|1|1|1,118.4|858.1|572.1|25.43|381.4
1709,5,0.4371,4.371,3898.0,0.001117,0.996692,CEP164 CNTN2 GDF15 NBL1 TMEM81,establishment of protein localization to juxtaparanode region of axon|negative regulation of growth hormone receptor signaling pathway|regulation of neuron differentiation|positive regulation of adenosine receptor signaling pathway|clustering of voltage-gated potassium channels,0.0004854|0.000728|0.0008838|0.0009706|0.0009706,1|1|1|1|1,4119|2060|42.46|1373|1373
1710,17,0.4129,56.15,12810.0,0.004351,1.0,CAPN5 FCHSD2 FOLR1 FOLR2 GDPD4 GDPD5 KCTD21 KRTAP5-1 KRTAP5-10 KRTAP5-7 KRTAP5-9 OMP P2RY2 P2RY6 PLEKHB1 THRSP UCP3,keratinization|keratinocyte differentiation|cellular response to folic acid|epidermal cell differentiation|folate import across plasma membrane,1.288e-06|2.923e-06|4.317e-06|6.44e-06|1.509e-05,0.02031|0.02305|0.0227|0.02539|0.04759,25.31|21.35|1144|18.1|457.7
1711,9,0.4066,14.64,5804.0,0.002508,0.9998530000000001,EAF1 GEMIN2 GEMIN4 GEMIN6 GEMIN7 ICE2 SNRPB2 SNUPN TGS1,"spliceosomal snRNP assembly|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|RNA splicing",6.412e-15|5.596e-12|5.596e-12|5.99e-12|4.373e-11,1.011e-10|4.413e-08|2.942e-08|2.362e-08|1.38e-07,352.1|53.04|53.04|52.52|39.36
1712,7,0.4192,8.802999999999999,5847.0,0.0015,0.9992989999999999,AK1 GFOD2 IFI6 KLHL26 OR51D1 RIPOR1 URGCP,negative regulation of Rho guanyl-nucleotide exchange factor activity|ADP biosynthetic process|purine ribonucleoside diphosphate biosynthetic process|negative regulation of mitochondrial depolarization|negative regulation of guanyl-nucleotide exchange factor activity,0.001019|0.002037|0.002037|0.002376|0.002376,1|1|1|1|1,1471|588.4|588.4|490.4|490.4
1713,6,0.4325,6.487,4776.0,0.001353,0.998474,ABCA7 ACADS DDIAS GFRA3 LPP PRF1,butyrate catabolic process|positive regulation of engulfment of apoptotic cell|butyrate metabolic process|regulation of engulfment of apoptotic cell|regulation of DNA stability,0.0005824|0.0008735|0.0008735|0.001165|0.001456,1|1|1|1|1,3432|1716|1716|1144|858.1
1714,13,0.4034,31.46,10260.0,0.0030489999999999996,0.999993,FSHR GGCX LRRTM4 NAT8 PUS10 REG3G SFTPB SIX3 TEX261 TEX37 THNSL2 TRABD2A WBP1,regulation of acetylcholine metabolic process|neuroblast migration|2-oxobutyrate biosynthetic process|primary ovarian follicle growth|peptidyl-lysine N6-acetylation,0.001261|0.001261|0.001261|0.001891|0.001891,1|1|1|1|1,1584|1584|1584|792.1|792.1
1715,6,0.4483,6.724,5042.0,0.0013289999999999999,0.998474,FASTKD1 GHDC NAV3 PRM2 TBCK VSIG2,regulation of mitochondrial mRNA stability|negative regulation of microtubule depolymerization|negative regulation of interleukin-2 production|positive regulation of microtubule polymerization|regulation of microtubule depolymerization,0.002328|0.008128|0.008418|0.009285|0.009285,1|1|1|1|1,490.4|127.1|122.6|110.7|110.7
1716,7,0.4244,8.911,6175.0,0.001438,0.9992989999999999,CAPN13 CYP27A1 GHRL KLRC1 NIPAL3 SLC34A2 YWHAH,steroid catabolic process|response to estrogen|glucocorticoid catabolic process|cortisol secretion|hormone-mediated signaling pathway,3.725e-05|0.0003088|0.0006794|0.0006794|0.0008504,0.5876|1|1|1|1,226.3|75.44|2942|2942|44.92
1717,5,0.7495,7.495,3361.0,0.002218,0.996692,MCPH1 PIAS4 RBM4 RBM4B SRBD1,entrainment of circadian clock by photoperiod|photoperiodism|entrainment of circadian clock|regulation of circadian rhythm|circadian rhythm,2.185e-05|2.795e-05|2.96e-05|0.0003382|0.0004655,0.3447|0.2205|0.1556|1|1,284.1|249.6|242.3|69.23|58.84
1718,6,0.4044,6.066,4844.0,0.001248,0.998474,DUSP26 GIMAP8 MC2R MEDAG NFAM1 TMEM230,positive regulation of peptidyl-serine dephosphorylation|regulation of peptidyl-serine dephosphorylation|positive regulation of B cell receptor signaling pathway|negative regulation of protein kinase activity by regulation of protein phosphorylation|positive regulation of antigen receptor-mediated signaling pathway,0.0008735|0.001746|0.002328|0.002619|0.006391,1|1|1|1|1,1716|686.5|490.4|429.1|163.5
1719,8,0.4082,11.43,6232.0,0.0018260000000000001,0.9996790000000001,EFHD1 FAM69A GBP3 GBP4 GBP5 GINM1 OR2W3 ST6GALNAC3,cellular response to interferon-gamma|response to interferon-gamma|interleukin-18 production|endoplasmic reticulum tubular network membrane organization|regulation of response to salt stress,3.8e-05|5.657e-05|0.0008734|0.002182|0.002182,0.5995|0.4462|1|1|1,43.45|37.93|2288|572.1|572.1
1720,11,0.4116,22.64,8750.0,0.002574,0.999969,CD244 FYTTD1 KCNK7 LAMC2 MFGE8 OR10Z1 SLC36A1 SPINK6 SPRR4 STMND1 SWT1,epidermis development|positive regulation of granzyme B production|regulation of granzyme B production|supramolecular fiber organization|alkanesulfonate transport,0.001228|0.002134|0.002134|0.003403|0.003731,1|1|1|1|1,13.47|624.1|624.1|9.408|312
1721,6,0.4045,6.067,4808.0,0.001257,0.998474,GIPC2 POPDC2 QRICH2 SLC30A2 SPATC1L UNCX,positive regulation of sequestering of zinc ion|regulation of sequestering of zinc ion|positive regulation of cAMP-dependent protein kinase activity|common myeloid progenitor cell proliferation|olfactory bulb interneuron differentiation,0.0005824|0.001746|0.002037|0.002328|0.00349,1|1|1|1|1,3432|686.5|572.1|490.4|312
1722,6,0.4223,6.335,4556.0,0.001385,0.998474,ADIPOR1 DNAJC5 GIPC3 MET MFAP3 SIM2,negative regulation of thrombin-activated receptor signaling pathway|regulation of thrombin-activated receptor signaling pathway|negative regulation of hydrogen peroxide-mediated programmed cell death|regulation of epithelial cell migration|negative regulation of guanyl-nucleotide exchange factor activity,0.001165|0.001165|0.001746|0.001854|0.002037,1|1|1|1|1,1144|1144|686.5|29.72|572.1
1723,9,0.4058,14.61,8076.0,0.001802,0.9998530000000001,CGA GJA10 GJB7 HTR1E IL2 SCAPER ZDHHC14 ZKSCAN2 ZNF664,cell-cell signaling|adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation|positive regulation of dense core granule biogenesis|positive regulation of relaxation of cardiac muscle|mast cell cytokine production,0.000172|0.001067|0.001601|0.001601|0.001601,1|1|1|1|1,8.321|1872|936.1|936.1|936.1
1724,5,0.4177,4.177,3995.0,0.001042,0.996692,CUX2 GLB1 KHK KLK12 METTL14,hexose catabolic process|monosaccharide catabolic process|carbohydrate catabolic process|response to cortisone|hexose metabolic process,6.463e-05|8.02e-05|0.0003217|0.0004854|0.0005758,1|0.6325|1|1|1,161.5|144.5|71.02|4119|52.81
1725,13,0.4086,31.87,10920.0,0.002904,0.999993,CDK3 GALK1 GLB1L GPR142 LGALS3BP MIF4GD RHBDF2 SEPT9 SPHK1 SSTR2 TIMP2 TMEM235 UBE2O,galactitol metabolic process|G0 to G1 transition|regulation of endosomal vesicle fusion|glycolytic process from galactose|sphingoid catabolic process,0.001261|0.001261|0.001261|0.001261|0.001261,1|1|1|1|1,1584|1584|1584|1584|1584
1726,6,0.4101,6.151,4587.0,0.001336,0.998474,ADAMTSL4 BTG3 CNOT6L CNOT7 GLI3 TOB1,positive regulation of mRNA catabolic process|positive regulation of mRNA metabolic process|negative regulation of translation|positive regulation of nuclear-transcribed mRNA poly(A) tail shortening|negative regulation of cellular amide metabolic process,3.783e-07|1.492e-06|6.053e-06|8.468e-06|9.383e-06,0.005968|0.01177|0.03182|0.03339|0.0296,194.3|121.1|75.16|490.4|64.76
1727,5,0.431,4.31,3985.0,0.001078,0.996692,ADGRA3 GLIS1 ICOS IGLON5 LAMA3,T cell tolerance induction|hemidesmosome assembly|negative regulation of cell fate commitment|tolerance induction|cell-cell adhesion,0.000728|0.003152|0.003394|0.00412|0.005956,1|1|1|1|1,2060|343.3|316.8|257.4|16.03
1728,5,0.4235,4.235,3892.0,0.001084,0.996692,BCL2A1 GLRA3 GPR87 IP6K3 TMEM216,"synaptic transmission, glycinergic|inositol phosphate biosynthetic process|G protein-coupled purinergic nucleotide receptor signaling pathway|negative regulation of adenylate cyclase activity|negative regulation of cyclase activity",0.001456|0.003636|0.003636|0.005087|0.005812,1|1|1|1|1,823.8|294.2|294.2|205.9|179.1
1729,5,0.4386,4.386,3946.0,0.0011070000000000001,0.996692,CCDC178 FCHSD2 GLRB PITPNA TMEM86B,"membrane organization|visual perception|sensory perception of light stimulus|synaptic transmission, glycinergic|gamma-aminobutyric acid receptor clustering",0.0009372|0.001092|0.001132|0.001456|0.001456,1|1|1|1|1,12.93|38.14|37.45|823.8|823.8
1730,17,0.4052,55.11,14430.0,0.003796,1.0,BNIP2 CSNK1G1 FBXL22 IGDCC3 INSYN1 LOXL1 MEGF11 MYO5C PLCB2 PLEKHO2 PPIB RAB8B SCAMP2 SCAMP5 SLC24A1 SNX22 THAP10,protein deamination|macrophage apoptotic process|collagen fibril organization|Golgi vesicle fusion to target membrane|cell surface receptor signaling pathway involved in cell-cell signaling,0.001649|0.003295|0.003326|0.004117|0.00468,1|1|1|1|1,1211|403.8|23.52|302.9|8.674
1731,6,0.4051,6.077000000000001,4570.0,0.001324,0.998474,DDX10 GLT8D1 NUF2 OTOP1 RRP12 TKTL2,anterior head development|rRNA processing|rRNA metabolic process|negative regulation of interferon-gamma-mediated signaling pathway|negative regulation of response to interferon-gamma,0.001456|0.002337|0.002516|0.002619|0.002619,1|1|1|1|1,858.1|26.4|25.43|429.1|429.1
1732,7,0.4033,8.469,5304.0,0.00159,0.9992989999999999,EHF GLT8D2 NADK2 NPL PROK1 SAA4 SNX29,NADP biosynthetic process|N-acetylneuraminate catabolic process|N-acetylneuraminate metabolic process|amino sugar catabolic process|pyridine nucleotide biosynthetic process,0.001358|0.002376|0.004071|0.004748|0.01082,1|1|1|1|1,980.7|490.4|267.5|226.3|94.91
1733,5,0.4276,4.276,4027.0,0.001058,0.996692,DEFB134 GLYAT GNAL KCNH6 NAT1,glutamine transport|sodium ion transport|neutral amino acid transport|cation transport|ion transmembrane transport,5.928e-06|3.382e-05|0.0001074|0.0001607|0.0004054,0.0935|0.2668|0.5645|0.6339|1,643.6|44.39|132|12.47|9.798
1734,5,0.4017,4.0169999999999995,3735.0,0.0010710000000000001,0.996692,ERBB3 FUT8 GLYATL1 S100PBP ZNF514,protein glycosylation in Golgi|N-glycan fucosylation|positive regulation of cardiac muscle tissue development|GDP-L-fucose metabolic process|regulation of cardiac muscle tissue development,0.0004854|0.000728|0.000728|0.001213|0.001456,1|1|1|1|1,4119|2060|2060|1030|823.8
1735,7,0.4124,8.66,4818.0,0.001789,0.9992989999999999,ERBB2 ERBB3 FGFR1 FUT8 GMDS PHLDA2 SLC35C1,GDP-L-fucose metabolic process|phosphatidylinositol-mediated signaling|inositol lipid-mediated signaling|peptidyl-tyrosine phosphorylation|peptidyl-tyrosine modification,1.483e-06|2.262e-06|2.603e-06|1.296e-05|1.375e-05,0.0234|0.01784|0.01369|0.05111|0.04339,1471|109|103.8|60.04|58.84
1736,6,0.414,6.21,4706.0,0.001315,0.998474,CEP250 GMPPA IFT27 MTMR4 TAS2R9 TSPAN9,regulation of centriole-centriole cohesion|regulation of phosphatidylinositol dephosphorylation|positive regulation of protein localization to centrosome|regulation of protein localization to centrosome|response to denervation involved in regulation of muscle adaptation,0.001165|0.002037|0.002328|0.0032|0.00349,1|1|1|1|1,1144|572.1|490.4|343.2|312
1737,19,0.4071,69.61,13220.0,0.005225,1.0,ARHGAP21 ARHGEF12 BTBD9 GNA13 GRK2 LPAR1 LPAR2 LUZP1 MYL6 MYO9A MYO9B PDCL PKN2 RHOA RHOC RIC8A ROCK1 ROCK2 TMOD3,positive regulation of hydrolase activity|Rho protein signal transduction|regulation of hydrolase activity|regulation of small GTPase mediated signal transduction|small GTPase mediated signal transduction,1.358e-11|2.46e-11|1.498e-10|2.895e-10|2.627e-09,2.143e-07|1.94e-07|7.876e-07|1.142e-06|8.288e-06,15.35|106.6|9.944|26.52|28.96
1738,7,0.4086,8.581,5615.0,0.0015220000000000001,0.9992989999999999,FAM19A5 GNA12 KIAA1024 PPP2R5A SCUBE1 UTP18 VSIG10L,regulation of TOR signaling|negative regulation of lipid kinase activity|blood coagulation|coagulation|hemostasis,0.0003524|0.002619|0.00305|0.00309|0.003131,1|1|1|1|1,69.34|429.1|23.04|22.88|22.73
1739,5,0.4381,4.381,3881.0,0.001125,0.996692,GNAQ SHISAL1 SYT16 TMEM253 TOPORS,retinal rod cell development|retinal cone cell differentiation|retinal cone cell development|retinal rod cell differentiation|photoreceptor cell outer segment organization,0.002667|0.00291|0.00291|0.003394|0.003394,1|1|1|1|1,411.9|374.5|374.5|316.8|316.8
1740,7,0.4295,9.02,6111.0,0.001471,0.9992989999999999,CISD1 CKMT2 GNB3 HTR1D ITPRIPL1 TMEM138 TRAK2,anterograde dendritic transport of mitochondrion|dendritic transport of mitochondrion|phosphocreatine metabolic process|phosphagen metabolic process|phosphagen biosynthetic process,0.0006794|0.001019|0.001698|0.001698|0.001698,1|1|1|1|1,2942|1471|735.5|735.5|735.5
1741,5,0.4096,4.096,4086.0,0.0009988999999999998,0.996692,CSRNP1 DENND5B GNG10 LIMD2 RHEX,erythropoietin-mediated signaling pathway|cellular response to erythropoietin|response to erythropoietin|erythrocyte maturation|positive regulation of erythrocyte differentiation,0.001213|0.00194|0.002183|0.003636|0.007502,1|1|1|1|1,1030|588.4|514.9|294.2|137.3
1742,7,0.4045,8.494,5019.0,0.001685,0.9992989999999999,AHSA1 CDC37L1 DNAJB6 HNRNPU HSF1 HSF2 HSPA4,positive regulation of ATPase activity|regulation of ATPase activity|negative regulation of inclusion body assembly|regulation of inclusion body assembly|protein folding,8.572e-07|2.262e-06|7.705e-06|1.875e-05|4.711e-05,0.01352|0.01784|0.04051|0.07393|0.1486,152.2|109|534.9|326.9|38.71
1743,7,0.4153,8.721,5608.0,0.001549,0.9992989999999999,GALNT16 GNG2 HEATR4 PROX2 PTGDR PTGER2 RHOQ,cellular response to prostaglandin E stimulus|cellular response to prostaglandin stimulus|response to prostaglandin E|response to prostaglandin|negative regulation of inflammatory response to antigenic stimulus,3.713e-08|7.747e-08|1.119e-07|2.286e-07|7.386e-07,0.0005856|0.000611|0.0005884|0.0009016|0.00233,482.7|367.8|321.8|249.1|49.51
1744,7,0.4117,8.647,5816.0,0.0014810000000000001,0.9992989999999999,ACSM4 ACSM5 CXXC5 GCKR GNG8 PURA RMI2,acyl-CoA metabolic process|thioester metabolic process|cellular response to pheromone|long-chain fatty acid metabolic process|fatty acid biosynthetic process,0.0006281|0.0006281|0.0007765|0.0009513|0.001014,1|1|1|1|1,53.08|53.08|2574|42.91|41.52
1745,6,0.4325,6.4879999999999995,4745.0,0.001362,0.998474,C6orf48 GNGT2 SFR1 SMIM29 STK19 SYDE1,positive regulation of trophoblast cell migration|regulation of small GTPase mediated signal transduction|regulation of trophoblast cell migration|cellular response to estrogen stimulus|phototransduction,0.00194|0.002463|0.003394|0.004362|0.01088,1|1|1|1|1,588.4|25.19|316.8|242.3|93.61
1746,5,0.4418,4.418,3816.0,0.001153,0.996692,CYP2E1 FBXL4 GNRH2 PPTC7 ZCCHC4,4-nitrophenol metabolic process|benzene metabolic process|carbon tetrachloride metabolic process|regulation of ubiquinone biosynthetic process|halogenated hydrocarbon metabolic process,0.0004854|0.0004854|0.0004854|0.000728|0.000728,1|1|1|1|1,4119|4119|4119|2060|2060
1747,5,0.4053,4.053,3683.0,0.0010960000000000002,0.996692,AMBP CEL GOLGA4 IFT74 LCN1,protein esterification|transport|organic substance transport|establishment of localization|anion transport,0.0004854|0.0004999|0.0005665|0.0005901|0.0006953,1|1|1|1|1,4119|4.576|7.593|4.426|7.204
1748,5,0.453,4.53,4167.0,0.001083,0.996692,GOLIM4 RECQL5 SLC27A4 TEX44 TMEM244,"negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity|regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity|medium-chain fatty acid transport|cellular response to camptothecin|response to camptothecin",0.0004854|0.0004854|0.000728|0.001213|0.001456,1|1|1|1|1,4119|4119|2060|1030|823.8
1749,6,0.4243,6.365,4662.0,0.0013599999999999999,0.998474,CACNA2D3 GOLM1 HIST3H2BB IGF2BP3 KDF1 LCK,limb epidermis development|calcium ion transmembrane transport|regulation of epidermal cell division|calcium ion transport|negative regulation of stem cell proliferation,0.0004854|0.0008484|0.0009706|0.001387|0.001456,1|1|1|1|1,4119|43.36|1373|33.76|823.8
1750,6,0.414,6.21,4861.0,0.001273,0.998474,DOK4 EPPIN GOLT1A NDRG3 RBPMS2 SPRR3,negative regulation of cilium-dependent cell motility|negative regulation of flagellated sperm motility|negative regulation of cilium movement|negative regulation of calcium ion import|embryonic digestive tract morphogenesis,0.001456|0.001456|0.001456|0.002909|0.004942,1|1|1|1|1,858.1|858.1|858.1|381.4|214.5
1751,6,0.4112,6.167999999999999,4882.0,0.001259,0.998474,ADCK5 ANKRD46 CCDC173 GORAB NKAIN4 TTC16,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning|regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning|hair follicle morphogenesis|epidermis morphogenesis|positive regulation of smoothened signaling pathway,0.0005824|0.002619|0.008418|0.009574|0.01102,1|1|1|1|1,3432|429.1|122.6|107.3|92.77
1752,4,0.4435,2.661,2975.0,0.0008912000000000001,0.9929309999999999,FTL GORASP1 PRC1 SAMD11,intracellular sequestering of iron ion|sequestering of iron ion|mitotic spindle midzone assembly|spindle elongation|mitotic spindle elongation,0.001359|0.001553|0.001747|0.001747|0.001747,1|1|1|1|1,858.1|735.5|643.6|643.6|643.6
1753,6,0.4001,6.001,4859.0,0.001231,0.998474,APOC2 CD22 GCNT1 GOT1L1 KY SAXO2,positive regulation of very-low-density lipoprotein particle remodeling|cell adhesion molecule production|aspartate biosynthetic process|positive regulation of phospholipid catabolic process|negative regulation of very-low-density lipoprotein particle clearance,0.0008735|0.001165|0.001165|0.001165|0.001456,1|1|1|1|1,1716|1144|1144|1144|858.1
1754,6,0.4469,6.702999999999999,5074.0,0.0013160000000000001,0.998474,CCPG1 CD7 GP5 OLIG3 SGTB SYCP2L,regulation of Rho guanyl-nucleotide exchange factor activity|positive regulation of chaperone-mediated protein folding|spinal cord motor neuron migration|positive regulation of protein folding|regulation of chaperone-mediated protein folding,0.0008735|0.0008735|0.001456|0.001456|0.001746,1|1|1|1|1,1716|1716|858.1|858.1|686.5
1755,5,0.4471,4.471,4070.0,0.0010949999999999998,0.996692,COQ9 ERVW-1 GPALPP1 HPGDS WFDC13,cyclooxygenase pathway|ubiquinone biosynthetic process|quinone biosynthetic process|ubiquinone metabolic process|prostaglandin biosynthetic process,0.00291|0.00412|0.00412|0.004362|0.005087,1|1|1|1|1,374.5|257.4|257.4|242.3|205.9
1756,6,0.4055,6.082999999999999,4851.0,0.0012490000000000001,0.998474,CCM2 CDRT1 GPAM ITGB1BP1 MYMK ZNF276,integrin-mediated signaling pathway|positive regulation of skeletal muscle hypertrophy|negative regulation of cell adhesion involved in substrate-bound cell migration|negative regulation of activation-induced cell death of T cells|regulation of skeletal muscle hypertrophy,0.0003455|0.0008735|0.001165|0.001165|0.001165,1|1|1|1|1,70.05|1716|1144|1144|1144
1757,5,0.4435,4.435,4120.0,0.001073,0.996692,ARNTL2 GPATCH11 HLA-DPA1 IKBKE MPDZ,I-kappaB phosphorylation|positive regulation of type I interferon-mediated signaling pathway|positive regulation of circadian rhythm|positive regulation of lipid storage|TRIF-dependent toll-like receptor signaling pathway,0.003152|0.003394|0.004362|0.006295|0.007502,1|1|1|1|1,343.3|316.8|242.3|164.8|137.3
1758,5,0.4358,4.3580000000000005,3912.0,0.0011099999999999999,0.996692,GPATCH2L GPR182 HMOX1 HSPA1B SREK1,cellular response to heat|response to heat|negative regulation of extrinsic apoptotic signaling pathway|regulation of transcription from RNA polymerase II promoter in response to iron|regulation of extrinsic apoptotic signaling pathway,7.22e-05|0.0002219|0.0002646|0.0004854|0.0005758,1|1|1|1|1,152.6|85.81|78.46|4119|52.81
1759,5,0.4251,4.251,3907.0,0.001084,0.996692,CYP7B1 GPATCH3 NARF PCDH15 ZFAND2A,B cell chemotaxis|equilibrioception|negative regulation of RIG-I signaling pathway|negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway|negative regulation of intracellular estrogen receptor signaling pathway,0.001698|0.002183|0.002183|0.00291|0.00412,1|1|1|1|1,686.5|514.9|514.9|374.5|257.4
1760,5,0.4059,4.059,3986.0,0.001015,0.996692,CLEC4M GPC1 LYPD6B STXBP2 TNFRSF11B,negative regulation of animal organ morphogenesis|negative regulation of odontogenesis of dentin-containing tooth|negative regulation of odontogenesis|peptide antigen transport|heparan sulfate proteoglycan catabolic process,0.000728|0.000728|0.000728|0.0009706|0.0009706,1|1|1|1|1,2060|2060|2060|1373|1373
1761,22,0.4039,93.29,17360.0,0.005332,1.0,BCAS4 BMP7 CASS4 CNBD2 FAM209A FAM209B GGT7 MAP1LC3A MTRNR2L3 MYH7B NPBWR2 OPRL1 PARD6B PMEPA1 R3HDML RBM38 RIPOR3 SLC2A4RG TFAP2C WFDC11 WISP2 ZGPAT,opioid receptor signaling pathway|response to estradiol|negative regulation of molecular function|regulation of pathway-restricted SMAD protein phosphorylation|response to organic cyclic compound,7.128e-05|0.0004384|0.001156|0.002105|0.002124,1|1|1|1|1,187.2|20.35|4.797|30.2|5.283
1762,6,0.4442,6.662999999999999,4944.0,0.001343,0.998474,CHST4 GPLD1 KIAA0753 PNMA1 SELENBP1 SLC24A1,response to triglyceride|GPI anchor release|cellular response to triglyceride|positive regulation of high-density lipoprotein particle clearance|regulation of high-density lipoprotein particle clearance,0.0005824|0.0005824|0.0005824|0.0008735|0.001165,1|1|1|1|1,3432|3432|3432|1716|1144
1763,6,0.4181,6.271,4632.0,0.001349,0.998474,CUTC ELMO1 GPR132 JAKMIP1 PPP1R16A WDR54,negative regulation of receptor internalization|copper ion transport|copper ion homeostasis|Rac protein signal transduction|negative regulation of receptor-mediated endocytosis,0.004071|0.004942|0.005232|0.006391|0.008418,1|1|1|1|1,264|214.5|201.9|163.5|122.6
1764,6,0.4332,6.499,5021.0,0.0012900000000000001,0.998474,GPR137 PAQR8 PEAK1 SLC9A2 STRN4 THPO,thrombopoietin-mediated signaling pathway|regulation of myeloid cell differentiation|positive regulation of hematopoietic stem cell proliferation|regulation of hematopoietic stem cell proliferation|positive regulation of megakaryocyte differentiation,0.001746|0.001934|0.002037|0.002909|0.00349,1|1|1|1|1,686.5|29.09|572.1|381.4|312
1765,6,0.4224,6.336,5046.0,0.001251,0.998474,BOK CALHM5 GPR157 PAX7 TIMP2 TRIM3,regulation of granulosa cell apoptotic process|glial cell differentiation|regulation of Rap protein signal transduction|positive regulation of PERK-mediated unfolded protein response|nervous system development,0.0008735|0.001029|0.001456|0.001456|0.001609,1|1|1|1|1,1716|40.15|858.1|858.1|6.272
1766,6,0.4345,6.517,4896.0,0.001326,0.998474,FAM107B FAM76B FGFBP1 GPR161 MDFI SH3BGR,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning|positive regulation of fibroblast growth factor receptor signaling pathway|regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning|positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis|dorsal/ventral axis specification,0.001746|0.002619|0.002619|0.002909|0.00349,1|1|1|1|1,686.5|429.1|429.1|381.4|312
1767,6,0.4376,6.564,4768.0,0.001371,0.998474,ELF2 FAM131C GPR162 GPRC5A NCF1 SP5,regulation of epidermal growth factor-activated receptor activity|regulation of epidermal growth factor receptor signaling pathway|regulation of ERBB signaling pathway|regulation of protein tyrosine kinase activity|regulation of signaling receptor activity,4.885e-05|0.0003821|0.0004444|0.0004444|0.001833,0.7705|1|1|1|1,196.1|67.64|62.6|62.6|30.33
1768,5,0.4008,4.008,3805.0,0.001049,0.996692,CRY1 GPR180 ITFG2 OR8H1 SPINK13,negative regulation of acrosome reaction|cellular response to blue light|blue light signaling pathway|negative regulation of glucocorticoid secretion|negative regulation of corticosteroid hormone secretion,0.0004854|0.000728|0.000728|0.0009706|0.0009706,1|1|1|1|1,4119|2060|2060|1373|1373
1769,6,0.4173,6.26,4726.0,0.0013189999999999999,0.998474,FAM84A GPR37 LAMP3 LRCH3 PLA2G4C RHOU,platelet activating factor biosynthetic process|septin cytoskeleton organization|locomotion involved in locomotory behavior|positive regulation of dopamine metabolic process|positive regulation of catecholamine metabolic process,0.001456|0.001456|0.001746|0.001746|0.001746,1|1|1|1|1,858.1|858.1|686.5|686.5|686.5
1770,8,0.403,11.28,6362.0,0.001766,0.9996790000000001,GPR37L1 GRM2 NECAP2 OR13J1 OR2S2 RCHY1 SAXO1 SPAG8,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway|G protein-coupled receptor signaling pathway|cold acclimation|glutamate homeostasis|amino acid homeostasis,0.0004744|0.0009888|0.001552|0.002328|0.002715,1|1|1|1|1,61.29|7.748|858.1|514.9|429.1
1771,5,0.4499,4.499,4142.0,0.001083,0.996692,BCL2L11 GPR39 S100P SCN9A TCEA3,post-embryonic development|positive regulation of autophagy in response to ER overload|killing by symbiont of host cells|positive regulation of apoptotic process by virus|positive regulation by symbiont of host apoptotic process,0.0001709|0.0004854|0.000728|0.000728|0.000728,1|1|1|1|1,98.07|4119|2060|2060|2060
1772,19,0.4027,68.86,15050.0,0.004543,1.0,ASTL C2orf49 CCDC74B CFC1 CFC1B CNNM4 FAHD2A FAM178B GPR45 IL1F10 LYG1 LYG2 MGAT4A MRPL30 POTEI SLC9A2 ST6GAL2 TRIM43 TUBA3D,cell wall macromolecule catabolic process|cell wall organization or biogenesis|cell wall macromolecule metabolic process|peptidoglycan metabolic process|peptidoglycan catabolic process,4.824e-06|8.035e-06|8.035e-06|2.246e-05|2.246e-05,0.07609|0.06337|0.04225|0.08858|0.07086,1084|722.6|722.6|361.3|361.3
1773,6,0.442,6.629,5263.0,0.001255,0.998474,AQP8 CAMK2B DXO GPR55 NRG1 TMEM181,regulation of neuron migration|positive regulation of Ras protein signal transduction|positive regulation of small GTPase mediated signal transduction|ERBB4 signaling pathway|pathogenesis,6.651e-05|0.0002156|0.0002556|0.0005824|0.0005824,1|1|1|1|1,163.5|89.16|81.73|3432|3432
1774,5,0.4232,4.232,3861.0,0.001092,0.996692,GPR65 KCNK10 KRTAP26-1 TMEM141 ZNF706,negative regulation of stem cell population maintenance|stabilization of membrane potential|response to acidic pH|regulation of stem cell population maintenance|positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway,0.001698|0.004362|0.006295|0.007985|0.008226,1|1|1|1|1,686.5|242.3|164.8|128.7|124.8
1775,5,0.4073,4.073,3976.0,0.001021,0.996692,CCDC58 DLG1 GPR75 PNPLA8 WDR5B,cortical microtubule organization|regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization|phosphatidylethanolamine catabolic process|maintenance of postsynaptic density structure|negative regulation of p38MAPK cascade,0.0009706|0.0009706|0.0009706|0.001456|0.001698,1|1|1|1|1,1373|1373|1373|823.8|686.5
1776,6,0.4184,6.276,5045.0,0.00124,0.998474,GPR78 LRRC63 NSG2 PLAG1 VANGL1 ZAR1L,prostate gland growth|positive regulation of glial cell proliferation|clathrin coat assembly|dopamine receptor signaling pathway|regulation of glial cell proliferation,0.0032|0.004942|0.005522|0.009285|0.009285,1|1|1|1|1,343.2|214.5|190.7|110.7|110.7
1777,7,0.4267,8.96,6059.0,0.0014730000000000001,0.9992989999999999,CD248 COQ8B DNPH1 GPR4 GPR83 MDFI SLC9A3R2,glomerular mesangial cell development|mesangial cell development|glomerular mesangial cell differentiation|mesangial cell differentiation|glomerular mesangium development,0.002037|0.002376|0.002376|0.002715|0.003054,1|1|1|1|1,588.4|490.4|490.4|420.3|367.8
1778,6,0.4394,6.5920000000000005,4913.0,0.0013369999999999999,0.998474,DAB2 GPR85 MFSD4B NUAK2 TMEM168 TMEM229B,"leading edge cell differentiation|positive regulation of clathrin-dependent endocytosis|positive regulation of early endosome to late endosome transport|positive regulation of Wnt signaling pathway, planar cell polarity pathway|positive regulation of cytoplasmic transport",0.0005824|0.001746|0.002619|0.002909|0.004071,1|1|1|1|1,3432|686.5|429.1|381.4|264
1779,7,0.4023,8.449,5742.0,0.001466,0.9992989999999999,CEP57L1 GPRIN1 ODF1 REN TMEM81 TNR ZNF76,negative regulation of axon extension involved in regeneration|negative regulation of sprouting of injured axon|regulation of axon extension involved in regeneration|regulation of sprouting of injured axon|renin-angiotensin regulation of aldosterone production,0.001164|0.001164|0.001552|0.001552|0.00194,1|1|1|1|1,1287|1287|858.1|858.1|643.6
1780,4,0.4785,2.8710000000000004,2932.0,0.0009756,0.9929309999999999,GPRIN3 OR8K1 PNPLA6 RCN1,glycerophospholipid catabolic process|phospholipid catabolic process|glycerolipid catabolic process|phosphatidylcholine metabolic process|organophosphate catabolic process,0.005813|0.008517|0.01179|0.01621|0.02881,1|1|1|1|1,177.5|119.7|85.81|62.03|34.56
1781,6,0.4157,6.235,4812.0,0.001291,0.998474,CCDC144NL FAM186A GFOD1 GPSM1 LLGL1 PELI1,regulation of Toll signaling pathway|negative regulation of guanyl-nucleotide exchange factor activity|Toll signaling pathway|positive regulation of toll-like receptor 3 signaling pathway|regulation of toll-like receptor 3 signaling pathway,0.001456|0.002037|0.002037|0.002328|0.002619,1|1|1|1|1,858.1|572.1|572.1|490.4|429.1
1782,6,0.4033,6.05,4889.0,0.001233,0.998474,AMTN DERA GPX2 PRRC1 RBM45 TMPRSS11B,deoxyribonucleoside catabolic process|positive regulation of enamel mineralization|regulation of enamel mineralization|positive regulation of tooth mineralization|deoxyribonucleoside metabolic process,0.001165|0.001165|0.001746|0.002037|0.002619,1|1|1|1|1,1144|1144|686.5|572.1|429.1
1783,6,0.4323,6.484,4782.0,0.001351,0.998474,ARHGEF17 GRAMD1B MPPED1 RFPL4AL1 TARSL2 UHRF1BP1L,threonyl-tRNA aminoacylation|cellular response to cholesterol|cellular response to sterol|response to cholesterol|response to sterol,0.001165|0.005232|0.006681|0.008128|0.009574,1|1|1|1|1,1144|201.9|156|127.1|107.3
1784,7,0.4194,8.807,5882.0,0.001492,0.9992989999999999,B3GAT1 CEMP1 CHSY1 GRAMD1C TNFRSF14 TSGA10 UGT8,chondroitin sulfate proteoglycan biosynthetic process|chondroitin sulfate proteoglycan metabolic process|proteoglycan biosynthetic process|proteoglycan metabolic process|carbohydrate derivative biosynthetic process,4.885e-05|9.729e-05|0.0001853|0.0003651|0.0008152,0.7705|0.7673|0.9744|1|1,196.1|136.8|98.07|69.23|14.61
1785,5,0.4175,4.175,4060.0,0.001025,0.996692,GRAMD2B HS3ST4 SCRT1 SLC22A5 TMUB2,(R)-carnitine transmembrane transport|sodium-dependent organic cation transport|(R)-carnitine transport|positive regulation of intestinal epithelial structure maintenance|regulation of intestinal epithelial structure maintenance,0.0004854|0.0004854|0.0004854|0.0004854|0.000728,1|1|1|1|1,4119|4119|4119|4119|2060
1786,5,0.436,4.36,3891.0,0.001116,0.996692,GRB7 IGSF11 KIF21B OR5M9 PITHD1,penetration of cumulus oophorus|positive regulation of mini excitatory postsynaptic potential|regulation of mini excitatory postsynaptic potential|penetration of zona pellucida|positive regulation of megakaryocyte differentiation,0.0004854|0.000728|0.000728|0.002425|0.00291,1|1|1|1|1,4119|2060|2060|457.7|374.5
1787,8,0.4141,11.59,5666.0,0.002036,0.9996790000000001,DHPS DOHH EIF5A EIF5AL1 GREB1 PTGDS RTCB TTC4,peptidyl-lysine modification to peptidyl-hypusine|positive regulation of translational termination|positive regulation of translational elongation|regulation of translational termination|regulation of translational elongation,7.913e-07|1.977e-06|2.768e-06|1.027e-05|3.324e-05,0.01248|0.0156|0.01455|0.04049|0.1049,2574|1287|1030|468.1|245.2
1788,8,0.4284,11.99,6323.0,0.001889,0.9996790000000001,CCNA2 CENPE EXOSC9 GAR1 GRIA2 MRPL24 NAF1 SPATA5,snoRNA guided rRNA pseudouridine synthesis|rRNA pseudouridine synthesis|pseudouridine synthesis|rRNA processing|rRNA modification,1.319e-06|8.691e-06|2.498e-05|0.0001098|0.0001127,0.0208|0.06854|0.1313|0.4331|0.3556,1716|514.9|286|29.7|128.7
1789,5,0.4272,4.272,3783.0,0.001125,0.996692,C1orf56 CEP104 GRIA4 MFSD14A NPR3,osteoclast proliferation|pancreatic juice secretion|positive regulation of urine volume|secretion by tissue|negative regulation of adenylate cyclase activity,0.001213|0.00194|0.003636|0.004362|0.005087,1|1|1|1|1,1030|588.4|294.2|242.3|205.9
1790,5,0.4397,4.397,3982.0,0.0011,0.996692,EFCAB6 EN2 GRIK4 RAPGEF5 TMEM45B,"embryonic brain development|synaptic transmission, glutamatergic|ionotropic glutamate receptor signaling pathway|glutamate receptor signaling pathway|midbrain development",0.003152|0.006778|0.006778|0.0116|0.02094,1|1|1|1|1,343.3|152.6|152.6|87.64|47.9
1791,7,0.4298,9.026,5249.0,0.0017120000000000002,0.9992989999999999,GRIN2A KRT81 LILRB2 PRB1 PRB2 PRB4 RRP15,regulation of lipid kinase activity|negative regulation of postsynaptic density organization|negative regulation of G1/S transition of mitotic cell cycle|negative regulation of cell cycle G1/S phase transition|interleukin-10-mediated signaling pathway,0.0004267|0.0008734|0.0009744|0.001028|0.00131,1|1|1|1|1,65.38|2288|42.77|41.61|1144
1792,28,0.4005,151.4,22070.0,0.006795000000000001,1.0,A2M C3AR1 CLEC12A CLEC12B CLEC2B CLEC4C CLEC4D CLEC6A GALNT8 GYS2 IAPP KCNA1 KCNA6 KCNJ8 KLRC1 MANSC4 PKP2 PRB4 PRH2 PZP SLCO1B1 SLCO1B3 SLCO1C1 TAS2R13 TAS2R20 TAS2R7 TAS2R9 TSPAN11,detection of chemical stimulus involved in sensory perception of bitter taste|sensory perception of bitter taste|detection of chemical stimulus involved in sensory perception of taste|sodium-independent organic anion transport|sensory perception of taste,2.402e-07|3.897e-07|4.264e-07|2.14e-06|2.624e-06,0.003788|0.003074|0.002242|0.008441|0.008278,81.73|71.76|70.05|137.9|43.27
1793,5,0.4159,4.159,3834.0,0.0010810000000000001,0.996692,AP4S1 CASP7 GBF1 GRIN2C ZC2HC1C,post-Golgi vesicle-mediated transport|protein localization to endoplasmic reticulum tubular network|endoplasmic reticulum-Golgi intermediate compartment organization|directional locomotion|cellular response to staurosporine,0.0004271|0.0004854|0.000728|0.0009706|0.001456,1|1|1|1|1,61.48|4119|2060|1373|823.8
1794,7,0.4197,8.812999999999999,6151.0,0.0014269999999999999,0.9992989999999999,BDKRB1 CPNE9 DLG2 GRTP1 HRH1 TSKU U2AF1L4,retrograde axonal protein transport|positive regulation of hair cycle|negative regulation of myofibroblast differentiation|ciliary body morphogenesis|corpus callosum morphogenesis,0.001164|0.001164|0.00194|0.00194|0.002328,1|1|1|1|1,1287|1287|643.6|643.6|514.9
1795,6,0.4123,6.184,4709.0,0.001308,0.998474,GSC2 KCNMB1 KCTD17 MPP5 RLBP1 SDF2L1,protein localization to myelin sheath abaxonal region|cellular response to bile acid|response to bile acid|peripheral nervous system myelin maintenance|vitamin A metabolic process,0.0005824|0.001746|0.001746|0.002619|0.002909,1|1|1|1|1,3432|686.5|686.5|429.1|381.4
1796,5,0.4331,4.331,3552.0,0.001214,0.996692,CCDC6 CDCA4 FAM122A GSG1 PLEKHA4,"positive regulation of Wnt signaling pathway, planar cell polarity pathway|chromatin-mediated maintenance of transcription|regulation of Wnt signaling pathway, planar cell polarity pathway|positive regulation of non-canonical Wnt signaling pathway|regulation of non-canonical Wnt signaling pathway",0.002425|0.003152|0.003878|0.003878|0.006295,1|1|1|1|1,457.7|343.3|274.6|274.6|164.8
1797,21,0.4005,84.11,16340.0,0.005107,1.0,AKAP2 C9orf16 CERCAM FAM129B FAM206A FBP1 FBP2 GBGT1 GSN KIF12 OR1J1 OR1J2 OR1J4 OR1L1 OR1L8 OR1N2 PALM2 TOR1B TXNDC8 ZBTB6 ZNF782,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|sucrose biosynthetic process|detection of chemical stimulus,3.01e-06|4.219e-06|5.227e-06|5.359e-06|7.833e-06,0.04747|0.03328|0.02748|0.02113|0.02471,14.01|13.2|12.71|1030|11.84
1798,5,0.4127,4.127,4106.0,0.0010019999999999999,0.996692,ADRB3 ARHGAP9 GSX1 HAS2 IRAK3,positive regulation of macrophage tolerance induction|regulation of macrophage tolerance induction|cellular response to interleukin-1|response to interleukin-1|extracellular polysaccharide biosynthetic process,0.0004854|0.0004854|0.0007217|0.0009476|0.0009706,1|1|1|1|1,4119|4119|47.07|40.99|1373
1799,8,0.4047,11.33,5586.0,0.002019,0.9996790000000001,DERL1 FAF2 GSX2 PDGFRA PRRX1 SCFD2 TWIST2 UBE2G2,"ubiquitin-dependent ERAD pathway|ERAD pathway|retrograde protein transport, ER to cytosol|endoplasmic reticulum to cytosol transport|protein exit from endoplasmic reticulum",2.884e-06|4.905e-06|2.249e-05|2.249e-05|4.268e-05,0.04548|0.03869|0.1182|0.08867|0.1346,103|85.81|302.9|302.9|214.5
1800,5,0.4366,4.3660000000000005,3784.0,0.001149,0.996692,GTDC1 MOGAT2 RIN1 SPSB4 TRIM8,monoacylglycerol biosynthetic process|diacylglycerol biosynthetic process|monoacylglycerol metabolic process|positive regulation of protein polyubiquitination|negative regulation of viral release from host cell,0.00194|0.002183|0.003636|0.003636|0.003878,1|1|1|1|1,588.4|514.9|294.2|294.2|274.6
1801,9,0.421,15.16,5905.0,0.002552,0.9998530000000001,AHR AHSA1 ARNT DNAJA1 DNAJA2 HSF1 HSPA4 STIP1 TIPARP,"positive regulation of ATPase activity|response to 2,3,7,8-tetrachlorodibenzodioxine|regulation of ATPase activity|response to heat|cellular response to organic cyclic compound",2.048e-06|2.542e-06|5.395e-06|8.851e-06|4.043e-05,0.0323|0.02005|0.02837|0.0349|0.1276,118.4|1144|84.75|71.51|18.31
1802,6,0.4268,6.402,4945.0,0.0012900000000000001,0.998474,CDH24 GPR68 GUCA1B RPS6KL1 SDCBP2 UBR7,positive regulation of osteoclast development|negative regulation of monocyte differentiation|positive regulation of guanylate cyclase activity|receptor guanylyl cyclase signaling pathway|regulation of osteoclast development,0.001746|0.002328|0.002909|0.0032|0.003781,1|1|1|1|1,686.5|490.4|381.4|343.2|286
1803,27,0.4015,140.9,20090.0,0.0069489999999999994,1.0,BTN2A1 BTN2A2 CDKAL1 GPX6 HIST1H1C HIST1H1T HIST1H2AC HIST1H2AD HIST1H2BD HLA-DMB OR14J1 OR2B3 OR2B6 OR2J2 OR2J3 OR2W1 OR5V1 PSORS1C2 SLC17A2 SLC17A4 TRIM10 TRIM26 ZKSCAN4 ZNF165 ZNF184 ZSCAN16 ZSCAN31,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,5.483e-07|8.119e-07|1.041e-06|1.666e-06|2.132e-06,0.008649|0.006404|0.005475|0.006569|0.006725,13.62|12.84|12.36|11.51|11.08
1804,38,0.3947,277.5,30840.0,0.008896,1.0,C5AR1 C5AR2 CABP5 ERVV-2 FFAR3 GPR32 KIR2DL1 KIR2DL3 KLK11 KLK3 KLK6 LAIR1 LAIR2 LILRA4 LILRB2 LILRB5 NLRP11 NLRP9 PSG2 SIGLEC11 SIGLEC12 SIGLEC5 SPIB SULT2B1 VN1R4 ZNF175 ZNF28 ZNF320 ZNF415 ZNF528 ZNF534 ZNF571 ZNF578 ZNF610 ZNF665 ZNF677 ZNF701 ZNF880,complement receptor mediated signaling pathway|complement component C5a signaling pathway|cellular metabolic process|defense response|regulation of gene expression,3.713e-06|2.193e-05|4.394e-05|5.931e-05|9.596e-05,0.05857|0.173|0.2311|0.2339|0.3027,118.8|514.9|0.204|4|2.219
1805,4,0.4374,2.6239999999999997,2889.0,0.0009051,0.9929309999999999,FCF1 GZMM NARS2 PEF1,asparaginyl-tRNA aminoacylation|positive regulation of protein monoubiquitination|regulation of protein monoubiquitination|T cell mediated cytotoxicity|neural crest formation,0.0007766|0.001165|0.001359|0.002328|0.002328,1|1|1|1|1,1716|1030|858.1|468.1|468.1
1806,6,0.4363,6.544,4918.0,0.001326,0.998474,COL23A1 HABP2 HSPA12A NR2E1 NUDT13 PAX2,optic nerve structural organization|positive regulation of optic nerve formation|regulation of optic nerve formation|regulation of metanephros size|optic chiasma development,0.0005824|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,3432|3432|3432|3432|3432
1807,5,0.4123,4.123,3780.0,0.0010869999999999999,0.996692,HABP4 KANK2 PAIP1 SLC39A13 ZNF470,regulation of translational initiation|positive regulation of translation|positive regulation of cellular amide metabolic process|negative regulation of vitamin D receptor signaling pathway|glomerular visceral epithelial cell migration,0.000163|0.0004397|0.0006583|0.000728|0.001698,1|1|1|1|1,100.5|60.57|49.33|2060|686.5
1808,6,0.4091,6.1370000000000005,4643.0,0.001317,0.998474,HACD1 NRM SPATA22 WDR31 WRAP53 ZNF474,DNA biosynthetic process|telomerase RNA localization|telomerase RNA localization to Cajal body|telomere formation via telomerase|protein localization to Cajal body,0.0004889|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,58.68|3432|3432|3432|3432
1809,12,0.4052,26.74,8253.0,0.00322,0.999986,C11orf53 CCNE2 CKS1B COMMD4 E2F3 IDE POU2F3 SKP2 SOX4 STAM2 UBE2Q1 WASHC3,G1 phase|mitotic G1 phase|mitotic interphase|interphase|mitotic cell cycle phase transition,3.033e-07|3.033e-07|1.302e-05|1.302e-05|1.716e-05,0.004784|0.002392|0.06845|0.05134|0.05415,245.2|245.2|65.17|65.17|24.09
1810,5,0.4343,4.343,3988.0,0.001085,0.996692,C16orf58 C9orf85 GFRA4 HADHB ZNF282,cardiolipin acyl-chain remodeling|glial cell-derived neurotrophic factor receptor signaling pathway|cardiolipin metabolic process|phosphatidylglycerol metabolic process|negative regulation of ossification,0.002183|0.002425|0.00412|0.008708|0.009431,1|1|1|1|1,514.9|457.7|257.4|117.7|108.4
1811,21,0.4044,84.93,14550.0,0.005786,1.0,ABCG1 BUB3 CHCHD1 CNIH4 DUX4 EIF2S1 FOXD4 HAMP HSPE1 NBEAL1 NUTF2 OR2A25 RPL12 RPL17 RPL37 RPL4 RPLP2 RPS13 SNU13 ST20 TSPYL5,translational initiation|SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum,1.459e-10|8.842e-10|1.183e-09|2.033e-09|2.492e-09,2.301e-06|6.974e-06|6.219e-06|8.018e-06|7.861e-06,45.82|58.51|55.61|50.6|48.84
1812,30,0.4052,176.3,21610.0,0.008071,1.0,CNN1 P2RY11 ZNF20 ZNF43 ZNF433 ZNF439 ZNF441 ZNF442 ZNF443 ZNF486 ZNF490 ZNF492 ZNF563 ZNF564 ZNF625 ZNF627 ZNF682 ZNF69 ZNF700 ZNF709 ZNF714 ZNF737 ZNF763 ZNF791 ZNF799 ZNF844 ZNF878 ZNF91 ZNF98 ZNF99,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",4.128e-25|2.305e-21|2.325e-21|2.426e-21|2.172e-20,6.511e-21|1.818e-17|1.223e-17|9.567e-18|6.853e-17,7.466|5.574|5.572|5.564|5.165
1813,5,0.4187,4.187,3874.0,0.001077,0.996692,CPED1 HBD MUTYH PRSS53 ZNF471,"depurination|oxygen transport|base-excision repair, AP site formation|gas transport|hydrogen peroxide catabolic process",0.003152|0.003636|0.004845|0.004845|0.007261,1|1|1|1|1,343.3|294.2|216.8|216.8|142
1814,11,0.3853,21.19,8272.0,0.002548,0.999969,ART5 HBE1 OR51B4 OR51I1 OR52B2 OR52B6 OR52M1 OR52N4 OR52W1 OR56A1 ZNF214,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,7.444e-12|1.188e-11|1.598e-11|2.803e-11|3.767e-11,1.174e-07|9.368e-08|8.403e-08|1.105e-07|1.188e-07,33.96|32|30.82|28.69|27.64
1815,6,0.4311,6.4670000000000005,4855.0,0.001327,0.998474,BMP1 FASLG HBG2 OR1J2 TMEM9 XIRP2,endosomal lumen acidification|intracellular pH reduction|pH reduction|endosome organization|regulation of intracellular pH,1.06e-06|8.606e-05|9.677e-05|0.0002156|0.0002799,0.01672|0.6788|0.5088|0.8504|0.8831,1716|143|134.6|89.16|78.01
1816,5,0.4309,4.309,4027.0,0.001066,0.996692,CSTF2T HCRT LURAP1L PHYHIP WSB1,positive regulation of transmission of nerve impulse|negative regulation of transmission of nerve impulse|pre-mRNA cleavage required for polyadenylation|mRNA cleavage involved in mRNA processing|sleep,0.001698|0.001698|0.003394|0.003636|0.003636,1|1|1|1|1,686.5|686.5|316.8|294.2|294.2
1817,7,0.4097,8.605,5412.0,0.001583,0.9992989999999999,APOL6 ECHS1 HCST JAK3 MCEMP1 REEP4 TNFSF15,negative regulation of FasL production|regulation of FasL production|negative regulation of dendritic cell cytokine production|negative regulation of T-helper 1 cell differentiation|interleukin-4-mediated signaling pathway,0.0006794|0.0006794|0.001019|0.001358|0.001698,1|1|1|1|1,2942|2942|1471|980.7|735.5
1818,27,0.4063,142.6,21780.0,0.006488,1.0,ABHD3 B4GALT6 C18orf32 CABLES1 CDH20 CDH7 CELF4 CHST9 CTIF DSC1 DSC3 DSG1 DSG2 DSG3 DSG4 HRH4 IMPACT KIAA1328 LAMA3 MAPRE2 RMC1 SERPINB5 SERPINB7 TPGS2 ZBTB7C ZNF396 ZNF397,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|cell-cell adhesion|cornification|keratinization,2.919e-14|1.942e-12|5.991e-11|2.655e-10|2.711e-08,4.604e-10|1.531e-08|3.15e-07|1.047e-06|8.554e-05,42.53|27.42|15.2|43.99|22
1819,6,0.4122,6.184,4730.0,0.001302,0.998474,CD63 GCSAM HELB IFNG MAP4K1 RESP18,"regulation of carbohydrate phosphatase activity|positive regulation of fructose 1,6-bisphosphate metabolic process|regulation of fructose 1,6-bisphosphate metabolic process|positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity|regulation of fructose 1,6-bisphosphate 1-phosphatase activity",0.0005824|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,3432|3432|3432|3432|3432
1820,7,0.406,8.526,5725.0,0.001483,0.9992989999999999,C2 CFAP206 DCUN1D2 HERC6 RASSF2 SPO11 TREML2,epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade|epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity|spermatid development|spermatid differentiation|meiotic DNA double-strand break processing,0.0006794|0.0006794|0.001182|0.001273|0.001698,1|1|1|1|1,2942|2942|37.96|36.55|735.5
1821,6,0.4202,6.3020000000000005,4856.0,0.0012929999999999999,0.998474,AGTRAP C17orf97 FBXO44 FBXO6 HES2 PINK1,glycoprotein catabolic process|ubiquitin-dependent ERAD pathway|ubiquitin-dependent protein catabolic process|modification-dependent protein catabolic process|modification-dependent macromolecule catabolic process,1.777e-05|0.0001369|0.0001685|0.0001751|0.0001858,0.2803|1|0.8858|0.6904|0.5862,316.8|109.8|23.18|22.88|22.43
1822,5,0.4415,4.415,3953.0,0.001113,0.996692,CHRNE FN3K HEXDC SUOX WNT1,midbrain-hindbrain boundary maturation|midbrain-hindbrain boundary maturation during brain development|cerebellum formation|hindbrain formation|fructoselysine metabolic process,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
1823,7,0.4041,8.486,5009.0,0.001686,0.9992989999999999,EHF ELF5 HFM1 RBP7 USP17L10 USP17L13 USP17L5,protein deubiquitination|protein modification by small protein removal|protein phosphopantetheinylation|ubiquitin-dependent protein catabolic process|modification-dependent protein catabolic process,8.438e-05|0.0001004|0.0001472|0.0005669|0.0005888,1|0.7922|0.7738|1|1,31.75|29.92|26.27|16.56|16.35
1824,7,0.405,8.506,5874.0,0.001443,0.9992989999999999,C10orf62 CYB561 HGFAC RANBP6 RLN1 TCERG1L TNFRSF13C,B cell costimulation|positive regulation of B cell proliferation|zymogen activation|T cell costimulation|lymphocyte costimulation,0.001698|0.01419|0.0162|0.01821|0.01888,1|1|1|1|1,735.5|71.76|62.6|55.51|53.49
1825,5,0.4309,4.309,3955.0,0.001086,0.996692,ENDOU HGH1 JPT2 RHEBL1 SLC30A3,zinc ion import into synaptic vesicle|zinc ion import into organelle|regulation of sequestering of zinc ion|zinc ion transmembrane transport|zinc ion transport,0.000728|0.000728|0.001456|0.006054|0.00702,1|1|1|1|1,2060|2060|823.8|171.6|147.1
1826,11,0.4045,22.25,8520.0,0.002598,0.999969,C4BPB CDK18 CFHR1 CHIT1 NFASC RGS13 RGS18 RGS2 RGS21 TMEM206 TROVE2,regulation of G protein-coupled receptor signaling pathway|negative regulation of G protein-coupled receptor signaling pathway|negative regulation of response to stimulus|immune effector process|regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,3.016e-05|0.0002055|0.0004835|0.0008171|0.0008734,0.4757|1|1|1|1,47.02|95.35|6.342|8.359|2288
1827,6,0.4027,6.04,4669.0,0.001289,0.998474,ARRDC4 EFNA2 HHLA2 MROH2B PLEK SLC46A3,regulation of cell diameter|phospholipase C-inhibiting G protein-coupled receptor signaling pathway|positive regulation of inositol-polyphosphate 5-phosphatase activity|regulation of inositol-polyphosphate 5-phosphatase activity|negative regulation of inositol phosphate biosynthetic process,0.0005824|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,3432|3432|3432|3432|3432
1828,7,0.4158,8.732000000000001,5865.0,0.001483,0.9992989999999999,ASCL2 HAL HHLA3 LSR LZIC NUCKS1 PIP5K1C,modulation by host of viral RNA-binding transcription factor activity|modulation by host of RNA binding by virus|tricellular tight junction assembly|spongiotrophoblast layer development|cell-cell junction assembly,0.0006794|0.0006794|0.0006794|0.0006794|0.0008004,1|1|1|1|1,2942|2942|2942|2942|46.33
1829,5,0.4449,4.449,4133.0,0.001073,0.996692,ART3 ATF1 HIP1R PIP4K2B TPH2,"positive regulation of clathrin coat assembly|regulation of clathrin coat assembly|1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process|1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate metabolic process|positive regulation of platelet-derived growth factor receptor-beta signaling pathway",0.000728|0.000728|0.0009706|0.0009706|0.0009706,1|1|1|1|1,2060|2060|1373|1373|1373
1830,6,0.4313,6.468999999999999,4945.0,0.001303,0.998474,CSNK1G2 CYP1A1 HIPK4 HSP90AB1 TSPAN16 ZNF76,xenobiotic metabolic process|dibenzo-p-dioxin catabolic process|ethylene metabolic process|cellular response to xenobiotic stimulus|response to xenobiotic stimulus,0.0005478|0.0005824|0.0005824|0.000592|0.0006566,1|1|1|1|1,55.36|3432|3432|53.22|50.48
1831,22,0.4028,93.04,16740.0,0.005514,1.0,AIF1 BTN2A1 BTN2A2 C6orf48 GSTA3 HLA-A HLA-DMB HLA-F LY6G6F MICB MSH5 NCR3 NUDT3 OR14J1 OR2J2 OR2J3 PPT2 PSORS1C2 STK19 TAPBP TRIM10 TRIM26,immune response|antigen processing and presentation of endogenous peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen|antigen processing and presentation of endogenous antigen|positive regulation of immune system process,8.98e-07|1.027e-06|1.385e-06|3.272e-06|5.348e-06,0.01417|0.008099|0.007284|0.0129|0.01687,5.471|173.1|154.8|113.2|7.451
1832,8,0.4194,11.74,6178.0,0.0018920000000000002,0.9996790000000001,ATP13A2 HIST1H4H HLA-DMB LY6G5B OR7G2 PSORS1C2 TCF19 TRIM10,peptidyl-aspartic acid autophosphorylation|polyamine transmembrane transport|peptidyl-aspartic acid phosphorylation|regulation of autophagosome size|spermine transmembrane transport,0.0007765|0.0007765|0.0007765|0.0007765|0.0007765,1|1|1|1|1,2574|2574|2574|2574|2574
1833,6,0.4435,6.652,5067.0,0.001308,0.998474,BRINP3 GPR25 HIVEP3 PTX3 SUSD4 ZNF648,positive regulation of cell proliferation in midbrain|negative regulation of exo-alpha-sialidase activity|negative regulation by host of viral glycoprotein metabolic process|modulation by host of viral glycoprotein metabolic process|negative regulation by host of viral exo-alpha-sialidase activity,0.0006794|0.001019|0.001019|0.001019|0.001019,1|1|1|1|1,2942|1471|1471|1471|1471
1834,19,0.4024,68.8,14470.0,0.00472,1.0,AIF1 C2 C6orf48 GSTA3 HLA-DMB HLA-DQB2 HLA-E HLA-F LY6G6F MICB MSH5 NCR3 NUDT3 OR14J1 OR2J3 PSORS1C2 STK19 TRIM10 TRIM26,cellular response to interferon-gamma|response to interferon-gamma|interferon-gamma-mediated signaling pathway|positive regulation of immune system process|immune response,2.292e-07|4.415e-07|5.02e-07|1.322e-06|1.401e-06,0.003616|0.003482|0.00264|0.005215|0.004419,36.21|31.61|63.56|8.693|5.802
1835,12,0.41,27.06,8072.0,0.003331,0.999986,AQP7 DCTN3 EXOSC3 HAUS6 NOL6 RCL1 RPS6 SMU1 SNAPC3 TLN1 UBAP1 VCP,rRNA processing|rRNA metabolic process|cellular component biogenesis|ribosome biogenesis|cellular localization,1.202e-05|1.392e-05|2.669e-05|3.099e-05|5.866e-05,0.1896|0.1098|0.1403|0.1222|0.1851,26.4|25.43|5.083|20.68|4.572
1836,6,0.4162,6.242999999999999,4942.0,0.001259,0.998474,ABI2 ANKAR CARD9 HMX1 MRO TMEM86B,zonula adherens assembly|lens fiber cell morphogenesis|positive regulation of Arp2/3 complex-mediated actin nucleation|response to peptidoglycan|lens fiber cell development,0.0008735|0.001746|0.0032|0.004071|0.004071,1|1|1|1|1,1716|686.5|343.2|264|264
1837,13,0.4038,31.49,9368.0,0.003341,0.999993,ATP13A1 AUP1 CEBPG HMX3 JOSD1 NF1 PCNX1 SPRED2 STUB1 TM2D1 TM2D2 TM2D3 ZDHHC6,cellular response to misfolded protein|response to misfolded protein|protein quality control for misfolded or incompletely synthesized proteins|regulation of cellular response to growth factor stimulus|negative regulation of MAP kinase activity,0.0001173|0.000138|0.0001844|0.0009401|0.001218,1|1|0.9695|1|1,133.7|122.6|105.1|15.11|39.23
1838,6,0.407,6.105,4878.0,0.001247,0.998474,CABP1 CLIP1 HNRNPA1L2 LY6G6D PHOSPHO2 PHYKPL,lysine catabolic process|negative regulation of protein import|negative regulation of protein import into nucleus|lysine metabolic process|negative regulation of nucleocytoplasmic transport,0.004409|0.004409|0.004409|0.004748|0.007114,1|1|1|1|1,245.2|245.2|245.2|226.3|147.1
1839,5,0.4164,4.164,3285.0,0.0012619999999999999,0.996692,HNRNPM MATR3 RPRD2 SCAF1 SCAF8,mRNA processing|mRNA metabolic process|RNA processing|transcription by RNA polymerase II|RNA metabolic process,1.527e-06|6.36e-06|1.965e-05|7.542e-05|0.0001714,0.02408|0.05016|0.1033|0.2974|0.5406,34.04|23.74|17.85|30.44|10.3
1840,10,0.4238,19.07,6304.0,0.003006,0.999933,KRAS MAP2K5 MAP3K2 MAPK1 MAPK7 NRAS RAF1 RCE1 SHOC2 SYNCRIP,MAPK cascade|intracellular signal transduction|cellular response to growth factor stimulus|regulation of protein metabolic process|activation of MAPKK activity,5.249e-15|8.55e-10|2.032e-06|2.281e-06|2.638e-06,8.28e-11|6.743e-06|0.01068|0.008994|0.008322,45.32|11.77|20.47|6.349|110.3
1841,7,0.4002,8.404,5657.0,0.00148,0.9992989999999999,DGKD HOMER2 KLHL30 SERPINE2 SIGLEC12 SLC8A2 USP40,regulation of calcineurin-mediated signaling|long-term synaptic potentiation|regulation of calcium-mediated signaling|negative regulation of intracellular signal transduction|regulation of action potential firing pattern,6.553e-05|0.0001108|0.0002364|0.000449|0.0006794,1|0.8739|1|1|1,168.1|127.9|86.53|17.94|2942
1842,4,0.4694,2.8160000000000003,3098.0,0.0009059,0.9929309999999999,HORMAD1 NYAP2 RHOT1 TRAK1,"mitochondrion transport along microtubule|establishment of mitochondrion localization, microtubule-mediated|establishment of mitochondrion localization|mitochondrion localization|organelle transport along microtubule",8.472e-06|8.472e-06|1.146e-05|3.595e-05|9.117e-05,0.1336|0.06682|0.06027|0.1418|0.2876,447.7|447.7|381.4|210.2|130.3
1843,6,0.4078,6.117000000000001,4836.0,0.00126,0.998474,CFAP161 HOXA2 PLAC8L1 PPIB SNX22 TGM7,rhombomere 3 morphogenesis|rhombomere morphogenesis|rhombomere 2 development|rhombomere 3 development|brain segmentation,0.0008735|0.0008735|0.0008735|0.001165|0.001165,1|1|1|1|1,1716|1716|1716|1144|1144
1844,5,0.4385,4.385,3714.0,0.001176,0.996692,CTDSP2 HOXA3 LGR5 OR2T5 PMPCA,specification of animal organ position|glossopharyngeal nerve morphogenesis|epithelial cell proliferation involved in renal tubule morphogenesis|glossopharyngeal nerve development|protein processing involved in protein targeting to mitochondrion,0.0009706|0.001213|0.001213|0.001456|0.001456,1|1|1|1|1,1373|1030|1030|823.8|823.8
1845,5,0.4222,4.2219999999999995,3646.0,0.0011539999999999999,0.996692,DALRD3 HIST1H2AE HIST1H2AI HOXB2 PITRM1,"chromatin silencing|chromatin organization involved in negative regulation of transcription|negative regulation of gene expression, epigenetic|chromatin organization involved in regulation of transcription|gene silencing",7.22e-05|0.0001441|0.0001478|0.0001913|0.0005331,1|1|0.7772|0.7546|1,152.6|107|105.6|92.56|54.92
1846,5,0.4211,4.211,4015.0,0.001045,0.996692,DCK HOXB3 PAIP2 SLC29A1 TK1,deoxyribonucleoside monophosphate biosynthetic process|pyrimidine nucleoside salvage|pyrimidine-containing compound salvage|pyrimidine nucleoside biosynthetic process|nucleoside salvage,2.119e-06|3.672e-06|3.672e-06|7.2e-06|7.2e-06,0.03343|0.02896|0.01931|0.02839|0.02271,1030|748.9|748.9|514.9|514.9
1847,6,0.4486,6.73,4936.0,0.001358,0.998474,CREM HOXC9 LASP1 LRRC23 PAAF1 PLCB3,"retinoic acid receptor signaling pathway|proximal/distal pattern formation|Wnt signaling pathway, calcium modulating pathway|inositol phosphate metabolic process|phosphatidylinositol-mediated signaling",0.005812|0.01044|0.01102|0.01735|0.02365,1|1|1|1|1,180.7|98.07|92.77|58.18|42.38
1848,10,0.4043,18.19,6312.0,0.002865,0.999933,IER3IP1 MON2 OSBPL11 OSBPL9 PTDSS1 SCYL1 UNC50 VKORC1L1 VPS54 YIPF5,Golgi vesicle transport|macromolecule localization|transport|establishment of localization|organic substance transport,2.678e-05|3.831e-05|0.000153|0.0001963|0.0001985,0.4225|0.3021|0.8045|0.774|0.6263,20.8|5.654|3.661|3.541|5.694
1849,9,0.4014,14.45,7533.0,0.0019100000000000002,0.9998530000000001,AZIN2 EVA1B HPCA PPFIA2 TMEM39B TSSK3 UBFD1 ZNF827 ZSCAN20,response to ketamine|trans-Golgi network membrane organization|response to Aroclor 1254|cellular response to monosodium glutamate|positive regulation of polyamine transmembrane transport,0.0008734|0.0008734|0.0008734|0.0008734|0.00131,1|1|1|1|1,2288|2288|2288|2288|1144
1850,7,0.4288,9.006,5525.0,0.001623,0.9992989999999999,ETFA ETFB ETFDH GBP7 HPGD KCNK7 RAB1B,fatty acid beta-oxidation using acyl-CoA dehydrogenase|fatty acid beta-oxidation|fatty acid metabolic process|fatty acid oxidation|lipid oxidation,6.859e-09|9.006e-07|2.205e-06|2.515e-06|2.881e-06,0.0001082|0.007103|0.01159|0.009917|0.009088,882.6|149.6|35.99|105.1|100.3
1851,5,0.4363,4.363,3969.0,0.0010949999999999998,0.996692,CAPN10 CEP290 FAM43A HPR LRRC28,type B pancreatic cell apoptotic process|positive regulation of type B pancreatic cell apoptotic process|positive regulation of intracellular transport|pronephros development|otic vesicle formation,0.000728|0.0009706|0.001204|0.002183|0.002183,1|1|1|1|1,2060|1373|36.29|514.9|514.9
1852,5,0.4187,4.187,3685.0,0.001132,0.996692,FAM220A HPS4 HSPA4 RBM27 WDR45B,vacuole organization|positive regulation of eye pigmentation|regulation of eye pigmentation|outer mitochondrial membrane organization|protein insertion into mitochondrial outer membrane,0.0004525|0.0004854|0.0009706|0.001213|0.001213,1|1|1|1|1,59.7|4119|1373|1030|1030
1853,6,0.4393,6.59,4891.0,0.001342,0.998474,ACTA1 C1orf198 FAM78A FBXO28 GRID2IP HPSE2,skeletal muscle fiber adaptation|mesenchyme migration|skeletal muscle thin filament assembly|skeletal myofibril assembly|skeletal muscle adaptation,0.001456|0.001746|0.002037|0.002619|0.004071,1|1|1|1|1,858.1|686.5|572.1|429.1|264
1854,6,0.4401,6.602,4943.0,0.0013310000000000002,0.998474,CLPTM1L CTRL HRH2 MINDY3 SFI1 ZNF70,gastric acid secretion|acid secretion|positive regulation of vasoconstriction|protein K48-linked deubiquitination|G protein-coupled serotonin receptor signaling pathway,0.002619|0.006391|0.009285|0.009863|0.01015,1|1|1|1|1,429.1|163.5|110.7|104|101
1855,5,0.4448,4.448,3480.0,0.001273,0.996692,EIF4A1 EIF4B EIF4E EIF4G1 HRK,translational initiation|cytoplasmic translational initiation|cytoplasmic translation|translation|peptide biosynthetic process,1.238e-08|3.737e-08|5.194e-07|6.105e-07|7.837e-07,0.0001952|0.0002947|0.002731|0.002408|0.002472,115.2|411.9|164.8|42.91|40.28
1856,9,0.4044,14.56,7325.0,0.001979,0.9998530000000001,CCDC121 FNDC4 HS1BP3 IFT172 LBH MYCN NDUFAF2 PEBP1 TLX2,positive regulation of mammary stem cell proliferation|regulation of mammary stem cell proliferation|positive regulation of somatic stem cell division|regulation of somatic stem cell division|positive regulation of somatic stem cell population maintenance,0.0008734|0.0008734|0.0008734|0.0008734|0.00131,1|1|1|1|1,2288|2288|2288|2288|1144
1857,5,0.4254,4.254,3848.0,0.001101,0.996692,ABHD14A FAM19A1 GJA5 HSD11B1L SIRPB2,regulation of Purkinje myocyte action potential|vasomotion|Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling|bundle of His cell to Purkinje myocyte communication by electrical coupling|atrial cardiac muscle cell to AV node cell communication by electrical coupling,0.0004854|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,4119|4119|4119|4119|4119
1858,14,0.4028,36.66,8961.0,0.004061,0.9999969999999999,ACACA ACLY CERS2 CERS6 COL4A3BP ELOVL1 FASN HSD17B12 KDSR PI4KB SPTLC2 SPTSSA TECR TMEM189,lipid biosynthetic process|cellular lipid metabolic process|lipid metabolic process|amide biosynthetic process|fatty-acyl-CoA biosynthetic process,1.208e-20|6.555e-18|1.212e-16|3.61e-14|3.719e-14,1.905e-16|5.17e-14|6.37e-13|1.424e-10|1.173e-10,34.44|21.12|16.85|30|306.6
1859,7,0.4163,8.741,5853.0,0.0014880000000000002,0.9992989999999999,CNGB1 HHATL HSD17B14 MXRA8 SYNDIG1L VSIG10L WDR88,negative regulation of N-terminal protein palmitoylation|regulation of N-terminal protein palmitoylation|negative regulation of protein lipidation|establishment of glial blood-brain barrier|negative regulation of lipoprotein metabolic process,0.0006794|0.0006794|0.001019|0.001019|0.002037,1|1|1|1|1,2942|2942|1471|1471|588.4
1860,6,0.4225,6.337999999999999,4810.0,0.0013130000000000001,0.998474,BCL2L10 CYP1B1 DGKQ HSPA1A HSPA1B LRRC37A,heat acclimation|positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway|cellular heat acclimation|positive regulation of microtubule nucleation|positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,1.484e-06|1.484e-06|1.484e-06|1.978e-06|1.978e-06,0.0234|0.0117|0.007801|0.0078|0.00624,1373|1373|1373|1144|1144
1861,4,0.4305,2.583,3036.0,0.0008479,0.9929309999999999,HSPA2 LMO4 RDH11 UBXN2B,synaptonemal complex disassembly|negative regulation of protein localization to centrosome|positive regulation of mitotic centrosome separation|positive regulation of ATPase-coupled calcium transmembrane transporter activity|positive regulation of cell cycle process,0.0005825|0.0005825|0.0007766|0.001165|0.001228,1|1|1|1|1,2574|2574|1716|1030|34.79
1862,5,0.4038,4.038,3756.0,0.0010710000000000001,0.996692,ACTR10 CLEC14A HSPB1 OR10A5 ZNF559,axonal transport|axo-dendritic transport|vascular endothelial growth factor receptor signaling pathway|vascular endothelial growth factor receptor-3 signaling pathway|transport along microtubule,8.295e-05|0.0001163|0.000123|0.0004854|0.0005758,1|0.9176|0.6468|1|1,142|119.4|116|4119|52.81
1863,4,0.4285,2.571,3056.0,0.0008384,0.9929309999999999,ARRDC5 CLCF1 HSPB11 PDGFRL,positive regulation of isotype switching to IgE isotypes|regulation of isotype switching to IgE isotypes|platelet-derived growth factor receptor-beta signaling pathway|positive regulation of astrocyte differentiation|regulation of astrocyte differentiation,0.0009706|0.001553|0.001747|0.002328|0.004653,1|1|1|1|1,1287|735.5|643.6|468.1|223.9
1864,17,0.4012,54.57,12870.0,0.00421,1.0,ADAMTS15 ADAMTS8 APOA1 CRYAB FXYD6 HSPB2 HTR3A HTR3B KCNJ1 NXPE1 NXPE2 NXPE4 OR10G9 OR4D5 OR8B8 RAB39A TMEM136,transmembrane transport|serotonin receptor signaling pathway|system process|ion transmembrane transport|cellular response to dopamine,0.0004173|0.0005152|0.0007467|0.00129|0.002095,1|1|1|1|1,5.626|62.13|4.157|5.763|29.91
1865,17,0.4012,54.57,14360.0,0.0037770000000000004,1.0,AP3B2 BNIP2 CELF6 FBXL22 GOLGA6B HSPB7 LINGO1 MYO5C PLEKHO2 PPIB SCAMP2 SCAMP5 SEMA7A SKOR1 SLC24A1 SNX22 THAP10,vesicle cytoskeletal trafficking|negative regulation of axonogenesis|macrophage apoptotic process|polyphosphate catabolic process|negative regulation of neuron projection development,0.001496|0.001496|0.003295|0.004939|0.005587,1|1|1|1|1,35.63|35.63|403.8|242.3|17.95
1866,24,0.4075,112.5,16370.0,0.006802,1.0,CNIH4 DUX4 HSPE1 NEDD1 OR2A25 PAFAH1B1 RPL11 RPL12 RPL13 RPL17 RPL18 RPL18A RPL23 RPL23A RPL27 RPL37 RPL4 RPL6 RPL9 RPLP0 RPLP2 RPS13 RPS15A RPS6,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,2.652e-36|6.104e-36|2.903e-35|5.224e-35|6.033e-35,4.183e-32|4.814e-32|1.526e-31|2.06e-31|1.903e-31,154.5|146.8|133.6|128.9|127.8
1867,25,0.4009,120.3,21290.0,0.005603,1.0,AARD C8orf76 CA1 CA13 CA2 CA3 CA8 CNGB3 COL14A1 CYP7A1 DECR1 KLHL38 LRRCC1 MCMDC2 MTSS1 NOV PKIA PMP2 PPDPFL RNF139 SGK3 SLC26A7 SLC30A8 XKR9 ZFHX4,one-carbon metabolic process|bicarbonate transport|organic anion transport|cellular response to fluid shear stress|response to fluid shear stress,2.726e-09|3.84e-09|4.695e-06|0.0003091|0.0009025,4.3e-05|3.029e-05|0.02469|1|1,97.79|90.81|13.46|84.75|47.67
1868,8,0.4008,11.22,6548.0,0.001707,0.9996790000000001,FADS3 FAM81B HTRA1 IL17B MAP4K2 PCK1 TNFAIP8 ZDHHC18,pyruvate metabolic process|cellular glucose homeostasis|monocarboxylic acid metabolic process|glucose metabolic process|positive regulation of transcription from RNA polymerase II promoter in response to acidic pH,0.0003235|0.0005545|0.0008007|0.0008755|0.001164,1|1|1|1|1,74.62|56.58|15.03|44.77|1287
1869,6,0.4403,6.604,5005.0,0.001315,0.998474,CAPSL HTRA3 MICAL1 MPZL3 SNRNP70 SPAG1,sulfur oxidation|negative regulation of chaperone-mediated autophagy|negative regulation of protein refolding|regulation of protein refolding|negative regulation of protein folding,0.0008735|0.001165|0.001456|0.001456|0.002037,1|1|1|1|1,1716|1144|858.1|858.1|572.1
1870,8,0.4336,12.14,5565.0,0.002171,0.9996790000000001,AMD1 AZIN1 METTL5 OAZ1 ODC1 RFX6 SLC4A7 SRM,polyamine biosynthetic process|polyamine metabolic process|cellular biogenic amine biosynthetic process|amine biosynthetic process|cellular biogenic amine metabolic process,2.102e-14|7.68e-14|1.958e-12|2.202e-12|1.646e-10,3.316e-10|6.057e-10|1.029e-08|8.683e-09|5.191e-07,919.4|677.5|330|321.8|130
1871,5,0.417,4.17,3886.0,0.0010689999999999999,0.996692,FAM149B1 ICA1L PTMA SLC16A9 UGT2B17,urate metabolic process|cellular glucuronidation|uronic acid metabolic process|glucuronate metabolic process|estrogen metabolic process,0.003636|0.004845|0.006054|0.006054|0.009431,1|1|1|1|1,294.2|216.8|171.6|171.6|108.4
1872,5,0.4259,4.2589999999999995,3833.0,0.0011070000000000001,0.996692,COL27A1 ICAM2 LDHC OR1A2 ZNF560,lactate biosynthetic process from pyruvate|lactate oxidation|lactate biosynthetic process|growth plate cartilage chondrocyte development|chondrocyte development involved in endochondral bone morphogenesis,0.0004854|0.0004854|0.0009706|0.001456|0.002183,1|1|1|1|1,4119|4119|1373|823.8|514.9
1873,7,0.4157,8.73,5390.0,0.0016129999999999999,0.9992989999999999,CFAP298 FRG2B HHIP ICAM5 SOD1 URB1 USP25,response to antipsychotic drug|response to carbon monoxide|negative regulation of cholesterol biosynthetic process|negative regulation of cholesterol metabolic process|negative regulation of sterol biosynthetic process,0.001019|0.001698|0.002037|0.002037|0.002037,1|1|1|1|1,1471|735.5|588.4|588.4|588.4
1874,17,0.4105,55.83,11590.0,0.004782,1.0,CCND2 HERPUD1 ID2 IKBKB IKZF3 IPO5 IRF4 MEF2C NFKB1 POU2AF1 PRDM1 RC3H1 RELA RELB SMAD7 TCF12 TCF3,positive regulation of macromolecule metabolic process|regulation of nitrogen compound metabolic process|positive regulation of metabolic process|regulation of primary metabolic process|regulation of cellular metabolic process,3.952e-11|8.933e-11|1.386e-10|1.683e-10|3.195e-10,6.234e-07|7.045e-07|7.29e-07|6.636e-07|1.008e-06,5.336|3.621|4.922|3.495|3.373
1875,6,0.4012,6.018,4893.0,0.001225,0.998474,ABHD14B GDPD3 IER3 MAIP1 SLC19A3 SSMEM1,thiamine transmembrane transport|protein insertion into mitochondrial inner membrane from matrix|protein insertion into membrane from inner side|thiamine transport|N-acylethanolamine metabolic process,0.001165|0.001456|0.001456|0.001456|0.001746,1|1|1|1|1,1144|858.1|858.1|858.1|686.5
1876,5,0.4117,4.117,3844.0,0.001067,0.996692,IER5L LEFTY2 RALGPS1 TCHH TMEM18,regulation of Ral protein signal transduction|intermediate filament organization|positive regulation of pathway-restricted SMAD protein phosphorylation|intermediate filament cytoskeleton organization|intermediate filament-based process,0.0009706|0.006054|0.01184|0.01256|0.0128,1|1|1|1|1,1373|171.6|85.81|80.76|79.21
1877,5,0.4388,4.388,4016.0,0.0010890000000000001,0.996692,FTCD IFI27L1 IGFALS KLHL32 PLXNA2,cerebellar granule cell precursor tangential migration|hindbrain tangential cell migration|formamide metabolic process|histidine catabolic process to glutamate and formate|histidine catabolic process to glutamate and formamide,0.000728|0.0009706|0.001213|0.001213|0.001213,1|1|1|1|1,2060|1373|1030|1030|1030
1878,5,0.415,4.15,3900.0,0.00106,0.996692,C1orf116 IFT81 PGF PPP1R1B ZNF12,negative regulation of female receptivity|positive regulation of mast cell chemotaxis|female mating behavior|regulation of mast cell chemotaxis|regulation of female receptivity,0.001213|0.001698|0.002183|0.002183|0.002183,1|1|1|1|1,1030|686.5|514.9|514.9|514.9
1879,7,0.4205,8.831,5992.0,0.001468,0.9992989999999999,ECH1 FADS6 FCGRT GALNT7 KRTAP10-12 SGCA STOML3,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor|immunoglobulin transcytosis in epithelial cells|response to denervation involved in regulation of muscle adaptation|response to muscle inactivity involved in regulation of muscle adaptation|response to muscle inactivity,0.0006794|0.001358|0.004071|0.004071|0.004409,1|1|1|1|1,2942|980.7|267.5|267.5|245.2
1880,7,0.4063,8.532,5715.0,0.0014869999999999998,0.9992989999999999,ADGRF3 IGF2 KANK1 MS4A2 OR5A1 PLB1 TRIM54,regulation of cellular response to insulin stimulus|regulation of insulin receptor signaling pathway|negative regulation of lamellipodium morphogenesis|negative regulation of cytoskeleton organization|negative regulation of supramolecular fiber organization,0.000223|0.0002364|0.001019|0.001137|0.001167,1|1|1|1|1,89.16|86.53|1471|38.71|38.21
1881,6,0.4339,6.507999999999999,4884.0,0.001327,0.998474,ADPRM ATG16L2 C6orf52 IGF2BP2 PTPRH SLC38A4,negative stranded viral RNA replication|viral RNA genome replication|viral genome replication|nitrogen compound transport|nucleobase-containing small molecule catabolic process,0.001165|0.004071|0.008128|0.01095|0.01448,1|1|1|1|1,1144|264|127.1|5.718|70.05
1882,7,0.4059,8.525,5801.0,0.001464,0.9992989999999999,IGFBP1 INHBA NINJ1 NUP210 PPIA THADA WDR38,tissue regeneration|hematopoietic progenitor cell differentiation|uncoating of virus|positive regulation of ovulation|negative regulation of protein K48-linked ubiquitination,0.0002101|0.0003821|0.0006794|0.001019|0.001019,1|1|1|1|1,91.94|67.64|2942|1471|1471
1883,6,0.427,6.405,4828.0,0.0013210000000000001,0.998474,IGFBP5 LRRC74A MOSPD3 MYOC RTN1 TCF4,osteoblast differentiation|ERBB2-ERBB3 signaling pathway|negative regulation of skeletal muscle hypertrophy|skeletal muscle hypertrophy|ERBB3 signaling pathway,0.0005306|0.0005824|0.0005824|0.0005824|0.0008735,1|1|1|1|1,56.27|3432|3432|3432|1716
1884,7,0.4136,8.686,5539.0,0.001562,0.9992989999999999,CCDC122 CHRNE IGSF23 OR2L5 OR51A7 RELL2 VWA8,"nervous system process|detection of chemical stimulus involved in sensory perception of smell|synaptic transmission, cholinergic|positive regulation of p38MAPK cascade|sensory perception of smell",0.008607|0.009019|0.009139|0.009476|0.01011,1|1|1|1|1,6.396|13.34|113.2|109|12.57
1885,28,0.4008,151.5,21870.0,0.006862999999999999,1.0,ADAL ARHGAP11B BNIP2 C15orf53 CHRFAM7A CHRNA7 DEXI DUOXA1 DUOXA2 EPB42 GABRA5 GOLGA8M MYO5A MYO5C NIPA2 PIGH PLA2G4D PLA2G4E PPIB RASGRP1 SERINC4 SNURF TGM5 TGM7 TMCO5A TMEM62 TYRO3 WDR76,"synaptic transmission, cholinergic|regulation of postsynaptic membrane potential|positive regulation of hydrogen peroxide biosynthetic process|regulation of thyroid hormone generation|positive regulation of hydrogen peroxide metabolic process",8.912e-06|1.315e-05|3.992e-05|5.318e-05|6.831e-05,0.1406|0.1037|0.2099|0.2097|0.2155,81.94|28.41|284.1|236.7|202.9
1886,5,0.4419,4.419,3986.0,0.001105,0.996692,CCDC184 IGSF6 KCNH3 MEP1B TPH2,serotonin biosynthetic process|primary amino compound biosynthetic process|indole-containing compound biosynthetic process|indolalkylamine biosynthetic process|serotonin metabolic process,0.0009706|0.001456|0.001456|0.001456|0.002667,1|1|1|1|1,1373|823.8|823.8|823.8|411.9
1887,7,0.4186,8.791,5662.0,0.001546,0.9992989999999999,FLG HHAT IKBIP ODF1 REN TMEM81 ZNF76,renin-angiotensin regulation of aldosterone production|regulation of aldosterone secretion|regulation of mineralocorticoid secretion|regulation of blood volume by renin-angiotensin|response to cGMP,0.00194|0.002715|0.002715|0.003103|0.003103,1|1|1|1|1,643.6|429.1|429.1|367.8|367.8
1888,6,0.4179,6.269,4785.0,0.0013050000000000002,0.998474,IL10RA MS4A7 RPS6KB2 SMCO4 SPP1 TCN1,negative regulation of collateral sprouting of intact axon in response to injury|regulation of collateral sprouting of intact axon in response to injury|positive regulation of estradiol secretion|sphinganine-1-phosphate metabolic process|regulation of estradiol secretion,0.0006794|0.0006794|0.001019|0.001019|0.001358,1|1|1|1|1,2942|2942|1471|1471|980.7
1889,7,0.402,8.441,5895.0,0.0014269999999999999,0.9992989999999999,ARHGEF25 GDF9 IL15RA NUCB1 SCUBE3 TEKT2 TNFRSF1B,regulation of progesterone secretion|oocyte growth|signal transduction|glial cell-neuron signaling|regulation of transport,0.001019|0.001019|0.00133|0.001358|0.001511,1|1|1|1|1,1471|1471|3.436|980.7|6.694
1890,6,0.428,6.42,5078.0,0.00126,0.998474,H1FOO IL17C KCNS2 LRIT3 PDE6C SLC16A4,visual perception|sensory perception of light stimulus|interleukin-17-mediated signaling pathway|cellular response to interleukin-17|response to interleukin-17,0.001092|0.001132|0.002425|0.002425|0.002425,1|1|1|1|1,38.14|37.45|457.7|457.7|457.7
1891,6,0.4291,6.436,4751.0,0.00135,0.998474,B4GALNT3 BAIAP2L1 DPEP2 EPS8 IL18 NSMAF,actin crosslink formation|actin filament bundle assembly|actin filament bundle organization|interleukin-13 production|regulation of actin filament polymerization,8.468e-06|0.0001242|0.000137|0.0008735|0.001052,0.1336|0.9795|0.7202|1|1,490.4|118.4|112.5|1716|39.68
1892,7,0.4078,8.564,5772.0,0.001478,0.9992989999999999,DIABLO IL19 KITLG NOS1 SDS TMEM233 ZNF664,alpha-amino acid catabolic process|extrinsic apoptotic signaling pathway|cellular amino acid catabolic process|negative regulation of mast cell apoptotic process|reactive oxygen species metabolic process,0.000508|0.0005545|0.0007061|0.0007765|0.0009055,1|1|1|1|1,59.18|56.58|49.99|2574|44.01
1893,6,0.4243,6.364,4905.0,0.001292,0.998474,ALPK2 CGNL1 IL1R2 KCTD3 MEOX2 SCX,striated muscle tissue development|muscle tissue development|muscle structure development|somite development|skeletal muscle tissue development,4.23e-05|4.975e-05|0.0002145|0.0002267|0.0005221,0.6672|0.3924|1|0.894|1,38.86|36.78|22.39|86.9|56.74
1894,6,0.4161,6.242000000000001,4910.0,0.001267,0.998474,ACAA1 DIO2 IL1RL2 MAP1A MPHOSPH9 ZNF280D,phenylacetate catabolic process|retrograde axonal protein transport|thyroid hormone catabolic process|negative regulation of protein localization to microtubule|regulation of protein localization to microtubule,0.0008735|0.0008735|0.0008735|0.001746|0.001746,1|1|1|1|1,1716|1716|1716|686.5|686.5
1895,6,0.4211,6.316,4842.0,0.0013,0.998474,CTNNBIP1 IL20RB KCNA2 KLF4 RCAN3 TSPAN2,negative regulation of smooth muscle cell proliferation|inflammatory response|regulation of DNA binding|negative regulation of type IV hypersensitivity|negative regulation of leukocyte adhesion to arterial endothelial cell,7.597e-05|0.0002675|0.0005392|0.0005824|0.0005824,1|1|1|1|1,152.6|20.76|55.81|3432|3432
1896,6,0.4131,6.196000000000001,4991.0,0.0012369999999999998,0.998474,FAXDC2 IL21 KCNJ15 SERTAD1 SPINT3 TMEM229A,germinal center B cell differentiation|T follicular helper cell differentiation|regulation of cellular protein metabolic process|interleukin-21-mediated signaling pathway|cellular response to interleukin-21,0.002037|0.002037|0.002419|0.002619|0.002619,1|1|1|1|1,572.1|572.1|5.634|429.1|429.1
1897,6,0.4183,6.275,4703.0,0.0013289999999999999,0.998474,C2orf73 CC2D2B FAM135B IL22RA2 NAA11 SH3D19,N-terminal peptidyl-serine acetylation|peptidyl-serine acetylation|N-terminal peptidyl-glutamic acid acetylation|N-terminal protein amino acid acetylation|positive regulation of membrane protein ectodomain proteolysis,0.0008735|0.0008735|0.001165|0.004942|0.005232,1|1|1|1|1,1716|1716|1144|214.5|201.9
1898,6,0.4288,6.432,4837.0,0.001325,0.998474,CACNG5 HIST1H4I IL23A LLPH MGST1 OTOP3,cellular response to lipid hydroperoxide|response to lipid hydroperoxide|positive regulation of T-helper 17 cell lineage commitment|positive regulation of NK T cell proliferation|negative regulation of megakaryocyte differentiation,0.0005824|0.001165|0.001456|0.001456|0.001746,1|1|1|1|1,3432|1144|858.1|858.1|686.5
1899,6,0.4033,6.0489999999999995,4786.0,0.001259,0.998474,ADGRE3 DDX25 IL23R LAMA2 PCMTD2 TTC39B,"positive regulation of T-helper 17 cell lineage commitment|positive regulation of synaptic transmission, cholinergic|regulation of synaptic transmission, cholinergic|regulation of T-helper 17 cell lineage commitment|positive regulation of T-helper 17 cell differentiation",0.001456|0.001456|0.002037|0.002328|0.002328,1|1|1|1|1,858.1|858.1|572.1|490.4|490.4
1900,6,0.4016,6.024,4479.0,0.00134,0.998474,ATG4D IL2RA KIF23 KLHL8 PRC1 RACGAP1,mitotic spindle midzone assembly|spindle elongation|mitotic spindle elongation|spindle midzone assembly|mitotic spindle assembly,2.263e-09|2.263e-09|2.263e-09|6.238e-09|2.677e-07,3.57e-05|1.785e-05|1.19e-05|2.46e-05|0.0008445,1287|1287|1287|858.1|219.1
1901,6,0.4066,6.099,4847.0,0.001254,0.998474,C2orf40 FAP IL36A LYG2 RSPO3 TEKT4,blood vessel morphogenesis|blood vessel development|vasculature development|melanocyte apoptotic process|tube morphogenesis,0.0002562|0.0004411|0.0005043|0.0006794|0.0009861,1|1|1|1|1,21.74|18.05|17.24|2942|13.68
1902,7,0.41,8.611,5735.0,0.001495,0.9992989999999999,CXCL11 FBLIM1 IL36RN NANP PSD3 UBOX5 UGT1A8,N-acetylneuraminate biosynthetic process|N-acetylglucosamine biosynthetic process|glucosamine-containing compound biosynthetic process|antimicrobial humoral response|cellular response to lipopolysaccharide,0.0006794|0.001019|0.001019|0.001197|0.0016,1|1|1|1|1,2942|1471|1471|37.72|32.51
1903,23,0.3932,99.47,18520.0,0.00533,1.0,ASTL C2orf49 CCDC74B CFC1 CFC1B CNNM4 FAHD2A FAM178B IL1F10 IL1RN IL36G IL37 LYG1 LYG2 MGAT4A MRPL30 POTEI SLC9A2 SULT1C2 SULT1C3 SULT1C4 TRIM43 TUBA3D,inflammatory response to antigenic stimulus|sulfation|purine ribonucleoside bisphosphate metabolic process|3'-phosphoadenosine 5'-phosphosulfate metabolic process|cell wall macromolecule catabolic process,9.429e-08|3.485e-06|3.901e-06|3.901e-06|7.132e-06,0.001487|0.02749|0.02051|0.01538|0.0225,102.3|111.9|107.5|107.5|895.4
1904,6,0.4003,6.005,4900.0,0.001221,0.998474,EIF4H IL9 MKX MORN2 PLCB2 TLR6,toll-like receptor 6 signaling pathway|detection of diacyl bacterial lipopeptide|eukaryotic translation initiation factor 4F complex assembly|detection of bacterial lipopeptide|cellular response to diacyl bacterial lipopeptide,0.0005824|0.0008735|0.0008735|0.001165|0.001456,1|1|1|1|1,3432|1716|1716|1144|858.1
1905,6,0.4243,6.364,4947.0,0.001282,0.998474,HHATL ILDR1 SYNDIG1L TEKT5 TNFSF9 WDR88,negative regulation of N-terminal protein palmitoylation|regulation of N-terminal protein palmitoylation|positive regulation of cytotoxic T cell differentiation|negative regulation of protein lipidation|regulation of cytotoxic T cell differentiation,0.0005824|0.0005824|0.0008735|0.0008735|0.001165,1|1|1|1|1,3432|3432|1716|1716|1144
1906,6,0.4009,6.013999999999999,4856.0,0.001234,0.998474,CELF2 ILDR2 NTRK3 RBFOX3 TCAIM TNNI2,"regulation of alternative mRNA splicing, via spliceosome|regulation of mRNA splicing, via spliceosome|modulation by virus of host transcription|modulation of transcription in other organism involved in symbiotic interaction|modulation by symbiont of host transcription",0.0001242|0.0003737|0.0005824|0.0005824|0.0005824,1|1|1|1|1,118.4|67.3|3432|3432|3432
1907,7,0.4244,8.913,5738.0,0.001547,0.9992989999999999,ARTN IMMP1L KIAA0319 LRSAM1 NAGA SRPK2 UBXN11,organonitrogen compound catabolic process|negative regulation of axon extension involved in regeneration|negative regulation of sprouting of injured axon|N-acetylglucosamine catabolic process|regulation of axon extension involved in regeneration,0.0004498|0.001164|0.001164|0.001552|0.001552,1|1|1|1|1,9.535|1287|1287|858.1|858.1
1908,6,0.408,6.12,4871.0,0.0012519999999999999,0.998474,C12orf73 IMPA2 RNASEH1 RNF220 SGSM2 WNT11,positive regulation of transforming growth factor beta2 production|mediolateral intercalation|negative regulation of fibroblast growth factor production|planar cell polarity pathway involved in gastrula mediolateral intercalation|cloacal septation,0.000728|0.000728|0.000728|0.000728|0.0009706,1|1|1|1|1,2060|2060|2060|2060|1373
1909,6,0.4078,6.117000000000001,4898.0,0.0012439999999999999,0.998474,CNR2 IMPDH1 PTPRR TNNT2 TRIM13 TRMT1L,regulation of muscle filament sliding speed|vestibular receptor cell morphogenesis|tRNA N2-guanine methylation|vestibular receptor cell development|vestibular receptor cell differentiation,0.0008735|0.0008735|0.0008735|0.001165|0.001165,1|1|1|1|1,1716|1716|1716|1144|1144
1910,10,0.4135,18.61,6695.0,0.002763,0.999933,CHTF18 MMS22L NUS1 ORC3 PNISR REV3L RPF2 TRAIP TTK ZWINT,DNA-dependent DNA replication|DNA replication|DNA metabolic process|cellular macromolecule biosynthetic process|macromolecule biosynthetic process,1.936e-08|9.921e-08|1.713e-05|4.299e-05|4.941e-05,0.0003054|0.0007825|0.09007|0.1695|0.1559,53.08|38|13.19|7.466|7.286
1911,6,0.4085,6.127999999999999,4854.0,0.001258,0.998474,ANXA5 INPP5B MPV17 PRAP1 SLC10A5 TINAG,regulation of mitochondrial DNA metabolic process|glomerular basement membrane development|inositol phosphate dephosphorylation|inositol phosphate catabolic process|mitochondrial genome maintenance,0.001165|0.00349|0.005232|0.005812|0.005812,1|1|1|1|1,1144|312|201.9|180.7|180.7
1912,15,0.4057,42.6,11930.0,0.0035479999999999995,0.999999,ATP12A C1QTNF9 C1QTNF9B DGKH GJB2 GJB6 HTR2A INPP5F PCDH8 RCBTB2 RNF6 SIAH3 SLC25A30 SOHLH2 SPATA13,gap junction-mediated intercellular transport|intercellular transport|gap junction assembly|cell communication by electrical coupling|sensory perception of mechanical stimulus,1.381e-05|1.775e-05|2.217e-05|0.0001133|0.0002583,0.2178|0.14|0.1166|0.4466|0.8148,457.7|392.3|343.2|137.3|23.81
1913,6,0.4133,6.2,4273.0,0.0014449999999999999,0.998474,DNAJA2 HSP90AA1 INSL3 ITM2B STIP1 TMEM221,protein refolding|response to heat|response to temperature stimulus|protein unfolding|outer mitochondrial membrane organization,1.481e-05|0.0003318|0.0009705|0.001165|0.001456,0.2336|1|1|1|1,361.3|71.51|41.36|1144|858.1
1914,5,0.4284,4.284,4091.0,0.001044,0.996692,BCAN BMP7 ERGIC1 GCH1 INSYN2,regulation of removal of superoxide radicals|regulation of response to reactive oxygen species|regulation of superoxide metabolic process|regulation of cellular response to oxidative stress|regulation of response to oxidative stress,1.319e-06|2.185e-05|2.331e-05|0.0001369|0.0001709,0.0208|0.1724|0.1226|0.5399|0.5391,1373|284.1|274.6|109.8|98.07
1915,6,0.4149,6.224,4746.0,0.001306,0.998474,ANAPC7 C17orf58 DND1 INSYN2B OXLD1 RXFP1,lung connective tissue development|nipple morphogenesis|nipple development|metaphase/anaphase transition of mitotic cell cycle|metaphase/anaphase transition of cell cycle,0.0005824|0.0005824|0.0005824|0.002328|0.002328,1|1|1|1|1,3432|3432|3432|490.4|490.4
1916,13,0.4173,32.55,9202.0,0.003515,0.999993,CDK11A CLSPN EIF3I GNL2 INTS11 NOL9 PABPC1 PSMB2 SF3A3 SNIP1 TRAPPC3 UTP11 YARS,ribonucleoprotein complex biogenesis|RNA processing|gene expression|nucleic acid metabolic process|RNA metabolic process,6.683e-06|1.079e-05|1.281e-05|1.497e-05|1.943e-05,0.1054|0.08508|0.06737|0.05902|0.0613,17.03|10.3|5.798|5.678|6.935
1917,12,0.4105,27.09,7896.0,0.003409,0.999986,BRAT1 C7orf26 INTS1 INTS10 INTS13 INTS14 INTS2 INTS5 INTS6 INTS7 INTS8 INTS9,snRNA transcription by RNA polymerase II|snRNA transcription|snRNA processing|ncRNA transcription|snRNA metabolic process,2.844e-23|3.245e-23|1.053e-22|4.499e-22|8.986e-22,4.487e-19|2.559e-19|5.535e-19|1.774e-18|2.835e-18,245.2|241.7|429.1|182.6|328.6
1918,12,0.413,27.26,8010.0,0.0033810000000000003,0.999986,EIF3A EIF3D EIF3E EIF3F EIF3G EIF3H EIF3I EIF3M EIF4G1 EIF4G2 IPO7 RPL27A,translational initiation|cytoplasmic translational initiation|formation of cytoplasmic translation initiation complex|translation|peptide biosynthetic process,2.744e-25|8.173e-23|1.171e-21|2.745e-20|5.775e-20,4.329e-21|6.446e-19|6.156e-18|1.083e-16|1.822e-16,132.9|475.3|792.1|49.51|46.48
1919,5,0.4631,4.631,3698.0,0.001247,0.996692,BAMBI CEP85L IQCB1 RWDD1 ZNF263,maintenance of animal organ identity|negative regulation of cell differentiation|photoreceptor cell maintenance|negative regulation of osteoblast differentiation|positive regulation of epithelial to mesenchymal transition,0.001456|0.009054|0.01112|0.01136|0.01184,1|1|1|1|1,823.8|12.91|91.53|89.54|85.81
1920,6,0.4108,6.162000000000001,4789.0,0.001282,0.998474,IQCC LRRC47 OBSL1 SCN2A TMEM237 ZDHHC18,intrinsic apoptotic signaling pathway in response to osmotic stress|cardiac myofibril assembly|peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine|peptidyl-L-cysteine S-palmitoylation|retina layer formation,0.0008735|0.004942|0.00726|0.00726|0.007839,1|1|1|1|1,1716|214.5|143|143|132
1921,13,0.4013,31.3,10240.0,0.003041,0.999993,FAM131A HRASLS HTR3D IQCG MB21D2 MUC20 MUC4 PDCD6 RTP2 SERPINI1 SLC51A TCTEX1D2 TM4SF19,O-glycan processing|regulation of intraciliary retrograde transport|protein O-linked glycosylation|stimulatory C-type lectin receptor signaling pathway|innate immune response activating cell surface receptor signaling pathway,0.000702|0.001891|0.00197|0.002393|0.002556,1|1|1|1|1,51.94|792.1|30.47|27.55|26.63
1922,5,0.4293,4.293,3766.0,0.0011359999999999999,0.996692,CLRN3 EIF3M IQCH PCDHA4 ZNF555,formation of cytoplasmic translation initiation complex|cytoplasmic translational initiation|cytoplasmic translation|translational initiation|homophilic cell adhesion via plasma membrane adhesion molecules,0.00412|0.007502|0.01831|0.03447|0.04012,1|1|1|1|1,257.4|137.3|54.92|28.8|24.66
1923,11,0.4049,22.27,7225.0,0.0030629999999999998,0.999969,ACO2 CIAO1 CIAO2B CIAPIN1 GLRX3 IREB2 NDOR1 NUBP2 SLC25A3 SOD1 SOD2,metallo-sulfur cluster assembly|iron-sulfur cluster assembly|sulfur compound metabolic process|protein maturation by iron-sulfur cluster transfer|citrate metabolic process,2.056e-15|2.056e-15|1.975e-10|9.194e-08|5.433e-06,3.243e-11|1.621e-11|1.038e-06|0.0003626|0.01714,488.4|488.4|35.52|374.5|748.9
1924,8,0.4159,11.65,5289.0,0.002191,0.9996790000000001,FOSL1 HIVEP1 IRF2BP1 IRF2BP2 IRF2BPL JUN STK40 VGLL4,"negative regulation of transcription, DNA-templated|negative regulation of nucleic acid-templated transcription|negative regulation of RNA biosynthetic process|negative regulation of RNA metabolic process|negative regulation of cellular macromolecule biosynthetic process",1.523e-06|1.537e-06|1.551e-06|2.422e-06|3.535e-06,0.02402|0.01212|0.008154|0.00955|0.01115,11.99|11.97|11.96|11.08|10.39
1925,8,0.4164,11.66,6798.0,0.0017079999999999999,0.9996790000000001,BLZF1 CNGB3 IRGM MMP16 NCALD OC90 RDH11 UBE2W,otolith mineralization|calcium-mediated signaling|CAMKK-AMPK signaling cascade|protein lipidation involved in autophagosome assembly|calmodulin dependent kinase signaling pathway,0.001164|0.001376|0.00194|0.00194|0.002328,1|1|1|1|1,1287|35.51|643.6|643.6|514.9
1926,18,0.4043,61.86,12000.0,0.005116,1.0,C1orf109 CIAO1 CIAO2B DHX33 FXN HSCB LONP1 LYRM4 NFS1 PAK1IP1 POP5 RPP21 SOD1 SPATA5L1 TIMM10 TIMM9 UTP4 WDR18,metallo-sulfur cluster assembly|iron-sulfur cluster assembly|sulfur compound metabolic process|protein maturation by iron-sulfur cluster transfer|cellular component biogenesis,8.188e-14|8.188e-14|1.701e-08|4.525e-07|2.616e-06,1.292e-09|6.458e-10|8.945e-05|0.001784|0.008253,298.5|298.5|21.71|228.8|4.66
1927,12,0.4074,26.89,8454.0,0.0031620000000000003,0.999986,CCT3 COPA INTS3 ISG20L2 PRCC PRPF3 PSMB3 PSMB4 PSMD4 SF3B4 SMG5 TARS2,negative regulation of G2/M transition of mitotic cell cycle|negative regulation of cell cycle G2/M phase transition|negative regulation of mitotic cell cycle|regulation of G2/M transition of mitotic cell cycle|regulation of cell cycle G2/M phase transition,2.611e-07|3.958e-07|4.532e-07|4.597e-06|6.173e-06,0.004118|0.003121|0.002383|0.01813|0.01948,70.77|63.56|29.19|33.82|31.35
1928,6,0.4339,6.507999999999999,4902.0,0.001323,0.998474,GGA3 ISM1 MLXIPL OR4F6 TMEM52 ZNF512,glucose mediated signaling pathway|sugar mediated signaling pathway|hexose mediated signaling|carbohydrate mediated signaling|negative regulation of oxidative phosphorylation,0.001165|0.001165|0.001165|0.001746|0.002037,1|1|1|1|1,1144|1144|1144|686.5|572.1
1929,27,0.4021,141.1,21090.0,0.006631000000000001,1.0,ADAL APBA2 ARHGAP11B BCL2L10 BNIP2 C15orf53 CHRFAM7A CHRNA7 CSNK1G1 DEXI DUOXA1 DUOXA2 EPB42 GABRA5 GOLGA8M MYO5A MYO5C NIPA1 NIPA2 PLA2G4D PLA2G4E PLEKHO2 RPUSD2 SNURF TGM5 TMCO5A TYRO3,"synaptic transmission, cholinergic|regulation of postsynaptic membrane potential|positive regulation of hydrogen peroxide biosynthetic process|regulation of thyroid hormone generation|positive regulation of hydrogen peroxide metabolic process",7.998e-06|1.138e-05|3.717e-05|4.952e-05|6.362e-05,0.1262|0.08978|0.1955|0.1953|0.2007,84.87|29.42|294.2|245.2|210.2
1930,7,0.4093,8.595,5661.0,0.0015119999999999999,0.9992989999999999,ANXA2 G0S2 GPR156 ITGA7 LTA SLC5A2 TEX2,regulation of fibroblast proliferation|multi-organism metabolic process|multi-organism catabolic process|positive regulation of low-density lipoprotein particle receptor binding|negative regulation of development of symbiont involved in interaction with host,0.0003324|0.0006794|0.0006794|0.0006794|0.0006794,1|0.5954|0.6304|0.6698|0.7655,72.65|2942|2942|2942|2942
1931,18,0.4014,61.42,14020.0,0.00435,1.0,AIF1 C6orf106 C6orf222 C6orf48 HLA-DMB HLA-DPB1 LY6G6F MICB MSH5 NCR3 NUDT3 PSMB8 PSORS1C2 STK19 TAP1 TAP2 TNXB TRIM26,antigen processing and presentation of peptide antigen|antigen processing and presentation|antigen processing and presentation of exogenous peptide antigen|antigen processing and presentation of exogenous antigen|antigen processing and presentation of endogenous peptide antigen via MHC class I,8.507e-09|1.968e-08|2.964e-07|3.665e-07|5.266e-07,0.0001342|0.0001552|0.001558|0.001445|0.001661,37.66|32.6|34.03|32.57|213.8
1932,6,0.4197,6.295,4810.0,0.0013039999999999998,0.998474,INPP5J ITGAE P2RY2 PNPLA5 TTLL5 WNT1,midbrain-hindbrain boundary maturation|midbrain-hindbrain boundary maturation during brain development|cerebellum formation|hindbrain formation|central nervous system morphogenesis,0.0005824|0.0005824|0.0005824|0.0005824|0.0008735,1|1|1|1|1,3432|3432|3432|3432|1716
1933,18,0.4085,62.5,14950.0,0.004155,1.0,BNIP2 CELF6 CSNK1G1 FBXL22 GOLGA6B IGDCC3 MAP2K5 MYO5C PLA2G4D PLEKHO2 PPIB RAB8B SCAMP2 SCAMP5 SLC24A1 SNX22 TBC1D21 THAP10,negative regulation of chemokine (C-X-C motif) ligand 2 production|ERK5 cascade|macrophage apoptotic process|Golgi vesicle fusion to target membrane|polyphosphate catabolic process,0.002618|0.002618|0.003489|0.004359|0.005229,1|1|1|1|1,572.1|572.1|381.4|286|228.8
1934,5,0.4141,4.141,4001.0,0.001031,0.996692,CCDC166 FAM234A JAM3 TKTL2 TLR2,myelination|ensheathment of neurons|axon ensheathment|regulation of actin cytoskeleton organization by cell-cell adhesion|positive regulation of cellular response to macrophage colony-stimulating factor stimulus,0.0002695|0.0002796|0.0002796|0.0004854|0.000728,1|1|1|1|1,77.72|76.28|76.28|4119|2060
1935,5,0.4492,4.492,4009.0,0.001116,0.996692,ATP2C2 CHGA JAML PKLR SLC5A10,myeloid leukocyte migration|leukocyte chemotaxis|adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation|positive regulation of dense core granule biogenesis|positive regulation of relaxation of cardiac muscle,0.0003725|0.000472|0.0004854|0.000728|0.000728,1|1|1|1|1,65.9|58.43|4119|2060|2060
1936,5,0.4297,4.297,4088.0,0.001047,0.996692,JCAD OR4E2 RETREG2 SZRD1 TSHR,cellular response to thyrotropin-releasing hormone|cellular response to glycoprotein|thyroid-stimulating hormone signaling pathway|response to thyrotropin-releasing hormone|positive regulation of vascular endothelial growth factor signaling pathway,0.0004854|0.0004854|0.000728|0.000728|0.001698,1|1|1|1|1,4119|4119|2060|2060|686.5
1937,7,0.4317,9.065,6064.0,0.001489,0.9992989999999999,CPLANE1 DYNLL2 FABP6 FAXDC2 JCHAIN PCDHA8 SLC45A2,"positive regulation of ATP-dependent microtubule motor activity, plus-end-directed|regulation of ATP-dependent microtubule motor activity, plus-end-directed|organic hydroxy compound biosynthetic process|positive regulation of microtubule motor activity|oligosaccharide transport",0.001358|0.001358|0.001482|0.001698|0.001698,1|1|1|1|1,980.7|980.7|33.82|735.5|735.5
1938,6,0.4208,6.311,4776.0,0.001317,0.998474,ABHD12B JPH1 KCNMB2 KRTCAP3 SLC15A3 TMEM204,detection of calcium ion|neuronal action potential|transmission of nerve impulse|positive regulation of potassium ion transmembrane transport|regulation of cation transmembrane transport,1.185e-05|4.285e-05|0.0001404|0.0001914|0.0001983,0.1869|0.338|0.7383|0.7547|0.6256,420.3|210.2|113.2|96.46|23.73
1939,12,0.4036,26.64,9942.0,0.002666,0.999986,DDX58 GPR142 JPT1 KCTD2 LGALS3BP MCRIP1 MIF4GD RHBDF2 SPHK1 SSTR2 TMEM235 UBE2O,regulation of endosomal vesicle fusion|sphingoid catabolic process|regulation of type III interferon production|somatostatin signaling pathway|somatostatin receptor signaling pathway,0.001164|0.001164|0.002909|0.003489|0.003489,1|1|1|1|1,1716|1716|429.1|343.2|343.2
1940,5,0.4667,4.667,4001.0,0.0011619999999999998,0.996692,BCL2A1 GLRX2 GPR87 JRKL TPCN1,DNA protection|aging|G protein-coupled purinergic nucleotide receptor signaling pathway|cellular response to superoxide|cellular response to oxygen radical,0.001456|0.001767|0.003636|0.003878|0.003878,1|1|1|1|1,823.8|29.85|294.2|274.6|274.6
1941,6,0.4211,6.317,4807.0,0.001309,0.998474,BRSK1 CRISP1 DCUN1D4 DEFB112 JSRP1 USP13,microtubule cytoskeleton organization involved in establishment of planar polarity|protein K6-linked deubiquitination|maintenance of unfolded protein|maintenance of unfolded protein involved in ERAD pathway|positive regulation of protein neddylation,0.0008735|0.001165|0.001165|0.001165|0.001746,1|1|1|1|1,1716|1144|1144|1144|686.5
1942,6,0.4087,6.13,4729.0,0.001291,0.998474,CA14 CBLB ECHDC3 KANK4 SPATA46 ST14,epithelial cell morphogenesis involved in placental branching|epithelial cell differentiation involved in embryonic placenta development|positive regulation of T cell anergy|positive regulation of lymphocyte anergy|regulation of platelet-derived growth factor receptor-alpha signaling pathway,0.001165|0.001165|0.001456|0.001456|0.001746,1|1|1|1|1,1144|1144|858.1|858.1|686.5
1943,11,0.403,22.16,7442.0,0.002961,0.999969,ACTR1A DYNC1LI1 DYNC1LI2 ESCO2 NDE1 PPP2R5C PPP2R5D PPP2R5E SGO1 SNRK ZWINT,biological phase|mitotic cell cycle phase|cell cycle phase|mitotic prometaphase|cell cycle process,1.653e-11|1.653e-11|1.653e-11|1.432e-10|7.838e-09,2.608e-07|1.304e-07|8.693e-08|5.649e-07|2.473e-05,51|51|51|67.27|14
1944,5,0.423,4.23,3957.0,0.001065,0.996692,ASB15 CDH20 KBTBD12 SLC5A7 UCN3,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|homophilic cell adhesion via plasma membrane adhesion molecules|acetate ester biosynthetic process|acetylcholine biosynthetic process|acetate ester metabolic process,6.651e-05|0.000982|0.001165|0.001165|0.001746,1|1|1|1|1,163.5|41.11|1144|1144|686.5
1945,6,0.4415,6.622999999999999,4896.0,0.001348,0.998474,ANKRD62 AOX1 CALD1 KBTBD13 SLC28A1 ZBTB21,cytidine transport|relaxation of skeletal muscle|regulation of skeletal muscle contraction by chemo-mechanical energy conversion|regulation of the force of skeletal muscle contraction|purine nucleobase transmembrane transport,0.0005824|0.001165|0.001165|0.001165|0.001456,1|1|1|1|1,3432|1144|1144|1144|858.1
1946,17,0.3895,52.98,13840.0,0.003804,1.0,AMER2 ATP12A C1QTNF9 C1QTNF9B GJB2 GJB6 KBTBD7 KRTAP21-1 NEK3 RCBTB2 RNF6 SIAH3 SLC25A30 SOHLH2 SPATA13 VANGL1 ZAR1L,gap junction-mediated intercellular transport|intercellular transport|gap junction assembly|cell communication by electrical coupling|response to human chorionic gonadotropin,1.787e-05|2.297e-05|2.87e-05|0.0001465|0.003295,0.282|0.1812|0.1509|0.5776|1,403.8|346.1|302.9|121.1|403.8
1947,7,0.4102,8.613,5698.0,0.001506,0.9992989999999999,ADAT1 CCDC102A CDCA4 KCNA4 MGAT3 SULT1C3 TMEM150C,negative regulation of lysosomal protein catabolic process|negative regulation of protein catabolic process in the vacuole|proprioception|regulation of lysosomal protein catabolic process|positive regulation of protein localization to early endosome,0.001358|0.001358|0.002037|0.003054|0.003393,1|1|1|1|1,980.7|980.7|588.4|367.8|326.9
1948,8,0.4068,11.39,6648.0,0.0017059999999999998,0.9996790000000001,C1orf141 KCNAB3 MDP1 PCDHA5 SLC36A1 SPINK6 SPRR4 TWSG1,fructosamine metabolic process|alkanesulfonate transport|taurine transport|negative regulation of serine-type peptidase activity|negative regulation of serine-type endopeptidase activity,0.00131|0.003054|0.003054|0.00349|0.00349,1|1|1|1|1,1144|381.4|381.4|326.9|326.9
1949,24,0.4046,111.7,19830.0,0.005586,1.0,C8orf44 CA1 CA13 CA2 CA3 CA8 CEBPD CNGB3 CPA6 CYP7A1 FABP12 FABP4 KCNB2 LYN MCMDC2 NSMAF PKIA PMP2 PPDPFL PRDM14 SGK3 SLC26A7 TRIM55 UBE2W,one-carbon metabolic process|bicarbonate transport|organic anion transport|ion transport|triglyceride catabolic process,1.443e-09|2.034e-09|2.23e-06|0.0001727|0.0005171,2.276e-05|1.604e-05|0.01172|0.6812|1,110|102.2|15.14|3.276|63.56
1950,6,0.4216,6.3229999999999995,4894.0,0.001287,0.998474,GPR87 KCNE4 LURAP1 RWDD4 SAMD13 SLC2A12,negative regulation of delayed rectifier potassium channel activity|ventricular cardiac muscle cell membrane repolarization|membrane repolarization during ventricular cardiac muscle cell action potential|negative regulation of voltage-gated potassium channel activity|G protein-coupled purinergic nucleotide receptor signaling pathway,0.003781|0.003781|0.003781|0.004071|0.004361,1|1|1|1|1,286|286|286|264|245.2
1951,5,0.4227,4.227,3748.0,0.001124,0.996692,BCAM KCNF1 KLK14 LLPH OR52N2,seminal clot liquefaction|dendrite extension|insemination|copulation|positive regulation of G protein-coupled receptor signaling pathway,0.0004854|0.002425|0.003152|0.003878|0.006778,1|1|1|1|1,4119|457.7|343.3|274.6|152.6
1952,5,0.402,4.02,3889.0,0.00103,0.996692,ACAD10 FCGR3A KCNJ14 TRMT44 VSNL1,potassium ion import across plasma membrane|inorganic ion import across plasma membrane|inorganic cation import across plasma membrane|import across plasma membrane|potassium ion transmembrane transport,6.651e-05|0.0002497|0.0002497|0.0006378|0.000881,1|1|1|1|1,163.5|82.71|82.71|51.23|43.45
1953,10,0.4079,18.36,8010.0,0.002281,0.999933,C11orf71 ENPP3 KCNJ3 METTL24 NKAIN2 OLIG3 TAAR2 TAAR6 TAAR8 VNN2,basophil activation involved in immune response|basophil activation|negative regulation of mast cell proliferation|regulation of mast cell proliferation|spinal cord motor neuron migration,0.001455|0.00194|0.00194|0.002424|0.002424,1|1|1|1|1,1030|686.5|686.5|514.9|514.9
1954,6,0.4157,6.236000000000001,4841.0,0.001283,0.998474,KCNK1 OAZ3 SELENOM SLC2A13 SULF2 VPS13B,corticosterone secretion|organic hydroxy compound transport|glucocorticoid secretion|esophagus smooth muscle contraction|negative regulation of polyamine transmembrane transport,0.0005824|0.0008061|0.0008735|0.0008735|0.001165,1|1|1|1|1,3432|45.46|1716|1716|1144
1955,6,0.422,6.33,4953.0,0.001273,0.998474,CALR3 HSPB7 KCNK18 PRKG1 RHBDD3 SLC10A1,response to unfolded protein|response to 17alpha-ethynylestradiol|response to topologically incorrect protein|negative regulation of cell activation|regulation of bile acid secretion,0.000982|0.001165|0.001239|0.001398|0.001746,1|1|1|1|1,41.11|1144|36.52|34.33|686.5
1956,7,0.4015,8.432,5569.0,0.001508,0.9992989999999999,ADGRD1 CMC2 DGCR2 GNG4 KCNK4 NID1 NUDT1,purine nucleoside triphosphate metabolic process|nucleoside triphosphate metabolic process|cellular response to alkaline pH|detection of mechanical stimulus involved in sensory perception of touch|dATP catabolic process,0.0003055|0.0005545|0.001164|0.001164|0.001552,1|1|1|1|1,76.85|56.58|1287|1287|858.1
1957,5,0.4112,4.112,3973.0,0.001031,0.996692,CTSH KCNK9 NAT14 POMT1 ZBTB20,dichotomous subdivision of terminal units involved in lung branching|neuropeptide catabolic process|positive regulation of protein O-linked glycosylation|regulation of protein O-linked glycosylation|bradykinin catabolic process,0.000728|0.000728|0.0009706|0.0009706|0.001456,1|1|1|1|1,2060|2060|1373|1373|823.8
1958,7,0.4054,8.513,5565.0,0.001524,0.9992989999999999,ASIP KCNMA1 MRC2 OPN4 PAQR9 PDE7B TLL2,"smooth muscle contraction involved in micturition|regulation of molecular function, epigenetic|negative regulation of skeletal muscle tissue growth|thermotaxis|optokinetic behavior",0.001019|0.001019|0.001019|0.001019|0.001019,1|1|1|1|1,1471|1471|1471|1471|1471
1959,6,0.4038,6.057,4477.0,0.001347,0.998474,CNIH2 ITGA3 KCNN1 MAP3K11 SNX17 TMEM179B,negative regulation of receptor localization to synapse|negative regulation of vesicle transport along microtubule|negative regulation of anterograde synaptic vesicle transport|negative regulation of synaptic vesicle transport|regulation of anterograde synaptic vesicle transport,0.0005824|0.0005824|0.0005824|0.0005824|0.001165,1|1|1|1|1,3432|3432|3432|3432|1144
1960,5,0.4057,4.0569999999999995,3767.0,0.001073,0.996692,ITGA4 KCNN3 OR2T35 TANK ZC3H14,clathrin-dependent extracellular exosome endocytosis|negative regulation of protein homodimerization activity|positive regulation of ubiquitin-specific protease activity|cell-cell adhesion in response to extracellular stimulus|regulation of protein homodimerization activity,0.0004854|0.0004854|0.000728|0.000728|0.000728,1|1|1|1|1,4119|4119|2060|2060|2060
1961,5,0.4326,4.3260000000000005,3872.0,0.001113,0.996692,ADGRL2 KCNV2 KCTD17 NAGS SHISA3,protein homooligomerization|arginine biosynthetic process|protein complex oligomerization|urea cycle|nitrogen cycle metabolic process,0.0007628|0.001213|0.001267|0.003152|0.003394,1|1|1|1|1,45.77|1030|35.36|343.3|316.8
1962,7,0.4294,9.017999999999999,5855.0,0.001534,0.9992989999999999,CFAP58 CHMP4A IDE KCTD18 KLF13 MACF1 XXYLT1,insulin catabolic process|insulin metabolic process|bradykinin catabolic process|viral life cycle|amyloid-beta clearance by cellular catabolic process,0.001358|0.002037|0.002037|0.002447|0.002715,1|1|1|1|1,980.7|588.4|588.4|26.15|420.3
1963,6,0.4316,6.475,4964.0,0.001299,0.998474,BSDC1 GFY GGT6 GRIN1 KCTD4 TNF,ionotropic glutamate receptor signaling pathway|glutamate receptor signaling pathway|positive regulation of reactive oxygen species biosynthetic process|regulation of reactive oxygen species biosynthetic process|positive regulation of reactive oxygen species metabolic process,4e-05|0.0001155|0.0001511|0.0004352|0.0005114,0.631|0.9109|0.7943|1|1,217.9|125.2|109|63.27|58.26
1964,7,0.4128,8.669,5717.0,0.00151,0.9992989999999999,B4GALNT3 CACFD1 ERC1 KHDRBS3 NRIP2 SLC6A12 WNT5B,positive regulation of convergent extension involved in gastrulation|regulation of convergent extension involved in gastrulation|gamma-aminobutyric acid reuptake|amino acid neurotransmitter reuptake|maintenance of presynaptic active zone structure,0.001019|0.001019|0.001698|0.002376|0.002376,1|1|1|1|1,1471|1471|735.5|490.4|490.4
1965,7,0.4044,8.493,5799.0,0.001459,0.9992989999999999,DUXA ITGA2 KHNYN SPATC1L TMEM100 TRIM67 ZNF286A,positive regulation of collagen binding|regulation of collagen binding|regulation of nervous system process|response to L-ascorbic acid|positive regulation of transmission of nerve impulse,0.0006794|0.001019|0.001023|0.002376|0.002376,1|1|1|1|1,2942|1471|40.86|490.4|490.4
1966,5,0.4153,4.1530000000000005,3676.0,0.001125,0.996692,APCS DCAF4L1 DNTTIP1 ELMSAN1 KIAA0513,negative regulation of exo-alpha-sialidase activity|negative regulation by host of viral glycoprotein metabolic process|modulation by host of viral glycoprotein metabolic process|negative regulation by host of viral exo-alpha-sialidase activity|modulation by host of viral catalytic activity,0.0005825|0.0005825|0.0005825|0.0005825|0.0005825,1|1|1|1|1,2574|2574|2574|2574|2574
1967,5,0.404,4.04,3769.0,0.001068,0.996692,KIAA0825 NAA80 SLC39A6 SPATA31D1 UBE3D,N-terminal peptidyl-aspartic acid acetylation|N-terminal peptidyl-glutamic acid acetylation|peptidyl-aspartic acid modification|actin modification|zinc ion import across plasma membrane,0.0004854|0.0009706|0.001213|0.001213|0.00194,1|1|1|1|1,4119|1373|1030|1030|588.4
1968,7,0.4079,8.565,4911.0,0.001736,0.9992989999999999,CEP192 CEP85 IL17D KIAA1522 KIF18B KIF2C SLFN13,microtubule polymerization or depolymerization|microtubule depolymerization|mitotic nuclear division|protein depolymerization|chromosome segregation,6.254e-07|1.688e-05|3.647e-05|6.916e-05|9.171e-05,0.009865|0.1331|0.1918|0.2727|0.2893,169.7|346.1|42.23|163.5|30.86
1969,22,0.4054,93.64,14930.0,0.006213000000000001,1.0,ABCG1 BUB3 CNIH4 DUX4 HSPE1 KIF11 NEDD1 OR2A25 RNPC3 RPL11 RPL12 RPL13 RPL17 RPL18A RPL23 RPL23A RPL37 RPL4 RPL9 RPLP2 RPS13 SARS,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,2.928e-22|5.176e-22|1.499e-21|2.236e-21|2.467e-21,4.619e-18|4.082e-18|7.882e-18|8.82e-18|7.782e-18,111.9|106.4|96.8|93.44|92.63
1970,6,0.4236,6.355,4910.0,0.001289,0.998474,CYTH4 HP KIF21A PBLD VIM ZMYND19,negative regulation of hydrogen peroxide catabolic process|regulation of hydrogen peroxide catabolic process|negative regulation of hydrogen peroxide metabolic process|negative regulation of SMAD protein signal transduction|Bergmann glial cell differentiation,0.0005824|0.001165|0.002037|0.002328|0.002619,1|1|1|1|1,3432|1144|572.1|490.4|429.1
1971,6,0.4003,6.005,4710.0,0.0012699999999999999,0.998474,ENTPD5 EPHX2 KIF25 LRRC74A NSFL1C VAV1,regulation of mitotic centrosome separation|establishment of spindle orientation|establishment of spindle localization|spindle localization|establishment of cell polarity,3.883e-06|4.946e-05|9.313e-05|0.000112|0.0005054,0.06126|0.3901|0.4897|0.4418|1,762.8|190.7|137.3|124.8|57.69
1972,5,0.4129,4.129,3838.0,0.001072,0.996692,EML3 IL4R KIF26A NKAIN1 STAT6,interleukin-4-mediated signaling pathway|cellular response to interleukin-4|regulation of type 2 immune response|response to interleukin-4|positive regulation of immunoglobulin production,7.067e-07|2.331e-05|2.481e-05|2.795e-05|5.073e-05,0.01115|0.1838|0.1305|0.1102|0.16,2060|274.6|265.7|249.6|183.1
1973,8,0.4005,11.21,6692.0,0.0016690000000000001,0.9996790000000001,ACBD3 FAM177B HTR3D HTR3E KIF3A SCHIP1 SERP1 SERPINI1,serotonin receptor signaling pathway|cellular response to dopamine|response to dopamine|cellular response to catecholamine stimulus|cellular response to monoamine stimulus,0.0001074|0.000442|0.0004526|0.0006281|0.0006281,1|1|1|1|1,132|63.56|62.79|53.08|53.08
1974,7,0.4207,8.834,5684.0,0.0015480000000000001,0.9992989999999999,APOB CIZ1 KIF3C OPRM1 PDGFD PTAFR SLC37A2,positive regulation of cellular extravasation|regulation of cellular extravasation|regulation of sensory perception of pain|regulation of sensory perception|response to lipopolysaccharide,1.51e-05|5.857e-05|8.465e-05|8.877e-05|0.0001241,0.2382|0.4619|0.4451|0.3501|0.3914,367.8|178.3|147.1|143.5|27.84
1975,6,0.4263,6.394,4958.0,0.001285,0.998474,C5 CAMK1 CLK1 CLK4 KIF4B OSM,positive regulation of peptidyl-serine phosphorylation|protein phosphorylation|regulation of peptidyl-serine phosphorylation|peptidyl-tyrosine phosphorylation|regulation of RNA splicing,0.0004255|0.0006849|0.0007344|0.0007647|0.0007853,1|1|1|1|1,62.98|15.05|47.67|46.7|46.07
1976,5,0.4178,4.178,3851.0,0.0010810000000000001,0.996692,KIF6 NDUFS4 OR2C3 SRGAP3 ZFP30,"cAMP-mediated signaling|mitochondrial electron transport, NADH to ubiquinone|positive regulation of fibroblast proliferation|cyclic-nucleotide-mediated signaling|NADH dehydrogenase complex assembly",0.007744|0.01208|0.01208|0.0128|0.01616,1|1|1|1|1,132.9|84.06|84.06|79.21|62.41
1977,7,0.4253,8.932,5346.0,0.001663,0.9992989999999999,ADCY6 ANKMY2 GPR3 KIF7 NFIB PTGES3 RIC8B,negative regulation of epithelial cell proliferation involved in lung morphogenesis|lung ciliated cell differentiation|adenylate cyclase-activating G protein-coupled receptor signaling pathway|principal sensory nucleus of trigeminal nerve development|trigeminal sensory nucleus development,0.0006794|0.0006794|0.0008889|0.001019|0.001019,1|1|1|1|1,2942|2942|43.91|1471|1471
1978,5,0.4247,4.247,3866.0,0.0010949999999999998,0.996692,CAMSAP1 KIFAP3 MCM7 MYBPC2 POLD2,DNA strand elongation involved in DNA replication|DNA strand elongation|nuclear DNA replication|cell cycle DNA replication|positive regulation of calcium-dependent cell-cell adhesion,9.879e-06|1.528e-05|8.295e-05|8.576e-05|0.0004854,0.1558|0.1205|0.4362|0.3382|1,433.6|343.3|142|139.6|4119
1979,23,0.4066,102.9,18780.0,0.005435,1.0,AGO1 AGO3 AGO4 ARMH1 AZIN2 BEST4 BSND C1QB C1orf123 CYP4X1 FAAH GJA4 GJB3 GJB4 GJB5 LURAP1 PCSK9 TSSK3 ZBTB8A ZBTB8B ZFP69 ZFP69B ZNF684,"miRNA loading onto RISC involved in gene silencing by miRNA|RNA secondary structure unwinding|small RNA loading onto RISC|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation",1.448e-07|1.989e-07|2.65e-07|6.726e-07|6.726e-07,0.002284|0.001569|0.001393|0.002652|0.002122,383.8|335.8|298.5|206.6|206.6
1980,7,0.404,8.485,5852.0,0.001444,0.9992989999999999,ARL5B CCL16 EBPL KIF5B KLC1 LMTK2 SLC2A8,stress granule disassembly|ribonucleoprotein complex disassembly|organelle disassembly|positive regulation of voltage-gated sodium channel activity|cytosolic transport,2.076e-06|3.558e-06|0.0002714|0.0006794|0.00108,0.03275|0.02807|1|1|1,1177|840.6|80.61|2942|39.76
1981,27,0.4039,141.8,21210.0,0.006623,1.0,ADCY10 AP5M1 ATXN7L3B C8orf44 CARNS1 CCNB1IP1 FEZF2 KIAA1257 KIF26B LYRM1 MAP3K7CL MCOLN3 NDRG3 NECAP2 NIPSNAP3B PCDHB12 PCDHGA9 PLEKHB1 RAB22A RNF114 SDR39U1 SLC25A36 TMEM100 TXNDC16 WDYHV1 ZNF286A ZNF512B,carnosine biosynthetic process|pyrimidine nucleotide transport|pyrimidine nucleotide import into mitochondrion|carnosine metabolic process|forebrain anterior/posterior pattern specification,0.002617|0.003923|0.003923|0.003923|0.005227,1|1|1|1|1,762.8|381.4|381.4|381.4|254.3
1982,5,0.4115,4.115,3940.0,0.001041,0.996692,GPATCH2L GPR182 HMOX1 HSPA1B KLF15,muscle adaptation|cellular response to heat|response to heat|negative regulation of extrinsic apoptotic signaling pathway|regulation of transcription from RNA polymerase II promoter in response to iron,2.636e-05|7.22e-05|0.0002219|0.0002646|0.0004854,0.4158|0.5695|1|1|1,257.4|152.6|85.81|78.46|4119
1983,6,0.4093,6.138999999999999,4734.0,0.001292,0.998474,IRS1 KLF16 NTPCR SLC23A2 SUMF1 TCF3,transepithelial L-ascorbic acid transport|L-ascorbic acid transmembrane transport|B cell lineage commitment|immunoglobulin V(D)J recombination|positive regulation of fatty acid beta-oxidation,0.001019|0.001019|0.002376|0.002376|0.003732,1|1|1|1|1,1471|1471|490.4|490.4|294.2
1984,5,0.4308,4.308,4059.0,0.001058,0.996692,APOBEC2 KLF9 LARGE1 RIPPLY2 ZNF578,cellular response to cortisol stimulus|response to cortisol|somite rostral/caudal axis specification|cytidine metabolic process|cytidine catabolic process,0.0004854|0.001456|0.00291|0.003152|0.003152,1|1|1|1|1,4119|823.8|374.5|343.3|343.3
1985,4,0.4731,2.838,3051.0,0.000927,0.9929309999999999,DUSP8 FOXE1 HEY1 KLHDC1,umbilical cord morphogenesis|umbilical cord development|pharynx development|negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation|soft palate development,0.0005825|0.0005825|0.0007766|0.0007766|0.001165,1|1|1|1|1,2574|2574|1716|1716|1030
1986,6,0.4319,6.479,4750.0,0.001359,0.998474,CNTN5 COL6A6 CRIPAK EAF2 KLHDC10 TUFT1,negative regulation of epithelial cell proliferation involved in prostate gland development|regulation of epithelial cell proliferation involved in prostate gland development|negative regulation of intracellular estrogen receptor signaling pathway|presynapse assembly|presynapse organization,0.002037|0.0032|0.004942|0.00697|0.007839,1|1|1|1|1,572.1|343.2|214.5|149.2|132
1987,6,0.4044,6.066,4350.0,0.001389,0.998474,KLHDC2 LSG1 NMD3 OR2T12 OR2T8 RFC4,ribosome localization|ribosomal subunit export from nucleus|rRNA-containing ribonucleoprotein complex export from nucleus|ribonucleoprotein complex export from nucleus|ribonucleoprotein complex localization,7.41e-06|7.41e-06|8.468e-06|0.0005741|0.000583,0.1169|0.05844|0.04452|1|1,528.1|528.1|490.4|54.06|53.63
1988,9,0.4323,15.56,6008.0,0.002576,0.9998530000000001,ANLN BIRC5 ECT2 KIF23 MASTL NUF2 PRC1 RACGAP1 TOP2A,cell division|cell cycle process|mitotic cell cycle process|cell cycle|mitotic cell cycle,2.769e-15|2.87e-12|1.375e-11|2.995e-11|3.164e-11,4.368e-11|2.263e-08|7.232e-08|1.181e-07|9.982e-08,41.86|19.25|26.73|14.82|24.06
1989,5,0.4114,4.114,3808.0,0.001076,0.996692,KLHL1 OR52K1 SCNN1A TMEM231 TMEM89,neuroepithelial cell differentiation|sensory perception of chemical stimulus|cerebellar Purkinje cell layer development|adult walking behavior|walking behavior,0.004362|0.006602|0.006778|0.006778|0.00702,1|1|1|1|1,242.3|15.2|152.6|152.6|147.1
1990,6,0.4252,6.377999999999999,4919.0,0.001292,0.998474,KLHL14 MYL7 PIK3AP1 SLC29A4 SNRPN UCMA,epinephrine uptake|histamine uptake|epinephrine transport|toll-like receptor 7 signaling pathway|toll-like receptor 2 signaling pathway,0.0008735|0.001165|0.001456|0.001746|0.001746,1|1|1|1|1,1716|1144|858.1|686.5|686.5
1991,6,0.4414,6.621,4867.0,0.001355,0.998474,ACTG2 ADORA2B CLIC4 KLHL21 REPIN1 ZNF843,chromosome passenger complex localization to spindle midzone|mesenchyme migration|G protein-coupled adenosine receptor signaling pathway|G protein-coupled purinergic receptor signaling pathway|retina vasculature morphogenesis in camera-type eye,0.0005824|0.001746|0.002909|0.002909|0.00349,1|1|1|1|1,3432|686.5|381.4|381.4|312
1992,7,0.4003,8.407,5708.0,0.001467,0.9992989999999999,ATP13A4 CHGA KLHL24 LEP MXD3 SLC16A8 XKR6,negative regulation of amine transport|negative regulation of peptide hormone secretion|leukocyte migration|negative regulation of hormone secretion|negative regulation of peptide secretion,4e-05|0.0001017|0.0002078|0.0002165|0.0002642,0.631|0.8021|1|0.8538|0.8335,217.9|133.7|23.35|90.53|81.73
1993,5,0.4369,4.369,4072.0,0.0010689999999999999,0.996692,B3GALT1 JPH2 KLHL3 MTREX RILP,negative regulation of cardiac muscle cell myoblast differentiation|regulation of cardiac muscle cell myoblast differentiation|negative regulation of cardioblast differentiation|intralumenal vesicle formation|distal tubule morphogenesis,0.0005824|0.0005824|0.0008735|0.0008735|0.001165,1|1|1|1|1,3432|3432|1716|1716|1144
1994,4,0.4486,2.6919999999999997,3042.0,0.0008818,0.9929309999999999,KLHL35 RASL10A SLC27A3 STX17,endoplasmic reticulum-Golgi intermediate compartment organization|autophagosome membrane docking|protein localization to phagophore assembly site|autophagosome maturation|long-chain fatty acid transport,0.0005825|0.0009706|0.002716|0.005813|0.01199,1|1|1|1|1,2574|1287|396.1|177.5|84.41
1995,5,0.4261,4.261,3989.0,0.001065,0.996692,CES4A KLHL36 PPP1R3E SKA2 TRPT1,"tRNA splicing, via endonucleolytic cleavage and ligation|positive regulation of glycogen biosynthetic process|RNA splicing, via endonucleolytic cleavage and ligation|positive regulation of glycogen metabolic process|regulation of glycogen biosynthetic process",0.003878|0.00412|0.00412|0.004604|0.007744,1|1|1|1|1,274.6|257.4|257.4|228.8|132.9
1996,6,0.4071,6.106,4794.0,0.001269,0.998474,CAPN3 GNS KLHL41 PRR7 SPATA31E1 ZDHHC22,sarcomere organization|regulation of myoblast differentiation|myofibril assembly|striated muscle cell development|negative regulation of protein modification by small protein conjugation or removal,4.188e-05|0.0001005|0.0001081|0.0002989|0.0002989,0.6606|0.7925|0.5684|1|0.9429,208|132|127.1|75.44|75.44
1997,6,0.4236,6.354,4888.0,0.001295,0.998474,ATP6V1C2 CDKN2D KLK13 LPCAT4 PSKH1 USP4,autophagic cell death|spliceosomal tri-snRNP complex assembly|phosphatidylglycerol acyl-chain remodeling|phosphatidylserine acyl-chain remodeling|phosphatidylethanolamine acyl-chain remodeling,0.002037|0.004071|0.005522|0.006681|0.007839,1|1|1|1|1,572.1|264|190.7|156|132
1998,9,0.4201,15.12,7384.0,0.002039,0.9998530000000001,GPR142 KIF19 LGALS3BP LXN MCRIP1 MIF4GD SPHK1 SSTR2 TTYH2,axonemal microtubule depolymerization|plus-end specific microtubule depolymerization|regulation of endosomal vesicle fusion|cytoplasmic microtubule depolymerization|cilium disassembly,0.0008734|0.0008734|0.0008734|0.0008734|0.0008734,1|1|1|1|1,2288|2288|2288|2288|2288
1999,5,0.4554,4.553999999999999,3970.0,0.001143,0.996692,AGAP3 KLRC2 SFT2D1 SLC46A2 SPSB2,positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway|regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway|positive regulation of natural killer cell degranulation|regulation of natural killer cell degranulation|positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,0.0009706|0.001213|0.001456|0.001456|0.001698,1|1|1|1|1,1373|1030|823.8|823.8|686.5
2000,5,0.4234,4.234,3993.0,0.001057,0.996692,KLRF2 MTTP OR10Q1 QRFP TMEM87B,triglyceride transport|acylglycerol transport|natural killer cell degranulation|ceramide 1-phosphate transport|chylomicron assembly,0.001456|0.001456|0.001456|0.002183|0.00291,1|1|1|1|1,823.8|823.8|823.8|514.9|374.5
2001,5,0.4572,4.572,3983.0,0.001144,0.996692,IL23A KNDC1 LLPH MGST1 OTOP3,cellular response to lipid hydroperoxide|response to lipid hydroperoxide|positive regulation of T-helper 17 cell lineage commitment|positive regulation of NK T cell proliferation|regulation of NK T cell proliferation,0.0004854|0.0009706|0.001213|0.001213|0.001456,1|1|1|1|1,4119|1373|1030|1030|823.8
2002,14,0.406,36.94,11190.0,0.003281,0.9999969999999999,ATP12A C1QTNF9 C1QTNF9B GJB2 HSPH1 KPNA3 LACC1 PSPC1 RCBTB2 RNF6 SIAH3 SLC25A30 SPATA13 ZMYM5,response to human chorionic gonadotropin|cellular monovalent inorganic cation homeostasis|oxaloacetate(2-) transmembrane transport|malate transmembrane transport|viral penetration into host nucleus,0.002715|0.002828|0.003392|0.003392|0.003392,1|1|1|1|1,490.4|25.36|367.8|367.8|367.8
2003,5,0.4056,4.056,3772.0,0.0010710000000000001,0.996692,ESRRB KPNA3 KPNA4 SLC25A33 ZSCAN30,NLS-bearing protein import into nucleus|modulation by virus of host cellular process|modulation by virus of host process|modulation by symbiont of host cellular process|modulation by symbiont of host process,9.879e-06|1.298e-05|2.795e-05|3.128e-05|8.02e-05,0.1558|0.1024|0.147|0.1234|0.253,433.6|374.5|249.6|235.4|144.5
2004,12,0.4018,26.52,9650.0,0.002734,0.999986,C1QTNF9 CLYBL DLEU7 KRTAP21-1 PCDH8 PCDHGA5 RCBTB2 RNF6 RUBCNL SIAH3 SLITRK5 ZIC5,positive regulation of cobalamin metabolic process|regulation of cobalamin metabolic process|autophagosome-endosome fusion|positive regulation of tetrapyrrole metabolic process|positive regulation of vitamin metabolic process,0.001164|0.001164|0.001164|0.001746|0.002909,1|1|1|1|1,1716|1716|1716|858.1|429.1
2005,5,0.4226,4.226,3812.0,0.001105,0.996692,GBF1 GRIN2C IL31 KPNA6 LRRC66,protein localization to endoplasmic reticulum tubular network|entry of viral genome into host nucleus through nuclear pore complex via importin|endoplasmic reticulum-Golgi intermediate compartment organization|directional locomotion|viral penetration into host nucleus,0.0004854|0.000728|0.000728|0.0009706|0.001213,1|1|1|1|1,4119|2060|2060|1373|1030
2006,31,0.4045,188.1,23280.0,0.007994,1.0,C8orf33 EXOSC4 FAM135B FOXH1 GLI4 GML GSDMC GSDMD KCNQ3 LRRC24 LY6K LYPD2 MAPK15 MROH6 NAPRT PLEC PPP1R16A PSCA PUF60 RHPN1 RPL8 SLURP2 TSNARE1 VPS28 WISP1 ZFP41 ZNF16 ZNF250 ZNF623 ZNF696 ZNF707,pyroptosis|response to sodium dodecyl sulfate|cellular response to sodium dodecyl sulfate|positive regulation of meiotic chromosome separation|NAD salvage,0.0004084|0.003004|0.003004|0.003004|0.003004,1|1|1|1|1,73.82|664.4|664.4|664.4|664.4
2007,5,0.4442,4.442,4112.0,0.001077,0.996692,CCDC112 KRCC1 LYSMD3 NT5DC3 TCHP,negative regulation of cilium assembly|negative regulation of plasma membrane bounded cell projection assembly|negative regulation of organelle assembly|regulation of cilium assembly|Golgi organization,0.003636|0.007502|0.01039|0.01448|0.03258,1|1|1|1|1,294.2|137.3|98.07|69.81|30.51
2008,6,0.4315,6.473,4934.0,0.001307,0.998474,CATSPER4 CD163L1 KREMEN1 LRRN2 TNFSF14 WNT3A,regulation of receptor internalization|regulation of synapse assembly|regulation of receptor-mediated endocytosis|negative regulation of heart induction by canonical Wnt signaling pathway|Wnt signaling pathway involved in forebrain neuroblast division,0.0001678|0.0004821|0.0005725|0.0006794|0.0006794,1|1|1|0.8244|0.8931,103.2|60.04|54.99|2942|2942
2009,10,0.4143,18.64,7208.0,0.002573,0.999933,DDX49 EIF3G KRI1 PPAN SF3A2 SNAPC2 TIMM44 TRAPPC5 XAB2 YJU2,ribonucleoprotein complex biogenesis|ribonucleoprotein complex assembly|ribonucleoprotein complex subunit organization|generation of catalytic spliceosome for first transesterification step|cellular component biogenesis,3.581e-10|1.749e-08|2.087e-08|2.118e-06|3.108e-06,5.649e-06|0.0001379|0.0001097|0.008353|0.009804,31|54.2|52.27|1373|6.1
2010,5,0.4607,4.607,4123.0,0.001113,0.996692,CAP2 CATSPER3 KRT38 NKIRAS2 SRRM5,epithelial cell-cell adhesion|sperm capacitation|cAMP-mediated signaling|regulation of adenylate cyclase activity|activation of adenylate cyclase activity,0.005522|0.007839|0.009285|0.009863|0.01217,1|1|1|1|1,190.7|132|110.7|104|83.72
2011,7,0.4102,8.615,5516.0,0.0015550000000000002,0.9992989999999999,CANT1 CUEDC1 GJB6 KRT6C PIP4K2B RASA3 ZFP90,"1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process|1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate metabolic process|negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity|regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity|autophagosome-lysosome fusion",0.001358|0.001358|0.001358|0.001698|0.002037,1|1|1|1|1,980.7|980.7|980.7|735.5|588.4
2012,5,0.4408,4.408,3927.0,0.001118,0.996692,KRTAP25-1 MGAT4C MNDA NOXO1 TOR1AIP1,protein localization to nuclear envelope|regulation of respiratory burst|negative regulation of B cell proliferation|regulation of hydrogen peroxide metabolic process|cellular response to interferon-beta,0.002667|0.00412|0.004604|0.004845|0.005571,1|1|1|1|1,411.9|257.4|228.8|216.8|187.2
2013,6,0.4018,6.027,4703.0,0.001277,0.998474,CDA FOXF1 KRTAP5-5 MSRB3 TBX2 ZBTB46,smooth muscle cell differentiation|endocardial cushion development|mesenchyme morphogenesis|artery morphogenesis|artery development,4.687e-05|6.96e-05|8.956e-05|0.0001458|0.0002799,0.7393|0.5489|0.4709|0.5751|0.8831,196.1|159.7|140.1|109|78.01
2014,6,0.4002,6.002999999999999,4867.0,0.0012289999999999998,0.998474,KRTAP5-6 STMN3 TEX101 TMC2 TMEM141 TXNDC5,vestibular reflex|negative regulation of Rac protein signal transduction|regulation of microtubule-based process|reflex|detection of mechanical stimulus involved in sensory perception of sound,0.001165|0.001165|0.001918|0.004942|0.004942,1|1|1|1|1,1144|1144|29.21|214.5|214.5
2015,16,0.4013,48.15,11380.0,0.004203,0.999999,CCDC137 DDX31 FTSJ3 GNL2 MRTO4 NLE1 NOL12 NOP2 PINX1 RBM34 RPF2 RPL28 RRS1 SDAD1 TENT4B WDR89,ribosome biogenesis|ribonucleoprotein complex biogenesis|ribosomal large subunit biogenesis|ribosomal large subunit assembly|rRNA processing,9.374e-17|3.5e-15|1.03e-13|3.305e-11|5.861e-10,1.479e-12|2.761e-11|5.416e-10|1.303e-07|1.849e-06,42.65|30.45|125.1|229.9|34.66
2016,6,0.4328,6.492000000000001,4871.0,0.001328,0.998474,BMPR1B CASP10 CXCR2 GPBAR1 KRTDAP SPARC,cell surface bile acid receptor signaling pathway|interleukin-8-mediated signaling pathway|positive regulation of cholangiocyte proliferation|regulation of cell population proliferation|ovarian cumulus expansion,0.0006794|0.001019|0.001019|0.001162|0.001358,1|1|1|1|1,2942|1471|1471|7.176|980.7
2017,8,0.4012,11.23,6878.0,0.001627,0.9996790000000001,C1RL CDNF CLN5 CPLX1 KTN1 NIPAL1 SERPINE3 TTPA,intracellular pH reduction|pH reduction|regulation of intracellular pH|regulation of cellular pH|regulation of pH,0.0001601|0.00018|0.0005194|0.000603|0.0007061,1|1|1|1|1,107.3|101|58.51|54.2|49.99
2018,6,0.4003,6.004,4917.0,0.001217,0.998474,ADCY2 KYNU NDN SST TMEM252 VCAM1,amine metabolic process|response to nutrient|response to organonitrogen compound|response to nitrogen compound|response to nutrient levels,2.77e-06|1.123e-05|7.683e-05|0.0001069|0.000266,0.0437|0.08857|0.404|0.4216|0.8391,98.07|60.93|13.77|12.65|20.8
2019,5,0.4341,4.341,4188.0,0.001033,0.996692,B4GALNT3 FRMD1 LACTB TNC TNFAIP1,mesenchymal-epithelial cell signaling involved in prostate gland development|bud outgrowth involved in lung branching|cellular response to prostaglandin D stimulus|response to prostaglandin D|positive regulation of hippo signaling,0.0004854|0.0009706|0.001213|0.001213|0.001456,1|1|1|1|1,4119|1373|1030|1030|823.8
2020,8,0.4004,11.21,6558.0,0.001703,0.9996790000000001,BNIP2 CELF6 CMTM8 GOLGA6D LAD1 LINGO1 SEMA7A SKOR1,negative regulation of axonogenesis|negative regulation of neuron projection development|negative regulation of neurogenesis|negative regulation of nervous system development|regulation of axonogenesis,0.0003144|0.001197|0.001232|0.001321|0.001627,1|1|1|1|1,75.72|38.14|37.58|36.26|32.59
2021,5,0.4297,4.297,4088.0,0.001048,0.996692,C11orf45 LAMA1 MDH1 THAP2 TRIM54,retinal blood vessel morphogenesis|malate metabolic process|oxaloacetate metabolic process|retina vasculature morphogenesis in camera-type eye|branching involved in salivary gland morphogenesis,0.001698|0.002183|0.002425|0.00291|0.003878,1|1|1|1|1,686.5|514.9|457.7|374.5|274.6
2022,6,0.4095,6.143,4829.0,0.001267,0.998474,APOE LAMA4 NPTN PLCB1 TCF7 TMEM170A,learning or memory|cognition|regulation of long-term synaptic potentiation|regulation of neuronal synaptic plasticity|cell-cell signaling,3.647e-05|5.745e-05|7.597e-05|7.927e-05|0.0001231,0.5753|0.4531|0.3995|0.3126|0.3884,40.86|35.03|152.6|149.2|12.2
2023,7,0.4209,8.839,5870.0,0.0015,0.9992989999999999,ABCB5 AGR3 CH25H DYSF EHD4 KCNQ4 LAMA5,monocyte activation involved in immune response|protein localization to plasma membrane|B cell chemotaxis|protein localization to cell periphery|localization,0.001019|0.001851|0.002376|0.002642|0.002674,1|1|1|1|1,1471|30.18|490.4|25.15|3.04
2024,7,0.4313,9.058,5833.0,0.001547,0.9992989999999999,ABCA3 CCDC83 CLIC6 CUL4A GHRL LAMP1 SMIM18,"positive regulation of lipid transport|positive regulation of cellular component biogenesis|positive regulation of lipid localization|cortisol secretion|negative regulation of circadian sleep/wake cycle, REM sleep",0.0003994|0.0005485|0.0006259|0.0006794|0.001019,1|1|1|1|1,66.12|16.75|52.54|2942|1471
2025,7,0.4042,8.488999999999999,5693.0,0.001485,0.9992989999999999,B3GALT5 CASP7 FAM107B LAMP5 SCGB2A2 ZNF765 ZNF841,cellular response to staurosporine|response to staurosporine|response to pheromone|poly-N-acetyllactosamine biosynthetic process|poly-N-acetyllactosamine metabolic process,0.002037|0.002037|0.003732|0.004409|0.004748,1|1|1|1|1,588.4|588.4|294.2|245.2|226.3
2026,7,0.4003,8.405,5682.0,0.001474,0.9992989999999999,CLCA1 FAIM FAM25A LAMTOR5 PPP2R3A SELL ZNF263,regulation of cell migration involved in somitogenic axis elongation|somatic muscle development|Wnt signaling pathway involved in somitogenesis|positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding|regulation of RNA polymerase II regulatory region sequence-specific DNA binding,0.001019|0.001358|0.001698|0.001698|0.005425,1|1|1|1|1,1471|980.7|735.5|735.5|196.1
2027,5,0.4038,4.038,3894.0,0.001033,0.996692,DCST2 LAPTM4B PPP1R12B SLCO5A1 XAB2,generation of catalytic spliceosome for first transesterification step|negative regulation of lysosomal protein catabolic process|negative regulation of protein catabolic process in the vacuole|regulation of lysosomal membrane permeability|regulation of lysosome organization,0.0009706|0.0009706|0.0009706|0.0009706|0.001456,1|1|1|1|1,1373|1373|1373|1373|823.8
2028,5,0.4483,4.4830000000000005,4006.0,0.001115,0.996692,DDX25 FMNL3 LARP1B PCMTD2 TTC39B,negative regulation of cholesterol storage|regulation of cholesterol storage|negative regulation of lipid storage|poly(A)+ mRNA export from nucleus|regulation of cholesterol efflux,0.002425|0.00412|0.005329|0.005571|0.007744,1|1|1|1|1,457.7|257.4|196.1|187.2|132.9
2029,7,0.401,8.421,5091.0,0.0016469999999999998,0.9992989999999999,C1orf43 FAM102A KIAA0100 KIAA1109 LATS1 RAB14 VAPA,endocytic recycling|phagocytosis|inner cell mass cellular morphogenesis|inner cell mass cell fate commitment|phagolysosome assembly involved in apoptotic cell clearance,8.877e-05|0.0001347|0.001019|0.001019|0.001019,1|1|1|1|1,143.5|27.07|1471|1471|1471
2030,6,0.4254,6.381,4726.0,0.0013449999999999998,0.998474,CD2AP FOXL2NB LBX1 NKX2-4 SLC25A35 ZNF208,"negative regulation of transforming growth factor beta1 production|neuron fate determination|substrate-dependent cell migration, cell extension|regulation of transforming growth factor beta1 production|negative regulation of transforming growth factor beta production",0.002328|0.002619|0.002909|0.004071|0.004361,1|1|1|1|1,490.4|429.1|381.4|264|245.2
2031,6,0.4285,6.4270000000000005,4904.0,0.001306,0.998474,ACRV1 DPCD HACD2 LCMT2 LCP1 MC4R,third ventricle development|wybutosine biosynthetic process|wybutosine metabolic process|regulation of grooming behavior|positive regulation of podosome assembly,0.001456|0.001456|0.001456|0.001746|0.002909,1|1|1|1|1,858.1|858.1|858.1|686.5|381.4
2032,21,0.4056,85.19,16960.0,0.004984000000000001,1.0,ABCA2 AK8 DPP7 ENTPD2 ENTR1 FAM69B FBXW5 GLT6D1 LCN10 LCN15 LCN6 LCN8 LCNL1 NPDC1 NTMT1 PHPT1 RNF224 SARDH STPG3 TUBB4B UAP1L1,negative regulation of ATP citrate synthase activity|negative regulation of cholesterol esterification|N-terminal peptidyl-proline methylation|N-terminal peptidyl-serine methylation|N-terminal peptidyl-serine dimethylation,0.002036|0.002036|0.002036|0.002036|0.002036,1|1|1|1|1,980.7|980.7|980.7|980.7|980.7
2033,7,0.4184,8.787,6191.0,0.0014140000000000001,0.9992989999999999,BDKRB2 BSPH1 CD2 CFAP65 DMC1 LCP2 SUMF1,spermatid development|spermatid differentiation|germ cell development|cellular process involved in reproduction in multicellular organism|negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,2.409e-05|2.693e-05|0.0001062|0.0002686|0.0007765,0.38|0.2124|0.5582|1|1,49.83|47.97|30.05|21.88|2574
2034,5,0.4008,4.008,3632.0,0.001099,0.996692,LDHA OR51S1 PSMA7 RAE1 TNIP2,interleukin-1-mediated signaling pathway|mRNA export from nucleus|mRNA-containing ribonucleoprotein complex export from nucleus|ribonucleoprotein complex export from nucleus|ribonucleoprotein complex localization,0.0003318|0.0004409|0.0004409|0.0005741|0.000583,1|1|1|1|1,71.51|61.85|61.85|54.06|53.63
2035,6,0.4169,6.254,4847.0,0.001285,0.998474,CRIM1 KIRREL3 LDLRAD2 METTL25 PITPNM2 PLEKHG7,principal sensory nucleus of trigeminal nerve development|trigeminal sensory nucleus development|inter-male aggressive behavior|aggressive behavior|glomerulus morphogenesis,0.0008735|0.0008735|0.0008735|0.002328|0.002619,1|1|1|1|1,1716|1716|1716|490.4|429.1
2036,6,0.4182,6.274,4826.0,0.001295,0.998474,ANKRD62 GYPA HRH4 HSD17B1 LECT2 NIPAL1,testosterone biosynthetic process|adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway|olefinic compound biosynthetic process|estrogen biosynthetic process|magnesium ion transmembrane transport,0.001746|0.002619|0.003781|0.004071|0.004942,1|1|1|1|1,686.5|429.1|286|264|214.5
2037,6,0.4265,6.397,4909.0,0.0012980000000000001,0.998474,BMP1 LEKR1 LGI2 RPUSD1 SCN1B TMEM247,corticospinal neuron axon guidance|membrane depolarization during Purkinje myocyte cell action potential|Purkinje myocyte action potential|response to pyrethroid|Purkinje myocyte to ventricular cardiac muscle cell signaling,0.0008735|0.001165|0.001165|0.001456|0.001746,1|1|1|1|1,1716|1144|1144|858.1|686.5
2038,40,0.4014,313.1,31820.0,0.009719,1.0,KIR2DL1 LAIR2 LENG9 LILRB5 NLRP11 NLRP13 NLRP4 NLRP9 SMIM17 VN1R1 VN1R4 ZFP28 ZNF135 ZNF211 ZNF264 ZNF28 ZNF304 ZNF324 ZNF324B ZNF416 ZNF460 ZNF524 ZNF528 ZNF534 ZNF548 ZNF550 ZNF581 ZNF586 ZNF587 ZNF610 ZNF665 ZNF667 ZNF701 ZNF749 ZNF772 ZNF773 ZNF805 ZNF814 ZNF880 ZSCAN5B,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|cellular process",1.404e-17|3.639e-14|3.667e-14|3.81e-14|1.183e-13,2.215e-13|2.87e-10|1.928e-10|1.502e-10|3.733e-10,5.633|4.205|4.204|4.198|0.2595
2039,26,0.4059,131.9,21150.0,0.006182,1.0,ACSF2 C17orf47 CALCOCO2 EPX HOXB5 HOXB9 LPO LRRC46 MKS1 MPO MYCBPAP NME1 NME2 OR4D1 OR4D2 OSBPL7 PLEKHM1 PRAC1 PRR15L RSAD1 SCPEP1 SCRN2 SEPT4 SGCA TBKBP1 TBX21,hydrogen peroxide catabolic process|hydrogen peroxide metabolic process|UTP biosynthetic process|GTP biosynthetic process|UTP metabolic process,8.614e-06|2.277e-05|0.0001001|0.0001182|0.0001378,0.1359|0.1796|0.5264|0.4662|0.4348,81.94|57.96|158.4|144|132
2040,11,0.4008,22.05,6953.0,0.00315,0.999969,KRAS MAP2K5 MAP3K2 MAPK1 MAPK7 NF1 NRAS PRKCE RAF1 RCE1 SHOC2,MAPK cascade|intracellular signal transduction|regulation of intracellular signal transduction|regulation of phosphate metabolic process|regulation of phosphorus metabolic process,1.174e-16|5.438e-13|1.213e-08|1.9e-07|1.9e-07,1.852e-12|4.289e-09|6.376e-05|0.0007493|0.0005995,45.78|13.08|9.531|9.297|9.297
2041,6,0.4066,6.099,4935.0,0.001231,0.998474,CXCR6 FBXW10 LGALS1 MCF2L2 MELTF OSBPL6,post-translational protein modification|negative regulation of cell-substrate adhesion|positive regulation of erythrocyte aggregation|regulation of erythrocyte aggregation|plasma cell differentiation,0.0001052|0.0001414|0.0005824|0.0005824|0.001165,1|1|1|1|1,28.52|110.7|3432|3432|1144
2042,6,0.4337,6.506,5015.0,0.0012929999999999999,0.998474,CALHM1 H2AFY2 H3F3C LGALS12 LMOD2 TMEM14A,lymphatic endothelial cell migration|sensory perception of umami taste|sensory perception of sweet taste|negative regulation of organelle organization|pointed-end actin filament capping,0.0005825|0.001359|0.001359|0.001539|0.001553,1|1|1|1|1,2574|858.1|858.1|31.02|735.5
2043,8,0.4093,11.46,6033.0,0.001891,0.9996790000000001,CHIT1 ISCU LHX4 RGS18 RGS2 RGS21 TMEM183A TROVE2,negative regulation of cation transmembrane transport|regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway|negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process|regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process|negative regulation of iron ion import across plasma membrane,0.0003907|0.0006794|0.0006794|0.0006794|0.0006794,1|1|1|1|1,66.87|2942|2942|2942|2942
2044,5,0.4105,4.105,3876.0,0.0010550000000000002,0.996692,EMILIN1 GREM2 LHX8 ONECUT1 ZNF114,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway|regulation of transmembrane receptor protein serine/threonine kinase signaling pathway|regulation of cellular response to growth factor stimulus|negative regulation of transforming growth factor beta receptor signaling pathway|negative regulation of cellular response to growth factor stimulus,3.242e-06|1.819e-05|2.846e-05|0.000163|0.0002951,0.05115|0.1435|0.1496|0.6428|0.9308,88.26|49.23|42.32|100.5|74.22
2045,6,0.4175,6.2620000000000005,5063.0,0.001232,0.998474,CHDH EXD2 G0S2 LHX9 LRSAM1 MANEAL,dorsal spinal cord interneuron anterior axon guidance|glycine betaine biosynthetic process from choline|glycine betaine biosynthetic process|glycine betaine metabolic process|gonad morphogenesis,0.0005824|0.0008735|0.0008735|0.0008735|0.0008735,1|1|1|1|1,3432|1716|1716|1716|1716
2046,7,0.4047,8.498,5699.0,0.001485,0.9992989999999999,ARL14EPL LIMCH1 MERTK OSBPL5 PCTP RNF157 TOM1L1,phospholipid transport|organophosphate ester transport|cytoplasmic actin-based contraction involved in cell motility|neutrophil clearance|localization,0.0004352|0.0008632|0.001358|0.001698|0.002674,1|1|1|1|1,63.27|44.58|980.7|735.5|3.04
2047,7,0.418,8.777000000000001,5887.0,0.001485,0.9992989999999999,ADCK5 AGO3 FAM76A LIN28A LRP3 PRR16 TTC16,pre-miRNA processing|production of miRNAs involved in gene silencing by miRNA|production of small RNA involved in gene silencing by RNA|dsRNA processing|gene silencing by miRNA,1.185e-05|4.885e-05|6.2e-05|6.2e-05|0.0001203,0.1869|0.3852|0.326|0.2445|0.3795,420.3|196.1|173.1|173.1|122.6
2048,6,0.4193,6.289,4865.0,0.001288,0.998474,AOC3 ASIC3 EPHB4 LIN7B MTPN WSCD1,amine metabolic process|enterobactin transport|negative regulation of primary amine oxidase activity|detection of chemical stimulus involved in sensory perception of pain|siderophore transport,0.0003955|0.0005824|0.0008735|0.001165|0.001165,1|1|1|1|1,65.38|3432|1716|1144|1144
2049,5,0.4564,4.564,4195.0,0.001084,0.996692,C15orf65 LIMS2 LMAN1L MYO16 TRIM69,negative regulation of hepatocyte proliferation|positive regulation of integrin-mediated signaling pathway|regulation of integrin-mediated signaling pathway|regulation of hepatocyte proliferation|negative regulation of neural precursor cell proliferation,0.001213|0.00194|0.003878|0.00412|0.005571,1|1|1|1|1,1030|588.4|274.6|257.4|187.2
2050,7,0.4372,9.181000000000001,5849.0,0.0015630000000000002,0.9992989999999999,ANO7 CD82 DECR2 DGKH LIN28A LMF1 POU5F2,acylglycerol metabolic process|neutral lipid metabolic process|calcium activated galactosylceramide scrambling|calcium activated phosphatidylserine scrambling|RNA 3' uridylation,0.0005517|0.000562|0.001698|0.001698|0.002037,1|1|1|1|1,56.04|55.51|735.5|735.5|588.4
2051,8,0.4085,11.44,6164.0,0.001847,0.9996790000000001,COMMD5 GSX2 KDR KIT LNX1 PDGFRA SCFD2 TWIST2,hematopoietic progenitor cell differentiation|positive regulation of phosphatidylinositol 3-kinase signaling|regulation of cell migration|regulation of cell motility|regulation of locomotion,4.443e-06|5.066e-06|7.471e-06|1.039e-05|1.289e-05,0.07009|0.03995|0.03928|0.04096|0.04067,88.77|84.87|14.54|13.59|13
2052,7,0.4144,8.703,6026.0,0.001439,0.9992989999999999,CALHM2 DES FBXL20 LAMB3 LMOD1 NT5C1A RNASEL,"supramolecular fiber organization|regulation of protein catabolic process at presynapse, modulating synaptic transmission|pointed-end actin filament capping|purine nucleoside monophosphate catabolic process|muscle contraction",0.0007881|0.001019|0.002715|0.002715|0.002844,1|1|1|1|1,14.78|1471|420.3|420.3|24.22
2053,6,0.4149,6.224,5027.0,0.001233,0.998474,C2CD2L DIRAS2 DNAJC6 IRF5 LNX2 SNTN,synaptic vesicle uncoating|clathrin coat disassembly|vesicle uncoating|response to peptidoglycan|regulation of clathrin-dependent endocytosis,0.001456|0.001746|0.002037|0.004071|0.005812,1|1|1|1|1,858.1|686.5|572.1|264|180.7
2054,5,0.4086,4.086,3583.0,0.0011359999999999999,0.996692,DDN LONRF2 SF3A2 XAB2 YJU2,"generation of catalytic spliceosome for first transesterification step|spliceosomal conformational changes to generate catalytic conformation|ribonucleoprotein complex assembly|ribonucleoprotein complex subunit organization|mRNA splicing, via spliceosome",4.712e-07|1.319e-06|7.986e-06|8.887e-06|3.144e-05,0.007432|0.0104|0.04199|0.03505|0.09919,2746|1373|65.04|62.73|40.92
2055,5,0.4153,4.1530000000000005,4003.0,0.001034,0.996692,IL21 KLHDC3 LOXHD1 TRIM59 TSPYL1,germinal center B cell differentiation|T follicular helper cell differentiation|interleukin-21-mediated signaling pathway|cellular response to interleukin-21|response to interleukin-21,0.001698|0.001698|0.002183|0.002183|0.002183,1|1|1|1|1,686.5|686.5|514.9|514.9|514.9
2056,6,0.4015,6.022,4272.0,0.0014039999999999999,0.998474,FDX2 LPAR5 PUM1 PUM2 TRA2B TWISTNB,positive regulation of RIG-I signaling pathway|regulation of RIG-I signaling pathway|regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway|positive regulation of gene silencing by miRNA|positive regulation of posttranscriptional gene silencing,3.108e-06|1.087e-05|1.411e-05|2.185e-05|2.331e-05,0.04902|0.0857|0.07418|0.08618|0.07354,823.8|411.9|358.2|284.1|274.6
2057,9,0.4184,15.06,6908.0,0.00217,0.9998530000000001,AKR1C1 AKR1C3 CALML3 CALML5 FAM208B LPCAT3 MKRN3 NET1 RANGRF,cellular response to jasmonic acid stimulus|response to jasmonic acid|doxorubicin metabolic process|daunorubicin metabolic process|polyketide metabolic process,3.882e-06|3.882e-06|1.421e-05|1.421e-05|1.421e-05,0.06123|0.03061|0.07473|0.05604|0.04484,936.1|936.1|416.1|416.1|416.1
2058,7,0.4118,8.648,5887.0,0.001463,0.9992989999999999,CNIH2 FAXDC2 LPL MAP3K11 TMEM179B YIF1A ZBTB3,negative regulation of receptor localization to synapse|negative regulation of vesicle transport along microtubule|negative regulation of anterograde synaptic vesicle transport|negative regulation of synaptic vesicle transport|low-density lipoprotein particle mediated signaling,0.0006794|0.0006794|0.0006794|0.0006794|0.001358,1|1|1|1|1,2942|2942|2942|2942|980.7
2059,5,0.408,4.08,3842.0,0.001058,0.996692,IRX5 LPXN NOD2 TFAM THEMIS,positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria|positive regulation of antibacterial peptide biosynthetic process|detection of muramyl dipeptide|regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria|regulation of antibacterial peptide biosynthetic process,0.0004854|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,4119|4119|4119|4119|4119
2060,7,0.4064,8.533999999999999,5924.0,0.0014349999999999999,0.9992989999999999,AP5S1 BMP10 DISC1 DNAH6 FAM131B LRFN1 TRABD2A,positive regulation of protein oxidation|regulation of protein oxidation|pyramidal neuron migration|positive regulation of developmental growth|positive regulation of sarcomere organization,0.001019|0.001019|0.001358|0.001432|0.001698,1|1|1|1|1,1471|1471|980.7|34.41|735.5
2061,5,0.4139,4.138999999999999,3989.0,0.001034,0.996692,C17orf97 GBX2 GPN1 LRP1 PRSS54,positive regulation of sterol import|positive regulation of collateral sprouting of injured axon|regulation of collateral sprouting of injured axon|positive regulation of axon extension involved in regeneration|positive regulation of sprouting of injured axon,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
2062,5,0.4459,4.459,3915.0,0.001135,0.996692,GRIN3B LRP2BP SENP5 SERPINB1 STYX,negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process|regulation of SCF-dependent proteasomal ubiquitin-dependent protein catabolic process|MAPK export from nucleus|protein desumoylation|type B pancreatic cell proliferation,0.0004854|0.0004854|0.000728|0.002183|0.002425,1|1|1|1|1,4119|4119|2060|514.9|457.7
2063,5,0.4419,4.419,3921.0,0.001123,0.996692,GNAL LRP8 LRPAP1 RIN3 SLC25A51,negative regulation of receptor internalization|negative regulation of receptor-mediated endocytosis|negative regulation of endocytosis|regulation of receptor internalization|regulation of receptor-mediated endocytosis,4.943e-06|2.045e-05|5.517e-05|8.02e-05|0.0002745,0.07796|0.1613|0.2901|0.3163|0.8661,633.7|294.2|175.3|144.5|76.99
2064,6,0.4275,6.412999999999999,4892.0,0.001306,0.998474,DNAJC27 ITGB7 LRRC15 RNF19A SLC25A29 ZNF813,"regulation of MAPK export from nucleus|cell-matrix adhesion involved in ameboidal cell migration|mitochondrial L-ornithine transmembrane transport|regulation of protein catabolic process at postsynapse, modulating synaptic transmission|acyl carnitine transport",0.0005824|0.0008735|0.001165|0.001165|0.001746,1|1|1|1|1,3432|1716|1144|1144|686.5
2065,6,0.4041,6.062,4725.0,0.0012779999999999998,0.998474,EEF1A2 LDAH LRRC31 OTOP1 TM4SF1 TNFAIP2,exocyst localization|negative regulation of interferon-gamma-mediated signaling pathway|negative regulation of response to interferon-gamma|regulation of chaperone-mediated autophagy|cellular protein-containing complex localization,0.001746|0.002619|0.002619|0.002619|0.006391,1|1|1|1|1,686.5|429.1|429.1|429.1|163.5
2066,6,0.4211,6.317,4936.0,0.001275,0.998474,ARMC2 LRRC34 NOVA2 SELP SNN ZBED2,positive regulation of platelet activation|positive regulation of leukocyte tethering or rolling|regulation of leukocyte tethering or rolling|regulation of integrin activation|positive regulation of keratinocyte differentiation,0.001456|0.002619|0.004071|0.005232|0.005522,1|1|1|1|1,858.1|429.1|264|201.9|190.7
2067,7,0.4005,8.41,6008.0,0.001395,0.9992989999999999,BAG3 CDR2L FAM178B FNDC9 LRRC4 PCDHGA10 PCDHGA5,cell-cell adhesion via plasma-membrane adhesion molecules|cell-cell adhesion|positive regulation of aggrephagy|regulation of aggrephagy|homophilic cell adhesion via plasma membrane adhesion molecules,6.853e-05|0.00051|0.001358|0.001358|0.001367,1|1|1|1|1,34.08|17.17|980.7|980.7|35.24
2068,7,0.4193,8.805,5788.0,0.001515,0.9992989999999999,ACKR3 DPP7 LRRC4B LRRC61 NUTM2F TRIM36 ZNF576,positive regulation of mesenchymal stem cell migration|regulation of mesenchymal stem cell migration|regulation of postsynaptic density assembly|regulation of postsynaptic specialization assembly|regulation of excitatory synapse assembly,0.001552|0.001552|0.004651|0.005038|0.005811,1|1|1|1|1,858.1|858.1|234|214.5|183.9
2069,5,0.4031,4.031000000000001,3882.0,0.001035,0.996692,ANXA2 CNGA4 LRRC4C SAMD11 TEX2,metabolism by host of substance in symbiont|multi-organism metabolic process|multi-organism catabolic process|positive regulation of low-density lipoprotein particle receptor binding|negative regulation of development of symbiont involved in interaction with host,0.0004854|0.0004854|0.0004854|0.0004854|0.0004854,1|0.4504|0.4785|0.5104|0.589,4119|4119|4119|4119|4119
2070,7,0.4046,8.497,5863.0,0.001444,0.9992989999999999,CTGF FBLN7 LRRC55 MOCOS NPPC SLC38A9 ZNF429,growth plate cartilage chondrocyte proliferation|negative regulation of oocyte maturation|Mo-molybdopterin cofactor biosynthetic process|molybdopterin cofactor biosynthetic process|prosthetic group metabolic process,0.0008735|0.001165|0.002037|0.002037|0.002037,1|1|1|1|1,1716|1144|572.1|572.1|572.1
2071,5,0.4174,4.1739999999999995,3909.0,0.001064,0.996692,D2HGDH GPATCH3 LRRC56 SMAD9 TMPRSS11D,negative regulation of RIG-I signaling pathway|response to cobalt ion|negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway|2-oxoglutarate metabolic process|response to manganese ion,0.002183|0.002667|0.00291|0.004362|0.004845,1|1|1|1|1,514.9|411.9|374.5|242.3|216.8
2072,6,0.438,6.57,4873.0,0.001343,0.998474,BTRC GLRX2 GPR87 LRRC71 RAB20 SMIM29,DNA protection|phagosome-lysosome fusion|mammary gland epithelial cell proliferation|positive regulation of ubiquitin protein ligase activity|G protein-coupled purinergic nucleotide receptor signaling pathway,0.001746|0.00349|0.003781|0.004071|0.004361,1|1|1|1|1,686.5|312|286|264|245.2
2073,6,0.4174,6.261,4725.0,0.00132,0.998474,EFCAB6 FAM71B HBEGF LDLRAD3 LRRC75A RAPGEF5,"negative regulation of elastin biosynthetic process|regulation of elastin biosynthetic process|wound healing, spreading of epidermal cells|positive regulation of keratinocyte migration|positive regulation of epidermal growth factor-activated receptor activity",0.0005824|0.0005824|0.0032|0.003781|0.004071,1|1|1|1|1,3432|3432|343.2|286|264
2074,6,0.4443,6.664,5039.0,0.001318,0.998474,APRT LRRC8A LRRC8D SLC35B3 SLC4A3 TNFRSF21,sulfur compound transport|organic anion transport|alkanesulfonate transport|taurine transport|anion transmembrane transport,3.017e-07|1.116e-06|1.978e-06|1.978e-06|3.614e-06,0.00476|0.008804|0.0104|0.0078|0.0114,210.2|40.38|1144|1144|29.98
2075,32,0.4004,198.6,25590.0,0.007683,1.0,ADA BPIFB4 CCM2L CNBD2 CPNE1 DEFB115 DEFB116 DUSP15 FAM209A FAM209B FAM83C FOXS1 GGT7 GHRH HCK HM13 LBP MAP1LC3A MYH7B MYLK2 NECAB3 NOL4L POFUT1 RALY RBPJL REM1 SOGA1 TLDC2 TM9SF4 WFDC11 WISP2 XKR7,"regulation of circadian sleep/wake cycle, sleep|regulation of circadian sleep/wake cycle|response to bacterium|positive regulation of multicellular organism growth|response to isoquinoline alkaloid",0.0003922|0.000578|0.0007602|0.001344|0.001421,1|1|1|1|1,75.72|61.29|5.378|39.01|37.86
2076,5,0.4425,4.425,3867.0,0.00114,0.996692,FAM193A GPX5 LRRIQ1 MTMR2 SLC13A4,negative regulation of receptor catabolic process|regulation of phosphatidylinositol dephosphorylation|positive regulation of early endosome to late endosome transport|negative regulation of myelination|negative regulation of excitatory postsynaptic potential,0.0009706|0.001698|0.002183|0.002183|0.002667,1|1|1|1|1,1373|686.5|514.9|514.9|411.9
2077,5,0.4571,4.571000000000001,4013.0,0.001135,0.996692,FAM102A LRRIQ3 MMP9 TBC1D10B TCHH,negative regulation of epithelial cell differentiation involved in kidney development|negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway|positive regulation of receptor binding|cellular response to UV-A|positive regulation of keratinocyte migration,0.001456|0.001698|0.002667|0.00291|0.003152,1|1|1|1|1,823.8|686.5|411.9|374.5|343.3
2078,24,0.4014,110.8,17800.0,0.006169,1.0,BTN2A1 BTN2A2 GPX6 HIST1H1T HIST1H2AD HIST1H2BD HIST1H3J HLA-A HLA-C HLA-F HLA-G MICB OR14J1 OR2B6 OR2J2 OR2J3 SLC17A4 TAPBP TRIM10 TRIM26 ZKSCAN4 ZNF184 ZSCAN16 ZSCAN31,"antigen processing and presentation of endogenous peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen|antigen processing and presentation of endogenous antigen|antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent|antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway",2.209e-11|3.561e-11|1.417e-10|4.784e-10|4.784e-10,3.485e-07|2.808e-07|7.448e-07|1.887e-06|1.509e-06,275.3|246.4|180|468.1|468.1
2079,18,0.4002,61.23,12260.0,0.004957,1.0,COPB1 EIF3F EIF3M FAU IPO7 NUP98 RPL11 RPL12 RPL13 RPL17 RPL23 RPL23A RPL27A RPL37 RPL4 RPL9 RPLP2 RPS13,translational initiation|viral gene expression|viral transcription|SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane,7.503e-30|1.044e-28|2.294e-28|1.01e-26|1.87e-26,1.184e-25|8.235e-25|1.206e-24|3.984e-23|5.9e-23,120|99.78|138.1|154.9|147.3
2080,6,0.43,6.449,5136.0,0.001251,0.998474,BPIFB3 CD300LF GLDN LRRTM1 POU4F2 TNFAIP1,interleukin-13-mediated signaling pathway|negative regulation of amacrine cell differentiation|negative regulation of MyD88-dependent toll-like receptor signaling pathway|negative regulation of apoptotic cell clearance|positive regulation of interleukin-4-mediated signaling pathway,0.0005824|0.0005824|0.0008735|0.0008735|0.0008735,1|1|1|1|1,3432|3432|1716|1716|1716
2081,6,0.4459,6.688,4829.0,0.0013800000000000002,0.998474,ATF7 CD52 LRTM2 METTL7A NLRP10 PTGR1,lipoxin A4 metabolic process|response to antineoplastic agent|positive regulation of interleukin-1 alpha production|leukotriene B4 metabolic process|lipoxin metabolic process,0.001456|0.001456|0.002037|0.002037|0.002619,1|1|1|1|1,858.1|858.1|572.1|572.1|429.1
2082,6,0.4047,6.071000000000001,4687.0,0.0012900000000000001,0.998474,BTG3 CNOT6 CNOT7 FHIT GLYCTK LSM14B,"signal transduction by p53 class mediator|nuclear-transcribed mRNA poly(A) tail shortening|exonucleolytic catabolism of deadenylated mRNA|nuclear-transcribed mRNA catabolic process, exonucleolytic|negative regulation of mitotic cell cycle",3.902e-06|2.114e-05|4.188e-05|4.687e-05|5.745e-05,0.06156|0.1668|0.2202|0.1848|0.1812,87.27|298.5|208|196.1|35.03
2083,6,0.4089,6.132999999999999,4926.0,0.00124,0.998474,ACSF3 CCDC39 LSP1 NLRP2 NUDT7 RGS7BP,fatty-acyl-CoA metabolic process|fatty acid derivative metabolic process|acyl-CoA metabolic process|thioester metabolic process|malonate catabolic process,6.651e-05|0.0002438|0.0003386|0.0003386|0.0005824,1|1|1|1|1,163.5|83.72|70.77|70.77|3432
2084,6,0.4118,6.1770000000000005,4475.0,0.001375,0.998474,GFRAL LTB TBC1D23 UBE2D1 UBE2D2 UBE2D3,TRIF-dependent toll-like receptor signaling pathway|MyD88-independent toll-like receptor signaling pathway|protein K48-linked ubiquitination|protein targeting to peroxisome|establishment of protein localization to peroxisome,7.465e-08|9.766e-08|4.668e-07|1.25e-06|1.25e-06,0.001178|0.0007702|0.002455|0.00493|0.003944,343.2|312|180.7|128.7|128.7
2085,21,0.4085,85.79,15630.0,0.005443,1.0,ANO1 BBS1 CARNS1 CCDC36 CPT1A CTTN DIXDC1 FGF19 FGF4 FOLR2 GAL IGHMBP2 KRTAP5-9 LTO1 MRGPRD MRGPRF MYEOV P2RY6 POLD4 TESMIN ZNF20,positive regulation of ERK1 and ERK2 cascade|cellular response to pyrimidine ribonucleotide|response to pyrimidine ribonucleotide|carnosine biosynthetic process|positive regulation of ion transmembrane transport,0.001752|0.002327|0.002327|0.002327|0.002509,1|1|1|1|1,12.56|858.1|858.1|858.1|11.05
2086,6,0.4251,6.377000000000001,4983.0,0.001275,0.998474,LUC7L MOV10 RGS11 TPGS1 VRK2 ZSCAN22,"mRNA cleavage involved in gene silencing|mRNA cleavage involved in gene silencing by miRNA|negative regulation of transposition, RNA-mediated|regulation of transposition, RNA-mediated|regulation of interleukin-1-mediated signaling pathway",0.0008735|0.0008735|0.001165|0.001165|0.002619,1|1|1|1|1,1716|1716|1144|1144|429.1
2087,8,0.4026,11.27,5581.0,0.00201,0.9996790000000001,AAR2 CD2BP2 DDX23 ICE2 LUM NCDN TEX9 USPL1,spliceosomal tri-snRNP complex assembly|ribonucleoprotein complex assembly|ribonucleoprotein complex subunit organization|spliceosomal snRNP assembly|RNA metabolic process,1.382e-05|4.378e-05|4.868e-05|0.0001074|0.0001303,0.218|0.3453|0.256|0.4234|0.4112,396.1|40.65|39.2|132|8.05
2088,6,0.4065,6.098,4978.0,0.001221,0.998474,CCDC150 DNALI1 LEMD1 LY75 PLEKHG3 TMC6,regulation of biological process|regulation of cellular process|UNCLASSIFIED|biological_process|biological regulation,0.005845|0.008451|0.03466|0.03466|0.03641,1|1|1|1|1,0|0|3.751|0.5769|0.273
2089,5,0.4216,4.216,3902.0,0.001077,0.996692,ABHD17B C1orf94 LY9 RILPL1 SNX20,protein transport from ciliary membrane to plasma membrane|negative regulation of protein localization to microtubule|regulation of protein localization to microtubule|protein transport within lipid bilayer|T-helper 17 cell lineage commitment,0.000728|0.001456|0.001456|0.001698|0.00194,1|1|1|1|1,2060|823.8|823.8|686.5|588.4
2090,5,0.4273,4.273,4043.0,0.001053,0.996692,DEPTOR IFRD2 IGFBP2 LY96 ZNF561,detection of lipopolysaccharide|negative regulation of MyD88-independent toll-like receptor signaling pathway|negative regulation of signal transduction|regulation of MyD88-independent toll-like receptor signaling pathway|positive regulation of lipopolysaccharide-mediated signaling pathway,0.001213|0.00194|0.002172|0.002183|0.002183,1|1|1|1|1,1030|588.4|9.684|514.9|514.9
2091,7,0.4127,8.667,6024.0,0.001433,0.9992989999999999,ADAMDEC1 AZGP1 KLHL2 LYPLA1 MGARP SEC24D SOWAHC,antigen processing and presentation of peptide antigen via MHC class I|antigen processing and presentation of peptide antigen|antigen processing and presentation of endogenous peptide antigen via MHC class Ib|negative regulation of Golgi to plasma membrane protein transport|cellular response to gonadotropin-releasing hormone,0.0005015|0.001814|0.002376|0.002376|0.002376,1|1|1|1|1,58.84|30.49|490.4|490.4|490.4
2092,5,0.4055,4.055,3915.0,0.001032,0.996692,CEP128 LYPLAL1 MYO1F TMEM132D ZCCHC10,protein depalmitoylation|macromolecule depalmitoylation|lipoprotein catabolic process|vesicle transport along actin filament|actin filament-based transport,0.002667|0.003636|0.00412|0.004845|0.005329,1|1|1|1|1,411.9|294.2|257.4|216.8|196.1
2093,5,0.4034,4.034,3905.0,0.001029,0.996692,AKT3 ARMH2 BHMT2 LZTS2 TSLP,S-methylmethionine metabolic process|positive regulation of chemokine (C-C motif) ligand 1 production|regulation of chemokine (C-C motif) ligand 1 production|primary ureteric bud growth|positive regulation of granulocyte colony-stimulating factor production,0.0004854|0.0004854|0.0004854|0.0004854|0.0009706,1|1|1|1|1,4119|4119|4119|4119|1373
2094,5,0.4153,4.1530000000000005,3932.0,0.001052,0.996692,BHLHA9 IRF7 M6PR SETX UST,protein targeting to lysosome|protein targeting to vacuole|protein localization to lysosome|establishment of protein localization to vacuole|protein localization to vacuole,2.29e-05|6.35e-05|7.275e-05|0.0001043|0.0001741,0.3613|0.5008|0.3825|0.4111|0.5493,286|167.4|156|129.5|99.49
2095,12,0.425,28.05,8095.0,0.003443,0.999986,BUB1B DLGAP5 DSN1 KNTC1 MAD1L1 MAD2L1 MAPRE1 NUSAP1 TRIP13 TTK ZWILCH ZWINT,microtubule cytoskeleton organization involved in mitosis|mitotic spindle organization|regulation of mitotic nuclear division|spindle organization|mitotic cell cycle process,5.168e-22|9.228e-20|1.138e-18|1.986e-18|2.045e-18,8.152e-18|7.278e-16|5.983e-15|7.833e-15|6.451e-15,102|104.6|140.4|76.28|30.07
2096,5,0.433,4.33,3863.0,0.001117,0.996692,CD300LB GPR153 LHX8 MAL SLC25A4,positive regulation of interleukin-15 production|regulation of interleukin-15 production|cytotoxic T cell differentiation|TIRAP-dependent toll-like receptor 4 signaling pathway|TIRAP-dependent toll-like receptor signaling pathway,0.0006794|0.0006794|0.0006794|0.0006794|0.0006794,1|1|1|1|1,2942|2942|2942|2942|2942
2097,6,0.4417,6.626,4725.0,0.001397,0.998474,FHL5 MAN1B1 PRG2 PRG3 PYGM ZFPL1,reactive oxygen species metabolic process|histamine biosynthetic process|trimming of second mannose on A branch|trimming of first mannose on A branch|trimming of terminal mannose on B branch,0.0009055|0.001164|0.001164|0.001164|0.001164,1|1|1|1|1,44.01|1287|1287|1287|1287
2098,5,0.4041,4.041,3869.0,0.0010400000000000001,0.996692,MAN2B2 RBM45 SELENOS SEMA3C SEMA3E,negative regulation of axon extension involved in axon guidance|regulation of axon extension involved in axon guidance|semaphorin-plexin signaling pathway|negative regulation of axon extension|negative chemotaxis,1.777e-05|2.636e-05|3.663e-05|4.857e-05|5.293e-05,0.2803|0.2079|0.1926|0.1916|0.167,316.8|257.4|216.8|187.2|179.1
2099,13,0.4028,31.42,8301.0,0.003759,0.999993,ASNS ATF4 C2orf69 EIF2AK4 GCN1 GLUL PC QARS SLC3A2 SLC7A1 SLC7A11 SLC7A5 TRPM7,amino acid import across plasma membrane|amino acid import|L-alpha-amino acid transmembrane transport|L-amino acid transport|import into cell,1.183e-08|2.659e-08|8.647e-08|1.125e-07|1.67e-07,0.0001866|0.0002097|0.0004547|0.0004435|0.0005268,166.4|134|98.07|91.53|37.51
2100,6,0.4215,6.3229999999999995,4933.0,0.001277,0.998474,C12orf40 DNAJC10 FGF14 MANEA PLPPR3 SYCE1,positive regulation of high voltage-gated calcium channel activity|regulation of voltage-gated sodium channel activity|protein folding in endoplasmic reticulum|positive regulation of voltage-gated calcium channel activity|regulation of high voltage-gated calcium channel activity,0.001746|0.002328|0.00349|0.003781|0.004361,1|1|1|1|1,686.5|490.4|312|286|245.2
2101,6,0.4101,6.152,4705.0,0.001302,0.998474,BLVRB CSKMT IQCB1 MAP1LC3B OXLD1 SLC25A10,oxaloacetate(2-) transmembrane transport|malate transmembrane transport|malate transport|oxaloacetate transport|thiosulfate transport,0.001456|0.001456|0.001456|0.001456|0.001456,1|1|1|1|1,858.1|858.1|858.1|858.1|858.1
2102,5,0.4454,4.454,3950.0,0.001123,0.996692,C1QTNF12 MAP1S PRKAG1 SCNN1D TNFRSF4,regulation of chromatin disassembly|regulation of carbohydrate metabolic process|autophagy|process utilizing autophagic mechanism|regulation of small molecule metabolic process,0.000728|0.001072|0.002163|0.002163|0.004342,1|1|1|1|1,2060|38.5|26.92|26.92|18.85
2103,6,0.4481,6.721,5085.0,0.001317,0.998474,ADAM11 MAP2K6 OTOL1 PYY SLC30A5 SPATC1L,otolith mineralization|cellular response to sorbitol|response to sorbitol|positive regulation of cAMP-dependent protein kinase activity|cobalt ion transport,0.0008735|0.001165|0.001746|0.002037|0.002328,1|1|1|1|1,1716|1144|686.5|572.1|490.4
2104,7,0.4222,8.866,6136.0,0.001439,0.9992989999999999,CHRM1 DNASE1L3 GHRH MAP3K13 SLC43A3 TOB2 ZNF341,"positive regulation of circadian sleep/wake cycle, REM sleep|positive regulation of branching morphogenesis of a nerve|phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway|positive regulation of developmental growth|regulation of circadian sleep/wake cycle, REM sleep",0.0006794|0.0006794|0.001358|0.001432|0.001698,1|1|1|1|1,2942|2942|980.7|34.41|735.5
2105,6,0.4258,6.3870000000000005,4695.0,0.001355,0.998474,HCAR1 MAP3K21 NR4A2 NR5A2 SLC38A7 VGLL2,methionine transport|general adaptation syndrome|transcription initiation from RNA polymerase II promoter|asparagine transport|epithalamus development,0.0005824|0.0008735|0.001162|0.001165|0.001165,1|1|1|1|1,3432|1716|37.72|1144|1144
2106,5,0.4163,4.163,3936.0,0.0010539999999999998,0.996692,CCNO FAM161B MAP3K3 PMAIP1 SALL4,positive regulation of cell proliferation in bone marrow|regulation of cell proliferation in bone marrow|protein insertion into mitochondrial membrane involved in apoptotic signaling pathway|multi-ciliated epithelial cell differentiation|positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,0.001698|0.001698|0.00194|0.002425|0.00291,1|1|1|1|1,686.5|686.5|588.4|457.7|374.5
2107,5,0.4564,4.564,3884.0,0.0011710000000000002,0.996692,C1QTNF8 FAM173A MAP6D1 TMEM95 UBE2Q2,N-terminal protein palmitoylation|N-terminal peptidyl-L-cysteine N-palmitoylation|N-terminal protein lipidation|fusion of sperm to egg plasma membrane involved in single fertilization|plasma membrane fusion,0.0003883|0.0003883|0.001165|0.004266|0.00504,1|1|1|1|1,5149|5149|1030|245.2|205.9
2108,32,0.4047,200.7,26200.0,0.007586,1.0,C5AR1 C5AR2 CABP5 COX6B2 FFAR3 GPR32 KIR2DL1 KIR2DL3 KIR2DL4 KLK11 KLK3 LAIR1 LAIR2 LILRA4 LILRB2 LILRB4 LILRB5 MYBPC2 NLRP11 NLRP9 PSG2 PTPRH SHISA7 SIGLEC11 SIGLEC12 SPIB SULT2A1 SULT2B1 VN1R4 ZNF28 ZNF665 ZNF880,immune response-inhibiting cell surface receptor signaling pathway|immune response-inhibiting signal transduction|regulation of immune response|complement receptor mediated signaling pathway|regulation of immune system process,6.689e-07|1.157e-06|1.233e-06|2.257e-06|1.005e-05,0.01055|0.009123|0.006483|0.008902|0.03171,227.2|181.7|5.902|139.8|4.273
2109,6,0.4093,6.14,4514.0,0.001355,0.998474,FAM217B MAPKBP1 NCOA5 SEC14L4 ZNF318 ZNF638,negative regulation of defense response to bacterium|regulation of defense response to bacterium|negative regulation of interleukin-8 production|negative regulation of insulin receptor signaling pathway|negative regulation of cellular response to insulin stimulus,0.001746|0.004942|0.005812|0.01073|0.01131,1|1|1|1|1,686.5|214.5|180.7|95.35|90.33
2110,7,0.4068,8.542,5818.0,0.001463,0.9992989999999999,MARCKSL1 MPZL2 POLL SHTN1 TMEM69 TPTE ZNF19,actin filament bundle distribution|actin filament bundle retrograde transport|endoplasmic reticulum polarization|cytoplasmic actin-based contraction involved in cell motility|Cdc42 protein signal transduction,0.0006794|0.0006794|0.0006794|0.001358|0.002715,1|1|1|1|1,2942|2942|2942|980.7|420.3
2111,7,0.4003,8.407,5888.0,0.001422,0.9992989999999999,MARCO MYPN SEC24C SFTPB TMEM200A TNFRSF1B WNK4,negative regulation of secretion|distal tubule morphogenesis|negative regulation of pancreatic juice secretion|glial cell-neuron signaling|negative regulation of extracellular matrix constituent secretion,0.001288|0.001358|0.001358|0.001358|0.001698,1|1|1|1|1,36.32|980.7|980.7|980.7|735.5
2112,14,0.4002,36.41,9530.0,0.003795,0.9999969999999999,ACTR10 ACTR1A ANAPC5 DCTN2 DCTN4 DCTN5 DCTN6 DYNC1LI2 DYNLRB1 NDE1 SGO1 SPDL1 UBE2C VEZT,antigen processing and presentation of exogenous peptide antigen via MHC class II|antigen processing and presentation of peptide antigen via MHC class II|antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|biological phase|mitotic cell cycle phase,2.595e-13|2.967e-13|3.17e-13|1.889e-12|1.889e-12,4.093e-09|2.34e-09|1.667e-09|7.45e-09|5.96e-09,104|102|101|45.79|45.79
2113,5,0.4351,4.351,3904.0,0.0011099999999999999,0.996692,FN3KRP MATK NECAB1 ROBO2 SEC11C,negative regulation of negative chemotaxis|apoptotic process involved in luteolysis|regulation of negative chemotaxis|positive regulation of Notch signaling pathway involved in heart induction|regulation of Notch signaling pathway involved in heart induction,0.000728|0.0009706|0.001213|0.001213|0.001213,1|1|1|1|1,2060|1373|1030|1030|1030
2114,11,0.4018,22.1,7750.0,0.002836,0.999969,ARL2 CCDC86 FAU INTS5 NXF1 OSBP POLA2 SART1 STX5 TMEM258 WDR74,RNA metabolic process|maturation of 5S rRNA|ncRNA processing|positive regulation of cytotoxic T cell differentiation|regulation of cytotoxic T cell differentiation,0.0008807|0.001067|0.001359|0.001601|0.002134,1|1|1|1|1,5.855|1872|13|936.1|624.1
2115,7,0.4286,9.001,5868.0,0.0015279999999999998,0.9992989999999999,ALLC FRMPD2 GPR3 GRAMD2A MBL2 MYL5 SFRP1,convergent extension involved in somitogenesis|negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation|negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification|regulation of Wnt signaling pathway involved in dorsal/ventral axis specification|stromal-epithelial cell signaling involved in prostate gland development,0.0007765|0.0007765|0.0007765|0.0007765|0.0007765,1|1|1|1|1,2574|2574|2574|2574|2574
2116,7,0.428,8.988999999999999,5292.0,0.001691,0.9992989999999999,DNAJC30 FBN3 MBOAT1 OR1M1 OR7G1 OR7G3 ZNF266,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,0.0003262|0.0003881|0.0004332|0.0005335|0.0005952,1|1|1|1|1,20.01|18.86|18.16|16.91|16.28
2117,6,0.4002,6.002999999999999,4826.0,0.001239,0.998474,C16orf70 KIAA1958 LIPG LIPI MBOAT7 SLC34A2,triglyceride metabolic process|acylglycerol metabolic process|glycerolipid metabolic process|neutral lipid metabolic process|triglyceride catabolic process,2.026e-06|4.829e-06|4.867e-06|4.965e-06|4e-05,0.03196|0.03809|0.02559|0.01958|0.1262,113.2|84.06|29.42|83.27|217.9
2118,6,0.403,6.045,4875.0,0.001235,0.998474,BMP5 DIRC2 GRXCR2 MC3R OR1J4 PLCH2,allantois development|homoiothermy|neural fold elevation formation|epithelial cell development|negative regulation of cortisol biosynthetic process,0.0008735|0.0008735|0.001165|0.001304|0.001456,1|1|1|1|1,1716|1716|1144|35.57|858.1
2119,8,0.4007,11.22,6221.0,0.001796,0.9996790000000001,FOXK1 MCAM MCTP2 NR2F1 PQLC2 RANBP3 TMEM129 UBALD1,"vascular wound healing|glomerular filtration|renal filtration|angiogenesis involved in wound healing|retrograde protein transport, ER to cytosol",0.003054|0.005086|0.005425|0.006101|0.006101,1|1|1|1|1,367.8|210.2|196.1|173.1|173.1
2120,13,0.4091,31.91,9134.0,0.003471,0.999993,CDT1 CFDP1 GINS2 GINS3 MCM2 MCM3 MCM4 MCM5 MCM6 MCM7 NUP93 ORC1 ORC6,DNA replication initiation|DNA-dependent DNA replication|pre-replicative complex assembly|DNA replication|double-strand break repair via break-induced replication,1.46e-24|5.522e-21|4.237e-20|1.974e-19|2.755e-19,2.303e-20|4.355e-17|2.228e-16|7.783e-16|8.692e-16,368.4|89.83|219.4|64.3|924.1
2121,6,0.4266,6.399,4874.0,0.001308,0.998474,ABCA12 ARL5A CCNI2 MCOLN1 PACS1 RALGDS,protein localization to Golgi apparatus|protein localization to membrane|protein localization to Golgi membrane|protein localization to plasma membrane|protein localization,3.275e-05|0.0003377|0.001165|0.001331|0.001524,0.5166|1|1|1|1,236.7|19.18|1144|35.21|6.362
2122,5,0.422,4.22,3771.0,0.001115,0.996692,APOPT1 BAG5 GOLGA5 MCOLN2 ZNF446,"Golgi organization|positive regulation of macrophage inflammatory protein 1 alpha production|retrograde transport, vesicle recycling within Golgi|negative regulation of protein refolding|regulation of protein refolding",0.0002612|0.0003883|0.0005825|0.0009706|0.0009706,1|1|1|1|1,76.28|5149|2574|1287|1287
2123,5,0.4156,4.156000000000001,3913.0,0.001058,0.996692,CYP2U1 EEF1D MCUB OLIG2 PHLDA3,spinal cord oligodendrocyte cell fate specification|glial cell fate specification|oligodendrocyte cell fate commitment|oligodendrocyte cell fate specification|spinal cord oligodendrocyte cell differentiation,0.0009706|0.001213|0.001213|0.001213|0.001456,1|1|1|1|1,1373|1030|1030|1030|823.8
2124,5,0.4221,4.221,3965.0,0.0010609999999999999,0.996692,BIRC5 FGR MDFIC WDR27 WNT7B,activation of JUN kinase activity|positive regulation of JUN kinase activity|regulation of JUN kinase activity|JNK cascade|positive regulation of kinase activity,4.239e-05|0.0001163|0.0001749|0.0001789|0.0002483,0.6687|0.9176|0.9195|0.7056|0.7834,200.9|119.4|96.92|95.79|20.32
2125,5,0.4321,4.321000000000001,3836.0,0.0011220000000000002,0.996692,ABCA7 FKBP5 MDH1B MIOX NR1D2,inositol catabolic process|positive regulation of engulfment of apoptotic cell|regulation of engulfment of apoptotic cell|positive regulation of phospholipid efflux|regulation of phospholipid efflux,0.0004854|0.000728|0.0009706|0.001213|0.001213,1|1|1|1|1,4119|2060|1373|1030|1030
2126,5,0.4315,4.315,3731.0,0.001152,0.996692,CD63 HELB IFNG MDN1 RESP18,"regulation of carbohydrate phosphatase activity|positive regulation of fructose 1,6-bisphosphate metabolic process|regulation of fructose 1,6-bisphosphate metabolic process|positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity|regulation of fructose 1,6-bisphosphate 1-phosphatase activity",0.0004854|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,4119|4119|4119|4119|4119
2127,6,0.4067,6.1,4551.0,0.001335,0.998474,ARHGAP12 ARIH2 ASAP1 ME1 RAB40C RGS6,positive regulation of GTPase activity|regulation of GTPase activity|positive regulation of hydrolase activity|regulation of NADP metabolic process|positive regulation of membrane tubulation,0.0001563|0.0002582|0.0009925|0.001746|0.001746,1|1|1|1|1,24.93|21.02|13.25|686.5|686.5
2128,6,0.4522,6.782,4822.0,0.001401,0.998474,ARL15 C6orf48 MEA1 OARD1 SMIM29 UBE3C,peptidyl-glutamate ADP-deribosylation|protein de-ADP-ribosylation|biological regulation|regulation of biological process|purine nucleoside metabolic process,0.0009706|0.001698|0.008988|0.01377|0.0152,1|1|1|1|1,1373|686.5|0|0|66.44
2129,10,0.4011,18.05,7904.0,0.002273,0.999933,BIVM CLYBL COL4A2 GPR183 KCTD12 SLITRK1 SLITRK5 SLITRK6 ZIC2 ZIC5,regulation of presynapse assembly|regulation of presynapse organization|positive regulation of synapse assembly|positive regulation of cell junction assembly|regulation of synapse assembly,5.828e-07|5.828e-07|3.067e-06|1.298e-05|1.338e-05,0.009193|0.004597|0.01612|0.05121|0.04221,187.2|187.2|104.7|63.7|63.05
2130,6,0.4341,6.511,4854.0,0.001336,0.998474,ANXA10 CFAP97D1 MEIOC MTNR1A RRAD STRADA,"spermatid development|spermatid differentiation|cell cycle switching|germline cell cycle switching, mitotic to meiotic cell cycle|cell cycle switching, mitotic to meiotic cell cycle",0.0008485|0.0009141|0.001165|0.001165|0.001165,1|1|1|1|1,44.29|42.64|1144|1144|1144
2131,5,0.4489,4.489,4029.0,0.0011099999999999999,0.996692,EVL MEOX1 QPCTL SCNN1D TULP2,"peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase|peptidyl-glutamine modification|sclerotome development|somite specification|negative regulation of ruffle assembly",0.000728|0.001213|0.001213|0.001456|0.001698,1|1|1|1|1,2060|1030|1030|823.8|686.5
2132,10,0.4111,18.5,7666.0,0.0024010000000000004,0.999933,ADPRHL1 DUX4 EPHA5 MEPE NBEAL1 OVOL2 POGZ ST20 TSPYL5 UQCRH,positive regulation of cellular metabolic process|endocardium formation|positive regulation of apoptotic DNA fragmentation|negative regulation of stem cell proliferation|cellular response to radiation,0.001791|0.002424|0.002909|0.002909|0.003226,1|1|1|1|1,3.816|514.9|411.9|411.9|23.27
2133,16,0.402,48.25,13240.0,0.003621,0.999999,ADAMTS7 BNIP2 CELF6 CSNK1G1 GOLGA6B LOXL1 MAP2K5 MESP2 PLEKHO2 PPIB SCAMP2 SCAMP5 SEMA7A SLC24A1 SNX22 THAP10,positive regulation of growth|protein deamination|negative regulation of chemokine (C-X-C motif) ligand 2 production|ERK5 cascade|collagen fibril organization,0.0009949|0.001552|0.002327|0.002327|0.002944,1|1|1|1|1,14.97|1287|643.6|643.6|24.99
2134,5,0.4479,4.479,4009.0,0.001113,0.996692,ATP4B FOXD2 METTL11B RTP5 TSC22D1,N-terminal protein amino acid methylation|establishment or maintenance of transmembrane electrochemical gradient|sodium ion export across plasma membrane|cellular potassium ion homeostasis|cellular sodium ion homeostasis,0.000728|0.003394|0.003636|0.003636|0.004845,1|1|1|1|1,2060|316.8|294.2|294.2|216.8
2135,6,0.4153,6.23,4692.0,0.001323,0.998474,B9D1 CLHC1 DIS3L2 ITGA9 METTL18 SLC16A9,"peptidyl-histidine methylation, to form tele-methylhistidine|peptidyl-histidine methylation|mitotic sister chromatid separation|polyuridylation-dependent mRNA catabolic process|miRNA catabolic process",0.0008735|0.001165|0.001165|0.001165|0.002328,1|1|1|1|1,1716|1144|1144|1144|490.4
2136,6,0.4194,6.291,4931.0,0.001271,0.998474,BTBD8 C2orf88 IRAK3 KIF1B METTL21A METTL25,response to rotenone|positive regulation of macrophage tolerance induction|regulation of macrophage tolerance induction|clathrin-dependent synaptic vesicle endocytosis|retrograde neuronal dense core vesicle transport,0.0005824|0.0005824|0.0005824|0.001456|0.001746,1|1|1|1|1,3432|3432|3432|858.1|686.5
2137,4,0.4356,2.613,3117.0,0.0008357000000000001,0.9929309999999999,FOXJ1 METTL21C MZT2B TAS2R5,positive regulation of central tolerance induction|regulation of central tolerance induction|glomerular parietal epithelial cell development|positive regulation of lung ciliated cell differentiation|positive regulation of central B cell tolerance induction,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
2138,6,0.4014,6.02,4675.0,0.001283,0.998474,BTN1A1 BTN2A1 DRC1 LCE3E METTL27 SLC17A4,axonemal dynein complex assembly|axoneme assembly|microtubule bundle formation|T cell receptor signaling pathway|sialic acid transport,6.916e-05|0.0003088|0.0005936|0.001583|0.002037,1|1|1|1|1,163.5|75.44|53.98|32.69|588.4
2139,7,0.4176,8.769,5971.0,0.001463,0.9992989999999999,COL4A3 HOPX LINGO3 MEX3D MYOZ3 PCDHGB7 SH3BP1,mRNA localization resulting in posttranscriptional regulation of gene expression|negative regulation of vascular endothelial cell proliferation|endothelial cell apoptotic process|intracellular mRNA localization|glomerular basement membrane development,0.001019|0.002037|0.003054|0.003393|0.004071,1|1|1|1|1,1471|588.4|367.8|326.9|267.5
2140,8,0.4083,11.43,6363.0,0.001789,0.9996790000000001,ARHGAP31 ERICH6 GPR160 MFSD1 NPHP3 ROPN1 SCHIP1 WDR5B,determination of stomach left/right asymmetry|determination of intestine left/right asymmetry|regulation of planar cell polarity pathway involved in neural tube closure|cilium movement|stomach development,0.0007765|0.0007765|0.0007765|0.001358|0.001552,1|1|1|1|1,2574|2574|2574|35.76|858.1
2141,5,0.4083,4.083,3839.0,0.00106,0.996692,GLT8D1 LBR MFSD3 RHNO1 TKTL2,positive regulation of G0 to G1 transition|neutrophil differentiation|granulocyte differentiation|secondary alcohol biosynthetic process|cholesterol biosynthetic process,0.001213|0.001456|0.007261|0.009913|0.009913,1|1|1|1|1,1030|823.8|142|103|103
2142,6,0.4148,6.221,4847.0,0.001279,0.998474,CDH20 CEP95 GMPPA KCTD3 MFSD4A REG1A,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|cellular response to gastrin|response to gastrin|response to growth hormone-releasing hormone|pancreas regeneration,9.298e-05|0.0006794|0.0006794|0.0006794|0.0006794,1|1|1|1|1,140.1|2942|2942|2942|2942
2143,5,0.4267,4.2669999999999995,4122.0,0.001032,0.996692,ADAMTS14 MFSD5 PXDN SLC6A7 THPO,hydrogen peroxide catabolic process|hydrogen peroxide metabolic process|cellular oxidant detoxification|collagen fibril organization|cellular detoxification,2.185e-05|4.239e-05|0.0002174|0.0002548|0.0002796,0.3447|0.3343|1|1|0.8821,284.1|200.9|86.72|79.98|76.28
2144,6,0.41,6.149,4804.0,0.001275,0.998474,LYPD4 MEDAG MFSD9 PTPDC1 ZNF518B ZNF799,positive regulation of fat cell differentiation|smoothened signaling pathway|peptidyl-tyrosine dephosphorylation|cellular process|regulation of fat cell differentiation,0.01907|0.0205|0.03077|0.0366|0.03699,1|1|1|1|1,52.81|49.04|32.38|0.4433|26.82
2145,5,0.4265,4.265,3939.0,0.0010789999999999999,0.996692,ATF7 HIST1H1T MGP PRM2 ZNF75A,cartilage condensation|cell aggregation|chromosome condensation|negative regulation of transcription by RNA polymerase II|regulation of bone mineralization,0.004266|0.004459|0.01045|0.01088|0.01468,1|1|1|1|1,245.2|234|97.15|11.42|68.65
2146,5,0.4193,4.1930000000000005,3888.0,0.001075,0.996692,CCDC122 CDKN2AIP DEFB131A MICALCL SH2D7,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion|cellular response to lipoteichoic acid|response to lipoteichoic acid|positive regulation of monocyte chemotaxis|positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,0.000728|0.00291|0.00291|0.005571|0.005812,1|1|1|1|1,2060|374.5|374.5|187.2|179.1
2147,5,0.4513,4.513,3850.0,0.001168,0.996692,LLGL2 MICU2 PABPC1L PIP5K1B ZNF705G,negative regulation of mitochondrial calcium ion concentration|leucine transport|positive regulation of mitochondrial calcium ion concentration|calcium import into the mitochondrion|chromatin-mediated maintenance of transcription,0.001213|0.001698|0.00291|0.00291|0.003152,1|1|1|1|1,1030|686.5|374.5|374.5|343.3
2148,7,0.4125,8.662,5429.0,0.0015890000000000001,0.9992989999999999,ADAMTS12 C5orf51 FBXO4 MIP MLANA OR10G7 PLCXD3,negative regulation of cellular response to hepatocyte growth factor stimulus|negative regulation of hepatocyte growth factor receptor signaling pathway|regulation of cellular response to hepatocyte growth factor stimulus|regulation of hepatocyte growth factor receptor signaling pathway|proteoglycan catabolic process,0.0009704|0.0009704|0.001455|0.002424|0.002424,1|1|1|1|1,2060|2060|1030|514.9|514.9
2149,25,0.4056,121.7,20610.0,0.005856,1.0,C8orf44 CA1 CA13 CA2 CA3 CHCHD7 CHMP4C CNGB3 CPA6 CYP7A1 FABP12 FABP4 LYN MCMDC2 NSMAF PMP2 PRDM14 SGK3 SLC26A7 SNX16 SULF1 TMEM67 TMEM69 TRIM55 UBE2W,bicarbonate transport|one-carbon metabolic process|organic anion transport|ion transport|organic substance transport,2.537e-09|2.008e-07|2.891e-06|4.974e-05|0.000125,4.002e-05|0.001584|0.0152|0.1961|0.3944,98.07|84.49|14.54|3.431|3.796
2150,6,0.418,6.269,4827.0,0.001294,0.998474,CACNA2D4 EEA1 ENTPD7 FAM149A MKKS RAB29,viral RNA genome replication|viral genome replication|cellular pigmentation|pigmentation|UTP catabolic process,1.037e-05|4e-05|0.0001302|0.0003907|0.0006794,0.1636|0.3155|0.6844|1|1,452.6|217.9|117.7|66.87|2942
2151,26,0.4003,130.1,20820.0,0.006193,1.0,ADGRF1 CRISP1 CRISP2 ENPP4 ENPP5 FBXO9 FRS3 GLYATL3 GSTA1 GSTA2 GSTA3 GSTA4 GUCA1A IL17A IL17F KLHL31 MLIP MUT PAQR8 PGC PKHD1 PRPH2 RAB23 SPATS1 TFAP2D ZNF318,glutathione derivative biosynthetic process|glutathione derivative metabolic process|positive regulation of antimicrobial peptide production|regulation of antimicrobial peptide production|positive regulation of antimicrobial humoral response,2.467e-08|2.467e-08|1.316e-07|1.879e-07|1.879e-07,0.0003891|0.0001946|0.000692|0.0007408|0.0005926,149.8|149.8|411.9|353.1|353.1
2152,5,0.4135,4.135,3986.0,0.001034,0.996692,C1orf189 CD1E MERTK MLLT11 ZNF559,"neutrophil clearance|antigen processing and presentation, endogenous lipid antigen via MHC class Ib|antigen processing and presentation, exogenous lipid antigen via MHC class Ib|antigen processing and presentation of lipid antigen via MHC class Ib|positive regulation of mitochondrial depolarization",0.001213|0.001456|0.00194|0.00194|0.002425,1|1|1|1|1,1030|823.8|588.4|588.4|457.7
2153,6,0.4152,6.228,4934.0,0.001258,0.998474,CCDC97 CFL2 MLNR REC8 WDR19 ZNF180,ciliary receptor clustering involved in smoothened signaling pathway|myotome development|actin filament fragmentation|gonad development|development of primary sexual characteristics,0.0008735|0.001165|0.001456|0.001524|0.001611,1|1|1|1|1,1716|1144|858.1|32.85|31.93
2154,8,0.4047,11.33,6615.0,0.0017059999999999998,0.9996790000000001,CCL24 FAM198A KRBOX1 MLPH SLC6A11 TATDN2 VIPR1 ZNF860,gamma-aminobutyric acid reuptake|positive regulation of eosinophil migration|amino acid neurotransmitter reuptake|regulation of eosinophil migration|gamma-aminobutyric acid transport,0.001698|0.001698|0.002376|0.002376|0.003393,1|1|1|1|1,735.5|735.5|490.4|490.4|326.9
2155,6,0.4417,6.626,4853.0,0.0013599999999999999,0.998474,CHCHD7 MMAA OR6K6 PNLIPRP1 SLURP1 TMEM177,urokinase plasminogen activator signaling pathway|short-chain fatty acid catabolic process|lipid catabolic process|negative regulation of keratinocyte proliferation|neuromuscular process controlling posture,0.001019|0.003393|0.004396|0.004748|0.005763,1|1|1|1|1,1471|326.9|19.36|226.3|183.9
2156,37,0.4012,267.2,29060.0,0.009087,1.0,ADAP2 ALDOC C17orf50 C17orf75 CCL13 CCL2 CCL7 CRYBA1 DHRS11 EPOP EVI2A GAS2L2 GSDMA GSDMB HAP1 KRT25 KRT26 KRT28 KRT31 KRT40 KRTAP1-4 KRTAP4-11 KRTAP4-2 KRTAP4-8 KRTAP9-8 KRTAP9-9 LGALS9 LYRM9 MMP28 PIPOX RDM1 SLC13A2 SLFN12 SLFN14 SPAG5 TIAF1 UNC119,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,4.594e-13|2.718e-12|1.511e-11|1.111e-10|2.676e-10,7.247e-09|2.144e-08|7.946e-08|4.382e-07|8.441e-07,25.7|21.67|18.38|15.17|13.93
2157,14,0.4046,36.82,11180.0,0.003273,0.9999969999999999,C1QTNF9 C1QTNF9B DZIP1 GJB2 GJB6 MN1 N4BP2L1 PCDH8 POSTN RNF6 RXFP2 SOHLH2 SPATA13 ZAR1L,gap junction-mediated intercellular transport|intercellular transport|gap junction assembly|cell communication by electrical coupling|oocyte differentiation,1.197e-05|1.539e-05|1.922e-05|9.822e-05|0.0003809,0.1888|0.1213|0.1011|0.3873|1,490.4|420.3|367.8|147.1|71.76
2158,5,0.4194,4.194,3951.0,0.001058,0.996692,CCDC198 MOB3A NDST4 RBM6 SERPINB1,"heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process|type B pancreatic cell proliferation|heparin biosynthetic process|heparin metabolic process|heparan sulfate proteoglycan biosynthetic process",0.002183|0.002425|0.00291|0.003152|0.005571,1|1|1|1|1,514.9|457.7|374.5|343.3|187.2
2159,5,0.4467,4.467,3962.0,0.001123,0.996692,DEFB123 MOBP NET1 SLC44A1 TRIM77,neurotransmitter uptake|sodium ion transmembrane transport|glycine import across plasma membrane|neurotransmitter transport|negative regulation of netrin-activated signaling pathway,6.1e-05|0.0009513|0.001164|0.001321|0.00194,0.9623|1|1|1|1,177.5|42.91|1287|36.26|643.6
2160,6,0.4011,6.017,4911.0,0.001221,0.998474,ANKRD34C ARPIN MOCS2 SPTBN5 TMEM74 WEE2,negative regulation of cytoskeleton organization|negative regulation of supramolecular fiber organization|negative regulation of lamellipodium morphogenesis|female pronucleus assembly|regulation of actin filament polymerization,0.0008166|0.0008378|0.0008735|0.0008735|0.001052,1|1|1|1|1,45.16|44.58|1716|1716|39.68
2161,5,0.4424,4.4239999999999995,3940.0,0.001119,0.996692,APOC4 CCDC171 MOG PRND SYNPO2L,very-low-density lipoprotein particle clearance|positive regulation of sequestering of triglyceride|very-low-density lipoprotein particle assembly|cellular copper ion homeostasis|regulation of sequestering of triglyceride,0.001698|0.002425|0.003394|0.003636|0.003636,1|1|1|1|1,686.5|457.7|316.8|294.2|294.2
2162,7,0.42,8.818999999999999,5970.0,0.001472,0.9992989999999999,ACADL COPS7B CRYGB MOGAT1 RETREG2 TRIM61 WNT10A,"carnitine catabolic process|carnitine metabolic process, CoA-linked|amino-acid betaine catabolic process|lens fiber cell morphogenesis|long-chain fatty acid catabolic process",0.0006794|0.001358|0.001358|0.002037|0.002037,1|1|1|1|1,2942|980.7|980.7|588.4|588.4
2163,6,0.4089,6.1339999999999995,4861.0,0.001257,0.998474,DECR2 KNSTRN MON1A REG1A SAMD7 ZSCAN31,cellular response to gastrin|response to gastrin|response to growth hormone-releasing hormone|pancreas regeneration|positive regulation of acinar cell proliferation,0.0005824|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,3432|3432|3432|3432|3432
2164,9,0.4056,14.6,7215.0,0.002014,0.9998530000000001,ATAD3C C1QTNF12 CALML6 FAAP20 HES3 MORN1 PRKCZ SLC35E2B TNFRSF4,positive regulation of insulin receptor signaling pathway|positive regulation of cellular response to insulin stimulus|regulation of cellular response to insulin stimulus|regulation of insulin receptor signaling pathway|positive regulation of production of molecular mediator of immune response,5.062e-05|6.374e-05|0.0003806|0.0004033|0.0009047,0.7985|0.5027|1|1|1,199|176|69.34|67.3|44.43
2165,6,0.4187,6.281000000000001,4697.0,0.001332,0.998474,CSN1S1 GSAP MDGA2 MPLKIP PTGDR2 ROR1,response to 11-deoxycorticosterone|response to dehydroepiandrosterone|negative regulation of male germ cell proliferation|negative regulation of germ cell proliferation|regulation of male germ cell proliferation,0.0005824|0.0005824|0.0008735|0.0008735|0.001165,1|1|1|1|1,3432|3432|1716|1716|1144
2166,5,0.4428,4.428,3981.0,0.001108,0.996692,AMBN ATP8A2 GOT1L1 MPND MTUS2,involuntary skeletal muscle contraction|aspartate biosynthetic process|positive regulation of phospholipid translocation|regulation of phospholipid translocation|aminophospholipid translocation,0.0009706|0.0009706|0.001456|0.001698|0.00194,1|1|1|1|1,1373|1373|823.8|686.5|588.4
2167,6,0.4313,6.47,4795.0,0.001344,0.998474,ATP10A C1orf100 DISP1 MPP2 PAPLN PIK3C2B,protein homooligomerization|maintenance of postsynaptic density structure|positive regulation of membrane tubulation|protein complex oligomerization|maintenance of postsynaptic specialization structure,0.001583|0.002037|0.002037|0.00262|0.002715,1|1|1|1|1,32.69|588.4|588.4|25.25|420.3
2168,6,0.4338,6.507000000000001,4984.0,0.001301,0.998474,CDK18 LRTM2 MPP4 PRR15 RSPH4A SYPL1,radial spoke assembly|regulation of transcription involved in G1/S transition of mitotic cell cycle|negative chemotaxis|positive regulation of synapse assembly|protein localization to synapse,0.0008735|0.01015|0.01361|0.01735|0.01792,1|1|1|1|1,1716|101|74.62|58.18|56.27
2169,18,0.3843,58.81,12390.0,0.004711,1.0,FLII GNA13 LRRFIP2 LUZP1 MPRIP MYH9 MYL12A MYL12B MYL6 NUAK2 PPP1R12A PPP1R12C ROCK1 ROCK2 SIAH1 SPECC1L SSH2 TMOD3,actin filament-based process|actin cytoskeleton organization|cytoskeleton organization|actomyosin structure organization|muscle contraction,1.639e-11|1.91e-10|1.372e-08|3.057e-08|4.809e-08,2.585e-07|1.506e-06|7.213e-05|0.0001206|0.0001517,19.13|19.65|9.503|55.01|28.25
2170,5,0.4562,4.562,3942.0,0.001153,0.996692,LELP1 MR1 SLC38A8 SNX32 TXLNB,positive regulation of T cell mediated cytotoxicity directed against tumor cell target|regulation of T cell mediated cytotoxicity directed against tumor cell target|methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione|methylglyoxal catabolic process|methylglyoxal catabolic process to lactate,0.0008735|0.0008735|0.001165|0.001456|0.001456,1|1|1|1|1,1716|1716|1144|858.1|858.1
2171,9,0.4372,15.74,6822.0,0.0022960000000000003,0.9998530000000001,ANAPC7 C17orf58 CLSPN DND1 LRRC37A LRRC37A2 LRRC37A3 LRRC37B PTDSS2,phosphatidylserine biosynthetic process|UNCLASSIFIED|biological_process|metaphase/anaphase transition of mitotic cell cycle|metaphase/anaphase transition of cell cycle,0.002182|0.003331|0.003331|0.00349|0.00349,1|1|1|1|1,572.1|4.168|0.5128|326.9|326.9
2172,42,0.4004,344.7,32670.0,0.010409999999999999,1.0,ADAP2 ALDOC AOC2 C17orf50 C17orf75 CCL13 CCL2 CCL7 DHRS11 EPOP EVI2A GAS2L2 GSDMB HAP1 KRT16 KRT20 KRT25 KRT26 KRT27 KRT28 KRT31 KRT40 KRTAP1-4 KRTAP1-5 KRTAP3-1 KRTAP4-11 KRTAP4-2 KRTAP4-3 KRTAP4-4 KRTAP4-8 KRTAP9-8 KRTAP9-9 LYRM9 MRM1 NME1 PIGS PIGW RDM1 SLC13A2 SLFN12 SPAG5 UNC119,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,8.463e-24|1.545e-22|2.578e-21|6.91e-20|2.958e-19,1.335e-19|1.219e-18|1.355e-17|2.725e-16|9.333e-16,37.28|31.44|26.66|22|20.2
2173,6,0.4033,6.0489999999999995,4676.0,0.001289,0.998474,ACADSB C8G MRNIP OR5AN1 TOPAZ1 TP53INP2,spermatocyte division|isoleucine catabolic process|positive regulation of meiotic cell cycle phase transition|isoleucine metabolic process|regulation of meiotic cell cycle phase transition,0.0005824|0.001456|0.001746|0.002328|0.002909,1|1|1|1|1,3432|858.1|686.5|490.4|381.4
2174,5,0.4103,4.103,3707.0,0.001103,0.996692,DHRS7C MESP1 MRS2 SLC25A1 SYT5,mitochondrial transmembrane transport|mitochondrial citrate transmembrane transport|mitochondrial magnesium ion transmembrane transport|mitochondrial tricarboxylic acid transmembrane transport|positive regulation of hepatocyte differentiation,0.0002646|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,78.46|4119|4119|4119|4119
2175,5,0.4224,4.224,3964.0,0.001062,0.996692,BPIFA3 DYM MS4A1 TM9SF3 ZFP90,store-operated calcium entry|calcium ion import into cytosol|B cell proliferation|calcium ion import|negative regulation of DNA binding,0.002183|0.004362|0.01015|0.01208|0.01352,1|1|1|1|1,514.9|242.3|100.5|84.06|74.89
2176,8,0.4162,11.65,6860.0,0.0016920000000000001,0.9996790000000001,ARGFX C20orf194 CAMK2A CER1 LCA5L MS4A10 PLPP6 WASF1,peptidyl-threonine autophosphorylation|dendritic transport of mitochondrion|negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry|negative regulation of nodal signaling pathway involved in determination of left/right asymmetry|growth plate cartilage chondrocyte proliferation,0.001164|0.001164|0.001164|0.001164|0.001164,1|1|1|1|1,1287|1287|1287|1287|1287
2177,5,0.4062,4.062,3726.0,0.001086,0.996692,C1orf226 EMP2 MS4A12 PYHIN1 RPF2,"regulation of signal transduction by p53 class mediator|positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|protein localization to nucleolus|positive regulation of integrin-mediated signaling pathway",0.0009018|0.0009706|0.0009706|0.00194|0.00194,1|1|1|1|1,42.03|1373|1373|588.4|588.4
2178,6,0.4136,6.204,5016.0,0.001232,0.998474,CYP27A1 MS4A4A MS4A6E NIPAL3 RWDD2A SLC34A2,sodium-dependent phosphate transport|cellular alcohol biosynthetic process|cellular alcohol metabolic process|calcitriol biosynthetic process from calciol|vitamin D biosynthetic process,0.001165|0.001456|0.001456|0.001456|0.001456,1|1|1|1|1,1144|858.1|858.1|858.1|858.1
2179,6,0.4006,6.007999999999999,4949.0,0.00121,0.998474,AZIN2 CNPY3 KNCN MS4A6A SNX15 SPATS1,trans-Golgi network membrane organization|positive regulation of polyamine transmembrane transport|agmatine biosynthetic process|putrescine biosynthetic process from ornithine|regulation of polyamine transmembrane transport,0.0005824|0.0008735|0.0008735|0.001165|0.001746,1|1|1|1|1,3432|1716|1716|1144|686.5
2180,6,0.4022,6.0329999999999995,4748.0,0.001266,0.998474,ADAMTS15 MN1 MS4A8 RNF175 S100Z SYNJ2BP,positive regulation of vitamin D receptor signaling pathway|intramembranous ossification|regulation of vitamin D receptor signaling pathway|direct ossification|negative regulation of osteoblast proliferation,0.001165|0.002328|0.002328|0.002328|0.0032,1|1|1|1|1,1144|490.4|490.4|490.4|343.2
2181,7,0.4041,8.486,5827.0,0.001451,0.9992989999999999,DCHS1 GHITM MSANTD1 OCIAD1 PLB1 SLC35D3 SLC38A11,UDP-N-acetylgalactosamine transmembrane transport|UDP-glucuronic acid transmembrane transport|mitral valve formation|condensed mesenchymal cell proliferation|positive regulation of mitochondrial ATP synthesis coupled electron transport,0.001358|0.001358|0.001358|0.001698|0.001698,1|1|1|1|1,980.7|980.7|980.7|735.5|735.5
2182,4,0.4411,2.647,2771.0,0.0009513999999999999,0.9929309999999999,MSGN1 TRAF2 ZNF699 ZSCAN23,I-kappaB kinase/NF-kappaB signaling|tumor necrosis factor-mediated signaling pathway|positive regulation of ubiquitin-specific protease activity|positive regulation of peptidase activity|regulation of I-kappaB kinase/NF-kappaB signaling,0.0001197|0.0003725|0.000728|0.0009109|0.001376,1|1|1|1|1,117.7|65.9|2060|41.82|33.9
2183,5,0.4502,4.502,3964.0,0.001131,0.996692,C5orf24 GRIN1 MSH2 MYDGF PWWP2A,ionotropic glutamate receptor signaling pathway|glutamate receptor signaling pathway|propylene metabolic process|response to glycine|cellular alkene metabolic process,2.86e-05|8.263e-05|0.0005824|0.0008735|0.0008735,0.4511|0.6517|1|1|1,254.3|146.1|3432|1716|1716
2184,21,0.4004,84.09,16050.0,0.0051979999999999995,1.0,AIF1 C6orf106 C6orf48 EGFL8 HLA-DMB HLA-F LY6G6F MICB MSH5 NCR3 NUDT3 OR14J1 OR2J3 PSORS1C2 STK19 TAP1 TAP2 TAPBP TNXB TRIM10 TRIM26,antigen processing and presentation of endogenous peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen|antigen processing and presentation of endogenous antigen|antigen processing and presentation of peptide antigen|antigen processing and presentation of peptide antigen via MHC class I,1.303e-11|2.101e-11|8.362e-11|2.598e-08|4.543e-08,2.055e-07|1.657e-07|4.397e-07|0.0001025|0.0001433,302.9|271|198|32.01|51.49
2185,5,0.4498,4.498,3883.0,0.0011539999999999999,0.996692,LRP5 MSI1 SIGIRR TSPAN3 USP6NL,"retrograde transport, plasma membrane to Golgi|cell-cell signaling involved in mammary gland development|Norrin signaling pathway|apoptotic process involved in blood vessel morphogenesis|extracellular matrix-cell signaling",0.000728|0.000728|0.0009706|0.001456|0.001456,1|1|1|1|1,2060|2060|1373|823.8|823.8
2186,6,0.4068,6.102,4928.0,0.001234,0.998474,CATSPER1 GPR176 MSS51 PLCL2 TC2N TCF25,B-1a B cell differentiation|B-1 B cell differentiation|B cell proliferation involved in immune response|regulation of cilium beat frequency involved in ciliary motility|negative regulation of B cell receptor signaling pathway,0.0008735|0.001746|0.002037|0.002328|0.002328,1|1|1|1|1,1716|686.5|572.1|490.4|490.4
2187,6,0.4114,6.171,4640.0,0.001325,0.998474,CLCNKA FAM131C MMEL1 MST1R PRAMEF18 TMPPE,macrophage colony-stimulating factor signaling pathway|cellular response to macrophage colony-stimulating factor stimulus|response to macrophage colony-stimulating factor|hepatocyte growth factor receptor signaling pathway|excretion,0.001456|0.002619|0.002619|0.003781|0.01188,1|1|1|1|1,858.1|429.1|429.1|286|85.81
2188,7,0.4004,8.408,5533.0,0.0015140000000000002,0.9992989999999999,C2orf54 ICAM2 MSTN OR13J1 OR2S2 SCN4A SPAG8,regulation of skeletal muscle contraction by action potential|negative regulation of myoblast proliferation|negative regulation of skeletal muscle tissue growth|system process|negative regulation of satellite cell differentiation,0.0005824|0.0008735|0.0008735|0.00123|0.001456,1|1|1|1|1,3432|1716|1716|6.73|858.1
2189,4,0.4616,2.7689999999999997,3063.0,0.0009011000000000001,0.9929309999999999,AKR1C1 MSX1 TCF4 TSSC4,positive regulation of mesenchymal cell apoptotic process|embryonic nail plate morphogenesis|cellular response to jasmonic acid stimulus|activation of meiosis|response to jasmonic acid,0.0005825|0.0005825|0.0009706|0.0009706|0.0009706,1|1|1|1|1,2574|2574|1287|1287|1287
2190,6,0.4027,6.04,4967.0,0.001212,0.998474,ACOX3 C1QTNF2 CYR61 MSX2 PTX3 SLC9A8,positive regulation of cell proliferation in midbrain|negative regulation of exo-alpha-sialidase activity|negative regulation by host of viral glycoprotein metabolic process|modulation by host of viral glycoprotein metabolic process|negative regulation by host of viral exo-alpha-sialidase activity,0.0005824|0.0008735|0.0008735|0.0008735|0.0008735,1|1|1|1|1,3432|1716|1716|1716|1716
2191,13,0.407,31.74,9072.0,0.0034770000000000005,0.999993,CARS EIF3CL GGPS1 GUK1 NARS NEDD8 OSGEP PSMA2 RABGGTA RABGGTB RARS THG1L YARS,tRNA metabolic process|tRNA aminoacylation for protein translation|tRNA aminoacylation|amino acid activation|ncRNA metabolic process,8.385e-10|2.157e-08|2.739e-08|2.958e-08|3.829e-07,1.323e-05|0.0001701|0.000144|0.0001166|0.001208,52.52|137.8|129.3|126.7|18.39
2192,5,0.442,4.42,3855.0,0.001142,0.996692,MTERF2 MUSK SLC22A17 SLC26A10 TNFRSF13B,positive regulation of protein geranylgeranylation|regulation of protein geranylgeranylation|termination of mitochondrial transcription|siderophore transport|regulation of synaptic growth at neuromuscular junction,0.0004854|0.0004854|0.000728|0.0009706|0.001456,1|1|1|1|1,4119|4119|2060|1373|823.8
2193,6,0.4053,6.079,4298.0,0.001408,0.998474,DHX9 EVA1C MTMR14 RNPC3 TMEM247 ZMAT5,"mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|RNA splicing|mRNA processing",6.218e-05|6.218e-05|6.402e-05|0.0001497|0.000249,0.9808|0.4904|0.3366|0.5903|0.7855,34.1|34.1|33.76|25.3|21.28
2194,7,0.4078,8.562999999999999,5801.0,0.00147,0.9992989999999999,ADAMTS13 CBS CHST5 CPNE2 MTMR7 SMIM21 SPATS2L,cysteine biosynthetic process from serine|cysteine biosynthetic process via cystathionine|homocysteine catabolic process|sulfur compound biosynthetic process|L-cysteine catabolic process,0.001019|0.001358|0.001358|0.001618|0.001698,1|1|1|1|1,1471|980.7|980.7|32.33|735.5
2195,7,0.4177,8.771,5939.0,0.001471,0.9992989999999999,ADRA2C AK9 FAM83C GRXCR2 MRPS10 MTX3 SLC12A5,AMP phosphorylation|thermosensory behavior|dGDP phosphorylation|dADP phosphorylation|negative regulation of uterine smooth muscle contraction,0.0006794|0.0006794|0.0006794|0.0006794|0.0006794,1|1|1|1|1,2942|2942|2942|2942|2942
2196,5,0.4198,4.198,3936.0,0.0010630000000000001,0.996692,C22orf15 DENND6B MUC17 PRB4 SEMA4F,retinal ganglion cell axon guidance|negative regulation of axon extension involved in axon guidance|regulation of axon extension involved in axon guidance|semaphorin-plexin signaling pathway|negative regulation of axon extension,0.004362|0.006537|0.007985|0.009431|0.01088,1|1|1|1|1,242.3|158.4|128.7|108.4|93.61
2197,6,0.4617,6.925,4810.0,0.001434,0.998474,ANKDD1A CABCOCO1 MUC21 NDST1 PRF1 TRIM36,negative regulation of cell-cell adhesion|negative regulation of cell adhesion|regulation of cell-cell adhesion|regulation of cell adhesion|defense response to tumor cell,3.985e-05|0.0001379|0.0004902|0.002162|0.002328,0.6286|1|1|1|1,41.97|27.48|17.8|10.64|514.9
2198,5,0.4485,4.485,3976.0,0.001124,0.996692,DNAH10 HCAR3 LITAF MUC22 TMEM119,positive regulation of bone development|regulation of bone development|positive regulation of osteoblast proliferation|negative regulation of myotube differentiation|negative regulation of bone resorption,0.0009706|0.00194|0.00291|0.003636|0.004362,1|1|1|1|1,1373|588.4|374.5|294.2|242.3
2199,6,0.4057,6.086,4371.0,0.001387,0.998474,CD5L CLDN4 MUC5B POU2AF1 PRDM1 TEX29,sebum secreting cell proliferation|positive regulation of complement-dependent cytotoxicity|regulation of extrathymic T cell differentiation|female pregnancy|multi-multicellular organism process,0.0005824|0.0005824|0.0008735|0.001125|0.00151,1|1|1|1|1,3432|3432|1716|38.35|33
2200,7,0.4059,8.524,5502.0,0.0015429999999999999,0.9992989999999999,ATP13A2 HIST1H4H HLA-DMB MUL1 OR7G2 PKDREJ PSMB8,regulation of endopeptidase activity|regulation of peptidase activity|peptidyl-aspartic acid autophosphorylation|polyamine transmembrane transport|peptidyl-aspartic acid phosphorylation,0.0002908|0.0003506|0.0006794|0.0006794|0.0006794,1|1|1|1|1,20.82|19.53|2942|2942|2942
2201,5,0.4096,4.096,3853.0,0.001059,0.996692,KANK2 MVB12A SLC39A13 TMED8 ZNF470,virus maturation|negative regulation of vitamin D receptor signaling pathway|glomerular visceral epithelial cell migration|endosome to lysosome transport via multivesicular body sorting pathway|regulation of vitamin D receptor signaling pathway,0.000728|0.000728|0.001698|0.00194|0.00194,1|1|1|1|1,2060|2060|686.5|588.4|588.4
2202,6,0.4007,6.011,4640.0,0.001291,0.998474,DMRT2 FAM20C FBXO45 MVB12B SMIM18 SUSD1,synapse assembly involved in innervation|regulation of myotome development|positive regulation of myotome development|virus maturation|odontoblast differentiation,0.0005824|0.0005824|0.0005824|0.0008735|0.001165,1|1|1|1|1,3432|3432|3432|1716|1144
2203,4,0.4635,2.781,3146.0,0.0008807999999999999,0.9929309999999999,DCLK3 INHA MYADM SYT5,regulation of localization|negative regulation of follicle-stimulating hormone secretion|negative regulation of protein kinase C signaling|negative regulation of B cell differentiation|positive regulation of gonadotropin secretion,0.0003115|0.0007766|0.0009706|0.001165|0.001165,1|1|1|1|1,7.533|1716|1287|1030|1030
2204,6,0.4034,6.05,4987.0,0.001209,0.998474,CFAP299 HADHA IRGM MYBPH TFPI ZNF445,maintenance of imprinting at mating-type locus|genetic imprinting at mating-type locus|regulation of mating type switching|cellular response to lipopolysaccharide|cellular response to molecule of bacterial origin,0.0005824|0.0008735|0.0008735|0.00115|0.001278,1|1|1|1|1,3432|1716|1716|37.93|35.94
2205,5,0.4133,4.133,3758.0,0.0010960000000000002,0.996692,ACTN4 CHST9 MYEF2 RNF115 ZNF583,regulation of mRNA stability involved in response to oxidative stress|regulation of mRNA stability involved in response to stress|positive regulation of sodium:proton antiporter activity|regulation of sodium:proton antiporter activity|peroxisome proliferator activated receptor signaling pathway,0.000728|0.0009706|0.001213|0.001698|0.00194,1|1|1|1|1,2060|1373|1030|686.5|588.4
2206,5,0.4259,4.2589999999999995,3818.0,0.001111,0.996692,ERCC6L2 MBNL2 MYH15 TMEM131L TRPC3,positive regulation of cardiac muscle hypertrophy in response to stress|positive regulation of cardiac muscle adaptation|extraocular skeletal muscle development|negative regulation of immature T cell proliferation in thymus|negative regulation of immature T cell proliferation,0.000728|0.000728|0.001213|0.001456|0.001698,1|1|1|1|1,2060|2060|1030|823.8|686.5
2207,4,0.4519,2.7110000000000003,3068.0,0.0008807,0.9929309999999999,LUZP6 MYL10 SART3 ZDHHC23,positive regulation of histone deubiquitination|regulation of histone deubiquitination|positive regulation of protein deubiquitination|regulation of protein deubiquitination|spliceosomal tri-snRNP complex assembly,0.0003883|0.0003883|0.001553|0.002716|0.002716,1|1|1|1|1,5149|5149|735.5|396.1|396.1
2208,6,0.4254,6.382000000000001,5216.0,0.001219,0.998474,ANKRD34B BTBD10 DNASE1L2 MCAM MYL4 PAFAH2,corneocyte development|vascular wound healing|type B pancreatic cell proliferation|keratinocyte development|glomerular filtration,0.0008735|0.002619|0.002909|0.0032|0.004361,1|1|1|1|1,1716|429.1|381.4|343.2|245.2
2209,7,0.4045,8.494,5731.0,0.0014759999999999999,0.9992989999999999,C1QTNF12 MYLK OR1L6 SLC34A3 SLF2 TNFRSF4 TRAF3IP1,regulation of response to stress|aorta smooth muscle tissue morphogenesis|sodium-dependent phosphate transport|positive regulation of maintenance of mitotic sister chromatid cohesion|positive regulation of maintenance of sister chromatid cohesion,0.0009284|0.001358|0.001358|0.002037|0.002037,1|1|1|1|1,7.612|980.7|980.7|588.4|588.4
2210,4,0.4654,2.792,3036.0,0.0009164999999999999,0.9929309999999999,MYLK4 OLFM3 OR10AG1 OR14C36,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,0.00269|0.003023|0.003256|0.003746|0.004032,1|1|1|1|1,23.35|22|21.19|19.73|19
2211,35,0.4003,238.2,27300.0,0.008627,1.0,ADAP2 ALDOC C17orf50 C17orf75 CCL13 CCL2 CCL7 DHRS11 EPOP EVI2A GAS2L2 GSDMB HAP1 KRT16 KRT25 KRT26 KRT27 KRT28 KRT31 KRTAP1-4 KRTAP4-11 KRTAP4-2 KRTAP4-8 KRTAP9-8 LYRM9 MRM1 MYO19 NME1 PIGS PIGW RDM1 SLC13A2 SLFN12 SPAG5 UNC119,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,2.394e-13|1.422e-12|7.938e-12|5.871e-11|1.418e-10,3.776e-09|1.121e-08|4.174e-08|2.315e-07|4.474e-07,27.09|22.85|19.38|15.99|14.68
2212,6,0.407,6.106,4716.0,0.0012900000000000001,0.998474,MYO5B RNF130 SMIM14 SPZ1 SRM SUMO4,spermidine biosynthetic process|spermidine metabolic process|polyamine biosynthetic process|polyamine metabolic process|vesicle transport along actin filament,0.001165|0.002619|0.004361|0.005812|0.005812,1|1|1|1|1,1144|429.1|245.2|180.7|180.7
2213,11,0.4161,22.89,7601.0,0.002993,0.999969,ABCE1 ANAPC10 HSPA13 LSM5 LSM6 NAF1 PSMA2 SPCS3 TMA16 TRAPPC11 UFSP2,"exonucleolytic catabolism of deadenylated mRNA|nuclear-transcribed mRNA catabolic process, exonucleolytic|nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay|ribosome biogenesis|anaphase-promoting complex-dependent catabolic process",0.0001527|0.0001708|0.0004971|0.0006378|0.0009892,1|1|1|1|1,113.5|107|61.39|16.92|43.04
2214,7,0.4228,8.879,5825.0,0.001518,0.9992989999999999,ACYP1 ANAPC16 CHMP2B GALNT16 MYOF TECTB TMEM63C,multivesicular body-lysosome fusion|membrane fusion|endosome to lysosome transport via multivesicular body sorting pathway|T-tubule organization|protein O-linked glycosylation via threonine,0.001019|0.001094|0.002715|0.003393|0.003393,1|1|1|1|1,1471|39.49|420.3|326.9|326.9
2215,7,0.4239,8.902000000000001,6040.0,0.001468,0.9992989999999999,GDF3 GPR148 LMBR1L MYOZ2 OTUD7B SLC39A11 TACR3,negative regulation of signal transduction|negative regulation of cell communication|negative regulation of signaling|negative regulation of response to stimulus|skeletal muscle fiber adaptation,0.0004459|0.0005904|0.0005954|0.001666|0.001698,1|1|1|1|1,9.223|8.571|8.553|6.524|735.5
2216,6,0.4012,6.018,4770.0,0.001257,0.998474,ANK2 BTC CBR4 MZB1 PI4K2A RNF38,protein localization to T-tubule|protein localization to M-band|regulation of SA node cell action potential|regulation of atrial cardiac muscle cell action potential|membrane depolarization during SA node cell action potential,0.0008735|0.0008735|0.001165|0.001456|0.001746,1|1|1|1|1,1716|1716|1144|858.1|686.5
2217,6,0.4223,6.334,4841.0,0.0013039999999999998,0.998474,BTF3L4 COX20 LGI2 N4BP2 SEL1L3 SLC34A2,sodium-dependent phosphate transport|cellular phosphate ion homeostasis|cellular trivalent inorganic anion homeostasis|inhibitory synapse assembly|phosphate ion homeostasis,0.001165|0.002909|0.002909|0.003781|0.004071,1|1|1|1|1,1144|381.4|381.4|286|264
2218,10,0.4125,18.56,6922.0,0.002667,0.999933,HSPA13 HYPK NAA15 NAF1 NOP10 RPL28 SPATA5 SPCS3 TMA16 TRAPPC11,snoRNA guided rRNA pseudouridine synthesis|rRNA pseudouridine synthesis|positive regulation of telomerase RNA localization to Cajal body|pseudouridine synthesis|regulation of telomerase RNA localization to Cajal body,2.118e-06|1.396e-05|2.872e-05|4.009e-05|4.009e-05,0.03341|0.1101|0.151|0.1581|0.1265,1373|411.9|274.6|228.8|228.8
2219,6,0.4301,6.452000000000001,4871.0,0.0013189999999999999,0.998474,NAA16 ORMDL2 SH3PXD2A SLC12A4 SLC1A4 SLC31A2,chloride transmembrane transport|chloride transport|inorganic anion transmembrane transport|cation transmembrane transport|regulation of copper ion transmembrane transport,0.0003386|0.0003809|0.0004889|0.0005564|0.0005824,1|1|1|1|1,70.77|66.65|58.68|16.17|3432
2220,8,0.4148,11.61,5510.0,0.002097,0.9996790000000001,ANAPC5 CCDC59 DCTN2 DYNC1LI2 LEMD2 NAA20 NAA25 VEZT,N-terminal peptidyl-methionine acetylation|peptidyl-methionine modification|N-terminal protein amino acid acetylation|N-terminal protein amino acid modification|biological phase,4.743e-06|1.382e-05|2.012e-05|5.328e-05|0.0001062,0.07482|0.109|0.1058|0.2101|0.3349,735.5|396.1|321.8|190.7|30.05
2221,14,0.4128,37.57,9106.0,0.004096,0.9999969999999999,ARIH2 CUL1 CUL5 DCUN1D1 NAA35 NAE1 NEDD8 RNF7 SENP8 UBA3 UBE2F UBE2M UBE2Q1 UBE2R2,protein neddylation|protein modification by small protein conjugation or removal|protein modification by small protein conjugation|post-translational protein modification|cellular protein modification process,8.468e-19|1.798e-16|1.487e-15|2.975e-15|2.179e-12,1.336e-14|1.418e-12|7.82e-12|1.173e-11|6.875e-09,792.1|18.55|21.5|40.75|6.822
2222,27,0.4067,142.8,21090.0,0.006706,1.0,ADAL APBA2 ARHGAP11B BMF BNIP2 C15orf53 CHRFAM7A CHRNA7 DEXI DUOXA1 DUOXA2 EPB42 GABRA5 GOLGA8M LPCAT4 MYO5A MYO5C NIPA1 NIPA2 PLA2G4D PLA2G4E PPP1R14D SNURF SPINT1 TGM5 TMCO5A WDR76,"phosphatidylserine acyl-chain remodeling|synaptic transmission, cholinergic|phosphatidylethanolamine acyl-chain remodeling|regulation of postsynaptic membrane potential|phosphatidylcholine acyl-chain remodeling",5.053e-06|7.998e-06|7.998e-06|1.138e-05|1.19e-05,0.0797|0.06308|0.04206|0.04489|0.03754,100.3|84.87|84.87|29.42|73.55
2223,6,0.4132,6.1979999999999995,4756.0,0.0012980000000000001,0.998474,ALPK1 DHRS3 NABP1 RARB RARG RXRA,retinoic acid receptor signaling pathway|intracellular receptor signaling pathway|transcription by RNA polymerase II|bone morphogenesis|hormone-mediated signaling pathway,2.11e-08|1.274e-07|2.247e-06|2.332e-06|5.306e-06,0.0003328|0.001005|0.01182|0.009194|0.01674,542|70.05|33.82|104|78.61
2224,7,0.406,8.526,5661.0,0.0015,0.9992989999999999,AIMP1 ERBB4 GPBAR1 NACAD NUDT17 SLC1A5 SPARC,negative regulation of endothelial cell proliferation|regulation of epithelial cell proliferation|cell surface bile acid receptor signaling pathway|L-glutamine import across plasma membrane|glutamine secretion,9.729e-05|0.000155|0.0006794|0.0006794|0.0006794,1|1|1|1|1,136.8|25.81|2942|2942|2942
2225,6,0.4335,6.502999999999999,4977.0,0.001302,0.998474,EPN3 NADSYN1 NARF SMIM21 ZBTB47 ZNF160,'de novo' NAD biosynthetic process|NAD biosynthetic process|pyridine nucleotide biosynthetic process|nicotinamide nucleotide biosynthetic process|pyridine nucleotide metabolic process,0.002328|0.008418|0.009285|0.009285|0.01015,1|1|1|1|1,490.4|122.6|110.7|110.7|101
2226,4,0.4333,2.6,3023.0,0.000857,0.9929309999999999,LEFTY2 NANOGNB RAP1GAP2 TCHH,intermediate filament organization|positive regulation of pathway-restricted SMAD protein phosphorylation|intermediate filament cytoskeleton organization|intermediate filament-based process|SMAD protein signal transduction,0.004846|0.009482|0.01006|0.01025|0.01218,1|1|1|1|1,214.5|107.3|101|99.01|83.04
2227,5,0.4348,4.348,3998.0,0.001083,0.996692,FAM114A2 GRM3 NAXD PAIP2B TRDN,metabolite repair|positive regulation of cell communication by electrical coupling involved in cardiac conduction|positive regulation of cell communication by electrical coupling|endoplasmic reticulum membrane organization|adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway,0.0004854|0.0004854|0.000728|0.001698|0.00194,1|1|1|1|1,4119|4119|2060|686.5|588.4
2228,7,0.4098,8.606,5020.0,0.001707,0.9992989999999999,NBEA POTEG POTEI POTEM SSBP3 TOMM40 USP10,midbrain-hindbrain boundary initiation|prechordal plate formation|positive regulation of anterior head development|regulation of anterior head development|neural plate anterior/posterior regionalization,0.0007765|0.0007765|0.001164|0.001164|0.001552,1|1|1|1|1,2574|2574|1287|1287|858.1
2229,7,0.4084,8.576,5504.0,0.001552,0.9992989999999999,ATP12A C1QTNF9 DHRS12 NBPF10 OR10J1 RNF6 SIAH3,protein K27-linked ubiquitination|negative regulation of protein targeting to mitochondrion|negative regulation of establishment of protein localization to mitochondrion|protein K6-linked ubiquitination|establishment or maintenance of transmembrane electrochemical gradient,0.002037|0.002376|0.003054|0.003393|0.004748,1|1|1|1|1,588.4|490.4|367.8|326.9|226.3
2230,5,0.458,4.58,3900.0,0.00117,0.996692,GRAP2 MRGPRD NCAM2 PVALB TJP3,positive regulation of blood-brain barrier permeability|regulation of blood-brain barrier permeability|establishment of endothelial intestinal barrier|positive regulation of vascular permeability|neuron cell-cell adhesion,0.001456|0.002183|0.003152|0.003878|0.004362,1|1|1|1|1,823.8|514.9|343.3|274.6|242.3
2231,6,0.4316,6.473,4805.0,0.001342,0.998474,ERGIC3 NCAN NUB1 TMEM161A TRMO ZBTB26,dermatan sulfate biosynthetic process|dermatan sulfate metabolic process|chondroitin sulfate catabolic process|dermatan sulfate proteoglycan biosynthetic process|dermatan sulfate proteoglycan metabolic process,0.003781|0.004071|0.004361|0.004651|0.004942,1|1|1|1|1,286|264|245.2|228.8|214.5
2232,5,0.4142,4.1419999999999995,3623.0,0.001139,0.996692,ARC NCBP3 PSME1 RNASE7 SNIP1,vesicle-mediated intercellular transport|mRNA transport|RNA transport|nucleic acid transport|establishment of RNA localization,0.0004854|0.0005977|0.0009476|0.0009476|0.0009662,1|1|1|1|1,4119|51.81|40.99|40.99|40.58
2233,6,0.4219,6.329,4823.0,0.001307,0.998474,EFCAB5 NCK1 RNF220 SLC30A3 TIPIN UTS2R,positive regulation of cap-dependent translational initiation|regulation of cap-dependent translational initiation|zinc ion import into synaptic vesicle|zinc ion import into organelle|positive regulation of cap-independent translational initiation,0.0005824|0.0005824|0.0008735|0.0008735|0.001165,1|1|1|1|1,3432|3432|1716|1716|1144
2234,11,0.3878,21.33,8011.0,0.002648,0.999969,ADIPOR2 BCL2 DENND4A FLT3 IRF8 MEF2D NCKAP1L PLCG2 SIK3 SLC5A3 ZFP64,positive regulation of cellular metabolic process|leukocyte homeostasis|hemopoiesis|positive regulation of metabolic process|hematopoietic or lymphoid organ development,2.406e-06|6.615e-06|6.797e-06|7.95e-06|9.951e-06,0.03795|0.05217|0.03574|0.03135|0.03139,5.204|81.4|16.37|4.531|15.12
2235,6,0.4191,6.2860000000000005,4835.0,0.001295,0.998474,ALKAL2 CD302 CPLX2 KRTAP25-1 LRRC8E NCKAP5,positive regulation of ERK5 cascade|regulation of ERK5 cascade|regulation of synaptic vesicle fusion to presynaptic active zone membrane|positive regulation of synaptic plasticity|aspartate transmembrane transport,0.0008735|0.0008735|0.002619|0.002909|0.002909,1|1|1|1|1,1716|1716|429.1|381.4|381.4
2236,6,0.414,6.21,4963.0,0.001247,0.998474,CRYAB DAAM2 LEP MYL3 NCR3LG1 SARDH,multicellular organism aging|muscle system process|negative regulation of glutamine transport|cellular response to L-ascorbic acid|sarcosine catabolic process,4.687e-05|5.462e-05|0.0005824|0.0005824|0.0005824,0.7393|0.4308|1|1|1,196.1|35.63|3432|3432|3432
2237,40,0.4025,313.9,31800.0,0.009751000000000001,1.0,KIR2DL1 LILRB5 NLRP11 NLRP4 NLRP9 VN1R1 VN1R4 ZFP28 ZIM3 ZNF132 ZNF135 ZNF211 ZNF264 ZNF28 ZNF304 ZNF324 ZNF324B ZNF416 ZNF460 ZNF497 ZNF528 ZNF534 ZNF543 ZNF548 ZNF550 ZNF551 ZNF581 ZNF586 ZNF587 ZNF610 ZNF665 ZNF667 ZNF701 ZNF71 ZNF772 ZNF773 ZNF805 ZNF814 ZNF880 ZSCAN5B,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",7.38e-23|7.349e-19|7.415e-19|7.757e-19|7.91e-18,1.164e-18|5.796e-15|3.899e-15|3.059e-15|2.495e-14,6.41|4.785|4.784|4.777|4.435
2238,6,0.4161,6.2410000000000005,4946.0,0.001257,0.998474,CDA DISP2 HIC1 NDNF PCDH12 SERPINF2,cytosine metabolic process|renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure|maintenance of blood vessel diameter homeostasis by renin-angiotensin|hypothalamic tangential migration using cell-axon interactions|gonadotrophin-releasing hormone neuronal migration to the hypothalamus,0.0008735|0.001165|0.001165|0.001165|0.001165,1|1|1|1|1,1716|1144|1144|1144|1144
2239,5,0.432,4.32,4033.0,0.001067,0.996692,FUK NDRG4 PI3 PLSCR4 TSC22D4,regulation of endocytic recycling|cardiac muscle cell proliferation|negative regulation of platelet-derived growth factor receptor signaling pathway|cell migration involved in heart development|striated muscle cell proliferation,0.002522|0.002522|0.002716|0.00291|0.00291,1|1|1|1|1,429.1|429.1|396.1|367.8|367.8
2240,7,0.4057,8.52,5906.0,0.001437,0.9992989999999999,ASPSCR1 DOPEY1 FAM241B NDUFA12 TBKBP1 TIMP2 ZP1,regulation of Rap protein signal transduction|negative regulation of metallopeptidase activity|negative regulation of membrane protein ectodomain proteolysis|positive regulation of adenylate cyclase activity|regulation of metallopeptidase activity,0.001456|0.002328|0.002619|0.0032|0.004361,1|1|1|1|1,858.1|490.4|429.1|343.2|245.2
2241,6,0.403,6.045,4928.0,0.001222,0.998474,C11orf54 DCAKD FAT4 LRIT3 NDUFA7 SLC25A15,mitochondrial L-ornithine transmembrane transport|condensed mesenchymal cell proliferation|L-ornithine transmembrane transport|regulation of metanephric nephron tubule epithelial cell differentiation|ornithine transport,0.001165|0.001456|0.002037|0.002328|0.002328,1|1|1|1|1,1144|858.1|572.1|490.4|490.4
2242,5,0.4305,4.305,4230.0,0.0010140000000000001,0.996692,JPH2 MYMK NEFH SERPINA9 SFXN3,peripheral nervous system neuron axonogenesis|positive regulation of skeletal muscle hypertrophy|neurofilament bundle assembly|serine import into mitochondrion|postsynaptic intermediate filament cytoskeleton organization,0.000728|0.000728|0.0009706|0.0009706|0.0009706,1|1|1|1|1,2060|2060|1373|1373|1373
2243,7,0.4097,8.603,5692.0,0.001505,0.9992989999999999,ABR HIC1 NEGR1 NEK10 NHLRC3 PRKAG1 SERPINF2,regulation of intracellular signal transduction|regulation of signal transduction|protein phosphorylation|renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure|maintenance of blood vessel diameter homeostasis by renin-angiotensin,8.503e-05|0.001149|0.001169|0.001358|0.001358,1|1|1|1|1,8.321|4.828|12.9|980.7|980.7
2244,11,0.4006,22.04,8909.0,0.002461,0.999969,C1QTNF9 CSNK1A1L HSPH1 KPNA3 LCP1 NEK5 PCDH17 RCBTB2 RNF6 SIAH3 SLC25A15,mitochondrial L-ornithine transmembrane transport|presynaptic active zone assembly|viral penetration into host nucleus|protein K27-linked ubiquitination|negative regulation of protein targeting to mitochondrion,0.002134|0.002134|0.002667|0.003199|0.003731,1|1|1|1|1,624.1|624.1|468.1|374.5|312
2245,5,0.4383,4.383,3702.0,0.001179,0.996692,FOXJ3 KLF6 NEK6 NEK9 SOX5,mitotic nuclear envelope disassembly|nuclear envelope disassembly|membrane disassembly|cell division|nuclear envelope organization,4.284e-06|6.401e-06|6.401e-06|0.000133|0.0001669,0.06758|0.05048|0.03365|0.5246|0.5266,686.5|549.2|549.2|25.12|99.25
2246,8,0.4027,11.28,6913.0,0.001625,0.9996790000000001,AP3M1 CYP2C9 ELOVL6 NELL1 PPP3CB RUNX1T1 SLC44A4 SRGN,long-chain fatty acid biosynthetic process|regulation of bone mineralization|regulation of biomineral tissue development|regulation of biomineralization|unsaturated fatty acid metabolic process,7.8e-05|0.0003804|0.0005785|0.000603|0.0007061,1|1|1|1|1,156|68.65|55.36|54.2|49.99
2247,6,0.4192,6.287000000000001,4852.0,0.001291,0.998474,C2orf88 FBXW12 LST1 MUCL1 NEMP2 SMIM6,pigment catabolic process|porphyrin-containing compound catabolic process|tetrapyrrole catabolic process|sodium-independent organic anion transport|heme catabolic process,0.005763|0.005763|0.005763|0.005763|0.005763,1|1|1|1|1,183.9|183.9|183.9|183.9|183.9
2248,25,0.4006,120.2,18810.0,0.006332,1.0,BTN2A1 BTN2A2 GPX6 HIST1H1T HLA-DMB HLA-F LY6G6F MSH5 NUDT3 OR14J1 OR2B6 OR2J2 OR2J3 OR2W1 PPT2 PSORS1C2 SLC17A2 SLC17A4 TRIM10 TRIM26 ZKSCAN4 ZNF165 ZNF184 ZSCAN16 ZSCAN31,sialic acid transport|detection of chemical stimulus involved in sensory perception of smell|cellular oxidant detoxification|sensory perception of smell|detection of chemical stimulus involved in sensory perception,3.198e-05|0.0002091|0.00025|0.0002745|0.0003261,0.5044|1|1|1|1,316.8|8.981|25.01|8.463|8.149
2249,5,0.4307,4.3069999999999995,3948.0,0.0010869999999999999,0.996692,FAM180A GOLGA3 LSMEM1 NEU3 SHPK,"cellular response to interleukin-13|response to interleukin-13|negative regulation of clathrin-dependent endocytosis|pentose-phosphate shunt, non-oxidative branch|ganglioside catabolic process",0.0009706|0.001213|0.001456|0.001698|0.00194,1|1|1|1|1,1373|1030|823.8|686.5|588.4
2250,7,0.4402,9.244,6125.0,0.001504,0.9992989999999999,AREG CNIH2 GAPT KIAA1191 MDGA1 NEURL2 POU4F3,"COPII vesicle coating|vesicle targeting, rough ER to cis-Golgi|vesicle coating|COPII-coated vesicle budding|vesicle targeting, to, from or within Golgi",0.0002037|0.0002037|0.0002297|0.0002501|0.0002501,1|1|1|0.9862|0.789,93.4|93.4|87.83|84.06|84.06
2251,6,0.4362,6.542999999999999,5023.0,0.0012980000000000001,0.998474,ABHD15 KLRD1 MATN2 MYO1E NEUROD2 RAB11FIP4,positive regulation of G1 to G0 transition|regulation of G1 to G0 transition|negative regulation of synapse maturation|post-embryonic hemopoiesis|negative regulation of T cell mediated cytotoxicity,0.0005824|0.0005824|0.001165|0.001456|0.002909,1|1|1|1|1,3432|3432|1144|858.1|381.4
2252,5,0.4158,4.158,3762.0,0.001101,0.996692,ACTC1 NEUROD4 PHLDB3 ZFP36L1 ZNF879,response to raffinose|cellular response to raffinose|septum transversum development|proepicardium development|positive regulation of intracellular mRNA localization,0.0004854|0.0004854|0.0004854|0.0004854|0.0009706,1|1|1|1|1,4119|4119|4119|4119|1373
2253,27,0.4004,140.5,21810.0,0.0063869999999999994,1.0,ACSF2 ADAM11 C17orf47 C17orf67 EPX HOXB5 HOXB9 KRT28 LPO LRRC46 MKS1 MPO MYCBPAP NFE2L3 NME1 NME2 OR4D1 OR4D2 OSBPL7 PLEKHM1 RSAD1 SCPEP1 SCRN2 SEPT4 SGCA TBKBP1 TBX21,hydrogen peroxide catabolic process|hydrogen peroxide metabolic process|UTP biosynthetic process|GTP biosynthetic process|UTP metabolic process,9.679e-06|2.558e-05|0.0001081|0.0001276|0.0001488,0.1527|0.2017|0.5683|0.5033|0.4694,78.91|55.81|152.6|138.7|127.1
2254,19,0.4065,69.51,13710.0,0.005032,1.0,CCDC137 DDX31 DNAJC21 FTSJ3 GNL1 GNL2 MRTO4 NOL12 NOP2 NSUN5 PINX1 PWP1 RBM34 RPF1 RPF2 RPL28 RRS1 TENT4B WDR89,ribosome biogenesis|ribonucleoprotein complex biogenesis|rRNA processing|rRNA metabolic process|ribosomal large subunit biogenesis,4.304e-17|2.188e-15|1.422e-12|1.975e-12|8.962e-11,6.788e-13|1.725e-11|7.475e-09|7.787e-09|2.827e-07,37.22|26.57|35.65|34.33|85.81
2255,6,0.4265,6.397,4774.0,0.001335,0.998474,CYP19A1 KCNA3 NHLH1 PABPC3 REG3G TPRN,positive regulation of estradiol secretion|stereocilium maintenance|regulation of estradiol secretion|cell wall disruption in other organism|androgen catabolic process,0.0008735|0.0008735|0.001165|0.001456|0.001746,1|1|1|1|1,1716|1716|1144|858.1|686.5
2256,7,0.4392,9.222999999999999,5959.0,0.001542,0.9992989999999999,C5orf63 ENTHD1 NIPAL2 RIDA SLC30A8 TNFRSF11B TPPP,negative regulation of animal organ morphogenesis|negative regulation of odontogenesis of dentin-containing tooth|negative regulation of odontogenesis|sequestering of zinc ion|threonine catabolic process,0.001019|0.001019|0.001019|0.001698|0.002037,1|1|1|1|1,1471|1471|1471|735.5|588.4
2257,5,0.4397,4.397,4060.0,0.0010789999999999999,0.996692,NKX2-8 RALGDS SGIP1 TMEM176A TMEM259,negative regulation of dendritic cell differentiation|positive regulation of feeding behavior|regulation of dendritic cell differentiation|positive regulation of ERAD pathway|clathrin coat assembly,0.001698|0.002667|0.003152|0.003636|0.004604,1|1|1|1|1,686.5|411.9|343.3|294.2|228.8
2258,5,0.4418,4.418,4078.0,0.0010789999999999999,0.996692,CTGF DEFB114 NLN SLC39A3 ZNF480,regulation of skeletal muscle fiber differentiation|antifungal innate immune response|negative regulation of lipopolysaccharide-mediated signaling pathway|regulation of skeletal muscle cell differentiation|negative regulation of multi-organism process,0.0009706|0.001165|0.002716|0.003878|0.004072,1|1|1|1|1,1287|1030|396.1|271|257.4
2259,37,0.4012,267.2,29510.0,0.008951,1.0,COX6B2 FCAR GP6 GPR32 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 LAIR1 LAIR2 LILRA4 LILRB2 LILRB4 LILRB5 NLRP11 NLRP13 NLRP4 NLRP9 PTPRH RFPL4A SHISA7 ZFP28 ZNF28 ZNF304 ZNF324 ZNF329 ZNF524 ZNF534 ZNF581 ZNF587 ZNF665 ZNF667 ZNF701 ZNF772 ZNF773 ZNF880 ZSCAN5B,immune response-inhibiting cell surface receptor signaling pathway|regulation of transcription by RNA polymerase II|regulation of gene expression|immune response-inhibiting signal transduction|regulation of immune response,9.413e-07|1.023e-06|1.365e-06|1.627e-06|4.22e-06,0.01485|0.008066|0.007178|0.006418|0.01331,203.2|3.563|2.559|162.6|5.281
2260,6,0.4037,6.056,4675.0,0.0012900000000000001,0.998474,DNPEP GDPD1 METTL23 MTRF1 NME5 VWDE,N-acylethanolamine metabolic process|ethanolamine-containing compound metabolic process|UTP biosynthetic process|regulation of translational termination|GTP biosynthetic process,0.001746|0.002909|0.0032|0.00349|0.00349,1|1|1|1|1,686.5|381.4|343.2|312|312
2261,5,0.4253,4.253,3857.0,0.001099,0.996692,ARL14EP NME7 NME8 SEMA6A SENP7,negative regulation of cell adhesion involved in sprouting angiogenesis|regulation of cell adhesion involved in sprouting angiogenesis|protein desumoylation|UTP biosynthetic process|GTP biosynthetic process,0.0004854|0.0004854|0.002183|0.002667|0.00291,1|1|1|1|1,4119|4119|514.9|411.9|374.5
2262,5,0.4381,4.381,3961.0,0.001102,0.996692,CISD1 FAM83G NDUFB1 NME9 SIGLEC11,UTP biosynthetic process|GTP biosynthetic process|UTP metabolic process|guanosine-containing compound biosynthetic process|CTP biosynthetic process,0.002667|0.00291|0.003152|0.003394|0.003636,1|1|1|1|1,411.9|374.5|343.3|316.8|294.2
2263,6,0.4155,6.233,4911.0,0.0012640000000000001,0.998474,HMBOX1 KCNG1 MACO1 MOV10 NMRK2 SLC6A4,"positive regulation of serotonin secretion|negative regulation of synaptic transmission, dopaminergic|regulation of thalamus size|mRNA cleavage involved in gene silencing|mRNA cleavage involved in gene silencing by miRNA",0.0005824|0.0005824|0.0005824|0.0008735|0.0008735,1|1|1|1|1,3432|3432|3432|1716|1716
2264,19,0.4028,68.88,15100.0,0.004528,1.0,ASTL C2orf49 CFC1 CNNM4 FAHD2A IL1F10 IL1RN IL36G LYG1 MGAT4A MRPL30 NMS POTEI RNF149 SCTR SLC9A2 SULT1C2 TMEM177 TUBA3D,inflammatory response to antigenic stimulus|sulfation|purine ribonucleoside bisphosphate metabolic process|3'-phosphoadenosine 5'-phosphosulfate metabolic process|prevention of polyspermy,6.446e-06|0.0002866|0.0003093|0.0003093|0.002908,0.1017|1|1|1|1,88.26|85.81|82.38|82.38|514.9
2265,18,0.4001,61.21,12490.0,0.004861,1.0,ARHGAP21 ARHGEF12 BTBD9 GNA13 GNAI2 GNAI3 GRK2 KCTD10 LPAR1 LPAR2 LUZP1 MYO9A MYO9B PDCL RHOA RHOC RIC8A ROCK2,regulation of small GTPase mediated signal transduction|positive regulation of catalytic activity|positive regulation of hydrolase activity|regulation of hydrolase activity|positive regulation of molecular function,3.12e-12|4.958e-12|5.927e-12|5.865e-11|8.015e-11,4.922e-08|3.911e-08|3.116e-08|2.313e-07|2.529e-07,31.49|10.51|16.2|10.5|8.423
2266,6,0.4045,6.068,4764.0,0.001269,0.998474,CLEC3B NNMT PCDHA12 PCDHB3 SLC22A5 VAX1,(R)-carnitine transmembrane transport|sodium-dependent organic cation transport|(R)-carnitine transport|positive regulation of intestinal epithelial structure maintenance|regulation of intestinal epithelial structure maintenance,0.0005824|0.0005824|0.0005824|0.0005824|0.0008735,1|1|1|1|1,3432|3432|3432|3432|1716
2267,5,0.4153,4.1530000000000005,3870.0,0.0010689999999999999,0.996692,EVI5L IL22 MTHFSD NOCT SHOX2,regulation of branching morphogenesis of a nerve|sinoatrial node cell development|cardiac pacemaker cell development|sinoatrial node cell differentiation|sinoatrial node development,0.001456|0.001456|0.001698|0.001698|0.001698,1|1|1|1|1,823.8|823.8|686.5|686.5|686.5
2268,6,0.4099,6.149,4852.0,0.001263,0.998474,CCDC126 GCNT2 HUS1B NOD1 POU5F2 SLC22A2,activation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of cysteine-type endopeptidase activity|meiotic DNA integrity checkpoint|positive regulation of endopeptidase activity,0.0002989|0.0006756|0.0008378|0.0008735|0.001137,1|1|1|1|1,75.44|49.75|44.58|1716|38.14
2269,32,0.4007,198.7,25920.0,0.007592,1.0,C5AR1 C5AR2 CABP5 CALM3 CRX CYP2A13 EML2 FFAR3 FLT3LG FUT1 FUT2 GPR32 IGFL1 IGFL2 IGFL3 KIR2DL1 KIR2DL3 KLK11 KLK3 KLK6 LAIR2 PSG2 PSG8 SIGLEC5 SIGLEC9 SPIB SULT2A1 SULT2B1 VN1R4 ZNF155 ZNF665 ZNF880,complement receptor mediated signaling pathway|complement component C5a signaling pathway|fucose catabolic process|L-fucose catabolic process|L-fucose metabolic process,2.257e-06|1.579e-05|0.0001437|0.0001437|0.0001437,0.03561|0.1245|0.7554|0.5666|0.4533,139.8|605.7|134.6|134.6|134.6
2270,5,0.4199,4.199,3857.0,0.001085,0.996692,EPHA6 GJD3 NOP53 SERINC1 SLC24A5,positive regulation of protein K63-linked deubiquitination|regulation of protein K63-linked deubiquitination|protein localization to nucleoplasm|positive regulation of serine C-palmitoyltransferase activity|positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,0.000728|0.000728|0.0009706|0.0009706|0.0009706,1|1|1|1|1,2060|2060|1373|1373|1373
2271,5,0.447,4.47,3854.0,0.0011560000000000001,0.996692,EIF2B1 FARSA NOSTRIN NUF2 PRR23B,phenylalanyl-tRNA aminoacylation|attachment of mitotic spindle microtubules to kinetochore|translation|protein heterotetramerization|peptide biosynthetic process,0.0009706|0.003152|0.003373|0.003636|0.003816,1|1|1|1|1,1373|343.3|21.45|294.2|20.14
2272,22,0.4006,92.53,18390.0,0.004995,1.0,AARD C8orf76 COL14A1 COLEC10 CSMD3 DCDC2 ENPP2 FAM84B FBXO32 GNPNAT1 KLHL38 MTSS1 NETO2 NOV RNF139 RRM2B SLC22A4 SLC30A8 TRHR TRMT12 WDYHV1 ZHX2,chemotaxis|taxis|nephron tubule epithelial cell differentiation|smooth muscle cell proliferation|regulation of kainate selective glutamate receptor activity,0.002963|0.003022|0.003343|0.003343|0.004455,1|1|1|1|1,6.56|6.524|447.7|447.7|298.5
2273,5,0.4495,4.495,3823.0,0.0011710000000000002,0.996692,ADAMTSL3 ADCY3 EVC NOXA1 SLC10A2,olfactory learning|olfactory behavior|cAMP biosynthetic process|cellular response to forskolin|response to forskolin,0.000728|0.002425|0.002667|0.002667|0.002667,1|1|1|1|1,2060|457.7|411.9|411.9|411.9
2274,5,0.4509,4.5089999999999995,4014.0,0.001119,0.996692,HOOK2 NPBWR1 NPHP4 SERPINE2 STAP2,mating plug formation|seminal vesicle epithelium development|seminal vesicle development|negative regulation of plasminogen activation|regulation of timing of cell differentiation,0.0004854|0.0004854|0.000728|0.001698|0.00194,1|1|1|1|1,4119|4119|2060|686.5|588.4
2275,5,0.4179,4.178999999999999,3915.0,0.0010630000000000001,0.996692,C9orf78 ENPP2 NPHP1 PPIL3 STMN2,protein localization involved in establishment of planar polarity|positive regulation of microtubule depolymerization|positive regulation of cellular component organization|positive regulation of lamellipodium morphogenesis|positive regulation of bicellular tight junction assembly,0.000728|0.001213|0.001546|0.00194|0.00194,1|1|1|1|1,2060|1030|10.89|588.4|588.4
2276,6,0.4214,6.322,4793.0,0.001314,0.998474,FRZB LMBR1 NPR1 NUP85 SMAD9 TAGLN3,negative regulation of hepatocyte differentiation|regulation of hepatocyte differentiation|negative regulation of cell growth|convergent extension involved in organogenesis|negative regulation of growth,0.0005824|0.0008735|0.001226|0.001746|0.002097,1|1|1|1|1,3432|1716|36.71|686.5|27.91
2277,6,0.4449,6.672999999999999,5018.0,0.001325,0.998474,CXCL12 GABRA6 KRTAP22-2 NPS SLC25A30 WIPI1,"inorganic anion transmembrane transport|response to ultrasound|vesicle targeting, trans-Golgi to endosome|inorganic anion transport|positive regulation of circadian sleep/wake cycle, wakefulness",0.0004889|0.0008735|0.0008735|0.000881|0.001165,1|1|1|1|1,58.68|1716|1716|43.45|1144
2278,5,0.447,4.47,3856.0,0.001155,0.996692,ATP13A5 CPT1B NPW TMEM41B VMP1,autophagosome assembly|autophagosome organization|vacuole organization|macroautophagy|response to blue light,9.744e-05|0.0001067|0.0004525|0.000866|0.001698,1|0.8414|1|1|1,130.8|124.8|59.7|42.91|686.5
2279,5,0.4491,4.4910000000000005,3922.0,0.001141,0.996692,CCDC32 GALNTL6 LRRC40 NPY1R TMEM252,"protein O-linked glycosylation via threonine|regulation of multicellular organism growth|G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger|outflow tract morphogenesis|sensory perception of pain",0.002425|0.01592|0.0164|0.01688|0.01807,1|1|1|1|1,457.7|63.37|61.48|59.7|55.66
2280,7,0.4034,8.471,5761.0,0.001465,0.9992989999999999,CAV3 NR1I2 RIPPLY3 TLL1 TMEM178A TMPRSS11B UGT2B7,negative regulation of sarcomere organization|regulation of signal transduction by receptor internalization|negative regulation of membrane depolarization during cardiac muscle cell action potential|regulation of nerve growth factor receptor activity|positive regulation of caveolin-mediated endocytosis,0.0006794|0.0006794|0.0006794|0.0006794|0.001698,1|1|1|1|1,2942|2942|2942|2942|735.5
2281,6,0.4332,6.497999999999999,4725.0,0.00137,0.998474,ABLIM1 CHORDC1 DQX1 NDN NR1I3 ZNF782,negative regulation of Rho-dependent protein serine/threonine kinase activity|regulation of Rho-dependent protein serine/threonine kinase activity|positive regulation of transcription by RNA polymerase II|axonal fasciculation|neuron projection fasciculation,0.001165|0.001746|0.003526|0.006101|0.006101,1|1|1|1|1,1144|686.5|8.539|171.6|171.6
2282,6,0.4232,6.347,4890.0,0.0012929999999999999,0.998474,AKAP13 BTBD11 CALHM5 CHST11 NR3C1 USP43,glucocorticoid mediated signaling pathway|polysaccharide localization|adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process|regulation of sarcomere organization|glucocorticoid receptor signaling pathway,0.0005824|0.0008735|0.001456|0.002037|0.002037,1|1|1|1|1,3432|1716|858.1|572.1|572.1
2283,6,0.4125,6.188,4827.0,0.001277,0.998474,CCDC71L CLCN6 KLC4 NR3C2 RAD21L1 SMCHD1,inactivation of X chromosome by DNA methylation|inactivation of X chromosome by heterochromatin assembly|double-strand break repair|meiotic telomere tethering at nuclear periphery|heterochromatin organization involved in chromatin silencing,0.0005824|0.0005824|0.001426|0.001746|0.001746,1|1|1|1|1,3432|3432|33.99|686.5|686.5
2284,5,0.4282,4.282,3928.0,0.001086,0.996692,FNBP1L MUCL1 NR5A1 RSRC2 SPATA24,primary sex determination|negative regulation of female gonad development|negative regulation of gonad development|regulation of female gonad development|response to gonadotropin-releasing hormone,0.000728|0.0009706|0.001213|0.001698|0.00194,1|1|1|1|1,2060|1373|1030|686.5|588.4
2285,9,0.4005,14.42,7514.0,0.001911,0.9998530000000001,CALHM3 CFAP43 COL2A1 CPLX3 CYP17A1 DPCD GSTO2 NRAP PNLIP,epithelial cilium movement involved in extracellular fluid movement|extracellular transport|sperm motility|flagellated sperm motility|cilium movement involved in cell motility,0.0001324|0.0001556|0.000867|0.000867|0.001023,1|1|1|1|1,121.1|111.3|45.77|45.77|42.03
2286,7,0.4098,8.606,5672.0,0.001511,0.9992989999999999,ATP10B C11orf42 FAM205A IFNA16 NRCAM PRAMEF4 PTGES2,lysosomal membrane organization|clustering of voltage-gated sodium channels|cyclooxygenase pathway|neuronal ion channel clustering|axonal fasciculation,0.002037|0.002376|0.004071|0.004071|0.007114,1|1|1|1|1,588.4|490.4|267.5|267.5|147.1
2287,8,0.417,11.68,5736.0,0.002026,0.9996790000000001,EIF4B NBEAL1 NRDC OR2T4 POGZ TSPYL5 UQCRH YBX1,eukaryotic translation initiation factor 4F complex assembly|miRNA transport|CRD-mediated mRNA stabilization|protein localization to cytoplasmic stress granule|cellular protein-containing complex assembly,0.001164|0.001552|0.002328|0.003103|0.00349,1|1|1|1|1,1287|858.1|514.9|367.8|8.991
2288,4,0.4466,2.68,3099.0,0.0008617000000000001,0.9929309999999999,ALX3 CROCC MREG NRGN,ciliary basal body organization|minus-end-directed organelle transport along microtubule|positive regulation of protein localization to cilium|regulation of protein localization to cilium|establishment of organelle localization,0.0009706|0.001165|0.001165|0.001747|0.002188,1|1|1|1|1,1287|1030|1030|643.6|25.94
2289,6,0.4211,6.316,4810.0,0.001308,0.998474,HMX2 NRIP3 PKNOX2 TRIM65 TSTA3 UPK3B,'de novo' GDP-L-fucose biosynthetic process|GDP-L-fucose biosynthetic process|GDP-L-fucose metabolic process|positive regulation of endothelial cell-matrix adhesion via fibronectin|regulation of endothelial cell-matrix adhesion via fibronectin,0.0008735|0.001165|0.001456|0.001746|0.002037,1|1|1|1|1,1716|1144|858.1|686.5|572.1
2290,6,0.4282,6.422000000000001,5220.0,0.0012259999999999999,0.998474,ABHD6 C10orf120 CBY3 IL17RC NRN1 NTF3,lysobisphosphatidic acid metabolic process|regulation of endocannabinoid signaling pathway|positive regulation of neurotrophin TRK receptor signaling pathway|monoacylglycerol catabolic process|interleukin-17-mediated signaling pathway,0.0008735|0.001165|0.002037|0.002328|0.002909,1|1|1|1|1,1716|1144|572.1|490.4|381.4
2291,5,0.4424,4.4239999999999995,3962.0,0.001113,0.996692,APOA5 FAM3D ITPKB NRP2 PI16,alcohol biosynthetic process|vestibulocochlear nerve structural organization|negative regulation of neutrophil apoptotic process|dorsal root ganglion morphogenesis|ganglion morphogenesis,0.0003524|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,69.34|3432|3432|3432|3432
2292,6,0.4125,6.188,4807.0,0.001282,0.998474,DOCK8 FZD1 NRTN PCDH20 PRSS54 PTGER3,memory T cell proliferation|stem cell differentiation|canonical Wnt signaling pathway involved in osteoblast differentiation|positive regulation of establishment of T cell polarity|canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,0.0005824|0.0008378|0.0008735|0.0008735|0.001165,1|1|1|1|1,3432|44.58|1716|1716|1144
2293,17,0.4058,55.19,12350.0,0.004436,1.0,ABCE1 LSM5 MAD2L1 NSA2 NUF2 PSMA4 PSMB7 RPF2 RPL14 RPL18 RPL30 RPL35A RPL5 RPL7 RPS17 TTK WDR33,ribosome biogenesis|translational initiation|rRNA processing|rRNA metabolic process|ribonucleoprotein complex biogenesis,2.434e-14|1.582e-13|2.132e-13|2.965e-13|6.473e-13,3.84e-10|1.248e-09|1.121e-09|1.169e-09|2.042e-09,36.49|67.77|41.94|40.38|26.05
2294,5,0.4536,4.5360000000000005,4029.0,0.0011220000000000002,0.996692,C1QTNF12 NT5C2 PRKAG1 SCNN1D TNFRSF4,regulation of carbohydrate metabolic process|adenosine metabolic process|IMP metabolic process|regulation of small molecule metabolic process|negative regulation of gluconeogenesis,0.001072|0.002425|0.003636|0.004342|0.004604,1|1|1|1|1,38.5|457.7|294.2|18.85|228.8
2295,6,0.4308,6.462000000000001,4823.0,0.001335,0.998474,CFAP65 CTSE IGSF9B NT5C3A OR2M4 ZFHX4,adenosine metabolic process|sperm axoneme assembly|pyrimidine nucleoside catabolic process|protein autoprocessing|nucleoside catabolic process,0.002909|0.006681|0.00697|0.00726|0.01015,1|1|1|1|1,381.4|156|149.2|143|101
2296,6,0.4167,6.25,4610.0,0.001351,0.998474,BTNL9 MXD3 NT5C3B OR2V2 RAB24 TRIM41,"cellular response to muramyl dipeptide|response to muramyl dipeptide|exonucleolytic catabolism of deadenylated mRNA|nuclear-transcribed mRNA catabolic process, exonucleolytic|nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",0.002909|0.006101|0.009863|0.01044|0.01792,1|1|1|1|1,381.4|171.6|104|98.07|56.27
2297,6,0.4268,6.402,4965.0,0.001285,0.998474,FZD10 IL25 INSM2 NTF4 RELCH STATH,formation of animal organ boundary|taste bud development|sensory organ boundary specification|ganglion mother cell fate determination|response to nematode,0.0005824|0.0005824|0.0005824|0.0008735|0.001165,1|1|1|1|1,3432|3432|3432|1716|1144
2298,7,0.4075,8.558,5797.0,0.00147,0.9992989999999999,CCDC82 CYB561D1 DUS2 NRN1L NTN3 TLDC1 TNNT1,tRNA dihydrouridine synthesis|tRNA modification|tRNA processing|slow-twitch skeletal muscle fiber contraction|positive regulation of protein localization to lysosome,2.768e-06|0.0005427|0.001146|0.001164|0.001164,0.04366|1|1|1|1,1030|57.21|39.01|1287|1287
2299,6,0.4145,6.218,4875.0,0.001271,0.998474,BAG4 CAVIN4 CSN3 KNOP1 NTN4 TBC1D10C,"negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity|regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity|negative regulation of mRNA modification|regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling|regulation of mRNA modification",0.0006794|0.0006794|0.0006794|0.0006794|0.001019,1|1|1|1|1,2942|2942|2942|2942|1471
2300,28,0.3793,143.4,23660.0,0.00601,1.0,AARD C8orf44 C8orf76 CA1 CA13 CA2 CA3 CA8 CNGB3 COL14A1 CSMD3 CYP7A1 FABP12 KLHL38 MCMDC2 MTSS1 NOV PKIA PMP2 PPDPFL RNF139 SGK3 SLC30A8 TMEM67 TMEM69 TRPA1 ZFHX4 ZHX2,one-carbon metabolic process|bicarbonate transport|organic anion transport|cellular response to fluid shear stress|response to fluid shear stress,4.786e-09|5.687e-07|0.0001285|0.0003823|0.001115,7.549e-05|0.004485|0.6758|1|1,88.01|65.38|10.1|76.28|42.91
2301,6,0.42,6.301,4673.0,0.001343,0.998474,BPIFA3 GP1BA KBTBD8 MRPS15 NTRK1 TMEM183A,behavioral response to formalin induced pain|behavioral response to chemical pain|olfactory nerve development|axonogenesis involved in innervation|response to hydrostatic pressure,0.0008735|0.0008735|0.001456|0.001746|0.002037,1|1|1|1|1,1716|1716|858.1|686.5|572.1
2302,5,0.4641,4.641,3913.0,0.001181,0.996692,FNBP4 HOXA10 LIPC NTS ULBP1,cell killing|intermediate-density lipoprotein particle remodeling|triglyceride-rich lipoprotein particle clearance|chylomicron remnant clearance|very-low-density lipoprotein particle remodeling,0.0003438|0.0004854|0.00194|0.00194|0.002425,1|1|1|1|1,68.65|4119|588.4|588.4|457.7
2303,7,0.4016,8.433,5586.0,0.001504,0.9992989999999999,CHDH DOK4 EPPIN NTSR1 PTPRS SARS UTRN,negative regulation of calcium ion transport|glycine betaine biosynthetic process from choline|seryl-tRNA aminoacylation|glycine betaine biosynthetic process|glycine betaine metabolic process,0.0001794|0.001019|0.001019|0.001019|0.001019,1|1|1|1|1,99.73|1471|1471|1471|1471
2304,4,0.4535,2.721,3129.0,0.0008663999999999999,0.9929309999999999,NUDCD1 PBLD ZBTB44 ZMYND19,negative regulation of SMAD protein signal transduction|negative regulation of pathway-restricted SMAD protein phosphorylation|cellular process|maintenance of gastrointestinal epithelium|epithelial structure maintenance,0.001553|0.002716|0.00379|0.004072|0.005426,1|1|1|1|1,735.5|396.1|0|257.4|190.7
2305,5,0.4342,4.342,3971.0,0.00109,0.996692,BST1 GGCT KCNA5 NUDT12 SEC11A,membrane repolarization during SA node cell action potential|membrane repolarization during bundle of His cell action potential|NAD-cap decapping|NADP catabolic process|NAD catabolic process,0.0004854|0.0004854|0.000728|0.0009706|0.0009706,1|1|1|1|1,4119|4119|2060|1373|1373
2306,7,0.4048,8.501,5459.0,0.001551,0.9992989999999999,LCN8 LCNL1 NUDT15 OR2AG2 STPG3 STRBP USHBP1,dGTP catabolic process|dGTP metabolic process|purine deoxyribonucleoside triphosphate catabolic process|DNA protection|purine nucleoside triphosphate catabolic process,0.001358|0.001698|0.002037|0.002037|0.002376,1|1|1|1|1,980.7|735.5|588.4|588.4|490.4
2307,6,0.4329,6.494,5224.0,0.001239,0.998474,AIDA APOBEC4 KCTD18 NUDT5 TMEM171 TPD52,determination of ventral identity|D-ribose catabolic process|D-ribose metabolic process|ATP generation from poly-ADP-D-ribose|determination of dorsal/ventral asymmetry,0.0005824|0.0008735|0.001165|0.001456|0.001746,1|1|1|1|1,3432|1716|1144|858.1|686.5
2308,7,0.4298,9.025,5872.0,0.001531,0.9992989999999999,C1QL1 CDHR2 COL22A1 ICA1 KLK1 LILRB5 NUDT6,negative regulation of cell growth involved in contact inhibition|intermicrovillar adhesion|brush border assembly|motor learning|regulation of microvillus length,0.0006794|0.001019|0.002037|0.002376|0.002715,1|1|1|1|1,2942|1471|588.4|490.4|420.3
2309,12,0.4012,26.48,8319.0,0.003164,0.999986,C12orf45 DDX21 DDX51 HSPA14 NCL NOLC1 NOP58 NUFIP1 PINX1 RPF1 ZNHIT3 ZNHIT6,rRNA processing|rRNA metabolic process|ribonucleoprotein complex biogenesis|ribosome biogenesis|ncRNA processing,4.38e-12|5.877e-12|7.393e-12|2.941e-11|2.287e-10,6.909e-08|4.635e-08|3.887e-08|1.16e-07|7.214e-07,42.25|40.68|26.57|33.08|25.43
2310,25,0.4076,122.3,16280.0,0.007431999999999999,1.0,CHCHD3 CLPB CRLS1 DNAJC11 FAM136A HAX1 HTRA2 IMMP2L IMMT MFN2 MTCH2 MTX1 MTX2 OPA1 PARL PGS1 PTPMT1 ROMO1 SAMM50 TAMM41 TIMM13 TIMM17A TIMM44 TRIAP1 YME1L1,mitochondrion organization|inner mitochondrial membrane organization|mitochondrial membrane organization|protein localization to mitochondrion|protein targeting to mitochondrion,2.688e-18|4.205e-17|2.322e-15|1.986e-13|1.49e-12,4.24e-14|3.316e-13|1.221e-11|7.832e-10|4.701e-09,25.04|132|54.48|74.42|95.35
2311,16,0.4148,49.78,10820.0,0.004565,0.999999,DHX33 ELAC2 GEMIN4 METTL16 MYBBP1A NDE1 NUP88 PAFAH1B1 PRPF8 PSMB6 RNASEK RPA1 RPAIN TRAPPC1 TSR1 VPS53,cellular component biogenesis|ribonucleoprotein complex biogenesis|ribosome biogenesis|nucleic acid metabolic process|regulation of microtubule motor activity,1.156e-06|1.378e-06|5.971e-06|2.246e-05|4.967e-05,0.01824|0.01087|0.0314|0.08858|0.1567,4.934|15.63|18.25|4.885|220.3
2312,6,0.4133,6.2,4895.0,0.0012619999999999999,0.998474,BLOC1S4 C21orf62 GIPC2 NDN NUTM1 PRRX1,positive regulation of DNA repair by transcription from RNA polymerase II promoter|neuron differentiation|neuron fate determination|generation of neurons|synaptic vesicle transport along microtubule,0.0008735|0.00223|0.002619|0.003897|0.004942,1|1|1|1|1,1716|10.02|429.1|8.245|214.5
2313,5,0.4658,4.658,3950.0,0.001175,0.996692,ANKRD42 C14orf119 GLTPD2 NXPH4 TSPAN12,ceramide 1-phosphate transport|ceramide transport|regulation of vascular endothelial growth factor signaling pathway|positive regulation of cytokine production involved in inflammatory response|regulation of cellular response to vascular endothelial growth factor stimulus,0.002183|0.003636|0.005087|0.005329|0.005571,1|1|1|1|1,514.9|294.2|205.9|196.1|187.2
2314,20,0.4345,82.55,13780.0,0.005939,1.0,ADAR DCP2 DDX6 EDC3 EDC4 EIF2AK2 IFNAR1 IFNAR2 IRF9 ISG15 JAK1 LSM14A MARF1 PNRC2 STAT1 STAT2 TYK2 USP18 XRN1 ZNFX1,type I interferon signaling pathway|cellular response to type I interferon|response to type I interferon|response to virus|defense response to symbiont,1.418e-17|1.602e-17|3.224e-17|6.215e-12|1.671e-11,2.236e-13|1.263e-13|1.695e-13|2.451e-08|5.272e-08,136.3|134.3|123.6|30.09|38.86
2315,5,0.4426,4.426,3978.0,0.001109,0.996692,GKN1 MTNR1A OAF OR8G5 ZNF749,"mating behavior|reproductive behavior|mating|G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger|adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway",0.004845|0.006778|0.007985|0.0164|0.02046,1|1|1|1|1,216.8|152.6|128.7|61.48|49.04
2316,7,0.4193,8.805,5754.0,0.001524,0.9992989999999999,APP CLUL1 DUSP14 NIN OAZ2 SLC12A7 SLC6A19,collateral sprouting|developmental cell growth|cell growth|developmental growth involved in morphogenesis|regulation of response to calcium ion,3.558e-06|0.0003568|0.0003736|0.0006369|0.0006794,0.05613|1|1|1|1,840.6|70.05|68.42|52.07|2942
2317,6,0.4154,6.232,4513.0,0.001375,0.998474,ABHD17A EBNA1BP2 OBSCN PABPC1 PPIE SF3A3,"positive regulation of viral genome replication|RNA processing|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions",3.718e-05|5.682e-05|6.218e-05|6.218e-05|6.402e-05,0.5864|0.4481|0.3269|0.2452|0.202,221.5|14.88|34.1|34.1|33.76
2318,6,0.4378,6.567,4811.0,0.0013599999999999999,0.998474,GJA8 OCEL1 SCML4 SSTR4 ZNF488 ZNF503,G1 to G0 transition involved in cell differentiation|somatostatin signaling pathway|somatostatin receptor signaling pathway|positive regulation of arachidonic acid secretion|gap junction-mediated intercellular transport,0.001165|0.001746|0.001746|0.002037|0.002037,1|1|1|1|1,1144|686.5|686.5|572.1|572.1
2319,7,0.403,8.464,5755.0,0.001465,0.9992989999999999,ARL14EPL CCDC179 CCKAR ODF2 REN SLC26A9 SLC35A5,cholecystokinin signaling pathway|renin-angiotensin regulation of aldosterone production|regulation of aldosterone secretion|regulation of mineralocorticoid secretion|regulation of blood volume by renin-angiotensin,0.001164|0.00194|0.002715|0.002715|0.003103,1|1|1|1|1,1287|643.6|429.1|429.1|367.8
2320,6,0.4338,6.507000000000001,4899.0,0.001323,0.998474,C6orf226 GJA4 OGFRL1 RPL3L SLC12A3 TMX4,opioid receptor signaling pathway|monovalent inorganic anion homeostasis|chloride ion homeostasis|response to pain|ribosomal large subunit assembly,0.0032|0.004942|0.004942|0.008418|0.008418,1|1|1|1|1,343.2|214.5|214.5|122.6|122.6
2321,11,0.4787,26.33,7682.0,0.003406,0.999969,DCP2 DDX6 EDC3 EDC4 EIF4E2 EIF4ENIF1 GIGYF2 LSM14A PNRC2 PPP5C XRN1,negative regulation of gene expression|negative regulation of translation|methylguanosine-cap decapping|negative regulation of cellular amide metabolic process|RNA decapping,5.61e-13|4.513e-11|7.971e-11|1.075e-10|1.34e-10,8.85e-09|3.559e-07|4.191e-07|4.241e-07|4.226e-07,19.42|82|624.1|70.65|534.9
2322,6,0.4457,6.685,5100.0,0.001306,0.998474,ATP2B2 AVPI1 C2orf91 CNPY1 GRIK1 OLFM4,regulation of cardiac conduction|negative regulation of citrulline biosynthetic process|regulation of citrulline biosynthetic process|negative regulation of cellular amine catabolic process|regulation of cellular amine catabolic process,0.0001621|0.0006794|0.0006794|0.0006794|0.0006794,1|1|1|1|1,105.1|2942|2942|2942|2942
2323,5,0.4097,4.0969999999999995,3665.0,0.001114,0.996692,CRYAB FOXM1 NCR3LG1 OLFML1 PSME3,regulation of reactive oxygen species metabolic process|tubulin complex assembly|response to hypoxia|response to decreased oxygen levels|negative regulation of amyloid fibril formation,0.0008136|0.002425|0.00272|0.002941|0.003152,1|1|1|1|1,44.29|457.7|23.95|23.01|343.3
2324,37,0.4017,267.5,28410.0,0.009304,1.0,ABHD11 ARPC1B ASL CASTOR3 CLDN3 CYP3A43 CYP3A5 CYP3A7 GNAI1 GNAT3 GRM8 GUSB PILRA PILRB PMS2 PON1 SEMA3E SEPT14 SLC29A4 SPDYE1 TBL2 TPST1 TRIM50 TYW1 VKORC1L1 ZKSCAN1 ZNF138 ZNF273 ZNF479 ZNF679 ZNF716 ZNF727 ZNF736 ZNF804B ZNF92 ZSCAN21 ZSCAN25,oxidative demethylation|lipid hydroxylation|demethylation|adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway|steroid metabolic process,8.663e-06|0.0001179|0.0002777|0.000549|0.001412,0.1367|0.9302|1|1|1,85.57|154.8|24.64|19.36|8.274
2325,6,0.4083,6.124,4711.0,0.001295,0.998474,ABHD2 DCBLD2 GJA5 OPALIN RAB38 SEMA5A,regulation of Purkinje myocyte action potential|signal clustering|vasomotion|Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling|bundle of His cell to Purkinje myocyte communication by electrical coupling,0.0005824|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,3432|3432|3432|3432|3432
2326,5,0.4606,4.606,4040.0,0.0011359999999999999,0.996692,ANO4 OPN1SW PLK5 WNT9A YIPF7,calcium activated galactosylceramide scrambling|calcium activated phosphatidylserine scrambling|defense response to tumor cell|calcium activated phosphatidylcholine scrambling|calcium activated phospholipid scrambling,0.001213|0.001213|0.001456|0.001456|0.001698,1|1|1|1|1,1030|1030|823.8|823.8|686.5
2327,6,0.4282,6.422999999999999,4858.0,0.001317,0.998474,C19orf84 COL6A3 HSPA12A LELP1 OPN3 PCMTD1,positive regulation of cellular respiration|negative regulation of secondary metabolite biosynthetic process|negative regulation of melanin biosynthetic process|response to blue light|positive regulation of secondary metabolite biosynthetic process,0.001746|0.001746|0.001746|0.002037|0.002328,1|1|1|1|1,686.5|686.5|686.5|572.1|490.4
2328,5,0.4326,4.3260000000000005,3918.0,0.0011,0.996692,DLG1 ESRRB KLHL29 MRPS30 OPRD1,positive regulation of transcription involved in G2/M transition of mitotic cell cycle|regulation of transcription involved in G2/M transition of mitotic cell cycle|positive regulation of phosphorylation|positive regulation of transcription involved in G1/S transition of mitotic cell cycle|cortical microtubule organization,0.0004854|0.000728|0.0008192|0.0009706|0.0009706,1|1|1|1|1,4119|2060|13.53|1373|1373
2329,6,0.4079,6.119,5040.0,0.00121,0.998474,ADD2 LRFN1 OPTC PRR14 PYGL TNRC6C,"5-phosphoribose 1-diphosphate biosynthetic process|5-phosphoribose 1-diphosphate metabolic process|regulation of postsynaptic density assembly|regulation of postsynaptic specialization assembly|negative regulation of translation, ncRNA-mediated",0.002037|0.002037|0.00349|0.003781|0.004071,1|1|1|1|1,572.1|572.1|312|286|264
2330,13,0.403,31.43,9791.0,0.003192,0.999993,ADAMTS15 ADAMTS8 CCDC153 KCNJ1 NXPE4 OR10G4 OR10G7 OR10G9 OR4D5 OR6M1 OR6X1 OR8D4 TMEM136,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,3.357e-09|5.035e-09|6.512e-09|1.06e-08|1.369e-08,5.295e-05|3.971e-05|3.424e-05|4.179e-05|4.319e-05,25.15|23.7|22.82|21.24|20.46
2331,5,0.4147,4.147,3773.0,0.0010949999999999998,0.996692,DRD1 NEK9 NEURL1B OR10K1 RASD2,locomotory behavior|ubiquitin-dependent endocytosis|cerebral cortex GABAergic interneuron migration|cerebral cortex GABAergic interneuron development|phospholipase C-activating dopamine receptor signaling pathway,0.0007712|0.0009706|0.001698|0.00194|0.002183,1|1|1|1|1,45.51|1373|686.5|588.4|514.9
2332,6,0.4107,6.16,4989.0,0.00123,0.998474,ABCB1 COQ8B MDFI OR10K2 QPCT TMEM235,"ceramide translocation|peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase|terpenoid transport|isoprenoid transport|positive regulation of anion channel activity",0.0008735|0.0008735|0.001165|0.001165|0.001456,1|1|1|1|1,1716|1716|1144|1144|858.1
2333,6,0.4161,6.2410000000000005,5114.0,0.001216,0.998474,ASPG LYSMD4 OR13C2 PLA1A TACSTD2 TTLL12,negative regulation of branching involved in ureteric bud morphogenesis|negative regulation of ruffle assembly|negative regulation of morphogenesis of an epithelium|cellular amino acid metabolic process|lipid catabolic process,0.001019|0.002376|0.003054|0.003721|0.004396,1|1|1|1|1,1471|490.4|367.8|21.09|19.36
2334,9,0.4092,14.73,6525.0,0.002246,0.9998530000000001,NIPSNAP3A NIPSNAP3B OR13C3 OR13C4 OR13C8 OR13C9 OR13D1 OR2K2 RALGAPA1,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,8.016e-09|1.138e-08|1.422e-08|2.166e-08|2.704e-08,0.0001264|8.975e-05|7.475e-05|8.543e-05|8.529e-05,31.13|29.34|28.25|26.3|25.33
2335,5,0.4367,4.367,3852.0,0.001129,0.996692,GRIN2B OR13G1 PCCA RASIP1 SLC8A2,long-term synaptic potentiation|calcium ion transmembrane import into cytosol|calcium ion transport into cytosol|cytosolic calcium ion transport|positive regulation of synaptic transmission,5.293e-05|0.0001005|0.0001299|0.0001956|0.0004024,0.8349|0.7924|0.6828|0.7713|1,179.1|128.7|112.8|91.53|63.37
2336,8,0.4037,11.3,6519.0,0.001727,0.9996790000000001,CAMK1D CASC10 ERBB4 GPR22 MTRNR2L3 NAPEPLD SPAG6 TNNT2,central nervous system morphogenesis|regulation of muscle filament sliding speed|host-mediated regulation of intestinal microbiota composition|negative regulation of eating behavior|regulation of muscle filament sliding,0.001019|0.001019|0.001019|0.001358|0.001698,1|1|1|1|1,1471|1471|1471|980.7|735.5
2337,5,0.4461,4.461,3829.0,0.001161,0.996692,EVA1C MTMR14 OR1K1 PRSS50 TMEM247,peptidyl-tyrosine dephosphorylation|phosphatidylinositol biosynthetic process|phosphatidylinositol metabolic process|macroautophagy|protein dephosphorylation,0.0257|0.02689|0.04341|0.04598|0.05158,1|1|1|1|1,38.86|37.11|22.76|21.45|19.07
2338,6,0.4107,6.16,5215.0,0.0011769999999999999,0.998474,ADAD1 ANKRD34B CCDC136 CNTN2 IBSP OR1N1,establishment of protein localization to juxtaparanode region of axon|spermatid development|spermatid differentiation|positive regulation of adenosine receptor signaling pathway|clustering of voltage-gated potassium channels,0.0005824|0.0008485|0.0009141|0.001165|0.001165,1|1|1|1|1,3432|44.29|42.64|1144|1144
2339,6,0.4418,6.626,4728.0,0.001396,0.998474,MAST4 OR1S2 RHCE SLC2A6 TTL XPC,"UV-damage excision repair, DNA incision|protein tyrosinylation|C-terminal protein-tyrosinylation|pyrimidine dimer repair by nucleotide-excision repair|fructose transmembrane transport",0.0005824|0.0005824|0.0005824|0.001456|0.001746,1|1|1|1|1,3432|3432|3432|858.1|686.5
2340,6,0.4017,6.026,4769.0,0.001259,0.998474,ETFA GTSF1L LRRC58 OR2AG1 SOX6 VCPKMT,positive regulation of mesenchymal stem cell differentiation|spinal cord oligodendrocyte cell differentiation|regulation of mesenchymal stem cell differentiation|negative regulation of cardiac muscle cell differentiation|fatty acid beta-oxidation using acyl-CoA dehydrogenase,0.001456|0.001746|0.002037|0.002328|0.0032,1|1|1|1|1,858.1|686.5|572.1|490.4|343.2
2341,5,0.4036,4.0360000000000005,3852.0,0.001044,0.996692,COL15A1 ITGA9 MYBPH OR2AK2 UPK1B,cell adhesion|biological adhesion|extracellular matrix organization|extracellular structure organization|external encapsulating structure organization,0.0009229|0.00094|0.003339|0.003356|0.003391,1|1|1|1|1,12.99|12.91|21.57|21.51|21.4
2342,5,0.4036,4.0360000000000005,3787.0,0.001062,0.996692,C6 IGDCC4 OR2AT4 RASSF3 SYF2,in utero embryonic development|mitotic G2 DNA damage checkpoint|chordate embryonic development|cytolysis|G2 DNA damage checkpoint,0.002893|0.005571|0.008066|0.008226|0.008467,1|1|1|1|1,23.21|187.2|13.71|124.8|121.1
2343,5,0.4032,4.032,3701.0,0.001085,0.996692,CIP2A OR2D3 PPP1R12B RAB3D TEX30,peptidyl-cysteine methylation|bone resorption|peptidyl-cysteine modification|vesicle docking involved in exocytosis|bone remodeling,0.000728|0.006054|0.009431|0.01064|0.01112,1|1|1|1|1,2060|171.6|108.4|95.79|91.53
2344,5,0.4197,4.197,3876.0,0.0010789999999999999,0.996692,MICA OR2G2 PRRX2 TLR9 VSNL1,defense response to symbiont|defense response to virus|negative regulation of ATPase-coupled calcium transmembrane transporter activity|tumor necrosis factor production|tumor necrosis factor superfamily cytokine production,0.001052|0.001052|0.001213|0.001213|0.001456,1|1|1|1|1,38.86|38.86|1030|1030|823.8
2345,6,0.4153,6.229,5100.0,0.001217,0.998474,CCDC157 DENND1A DPYS HSD17B8 OR2G6 OSM,uracil catabolic process|thymine catabolic process|pyrimidine nucleobase catabolic process|uracil metabolic process|thymine metabolic process,0.0008735|0.001165|0.001165|0.001165|0.001165,1|1|1|1|1,1716|1144|1144|1144|1144
2346,4,0.4469,2.681,3069.0,0.0008707000000000001,0.9929309999999999,ALOX5AP CDKN1A OR2H1 TPP2,leukotriene production involved in inflammatory response|arachidonic acid metabolite production involved in inflammatory response|negative regulation of cardiac muscle tissue regeneration|regulation of cardiac muscle tissue regeneration|response to toxic substance,0.0005825|0.0005825|0.0005825|0.0005825|0.000812,1|1|1|1|1,2574|2574|2574|2574|42.91
2347,6,0.4302,6.452999999999999,4803.0,0.0013390000000000001,0.998474,ARPC1B C1orf43 OR2L2 SHISA4 UROC1 ZNF264,formamide metabolic process|histidine catabolic process to glutamate and formate|histidine catabolic process to glutamate and formamide|formate metabolic process|histidine catabolic process,0.001456|0.001456|0.001456|0.002037|0.002619,1|1|1|1|1,858.1|858.1|858.1|572.1|429.1
2348,5,0.4116,4.1160000000000005,3829.0,0.0010710000000000001,0.996692,EBI3 IPP OR2M7 SH3PXD2A TMCO4,osteoclast fusion|multinuclear osteoclast differentiation|leptin-mediated signaling pathway|interleukin-35-mediated signaling pathway|interleukin-27-mediated signaling pathway,0.002037|0.002909|0.00349|0.00349|0.00349,1|1|1|1|1,572.1|381.4|312|312|312
2349,4,0.4603,2.762,2969.0,0.0009269,0.9929309999999999,C19orf44 OR2T10 OR2T34 UNC13A,dense core granule priming|presynaptic dense core vesicle exocytosis|neuronal dense core vesicle exocytosis|dense core granule exocytosis|synaptic vesicle docking,0.0007766|0.001165|0.001165|0.001553|0.002328,1|1|1|1|1,1716|1030|1030|735.5|468.1
2350,18,0.413,63.19,13660.0,0.004591,1.0,CCDC73 CYBC1 DDC FDX1 KCNK13 MAFB MAPKAPK5 NAT8L OR2T2 PSKH1 RPH3A SELE SLC5A12 STMP1 TAL2 TNFRSF19 UCKL1 WNT8A,rhombomere 6 development|polarity specification of proximal/distal axis|abducens nerve formation|abducens nerve morphogenesis|abducens nerve development,0.001746|0.002618|0.002618|0.002618|0.002618,1|1|1|1|1,1144|572.1|572.1|572.1|572.1
2351,5,0.4384,4.3839999999999995,3710.0,0.0011769999999999999,0.996692,CHRNB2 FCER1A OR10A2 OR2T29 TNN,lateral geniculate nucleus development|negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation|regulation of canonical Wnt signaling pathway involved in osteoblast differentiation|synaptic transmission involved in micturition|sensory perception,0.0004854|0.0004854|0.0004854|0.0009706|0.0009867,1|1|1|1|1,4119|4119|4119|1373|12.7
2352,5,0.4031,4.031000000000001,3967.0,0.001013,0.996692,ARL5A NXN OR2T3 RAB11FIP3 RALGDS,protein localization to Golgi membrane|negative regulation of adiponectin secretion|regulation of adiponectin secretion|protein localization to Golgi apparatus|endocytic recycling,0.0009706|0.001213|0.001698|0.007261|0.01015,1|1|1|1|1,1373|1030|686.5|142|100.5
2353,10,0.4049,18.22,7577.0,0.002393,0.999933,EIF4E1B FOLR1 FOLR2 KCNE3 KRTAP5-11 KRTAP5-9 OR2Y1 OR52E8 P2RY6 PLEKHB1,cellular response to folic acid|folate import across plasma membrane|keratinization|folate transmembrane transport|keratinocyte differentiation,1.864e-06|6.518e-06|6.976e-06|8.687e-06|1.352e-05,0.0294|0.0514|0.03668|0.03426|0.04266,1716|686.5|30.38|572.1|25.62
2354,5,0.4639,4.638999999999999,3624.0,0.001275,0.996692,N4BP2L1 OR4A15 OR4A16 OR4C15 OR4D6,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,1.056e-06|1.336e-06|1.552e-06|2.059e-06|2.39e-06,0.01666|0.01054|0.008159|0.008121|0.00754,37.36|35.21|33.9|31.56|30.4
2355,8,0.4104,11.49,5587.0,0.0020469999999999998,0.9996790000000001,DIS3L2 HBS1L LCN10 OR4C11 OR4P4 OR4S2 PELO TUT7,nuclear-transcribed mRNA catabolic process|mRNA catabolic process|polyuridylation-dependent mRNA catabolic process|RNA catabolic process|nucleobase-containing compound catabolic process,5.851e-07|8.564e-07|1.319e-06|1.426e-06|7.442e-06,0.00923|0.006754|0.006933|0.005623|0.02348,52.54|47.67|1716|41.86|27.46
2356,6,0.4221,6.331,4650.0,0.001356,0.998474,AXDND1 COA1 GXYLT1 OR4C6 RPRD1A SH2D2A,dephosphorylation of RNA polymerase II C-terminal domain|mitochondrial cytochrome c oxidase assembly|respiratory chain complex IV assembly|cytochrome complex assembly|O-glycan processing,0.00349|0.006681|0.007839|0.01073|0.01792,1|1|1|1|1,312|156|132|95.35|56.27
2357,5,0.4369,4.369,3884.0,0.001121,0.996692,APLNR OR4F15 PUM3 SMIM2 SOX1,positive regulation of inhibitory G protein-coupled receptor phosphorylation|regulation of inhibitory G protein-coupled receptor phosphorylation|apelin receptor signaling pathway|ventral spinal cord interneuron specification|cell fate specification involved in pattern specification,0.0004854|0.0004854|0.0009706|0.00194|0.00194,1|1|1|1|1,4119|4119|1373|588.4|588.4
2358,18,0.4017,61.46,13470.0,0.004531,1.0,A1BG ACR ANHX C8orf33 CHAMP1 FRG2B MZF1 OR4F21 OR4F5 PARD6G PGBD2 RABL2B SLC27A5 TUBB8 ZBTB45 ZNF132 ZNF672 ZNF891,acrosome matrix dispersal|sister chromatid biorientation|triglyceride mobilization|long-chain fatty acid import across plasma membrane|spindle assembly involved in female meiosis,0.001746|0.003489|0.004359|0.004359|0.005229,1|1|1|1|1,1144|381.4|286|286|228.8
2359,5,0.4147,4.147,3869.0,0.001068,0.996692,IER5L KCNG2 OR51L1 RALGPS1 TMEM18,regulation of Ral protein signal transduction|potassium ion transmembrane transport|potassium ion transport|protein homooligomerization|regulation of insulin secretion,0.0009706|0.038|0.04036|0.04317|0.04528,1|1|1|1|1,1373|26.07|24.52|22.88|21.79
2360,8,0.4041,11.31,6015.0,0.001872,0.9996790000000001,CALCB HBE1 OR51B4 OR52E2 OR52M1 OR52W1 OR56A1 VAT1L,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,2.467e-07|3.303e-07|3.976e-07|5.646e-07|6.79e-07,0.003892|0.002605|0.00209|0.002227|0.002142,29.19|27.5|26.49|24.66|23.75
2361,6,0.4033,6.0489999999999995,4910.0,0.001228,0.998474,GSG1L MEIOC OR52E4 PRMT9 SLC30A2 SLC36A4,positive regulation of sequestering of zinc ion|proline import across plasma membrane|L-tryptophan transmembrane transport|L-proline transmembrane transport|L-proline import across plasma membrane,0.0005824|0.0008735|0.0008735|0.0008735|0.0008735,1|1|1|1|1,3432|1716|1716|1716|1716
2362,6,0.4207,6.31,4625.0,0.001359,0.998474,ATP8A2 FAM177A1 HNRNPH3 OR52E6 SIGMAR1 XCL2,involuntary skeletal muscle contraction|cell death in response to hydrogen peroxide|positive regulation of phospholipid translocation|regulation of phospholipid translocation|aminophospholipid translocation,0.001165|0.001456|0.001746|0.002037|0.002328,1|1|1|1|1,1144|858.1|686.5|572.1|490.4
2363,5,0.4255,4.255,3810.0,0.001113,0.996692,MAPK13 OR52H1 TLE4 ZKSCAN3 ZNF609,cellular response to anisomycin|response to anisomycin|cellular response to sorbitol|cellular response to sodium arsenite|response to sorbitol,0.0004854|0.000728|0.0009706|0.001456|0.001456,1|1|1|1|1,4119|2060|1373|823.8|823.8
2364,4,0.4611,2.766,2959.0,0.0009316000000000001,0.9929309999999999,CCDC85B FAM50B OR52J3 SYT5,calcium ion-regulated exocytosis of neurotransmitter|regulation of dopamine secretion|calcium-ion regulated exocytosis|regulation of calcium ion-dependent exocytosis|negative regulation of fat cell differentiation,0.003104|0.006973|0.007745|0.008131|0.009289,1|1|1|1|1,343.2|147.1|132|125.6|109.5
2365,5,0.418,4.18,3841.0,0.001084,0.996692,CASS4 CCDC33 OR52N1 OR52N5 OR8S1,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,9.63e-05|0.0001148|0.0001283|0.0001584|0.000177,1|0.9052|0.6746|0.6247|0.5584,28.02|26.4|25.43|23.67|22.8
2366,5,0.442,4.42,3812.0,0.001155,0.996692,ANGPTL4 C10orf82 CDHR5 OR5AP2 OR8K1,intermicrovillar adhesion|protein unfolding|brush border assembly|negative regulation of lipoprotein lipase activity|regulation of microvillus length,0.000728|0.0009706|0.001456|0.001698|0.00194,1|1|1|1|1,2060|1373|823.8|686.5|588.4
2367,7,0.413,8.673,5775.0,0.0014960000000000002,0.9992989999999999,ACSL6 BSND FAAH FAM131C OR5B21 PXYLP1 RAB3B,fatty acid metabolic process|monocarboxylic acid metabolic process|long-chain fatty acid metabolic process|sebaceous gland cell differentiation|glucosylceramide biosynthetic process,0.0002148|0.0008007|0.0009513|0.001164|0.001164,1|1|1|1|1,23.62|15.03|42.91|1287|1287
2368,5,0.4048,4.048,4054.0,0.0009951,0.996692,ACOD1 DGKA IFT172 OR5D14 RBFOX1,tolerance induction to lipopolysaccharide|cellular response to progesterone stimulus|'de novo' UMP biosynthetic process|negative regulation of toll-like receptor 2 signaling pathway|'de novo' pyrimidine nucleobase biosynthetic process,0.000728|0.001213|0.001213|0.001698|0.00194,1|1|1|1|1,2060|1030|1030|686.5|588.4
2369,5,0.4416,4.416,3727.0,0.00118,0.996692,GORAB HACE1 OR5D16 RRP12 TIGD1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning|regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning|Rac protein signal transduction|hair follicle morphogenesis|epidermis morphogenesis,0.0004854|0.002183|0.005329|0.00702|0.007985,1|1|1|1|1,4119|514.9|196.1|147.1|128.7
2370,6,0.4008,6.0120000000000005,4651.0,0.001288,0.998474,GPCPD1 OR5I1 PCNX1 TP53AIP1 UBE2QL1 ZNF713,glycerophospholipid catabolic process|phospholipid catabolic process|glycerolipid catabolic process|skeletal muscle tissue development|skeletal muscle organ development,0.008707|0.01275|0.01764|0.03501|0.03784,1|1|1|1|1,118.4|79.83|57.21|28.37|26.2
2371,6,0.4064,6.095,4818.0,0.00126,0.998474,CRIM1 FIGLA HNF4G IL27 OR5L2 TACSTD2,negative regulation of branching involved in ureteric bud morphogenesis|negative regulation of ruffle assembly|negative regulation of morphogenesis of an epithelium|regulation of T-helper 1 cell differentiation|interleukin-27-mediated signaling pathway,0.0008735|0.002037|0.002619|0.0032|0.00349,1|1|1|1|1,1716|572.1|429.1|343.2|312
2372,4,0.4408,2.645,2945.0,0.000895,0.9929309999999999,ATP2C1 DFFB OR5M11 OSBPL8,Golgi calcium ion transport|Golgi calcium ion homeostasis|cellular manganese ion homeostasis|protein localization to nuclear pore|manganese ion homeostasis,0.0005825|0.0005825|0.0005825|0.0007766|0.0007766,1|1|1|1|1,2574|2574|2574|1716|1716
2373,6,0.4061,6.0920000000000005,4546.0,0.001335,0.998474,BEND5 CLCN6 DHRS4L2 GRP MAPK12 OR5M8,neuropeptide signaling pathway|positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway|psychomotor behavior|regulation of phospholipase C-activating G protein-coupled receptor signaling pathway|negative regulation of SMAD protein signal transduction,0.00101|0.002182|0.002182|0.002618|0.00349,1|1|1|1|1,41.99|572.1|572.1|457.7|326.9
2374,5,0.4121,4.121,4001.0,0.001026,0.996692,GPCPD1 OR6A2 RIMBP2 SLC32A1 TICAM1,positive regulation of myeloid dendritic cell cytokine production|regulation of myeloid dendritic cell cytokine production|negative regulation of MyD88-independent toll-like receptor signaling pathway|regulation of MyD88-independent toll-like receptor signaling pathway|neurotransmitter loading into synaptic vesicle,0.001698|0.001698|0.00194|0.002183|0.002183,1|1|1|1|1,686.5|686.5|588.4|514.9|514.9
2375,5,0.4503,4.503,3689.0,0.001216,0.996692,ABHD12B DNAL1 OR6F1 PSMC6 SIX6,phosphatidylserine catabolic process|positive regulation of inclusion body assembly|monoacylglycerol catabolic process|positive regulation of RNA polymerase II transcription preinitiation complex assembly|regulation of RNA polymerase II transcription preinitiation complex assembly,0.001456|0.002037|0.002328|0.0032|0.004071,1|1|1|1|1,858.1|572.1|490.4|343.2|264
2376,5,0.4153,4.1530000000000005,3794.0,0.001091,0.996692,COIL CYP1A2 METTL2B NOLC1 OR6K3,toxin biosynthetic process|RNA processing|dibenzo-p-dioxin metabolic process|box H/ACA RNA metabolic process|nucleolus organization,0.0004854|0.0008457|0.0009706|0.0009706|0.001698,1|1|1|1|1,4119|13.39|1373|1373|686.5
2377,5,0.4199,4.199,3936.0,0.0010630000000000001,0.996692,CASS4 NPPB OR7A17 SCN4B ST18,signaling|cell communication|AV node cell to bundle of His cell signaling|AV node cell action potential|receptor guanylyl cyclase signaling pathway,0.001343|0.001452|0.00194|0.00194|0.002667,1|1|1|1|1,3.755|3.696|588.4|588.4|411.9
2378,27,0.4068,142.8,19610.0,0.0072109999999999995,1.0,C19orf66 CNN1 DAND5 OR1M1 OR7G1 OR7G3 P2RY11 QTRT1 ZNF121 ZNF20 ZNF433 ZNF439 ZNF441 ZNF442 ZNF443 ZNF490 ZNF563 ZNF564 ZNF625 ZNF627 ZNF69 ZNF700 ZNF709 ZNF763 ZNF791 ZNF844 ZNF878,"regulation of transcription by RNA polymerase II|regulation of cellular macromolecule biosynthetic process|regulation of macromolecule biosynthetic process|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription",6.203e-14|1.609e-11|1.893e-11|2.019e-11|2.031e-11,9.785e-10|1.269e-07|9.952e-08|7.964e-08|6.407e-08,5.973|4.135|4.103|4.459|4.458
2379,6,0.4029,6.042999999999999,4712.0,0.0012779999999999998,0.998474,DNAJC27 OR5T3 OR8A1 PDYN SLC25A29 ZNF813,regulation of MAPK export from nucleus|mitochondrial L-ornithine transmembrane transport|acyl carnitine transport|sensory perception|L-lysine transport,0.0005824|0.001165|0.001746|0.001904|0.002037,1|1|1|1|1,3432|1144|686.5|10.58|572.1
2380,16,0.4008,48.1,12010.0,0.003978,0.999999,ADAMTS15 ADAMTS8 CCDC153 GLB1L3 KCNJ1 NTM NXPE4 OR10G9 OR10S1 OR4D5 OR6M1 OR6X1 OR8B12 OR8B3 OR8D4 TMEM136,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,5.265e-10|8.351e-10|1.119e-09|1.947e-09|2.606e-09,8.305e-06|6.586e-06|5.884e-06|7.68e-06|8.221e-06,23.35|22|21.19|19.73|19
2381,5,0.4462,4.462,3753.0,0.001184,0.996692,DDX24 FAM89A OR8H2 SLURP2 SNAP25,exocytic insertion of neurotransmitter receptor to postsynaptic membrane|synaptic vesicle docking|vesicle fusion to plasma membrane|synaptic vesicle fusion to presynaptic active zone membrane|neurotransmitter receptor transport to postsynaptic membrane,0.001213|0.00291|0.003394|0.003394|0.003636,1|1|1|1|1,1030|374.5|316.8|316.8|294.2
2382,5,0.4111,4.111000000000001,3921.0,0.001045,0.996692,OLFM3 OR8H3 PDE6H PGF SYNGR2,synaptic vesicle membrane organization|positive regulation of mast cell chemotaxis|regulation of mast cell chemotaxis|induction of positive chemotaxis|vascular endothelial growth factor signaling pathway,0.001213|0.001698|0.002183|0.003878|0.005812,1|1|1|1|1,1030|686.5|514.9|274.6|179.1
2383,6,0.438,6.57,4780.0,0.001369,0.998474,GP2 GRK5 HDGFL3 OR8J1 PUS10 TTN,striated muscle myosin thick filament assembly|sarcomerogenesis|skeletal muscle myosin thick filament assembly|myosin filament assembly|myosin filament organization,0.001165|0.001165|0.001165|0.001456|0.001456,1|1|1|1|1,1144|1144|1144|858.1|858.1
2384,24,0.4016,110.8,18820.0,0.0058390000000000004,1.0,C1QTNF3 CDH10 CDH12 CDH18 CDH6 CDH9 CEP72 DNAH5 FAM173B FBXO4 HCN1 NIM1K NNT OTULIN OTULINL OXCT1 PRLR SLC1A3 SLC45A2 SLC6A18 SLC6A19 TMEM267 UGT3A1 UGT3A2,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|adherens junction organization|cell-cell junction assembly|homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell junction organization,1.613e-09|1.001e-08|3.057e-07|1.136e-06|1.902e-06,2.544e-05|7.894e-05|0.001608|0.004478|0.006001,106.6|72.21|35.25|26.81|24.07
2385,4,0.4674,2.804,3094.0,0.0009031000000000001,0.9929309999999999,C2orf42 CCDC85A CEP68 OR8U1,centriole-centriole cohesion|centrosome cycle|microtubule organizing center organization|biological regulation|metabolic process,0.003152|0.02142|0.02428|0.07935|0.08568,1|1|1|1|1,343.3|46.81|41.19|0.3277|0
2386,5,0.4102,4.102,3891.0,0.001051,0.996692,CRYBB3 DYDC2 EFCAB13 FAM169B OR9G1,chromatin silencing at telomere|histone H3-K4 methylation|chromatin silencing|histone lysine methylation|lens development in camera-type eye,0.002425|0.008226|0.01328|0.01664|0.01855,1|1|1|1|1,457.7|124.8|76.28|60.57|54.2
2387,5,0.4402,4.402,3934.0,0.001115,0.996692,DNAAF4 OR9I1 REXO1 USH1G YIF1A,equilibrioception|inner dynein arm assembly|outer dynein arm assembly|epithelial cilium movement involved in extracellular fluid movement|inner ear receptor cell stereocilium organization,0.002183|0.00412|0.005329|0.008467|0.008708,1|1|1|1|1,514.9|257.4|196.1|121.1|117.7
2388,6,0.4265,6.398,4890.0,0.001303,0.998474,CCDC148 MAB21L1 OR9Q1 PRKAR2B SCUBE1 SVEP1,lymph circulation|response to antipsychotic drug|response to clozapine|Tie signaling pathway|negative regulation of cAMP-dependent protein kinase activity,0.0008735|0.0008735|0.001165|0.001456|0.002909,1|1|1|1|1,1716|1716|1144|858.1|381.4
2389,4,0.4344,2.6060000000000003,3125.0,0.0008312000000000001,0.9929309999999999,CDNF EML4 OR9Q2 PRKG1,relaxation of vascular associated smooth muscle|negative regulation of vascular associated smooth muscle cell migration|relaxation of smooth muscle|negative regulation of platelet aggregation|negative regulation of smooth muscle contraction,0.001359|0.001359|0.001553|0.002522|0.002716,1|1|1|1|1,858.1|858.1|735.5|429.1|396.1
2390,5,0.4305,4.305,4109.0,0.001044,0.996692,DSE MSMP ORAI2 ZNF44 ZNF721,store-operated calcium entry|dermatan sulfate biosynthetic process|dermatan sulfate metabolic process|dermatan sulfate proteoglycan biosynthetic process|dermatan sulfate proteoglycan metabolic process,0.002183|0.003152|0.003394|0.003878|0.00412,1|1|1|1|1,514.9|343.3|316.8|274.6|257.4
2391,5,0.44,4.4,3820.0,0.001147,0.996692,ATG12 FER KRTAP5-5 OR5M1 OSBPL1A,Kit signaling pathway|cellular response to stem cell factor stimulus|response to stem cell factor|insulin receptor signaling pathway via phosphatidylinositol 3-kinase|extracellular matrix-cell signaling,0.000728|0.000728|0.000728|0.001213|0.001456,1|1|1|1|1,2060|2060|2060|1030|823.8
2392,6,0.4381,6.572,5206.0,0.001258,0.998474,CA9 CDK5RAP1 MYO1C OSBPL2 RNF222 SYN3,vesicle transport along actin filament|actin filament-based transport|vesicle localization|vesicle cytoskeletal trafficking|actin filament-based movement,2.072e-05|2.495e-05|3.751e-05|0.0002364|0.0007047,0.3268|0.1968|0.1972|0.9321|1,309.7|280.2|41.83|86.53|49.45
2393,7,0.4014,8.429,5686.0,0.001477,0.9992989999999999,ACBD7 C6orf58 KCNG1 OSCAR PCSK4 TOR1B ZNF429,multinuclear osteoclast differentiation|collagen-activated signaling pathway|positive regulation of bone resorption|regulation of delayed rectifier potassium channel activity|acrosome reaction,0.002909|0.004651|0.006101|0.006391|0.00697,1|1|1|1|1,381.4|228.8|171.6|163.5|149.2
2394,6,0.4079,6.117999999999999,4976.0,0.001225,0.998474,OSR2 SERTM1 TCIRG1 TSSK3 TXNDC15 ZUP1,odontogenesis|response to silver ion|dentin mineralization|memory T cell activation|T-helper 1 cell activation,0.0004971|0.0005824|0.0005824|0.0008735|0.001165,1|1|1|1|1,58.18|3432|3432|1716|1144
2395,7,0.4107,8.625,5666.0,0.001516,0.9992989999999999,GAREM2 HS1BP3 OTOF PEX11G SHLD2 TTC32 ZNF512,regulation of peroxisome size|peroxisome fission|synaptic vesicle priming|positive regulation of double-strand break repair via nonhomologous end joining|negative regulation of double-strand break repair via homologous recombination,0.001358|0.003732|0.005086|0.006101|0.006777,1|1|1|1|1,980.7|294.2|210.2|173.1|154.8
2396,5,0.4169,4.169,3842.0,0.0010810000000000001,0.996692,LRP4 NEK9 OTUB2 SAA4 SGCZ,positive regulation of presynaptic membrane organization|regulation of presynaptic membrane organization|membrane organization|positive regulation of skeletal muscle acetylcholine-gated channel clustering|negative regulation of histone ubiquitination,0.000728|0.000728|0.0009372|0.0009706|0.001213,1|1|1|1|1,2060|2060|12.93|1373|1030
2397,10,0.4012,18.05,7429.0,0.002418,0.999933,ARL15 C2CD5 CDK5 DUS2 FIBP PTP4A1 RCE1 RWDD4 TMEM94 ZNF330,tRNA dihydrouridine synthesis|positive regulation of protein targeting to membrane|regulation of protein targeting to membrane|regulation of protein targeting|tRNA modification,5.433e-06|0.0001356|0.0001899|0.0009028|0.001056,0.08569|1|0.9986|1|1,748.9|120.8|101.2|45.12|41.61
2398,8,0.4159,11.65,5290.0,0.0021899999999999997,0.9996790000000001,ANKRD17 CAPRIN1 CNOT4 G3BP1 G3BP2 OTUD6B SERBP1 SRRD,positive regulation of stress granule assembly|regulation of stress granule assembly|stress granule assembly|positive regulation of organelle assembly|posttranscriptional regulation of gene expression,7.913e-07|2.768e-06|3.036e-05|0.0003055|0.0009585,0.01248|0.02183|0.1596|1|1,2574|1030|257.4|76.85|14.12
2399,6,0.4315,6.472,5015.0,0.001286,0.998474,ABCC10 EDEM3 MYBPC3 OVOL1 PCDH12 SPATA45,"cell cycle switching|germline cell cycle switching, mitotic to meiotic cell cycle|cell cycle switching, mitotic to meiotic cell cycle|regulation of muscle filament sliding|negative regulation of meiotic cell cycle phase transition",0.001165|0.001165|0.001165|0.001456|0.001456,1|1|1|1|1,1144|1144|1144|858.1|858.1
2400,5,0.4239,4.239,3966.0,0.001065,0.996692,ANP32A AOAH IRAK2 OXR1 PPP1R3D,cellular polysaccharide metabolic process|polysaccharide metabolic process|lipopolysaccharide catabolic process|lipopolysaccharide metabolic process|negative regulation of cellular response to oxidative stress,0.000163|0.0001789|0.0004854|0.0004854|0.000728,1|1|1|1|1,100.5|95.79|4119|4119|2060
2401,13,0.4067,31.72,9152.0,0.0034439999999999996,0.999993,C12orf45 C16orf72 DDX21 DDX31 GNL1 HSPA14 NCL NOLC1 PINX1 RPF1 ZNF622 ZNHIT3 ZNHIT6,ribosome biogenesis|ribonucleoprotein complex biogenesis|rRNA processing|rRNA metabolic process|ribosomal large subunit biogenesis,5.795e-11|7.944e-10|3.138e-08|3.908e-08|3.004e-07,9.141e-07|6.266e-06|0.000165|0.0001541|0.0009476,31.02|22.15|29.7|28.6|71.51
2402,7,0.4039,8.481,5614.0,0.001505,0.9992989999999999,DPT ITLN2 LTB OR6N2 PACRGL S100A7A VAMP4,synaptic vesicle to endosome fusion|synaptic vesicle endosomal processing|SNARE complex assembly|Golgi ribbon formation|regulation of synaptic vesicle endocytosis,0.001358|0.003732|0.003732|0.004748|0.006101,1|1|1|1|1,980.7|294.2|294.2|226.3|173.1
2403,5,0.4033,4.033,3826.0,0.00105,0.996692,COPS8 IQCA1 PACSIN2 RARRES2 TMEM170B,caveola assembly|response to caloric restriction|plasma membrane raft assembly|antifungal innate immune response|COP9 signalosome assembly,0.001213|0.001213|0.001456|0.001456|0.001456,1|1|1|1|1,1030|1030|823.8|823.8|823.8
2404,5,0.4241,4.2410000000000005,4008.0,0.0010539999999999998,0.996692,NEGR1 NHLRC3 PALLD PKDCC PTPRR,vestibular receptor cell morphogenesis|vestibular receptor cell development|vestibular receptor cell differentiation|negative regulation of Golgi to plasma membrane protein transport|epidermal cell differentiation,0.000728|0.0009706|0.0009706|0.001698|0.002304,1|1|1|1|1,2060|1373|1373|686.5|26.07
2405,6,0.4273,6.409,4068.0,0.001568,0.998474,PAN2 PAN3 SMG5 SMG6 SMG7 UPF2,nuclear-transcribed mRNA catabolic process|mRNA catabolic process|RNA catabolic process|nucleobase-containing compound catabolic process|heterocycle catabolic process,2.272e-11|4.023e-11|8.656e-11|1.044e-09|1.983e-09,3.583e-07|3.173e-07|4.551e-07|4.116e-06|6.257e-06,78.81|71.51|62.79|41.19|36.95
2406,4,0.4591,2.755,3041.0,0.0009025,0.9929309999999999,GSX2 IGFBP4 MS4A6E PANX2,subpallium neuron fate commitment|forebrain dorsal/ventral pattern formation|type B pancreatic cell proliferation|olfactory bulb interneuron differentiation|spinal cord association neuron differentiation,0.0005825|0.001359|0.001941|0.002328|0.002522,1|1|1|1|1,2574|858.1|572.1|468.1|429.1
2407,6,0.4037,6.055,4909.0,0.0012289999999999998,0.998474,ADAM10 FAM24A LENEP NOTCH3 PANK4 PAOX,regulation of Notch signaling pathway|Notch signaling pathway|positive regulation of spermidine biosynthetic process|regulation of spermidine biosynthetic process|constitutive protein ectodomain proteolysis,0.0004029|0.0004971|0.0005824|0.0005824|0.0005824,1|1|1|1|1,64.76|58.18|3432|3432|3432
2408,5,0.4329,4.329,4229.0,0.0010199999999999999,0.996692,LOXL1 MESP2 PAPOLG STX12 THAP10,protein deamination|peptidyl-lysine oxidation|somite rostral/caudal axis specification|protein oxidation|cholesterol efflux,0.0004854|0.001456|0.00291|0.003152|0.006295,1|1|1|1|1,4119|823.8|374.5|343.3|164.8
2409,25,0.3726,111.8,16560.0,0.006684999999999999,1.0,CNIH1 COG1 GET4 GOSR2 RAB18 RAB1A RAB1B SAR1A SCFD1 SEC23B SEC23IP SEC24A SEC31A SURF4 TBC1D20 TM9SF3 TRAPPC1 TRAPPC11 TRAPPC12 TRAPPC13 TRAPPC2L TRAPPC3 TRAPPC4 TRAPPC5 UNC50,endoplasmic reticulum to Golgi vesicle-mediated transport|COPII-coated vesicle budding|vesicle budding from membrane|Golgi vesicle transport|COPII vesicle coating,1.649e-33|3.78e-33|1.038e-30|3.835e-30|1.265e-28,2.601e-29|2.982e-29|5.458e-27|1.512e-26|3.99e-25,79.86|188.3|128|41.61|183.1
2410,5,0.4039,4.039,3970.0,0.0010140000000000001,0.996692,PAQR7 PRF1 RNASEH1 TTC34 ZNF655,"DNA replication, removal of RNA primer|defense response to tumor cell|immune response to tumor cell|T cell mediated cytotoxicity|positive regulation of killing of cells of other organism",0.001213|0.001456|0.001698|0.00291|0.00291,1|1|1|1|1,1030|823.8|686.5|374.5|374.5
2411,6,0.4254,6.381,5112.0,0.0012439999999999999,0.998474,C5orf30 CHST15 DGAT2 KIAA1217 PARPBP PROKR1,cellular response to oleic acid|fat pad development|response to oleic acid|monoacylglycerol biosynthetic process|cellular triglyceride homeostasis,0.001165|0.001746|0.002037|0.002328|0.002328,1|1|1|1|1,1144|686.5|572.1|490.4|490.4
2412,6,0.4035,6.0520000000000005,4894.0,0.001232,0.998474,CD74 CEACAM21 PASK RBAK SH3BGRL2 SUGCT,macrophage migration inhibitory factor signaling pathway|positive regulation of macrophage migration inhibitory factor signaling pathway|regulation of macrophage migration inhibitory factor signaling pathway|negative regulation of mature B cell apoptotic process|regulation of mature B cell apoptotic process,0.0005824|0.0008735|0.001165|0.001165|0.001165,1|1|1|1|1,3432|1716|1144|1144|1144
2413,5,0.4274,4.274,4024.0,0.001058,0.996692,AKR1C2 DQX1 PAXX RNF26 TIGD2,protein localization to perinuclear region of cytoplasm|cellular response to prostaglandin D stimulus|response to prostaglandin D|cellular response to jasmonic acid stimulus|response to jasmonic acid,0.000728|0.001213|0.001213|0.001213|0.001213,1|1|1|1|1,2060|1030|1030|1030|1030
2414,6,0.4171,6.257000000000001,4888.0,0.001275,0.998474,BCL2L10 CRABP1 CYP1B1 DGKQ HSPA1B PBOV1,regulation of hormone levels|retinoid metabolic process|diterpenoid metabolic process|terpenoid metabolic process|cellular hormone metabolic process,0.0003285|0.0004179|0.0004646|0.0005478|0.000592,1|1|1|1|1,19.36|63.56|60.22|55.36|53.22
2415,6,0.4261,6.391,4932.0,0.001291,0.998474,CYTH4 HRK PBX4 SLC25A2 SPIRE2 VIM,formin-nucleated actin cable organization|mitochondrial L-ornithine transmembrane transport|formin-nucleated actin cable assembly|polar body extrusion after meiotic divisions|establishment of meiotic spindle localization,0.001165|0.001165|0.001165|0.001456|0.001746,1|1|1|1|1,1144|1144|1144|858.1|686.5
2416,4,0.4288,2.573,3033.0,0.0008451999999999999,0.9929309999999999,IL20RA LEFTY1 PCDH1 PTBP2,negative regulation of RNA splicing|mRNA splice site selection|regulation of bone resorption|positive regulation of pathway-restricted SMAD protein phosphorylation|regulation of bone remodeling,0.005233|0.006393|0.009096|0.009482|0.01045,1|1|1|1|1,198|160.9|111.9|107.3|97.15
2417,6,0.4002,6.002999999999999,4629.0,0.001292,0.998474,CPAMD8 ERBB4 GARS GPBAR1 PCDH18 SZRD1,cell surface bile acid receptor signaling pathway|glycyl-tRNA aminoacylation|mitochondrial glycyl-tRNA aminoacylation|central nervous system morphogenesis|positive regulation of cholangiocyte proliferation,0.0006794|0.0006794|0.0006794|0.001019|0.001019,1|1|1|1|1,2942|2942|2942|1471|1471
2418,7,0.418,8.779,6100.0,0.001434,0.9992989999999999,DAGLA FLRT1 GRK4 PCDH7 SH3BP2 TMBIM1 UVSSA,negative regulation of Fas signaling pathway|positive regulation of blood vessel remodeling|endocannabinoid signaling pathway|regulation of Fas signaling pathway|retrograde trans-synaptic signaling by endocannabinoid,0.0007765|0.001164|0.001552|0.001552|0.001552,1|1|1|1|1,2574|1287|858.1|858.1|858.1
2419,5,0.4487,4.487,3921.0,0.00114,0.996692,GPR39 PCDHB1 PLA2G2F SAMD15 TCEA3,phosphatidylinositol acyl-chain remodeling|phosphatidylglycerol acyl-chain remodeling|phosphatidylserine acyl-chain remodeling|arachidonic acid secretion|arachidonate transport,0.004604|0.004604|0.005571|0.006054|0.006054,1|1|1|1|1,228.8|228.8|187.2|171.6|171.6
2420,11,0.4006,22.03,8981.0,0.002441,0.999969,ABCB11 BBS5 CASP10 CPO CRYGA CRYGB CRYGC CRYGD CXCR2 HOXD4 TTC30A,lens development in camera-type eye|visual perception|sensory perception of light stimulus|camera-type eye development|eye development,1.466e-07|1.627e-07|1.779e-07|3.742e-05|6.43e-05,0.002312|0.001283|0.0009351|0.1476|0.2029,83.38|36.67|36.01|19.93|17.31
2421,7,0.4026,8.456,5750.0,0.001465,0.9992989999999999,OPN1SW PCNX2 RASL11A RDH10 SMCR8 ST5 WDR78,retinoid metabolic process|diterpenoid metabolic process|terpenoid metabolic process|primary lung bud formation|positive regulation of retinoic acid biosynthetic process,0.0004179|0.0004646|0.0005478|0.0005824|0.0005824,1|1|1|1|1,63.56|60.22|55.36|3432|3432
2422,7,0.4021,8.445,5888.0,0.001429,0.9992989999999999,ARRDC1 ELOVL7 FAM186A PCNX3 TBC1D4 TMEM150C VSIG10,"proprioception|negative regulation of vesicle fusion|fatty acid elongation, unsaturated fatty acid|fatty acid elongation, saturated fatty acid|fatty acid elongation, polyunsaturated fatty acid",0.002037|0.002376|0.002715|0.002715|0.002715,1|1|1|1|1,588.4|490.4|420.3|420.3|420.3
2423,5,0.4047,4.047,3888.0,0.001037,0.996692,DOCK10 FLT4 KCTD16 PCP4 STXBP5L,calmodulin dependent kinase signaling pathway|regulation of blood vessel remodeling|marginal zone B cell differentiation|positive regulation of protein kinase C signaling|positive regulation of catalytic activity,0.001456|0.001698|0.002425|0.002667|0.002929,1|1|1|1|1,823.8|686.5|457.7|411.9|8.733
2424,6,0.4336,6.502999999999999,5109.0,0.001268,0.998474,ANKRD34B AZGP1 CLIP3 PCSK5 PDIA6 SLC6A17,nitrogen compound transport|renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure|cytokine precursor processing|renin secretion into blood stream|nerve growth factor processing,0.0007625|0.0008735|0.0008735|0.0008735|0.001456,1|1|1|1|1,7.624|1716|1716|1716|858.1
2425,5,0.4227,4.227,3915.0,0.001076,0.996692,LTBP2 PCYOX1L SRXN1 STK10 XPA,nucleotide-excision repair involved in interstrand cross-link repair|prenylcysteine metabolic process|prenylcysteine catabolic process|secretion by cell|prenylated protein catabolic process,0.000728|0.000728|0.000728|0.0009144|0.0009706,1|1|1|1|1,2060|2060|2060|13.03|1373
2426,16,0.4025,48.3,10760.0,0.004457,0.999999,AK6 C18orf21 C1D EXOSC1 EXOSC10 HEATR1 MDM2 NOL6 NOP9 PARN PDCD11 PDCD2 POP4 SRFBP1 WDR43 WDR75,rRNA processing|rRNA metabolic process|ncRNA processing|ribosome biogenesis|ncRNA metabolic process,1.912e-17|2.862e-17|4.837e-17|2.615e-16|3.976e-16,3.016e-13|2.257e-13|2.543e-13|1.031e-12|1.255e-12,51.25|49.36|33.65|40.14|28.12
2427,5,0.4061,4.061,3912.0,0.001034,0.996692,NTRK2 PDE11A S100A1 SEMA6B SNX30,"trans-synaptic signaling by neuropeptide, modulating synaptic transmission|trans-synaptic signaling by neuropeptide|trans-synaptic signaling by BDNF|trans-synaptic signaling by BDNF, modulating synaptic transmission|synaptic signaling via neuropeptide",0.0005824|0.0005824|0.0005824|0.0005824|0.0008735,1|1|1|1|1,3432|3432|3432|3432|1716
2428,6,0.4403,6.604,5048.0,0.0013039999999999998,0.998474,FAM43A IAPP PDE4C SCARA3 SLCO1A2 TPRG1,positive regulation of calcium ion import across plasma membrane|regulation of calcium ion import across plasma membrane|amylin receptor signaling pathway|calcitonin family receptor signaling pathway|cAMP catabolic process,0.001165|0.001746|0.002328|0.002619|0.002909,1|1|1|1|1,1144|686.5|490.4|429.1|381.4
2429,6,0.4084,6.126,4735.0,0.001289,0.998474,C1orf210 FOXF1 IGDCC4 PDGFRB RTP5 ZNF197,artery morphogenesis|vasculogenesis|artery development|detection of wounding|cell migration involved in coronary angiogenesis,0.0001458|0.0001841|0.0002799|0.0005824|0.0005824,1|1|1|0.7656|0.8352,109|96.69|78.01|3432|3432
2430,7,0.4061,8.527999999999999,5736.0,0.0014810000000000001,0.9992989999999999,CCDC24 ERBB4 GPR22 MGAT4C NAPEPLD PDLIM2 SNRPN,central nervous system morphogenesis|host-mediated regulation of intestinal microbiota composition|negative regulation of eating behavior|cardiac muscle tissue regeneration|N-acylethanolamine metabolic process,0.001019|0.001019|0.001358|0.001698|0.002037,1|1|1|1|1,1471|1471|980.7|735.5|588.4
2431,5,0.4397,4.397,3950.0,0.001109,0.996692,CACNA2D3 CASTOR1 PCIF1 PDPN SYNE3,regulation of myofibroblast contraction|regulation of cell shape|positive regulation of platelet aggregation|lymphatic endothelial cell fate commitment|cellular response to L-arginine,0.0004854|0.0005542|0.0009706|0.0009706|0.0009706,1|1|1|1|1,4119|53.84|1373|1373|1373
2432,6,0.4031,6.047000000000001,4735.0,0.0012720000000000001,0.998474,COL9A2 EPN2 PDZK1IP1 PTCH2 SLFNL1 TIE1,negative regulation of angiogenesis|negative regulation of blood vessel morphogenesis|negative regulation of vasculature development|branching involved in lymph vessel morphogenesis|epidermal cell fate specification,0.0003737|0.0003809|0.0003881|0.0005824|0.001165,1|1|1|1|1,67.3|66.65|66.01|3432|1144
2433,6,0.4123,6.184,4889.0,0.00126,0.998474,CDKN2D GSTK1 PER3 TARBP1 TMEM178A ZNF880,"autophagic cell death|response to light stimulus|regulation of circadian sleep/wake cycle, sleep|regulation of circadian sleep/wake cycle|response to radiation",0.002037|0.003357|0.005232|0.006391|0.00665,1|1|1|1|1,572.1|21.93|201.9|163.5|15.43
2434,6,0.4004,6.006,4931.0,0.001214,0.998474,AMIGO1 HECW2 KLRB1 PAFAH1B3 PERP SECTM1,cellular response to L-glutamate|regulation of ion transmembrane transporter activity|regulation of transmembrane transporter activity|regulation of transporter activity|response to L-glutamate,0.001746|0.002479|0.002682|0.002931|0.0032,1|1|1|1|1,686.5|25.62|24.61|23.51|343.2
2435,7,0.4213,8.847999999999999,5898.0,0.0014939999999999999,0.9992989999999999,CAMKMT FOLR2 ILDR2 KCNE3 NRN1L PGM1 STAG3,negative regulation of membrane repolarization during cardiac muscle cell action potential|negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential|cellular response to folic acid|regulation of membrane repolarization during ventricular cardiac muscle cell action potential|negative regulation of potassium ion export across plasma membrane,0.0006794|0.0006794|0.001019|0.001358|0.001358,1|1|1|1|1,2942|2942|1471|980.7|980.7
2436,7,0.4128,8.668,5598.0,0.001542,0.9992989999999999,EPHA5 NBEAL1 PHETA2 PPIAL4G SLC28A1 STK16 TMEM167B,cytidine transport|peptidyl-tyrosine phosphorylation|peptidyl-tyrosine modification|purine nucleobase transmembrane transport|constitutive secretory pathway,0.0006794|0.001065|0.001108|0.001698|0.002037,1|1|1|1|1,2942|40.03|39.23|735.5|588.4
2437,6,0.4191,6.287000000000001,4852.0,0.001291,0.998474,ARFGAP1 C1QTNF12 KLK6 MGME1 PHGR1 TNFRSF4,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum|endoplasmic reticulum to Golgi vesicle-mediated transport|COPI-coated vesicle budding|mitochondrial DNA repair|COPI coating of Golgi vesicle",0.0003651|0.00187|0.002376|0.002376|0.002376,1|1|1|1|1,69.23|30.02|490.4|490.4|490.4
2438,7,0.4028,8.459,5442.0,0.0015480000000000001,0.9992989999999999,GLT8D2 NADK2 NPL PHLDB2 PROK1 SAA4 SNX29,"NADP biosynthetic process|negative regulation of wound healing, spreading of epidermal cells|regulation of basement membrane organization|positive regulation of basement membrane assembly involved in embryonic body morphogenesis|regulation of basement membrane assembly involved in embryonic body morphogenesis",0.001358|0.001698|0.002037|0.002037|0.002037,1|1|1|1|1,980.7|735.5|588.4|588.4|588.4
2439,5,0.4474,4.474,4042.0,0.001103,0.996692,AQR PANK2 PI4K2B SCRT2 SLC30A7,sequestering of zinc ion|pantothenate metabolic process|coenzyme A biosynthetic process|sequestering of metal ion|regulation of bile acid metabolic process,0.001213|0.00194|0.00291|0.003152|0.003636,1|1|1|1|1,1030|588.4|374.5|343.3|294.2
2440,5,0.4324,4.324,3913.0,0.001101,0.996692,CD22 CMTM4 PID1 TGM2 UBQLNL,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine|negative regulation of ATP biosynthetic process|isopeptide cross-linking|peptidyl-glutamine modification|positive regulation of fat cell proliferation,0.000728|0.0009706|0.0009706|0.001213|0.001213,1|1|1|1|1,2060|1373|1373|1030|1030
2441,5,0.4411,4.4110000000000005,3842.0,0.001144,0.996692,CCDC83 CDC42EP1 DAD1 HCFC1R1 PIEZO1,positive regulation of protein-containing complex assembly|positive regulation of cell-cell adhesion mediated by integrin|regulation of cell-cell adhesion mediated by integrin|positive regulation of integrin activation|positive regulation of pseudopodium assembly,0.001443|0.001698|0.00291|0.00291|0.003394,1|1|1|1|1,33.08|686.5|374.5|374.5|316.8
2442,15,0.499,52.4,9958.0,0.0052179999999999995,0.999999,ATP5F1A C18orf21 HAUS1 NARS PIK3C3 RBFA RPL17 RTTN SKA1 TRAPPC8 TXNL4A VPS4A WDR7 ZNF236 ZNF407,cell division|autophagy of peroxisome|protein localization to phagophore assembly site|vacuole organization|organelle assembly,1.965e-05|4.476e-05|5.163e-05|0.0001343|0.0001738,0.3099|0.3531|0.2715|0.5295|0.5484,13.95|228.8|211.2|29.85|8.79
2443,5,0.4634,4.6339999999999995,3917.0,0.001178,0.996692,C9orf57 FGFBP1 MANBAL PIGZ PROM2,negative regulation of caveolin-mediated endocytosis|negative regulation of pinocytosis|regulation of caveolin-mediated endocytosis|positive regulation of fibroblast growth factor receptor signaling pathway|positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,0.000728|0.001456|0.00194|0.002183|0.002425,1|1|1|1|1,2060|823.8|588.4|514.9|457.7
2444,5,0.4523,4.523,3913.0,0.001152,0.996692,ANXA1 C14orf28 LSMEM2 NPFFR1 PIKFYVE,"granulocyte chemotaxis|granulocyte migration|myeloid leukocyte migration|leukocyte chemotaxis|1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process",0.0001669|0.0002219|0.0003725|0.000472|0.0004854,1|1|1|1|1,99.25|85.81|65.9|58.43|4119
2445,5,0.4115,4.115,3935.0,0.001042,0.996692,EFR3B MFGE8 PIM3 SLC7A2 ZNF177,L-arginine import across plasma membrane|L-lysine transport|L-lysine transmembrane transport|L-ornithine transmembrane transport|ornithine transport,0.001456|0.001698|0.001698|0.001698|0.00194,1|1|1|1|1,823.8|686.5|686.5|686.5|588.4
2446,5,0.4172,4.172,3500.0,0.001187,0.996692,FAM83D FAM83H HMMR PIP TUBB4B,protein localization to cytoskeleton|regulation of cell cycle phase transition|protein localization to mitotic spindle|regulation of cell cycle process|regulation of G2/M transition of mitotic cell cycle,6.651e-05|0.0002172|0.0005824|0.000974|0.00144,1|1|1|1|1,163.5|22.29|3432|13.34|33.82
2447,6,0.4053,6.08,4845.0,0.00125,0.998474,CYP39A1 DNMBP FREM3 PIRT SPATA6 TPD52,cholesterol catabolic process|sterol catabolic process|behavioral response to pain|motile cilium assembly|steroid catabolic process,0.00349|0.00349|0.004071|0.00755|0.007839,1|1|1|1|1,312|312|264|137.3|132
2448,5,0.4255,4.255,3770.0,0.001125,0.996692,DPRX IMMP1L NPFFR2 PITPNB TNS3,protein processing involved in protein targeting to mitochondrion|mitochondrial protein processing|regulation of cAMP-dependent protein kinase activity|regulation of adenylate cyclase activity|intermembrane lipid transfer,0.001456|0.00291|0.005087|0.008226|0.01184,1|1|1|1|1,823.8|374.5|205.9|124.8|85.81
2449,30,0.4053,176.3,18540.0,0.00939,1.0,C12orf66 DEPDC5 FNIP1 ITFG2 KPTN LAMTOR1 LAMTOR2 LAMTOR3 LAMTOR4 MIOS NPRL2 RAB7A RRAGA RRAGC SEH1L SPG21 SZT2 TBC1D5 TBC1D7 TSC1 TSC2 VPS16 VPS18 VPS29 VPS33A VPS35 VPS39 VPS41 WDR24 WDR59,regulation of TOR signaling|cellular response to amino acid starvation|response to amino acid starvation|response to starvation|cellular response to nutrient levels,8.916e-39|1.796e-30|3.06e-30|1.097e-29|1.876e-29,1.406e-34|1.416e-26|1.609e-26|4.327e-26|5.919e-26,138.7|137.3|132.3|55.98|54.35
2450,7,0.4019,8.44,5829.0,0.001442,0.9992989999999999,GBP5 GBP6 GRHL1 MVP PKD2L1 TMEM56 TMEM74,protein homotetramerization|protein tetramerization|interleukin-18 production|detection of chemical stimulus involved in sensory perception of sour taste|cellular response to interferon-gamma,0.0001621|0.0003651|0.0006794|0.001019|0.001227,1|1|1|1|1,105.1|69.23|2942|1471|37.24
2451,5,0.4509,4.5089999999999995,3756.0,0.001196,0.996692,DMXL1 ELF1 PKN3 SGCD TTC7A,vacuolar acidification|regulation of B cell receptor signaling pathway|cellular cation homeostasis|cellular ion homeostasis|cation homeostasis,0.005812|0.006295|0.009|0.009386|0.01098,1|1|1|1|1,179.1|164.8|12.95|12.67|11.69
2452,9,0.4064,14.63,6158.0,0.002363,0.9998530000000001,DNAAF5 ICE2 INTS14 PIH1D1 POLR2M RPAP3 SP2 WDCP ZNHIT3,snoRNA localization|box C/D snoRNP assembly|small nucleolar ribonucleoprotein complex assembly|RNA biosynthetic process|RNA metabolic process,3.558e-06|7.619e-06|1.117e-05|6.538e-05|0.0002744,0.05612|0.06009|0.05873|0.2578|0.8655,915.3|572.1|457.7|16.17|7.156
2453,6,0.4071,6.106,4786.0,0.001271,0.998474,CATIP ITM2C PLA2G1B PRKACG ST5 UBASH3B,regulation of calcium ion transport into cytosol|regulation of protein kinase activity|regulation of kinase activity|positive regulation of glomerular visceral epithelial cell apoptotic process|regulation of glomerular visceral epithelial cell apoptotic process,0.0002452|0.0005502|0.0008061|0.0009706|0.0009706,1|1|1|1|1,81.56|15.5|13.61|1373|1373
2454,5,0.4341,4.341,4059.0,0.001066,0.996692,C8orf86 EHD4 ENAM PLA2G2A ZFP42,ameloblast differentiation|intestinal stem cell homeostasis|positive regulation of enamel mineralization|regulation of enamel mineralization|positive regulation of tooth mineralization,0.0004854|0.0009706|0.0009706|0.001456|0.001698,1|1|1|1|1,4119|1373|1373|823.8|686.5
2455,6,0.4309,6.4639999999999995,4732.0,0.001361,0.998474,ATG4B FAM3B GABARAPL1 PLA2G3 RLF SHC4,positive regulation of mast cell differentiation|protein delipidation|regulation of mast cell differentiation|macroautophagy|positive regulation of histamine secretion by mast cell,0.0006794|0.0006794|0.001358|0.001796|0.002037,1|1|1|1|1,2942|2942|980.7|30.65|588.4
2456,5,0.4546,4.546,4012.0,0.001129,0.996692,C1orf54 LGI3 PLA2G4B POLB TRIM9,"immunoglobulin heavy chain V-D-J recombination|base-excision repair, base-free sugar-phosphate removal|DNA dephosphorylation|base-excision repair, DNA ligation|negative regulation of SNARE complex assembly",0.000728|0.000728|0.000728|0.0009706|0.0009706,1|1|1|1|1,2060|2060|2060|1373|1373
2457,20,0.4008,76.16,13920.0,0.005424,1.0,AK6 BMS1 C1D DHX33 EXOSC1 EXOSC10 HEATR1 IMP3 IMP4 NAT10 NOC4L NOL10 NOL6 NOP9 PDCD11 POP5 UTP25 UTP4 WDR43 WDR75,rRNA processing|rRNA metabolic process|ribosome biogenesis|ncRNA processing|ribonucleoprotein complex biogenesis,2.291e-28|4.252e-28|1.271e-26|9.843e-25|3.331e-24,3.614e-24|3.354e-24|6.685e-23|3.881e-21|1.051e-20,61.21|58.94|47.93|36.84|34.22
2458,7,0.4098,8.605,5734.0,0.001495,0.9992989999999999,BCL2L13 CYB5D1 DUOX2 NPY1R PLAGL1 TMEM252 UCN,feeding behavior|neuropeptide signaling pathway|adenohypophysis morphogenesis|hypophysis morphogenesis|diencephalon morphogenesis,0.0003404|0.0005936|0.0006794|0.001019|0.001358,1|1|1|1|1,71.76|53.98|2942|1471|980.7
2459,6,0.4162,6.242999999999999,4900.0,0.001269,0.998474,ANXA5 CEACAM16 CPT1C PDGFRB PLBD2 TEX19,metanephric glomerular mesangial cell proliferation involved in metanephros development|metanephric mesenchymal cell migration|cell migration involved in metanephros development|cell migration involved in coronary angiogenesis|male gonad development,0.0005824|0.0005824|0.0005824|0.0005824|0.0006285,1|1|1|1|1,3432|3432|3432|3432|51.62
2460,5,0.4548,4.548,3806.0,0.00119,0.996692,CTDSP2 LGR5 OR2T5 PLCE1 PSAPL1,urogenital system development|G protein-coupled receptor signaling pathway|signal transduction|adenylate cyclase-modulating G protein-coupled receptor signaling pathway|epithelial cell proliferation involved in renal tubule morphogenesis,3.731e-05|8.279e-05|0.0009685|0.001132|0.001213,0.5886|0.653|1|1|1,38.62|12.4|4.008|37.45|1030
2461,6,0.431,6.465,5036.0,0.001279,0.998474,CCDC88A HOXD8 PEBP1 PLCH1 RECQL TGOLN2,maintenance of protein location in plasma membrane|maintenance of protein location in membrane|positive regulation of protein localization to cilium|DNA replication|DNA strand renaturation,0.0008735|0.0008735|0.001746|0.002534|0.002619,1|1|1|1|1,1716|1716|686.5|25.33|429.1
2462,20,0.4095,77.81,12560.0,0.006137,1.0,AKT1 C12orf66 DEPDC5 ITFG2 KPTN LAMTOR3 MAPKAP1 MIOS MLST8 NPRL2 PTEN RICTOR SEH1L SESN2 SZT2 TBC1D7 TSC1 TSC2 WDR24 WDR59,regulation of TOR signaling|cellular response to amino acid starvation|response to amino acid starvation|cellular response to external stimulus|cellular response to nutrient levels,1.876e-36|1.01e-26|1.569e-26|4.04e-23|4.704e-23,2.96e-32|7.964e-23|8.248e-23|1.593e-19|1.484e-19,176.8|167.3|161.3|45.16|60.07
2463,6,0.4081,6.122000000000001,4464.0,0.001366,0.998474,ARF5 KCNK6 NAIF1 PLEKHA3 SLC30A1 SLC39A10,zinc ion transmembrane transport|zinc ion transport|cellular zinc ion homeostasis|zinc ion homeostasis|transport,2.29e-05|3.064e-05|4.687e-05|5.487e-05|0.0001094,0.3613|0.2417|0.2464|0.2164|0.345,286|245.2|196.1|180.7|4.576
2464,6,0.4025,6.037999999999999,4700.0,0.00128,0.998474,BCL6B GDF3 NSMCE4A PLEKHA5 SLC39A11 SLN,negative regulation of calcium ion binding|regulation of calcium ion binding|negative regulation of calcium ion import|type 2 immune response|regulation of ATPase-coupled calcium transmembrane transporter activity,0.001165|0.001165|0.002909|0.002909|0.00349,1|1|1|1|1,1144|1144|381.4|381.4|312
2465,5,0.4348,4.348,4179.0,0.001037,0.996692,IGFBP1 PLEKHA7 SQOR SYNJ2 TSPAN15,"zonula adherens maintenance|sulfide oxidation|sulfide oxidation, using sulfide:quinone oxidoreductase|hydrogen sulfide metabolic process|adherens junction maintenance",0.0009706|0.001456|0.001456|0.001698|0.001698,1|1|1|1|1,1373|823.8|823.8|686.5|686.5
2466,17,0.4044,54.99,12760.0,0.00428,1.0,ACR ANHX C8orf33 CHAMP1 MZF1 PARD6G PGBD2 RABL2B SLC27A5 ZBTB45 ZNF10 ZNF132 ZNF140 ZNF26 ZNF605 ZNF84 ZNF891,"regulation of transcription by RNA polymerase II|cellular process|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process",8.261e-06|9.269e-05|0.0001121|0.0001124|0.0001138,0.1303|0.731|0.5893|0.4431|0.359,4.685|0.3911|3.497|3.496|3.491
2467,6,0.4395,6.5920000000000005,4879.0,0.0013460000000000002,0.998474,ABHD15 ERGIC3 NUB1 PLEKHH1 PLIN1 TRMO,"tRNA methylation|retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum|RNA methylation|tRNA modification|positive regulation of proteasomal ubiquitin-dependent protein catabolic process",0.01217|0.02479|0.02508|0.02622|0.02622,1|1|1|1|1,83.72|40.38|39.91|38.14|38.14
2468,7,0.4122,8.656,5738.0,0.0015019999999999999,0.9992989999999999,ACBD6 C1orf105 CDC20B DNM3 OCLM PLEKHH2 PRG4,positive regulation of anaphase-promoting complex-dependent catabolic process|regulation of anaphase-promoting complex-dependent catabolic process|negative regulation of dendritic spine morphogenesis|synaptic vesicle budding from presynaptic endocytic zone membrane|dynamin family protein polymerization involved in mitochondrial fission,0.001358|0.001358|0.002376|0.002715|0.003054,1|1|1|1|1,980.7|980.7|490.4|420.3|367.8
2469,5,0.4089,4.0889999999999995,3899.0,0.001045,0.996692,ABRACL BRSK2 KIR2DL3 PLEKHM3 PRSS16,"microtubule cytoskeleton organization involved in establishment of planar polarity|regulation of synaptic vesicle clustering|regulation of retrograde protein transport, ER to cytosol|establishment of tissue polarity|establishment of planar polarity",0.000728|0.00194|0.003394|0.006054|0.006054,1|1|1|1|1,2060|588.4|316.8|171.6|171.6
2470,5,0.453,4.53,4036.0,0.001118,0.996692,ARL5C DCXR EPHB4 GRID1 PLEKHO1,protein localization to Golgi membrane|D-xylose metabolic process|xylulose metabolic process|glucuronate catabolic process|xylulose 5-phosphate biosynthetic process,0.0009706|0.0009706|0.001213|0.001456|0.001456,1|1|1|1|1,1373|1373|1030|823.8|823.8
2471,7,0.4139,8.691,5591.0,0.0015480000000000001,0.9992989999999999,ABCC5 DAAM1 FADS3 IL17B PCK1 PLEKHS1 VRK3,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH|glycerol biosynthetic process from pyruvate|propionate catabolic process|cellular response to potassium ion starvation|response to methionine,0.001019|0.001019|0.001019|0.001358|0.001358,1|1|1|1|1,1471|1471|1471|980.7|980.7
2472,11,0.4069,22.38,8579.0,0.002595,0.999969,CCR6 LPA PLG RAET1G SLC22A2 TAAR6 TCP10 TCP10L2 ULBP1 ULBP2 ULBP3,natural killer cell mediated cytotoxicity|natural killer cell mediated immunity|leukocyte mediated cytotoxicity|lymphocyte mediated immunity|cell killing,1.339e-09|1.791e-09|8.035e-09|2.224e-07|5.956e-07,2.113e-05|1.413e-05|4.225e-05|0.000877|0.001879,286|264|176|33.78|57.21
2473,6,0.4101,6.152,4784.0,0.001281,0.998474,ANTXRL LAMP1 OR2C3 PLK3 PRSS48 TMEM128,positive regulation of chaperone-mediated autophagy|positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia|endomitotic cell cycle|positive regulation of natural killer cell degranulation|regulation of natural killer cell degranulation,0.0005824|0.0008735|0.001165|0.001746|0.001746,1|1|1|1|1,3432|1716|1144|686.5|686.5
2474,8,0.4035,11.3,6744.0,0.001668,0.9996790000000001,ALDH1A1 BVES ENPP6 PLN PROSER2 PTGES RIOK3 ZDHHC14,regulation of heart rate|cellular response to dsDNA|response to dsDNA|negative regulation of calcium ion import into sarcoplasmic reticulum|regulation of the force of heart contraction by cardiac conduction,0.0006281|0.001164|0.001164|0.001164|0.001164,1|1|1|1|1,53.08|1287|1287|1287|1287
2475,14,0.4016,36.54,11540.0,0.003148,0.9999969999999999,ADGRV1 ANKRD55 BHMT CDH12 F2R F2RL1 F2RL2 FST GZMK ITGA1 ITGA2 PLPP1 RAB3C RNF138,thrombin-activated receptor signaling pathway|positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway|positive regulation of Rho protein signal transduction|regulation of renin secretion into blood stream|positive regulation of Ras protein signal transduction,5.47e-08|1.758e-06|1.913e-06|4.28e-06|1.988e-05,0.0008629|0.01387|0.01006|0.01688|0.06272,490.4|133.7|129.8|980.7|57.31
2476,6,0.4425,6.638,4730.0,0.001398,0.998474,C2CD4C MISP PALM PLPP2 TPGS1 UQCR11,negative regulation of dopamine receptor signaling pathway|establishment of centrosome localization|regulation of protein localization to cell cortex|regulation of dopamine receptor signaling pathway|cytoskeleton organization,0.001165|0.002909|0.002909|0.00349|0.003509,1|1|1|1|1,1144|381.4|381.4|312|8.553
2477,8,0.4004,11.21,6906.0,0.0016170000000000002,0.9996790000000001,CCDC105 EFCAB12 GEM LBH PLPP3 SCARA3 SH3GLB1 TMEM9,positive regulation of mammary stem cell proliferation|regulation of mammary stem cell proliferation|canonical Wnt signaling pathway involved in positive regulation of wound healing|canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion|canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration,0.0007765|0.0007765|0.0007765|0.0007765|0.0007765,1|1|1|1|1,2574|2574|2574|2574|2574
2478,6,0.4078,6.117000000000001,4919.0,0.001239,0.998474,LIMS2 OAZ1 PLPP4 REEP6 RND3 STK38L,negative regulation of polyamine transmembrane transport|negative regulation of hepatocyte proliferation|regulation of polyamine transmembrane transport|positive regulation of integrin-mediated signaling pathway|regulation of cell morphogenesis,0.001165|0.001456|0.001746|0.002328|0.003253,1|1|1|1|1,1144|858.1|686.5|490.4|22.29
2479,6,0.4427,6.641,5036.0,0.001314,0.998474,ANGPTL2 CYP27A1 MYO7B PLPPR1 ZNF782 ZNF79,cellular alcohol biosynthetic process|cellular alcohol metabolic process|calcitriol biosynthetic process from calciol|vitamin D biosynthetic process|brush border assembly,0.001456|0.001456|0.001456|0.001456|0.001746,1|1|1|1|1,858.1|858.1|858.1|858.1|686.5
2480,18,0.4147,63.45,13670.0,0.004608,1.0,CCDC73 CYBC1 DDC DEF8 FDX1 GGACT KCNK13 MAFB MAPKAPK5 NAT8L PSKH1 RDH10 RPH3A SLC5A12 TAL2 TNFRSF19 UCKL1 WNT8A,primary lung bud formation|rhombomere 6 development|positive regulation of retinoic acid biosynthetic process|positive regulation of isoprenoid metabolic process|canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,0.001746|0.001746|0.001746|0.001746|0.002618,1|1|1|1|1,1144|1144|1144|1144|572.1
2481,7,0.4076,8.56,5932.0,0.001438,0.9992989999999999,B2M EIF4EBP2 PLXDC1 SEC22A SLC16A6 TRAF3IP3 YPEL2,"antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent|cellular response to iron(III) ion|positive regulation of transferrin receptor binding|regulation of transferrin receptor binding|positive regulation of ferrous iron binding",0.0006794|0.001019|0.001019|0.001019|0.001019,1|1|1|1|1,2942|1471|1471|1471|1471
2482,6,0.4304,6.455,5057.0,0.0012720000000000001,0.998474,AKT1S1 CWC27 CYP19A1 DPEP2 PMFBP1 ZFP90,positive regulation of estradiol secretion|regulation of estradiol secretion|androgen catabolic process|negative regulation of cell size|hormone catabolic process,0.0008735|0.001165|0.001746|0.0032|0.00349,1|1|1|1|1,1716|1144|686.5|343.2|312
2483,5,0.4523,4.523,4139.0,0.0010890000000000001,0.996692,CYTH2 ENOSF1 FAM78B PMS1 RD3L,regulation of ARF protein signal transduction|mismatch repair|cellular carbohydrate catabolic process|cellular amino acid catabolic process|carbohydrate catabolic process,0.004845|0.008467|0.009672|0.02499|0.02808,1|1|1|1|1,216.8|121.1|105.6|39.99|35.51
2484,7,0.4362,9.16,5977.0,0.001527,0.9992989999999999,CPT1B DSCAM EMX2 NPW PNLDC1 SLC25A39 SLC8B1,mitochondrial transmembrane transport|post-embryonic retina morphogenesis in camera-type eye|calcium export from the mitochondrion|cerebral cortex regionalization|response to blue light,0.0005517|0.001019|0.001019|0.002376|0.002376,1|1|1|1|1,56.04|1471|1471|490.4|490.4
2485,5,0.4459,4.459,3877.0,0.001146,0.996692,DMBT1 FNDC1 LPA PNLIPRP3 TCP10,induction of bacterial agglutination|detection of bacterial lipoprotein|response to bacterial lipoprotein|detection of molecule of bacterial origin|detection of bacterium,0.001456|0.001456|0.002183|0.003152|0.004362,1|1|1|1|1,823.8|823.8|514.9|343.3|242.3
2486,7,0.406,8.525,5673.0,0.001497,0.9992989999999999,AZIN2 CCIN KNCN NKAIN1 PNMT QDPR RBBP8NL,alpha-amino acid metabolic process|cellular biogenic amine biosynthetic process|amine biosynthetic process|cellular amino acid metabolic process|cellular biogenic amine metabolic process,4.725e-05|0.0001074|0.0001127|0.000135|0.0006536,0.7453|0.8468|0.5926|0.5325|1,39.61|132|128.7|27.68|52.01
2487,7,0.4146,8.707,5842.0,0.001485,0.9992989999999999,APOM C1QTNF12 FFAR3 METTL2B NUDT7 PNP RGS7BP,purine nucleotide catabolic process|purine-containing compound catabolic process|regulation of insulin receptor signaling pathway|nucleotide catabolic process|nucleoside phosphate catabolic process,0.0001475|0.00018|0.0003144|0.000361|0.0004635,1|1|1|1|1,111.9|101|75.72|70.53|62.03
2488,11,0.4008,22.04,7395.0,0.002963,0.999969,ACTR1A DYNC1LI2 NDE1 PPP2R5C PPP2R5D PPP2R5E SGO1 SKA1 SNRK UBE2C ZWINT,biological phase|mitotic cell cycle phase|cell cycle phase|anaphase|mitotic anaphase,1.653e-11|1.653e-11|1.653e-11|9.988e-11|9.988e-11,2.608e-07|1.304e-07|8.693e-08|3.939e-07|3.151e-07,51|51|51|71.55|71.55
2489,6,0.42,6.3,4687.0,0.0013390000000000001,0.998474,CACNA2D1 HIST1H2AH KREMEN1 OR5B2 PNPLA3 TCN2,"triglyceride acyl-chain remodeling|cellular response to 3,3',5-triiodo-L-thyronine|response to 3,3',5-triiodo-L-thyronine|membrane depolarization during bundle of His cell action potential|calcium ion transmembrane transport via high voltage-gated calcium channel",0.0004854|0.000728|0.0009706|0.0009706|0.0009706,1|1|1|1|1,4119|2060|1373|1373|1373
2490,5,0.4352,4.352,3950.0,0.001098,0.996692,EMX1 MYO1F PNPO PRH2 TNFAIP8L1,pyridoxal phosphate biosynthetic process|pyridoxine biosynthetic process|pyridoxine metabolic process|pyridoxal phosphate metabolic process|vitamin B6 biosynthetic process,0.000728|0.000728|0.000728|0.0009706|0.0009706,1|1|1|1|1,2060|2060|2060|1373|1373
2491,9,0.4046,14.56,7098.0,0.002042,0.9998530000000001,CAPN2 HSPG2 JAG2 LRP10 PODN PREP SUSD6 TMEM127 WWP2,odontogenesis of dentin-containing tooth|epithelial cell apoptotic process involved in palatal shelf morphogenesis|regulation of Notch signaling pathway|positive regulation of presynaptic membrane organization|regulation of presynaptic membrane organization,0.0008611|0.001067|0.001451|0.001601|0.001601,1|1|1|1|1,46.23|1872|35.33|936.1|936.1
2492,5,0.4297,4.297,3962.0,0.00108,0.996692,BTBD3 IGLL1 PODNL1 PROX2 TMTC2,protein O-linked mannosylation|protein mannosylation|mannosylation|dendrite morphogenesis|protein O-linked glycosylation,0.004604|0.005812|0.008949|0.01472|0.02523,1|1|1|1|1,228.8|179.1|114.4|68.65|39.61
2493,5,0.4195,4.195,3824.0,0.001093,0.996692,CTXN1 OR4K13 PODXL TUFM WDR72,positive regulation of cell-cell adhesion mediated by integrin|regulation of microvillus assembly|regulation of cell-cell adhesion mediated by integrin|glomerular visceral epithelial cell development|glomerular epithelial cell development,0.001698|0.001698|0.00291|0.00291|0.003152,1|1|1|1|1,686.5|686.5|374.5|374.5|343.3
2494,6,0.4104,6.156000000000001,5093.0,0.001204,0.998474,ALOX5AP GAS8 POLI PROK2 TPP2 ZNF219,leukotriene production involved in inflammatory response|arachidonic acid metabolite production involved in inflammatory response|positive regulation of protein localization to cilium|lipoxin biosynthetic process|lipoxin metabolic process,0.0008735|0.0008735|0.001746|0.002328|0.002619,1|1|1|1|1,1716|1716|686.5|490.4|429.1
2495,7,0.4057,8.52,5963.0,0.001423,0.9992989999999999,LHFPL6 LIN28A POLN SOAT2 SPIRE1 ZNF83 ZYX,actin filament bundle assembly|actin filament bundle organization|formin-nucleated actin cable organization|formin-nucleated actin cable assembly|polar body extrusion after meiotic divisions,0.0001735|0.0001914|0.001358|0.001358|0.001698,1|1|1|1|1,101.5|96.46|980.7|980.7|735.5
2496,7,0.427,8.967,5100.0,0.00175,0.9992989999999999,CXADR POTEC POTED POTEF POTEG POTEH POTEM,AV node cell-bundle of His cell adhesion involved in cell communication|UNCLASSIFIED|biological_process|cellular process|regulation of AV node cell action potential,0.0006794|0.0007013|0.0007013|0.001287|0.001358,1|1|1|1|1,2942|5.359|0.3297|0.19|980.7
2497,7,0.412,8.652999999999999,5986.0,0.00144,0.9992989999999999,MATN2 POU3F1 SGSH SLC19A1 SPARC ZBTB26 ZNF613,cyclic-GMP-AMP transmembrane import across plasma membrane|methotrexate transport|guanine nucleotide transport|cyclic nucleotide transport|guanine nucleotide transmembrane transport,0.0006794|0.001019|0.001019|0.001019|0.001019,1|1|1|1|1,2942|1471|1471|1471|1471
2498,5,0.4354,4.354,3994.0,0.001086,0.996692,POU3F3 RAPGEF3 RELCH S100A3 ZNF618,metanephric DCT cell differentiation|metanephric macula densa development|metanephric juxtaglomerular apparatus development|DCT cell differentiation|macula densa development,0.0004854|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,4119|4119|4119|4119|4119
2499,6,0.4339,6.507999999999999,5001.0,0.001297,0.998474,DHRS7 LYPD5 MCTP2 MPZ PPFIBP1 WNT16,optic cup formation involved in camera-type eye development|oxidative stress-induced premature senescence|cell adhesion|biological adhesion|optic cup morphogenesis involved in camera-type eye development,0.0008735|0.001456|0.001782|0.001815|0.002328,1|1|1|1|1,1716|858.1|10.83|10.76|490.4
2500,6,0.4184,6.276,4881.0,0.001281,0.998474,C2orf69 ETFA MAMSTR MAN2C1 PPM1B RASSF7,N-terminal protein myristoylation|protein myristoylation|N-terminal protein lipidation|mannose metabolic process|fatty acid beta-oxidation using acyl-CoA dehydrogenase,0.001456|0.001456|0.001746|0.002909|0.0032,1|1|1|1|1,858.1|858.1|686.5|381.4|343.2
2501,5,0.4293,4.293,3988.0,0.001073,0.996692,BCL6B MSRA NSMCE4A PPM1H SLC39A11,protein repair|type 2 immune response|methionine metabolic process|zinc ion transmembrane transport|zinc ion transport,0.00194|0.002425|0.00412|0.006054|0.00702,1|1|1|1|1,588.4|457.7|257.4|171.6|147.1
2502,6,0.4154,6.231,4761.0,0.0013039999999999998,0.998474,ARPC5 CTRL PPP1R11 RHEX SCP2D1 STARD9,orbitofrontal cortex development|erythropoietin-mediated signaling pathway|positive regulation of intracellular cholesterol transport|positive regulation of intracellular sterol transport|positive regulation of intracellular lipid transport,0.001165|0.001456|0.001456|0.001456|0.001456,1|1|1|1|1,1144|858.1|858.1|858.1|858.1
2503,6,0.4192,6.289,4786.0,0.001309,0.998474,C5orf38 CASTOR1 PPP1R14B ROBO3 RWDD3 SPART,positive regulation of hypoxia-inducible factor-1alpha signaling pathway|regulation of hypoxia-inducible factor-1alpha signaling pathway|negative regulation of collateral sprouting in absence of injury|regulation of collateral sprouting in absence of injury|cellular response to L-arginine,0.0005824|0.0005824|0.0005824|0.001165|0.001165,1|1|1|1|1,3432|3432|3432|1144|1144
2504,6,0.4378,6.567,3912.0,0.0016710000000000002,0.998474,GIGYF2 PPP1R11 PPP1R2 PPP1R7 SUGT1 TLN1,regulation of phosphoprotein phosphatase activity|regulation of protein dephosphorylation|regulation of phosphatase activity|regulation of dephosphorylation|negative regulation of phosphoprotein phosphatase activity,4.304e-06|7.153e-06|1.375e-05|2.315e-05|0.0001458,0.06789|0.05641|0.07227|0.09128|0.4601,84.41|71.02|56.89|47.67|109
2505,26,0.4012,130.4,20270.0,0.006376,1.0,ADCY10 ATXN7L3B C8orf44 CARNS1 CCNB1IP1 EPB41L5 FEZF2 HMHB1 KIF26B LRRN1 LYRM1 MAP3K7CL MCOLN3 NDRG3 NECAP2 NIPSNAP3B PCDH10 PCDHB12 PCDHGA9 PLEKHB1 PPP1R9A RAB22A RNF114 SDR39U1 TEX12 ZNF286A,"homophilic cell adhesion via plasma membrane adhesion molecules|regulation of cell junction assembly|homologous chromosome pairing at meiosis|substrate-dependent cell migration, cell attachment to substrate|carnosine biosynthetic process",0.001392|0.002183|0.002183|0.002617|0.002617,1|1|1|1|1,13.7|11.68|29.91|762.8|762.8
2506,5,0.4326,4.3260000000000005,4053.0,0.0010630000000000001,0.996692,GJC1 PPP2R2B SMKR1 TM6SF1 ZNF845,gap junction assembly|cell communication by electrical coupling involved in cardiac conduction|cell communication by electrical coupling|cell communication involved in cardiac conduction|cardiac conduction,3.178e-06|9.595e-06|1.629e-05|6.96e-05|0.0003251,0.05013|0.07568|0.08564|0.2745|1,858.1|457.7|343.2|159.7|72.26
2507,6,0.4101,6.152,4867.0,0.001259,0.998474,EFCAB3 FTMT PPP2R2C RND2 S100A6 TSTD1,positive regulation of succinate dehydrogenase activity|regulation of succinate dehydrogenase activity|positive regulation of aconitate hydratase activity|regulation of aconitate hydratase activity|sulfide oxidation,0.0008735|0.0008735|0.001165|0.001165|0.001746,1|1|1|1|1,1716|1716|1144|1144|686.5
2508,5,0.4392,4.3919999999999995,4133.0,0.001059,0.996692,GPR88 KRT38 NCR3 PPP3R2 TACC2,motor learning|positive regulation of natural killer cell mediated cytotoxicity|neuronal action potential|positive regulation of natural killer cell mediated immunity|regulation of natural killer cell mediated cytotoxicity,0.001698|0.006295|0.00702|0.007502|0.01064,1|1|1|1|1,686.5|164.8|147.1|137.3|95.79
2509,5,0.4466,4.466,4096.0,0.0010869999999999999,0.996692,ABCC3 LTA4H PPY TCERG1L TPP2,glucuronoside transport|canalicular bile acid transport|secretion|glycoside transport|leukotriene transport,0.0004854|0.001213|0.00127|0.001456|0.00194,1|1|1|1|1,4119|1030|11.65|823.8|588.4
2510,4,0.4297,2.5780000000000003,3043.0,0.0008443999999999999,0.9929309999999999,MVB12A PQLC3 ZNF175 ZNF470,virus maturation|endosome to lysosome transport via multivesicular body sorting pathway|viral budding via host ESCRT complex|ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway|viral budding,0.0004369|0.001165|0.003056|0.003492|0.003782,1|1|1|1|1,3432|980.7|343.2|298.5|274.6
2511,5,0.4416,4.416,3930.0,0.001119,0.996692,CDHR3 EFCAB6 PITPNC1 PPP1R3G PRAME,positive regulation of glycogen (starch) synthase activity|regulation of glycogen (starch) synthase activity|negative regulation of retinoic acid receptor signaling pathway|positive regulation of glycogen biosynthetic process|regulation of retinoic acid receptor signaling pathway,0.001456|0.002425|0.002425|0.00412|0.00412,1|1|1|1|1,823.8|457.7|457.7|257.4|257.4
2512,16,0.4041,48.49,12480.0,0.0038619999999999995,0.999999,CASS4 CELA3B CTSZ FAM209A FAM209B HCAR3 IFNA16 MTRNR2L3 NPBWR2 OPRL1 PRAMEF2 RBM38 SLC2A4RG STX16 TFAP2C ZGPAT,opioid receptor signaling pathway|negative regulation of signaling receptor activity|positive regulation of gastric acid secretion|regulation of protein tyrosine kinase activity|conditioned place preference,3.712e-05|0.001249|0.002327|0.002469|0.003102,0.5855|1|1|1|1,257.4|39.01|643.6|27.39|429.1
2513,6,0.436,6.54,4881.0,0.001335,0.998474,COX8C FBF1 NT5C OTOP2 PRCD ZACN,IMP catabolic process|proton transmembrane transport|dGMP catabolic process|dGMP metabolic process|dTMP catabolic process,0.0005824|0.0006378|0.0008735|0.0008735|0.001165,1|1|1|1|1,3432|51.23|1716|1716|1144
2514,5,0.4219,4.218999999999999,3783.0,0.001111,0.996692,DIO3 GSTZ1 GULP1 PRDX1 ZNF616,cellular oxidant detoxification|cellular detoxification|cellular response to toxic substance|detoxification|negative regulation of eye photoreceptor cell development,0.0002174|0.0002796|0.0003163|0.0004208|0.000728,1|1|1|1|1,86.72|76.28|71.63|61.94|2060
2515,6,0.4354,6.531000000000001,5102.0,0.001276,0.998474,FBLN7 GPD1 KBTBD11 NRN1L PRICKLE1 ZNF781,negative regulation of cardiac muscle cell myoblast differentiation|regulation of cardiac muscle cell myoblast differentiation|glycerol-3-phosphate catabolic process|negative regulation of cardioblast differentiation|glycerophosphate shuttle,0.0005824|0.0005824|0.0008735|0.0008735|0.0008735,1|1|1|1|1,3432|3432|1716|1716|1716
2516,21,0.4095,86.0,14970.0,0.005698,1.0,ANXA2R BRIX1 CCL28 CCT5 DROSHA EXOC3 FGF10 HCN1 ICE1 MRPL36 MRPS30 NADK2 NNT NUP155 RAD1 RPL37 TARS UGT3A1 WDR70 ZFR ZNF622,ribosome biogenesis|ribonucleoprotein complex biogenesis|NADP metabolic process|translation|peptide biosynthetic process,2.373e-05|0.0001152|0.0005973|0.0006906|0.000872,0.3743|0.9082|1|1|1,14.1|10.07|58.51|9.751|9.155
2517,16,0.4062,48.74,12280.0,0.003943,0.999999,ADAMTS8 C11orf53 CLDN25 CRYAB FXYD6 HSPB2 HTR3A HTR3B KCNJ1 KDELC2 NXPE1 NXPE2 NXPE4 OR8B8 POU2F3 TMEM136,serotonin receptor signaling pathway|ion transmembrane transport|cellular response to dopamine|response to dopamine|transmembrane transport,0.0003988|0.0006824|0.001626|0.001665|0.001727,1|1|1|1|1,70.41|6.532|33.9|33.49|5.313
2518,12,0.4252,28.06,7947.0,0.003508,0.999986,CCNA2 CCNB1 CDC25B CDC7 CKS2 CUL1 DBF4 FBXO5 FOXM1 LIN37 LIN54 PKMYT1,mitotic cell cycle phase transition|cell cycle phase transition|regulation of cell cycle|mitotic cell cycle process|mitotic cell cycle,1.998e-17|2.62e-17|1.564e-15|1.11e-13|3.132e-13,3.152e-13|2.066e-13|8.223e-12|4.377e-10|9.88e-10,60.22|58.58|17.22|25.05|22.55
2519,8,0.4101,11.48,5910.0,0.001934,0.9996790000000001,ADCY6 ANKMY2 CMIP GNB1 GPR3 PRKACA PTGES3 RIC8B,cellular response to catecholamine stimulus|cellular response to monoamine stimulus|response to catecholamine|response to monoamine|adenylate cyclase-activating G protein-coupled receptor signaling pathway,9.123e-06|9.123e-06|1.027e-05|1.027e-05|2.346e-05,0.1439|0.07195|0.05397|0.04048|0.07401,70.77|70.77|67.97|67.97|51.23
2520,8,0.4195,11.75,5386.0,0.00217,0.9996790000000001,CMIP DHX29 PDE7A PRKAR1A SIK2 SIK3 STK11 STRADA,protein phosphorylation|regulation of TORC1 signaling|intracellular signal transduction|activation of protein kinase activity|negative regulation of reproductive process,7.751e-05|0.0001074|0.0001212|0.0002148|0.0002232,1|0.8468|0.6375|0.8471|0.7043,15.05|132|8.173|23.62|90.33
2521,5,0.4283,4.283,3821.0,0.001117,0.996692,CPNE5 PRKG2 STYX WDYHV1 YBX1,negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process|regulation of SCF-dependent proteasomal ubiquitin-dependent protein catabolic process|MAPK export from nucleus|negative regulation of chloride transport|miRNA transport,0.0004854|0.0004854|0.000728|0.0009706|0.0009706,1|1|1|1|1,4119|4119|2060|1373|1373
2522,5,0.4296,4.296,3986.0,0.001074,0.996692,ANKK1 JUND PRKN SMIM3 SURF6,"positive regulation of protein linear polyubiquitination|regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway|negative regulation of spontaneous neurotransmitter secretion|positive regulation of retrograde transport, endosome to Golgi|regulation of intralumenal vesicle formation",0.000728|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,2060|2060|2060|2060|2060
2523,6,0.4006,6.01,4734.0,0.001265,0.998474,ALPG C22orf42 CRYBA4 PRNP SLC24A4 SLC5A1,sodium ion transmembrane transport|alpha-glucoside transport|galactose transmembrane transport|fucose transmembrane transport|pentose transmembrane transport,0.0005137|0.0008735|0.0008735|0.0008735|0.0008735,1|1|1|1|1,57.21|1716|1716|1716|1716
2524,8,0.4098,11.47,6553.0,0.001744,0.9996790000000001,C12orf4 FGF23 MYO9A PROCR SPHK2 SYTL2 TMEM239 WDR60,regulation of mast cell degranulation|regulation of mast cell activation involved in immune response|regulation of mast cell activation|regulation of leukocyte degranulation|regulation of myeloid leukocyte mediated immunity,6.506e-05|6.924e-05|0.0001238|0.0001414|0.0002083,1|0.5461|0.6509|0.5575|0.6572,171.6|166.1|122.6|114.4|93.61
2525,6,0.4563,6.843999999999999,4739.0,0.001439,0.998474,ANKRD65 BMT2 FAM120B HES4 IPCEF1 PROM1,positive regulation of nephron tubule epithelial cell differentiation|glomerular parietal epithelial cell differentiation|positive regulation of epithelial cell differentiation involved in kidney development|peroxisome proliferator activated receptor signaling pathway|regulation of nephron tubule epithelial cell differentiation,0.001165|0.001165|0.002328|0.002328|0.004071,1|1|1|1|1,1144|1144|490.4|490.4|264
2526,6,0.4022,6.032,5042.0,0.001192,0.998474,ARHGAP15 ARRDC1 CCL14 MMP26 NLRP2 PROP1,positive regulation of hydrolase activity|extracellular vesicle biogenesis|regulation of hydrolase activity|positive regulation of catalytic activity|positive regulation of GTPase activity,0.0009925|0.002619|0.004445|0.005557|0.005755,1|1|1|1|1,13.25|429.1|7.873|7.277|16.62
2527,5,0.4045,4.045,3988.0,0.001011,0.996692,COL6A3 DUSP27 PRR23A SLC30A7 UGT1A4,bilirubin conjugation|sequestering of zinc ion|vitamin D3 metabolic process|negative regulation of cellular glucuronidation|negative regulation of glucuronosyltransferase activity,0.000728|0.001213|0.001698|0.002183|0.002183,1|1|1|1|1,2060|1030|686.5|514.9|514.9
2528,6,0.4109,6.162999999999999,4400.0,0.001395,0.998474,CALCB FAM214B IGSF22 MRGPRX1 PRR5L SAA1,acute-phase response|acute inflammatory response|response to chloroquine|TORC2 signaling|negative regulation of inflammatory response,6.35e-05|0.0001892|0.0005824|0.002328|0.003462,1|1|1|1|1,167.4|95.35|3432|490.4|21.59
2529,5,0.4273,4.273,4021.0,0.001059,0.996692,FAM20C NEU4 OC90 PEBP1 PRRG2,biomineralization|biomineral tissue development|otolith mineralization|odontoblast differentiation|ganglioside catabolic process,0.0002042|0.0002042|0.000728|0.0009706|0.00194,1|1|1|1|1,89.54|89.54|2060|1373|588.4
2530,6,0.4154,6.231,4934.0,0.001258,0.998474,HOPX NR2E1 PATJ PRRT2 SPATA18 ZXDC,negative regulation of short-term synaptic potentiation|regulation of short-term synaptic potentiation|mitophagy by induced vacuole formation|regulation of timing of neuron differentiation|negative regulation of SNARE complex assembly,0.0005824|0.0005824|0.0005824|0.001165|0.001165,1|1|1|1|1,3432|3432|3432|1144|1144
2531,18,0.4069,62.26,14250.0,0.004338,1.0,C6orf203 COL19A1 DDX43 DOPEY1 DPPA5 ENPP3 FAM135A GABRR1 KHDC1 KHDC1L KHDC3L LGSN PRSS35 TAAR2 TAAR6 TCF21 VNN2 WISP3,activation of cysteine-type endopeptidase activity involved in apoptotic process|basophil activation involved in immune response|glutamine biosynthetic process|basophil activation|metanephric glomerular capillary formation,0.002319|0.002327|0.002327|0.003102|0.003102,1|1|1|1|1,28.29|643.6|643.6|429.1|429.1
2532,5,0.4419,4.419,4016.0,0.0010960000000000002,0.996692,GRIN3B PALM PRSS36 STMP1 TRAFD1,negative regulation of dopamine receptor signaling pathway|positive regulation of NLRP3 inflammasome complex assembly|regulation of dopamine receptor signaling pathway|synapse maturation|cellular response to electrical stimulus,0.0009706|0.002425|0.00291|0.003152|0.003394,1|1|1|1|1,1373|457.7|374.5|343.3|316.8
2533,5,0.4506,4.506,3989.0,0.001125,0.996692,C2CD5 CDH24 HHIPL2 KIF16B PRSS57,insulin receptor signaling pathway via phosphatidylinositol 3-kinase|positive regulation of vesicle fusion|Golgi to endosome transport|regulation of receptor recycling|early endosome to late endosome transport,0.001213|0.002667|0.004362|0.005812|0.005812,1|1|1|1|1,1030|411.9|242.3|179.1|179.1
2534,5,0.4345,4.345,3958.0,0.001094,0.996692,ANXA10 MEIOC PRTG RRAD STRADA,"cell cycle switching|germline cell cycle switching, mitotic to meiotic cell cycle|cell cycle switching, mitotic to meiotic cell cycle|negative regulation of high voltage-gated calcium channel activity|female meiosis I",0.0009706|0.0009706|0.0009706|0.001456|0.002425,1|1|1|1|1,1373|1373|1373|823.8|457.7
2535,5,0.4128,4.128,3859.0,0.001066,0.996692,CLEC4F PRUNE2 PTGFRN RAB42 RUNX1T1,polyphosphate catabolic process|myoblast fusion involved in skeletal muscle regeneration|polyphosphate metabolic process|myotube differentiation involved in skeletal muscle regeneration|myoblast fusion,0.001456|0.001456|0.001698|0.002183|0.006295,1|1|1|1|1,823.8|823.8|686.5|514.9|164.8
2536,5,0.4049,4.0489999999999995,3889.0,0.001037,0.996692,ALOX12B APOD CDH23 ERVFRD-1 PSMA8,negative regulation of lipoprotein oxidation|negative regulation of lipoprotein lipid oxidation|negative regulation of smooth muscle cell-matrix adhesion|regulation of lipoprotein oxidation|regulation of lipoprotein lipid oxidation,0.0004854|0.0004854|0.000728|0.000728|0.000728,1|1|1|1|1,4119|4119|2060|2060|2060
2537,4,0.7809,4.685,2231.0,0.002088,0.9929309999999999,PSMB5 PSMB6 PSMB7 THAP1,proteasomal ubiquitin-independent protein catabolic process|regulation of cellular amino acid metabolic process|S phase|pre-replicative complex assembly|mitotic S phase,6.311e-09|1.373e-07|1.373e-07|1.373e-07|1.373e-07,9.955e-05|0.001083|0.0007219|0.0005415|0.0004332,702.1|237.6|237.6|237.6|237.6
2538,8,0.4012,11.23,6599.0,0.001695,0.9996790000000001,FAM198A KRBOX1 PSMB9 SLC22A14 SLC6A11 TATDN2 VIPR1 ZNF429,gamma-aminobutyric acid reuptake|amino acid neurotransmitter reuptake|gamma-aminobutyric acid transport|transmembrane transport|neurotransmitter reuptake,0.001698|0.002376|0.003393|0.00716|0.00779,1|1|1|1|1,735.5|490.4|326.9|6.832|133.7
2539,17,0.4121,56.05,11560.0,0.00481,1.0,AATF CDC27 CDC6 DHX8 PSMB3 PSMC5 PSMD1 PSMD11 PSMD12 PSMD3 PSMD6 PSMD7 RPL19 RPL23 RPL23A RPL27 ZNF830,negative regulation of G2/M transition of mitotic cell cycle|negative regulation of cell cycle G2/M phase transition|pre-replicative complex assembly|anaphase-promoting complex-dependent catabolic process|DNA-dependent DNA replication,1.742e-19|4.816e-19|1.422e-18|1.655e-17|1.323e-16,2.748e-15|3.798e-15|7.475e-15|6.526e-14|4.173e-13,124.9|112.2|167.7|125.3|62.45
2540,15,0.4119,43.25,10060.0,0.004268999999999999,0.999999,CDC27 CDC6 DHX8 PSMB3 PSMB4 PSMC5 PSMD1 PSMD11 PSMD12 PSMD13 PSMD3 PSMD4 PSMD6 PSMD7 ZNF830,negative regulation of G2/M transition of mitotic cell cycle|negative regulation of cell cycle G2/M phase transition|pre-replicative complex assembly|anaphase-promoting complex-dependent catabolic process|DNA-dependent DNA replication,1.425e-28|5.268e-28|1.356e-27|3.401e-26|7.46e-25,2.248e-24|4.155e-24|7.13e-24|1.341e-22|2.354e-21,184|165.3|253.5|189.4|92.01
2541,21,0.4056,85.18,13900.0,0.006074,1.0,COPB2 EIF2S1 EIF3B ETF1 NEDD8 PSMA1 PSMA2 PSMA3 PSMA4 PSMA5 PSMA6 PSMB1 PSMB3 PSMG1 PSMG2 PSMG3 PSMG4 SMU1 SNU13 SRP54 VCP,proteasomal ubiquitin-independent protein catabolic process|regulation of cellular amino acid metabolic process|S phase|pre-replicative complex assembly|mitotic S phase,1.456e-18|3.263e-15|3.263e-15|3.263e-15|3.263e-15,2.296e-14|2.574e-11|1.716e-11|1.287e-11|1.029e-11,356.6|120.7|120.7|120.7|120.7
2542,11,0.4134,22.74,8864.0,0.002552,0.999969,CD244 FYTTD1 KCNK7 MFGE8 OR10Z1 PEBP4 PSORS1C1 SLC36A1 SPINK6 SPRR4 STMND1,positive regulation of granzyme B production|regulation of granzyme B production|alkanesulfonate transport|taurine transport|negative regulation of serine-type peptidase activity,0.002134|0.002134|0.003731|0.003731|0.004263,1|1|1|1|1,624.1|624.1|312|312|267.5
2543,19,0.4026,68.85,13900.0,0.004915999999999999,1.0,ADAMTS10 C19orf66 CNN1 FBN3 ICAM1 ICAM3 OR1M1 OR7G1 OR7G3 P2RY11 QTRT1 ZNF121 ZNF266 ZNF433 ZNF443 ZNF625 ZNF627 ZNF69 ZNF700,regulation of cellular macromolecule biosynthetic process|regulation of macromolecule biosynthetic process|regulation of transcription by RNA polymerase II|regulation of cellular biosynthetic process|regulation of biosynthetic process,0.00105|0.00112|0.001296|0.001547|0.00182,1|1|1|1|1,2.77|2.748|3.353|2.641|2.588
2544,5,0.4096,4.096,3902.0,0.001046,0.996692,EPN2 PDZK1IP1 PSTPIP1 SLFNL1 TIE1,negative regulation of angiogenesis|negative regulation of blood vessel morphogenesis|negative regulation of vasculature development|branching involved in lymph vessel morphogenesis|regulation of angiogenesis,0.0002499|0.0002548|0.0002597|0.0004854|0.001779,1|1|1|1|1,80.76|79.98|79.21|4119|29.74
2545,5,0.419,4.19,3636.0,0.0011480000000000001,0.996692,DUSP5 EGR1 ESRP1 MIDN PTBP1,cellular response to growth factor stimulus|fibroblast growth factor receptor signaling pathway|response to growth factor|regulation of phosphate metabolic process|regulation of phosphorus metabolic process,0.000142|0.0001591|0.0001675|0.0001765|0.0001765,1|1|0.8809|0.6959|0.5567,24.57|101.7|23.23|10.23|10.23
2546,8,0.4001,11.2,6586.0,0.0016940000000000002,0.9996790000000001,ALDH3A1 ALOX15B AQP9 CPB2 PTCHD3 SLC30A2 TBC1D28 TMEM44,response to cAMP|cannabinoid biosynthetic process|positive regulation of sequestering of zinc ion|response to organophosphorus|response to purine-containing compound,0.0006407|0.0007765|0.0007765|0.001232|0.001509,1|1|1|1|1,52.54|2574|2574|37.58|33.87
2547,6,0.4192,6.287999999999999,4923.0,0.0012720000000000001,0.998474,AP4M1 CAPN11 HHLA2 LRFN4 MATN4 PTCRA,protein localization to basolateral plasma membrane|negative regulation of thymocyte apoptotic process|Golgi to lysosome transport|regulation of postsynaptic density assembly|regulation of postsynaptic specialization assembly,0.002328|0.002619|0.00349|0.00349|0.003781,1|1|1|1|1,490.4|429.1|312|312|286
2548,6,0.4148,6.222,4857.0,0.001276,0.998474,ARL4A CIDEA JPH3 MNS1 PTER ZNF23,response to stilbenoid|positive regulation of sequestering of triglyceride|cellular response to cold|regulation of apoptotic DNA fragmentation|left/right axis specification,0.002037|0.002909|0.0032|0.00349|0.003781,1|1|1|1|1,572.1|381.4|343.2|312|286
2549,7,0.4077,8.562000000000001,5755.0,0.001482,0.9992989999999999,BMP6 CYP27A1 PLA2G3 PTGER1 RASD2 SERPINA11 TEP1,alcohol catabolic process|response to activity|organic hydroxy compound catabolic process|positive regulation of lipid biosynthetic process|positive regulation of lipid transport,0.0002157|0.0003804|0.0004209|0.0004855|0.000531,1|1|1|1|1,91.94|68.65|65.17|60.57|57.85
2550,6,0.4183,6.274,4707.0,0.001328,0.998474,FAM166B FREM3 GRHPR PTGR2 RPS5 RXRG,glyoxylate metabolic process|retinoic acid receptor signaling pathway|regulation of translational fidelity|ribosomal small subunit assembly|monocarboxylic acid metabolic process,0.0032|0.005812|0.006101|0.006391|0.008785,1|1|1|1|1,343.2|180.7|171.6|163.5|13.36
2551,6,0.4091,6.1370000000000005,4715.0,0.001297,0.998474,HYAL3 OR52N2 PREX1 PTH1R RILPL1 VSTM1,hyaluronan catabolic process|hyaluronan metabolic process|glycosaminoglycan catabolic process|aminoglycan catabolic process|mucopolysaccharide metabolic process,1.875e-05|5.857e-05|0.0001975|0.0002364|0.0005936,0.2957|0.4619|1|0.9321|1,326.9|178.3|94.91|86.53|53.98
2552,6,0.4061,6.0920000000000005,4761.0,0.001275,0.998474,AFM C18orf54 DBX2 KCTD19 PTH2R TLE4,protein transport within extracellular region|beta-catenin-TCF complex assembly|vitamin transport|positive regulation of cold-induced thermogenesis|establishment of protein localization to extracellular region,0.0005824|0.008707|0.01217|0.02821|0.03077,1|1|1|1|1,3432|118.4|83.72|35.39|32.38
2553,7,0.4547,9.549,5021.0,0.001893,0.9992989999999999,ATOX1 NAIF1 PTK7 SLC30A1 SLC39A10 SLC39A6 UBE3D,cellular transition metal ion homeostasis|transition metal ion transport|transition metal ion homeostasis|zinc ion transmembrane transport|zinc ion transport,3.413e-08|4.602e-08|6.837e-08|7.001e-08|1.075e-07,0.0005383|0.000363|0.0003595|0.0002761|0.0003392,104.1|96.46|87.17|367.8|315.2
2554,6,0.4121,6.182,4953.0,0.0012439999999999999,0.998474,CA12 CCL17 GUSB KIAA0825 PRRX2 PTMS,glucuronoside catabolic process|glucuronoside metabolic process|glycoside catabolic process|monovalent inorganic anion homeostasis|chloride ion homeostasis,0.001456|0.001456|0.00349|0.004942|0.004942,1|1|1|1|1,858.1|858.1|312|214.5|214.5
2555,7,0.403,8.463,5312.0,0.001586,0.9992989999999999,CLEC12A CLEC4D CLEC5A CLEC9A PRB4 PTPN7 ST8SIA1,neutrophil degranulation|neutrophil activation involved in immune response|neutrophil mediated immunity|neutrophil activation|granulocyte activation,0.0004229|0.0004332|0.0004517|0.000457|0.0004679,1|1|1|1|1,18.31|18.16|17.9|17.83|17.69
2556,5,0.4455,4.455,3979.0,0.001116,0.996692,FAM131C ISLR NR2F2 PTPRCAP SH2D5,radial pattern formation|lymphatic endothelial cell fate commitment|endothelial cell fate commitment|lymphatic endothelial cell differentiation|trophoblast giant cell differentiation,0.0004854|0.0009706|0.002183|0.002183|0.003636,1|1|1|1|1,4119|1373|514.9|514.9|294.2
2557,5,0.4352,4.352,3973.0,0.001091,0.996692,BCL11A CAMKV CHRNE PTPRT RIOK1,negative regulation of branching morphogenesis of a nerve|negative regulation of protein homooligomerization|negative regulation of protein oligomerization|negative regulation of neuron remodeling|regulation of neuron remodeling,0.0004854|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,4119|4119|4119|4119|4119
2558,30,0.4019,174.8,24470.0,0.007076000000000001,1.0,C5AR1 C5AR2 CABP5 CALM3 CRX CYTH2 FFAR3 FLT3LG FUT1 GPR32 KIR2DL1 KIR2DL3 KLK11 KLK3 KLK6 LILRA4 PSG2 SIGLEC11 SIGLEC12 SIGLEC5 SIGLEC9 SPACA4 SPIB SULT2A1 SULT2B1 TPRX1 VN1R4 ZNF610 ZNF665 ZNF880,complement receptor mediated signaling pathway|complement component C5a signaling pathway|phospholipase C-activating G protein-coupled receptor signaling pathway|sulfation|purine ribonucleoside bisphosphate metabolic process,1.873e-06|1.396e-05|0.0005246|0.0007404|0.0007988,0.02955|0.1101|1|1|1,148.5|643.6|19.5|53.63|51.49
2559,6,0.4061,6.0920000000000005,4944.0,0.001228,0.998474,ASCL2 ATP13A5 MTSS1 NMI PXDC1 SYBU,spongiotrophoblast layer development|negative regulation of cell population proliferation|positive regulation of protein K48-linked ubiquitination|nephron tubule epithelial cell differentiation|regulation of synaptic activity,0.0005824|0.0006995|0.0008735|0.0008735|0.001165,1|1|1|1|1,3432|14.95|1716|1716|1144
2560,4,0.4723,2.8339999999999996,2970.0,0.0009507,0.9929309999999999,CFAP206 IMPA2 PXMP2 TREML2,inositol biosynthetic process|inositol metabolic process|regulation of cilium beat frequency|inositol phosphate dephosphorylation|inositol phosphate catabolic process,0.0007766|0.002328|0.00291|0.003491|0.003878,1|1|1|1|1,1716|468.1|367.8|302.9|271
2561,5,0.436,4.36,3885.0,0.001118,0.996692,ATP5MC1 R3HDM4 THADA ZFAND2B ZNF655,"negative regulation of ATPase-coupled calcium transmembrane transporter activity|SRP-dependent cotranslational protein targeting to membrane, translocation|negative regulation of endoplasmic reticulum calcium ion concentration|regulation of ATPase-coupled calcium transmembrane transporter activity|adaptive thermogenesis",0.001213|0.002183|0.002425|0.00291|0.004604,1|1|1|1|1,1030|514.9|457.7|374.5|228.8
2562,10,0.4252,19.13,8074.0,0.002358,0.999933,ABCB11 BBS5 CASP10 CRYGA CRYGB CRYGC CRYGD CXCR2 ILKAP PRLH,visual perception|sensory perception of light stimulus|lens development in camera-type eye|camera-type eye development|eye development,5.946e-08|6.503e-08|6.807e-08|1.771e-05|3.055e-05,0.0009379|0.0005129|0.0003579|0.06984|0.09637,43.34|42.55|98.54|23.55|20.46
2563,17,0.4057,55.18,11420.0,0.004795000000000001,1.0,C1orf109 CIAO1 CIAO2B CIAPIN1 FXN GLRX3 HSCB LONP1 LYRM4 NDOR1 NFS1 NUBP2 RTCB SOD1 TIMM10 TIMM9 WDR18,metallo-sulfur cluster assembly|iron-sulfur cluster assembly|sulfur compound metabolic process|protein maturation by iron-sulfur cluster transfer|[2Fe-2S] cluster assembly,4.696e-25|4.696e-25|8.118e-16|1.218e-09|2.603e-08,7.407e-21|3.704e-21|4.269e-12|4.802e-06|8.211e-05,526.7|526.7|36.11|323.1|726.9
2564,5,0.4296,4.296,3942.0,0.001086,0.996692,C9orf50 DTNA KRTAP4-5 RAB27A SLC44A1,cytotoxic T cell degranulation|positive regulation of constitutive secretory pathway|complement-dependent cytotoxicity|regulation of constitutive secretory pathway|exosomal secretion,0.0004854|0.0004854|0.000728|0.000728|0.001213,1|1|1|1|1,4119|4119|2060|2060|1030
2565,5,0.4448,4.448,4003.0,0.0011070000000000001,0.996692,DERA FGF4 MAFK RAB33B TPRG1L,"negative regulation of constitutive secretory pathway|regulation of retrograde vesicle-mediated transport, Golgi to ER|regulation of constitutive secretory pathway|deoxyribonucleoside catabolic process|skeletal system morphogenesis",0.0004854|0.000728|0.000728|0.0009706|0.001172,1|1|1|1|1,4119|2060|2060|1373|36.78
2566,6,0.4396,6.593999999999999,5053.0,0.0013,0.998474,ARHGEF10 COMMD1 HADHB LHFPL2 MATN2 RAB5A,receptor internalization involved in canonical Wnt signaling pathway|positive regulation of fertilization|regulation of endosome size|amyloid-beta clearance by transcytosis|cardiolipin acyl-chain remodeling,0.001165|0.001746|0.001746|0.002328|0.002619,1|1|1|1|1,1144|686.5|686.5|490.4|429.1
2567,7,0.4246,8.916,6326.0,0.001405,0.9992989999999999,ADGRV1 GAD2 MISP NQO1 RAB6B RHBDF1 TMEM8A,glutamate decarboxylation to succinate|response to flavonoid|response to hydrogen sulfide|gamma-aminobutyric acid biosynthetic process|response to L-glutamine,0.001019|0.001358|0.001358|0.001358|0.001698,1|1|1|1|1,1471|980.7|980.7|980.7|735.5
2568,14,0.415,37.76,8967.0,0.004181,0.9999969999999999,ATM CDKN1A CHEK2 DCLRE1B MDM2 MDM4 MRE11 NBN PPM1D PPM1G RAD50 TP53 UBE2D3 USP28,cell cycle checkpoint|cellular response to DNA damage stimulus|signal transduction by p53 class mediator|DNA damage checkpoint|DNA integrity checkpoint,5.432e-18|5.584e-18|1.874e-17|7.711e-17|1.252e-16,8.569e-14|4.404e-14|9.854e-14|3.041e-13|3.951e-13,77.83|24.3|112.2|95.25|90.07
2569,7,0.4009,8.419,5517.0,0.0015199999999999999,0.9992989999999999,DRD3 ENO2 IQCC LCORL OXR1 RAD51AP1 TLR10,positive regulation of nuclear division|toll-like receptor 10 signaling pathway|adult behavior|regulation of nuclear division|negative regulation of sodium:proton antiporter activity,0.0001678|0.0006794|0.0008504|0.0009151|0.001019,1|1|1|1|1,103.2|2942|44.92|43.27|1471
2570,5,0.4005,4.005,3998.0,0.0009982,0.996692,C3orf14 EAF2 NTAN1 RAD9B ZCCHC2,negative regulation of epithelial cell proliferation involved in prostate gland development|regulation of epithelial cell proliferation involved in prostate gland development|intra-S DNA damage checkpoint|DNA replication checkpoint|regulation of transcription elongation from RNA polymerase II promoter,0.001698|0.002667|0.004362|0.004362|0.007744,1|1|1|1|1,686.5|411.9|242.3|242.3|132.9
2571,7,0.4042,8.488,5638.0,0.0014990000000000001,0.9992989999999999,CERS4 EGFLAM EPHB3 HMX2 RAI14 SELENOK TTC23L,respiratory burst after phagocytosis|regulation of cell adhesion|peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|respiratory burst involved in defense response|foam cell differentiation,0.001358|0.001388|0.002376|0.002715|0.002715,1|1|1|1|1,980.7|12.16|490.4|420.3|420.3
2572,5,0.4004,4.004,3643.0,0.0010949999999999998,0.996692,CDH26 CRACR2B GPR21 LDHAL6B RALGPS2,regulation of Ral protein signal transduction|store-operated calcium entry|regulation of store-operated calcium entry|positive regulation of multicellular organism growth|negative regulation of insulin receptor signaling pathway,0.0009706|0.002183|0.003394|0.008226|0.008949,1|1|1|1|1,1373|514.9|316.8|124.8|114.4
2573,9,0.4006,14.42,7500.0,0.0019149999999999998,0.9998530000000001,ACADL CA13 CA2 CA3 NOXRED1 RALYL SERPINA1 SERPINA5 SLC7A13,one-carbon metabolic process|bicarbonate transport|organic anion transport|small molecule metabolic process|carnitine catabolic process,6.56e-07|8.103e-07|9.005e-06|0.0002943|0.0008734,0.01035|0.006391|0.04735|1|1,176|163.5|26.92|7.05|2288
2574,5,0.4004,4.004,3658.0,0.00109,0.996692,CDC42EP1 DAD1 HCFC1R1 NKX2-8 RAMP1,calcitonin gene-related peptide receptor signaling pathway|amylin receptor signaling pathway|calcitonin family receptor signaling pathway|positive regulation of protein glycosylation|positive regulation of pseudopodium assembly,0.0009706|0.00194|0.002183|0.002425|0.003394,1|1|1|1|1,1373|588.4|514.9|457.7|316.8
2575,5,0.45,4.5,4053.0,0.001106,0.996692,CYP7B1 DBN1 FBXL22 RAMP2 TMEM254,cell communication by chemical coupling|positive regulation of receptor localization to synapse|adrenomedullin receptor signaling pathway|B cell chemotaxis|amylin receptor signaling pathway,0.000728|0.001213|0.001213|0.001698|0.00194,1|1|1|1|1,2060|1030|1030|686.5|588.4
2576,7,0.4164,8.745,5979.0,0.001457,0.9992989999999999,C14orf39 C2orf73 MARCH3 MGAT5B RAMP3 SH3BP2 VTI1A,cross-receptor inhibition within G protein-coupled receptor heterodimer|meiotic DNA double-strand break processing involved in reciprocal meiotic recombination|positive regulation of calcium ion import across plasma membrane|adrenomedullin receptor signaling pathway|meiotic DNA double-strand break processing,0.001019|0.001019|0.001358|0.001698|0.001698,1|1|1|1|1,1471|1471|980.7|735.5|735.5
2577,7,0.4075,8.558,5076.0,0.001678,0.9992989999999999,ANKRD66 PSMD6 RAP1GAP RPP14 SHQ1 THOC7 UBA3,negative regulation of thyroid gland epithelial cell proliferation|regulation of thyroid gland epithelial cell proliferation|negative regulation of microvillus assembly|cellular response to glial cell derived neurotrophic factor|response to glial cell derived neurotrophic factor,0.0006794|0.0006794|0.0006794|0.001019|0.001019,1|1|1|1|1,2942|2942|2942|1471|1471
2578,5,0.439,4.39,3822.0,0.001144,0.996692,CHRD MMD MYOM2 RASEF ZCCHC14,BMP signaling pathway involved in spinal cord dorsal/ventral patterning|extraocular skeletal muscle development|floor plate development|spinal cord dorsal/ventral patterning|spinal cord patterning,0.0004854|0.001213|0.002425|0.004362|0.004845,1|1|1|1|1,4119|1030|457.7|242.3|216.8
2579,5,0.445,4.45,3963.0,0.001119,0.996692,CDC42EP5 CHSY1 HIVEP2 NFKBIZ RASL12,positive regulation of T-helper 17 cell differentiation|positive regulation of T-helper 17 type immune response|positive regulation of pseudopodium assembly|regulation of pseudopodium assembly|regulation of T-helper 17 cell differentiation,0.00194|0.002425|0.003394|0.003636|0.004604,1|1|1|1|1,588.4|457.7|316.8|294.2|228.8
2580,5,0.4347,4.3469999999999995,3846.0,0.001126,0.996692,CHCHD5 MALL OR8B4 RASSF1 ZNF320,negative regulation of cell cycle arrest|cholesterol homeostasis|sterol homeostasis|myelination|ensheathment of neurons,0.006054|0.02022|0.02046|0.0257|0.02618,1|1|1|1|1,171.6|49.63|49.04|38.86|38.14
2581,5,0.4265,4.265,3984.0,0.001067,0.996692,ANKRA2 FBXW9 LYSMD3 RASSF5 SCN1A,detection of mechanical stimulus involved in sensory perception of pain|detection of stimulus involved in sensory perception of pain|neuronal action potential|membrane depolarization during action potential|detection of mechanical stimulus involved in sensory perception,0.003636|0.006778|0.00702|0.007502|0.008467,1|1|1|1|1,294.2|152.6|147.1|137.3|121.1
2582,6,0.4001,6.001,4619.0,0.001294,0.998474,AREG BSPRY CWH43 EFCC1 RAVER1 ZMAT3,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis|epithelial cell proliferation involved in mammary gland duct elongation|thelarche|branch elongation involved in mammary gland duct branching|mammary gland branching involved in thelarche,0.0005824|0.001456|0.001746|0.001746|0.001746,1|1|1|1|1,3432|858.1|686.5|686.5|686.5
2583,15,0.4048,42.51,11860.0,0.003563,0.999999,ATP12A C1QTNF9 C1QTNF9B GJB2 GJB6 PCDH8 PSPC1 RCBTB2 RNF6 SIAH3 SLC25A30 SOHLH2 SPATA13 ZMYM2 ZMYM5,gap junction-mediated intercellular transport|intercellular transport|gap junction assembly|cell communication by electrical coupling|response to human chorionic gonadotropin,1.381e-05|1.775e-05|2.217e-05|0.0001133|0.002908,0.2178|0.14|0.1166|0.4466|1,457.7|392.3|343.2|137.3|457.7
2584,12,0.4099,27.05,8105.0,0.003317,0.999986,ADAR DCP2 DDX6 EDC3 EDC4 EIF4ENIF1 LSM14A PNRC2 RBM12 RPRD2 SCAF8 XRN1,mRNA metabolic process|methylguanosine-cap decapping|RNA decapping|P-body assembly|negative regulation of gene expression,1.195e-11|1.195e-10|2.008e-10|2.008e-10|2.177e-10,1.884e-07|9.424e-07|1.056e-06|7.918e-07|6.869e-07,22.26|572.1|490.4|490.4|16.02
2585,5,0.4323,4.323,4062.0,0.00106,0.996692,APOE GBX2 NOX3 RBM12B TEX36,intermediate-density lipoprotein particle clearance|negative regulation of phospholipid efflux|positive regulation of transport across blood-brain barrier|negative regulation of transport across blood-brain barrier|detection of gravity,0.0004854|0.0004854|0.0004854|0.0004854|0.0004854,1|0.4785|0.5469|0.589|0.638,4119|4119|4119|4119|4119
2586,11,0.4056,22.31,7554.0,0.002936,0.999969,ATR CHERP COPB2 EIF2S2 ISY1 RBM17 SEC61A1 SLU7 SRPRB TOPBP1 U2SURP,"mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|RNA splicing|mRNA processing",8.288e-07|8.288e-07|8.695e-07|3.515e-06|8.104e-06,0.01307|0.006536|0.004572|0.01386|0.02557,26.23|26.23|25.97|19.46|16.37
2587,7,0.4141,8.696,5734.0,0.001511,0.9992989999999999,CCBE1 PLA2G16 RBMS1 SCAMP2 SERTM1 TSSK3 WDR53,positive regulation of lymphangiogenesis|regulation of lymphangiogenesis|positive regulation of vascular endothelial growth factor signaling pathway|venous blood vessel morphogenesis|lymphangiogenesis,0.0008735|0.001746|0.002037|0.002619|0.004071,1|1|1|1|1,1716|686.5|572.1|429.1|264
2588,6,0.4199,6.297999999999999,4796.0,0.001308,0.998474,ADAM18 BTNL3 COL12A1 FKBP1B RBMS3 SFRP1,negative regulation of insulin secretion|negative regulation of peptide hormone secretion|negative regulation of protein secretion|negative regulation of hormone secretion|negative regulation of peptide secretion,5.487e-05|7.275e-05|0.000155|0.000155|0.0001892,0.8655|0.5738|0.8149|0.6112|0.5968,180.7|156|105.6|105.6|95.35
2589,6,0.4156,6.234,4938.0,0.001258,0.998474,LRP6 RBP5 REEP3 SLC36A2 TCP10L ZNF346,canonical Wnt signaling pathway involved in neural crest cell differentiation|external genitalia morphogenesis|receptor-mediated endocytosis involved in cholesterol transport|axis elongation involved in somitogenesis|Wnt signaling pathway involved in somitogenesis,0.001019|0.001019|0.001358|0.001698|0.001698,1|1|1|1|1,1471|1471|980.7|735.5|735.5
2590,6,0.4074,6.112,4830.0,0.001261,0.998474,DOCK3 HIP1 NPHS2 RDX ZNF860 ZSCAN4,metanephric glomerular epithelial cell development|metanephric glomerular epithelial cell differentiation|metanephric glomerular visceral epithelial cell development|metanephric glomerular visceral epithelial cell differentiation|metanephric glomerular epithelium development,0.0008735|0.0008735|0.0008735|0.0008735|0.0008735,1|1|1|1|1,1716|1716|1716|1716|1716
2591,5,0.4388,4.388,3853.0,0.001135,0.996692,BBS10 EXOC2 PDE3B REEP5 SLC12A3,regulation of entry of bacterium into host cell|negative regulation of cell adhesion mediated by integrin|cilium assembly|cilium organization|negative regulation of cAMP-mediated signaling,0.00194|0.003152|0.003271|0.003689|0.00412,1|1|1|1|1,588.4|343.3|21.79|20.49|257.4
2592,5,0.4336,4.336,3912.0,0.001104,0.996692,B4GALT4 DRD2 REG3A SLC15A1 WDR63,tripeptide import across plasma membrane|orbitofrontal cortex development|negative regulation of dopamine receptor signaling pathway|positive regulation of catecholamine uptake involved in synaptic transmission|positive regulation of dopamine uptake involved in synaptic transmission,0.0004854|0.0009706|0.0009706|0.0009706|0.0009706,1|1|1|1|1,4119|1373|1373|1373|1373
2593,5,0.4303,4.303,3890.0,0.001102,0.996692,ACTL7B DCANP1 RELL1 SHARPIN TLCD1,mastication|hard palate morphogenesis|negative regulation of saliva secretion|learned vocalization behavior|protein linear polyubiquitination,0.0009706|0.0009706|0.0009706|0.0009706|0.0009706,1|1|1|1|1,1373|1373|1373|1373|1373
2594,5,0.4458,4.458,3858.0,0.001151,0.996692,DEFB135 GSTK1 MT2A PAFAH1B2 REX1BD,detoxification|response to toxic substance|cellular response to interleukin-3|response to interleukin-3|cellular response to erythropoietin,0.0004208|0.001343|0.001698|0.001698|0.00194,1|1|1|1|1,61.94|34.33|686.5|686.5|588.4
2595,6,0.4174,6.261,4936.0,0.0012640000000000001,0.998474,DOK6 GSG1L REXO5 SLC30A2 SLC36A4 ZBTB8B,positive regulation of sequestering of zinc ion|proline import across plasma membrane|L-tryptophan transmembrane transport|L-proline transmembrane transport|L-proline import across plasma membrane,0.0005824|0.0008735|0.0008735|0.0008735|0.0008735,1|1|1|1|1,3432|1716|1716|1716|1716
2596,6,0.4305,6.457999999999999,4859.0,0.001324,0.998474,CADPS LCN10 LMX1A RFESD TNFSF18 TTC21A,negative regulation of T-helper 17 cell lineage commitment|T cell proliferation involved in immune response|regulation of T-helper 17 cell lineage commitment|dense core granule exocytosis|olfactory behavior,0.001165|0.001746|0.002328|0.002328|0.002909,1|1|1|1|1,1144|686.5|490.4|490.4|381.4
2597,5,0.4468,4.468,4136.0,0.001076,0.996692,APOA1 BDH2 C12orf43 RFPL4B RGMA,siderophore biosynthetic process|siderophore metabolic process|Spemann organizer formation|negative regulation of very-low-density lipoprotein particle remodeling|positive regulation of phospholipid efflux,0.0004854|0.0004854|0.001213|0.001213|0.001213,1|1|1|1|1,4119|4119|1030|1030|1030
2598,6,0.4001,6.001,4796.0,0.001247,0.998474,ITIH4 RFX3 ROBO1 SCN11A TAOK3 ZNF621,negative regulation of negative chemotaxis|chemorepulsion involved in postnatal olfactory bulb interneuron migration|postnatal olfactory bulb interneuron migration|substrate-dependent cerebral cortex tangential migration|cerebral cortex tangential migration using cell-cell interactions,0.0008735|0.0008735|0.0008735|0.0008735|0.0008735,1|1|1|1|1,1716|1716|1716|1716|1716
2599,5,0.4501,4.501,3782.0,0.001186,0.996692,BACE1 GLB1L3 RGCC THYN1 TMEFF1,negative regulation of exit from mitosis|negative regulation of fibroblast growth factor production|positive regulation of extracellular matrix constituent secretion|regulation of fibroblast growth factor production|fibroblast activation,0.0004854|0.000728|0.0009706|0.001698|0.001698,1|1|1|1|1,4119|2060|1373|686.5|686.5
2600,21,0.4037,84.78,14190.0,0.00592,1.0,ACTR10 ATP6V1D CCNK CINP DDX24 DYNC1H1 EIF2S1 EIF5 ERH EXOC5 LRR1 NRDE2 POLE2 PSMA3 PSMC1 PSMC6 RBM25 SNAPC1 TIMM9 TRMT5 WARS,antigen processing and presentation of exogenous peptide antigen|antigen processing and presentation of exogenous antigen|antigen processing and presentation of peptide antigen|cellular macromolecule biosynthetic process|macromolecule biosynthetic process,9.461e-07|1.168e-06|1.395e-06|1.769e-06|2.21e-06,0.01492|0.009215|0.007335|0.006976|0.006972,27.55|26.36|25.41|5.926|5.783
2601,7,0.4056,8.517000000000001,5588.0,0.001518,0.9992989999999999,CHRNB4 CIZ1 GPR35 OR1L8 RGS1 TMEM154 WDR38,negative regulation of neuronal action potential|positive regulation of DNA-dependent DNA replication initiation|synaptic transmission involved in micturition|regulation of neuronal action potential|leukotriene signaling pathway,0.0006794|0.001019|0.001358|0.002037|0.002037,1|1|1|1|1,2942|1471|980.7|588.4|588.4
2602,6,0.4457,6.685,4810.0,0.001384,0.998474,CNN1 COL6A2 DZIP3 MTRF1 RGS10 SNORC,regulation of translational termination|G protein-coupled acetylcholine receptor signaling pathway|negative regulation of vascular associated smooth muscle cell proliferation|acetylcholine receptor signaling pathway|response to amphetamine,0.00349|0.005812|0.006101|0.008707|0.009285,1|1|1|1|1,312|180.7|171.6|118.4|110.7
2603,6,0.4028,6.042000000000001,4775.0,0.00126,0.998474,DHRS2 DHRS4 FRMD6 NRL RGS12 SALL2,steroid metabolic process|retinal rod cell development|retinal rod cell differentiation|eye development|visual system development,0.002372|0.0032|0.004071|0.004552|0.004649,1|1|1|1|1,26.2|343.2|264|18.76|18.55
2604,9,0.4023,14.48,7728.0,0.001866,0.9998530000000001,AZIN2 C1orf127 C1orf216 CCDC28B DMRTB1 KNCN TSSK3 ZBTB8A ZBTB8B,trans-Golgi network membrane organization|positive regulation of polyamine transmembrane transport|agmatine biosynthetic process|putrescine biosynthetic process from ornithine|regulation of polyamine transmembrane transport,0.0008734|0.00131|0.00131|0.001746|0.002618,1|1|1|1|1,2288|1144|1144|762.8|457.7
2605,5,0.4181,4.181,3887.0,0.001072,0.996692,NTSR1 RGS20 SDR16C5 SRMS TMEM179,positive regulation of gamma-aminobutyric acid secretion|D-aspartate import across plasma membrane|D-aspartate transport|regulation of gamma-aminobutyric acid secretion|positive regulation of arachidonic acid secretion,0.0009706|0.001456|0.001456|0.001698|0.001698,1|1|1|1|1,1373|823.8|823.8|686.5|686.5
2606,5,0.432,4.32,4008.0,0.001074,0.996692,ATP23 C11orf42 FADS6 RGS9 UNK,regulation of calcium ion export across plasma membrane|mitochondrial proton-transporting ATP synthase complex assembly|proton-transporting ATP synthase complex assembly|positive regulation of NMDA glutamate receptor activity|negative regulation of cytoplasmic translation,0.000728|0.001698|0.00194|0.00194|0.002183,1|1|1|1|1,2060|686.5|588.4|588.4|514.9
2607,5,0.4241,4.2410000000000005,3917.0,0.0010789999999999999,0.996692,ATP6V0E2 C11orf94 PIP RGSL1 SHF,inositol phosphate dephosphorylation|inositol phosphate catabolic process|phosphorylated carbohydrate dephosphorylation|negative regulation of T cell apoptotic process|vacuolar acidification,0.005232|0.005812|0.005812|0.006391|0.00697,1|1|1|1|1,201.9|180.7|180.7|163.5|149.2
2608,6,0.4124,6.186,4831.0,0.001276,0.998474,COLEC12 COQ8A FSCN2 IFNB1 PROM1 RHBDD2,cellular response to exogenous dsRNA|cellular response to dsRNA|eye photoreceptor cell differentiation|response to exogenous dsRNA|response to dsRNA,1.481e-05|2.114e-05|8.263e-05|8.956e-05|0.000112,0.2336|0.1668|0.4345|0.3532|0.3534,361.3|298.5|146.1|140.1|124.8
2609,5,0.4377,4.377,3869.0,0.001127,0.996692,NUP37 PPP2R1B RHBDL3 TNNI3K WDR78,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand|bundle of His cell to Purkinje myocyte communication|apoptotic process involved in morphogenesis|apoptotic process involved in development|microtubule cytoskeleton organization,0.002425|0.003394|0.003878|0.00702|0.007181,1|1|1|1|1,457.7|316.8|274.6|147.1|14.55
2610,5,0.4192,4.192,3877.0,0.001077,0.996692,FAM69C OR52I2 RHCG ST8SIA2 TMEM50A,transepithelial ammonium transport|amine transport|ammonium transmembrane transport|ammonium transport|ganglioside biosynthetic process,0.0009706|0.002183|0.002667|0.002667|0.00412,1|1|1|1|1,1373|514.9|411.9|411.9|257.4
2611,5,0.4057,4.0569999999999995,3895.0,0.001038,0.996692,C2CD4C EMX1 FMO2 PITX1 RHOB,drug metabolic process|branchiomeric skeletal muscle development|oxygen metabolic process|myoblast fate commitment|cerebral cortex regionalization,7.927e-05|0.001165|0.001165|0.001746|0.002037,1|1|1|1|1,149.2|1144|1144|686.5|572.1
2612,5,0.4408,4.408,4103.0,0.00107,0.996692,FA2H FHL3 MXRA7 NSUN6 RILPL2,sebaceous gland cell differentiation|glucosylceramide biosynthetic process|tRNA C5-cytosine methylation|protein transport from ciliary membrane to plasma membrane|central nervous system myelin maintenance,0.000728|0.000728|0.000728|0.000728|0.001213,1|1|1|1|1,2060|2060|2060|2060|1030
2613,5,0.4383,4.383,3993.0,0.001094,0.996692,C22orf42 FBXO45 GYPC RIMKLA SAMD5,synapse assembly involved in innervation|anterior commissure morphogenesis|corticospinal tract morphogenesis|cerebral cortex tangential migration|innervation,0.0004854|0.001698|0.001698|0.001698|0.005812,1|1|1|1|1,4119|686.5|686.5|686.5|179.1
2614,20,0.402,76.38,15600.0,0.0048590000000000005,1.0,CCM2L COX4I2 CPNE1 DEFB115 DEFB116 DEFB118 DEFB119 DEFB121 DUSP15 FOXS1 HCK HM13 MYLK2 NOL4L REM1 RIMS4 SLPI TM9SF4 WFDC11 XKR7,defense response to bacterium|response to bacterium|innate immune response|defense response to other organism|defense response,2.553e-08|1.97e-07|6.431e-07|2.988e-06|3.02e-05,0.0004027|0.001554|0.003382|0.01178|0.09526,20.89|11.47|9.807|7.983|5.818
2615,6,0.4283,6.425,5049.0,0.001268,0.998474,DEPDC4 KCNN2 PBX4 PRADC1 RINL TMEM26,atrial cardiac muscle cell membrane repolarization|membrane repolarization during atrial cardiac muscle cell action potential|atrial cardiac muscle cell to AV node cell signaling|atrial cardiac muscle cell action potential|atrial cardiac muscle cell to AV node cell communication,0.001746|0.001746|0.004361|0.004361|0.004651,1|1|1|1|1,686.5|686.5|245.2|245.2|228.8
2616,6,0.41,6.15,4799.0,0.001277,0.998474,C17orf67 ENTPD5 KATNBL1 NEMP1 RITA1 SCPEP1,nucleoside diphosphate catabolic process|positive regulation of glycolytic process|retinoic acid metabolic process|negative regulation of Notch signaling pathway|'de novo' posttranslational protein folding,0.003781|0.00726|0.009863|0.01159|0.01159,1|1|1|1|1,286|143|104|88.01|88.01
2617,5,0.4508,4.508,4137.0,0.001086,0.996692,RNF112 SLC25A45 TEX33 TLR5 TMEM262,toll-like receptor 5 signaling pathway|acyl carnitine transmembrane transport|cell death in response to hydrogen peroxide|acyl carnitine transport|embryonic brain development,0.0004854|0.001213|0.001213|0.001456|0.003152,1|1|1|1|1,4119|1030|1030|823.8|343.3
2618,5,0.4036,4.0360000000000005,3805.0,0.001057,0.996692,C11orf52 MST1 NBPF3 RNF152 SCRN1,positive regulation of mammary gland epithelial cell proliferation|regulation of mammary gland epithelial cell proliferation|regulation of macrophage chemotaxis|regulation of macrophage migration|regulation of leukocyte chemotaxis,4.66e-06|1.481e-05|3.064e-05|6.35e-05|0.0005221,0.0735|0.1168|0.1611|0.2504|1,686.5|361.3|245.2|167.4|56.74
2619,6,0.4385,6.577999999999999,4992.0,0.0013130000000000001,0.998474,CFAP73 FHOD3 RNF167 SLC1A2 SOX18 TSPO2,amino acid import across plasma membrane|cortical actin cytoskeleton organization|amino acid import|cortical cytoskeleton organization|amino acid transmembrane transport,5.857e-05|7.671e-05|8.877e-05|0.0001735|0.0004082,0.9238|0.605|0.4667|0.6843|1,178.3|154.8|143.5|101.5|65.38
2620,4,0.4503,2.702,3010.0,0.0008944,0.9929309999999999,CHST2 RNF180 SAA1 TCN1,cobalt ion transport|cobalamin transport|serotonin metabolic process|norepinephrine metabolic process|primary amino compound metabolic process,0.001553|0.001747|0.002134|0.002716|0.00291,1|1|1|1|1,735.5|643.6|514.9|396.1|367.8
2621,6,0.4008,6.0120000000000005,4910.0,0.00122,0.998474,AP1S3 ELK4 RNF186 SLC44A3 TNFRSF12A WFDC8,protein K29-linked ubiquitination|histone H3 deacetylation|regulation of defense response to virus by virus|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress|phosphatidylcholine biosynthetic process,0.002037|0.006101|0.008707|0.009863|0.01044,1|1|1|1|1,572.1|171.6|118.4|104|98.07
2622,6,0.4107,6.1610000000000005,4952.0,0.00124,0.998474,C5AR2 PTPDC1 RNF19B SPATA22 SPIB TLCD2,complement component C5a signaling pathway|negative regulation of granulocyte chemotaxis|meiotic DNA repair synthesis|negative regulation of neutrophil chemotaxis|negative regulation of neutrophil migration,0.0008735|0.001165|0.001165|0.001165|0.001456,1|1|1|1|1,1716|1144|1144|1144|858.1
2623,5,0.4229,4.229,3899.0,0.0010810000000000001,0.996692,FAM166B GCNT2 MELK RNF207 VAMP1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization|regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization|regulation of heart looping|positive regulation of membrane repolarization during cardiac muscle cell action potential|positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,0.0004854|0.0004854|0.000728|0.000728|0.000728,1|1|1|1|1,4119|4119|2060|2060|2060
2624,6,0.4357,6.535,4823.0,0.00135,0.998474,ENO2 NPPB OXR1 RNF212 SGK3 ST18,"negative regulation of cellular response to oxidative stress|meiotic gene conversion|regulation of vacuole fusion, non-autophagic|gene conversion|negative regulation of peptidyl-cysteine S-nitrosylation",0.0008735|0.001165|0.001456|0.001456|0.001746,1|1|1|1|1,1716|1144|858.1|858.1|686.5
2625,7,0.4084,8.577,5979.0,0.001429,0.9992989999999999,ADGRF3 ATRAID KANK1 PLB1 RNF217 SMPD3 TRIM54,polysaccharide transport|negative regulation of lamellipodium morphogenesis|polysaccharide localization|negative regulation of cytoskeleton organization|negative regulation of supramolecular fiber organization,0.0006794|0.001019|0.001019|0.001137|0.001167,1|1|1|1|1,2942|1471|1471|38.71|38.21
2626,5,0.4272,4.272,3995.0,0.001066,0.996692,CA7 CLDN18 ENO2 OR51M1 RNF32,"TNFSF11-mediated signaling pathway|regulation of vacuole fusion, non-autophagic|negative regulation of osteoclast development|positive regulation of cellular pH reduction|regulation of cellular pH reduction",0.001213|0.001213|0.001456|0.001456|0.00194,1|1|1|1|1,1030|1030|823.8|823.8|588.4
2627,31,0.4021,187.0,24990.0,0.007409999999999999,1.0,ABCB5 ADCYAP1R1 AEBP1 AGR2 AGR3 CYP2W1 DAGLB GHRHR GRID2IP GSDME HOXA1 HOXA5 HOXA6 HOXA7 HOXA9 INMT KIAA0895 MICALL2 MINDY4 MTURN NME8 NPY PRR15 RBAK RSPH10B RSPH10B2 SCIN TMEM184A URGCP WIPF3 ZNF12,embryonic skeletal system morphogenesis|embryonic skeletal system development|skeletal system morphogenesis|lung goblet cell differentiation|regulation of myeloid cell differentiation,3.54e-07|1.222e-06|2.168e-05|2.18e-05|2.77e-05,0.005585|0.009637|0.114|0.08597|0.08738,35.34|27.23|14.83|442.9|14.08
2628,5,0.4264,4.263999999999999,3951.0,0.001075,0.996692,ERGIC2 FAM221A RNF44 SLC35F6 SRR,D-serine biosynthetic process|D-amino acid biosynthetic process|D-serine metabolic process|D-amino acid metabolic process|pyruvate biosynthetic process,0.0004854|0.0004854|0.000728|0.0009706|0.001698,1|1|1|1|1,4119|4119|2060|1373|686.5
2629,6,0.4188,6.282,4882.0,0.001282,0.998474,EXOC3L1 GALNT6 GRM5 HIBCH KNDC1 RNFT2,"phospholipase C-activating G protein-coupled glutamate receptor signaling pathway|trans-synaptic signaling by endocannabinoid, modulating synaptic transmission|trans-synaptic signaling by lipid, modulating synaptic transmission|regulation of intracellular calcium activated chloride channel activity|valine catabolic process",0.0008735|0.001165|0.001165|0.001165|0.001456,1|1|1|1|1,1716|1144|1144|1144|858.1
2630,6,0.4382,6.574,4701.0,0.001393,0.998474,CCDC42 PAFAH2 RNH1 SERPINB6 TRIM59 TSPYL1,"DNA replication, removal of RNA primer|RNA catabolic process|nucleobase-containing compound catabolic process|heterocycle catabolic process|cellular nitrogen compound catabolic process",0.001698|0.002912|0.0066|0.008136|0.008362,1|1|1|1|1,735.5|23.92|15.69|14.08|13.88
2631,6,0.4265,6.398,4986.0,0.0012779999999999998,0.998474,AKAIN1 AP5B1 PAX4 RFX8 RNPEP SPTLC3,sphingoid biosynthetic process|sphingosine biosynthetic process|sphingosine metabolic process|diol biosynthetic process|sphingoid metabolic process,0.004361|0.004361|0.006101|0.006391|0.006681,1|1|1|1|1,245.2|245.2|171.6|163.5|156
2632,5,0.4009,4.0089999999999995,3954.0,0.00101,0.996692,COX7B2 CRLF1 ROM1 TMEM202 UBXN1,negative regulation of protein K48-linked deubiquitination|negative regulation of ubiquitin-specific protease activity|regulation of protein K48-linked deubiquitination|negative regulation of motor neuron apoptotic process|negative regulation of protein deubiquitination,0.000728|0.000728|0.0009706|0.001213|0.001213,1|1|1|1|1,2060|2060|1373|1030|1030
2633,5,0.4373,4.373,3930.0,0.001109,0.996692,FTL MLX PLCH1 ROS1 SLC1A1,cellular transition metal ion homeostasis|transition metal ion homeostasis|response to anesthetic|cysteine transport|cysteine transmembrane transport,0.0003056|0.0004334|0.0004854|0.0004854|0.0004854,1|1|1|1|1,72.9|61.02|4119|4119|4119
2634,5,0.4325,4.325,3875.0,0.001112,0.996692,C1orf226 FAM173A RP1L1 SSTR5 TRIM72,somatostatin signaling pathway|somatostatin receptor signaling pathway|negative regulation of insulin-like growth factor receptor signaling pathway|plasma membrane repair|negative regulation of myotube differentiation,0.001165|0.001165|0.001359|0.002522|0.00291,1|1|1|1|1,1030|1030|858.1|429.1|367.8
2635,11,0.4116,22.64,8665.0,0.0025989999999999997,0.999969,CDK18 CHIT1 CNTN2 IGFN1 NFASC PEF1 RGS13 RGS18 RGS2 TMEM81 TROVE2,regulation of G protein-coupled receptor signaling pathway|negative regulation of G protein-coupled receptor signaling pathway|synapse organization|regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway|establishment of protein localization to juxtaparanode region of axon,5.477e-07|0.0002565|0.0003015|0.0009704|0.0009704,0.008639|1|1|1|1,56.42|85.81|21.68|2060|2060
2636,7,0.4163,8.743,5809.0,0.0014990000000000001,0.9992989999999999,AARD C5orf47 CFB NKD1 RPL10L SCGN SNCAIP,negative regulation of convergent extension involved in axis elongation|regulation of convergent extension involved in axis elongation|positive regulation of non-canonical Wnt signaling pathway via JNK cascade|regulation of non-canonical Wnt signaling pathway via JNK cascade|regulation of cell migration involved in somitogenic axis elongation,0.0006794|0.0006794|0.0006794|0.0006794|0.001019,1|1|1|1|1,2942|2942|2942|2942|1471
2637,17,0.4071,55.36,12820.0,0.004289,1.0,ALDOC ARL10 BPNT1 CCDC102A DVL3 GIMAP5 GML OR5AU1 OR8I2 PIGS PLEKHG4 PM20D1 PSD4 RAET1L VASH1 WFDC11 WRN,positive regulation of strand invasion|regulation of strand invasion|negative regulation of lymphangiogenesis|regulation of oxidative phosphorylation uncoupler activity|cellular amide catabolic process,0.001649|0.001649|0.003295|0.004117|0.004117,1|1|1|1|1,1211|1211|403.8|302.9|302.9
2638,13,0.4085,31.86,9300.0,0.0034049999999999996,0.999993,ATR COPB2 ISY1 MRPL3 MRPS22 NEPRO PIK3R4 RPL24 SRPRB TOPBP1 TRMT10C U2SURP ZBTB11,mitochondrial gene expression|establishment of protein localization to organelle|toxin transport|cellular nitrogen compound metabolic process|mRNA metabolic process,0.00014|0.0002593|0.0004595|0.001203|0.001321,1|1|1|1|1,29.42|12.23|65.38|3.224|7.914
2639,11,0.4119,22.65,7720.0,0.0029170000000000003,0.999969,CHERP DDX39B FAM32A HAUS8 MRPL34 RPL36 SUGP1 TIMM29 UBA52 UBL5 YJU2,"mRNA metabolic process|RNA processing|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions",1.5e-08|1.05e-07|3.05e-07|3.05e-07|3.201e-07,0.0002366|0.000828|0.001604|0.001203|0.00101,18.88|14.2|31|31|30.69
2640,25,0.4002,120.1,17150.0,0.006933,1.0,CNIH4 DUX4 EIF2S1 HSPE1 NBEAL1 NUTF2 OR2A25 RPL11 RPL12 RPL13 RPL17 RPL18 RPL18A RPL19 RPL23 RPL23A RPL27 RPL3 RPL37 RPL4 RPL9 RPLP2 RPS13 SNU13 ST20,SRP-dependent cotranslational protein targeting to membrane|translational initiation|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum,9.524e-31|1.645e-30|2.01e-30|8.118e-30|1.373e-29,1.502e-26|1.297e-26|1.057e-26|3.201e-26|4.332e-26,132|94.17|125.5|114.2|110.2
2641,19,0.4023,68.78,12570.0,0.0054280000000000005,1.0,AK6 C18orf21 C1D C1orf109 DHX33 METAP1 NEPRO NOL6 POP1 POP4 POP5 POP7 RPP14 RPP21 RPP25L RPP30 RPP38 RPP40 SSB,tRNA 5'-leader removal|tRNA 5'-end processing|ncRNA 5'-end processing|RNA 5'-end processing|tRNA processing,5.841e-29|3.047e-28|3.01e-27|6.668e-27|1.926e-19,9.214e-25|2.403e-24|1.582e-23|2.63e-23|6.077e-16,871.3|708|539.4|492.5|85.81
2642,6,0.425,6.375,4830.0,0.001315,0.998474,COL3A1 H6PD RPRM SNAI1 SPAG4 WDR38,"regulation of steroid biosynthetic process|regulation of steroid metabolic process|negative regulation of cell differentiation involved in embryonic placenta development|regulation of lipid biosynthetic process|pentose-phosphate shunt, oxidative branch",0.0002799|0.0005054|0.0005824|0.001358|0.001456,1|1|1|1|1,78.01|57.69|3432|34.85|858.1
2643,24,0.405,111.8,16360.0,0.006769,1.0,ABCG1 BUB3 CNIH4 DUX4 HSPE1 OR2A25 RPL11 RPL12 RPL13 RPL17 RPL18A RPL23 RPL23A RPL27A RPL37 RPL4 RPL6 RPL9 RPLP0 RPLP2 RPS13 RPS15A RPS28 RPS6,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,2.652e-36|6.104e-36|2.903e-35|5.224e-35|6.033e-35,4.183e-32|4.814e-32|1.526e-31|2.06e-31|1.903e-31,154.5|146.8|133.6|128.9|127.8
2644,5,0.4299,4.2989999999999995,3805.0,0.001125,0.996692,BIRC6 MIDN RNF126 RRH ZNF283,cytoplasm protein quality control by the ubiquitin-proteasome system|cytoplasm protein quality control|negative regulation of glucokinase activity|negative regulation of hexokinase activity|regulation of glucokinase activity,0.0004854|0.0004854|0.001456|0.001456|0.002667,1|1|1|1|1,4119|4119|823.8|823.8|411.9
2645,7,0.4069,8.545,5803.0,0.001467,0.9992989999999999,ATP5MC2 DCDC2 FAM177A1 KLHL38 OC90 RRNAD1 VPS13B,otolith mineralization|otolith development|mitochondrial ATP synthesis coupled proton transport|arachidonic acid secretion|ATP synthesis coupled proton transport,0.001019|0.003054|0.006777|0.008465|0.008465,1|1|1|1|1,1471|367.8|154.8|122.6|122.6
2646,9,0.4144,14.92,6523.0,0.002275,0.9998530000000001,ATRIP CCDC12 EXOSC7 GMPPB GNL3 QARS RFT1 RRP9 SACM1L,dolichol-linked oligosaccharide biosynthetic process|oligosaccharide-lipid intermediate biosynthetic process|ncRNA metabolic process|cellular biosynthetic process|organic substance biosynthetic process,6.515e-05|7.105e-05|0.0001157|0.0001391|0.0001739,1|0.5604|0.6086|0.5487|0.5485,178.3|170.2|14.49|4.838|4.674
2647,22,0.4027,93.02,17690.0,0.0052179999999999995,1.0,FBXO9 FRS3 GSTA1 GSTA3 GSTA4 GUCA1A IL17A IL17F MLIP NCR2 PGC PKHD1 PRICKLE4 PRPH2 RAB23 RSPH9 SPATS1 TFAP2D TFEB TJAP1 TMEM217 YIPF3,positive regulation of antimicrobial peptide production|regulation of antimicrobial peptide production|positive regulation of antimicrobial humoral response|regulation of antimicrobial humoral response|positive regulation of humoral immune response,1.014e-07|1.448e-07|1.448e-07|3.443e-07|2.116e-06,0.0016|0.001142|0.0007612|0.001358|0.006677,447.7|383.8|383.8|268.6|134.3
2648,7,0.4017,8.436,5340.0,0.001573,0.9992989999999999,FBXO5 LIN54 RNF19A RSPO2 ST8SIA2 VIP VIPR2,negative regulation of smooth muscle cell proliferation|negative regulation of DNA endoreduplication|epinephrine secretion|regulation of smooth muscle cell proliferation|negative regulation of animal organ morphogenesis,0.0001062|0.0006794|0.0006794|0.000876|0.001019,1|1|1|1|1,130.8|2942|2942|44.24|1471
2649,8,0.4017,11.25,6031.0,0.001857,0.9996790000000001,CFHR1 FCN2 RGS18 RGS2 RGS21 RSPRY1 TIAM2 TROVE2,positive regulation of GTPase activity|regulation of response to stimulus|regulation of GTPase activity|G protein-coupled receptor signaling pathway|regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,0.0002693|0.0004405|0.0004437|0.0005212|0.0006794,1|1|1|1|1,21.37|4.163|18.01|8.855|2942
2650,6,0.4303,6.455,4884.0,0.001317,0.998474,FA2H FHL3 NSUN6 RTKN SLC30A6 ZNF257,sebaceous gland cell differentiation|glucosylceramide biosynthetic process|septin ring organization|tRNA C5-cytosine methylation|actomyosin contractile ring assembly,0.0008735|0.0008735|0.0008735|0.0008735|0.001456,1|1|1|1|1,1716|1716|1716|1716|858.1
2651,7,0.4414,9.27,5889.0,0.001568,0.9992989999999999,BLOC1S2 CAMK1G PSD RTKN2 TMEM259 TPRA1 ZNF703,embryonic cleavage|positive regulation of cell population proliferation|platelet dense granule organization|positive regulation of mammary gland epithelial cell proliferation|adherens junction assembly,0.002376|0.002842|0.003393|0.003732|0.004748,1|1|1|1|1,490.4|9.47|326.9|294.2|226.3
2652,5,0.4303,4.303,3856.0,0.001112,0.996692,DNAH2 LTBP2 RTL1 SPATA7 TRIQK,protein localization to photoreceptor connecting cilium|protein localization to photoreceptor outer segment|protein localization to ciliary transition zone|protein localization to non-motile cilium|photoreceptor cell maintenance,0.0004854|0.001698|0.002183|0.002667|0.01112,1|1|1|1|1,4119|686.5|514.9|411.9|91.53
2653,6,0.4094,6.14,4774.0,0.001281,0.998474,NKX3-2 NLRP6 PALLD RTL6 SLC25A34 UMOD,citric acid secretion|metanephric thick ascending limb development|juxtaglomerular apparatus development|thick ascending limb development|creatinine homeostasis,0.0005824|0.0008735|0.0008735|0.0008735|0.0008735,1|1|1|1|1,3432|1716|1716|1716|1716
2654,7,0.401,8.421,5898.0,0.001422,0.9992989999999999,ANKIB1 CAPG GDF10 HOXA9 RHOBTB1 RTN2 TAGLN3,actin filament organization|endothelial cell activation|actin filament severing|engulfment of apoptotic cell|definitive hemopoiesis,0.004614|0.004651|0.006197|0.006583|0.006969,1|1|1|1|1,19.07|234|171.6|160.9|151.4
2655,7,0.4232,8.887,5536.0,0.001599,0.9992989999999999,MCCC1 PRG2 PRG3 PYGM RTN4R TMEM245 ZFPL1,reactive oxygen species metabolic process|histamine biosynthetic process|basophil activation|imidazole-containing compound metabolic process|leucine catabolic process,0.00116|0.00131|0.001746|0.003054|0.003054,1|1|1|1|1,39.12|1144|762.8|381.4|381.4
2656,6,0.4087,6.131,4851.0,0.001259,0.998474,COL1A1 GNAT1 NAA80 PROB1 RUFY3 SAMD14,actin cytoskeleton organization|supramolecular fiber organization|actin filament-based process|cellular response to fluoride|N-terminal peptidyl-aspartic acid acetylation,0.0003143|0.0004604|0.0004626|0.0005824|0.0005824,1|1|1|1|1,19.65|17.25|17.22|3432|3432
2657,6,0.4092,6.138,4836.0,0.001265,0.998474,C7orf61 CDK3 FAM166B GNG11 KIAA0355 RUNDC1,G0 to G1 transition|Rac protein signal transduction|peptidyl-tyrosine dephosphorylation|activation of GTPase activity|G1/S transition of mitotic cell cycle,0.0005824|0.006391|0.03077|0.0336|0.03615,1|1|1|1|1,3432|163.5|32.38|29.59|27.46
2658,6,0.4058,6.087000000000001,5043.0,0.0012029999999999999,0.998474,ALB CNOT6L KLRB1 RUNDC3A SLC24A1 ZDHHC13,maintenance of mitochondrion location|positive regulation of cytoplasmic mRNA processing body assembly|positive regulation of cGMP-mediated signaling|maintenance of organelle location|regulation of cytoplasmic mRNA processing body assembly,0.001019|0.002376|0.002715|0.003732|0.003732,1|1|1|1|1,1471|490.4|420.3|294.2|294.2
2659,6,0.4301,6.452000000000001,5057.0,0.001271,0.998474,HOPX JPH4 PRICKLE4 RUNDC3B SELENOP TIGD2,selenium compound metabolic process|regulation of store-operated calcium entry|trophectodermal cell differentiation|chaperone-mediated protein complex assembly|regulation of ryanodine-sensitive calcium-release channel activity,0.001746|0.004071|0.005522|0.006391|0.008128,1|1|1|1|1,686.5|264|190.7|163.5|127.1
2660,5,0.4283,4.283,3357.0,0.0012699999999999999,0.996692,CBFB RUNX1 RUNX2 RUNX3 SLC2A14,"positive regulation of CD8-positive, alpha-beta T cell differentiation|regulation of CD8-positive, alpha-beta T cell differentiation|positive regulation of CD8-positive, alpha-beta T cell activation|regulation of CD8-positive, alpha-beta T cell activation|negative regulation of CD4-positive, alpha-beta T cell differentiation",3.843e-10|8.233e-10|1.509e-09|1.056e-08|1.576e-08,6.062e-06|6.494e-06|7.935e-06|4.163e-05|4.973e-05,2471|1765|1373|650.4|561.7
2661,6,0.4261,6.391,4920.0,0.001294,0.998474,ATP2C2 BIRC7 GHR RANBP17 RHBDF1 RXFP3,regulation of natural killer cell apoptotic process|activation of MAPK activity|response to cycloheximide|positive regulation of MAP kinase activity|activation of Janus kinase activity,0.0005824|0.0008592|0.001746|0.00187|0.002037,1|1|1|1|1,3432|44.01|686.5|29.59|572.1
2662,6,0.4295,6.442,5051.0,0.001271,0.998474,APOF CHST3 NOX3 PPP1R3C S1PR1 TCF23,detection of gravity|cardiac muscle tissue growth involved in heart morphogenesis|growth involved in heart morphogenesis|blood vessel maturation|otolith development,0.0005824|0.0008735|0.001456|0.002619|0.002619,1|1|1|1|1,3432|1716|858.1|429.1|429.1
2663,5,0.4474,4.474,4010.0,0.001112,0.996692,ACER1 ANKRD10 FAM160A1 GOLGA4 S1PR3,negative regulation of establishment of endothelial barrier|negative regulation of endothelial cell development|response to alkaline pH|negative regulation of endothelial cell differentiation|sphingoid biosynthetic process,0.000728|0.000728|0.0009706|0.002425|0.003636,1|1|1|1|1,2060|2060|1373|457.7|294.2
2664,7,0.4095,8.599,5853.0,0.001464,0.9992989999999999,CLDN20 PDZD3 PPIL6 SAC3D1 SUMO3 TSPAN9 ZNF669,negative regulation of guanylate cyclase activity|negative regulation of purine nucleotide biosynthetic process|negative regulation of nucleotide biosynthetic process|negative regulation of cGMP-mediated signaling|receptor guanylyl cyclase signaling pathway,0.001358|0.002376|0.002376|0.002376|0.003732,1|1|1|1|1,980.7|490.4|490.4|490.4|294.2
2665,5,0.4169,4.169,3706.0,0.001121,0.996692,DNAJB6 MLF2 SAFB2 TP73 ZNF428,negative regulation of inclusion body assembly|negative regulation of cardiac muscle cell proliferation|Sertoli cell differentiation|regulation of inclusion body assembly|positive regulation of oligodendrocyte differentiation,0.00291|0.003636|0.004362|0.004604|0.005571,1|1|1|1|1,374.5|294.2|242.3|228.8|187.2
2666,5,0.4298,4.298,4019.0,0.001066,0.996692,GPR182 HBD KSR2 METTL7B SAG,rhodopsin mediated signaling pathway|protein neddylation|G protein-coupled receptor internalization|oxygen transport|response to redox state,0.004409|0.004748|0.005086|0.005086|0.005425,1|1|1|1|1,245.2|226.3|210.2|210.2|196.1
2667,4,0.445,2.67,3060.0,0.0008695,0.9929309999999999,C1orf68 HES6 NIPSNAP3A SAMD12,negative regulation of DNA-binding transcription factor activity|anterior/posterior pattern specification|cellular process|regionalization|regulation of neurogenesis,0.03204|0.03979|0.04971|0.06052|0.06681,1|1|1|1|1,31.02|24.87|0.3325|16.19|14.63
2668,6,0.436,6.539,4990.0,0.001306,0.998474,ARHGAP22 BBOF1 FBF1 FMNL2 OR6C65 SAMD9L,cilium assembly|cilium organization|plasma membrane bounded cell projection assembly|motile cilium assembly|cell projection assembly,0.004846|0.005462|0.007361|0.00755|0.007854,1|1|1|1|1,18.16|17.08|14.64|137.3|14.15
2669,6,0.4417,6.625,4847.0,0.001362,0.998474,ADAT1 CA9 FBXO10 FRMPD1 SAPCD2 UCK1,symmetric cell division|negative regulation of protein localization to cell cortex|CTP salvage|pyrimidine ribonucleotide salvage|pyrimidine nucleotide salvage,0.0005824|0.0005824|0.001165|0.001746|0.001746,1|1|1|1|1,3432|3432|1144|686.5|686.5
2670,6,0.4422,6.632999999999999,5014.0,0.001318,0.998474,ARMS2 ASIC5 CKM GGA3 HOXD8 SASH1,sodium ion transmembrane transport|sodium ion transport|phosphocreatine metabolic process|phosphagen metabolic process|phosphagen biosynthetic process,0.0007163|0.001482|0.001698|0.001698|0.001698,1|1|1|1|1,49.04|33.82|735.5|735.5|735.5
2671,6,0.4022,6.0329999999999995,4699.0,0.001279,0.998474,ACKR3 CHRNE SBK2 SLC6A16 SMG9 SUSD4,"positive regulation of mesenchymal stem cell migration|regulation of mesenchymal stem cell migration|regulation of complement activation, alternative pathway|negative regulation of complement activation, alternative pathway|regulation of complement activation, classical pathway",0.001165|0.001165|0.001165|0.001165|0.001456,1|1|1|1|1,1144|1144|1144|1144|858.1
2672,7,0.4122,8.657,6309.0,0.001367,0.9992989999999999,FGA FRMD4B MAP1B RIMS3 SCARB1 SNPH TMEM171,synaptic vesicle exocytosis|neurotransmitter secretion|signal release from synapse|regulation of vesicle-mediated transport|response to wounding,0.0001678|0.0004352|0.0004352|0.0005395|0.0005984,1|1|1|1|1,103.2|63.27|63.27|16.84|16.25
2673,7,0.4021,8.443999999999999,5834.0,0.001442,0.9992989999999999,CXCL8 DCUN1D2 DMRT2 KLHL8 RASSF2 SCARB2 SPO11,epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade|epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity|regulation of myotome development|positive regulation of myotome development|regulation of glucosylceramidase activity,0.0006794|0.0006794|0.0006794|0.0006794|0.001019,1|1|1|1|1,2942|2942|2942|2942|1471
2674,5,0.447,4.47,4020.0,0.001108,0.996692,CYP20A1 KLK12 LOXHD1 PELI1 SCEL,regulation of Toll signaling pathway|keratinocyte differentiation|Toll signaling pathway|positive regulation of toll-like receptor 3 signaling pathway|regulation of toll-like receptor 3 signaling pathway,0.001213|0.001667|0.001698|0.00194|0.002183,1|1|1|1|1,1030|30.74|686.5|588.4|514.9
2675,5,0.4622,4.622,3978.0,0.001158,0.996692,GLDC PCDH15 RORB SCN5A ZFAND2A,response to methylamine|response to lipoic acid|response to calcium ion|glycine decarboxylation via glycine cleavage system|membrane depolarization during atrial cardiac muscle cell action potential,0.0004854|0.0004854|0.0005401|0.0009706|0.0009706,1|1|1|1|1,4119|4119|54.56|1373|1373
2676,5,0.4068,4.0680000000000005,3824.0,0.00106,0.996692,FAM69B SCRG1 STAT1 STPG3 USHBP1,negative regulation of metanephric nephron tubule epithelial cell differentiation|negative regulation of nephron tubule epithelial cell differentiation|negative regulation by virus of viral protein levels in host cell|metanephric mesenchymal cell proliferation involved in metanephros development|kidney mesenchymal cell proliferation,0.0004854|0.000728|0.000728|0.0009706|0.0009706,1|1|1|1|1,4119|2060|2060|1373|1373
2677,7,0.4013,8.427,6033.0,0.001392,0.9992989999999999,GGH LMX1A SCRN3 SHROOM1 SLC37A1 SNX15 ZIC4,tetrahydrofolylpolyglutamate metabolic process|glucose-6-phosphate transport|hexose phosphate transport|olfactory behavior|midbrain dopaminergic neuron differentiation,0.001019|0.002376|0.002376|0.003393|0.004409,1|1|1|1|1,1471|490.4|490.4|326.9|245.2
2678,8,0.4057,11.36,6543.0,0.0017289999999999999,0.9996790000000001,BATF2 CD47 GULP1 IFITM1 LRFN5 PKIB SDC2 SMKR1,negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis|ATP export|response to interferon-gamma|monocyte extravasation|regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,0.001164|0.001552|0.002121|0.002328|0.003103,1|1|1|1|1,1287|858.1|28.45|514.9|367.8
2679,6,0.4103,6.154,4892.0,0.001253,0.998474,ACO1 CACNA1G HUS1B MAMDC4 NUTM2G SDCCAG8,response to nickel cation|meiotic DNA integrity checkpoint|regulation of G2/M transition of mitotic cell cycle|regulation of cell cycle G2/M phase transition|response to iron(II) ion,0.0005824|0.0008735|0.00144|0.00167|0.001746,1|1|1|1|1,3432|1716|33.82|31.35|686.5
2680,5,0.4552,4.552,3975.0,0.001141,0.996692,HUS1B NOD1 POU5F2 SDK1 SLC22A2,activation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of glucosylceramide catabolic process|regulation of glucosylceramide catabolic process|positive regulation of phospholipid scramblase activity|regulation of phospholipid scramblase activity,0.0002989|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,75.44|3432|3432|3432|3432
2681,6,0.4227,6.34,4731.0,0.001335,0.998474,CHRNB4 CSN1S1 DUSP22 EHD4 SDR42E1 STX1B,regulation of neurotransmitter secretion|regulation of neurotransmitter transport|negative regulation of macropinocytosis|negative regulation of non-membrane spanning protein tyrosine kinase activity|positive regulation of spontaneous neurotransmitter secretion,0.0002989|0.0003955|0.0005824|0.0005824|0.0005824,1|1|1|1|1,75.44|65.38|3432|3432|3432
2682,6,0.4235,6.353,4904.0,0.001291,0.998474,CX3CR1 NFASC PLA2G6 PLAC8L1 SEC16B TFAP2E,"chemotaxis|taxis|memory|multiple spine synapse organization, single dendrite|multiple spine synapse organization",0.0003545|0.0003603|0.0004726|0.0005824|0.0005824,1|1|1|1|1,18.86|18.76|59.7|3432|3432
2683,25,0.4005,120.1,17880.0,0.006658,1.0,GMIP MEF2B ZNF100 ZNF101 ZNF124 ZNF14 ZNF195 ZNF253 ZNF43 ZNF443 ZNF486 ZNF492 ZNF625 ZNF676 ZNF682 ZNF69 ZNF714 ZNF737 ZNF763 ZNF791 ZNF844 ZNF878 ZNF91 ZNF98 ZNF99,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",5.733e-21|5.912e-18|5.953e-18|6.16e-18|3.596e-17,9.043e-17|4.663e-14|3.13e-14|2.429e-14|1.134e-13,7.645|5.708|5.706|5.698|5.289
2684,6,0.4296,6.444,4817.0,0.001333,0.998474,IL36RN LGI2 PDIA5 SELENOO TTC3 UGT1A8,protein nucleotidylation|protein adenylylation|flavone metabolic process|negative regulation of cellular glucuronidation|coumarin metabolic process,0.0008735|0.0008735|0.002037|0.002619|0.002619,1|1|1|1|1,1716|1716|572.1|429.1|429.1
2685,5,0.4365,4.365,3874.0,0.001123,0.996692,APRT CELA2A LRRC49 SELENOW VWA2,adenine salvage|AMP salvage|adenine biosynthetic process|adenine metabolic process|insulin catabolic process,0.000728|0.000728|0.0009706|0.0009706|0.0009706,1|1|1|1|1,2060|2060|1373|1373|1373
2686,5,0.4471,4.471,3995.0,0.001115,0.996692,C4orf47 FRMD8 GSTZ1 GULP1 SELPLG,leukocyte adhesive activation|tyrosine catabolic process|regulation of acetyl-CoA biosynthetic process from pyruvate|regulation of acyl-CoA biosynthetic process|L-phenylalanine catabolic process,0.000728|0.001456|0.002183|0.002425|0.00291,1|1|1|1|1,2060|823.8|514.9|457.7|374.5
2687,6,0.4307,6.46,4697.0,0.00137,0.998474,C1orf43 KIAA0100 KIAA1109 NDRG1 SEMA4A SMIM6,positive regulation of inhibitory synapse assembly|positive regulation of excitatory synapse assembly|regulation of inhibitory synapse assembly|peripheral nervous system myelin maintenance|T-helper 1 cell differentiation,0.0008735|0.001165|0.001456|0.002619|0.0032,1|1|1|1|1,1716|1144|858.1|429.1|343.2
2688,6,0.4253,6.379,5046.0,0.00126,0.998474,B2M DGKG KCNJ15 SEMA4B ZNF415 ZNF576,"regulation of neuron projection development|antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent|regulation of plasma membrane bounded cell projection organization|negative regulation of neuron projection development|negative regulation of neurogenesis",0.0003198|0.0006794|0.0008835|0.000902|0.0009283,1|1|1|1|1,20.15|2942|14.21|43.59|42.95
2689,5,0.4322,4.322,3894.0,0.001106,0.996692,CLEC11A FSTL1 RSBN1L SCRIB SEMA5B,suppression by symbiont of host signal transduction pathway|neurotransmitter receptor transport postsynaptic membrane to endosome|suppression by virus of host STAT2 activity|suppression by virus of host STAT1 activity|suppression by virus of host STAT activity,0.0004854|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,4119|4119|4119|4119|4119
2690,14,0.4167,37.92,11230.0,0.003356,0.9999969999999999,C6orf203 ENPP1 ENPP3 GABRR1 SEMA6D TAAR1 TAAR2 TAAR5 TAAR6 TAAR8 TCF21 ULBP3 VNN2 WISP3,nucleoside triphosphate catabolic process|G protein-coupled receptor signaling pathway|negative regulation of hh target transcription factor activity|water-soluble vitamin metabolic process|nucleoside phosphate catabolic process,4.386e-05|8.44e-05|0.001261|0.001273|0.001273,0.6919|0.6657|1|1|1,226.3|7.152|1584|38.17|38.17
2691,6,0.4203,6.305,4664.0,0.001347,0.998474,AKR1A1 MMP1 PRKACA SERAC1 UCP3 USP47,peptidyl-threonine phosphorylation|response to abiotic stimulus|peptidyl-threonine modification|cellular response to UV|response to chemical,0.0002787|0.0003112|0.0003486|0.0004082|0.0005238,1|1|1|1|1,79.52|10.13|70.9|65.38|4.04
2692,18,0.4151,63.51,13640.0,0.004621,1.0,CCDC73 CYBC1 DDC DEF8 FDX1 KCNK13 MAFB MAPKAPK5 NAT8L PSKH1 RPH3A SELE SERPINC1 SLC5A12 TAL2 TNFRSF19 UCKL1 WNT8A,rhombomere 6 development|polarity specification of proximal/distal axis|abducens nerve formation|abducens nerve morphogenesis|abducens nerve development,0.001746|0.002618|0.002618|0.002618|0.002618,1|1|1|1|1,1144|572.1|572.1|572.1|572.1
2693,6,0.4165,6.247999999999999,5089.0,0.0012230000000000001,0.998474,CISD2 LGI3 SCARA3 SERPINH1 SOGA3 TSPYL1,chondrocyte development involved in endochondral bone morphogenesis|collagen biosynthetic process|regulation of autophagy|UV protection|chondrocyte differentiation involved in endochondral bone morphogenesis,0.002619|0.002909|0.003743|0.004071|0.004651,1|1|1|1|1,429.1|381.4|20.74|264|228.8
2694,5,0.4389,4.388999999999999,3945.0,0.001109,0.996692,CNN3 LASP1 LIMA1 RFFL SERTAD4,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis|regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis|intestinal cholesterol absorption|intestinal lipid absorption|lipid digestion,0.0009706|0.001456|0.002667|0.003152|0.003878,1|1|1|1|1,1373|823.8|411.9|343.3|274.6
2695,6,0.4038,6.057,4466.0,0.001351,0.998474,B3GNT4 COLCA2 POU2F3 SF3B6 TFAP2B ZNRF4,cellular urea homeostasis|cellular creatinine homeostasis|cellular ammonium homeostasis|urea homeostasis|creatinine homeostasis,0.0005824|0.0005824|0.0005824|0.0008735|0.0008735,1|1|1|1|1,3432|3432|3432|1716|1716
2696,5,0.4072,4.072,3845.0,0.0010550000000000002,0.996692,ICAM1 OR52E2 PDE4A SFT2D3 USH2A,sensory perception|nervous system process|system process|response to sulfur dioxide|sensory perception of sound,2.42e-05|9.602e-05|0.0004451|0.0004854|0.0005471,0.3817|0.7573|1|1|1,16.93|11.94|8.076|4119|54.2
2697,6,0.4067,6.101,4513.0,0.001347,0.998474,C19orf70 IMMT MINOS1 MRAS SFTPC SLIT3,cristae formation|inner mitochondrial membrane organization|mitochondrial membrane organization|apoptotic process involved in luteolysis|response to cortisol,2.481e-05|6.711e-05|0.0004655|0.0009706|0.001456,0.3914|0.5293|1|1|1,265.7|158.4|58.84|1373|823.8
2698,6,0.4317,6.476,5042.0,0.00128,0.998474,HESX1 NPR2 SGCG TMEM54 TSSK4 VIPR1,peptidyl-threonine autophosphorylation|negative regulation of oocyte maturation|regulation of oocyte maturation|positive regulation of cGMP-mediated signaling|negative regulation of cell maturation,0.0008735|0.001165|0.002037|0.002328|0.002328,1|1|1|1|1,1716|1144|572.1|490.4|490.4
2699,5,0.4308,4.308,3784.0,0.001134,0.996692,GAMT RPS6KB1 SGK1 SLC16A3 TRAPPC9,long-term memory|cellular response to corticosteroid stimulus|cellular response to ketone|regulation of growth|memory,2.96e-05|9.445e-05|0.0002086|0.000312|0.0003163,0.4668|0.7449|1|1|0.9978,242.3|132.9|88.58|18.81|71.63
2700,6,0.4226,6.3389999999999995,4861.0,0.001299,0.998474,DAAM2 EPB41L4B ERGIC3 SGK2 WDR17 ZNF639,negative regulation of oligodendrocyte differentiation|positive regulation of keratinocyte migration|regulation of keratinocyte migration|negative regulation by host of viral transcription|positive regulation by host of viral transcription,0.00349|0.003781|0.004361|0.004651|0.004942,1|1|1|1|1,312|286|245.2|228.8|214.5
2701,9,0.4037,14.53,8269.0,0.0017510000000000002,0.9998530000000001,ASB13 B3GNT8 C19orf12 DNAI1 GJA9 HSD11B1 PPP3CB SGMS2 UNC5B,ceramide phosphoethanolamine biosynthetic process|ceramide phosphoethanolamine metabolic process|locomotion involved in locomotory behavior|anterior/posterior axon guidance|sphingomyelin biosynthetic process,0.001601|0.001601|0.003199|0.004263|0.004263,1|1|1|1|1,936.1|936.1|374.5|267.5|267.5
2702,8,0.4182,11.71,6714.0,0.001737,0.9996790000000001,FAM221A FFAR4 GJD2 GLDN PCDHAC2 SGPP2 SLC5A1 ZNF74,negative regulation of somatostatin secretion|ghrelin secretion|alpha-glucoside transport|galactose transmembrane transport|fucose transmembrane transport,0.0007765|0.001164|0.001164|0.001164|0.001164,1|1|1|1|1,2574|1287|1287|1287|1287
2703,7,0.42,8.82,6026.0,0.001458,0.9992989999999999,ABHD4 FABP7 FAM178B FUCA1 SH2B3 SUCLG2 ZNF362,lipid catabolic process|negative regulation of Kit signaling pathway|regulation of Kit signaling pathway|monocyte homeostasis|cellular lipid catabolic process,0.0001097|0.0006794|0.0006794|0.001019|0.001945,1|1|1|1|1,29.03|2942|2942|1471|29.42
2704,22,0.402,92.86,17150.0,0.005372999999999999,1.0,ADCY10 ATXN7L3B CARNS1 CCNB1IP1 FAIM FEZF2 KIF26B KLK10 LRRC40 MAP3K7CL MCOLN3 NDRG3 NIPSNAP3B PCDHB12 PCDHGA9 PLEKHB1 PTH RNF114 SDR39U1 TEX12 TMEM100 ZNF286A,cAMP metabolic process|cyclic nucleotide metabolic process|homologous chromosome pairing at meiosis|carnosine biosynthetic process|homologous chromosome segregation,0.0003237|0.001045|0.001585|0.00223|0.002301,1|1|1|1|1,81.4|43.68|35.12|895.4|28.88
2705,6,0.4214,6.322,4893.0,0.001287,0.998474,DDX60 PLD3 SH3YL1 TBC1D8 USP53 WFIKKN2,striated muscle cell differentiation|positive regulation of MDA-5 signaling pathway|muscle cell differentiation|regulation of MDA-5 signaling pathway|positive regulation of RIG-I signaling pathway,0.001265|0.001456|0.001918|0.002328|0.0032,1|1|1|1|1,36.13|858.1|29.21|490.4|343.2
2706,7,0.4064,8.535,5843.0,0.0014550000000000001,0.9992989999999999,ACAD10 CTNNAL1 KBTBD4 RNF10 SHANK1 SLC17A8 TTC9C,determination of affect|regulation of nervous system process|sensory processing|habituation|synaptic growth at neuromuscular junction,0.0006794|0.001023|0.001698|0.001698|0.002037,1|1|1|1|1,2942|40.86|735.5|735.5|588.4
2707,6,0.434,6.51,5016.0,0.0012929999999999999,0.998474,CCNI2 HOGA1 LGALS3 OSR2 PLAGL1 SHCBP1L,oxalate metabolic process|male meiosis cytokinesis|negative regulation of immunological synapse formation|negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell|regulation of immunological synapse formation,0.0005824|0.0005824|0.0008735|0.001165|0.001165,1|1|1|1|1,3432|3432|1716|1144|1144
2708,6,0.4069,6.103,4791.0,0.001269,0.998474,C18orf54 FOXF1 IGDCC4 MC4R RTP5 SHISA2,right lung morphogenesis|embryonic ectodermal digestive tract morphogenesis|ectodermal digestive tract morphogenesis|lateral mesodermal cell differentiation|detection of wounding,0.0005824|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,3432|3432|3432|3432|3432
2709,6,0.4016,6.025,4703.0,0.001276,0.998474,C1QTNF5 FJX1 HBEGF LDLRAD3 LRRC75A SHISA6,negative regulation of elastin biosynthetic process|regulation of elastin biosynthetic process|regulation of signaling receptor activity|regulation of glutamate receptor clustering|regulation of AMPA glutamate receptor clustering,0.0005824|0.0005824|0.001317|0.002037|0.002037,1|1|1|1|1,3432|3432|35.39|572.1|572.1
2710,7,0.4184,8.786,5697.0,0.001536,0.9992989999999999,ATG4C C1orf123 CYR61 HMGCS2 MS4A6A PLA2G12A SHISAL2A,"isoprenoid biosynthetic process via mevalonate|farnesyl diphosphate biosynthetic process, mevalonate pathway|farnesyl diphosphate biosynthetic process|farnesyl diphosphate metabolic process|phospholipid biosynthetic process",0.000728|0.000728|0.001213|0.001456|0.001524,1|1|1|1|1,2060|2060|1030|823.8|32.18
2711,7,0.4365,9.166,5935.0,0.001538,0.9992989999999999,ATP2A1 B3GNT7 CD8B INPP1 SHISAL2B TMEM163 TMEM18,positive regulation of actin filament-based movement|positive regulation of cardiac muscle cell contraction|positive regulation of calcium ion import into sarcoplasmic reticulum|maintenance of mitochondrion location|zinc ion import into synaptic vesicle,0.0006794|0.0006794|0.001019|0.001019|0.001019,1|1|1|1|1,2942|2942|1471|1471|1471
2712,5,0.4301,4.301,3945.0,0.001086,0.996692,ANO4 CIC OPN1SW SHKBP1 WNT9A,calcium activated galactosylceramide scrambling|calcium activated phosphatidylserine scrambling|calcium activated phosphatidylcholine scrambling|calcium activated phospholipid scrambling|iris morphogenesis,0.001213|0.001213|0.001456|0.001698|0.002425,1|1|1|1|1,1030|1030|823.8|686.5|457.7
2713,6,0.403,6.045,5068.0,0.001188,0.998474,DPYS LCLAT1 MBNL2 SIDT2 TTC39A ZNF106,uracil catabolic process|thymine catabolic process|pyrimidine nucleobase catabolic process|uracil metabolic process|thymine metabolic process,0.0008735|0.001165|0.001165|0.001165|0.001165,1|1|1|1|1,1716|1144|1144|1144|1144
2714,6,0.4324,6.486000000000001,4985.0,0.001296,0.998474,CRYGA GNG8 GRB14 GUCA1C KCNN2 SIL1,cellular response to pheromone|atrial cardiac muscle cell membrane repolarization|membrane repolarization during atrial cardiac muscle cell action potential|visual perception|sensory perception of light stimulus,0.0006794|0.002037|0.002037|0.00226|0.002342,1|1|1|1|1,2942|588.4|588.4|27.24|26.75
2715,7,0.4025,8.452,5675.0,0.001483,0.9992989999999999,EEA1 ENTPD7 FAM149A MKKS PTGFR SIM1 ZNF165,UTP catabolic process|CTP catabolic process|pyrimidine ribonucleoside triphosphate catabolic process|pigment granule aggregation in cell center|UDP catabolic process,0.0007765|0.0007765|0.0007765|0.001164|0.001164,1|1|1|1|1,2574|2574|2574|1287|1287
2716,6,0.4103,6.155,4601.0,0.001333,0.998474,CAV1 KCNG3 RPN1 SIX1 SIX2 ZNF48,kidney mesenchyme development|middle ear morphogenesis|regulation of branching involved in ureteric bud morphogenesis|regulation of kidney development|embryonic cranial skeleton morphogenesis,1.875e-05|2.072e-05|2.495e-05|5.199e-05|0.0001155,0.2957|0.1634|0.1312|0.205|0.3644,326.9|309.7|280.2|189.8|125.2
2717,7,0.4368,9.172,5023.0,0.001818,0.9992989999999999,ETV6 EWSR1 FLI1 IGF2BP1 RNF216 TRIM11 TRIM8,negative regulation of viral release from host cell|negative regulation of viral transcription|negative regulation of viral entry into host cell|negative regulation of viral life cycle|regulation of gene expression,1.343e-05|1.51e-05|2.722e-05|3.725e-05|4.164e-05,0.2118|0.1191|0.1431|0.1469|0.1314,392.3|367.8|267.5|226.3|4.227
2718,5,0.4535,4.535,3951.0,0.001144,0.996692,DNAH14 ERO1A SLAIN2 THAP4 TMEM135,response to temperature stimulus|animal organ senescence|nitrate metabolic process|protein maturation by protein folding|peptidyl-proline hydroxylation to 4-hydroxy-L-proline,0.0006506|0.0009706|0.001213|0.002183|0.002667,1|1|1|1|1,49.63|1373|1030|514.9|411.9
2719,5,0.4537,4.537,3997.0,0.001131,0.996692,CDH20 CEP95 REG1A SLC14A1 USP50,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|cellular response to gastrin|response to gastrin|response to growth hormone-releasing hormone|pancreas regeneration,6.651e-05|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,163.5|3432|3432|3432|3432
2720,6,0.4074,6.111000000000001,4942.0,0.001232,0.998474,ITGBL1 RSRC1 SCAF1 SLC16A5 SPATA4 TPCN2,"receptor-mediated endocytosis of virus by host cell|endocytosis involved in viral entry into host cell|multi-organism cellular process|RNA splicing|alternative mRNA splicing, via spliceosome",0.002328|0.002328|0.005232|0.005594|0.006391,1|1|1|1|1,490.4|490.4|201.9|16.87|163.5
2721,6,0.4046,6.069,4849.0,0.001247,0.998474,ATP6V0E2 CA7 RGSL1 SHF SLC17A3 WDR41,regulation of intracellular pH|regulation of cellular pH|regulation of pH|cellular monovalent inorganic cation homeostasis|monovalent inorganic cation homeostasis,0.0002799|0.0003251|0.0003809|0.0004807|0.000775,1|1|1|1|1,78.01|72.26|66.65|59.18|46.39
2722,5,0.4449,4.449,4059.0,0.001092,0.996692,CCDC184 IGSF6 SLC22A18 SNX29 WNT2B,lung induction|regulation of branching involved in lung morphogenesis|mesenchymal-epithelial cell signaling|xenobiotic detoxification by transmembrane export across the plasma membrane|iris morphogenesis,0.0009706|0.001698|0.00194|0.002183|0.002425,1|1|1|1|1,1373|686.5|588.4|514.9|457.7
2723,6,0.4312,6.468,4915.0,0.0013109999999999999,0.998474,FGF18 LHFPL5 PATE3 SLC23A1 TRIM4 ZFP14,transepithelial L-ascorbic acid transport|L-ascorbic acid transmembrane transport|L-ascorbic acid metabolic process|vitamin transmembrane transport|transepithelial transport,5.936e-07|5.936e-07|7.705e-06|1.688e-05|3.725e-05,0.009363|0.004681|0.04051|0.06655|0.1175,2942|2942|534.9|346.1|226.3
2724,7,0.4021,8.445,5826.0,0.001444,0.9992989999999999,CDH24 GAA GUCA1B OSM SDCBP2 SLC23A3 ZNF451,negative regulation of histone H3-K9 acetylation|vacuolar sequestering|diaphragm contraction|involuntary skeletal muscle contraction|sucrose metabolic process,0.0006794|0.0006794|0.001019|0.001358|0.001358,1|1|1|1|1,2942|2942|1471|980.7|980.7
2725,20,0.4072,77.36,13800.0,0.005557,1.0,ABCF1 C1orf109 DHX16 EXOC2 FARS2 LYRM4 MRPS18B NOL7 NUP153 PAK1IP1 POP5 PPP1R10 PRPF4B PSMG4 RIOK1 RPP21 RPP40 SNRNP48 TUBB4B WDR46,RNA processing|gene expression|tRNA 5'-leader removal|tRNA 5'-end processing|ncRNA 5'-end processing,8.129e-08|1.163e-07|4.338e-07|7.492e-07|1.56e-06,0.001282|0.0009169|0.002281|0.002954|0.004922,10.04|5.653|237.6|193.1|147.1
2726,5,0.4339,4.3389999999999995,3859.0,0.00112,0.996692,APOL3 ILKAP PRDX5 SLC25A22 TRPM6,regulation of apoptosis involved in tissue homeostasis|negative regulation of transcription by RNA polymerase III|malate-aspartate shuttle|response to toxic substance|NADPH oxidation,0.0004854|0.0009706|0.001213|0.001343|0.001698,1|1|1|1|1,4119|1373|1030|34.33|686.5
2727,5,0.4376,4.376,4133.0,0.0010550000000000002,0.996692,ERN2 LYZL6 RAB34 SLC25A27 SLC28A1,cytidine transport|membrane fusion|negative regulation of mitochondrial calcium ion concentration|purine nucleobase transmembrane transport|pyrimidine nucleoside transport,0.0004854|0.0005261|0.001213|0.001213|0.001456,1|1|1|1|1,4119|55.29|1030|1030|823.8
2728,5,0.4136,4.136,3991.0,0.001033,0.996692,BNIPL CSAD GPR26 SLC26A11 SLITRK6,L-cysteine catabolic process to taurine|L-cysteine catabolic process to hypotaurine|linear vestibuloocular reflex|taurine biosynthetic process|alkanesulfonate biosynthetic process,0.0004854|0.0004854|0.0004854|0.000728|0.000728,1|1|1|1|1,4119|4119|4119|2060|2060
2729,10,0.4228,19.03,6665.0,0.002838,0.999933,ACIN1 BCAS2 CCNL1 CDK11A CTNNBL1 MMP23B PPP1R8 PRPF19 SAP30BP WBP11,RNA splicing|mRNA processing|RNA processing|mRNA metabolic process|nucleic acid metabolic process,2.653e-08|7.323e-08|1.05e-07|6.008e-07|2.349e-06,0.0004185|0.0005776|0.000552|0.002369|0.007411,27.6|23.21|14.2|16.19|6.711
2730,5,0.4442,4.442,3797.0,0.001165,0.996692,CYB5R2 GDNF NKX6-2 SLC28A3 ZDHHC4,postganglionic parasympathetic fiber development|regulation of semaphorin-plexin signaling pathway|positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis|positive regulation of ureteric bud formation|regulation of ureteric bud formation,0.000728|0.0009706|0.001213|0.001213|0.001213,1|1|1|1|1,2060|1373|1030|1030|1030
2731,6,0.4175,6.2620000000000005,4868.0,0.001282,0.998474,AMN DEGS2 OR2AG1 SLC2A9 SMIM2 TMEM204,sphinganine metabolic process|urate transport|cobalamin transport|high-density lipoprotein particle clearance|urate metabolic process,0.0008735|0.002037|0.002619|0.0032|0.004361,1|1|1|1|1,1716|572.1|429.1|343.2|245.2
2732,7,0.4051,8.508,5475.0,0.0015480000000000001,0.9992989999999999,FUT1 FUT8 GMDS RAB15 SLC30A10 SLC35C1 SPPL3,fucosylation|GDP-L-fucose metabolic process|fucose catabolic process|L-fucose catabolic process|L-fucose metabolic process,2.731e-08|1.483e-06|5.435e-06|5.435e-06|5.435e-06,0.0004308|0.0117|0.02858|0.02143|0.01715,519.2|1471|653.8|653.8|653.8
2733,6,0.4065,6.097,4800.0,0.001266,0.998474,ANKS1B ANO8 C14orf119 FAM160A2 IGIP SLC35A4,regulation of synaptic plasticity by receptor localization to synapse|positive regulation of translation in response to stress|pyrimidine nucleotide-sugar transmembrane transport|nucleotide-sugar transmembrane transport|regulation of translation in response to stress,0.0005824|0.002909|0.00349|0.003781|0.006101,1|1|1|1|1,3432|381.4|312|286|171.6
2734,6,0.4067,6.101,4795.0,0.001268,0.998474,HAND1 PLSCR5 PRRT2 SLC35G2 TREX1 ZDHHC19,detection of DNA damage stimulus involved in DNA damage checkpoint|detection of stimulus involved in cell cycle checkpoint|immune response in brain or nervous system|detection of endogenous biotic stimulus|negative regulation of short-term synaptic potentiation,0.0005824|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,3432|3432|3432|3432|3432
2735,19,0.4065,69.51,14620.0,0.004719,1.0,ATAT1 C6orf48 CFB CLIC1 HLA-DMB HLA-F LY6G6F MICB MPIG6B MSH5 NEU1 NUDT3 OR14J1 OR2J3 PSORS1C2 STK19 TNXB TRIM10 TRIM26,negative regulation of viral entry into host cell|negative regulation of viral life cycle|regulation of viral entry into host cell|regulation of immune effector process|modulation by symbiont of entry into host,0.0002195|0.0002999|0.0007782|0.0008325|0.001038,1|1|1|1|1,98.54|83.38|50.42|9.167|43.36
2736,5,0.4106,4.106,3573.0,0.001145,0.996692,ARNT EPAS1 EXD2 HIF1A SLC39A4,regulation of transcription from RNA polymerase II promoter in response to oxidative stress|regulation of transcription from RNA polymerase II promoter in response to hypoxia|embryonic placenta development|regulation of transcription from RNA polymerase II promoter in response to stress|regulation of DNA-templated transcription in response to stress,2.497e-09|5.824e-07|6.502e-07|1.681e-06|1.96e-06,3.938e-05|0.004593|0.003419|0.006629|0.006183,1123|158.4|152.6|110.3|104.7
2737,5,0.4164,4.164,3737.0,0.0011099999999999999,0.996692,IFITM2 IFITM3 KEL SLC3A1 XAB2,negative regulation of viral entry into host cell|response to interferon-alpha|negative regulation of viral life cycle|response to interferon-beta|regulation of viral entry into host cell,1.298e-05|1.528e-05|1.777e-05|2.636e-05|4.647e-05,0.2048|0.1205|0.09344|0.1039|0.1466,374.5|343.3|316.8|257.4|191.6
2738,6,0.4056,6.084,4956.0,0.0012230000000000001,0.998474,DCUN1D2 ERAP1 GPR52 MTTP PLCL1 SLC40A1,iron ion export across plasma membrane|triglyceride transport|acylglycerol transport|positive regulation of protein neddylation|multicellular organismal iron ion homeostasis,0.0005824|0.001746|0.001746|0.001746|0.002328,1|1|1|1|1,3432|686.5|686.5|686.5|490.4
2739,6,0.4391,6.586,4820.0,0.001361,0.998474,ACSS2 IRF6 SLC4A11 SYNJ2BP TRAF3IP3 ZFP82,borate transmembrane transport|borate transport|acetyl-CoA biosynthetic process from acetate|acetate biosynthetic process|acetate metabolic process,0.0005824|0.0005824|0.0008735|0.0008735|0.0008735,1|1|1|1|1,3432|3432|1716|1716|1716
2740,5,0.4039,4.039,3818.0,0.0010539999999999998,0.996692,C6 FAM184A KIAA1586 SLC17A6 SLC4A1AP,"hyaloid vascular plexus regression|neurotransmitter loading into synaptic vesicle|anatomical structure regression|L-glutamate transmembrane transport|synaptic transmission, glutamatergic",0.00194|0.002183|0.004362|0.005571|0.006778,1|1|1|1|1,588.4|514.9|242.3|187.2|152.6
2741,6,0.4255,6.382999999999999,4841.0,0.0013130000000000001,0.998474,A3GALT2 NYAP1 ORM1 SLC4A9 TUT7 UROC1,"polyuridylation-dependent mRNA catabolic process|negative regulation of transposition, RNA-mediated|regulation of transposition, RNA-mediated|formamide metabolic process|histidine catabolic process to glutamate and formate",0.001165|0.001165|0.001165|0.001456|0.001456,1|1|1|1|1,1144|1144|1144|858.1|858.1
2742,6,0.4238,6.358,5098.0,0.001243,0.998474,AMIGO3 IL22RA1 ITPR1 NRXN2 SLC6A20 TTLL3,isoleucine transport|L-isoleucine import across plasma membrane|isoleucine transmembrane transport|proline import across plasma membrane|L-proline transmembrane transport,0.0005824|0.0005824|0.0005824|0.0008735|0.0008735,1|1|1|1|1,3432|3432|3432|1716|1716
2743,32,0.4017,199.2,25750.0,0.007659,1.0,BCAS4 BPIFB4 CNBD2 CPNE1 DEFB116 DUSP15 EDEM2 EPPIN FAM209A FAM209B FAM83C FOXS1 GDF5 GGT7 GHRH HCK MAP1LC3A MYH7B MYLK2 NOL4L OCSTAMP RBPJL SLC12A5 SLC13A3 TLDC2 TM9SF4 WFDC11 WFDC6 WFDC8 WFDC9 WISP2 XKR7,regulation of multicellular organism growth|positive regulation of protein exit from endoplasmic reticulum|negative regulation of endopeptidase activity|negative regulation of peptidase activity|response to bacterium,0.0001442|0.0002589|0.0005048|0.0005853|0.0006365,1|1|1|1|1,30.66|94.91|10.85|10.42|5.552
2744,11,0.4075,22.41,8851.0,0.002519,0.999969,DUOXA1 HRASLS HTR3D LRRIQ4 MUC4 RTP1 SERPINI1 SLC51A SLC7A14 TCTEX1D2 TM4SF19,regulation of intraciliary retrograde transport|ion transport|positive regulation of hydrogen peroxide biosynthetic process|organic substance transport|regulation of thyroid hormone generation,0.001601|0.001844|0.003199|0.003488|0.003731,1|1|1|1|1,936.1|3.899|374.5|4.314|312
2745,6,0.4035,6.053,4848.0,0.0012439999999999999,0.998474,ALDOB FAM135B PRSS55 SLC8A1 TPP1 TRPA1,calcium ion transmembrane import into cytosol|calcium ion transport into cytosol|cytosolic calcium ion transport|cellular monovalent inorganic cation homeostasis|regulation of sequestering of calcium ion,0.0002101|0.0002714|0.0004082|0.0006704|0.0007047,1|1|1|1|1,91.94|80.61|65.38|50.73|49.45
2746,7,0.4099,8.609,5918.0,0.001449,0.9992989999999999,BLVRA ENTPD1 GOLGA3 HYAL4 IRF5 SLC9A5 TFPI,"negative regulation of blood coagulation, extrinsic pathway|regulation of blood coagulation, extrinsic pathway|blood coagulation, extrinsic pathway|negative regulation of protein activation cascade|regulation of protein activation cascade",0.001698|0.001698|0.001698|0.003732|0.004071,1|1|1|1|1,735.5|735.5|735.5|294.2|267.5
2747,6,0.4243,6.364,4856.0,0.001306,0.998474,CCDC140 CYTH3 PLCE1 SCN1A SLC9A9 VWA3B,sodium ion transmembrane transport|sodium ion transport|regulation of Ras protein signal transduction|diacylglycerol biosynthetic process|regulation of small GTPase mediated signal transduction,0.0005137|0.001064|0.001371|0.002619|0.003656,1|1|1|1|1,57.21|39.45|34.67|429.1|20.99
2748,12,0.4074,26.89,9520.0,0.002809,0.999986,FABP1 LRRTM4 REG3G RETSAT RNF103 SFTPB SIX3 SLC9B1 TEX37 THNSL2 TRABD2A WBP1,neuroblast migration|2-oxobutyrate biosynthetic process|positive regulation of protein oxidation|regulation of protein oxidation|optic vesicle morphogenesis,0.001164|0.001164|0.001746|0.001746|0.001746,1|1|1|1|1,1716|1716|858.1|858.1|858.1
2749,6,0.4472,6.707999999999999,4982.0,0.001341,0.998474,FLVCR2 GAS6 KCNIP1 SLC36A4 SLCO3A1 ZNF782,transmembrane transport|cation transport|ion transport|cation transmembrane transport|negative regulation of renal albumin absorption,5.584e-06|3.677e-05|0.0002851|0.0005564|0.0005824,0.08808|0.29|1|1|1,13.28|16.62|5.957|16.17|3432
2750,5,0.4503,4.503,3928.0,0.001142,0.996692,ARHGAP44 COQ10A ILDR1 SLIT1 TMEM200A,"modification of dendritic spine|dorsal/ventral axon guidance|regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane|negative regulation of Rac protein signal transduction|regulation of synapse organization",0.000728|0.0009706|0.0009706|0.0009706|0.001014,1|1|1|1|1,2060|1373|1373|1373|39.61
2751,8,0.4237,11.86,5147.0,0.002293,0.9996790000000001,BRAP MDM2 PLAA SLTM TP53 UBB UBC USP14,protein deubiquitination|protein modification by small protein removal|regulation of intrinsic apoptotic signaling pathway by p53 class mediator|cellular response to hypoxia|cellular response to decreased oxygen levels,5.684e-08|7.604e-08|2.575e-07|9.254e-07|1.109e-06,0.0008967|0.0005997|0.001354|0.003649|0.003499,41.16|38.79|245.2|48.18|46
2752,5,0.4156,4.156000000000001,3965.0,0.001044,0.996692,ABCA10 GCM1 SIRPG SLX4IP TJAP1,astrocyte fate commitment|regulation of cell differentiation involved in embryonic placenta development|branching involved in labyrinthine layer morphogenesis|glial cell fate commitment|labyrinthine layer morphogenesis,0.001213|0.001213|0.003152|0.003394|0.005087,1|1|1|1|1,1030|1030|343.3|316.8|205.9
2753,5,0.4273,4.273,3955.0,0.001077,0.996692,ETFBKMT ISL2 SLCO1B3 SMCO2 TMEM159,negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase|regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase|negative regulation of electron transfer activity|visceral motor neuron differentiation|negative regulation of fatty acid beta-oxidation,0.0004854|0.0004854|0.0004854|0.0009706|0.001698,1|1|1|1|1,4119|4119|4119|1373|686.5
2754,7,0.4198,8.815,4739.0,0.0018510000000000002,0.9992989999999999,CASC3 CNBP SMG5 SMG6 SMG7 SMG8 SMG9,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay|nuclear-transcribed mRNA catabolic process|mRNA catabolic process|RNA catabolic process|nucleobase-containing compound catabolic process",3.232e-13|5.727e-12|1.015e-11|2.187e-11|2.652e-10,5.099e-09|4.517e-08|5.338e-08|8.624e-08|8.365e-07,147.1|90.07|81.73|71.76|47.07
2755,6,0.4154,6.231,4766.0,0.001302,0.998474,ELOVL2 GKAP1 SMIM15 SNURF TMEM109 USP40,"fatty acid elongation, unsaturated fatty acid|fatty acid elongation, saturated fatty acid|fatty acid elongation, polyunsaturated fatty acid|fatty acid elongation, monounsaturated fatty acid|alpha-linolenic acid metabolic process",4.743e-06|4.743e-06|4.743e-06|4.743e-06|1.382e-05,0.07482|0.03741|0.02494|0.0187|0.04359,735.5|735.5|735.5|735.5|396.1
2756,5,0.4539,4.539,4024.0,0.001124,0.996692,ACTL9 ALKAL2 CD302 SMIM24 SOCS2,positive regulation of ERK5 cascade|regulation of ERK5 cascade|negative regulation of multicellular organism growth|interleukin-7-mediated signaling pathway|growth hormone receptor signaling pathway,0.000728|0.000728|0.00291|0.004845|0.005087,1|1|1|1|1,2060|2060|374.5|216.8|205.9
2757,5,0.4218,4.218,3948.0,0.001065,0.996692,ANXA5 LRRC25 SMIM4 THEGL VIM,Bergmann glial cell differentiation|cellular response to muramyl dipeptide|lens fiber cell development|response to muramyl dipeptide|intermediate filament organization,0.002183|0.002425|0.003394|0.005087|0.006054,1|1|1|1|1,514.9|457.7|316.8|205.9|171.6
2758,7,0.4272,8.971,5959.0,0.0015,0.9992989999999999,CNTFR HHIPL1 MAST4 PALM PLPP6 RGCC SMIM5,negative regulation of exit from mitosis|negative regulation of fibroblast growth factor production|negative regulation of dopamine receptor signaling pathway|positive regulation of extracellular matrix constituent secretion|ciliary neurotrophic factor-mediated signaling pathway,0.0006794|0.001019|0.001358|0.001358|0.002037,1|1|1|1|1,2942|1471|980.7|980.7|588.4
2759,5,0.4091,4.091,3901.0,0.001045,0.996692,AKAP12 GFOD1 LRRN4CL SMIM8 UST,positive regulation of hepatic stellate cell migration|positive regulation of oligodendrocyte apoptotic process|hepatic stellate cell activation|regulation of hepatic stellate cell migration|regulation of oligodendrocyte apoptotic process,0.0004854|0.0004854|0.000728|0.000728|0.000728,1|1|1|1|1,4119|4119|2060|2060|2060
2760,6,0.4512,6.768,4521.0,0.001491,0.998474,MAT2A MERTK OSBPL5 PCTP SRRD TOM1L1,phospholipid transport|organophosphate ester transport|regulation of tetrapyrrole biosynthetic process|regulation of heme biosynthetic process|S-adenosylmethionine biosynthetic process,0.0003119|0.0006192|0.001165|0.001165|0.001456,1|1|1|1|1,73.82|52.01|1144|1144|858.1
2761,5,0.4275,4.275,4004.0,0.001064,0.996692,DOPEY2 GPR171 HEPACAM IFT80 SNAP91,articular cartilage development|osteoblast proliferation|receptor localization to non-motile cilium|negative regulation of non-canonical Wnt signaling pathway|bone mineralization involved in bone maturation,0.0007766|0.001165|0.001165|0.001359|0.001553,1|1|1|1|1,1716|1030|1030|858.1|735.5
2762,14,0.4013,36.52,9280.0,0.003908,0.9999969999999999,EIF2S1 LRR1 POLE2 PSMA3 PSMA6 PSMC6 RBM25 RPS29 SNAPC1 SNAPC2 SNAPC3 SNAPC5 SNRPA1 SNRPB2,transcription by RNA polymerase III|cellular macromolecule biosynthetic process|macromolecule biosynthetic process|snRNA transcription by RNA polymerase III|macromolecule metabolic process,7.75e-09|8.542e-09|1.082e-08|4.104e-08|5.001e-08,0.0001222|6.737e-05|5.688e-05|0.0001619|0.0001578,183.9|8.889|8.674|551.7|3.326
2763,5,0.4385,4.385,3781.0,0.001155,0.996692,CRACR2A METTL16 MPHOSPH10 NSA2 SNRNP27,RNA processing|rRNA processing|rRNA metabolic process|ribosome biogenesis|ncRNA processing,1.965e-05|2.019e-05|2.257e-05|4.16e-05|9.061e-05,0.3099|0.1592|0.1187|0.1641|0.2858,17.85|47.53|45.77|37.22|28.6
2764,5,0.429,4.29,3871.0,0.001104,0.996692,AMOTL1 APAF1 CHST4 PRSS23 SNTB2,response to G1 DNA damage checkpoint signaling|response to mitotic cell cycle checkpoint signaling|establishment of cell polarity involved in ameboidal cell migration|cardiac muscle cell apoptotic process|striated muscle cell apoptotic process,0.0004854|0.0004854|0.0009706|0.001456|0.001456,1|1|1|1|1,4119|4119|1373|823.8|823.8
2765,5,0.4356,4.356,4041.0,0.001074,0.996692,NDNF RSPRY1 SNTG2 TEX15 TMEM174,hypothalamic tangential migration using cell-axon interactions|gonadotrophin-releasing hormone neuronal migration to the hypothalamus|hypothalamus gonadotrophin-releasing hormone neuron development|hypothalamus gonadotrophin-releasing hormone neuron differentiation|hypothalamus cell migration,0.0009706|0.0009706|0.001213|0.001213|0.001213,1|1|1|1|1,1373|1373|1030|1030|1030
2766,6,0.4,6.0,4757.0,0.001257,0.998474,CCDC110 CFAP57 MC1R OARD1 SNX19 VPS9D1,peptidyl-glutamate ADP-deribosylation|dense core granule maturation|secretory granule maturation|protein de-ADP-ribosylation|positive regulation of protein kinase C signaling,0.001165|0.001165|0.001456|0.002037|0.0032,1|1|1|1|1,1144|1144|858.1|572.1|343.2
2767,5,0.4486,4.486000000000001,4115.0,0.001086,0.996692,CNTNAP1 OR5AN1 RINL SNX2 UTP11,protein localization to paranode region of axon|protein localization to juxtaparanode region of axon|lamellipodium morphogenesis|neuronal action potential propagation|action potential propagation,0.0009706|0.001213|0.001456|0.001698|0.001698,1|1|1|1|1,1373|1030|823.8|686.5|686.5
2768,4,0.4575,2.745,3034.0,0.0009016,0.9929309999999999,IGFBP4 MS4A6E PANX2 SNX8,type B pancreatic cell proliferation|early endosome to Golgi transport|positive regulation of insulin-like growth factor receptor signaling pathway|regulation of insulin-like growth factor receptor signaling pathway|response to ischemia,0.001941|0.001941|0.002716|0.004459|0.01064,1|1|1|1|1,572.1|572.1|396.1|234|95.35
2769,20,0.4109,78.08,13530.0,0.005719,1.0,AK6 C18orf21 C1D C1orf109 DHX33 METAP1 MYBBP1A NEPRO NOL6 POP1 POP4 POP5 POP7 RPP14 RPP21 RPP30 RPP38 RPP40 RRP12 WDR18,tRNA 5'-leader removal|tRNA 5'-end processing|ncRNA 5'-end processing|RNA 5'-end processing|ncRNA processing,7.847e-23|3.218e-22|2.247e-21|4.402e-21|3.229e-17,1.238e-18|2.538e-18|1.182e-17|1.736e-17|1.019e-13,679|551.7|420.3|383.8|29.51
2770,5,0.4543,4.543,4010.0,0.001129,0.996692,C12orf54 FAM3B SEC11C SOHLH1 TNNT3,positive regulation of calcium-dependent ATPase activity|regulation of calcium-dependent ATPase activity|signal peptide processing|skeletal muscle contraction|sarcomere organization,0.0004854|0.000728|0.003152|0.007985|0.008226,1|1|1|1|1,4119|2060|343.3|128.7|124.8
2771,6,0.4185,6.278,4992.0,0.001253,0.998474,AKAP12 MCUR1 RAET1E SORBS1 ST6GAL2 ZDHHC14,positive regulation of hepatic stellate cell migration|positive regulation of oligodendrocyte apoptotic process|hepatic stellate cell activation|regulation of hepatic stellate cell migration|regulation of oligodendrocyte apoptotic process,0.0005824|0.0005824|0.0008735|0.0008735|0.0008735,1|1|1|1|1,3432|3432|1716|1716|1716
2772,6,0.4346,6.519,5041.0,0.001288,0.998474,ANHX CD28 NGFR RAB27B SLC6A4 SORBS2,"animal organ development|positive regulation of serotonin secretion|negative regulation of synaptic transmission, dopaminergic|regulation of thalamus size|circadian rhythm",0.0004655|0.0005824|0.0005824|0.0005824|0.000695,1|1|1|1|1,5.385|3432|3432|3432|49.04
2773,7,0.4028,8.458,5905.0,0.0014269999999999999,0.9992989999999999,BACH2 GOPC NQO2 RFNG SEPT9 SORL1 ZNF326,maintenance of protein location|positive regulation of choline O-acetyltransferase activity|regulation of choline O-acetyltransferase activity|primary adaptive immune response involving T cells and B cells|primary adaptive immune response,0.0004726|0.0006794|0.0006794|0.0006794|0.0006794,1|1|1|1|1,60.66|2942|2942|2942|2942
2774,5,0.4356,4.356,4019.0,0.00108,0.996692,IL10RA IZUMO4 JAGN1 SOX13 TRIM42,cellular response to tunicamycin|response to tunicamycin|granulocyte colony-stimulating factor signaling pathway|ubiquitin-dependent endocytosis|spinal cord oligodendrocyte cell differentiation,0.0004854|0.0004854|0.000728|0.0009706|0.001456,1|1|1|1|1,4119|4119|2060|1373|823.8
2775,5,0.4498,4.498,4069.0,0.001102,0.996692,C2CD4D PLPP7 SOX14 SPP2 SYDE1,positive regulation of trophoblast cell migration|dephosphorylation|regulation of type B pancreatic cell proliferation|regulation of trophoblast cell migration|negative regulation of myotube differentiation,0.002328|0.003505|0.003781|0.004071|0.004361,1|1|1|1|1,490.4|21.45|286|264|245.2
2776,5,0.4281,4.281000000000001,3330.0,0.00128,0.996692,C15orf41 DNAJC9 SOX2 SOX21 TIMELESS,cellular response to bleomycin|response to bleomycin|replication fork arrest|endodermal cell fate specification|cellular response to cisplatin,0.000728|0.000728|0.001213|0.001456|0.001698,1|1|1|1|1,2060|2060|1030|823.8|686.5
2777,7,0.4006,8.413,5414.0,0.0015480000000000001,0.9992989999999999,DPP3 PNLIPRP3 PREP SP7 UBE3A XPNPEP1 ZER1,proteolysis|positive regulation of Golgi lumen acidification|sperm entry|regulation of Golgi lumen acidification|protein metabolic process,1.53e-06|0.0007765|0.0007765|0.001164|0.001411,0.02413|1|1|1|1,11.98|2574|2574|1287|3.662
2778,5,0.4146,4.146,3795.0,0.001088,0.996692,IL15 NBEAL2 NKIRAS2 RALGAPB SP9,extrathymic T cell selection|extrathymic T cell differentiation|NK T cell proliferation|NK T cell activation|alpha-beta T cell proliferation,0.0004854|0.0004854|0.000728|0.000728|0.0009706,1|1|1|1|1,4119|4119|2060|2060|1373
2779,5,0.4196,4.196000000000001,3731.0,0.00112,0.996692,CDCA4 CLEC1A FAM122A HIST4H4 SPACA1,"chromatin organization involved in regulation of transcription|regulation of gene expression, epigenetic|negative regulation of megakaryocyte differentiation|DNA replication-dependent nucleosome assembly|DNA replication-dependent nucleosome organization",0.0001913|0.0006897|0.001456|0.002667|0.002667,1|1|1|1|1,92.56|48.18|823.8|411.9|411.9
2780,5,0.4236,4.236000000000001,3954.0,0.001068,0.996692,CCR1 SLC23A1 SPACA3 THUMPD3 UBXN2A,transepithelial L-ascorbic acid transport|L-ascorbic acid transmembrane transport|L-ascorbic acid metabolic process|vitamin transmembrane transport|transepithelial transport,4.24e-07|4.24e-07|5.506e-06|1.206e-05|2.663e-05,0.006689|0.003344|0.02895|0.04757|0.08402,3432|3432|624.1|403.8|264
2781,9,0.4116,14.82,7182.0,0.002054,0.9998530000000001,ATP5MC1 BIVM CLYBL CNMD COL4A1 F10 F7 SPACA7 ZIC5,"negative regulation of blood coagulation, extrinsic pathway|regulation of blood coagulation, extrinsic pathway|blood coagulation, extrinsic pathway|negative regulation of protein activation cascade|regulation of protein activation cascade",3.177e-06|3.177e-06|3.177e-06|1.396e-05|1.649e-05,0.05011|0.02505|0.0167|0.05503|0.05202,1030|1030|1030|411.9|374.5
2782,5,0.4029,4.029,3813.0,0.001053,0.996692,JAG1 JAG2 MINDY3 NRARP SPARCL1,regulation of Notch signaling pathway|Notch signaling pathway|inner ear auditory receptor cell differentiation|hair cell differentiation|positive regulation of Notch signaling pathway,1.43e-06|1.96e-06|2.331e-05|4.042e-05|7.482e-05,0.02256|0.01546|0.1226|0.1594|0.236,116.6|104.7|274.6|205.9|149.8
2783,4,0.4738,2.843,3109.0,0.0009112,0.9929309999999999,PPM1L PTK2B SPATA19 ZNF267,positive regulation of B cell chemotaxis|regulation of B cell chemotaxis|regulation of inositol trisphosphate biosynthetic process|activation of Janus kinase activity|endothelin receptor signaling pathway,0.0005825|0.0005825|0.001359|0.001359|0.001553,1|1|1|1|1,2574|2574|858.1|858.1|735.5
2784,5,0.4413,4.413,3947.0,0.001114,0.996692,ABCD3 CRYBB2 CTBS DENND4B SPATA20,long-chain fatty acid import into peroxisome|chitin catabolic process|chitin metabolic process|very long-chain fatty acid catabolic process|regulation of Rab protein signal transduction,0.001213|0.001698|0.001698|0.001698|0.00194,1|1|1|1|1,1030|686.5|686.5|686.5|588.4
2785,23,0.4008,101.4,17220.0,0.0058390000000000004,1.0,APTX AQP7 CBWD1 CBWD2 CBWD5 CNN2 CNTNAP3 CNTNAP3B CREB3 FOXD4L4 FOXD4L5 GALT IL11RA OR13J1 OR2S2 PGM5 SPAG8 SPATA31A3 SPATA31A6 SPATA31A7 TESK1 TOMM5 ZNF658,spermatogenesis|male gamete generation|gamete generation|multicellular organismal reproductive process|multicellular organism reproduction,0.0003073|0.000359|0.0008937|0.001889|0.002087,1|1|1|1|1,8.17|7.896|6.451|5.447|5.324
2786,6,0.4292,6.438,4784.0,0.001341,0.998474,CHAC2 FKBP14 FOXN3 GDPD1 OARD1 SPATA33,peptidyl-glutamate ADP-deribosylation|N-acylethanolamine metabolic process|protein de-ADP-ribosylation|ethanolamine-containing compound metabolic process|glutathione catabolic process,0.001165|0.001746|0.002037|0.002909|0.00349,1|1|1|1|1,1144|686.5|572.1|381.4|312
2787,16,0.4031,48.37,10740.0,0.004471,0.999999,APH1A CD109 CNEP1R1 CTDNEP1 IPO8 LEMD3 MIB1 NCSTN PSEN1 PSENEN RNF111 SMURF1 SPCS1 TGFBR1 TGFBR2 TGFBR3,"regulation of transforming growth factor beta receptor signaling pathway|regulation of cellular response to transforming growth factor beta stimulus|negative regulation of transforming growth factor beta receptor signaling pathway|Notch receptor processing, ligand-dependent|amyloid-beta formation",3.296e-12|3.887e-12|3.942e-11|7.964e-11|2.412e-10,5.2e-08|3.066e-08|2.073e-07|3.14e-07|7.61e-07,74.47|72.66|94.18|735.5|514.9
2788,5,0.4394,4.394,4064.0,0.001077,0.996692,FKBP15 LY75 SPDYC TCIM VAX2,endothelial cell activation involved in immune response|positive regulation of protein kinase C activity|regulation of protein kinase C activity|dorsal/ventral axis specification|endothelial cell activation,0.0004854|0.00194|0.00194|0.00291|0.00291,1|1|1|1|1,4119|588.4|588.4|374.5|374.5
2789,28,0.4036,152.5,22490.0,0.0067209999999999995,1.0,BCAS4 CASS4 CNBD2 CPNE1 DUSP15 EPPIN FAM209A FAM209B FAM83C GGT7 GHRH HCK LBP MAP1LC3A MTRNR2L3 MYH7B MYLK2 R3HDML RBM38 RBPJL RIPOR3 SLC12A5 TFAP2C TM9SF4 WFDC11 WFDC6 WISP2 ZGPAT,"lipopolysaccharide-mediated signaling pathway|response to bacterium|positive regulation of circadian sleep/wake cycle, REM sleep|thermosensory behavior|positive regulation of cytolysis",0.001012|0.00222|0.002617|0.002617|0.002617,1|1|1|1|1,44.87|5.312|762.8|762.8|762.8
2790,10,0.4192,18.86,8001.0,0.002346,0.999933,BIVM CLYBL CNMD COL4A1 F10 F7 SLITRK5 SPERT ZIC2 ZIC5,"negative regulation of blood coagulation, extrinsic pathway|regulation of blood coagulation, extrinsic pathway|blood coagulation, extrinsic pathway|negative regulation of protein activation cascade|regulation of protein activation cascade",3.882e-06|3.882e-06|3.882e-06|1.705e-05|2.014e-05,0.06123|0.03061|0.02041|0.06723|0.06355,936.1|936.1|936.1|374.5|340.4
2791,6,0.4354,6.531000000000001,4898.0,0.001328,0.998474,LY6E NT5C1A RNASE12 SPG11 ST8SIA2 TMEM50A,phagosome-lysosome fusion involved in apoptotic cell clearance|phagolysosome assembly involved in apoptotic cell clearance|phagosome maturation involved in apoptotic cell clearance|purine nucleoside monophosphate catabolic process|adenosine metabolic process,0.0005824|0.0008735|0.0008735|0.002328|0.002909,1|1|1|1|1,3432|1716|1716|490.4|381.4
2792,26,0.3894,126.6,21710.0,0.0057810000000000005,1.0,C8orf44 C8orf76 CA1 CA13 CA2 CA3 CA8 CEBPD CNGB3 CPA6 CYP7A1 EFCAB1 FABP12 GGH MCMDC2 MOS NPBWR1 NSMAF PKIA PMP2 PPDPFL SGK3 SPIDR TMEM69 TRIM55 UBE2W,one-carbon metabolic process|bicarbonate transport|organic anion transport|response to alcohol|response to ethanol,2.726e-09|3.662e-07|7.592e-05|0.0002971|0.0008283,4.3e-05|0.002888|0.3992|1|1,97.79|72.65|11.22|12.4|16.46
2793,6,0.4006,6.007999999999999,4888.0,0.001225,0.998474,CFH MUTYH NPR3 SPINK2 TCTEX1D4 ZYG11A,osteoclast proliferation|negative regulation of serine-type peptidase activity|negative regulation of serine-type endopeptidase activity|pancreatic juice secretion|regulation of complement-dependent cytotoxicity,0.001456|0.002328|0.002328|0.002328|0.002619,1|1|1|1|1,858.1|490.4|490.4|490.4|429.1
2794,6,0.4373,6.559,4876.0,0.00134,0.998474,CXCL11 IL36RN NANP SPINK9 UBOX5 UGT1A8,N-acetylneuraminate biosynthetic process|antimicrobial humoral response|N-acetylglucosamine biosynthetic process|glucosamine-containing compound biosynthetic process|cellular response to lipopolysaccharide,0.0005824|0.0008592|0.0008735|0.0008735|0.00115,1|1|1|1|1,3432|44.01|1716|1716|37.93
2795,5,0.4082,4.082,4060.0,0.0010019999999999999,0.996692,ARFIP1 DACT1 MDFIC PTPRD SPOCK1,"negative regulation of intracellular transport|negative regulation of retrograde transport, endosome to Golgi|embryonic hindgut morphogenesis|negative regulation of beta-catenin-TCF complex assembly|regulation of beta-catenin-TCF complex assembly",7.482e-05|0.0004854|0.000728|0.000728|0.000728,1|1|1|1|1,149.8|4119|2060|2060|2060
2796,5,0.4492,4.492,4011.0,0.001116,0.996692,ACOT7 FGF14 LMX1A RELN SPOP,positive regulation of cation channel activity|hippocampus development|limbic system development|positive regulation of ion transmembrane transporter activity|memory,0.0001334|0.0001478|0.0002548|0.0002745|0.0003163,1|1|1|1|0.9978,111.3|105.6|79.98|76.99|71.63
2797,7,0.4235,8.892999999999999,5796.0,0.0015279999999999998,0.9992989999999999,CTRL FAM69C PLA2G12A SFI1 SPRY1 TNK2 ZNF70,negative regulation of GTPase activity|negative regulation of hydrolase activity|epithelial to mesenchymal transition involved in cardiac fibroblast development|epicardium-derived cardiac fibroblast cell development|epicardium-derived cardiac fibroblast cell differentiation,0.0001108|0.0003574|0.001019|0.001358|0.001358,1|1|1|1|1,127.9|19.4|1471|980.7|980.7
2798,7,0.4009,8.418,6110.0,0.001373,0.9992989999999999,IFNLR1 IRF7 ITPRIPL1 PTPN22 RSBN1 SPTB ZNF707,positive regulation of interferon-alpha production|regulation of interferon-alpha production|positive regulation of interferon-beta production|regulation of defense response to virus by host|regulation of interferon-beta production,3.204e-05|4.885e-05|6.553e-05|0.0001017|0.0001352,0.5053|0.3852|0.3446|0.401|0.4267,245.2|196.1|168.1|133.7|115.4
2799,11,0.4075,22.41,8521.0,0.002617,0.999969,CLEC4D KCNA5 KCNA6 KRTAP9-1 NLRP8 PKP2 PRB1 PRB2 PRB4 SPX TAS2R19,regulation of heart rate|bundle of His cell to Purkinje myocyte communication|regulation of G1/S transition of mitotic cell cycle|cell-cell signaling involved in cardiac conduction|regulation of cell cycle G1/S phase transition,3.061e-05|3.839e-05|0.0001129|0.0001376|0.0001617,0.4828|0.3028|0.5938|0.5425|0.5102,49|243.7|31.27|121.9|27.63
2800,5,0.4315,4.315,3779.0,0.0011380000000000001,0.996692,OR10R2 S100A14 S100A16 SRD5A3 STMN3,dolichol biosynthetic process|polyprenol catabolic process|polyprenol biosynthetic process|negative regulation of Rac protein signal transduction|dolichol metabolic process,0.000728|0.0009706|0.0009706|0.0009706|0.001456,1|1|1|1|1,2060|1373|1373|1373|823.8
2801,6,0.4118,6.178,4987.0,0.001234,0.998474,AKNAD1 COX8C CREBRF FZD2 KCNN2 SREK1IP1,muscular septum morphogenesis|atrial cardiac muscle cell membrane repolarization|membrane repolarization during atrial cardiac muscle cell action potential|hard palate development|membranous septum morphogenesis,0.001165|0.001746|0.001746|0.002328|0.002328,1|1|1|1|1,1144|686.5|686.5|490.4|490.4
2802,5,0.4296,4.296,3879.0,0.001103,0.996692,CCDC190 IP6K3 SLC18A1 SRL ZNF699,aminergic neurotransmitter loading into synaptic vesicle|serotonin uptake|neurotransmitter loading into synaptic vesicle|amine transport|serotonin transport,0.001213|0.00194|0.002183|0.002183|0.002425,1|1|1|1|1,1030|588.4|514.9|514.9|457.7
2803,18,0.4017,61.46,12900.0,0.004727,1.0,CAMLG DCTN4 DDX41 DDX46 GEMIN5 IK LARS NHP2 PHAX RACK1 RBM22 RPS14 SLU7 SRFBP1 SRP19 THOC3 TTC1 ZMAT2,RNA metabolic process|RNA processing|gene expression|RNA splicing|nucleic acid metabolic process,2.307e-11|3.708e-11|4.836e-11|9.259e-10|1.484e-09,3.639e-07|2.924e-07|2.543e-07|3.651e-06|4.681e-06,9.302|13.64|7.328|22.49|6.664
2804,9,0.4292,15.45,6590.0,0.002333,0.9998530000000001,C1orf109 CENPE EXOC1 EXOSC9 GAR1 SPATA5 SRP72 TRIP13 YTHDC1,cellular component biogenesis|regulation of mitotic metaphase/anaphase transition|regulation of metaphase/anaphase transition of cell cycle|regulation of mitotic sister chromatid separation|regulation of sister chromatid segregation,0.000301|0.0003164|0.0003478|0.0003695|0.0004507,1|1|1|1|1,5.083|76.28|72.65|70.41|63.56
2805,7,0.4114,8.639,5808.0,0.001482,0.9992989999999999,C6orf203 CRYBA2 HOXD12 MAP2K6 RRM2B SSBP2 TMC7,cellular response to sorbitol|regulation of mitochondrial transcription|regulation of signal transduction by p53 class mediator|response to sorbitol|DNA damage induced protein phosphorylation,0.001358|0.001698|0.00187|0.002037|0.003054,1|1|1|1|1,980.7|735.5|30.02|588.4|367.8
2806,28,0.4002,151.3,22190.0,0.006756,1.0,ADA BPIFB4 CCM2L COX4I2 CPNE1 DEFB115 DEFB116 DEFB118 DEFB121 DUSP15 FAM83C FOXS1 GGT7 GHRH HCK HM13 KIF3B MAP1LC3A MYH7B MYLK2 NECAB3 NOL4L REM1 SOGA1 TM9SF4 WFDC11 WISP2 XKR7,"response to bacterium|defense response to bacterium|regulation of circadian sleep/wake cycle, sleep|regulation of circadian sleep/wake cycle|innate immune response",4.001e-05|9.752e-05|0.0002997|0.0004419|0.0008125,0.6312|0.7692|1|1|1,7.171|10.66|86.53|70.05|5.254
2807,8,0.4164,11.66,5817.0,0.001994,0.9996790000000001,ARHGAP45 ATP8B2 CLDN1 FGFR3 JAK3 MCEMP1 PRDM1 REEP4,regulation of alpha-beta T cell differentiation|immune response|regulation of alpha-beta T cell activation|negative regulation of FasL production|regulation of FasL production,0.0003806|0.0007325|0.0008708|0.0008734|0.0008734,1|1|1|1|1,69.34|5.802|45.31|2288|2288
2808,4,0.4578,2.747,3160.0,0.0008662000000000001,0.9929309999999999,B4GALT2 DNAJC4 HMCN1 SSUH2,cerebellar Purkinje cell layer development|keratan sulfate biosynthetic process|keratan sulfate metabolic process|visual learning|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,0.005426|0.00562|0.006586|0.00871|0.009482,1|1|1|1|1,190.7|183.9|156|117|107.3
2809,5,0.4367,4.367,3947.0,0.001102,0.996692,LUZP6 ST6GAL1 TIRAP TMEM71 ZDHHC23,positive regulation of interleukin-15 production|regulation of interleukin-15 production|TIRAP-dependent toll-like receptor 4 signaling pathway|TIRAP-dependent toll-like receptor signaling pathway|positive regulation of chemokine (C-X-C motif) ligand 1 production,0.0004854|0.0004854|0.0004854|0.0004854|0.001213,1|1|1|1|1,4119|4119|4119|4119|1030
2810,5,0.4388,4.388,3954.0,0.001106,0.996692,AAED1 BICD2 GALNT4 RAB11FIP2 ST6GALNAC1,TRAM-dependent toll-like receptor 4 signaling pathway|TRAM-dependent toll-like receptor signaling pathway|protein glycosylation|macromolecule glycosylation|glycosylation,0.0007766|0.0007766|0.0008254|0.0008254|0.0009151,1|1|1|1|1,1716|1716|42.55|42.55|40.38
2811,7,0.402,8.442,5731.0,0.001467,0.9992989999999999,ACYP1 ARHGAP31 BIN1 DDX58 MAP1B PHETA1 ST6GALNAC2,induction of synaptic plasticity by chemical substance|positive regulation of synaptic plasticity by chemical substance|regulation of synaptic plasticity by chemical substance|negative regulation of cardiac muscle cell contraction|negative regulation of ventricular cardiac muscle cell action potential,0.0006794|0.0006794|0.0006794|0.0006794|0.0006794,1|1|1|1|1,2942|2942|2942|2942|2942
2812,6,0.4054,6.08,4690.0,0.001291,0.998474,MIGA2 MRI1 OR1J1 OR1J4 ST6GALNAC4 XRRA1,L-methionine salvage from S-adenosylmethionine|L-methionine salvage from methylthioadenosine|S-adenosylmethionine cycle|L-methionine salvage|L-methionine biosynthetic process,0.001165|0.001746|0.002328|0.002328|0.002328,1|1|1|1|1,1144|686.5|490.4|490.4|490.4
2813,6,0.4438,6.656000000000001,4917.0,0.001349,0.998474,C10orf105 DHRS9 MFAP3 PAIP2B ST8SIA5 TNNC1,skeletal muscle contraction|actin-myosin filament sliding|muscle filament sliding|musculoskeletal movement|multicellular organismal movement,5.523e-05|7.671e-05|7.671e-05|0.0001017|0.0001017,0.8712|0.605|0.4034|0.401|0.3208,183.9|154.8|154.8|133.7|133.7
2814,6,0.4031,6.046,4775.0,0.001261,0.998474,ACBD4 ADAM23 ATP7B MPLKIP STAB2 TMTC1,copper ion export|sequestering of calcium ion|copper ion transmembrane transport|copper ion import|regulation of biological process,0.001358|0.002037|0.002376|0.002376|0.002481,1|1|1|1|1,980.7|588.4|490.4|490.4|0
2815,5,0.4335,4.335,3871.0,0.001116,0.996692,AGBL2 CD320 CDK5R1 STAC TPRG1L,positive regulation of protein localization to membrane|superior olivary nucleus maturation|superior olivary nucleus development|pons maturation|regulation of protein localization to membrane,0.0004024|0.000728|0.000728|0.000728|0.0009292,1|1|1|1|1,63.37|2060|2060|2060|41.4
2816,6,0.4224,6.336,4736.0,0.001333,0.998474,CARF CSF3R FAT1 POM121L12 SLC39A5 STAMBPL1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion|positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus|cellular response to calcium ion|establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis|response to zinc ion starvation,5.936e-07|2.958e-05|0.0003651|0.0006794|0.001019,0.009363|0.2333|1|1|1,2942|255.8|69.23|2942|1471
2817,28,0.402,152.0,21900.0,0.006875,1.0,ADAL APBA2 ARHGAP11B BNIP2 C15orf53 CHRFAM7A CHRNA7 DEXI DUOXA1 DUOXA2 EPB42 GABRA5 GANC GOLGA8M MYO5A MYO5C NIPA2 PIGH PLA2G4D PLA2G4E PLEKHO2 PPIB SERINC4 SNURF TGM5 TGM7 TMCO5A WDR76,"synaptic transmission, cholinergic|regulation of postsynaptic membrane potential|positive regulation of hydrogen peroxide biosynthetic process|regulation of thyroid hormone generation|positive regulation of hydrogen peroxide metabolic process",8.912e-06|1.315e-05|3.992e-05|5.318e-05|6.831e-05,0.1406|0.1037|0.2099|0.2097|0.2155,81.94|28.41|284.1|236.7|202.9
2818,6,0.4113,6.17,4475.0,0.001373,0.998474,LATS2 MARK2 NCS1 STARD3 VTN WWC2,regulation of organ growth|establishment or maintenance of cell polarity regulating cell shape|vesicle tethering to endoplasmic reticulum|smooth muscle cell-matrix adhesion|peptidyl-serine phosphorylation,0.0002989|0.0008735|0.0008735|0.0008735|0.001162,1|1|1|1|1,75.44|1716|1716|1716|37.72
2819,6,0.4511,6.766,5111.0,0.0013189999999999999,0.998474,AMIGO3 CKAP2 GGA1 KCNG1 STAT4 TMEM128,interleukin-21-mediated signaling pathway|cellular response to interleukin-21|response to interleukin-21|interleukin-23-mediated signaling pathway|protein localization to ciliary membrane,0.002619|0.002619|0.002619|0.002909|0.0032,1|1|1|1|1,429.1|429.1|429.1|381.4|343.2
2820,5,0.4133,4.133,3718.0,0.0011070000000000001,0.996692,HLX NOL6 PSMD5 STAU1 THBD,negative regulation of cell activation|proteasome regulatory particle assembly|negative regulation of T-helper 2 cell differentiation|positive regulation by virus of viral protein levels in host cell|positive regulation of T-helper 1 cell differentiation,0.0009384|0.0009706|0.001213|0.001213|0.001698,1|1|1|1|1,41.19|1373|1030|1030|686.5
2821,7,0.4012,8.425,5686.0,0.0014759999999999999,0.9992989999999999,EXOSC10 FGFBP2 MRFAP1L1 PPP2R2C S100P STIM2 ZFYVE28,antisense RNA transcript catabolic process|nuclear polyadenylation-dependent antisense transcript catabolic process|nuclear polyadenylation-dependent CUT catabolic process|nuclear polyadenylation-dependent snRNA catabolic process|nuclear polyadenylation-dependent snoRNA catabolic process,0.0006794|0.0006794|0.0006794|0.0006794|0.0006794,1|1|1|1|1,2942|2942|2942|2942|2942
2822,6,0.4008,6.011,4942.0,0.001212,0.998474,CCDC157 KCNK18 MAP1B SOCS1 STIMATE TEKT5,"induction of synaptic plasticity by chemical substance|positive regulation of synaptic plasticity by chemical substance|regulation of synaptic plasticity by chemical substance|negative regulation of CD8-positive, alpha-beta T cell differentiation|negative regulation of CD8-positive, alpha-beta T cell activation",0.0005824|0.0005824|0.0005824|0.0008735|0.002037,1|1|1|1|1,3432|3432|3432|1716|572.1
2823,6,0.4019,6.028,4612.0,0.001302,0.998474,ASB3 DCAF15 OCLM SEMG2 SLC2A10 STK11IP,negative regulation of proteoglycan biosynthetic process|negative regulation of connective tissue growth factor production|protein localization to T-tubule|galactose transmembrane transport|positive regulation of serine-type peptidase activity,0.0005824|0.0005824|0.0008735|0.0008735|0.001165,1|1|1|1|1,3432|3432|1716|1716|1144
2824,6,0.4033,6.05,5036.0,0.0011970000000000001,0.998474,CPT1B ELMOD2 PGAP1 SLC29A2 STK32A TPP2,guanine transport|thymine transport|hypoxanthine transport|adenosine transport|purine nucleoside transmembrane transport,0.0005824|0.0005824|0.0005824|0.001165|0.001456,1|1|1|1|1,3432|3432|3432|1144|858.1
2825,5,0.4448,4.448,3891.0,0.001139,0.996692,ARMS2 C1QA CACNG7 MMP3 STOX1,regulation of response to oxidative stress|positive regulation of otic vesicle morphogenesis|regulation of otic vesicle morphogenesis|regulation of mitochondrial DNA metabolic process|vertebrate eye-specific patterning,0.0001709|0.0004854|0.0004854|0.0009706|0.0009706,1|1|1|1|1,98.07|4119|4119|1373|1373
2826,5,0.4204,4.204,4009.0,0.001045,0.996692,DEPP1 FEZ2 OR8H3 STOX2 SYNGR2,synaptic vesicle membrane organization|regulation of autophagy|negative regulation of autophagosome assembly|maternal placenta development|negative regulation of macroautophagy,0.001213|0.002523|0.00412|0.008226|0.008949,1|1|1|1|1,1030|24.89|257.4|124.8|114.4
2827,5,0.4138,4.138,3833.0,0.001076,0.996692,ASB17 ATP6V1E1 LNX1 PTGES STRADB,regulation of fever generation|cyclooxygenase pathway|positive regulation of prostaglandin secretion|regulation of prostaglandin secretion|chronic inflammatory response,0.002425|0.00291|0.00291|0.003394|0.003636,1|1|1|1|1,457.7|374.5|374.5|316.8|294.2
2828,6,0.4166,6.249,5031.0,0.0012380000000000002,0.998474,DNAJC12 G6PC NME4 STX1A STYXL1 TMC6,negative regulation of stress granule assembly|response to resveratrol|positive regulation of norepinephrine secretion|regulation of stress granule assembly|response to stilbenoid,0.0005824|0.0008735|0.001456|0.001746|0.002037,1|1|1|1|1,3432|1716|858.1|686.5|572.1
2829,7,0.4014,8.429,5796.0,0.001449,0.9992989999999999,EFCAB13 MTCL1 RARS RBP3 REG1A RTL10 SULT6B1,cellular response to gastrin|response to gastrin|response to growth hormone-releasing hormone|pancreas regeneration|positive regulation of acinar cell proliferation,0.0006794|0.0006794|0.0006794|0.0006794|0.0006794,1|1|1|1|1,2942|2942|2942|2942|2942
2830,6,0.4115,6.172999999999999,4896.0,0.001256,0.998474,CHN2 CHRNG SFT2D3 SUMO1 ZBTB43 ZNF70,protein localization to nuclear pore|positive regulation of ATPase-coupled calcium transmembrane transporter activity|negative regulation of action potential|PML body organization|protein localization to nuclear envelope,0.001165|0.001746|0.002037|0.002328|0.0032,1|1|1|1|1,1144|686.5|572.1|490.4|343.2
2831,5,0.4407,4.407,3807.0,0.001153,0.996692,DRC1 NXPH1 SLC5A7 SUN1 TRMT1,axonemal dynein complex assembly|tRNA methylation|axoneme assembly|RNA methylation|tRNA modification,6.916e-05|8.877e-05|0.0003088|0.0003736|0.0004082,1|0.7001|1|1|1,163.5|143.5|75.44|68.42|65.38
2832,6,0.4236,6.354,4963.0,0.001275,0.998474,ACVR1C ARL14EPL PROM1 SIGLEC1 SUN3 TEX35,clathrin-dependent endocytosis of virus by host cell|trophectodermal cell proliferation|negative regulation of chorionic trophoblast cell proliferation|positive regulation of nephron tubule epithelial cell differentiation|glomerular parietal epithelial cell differentiation,0.0005824|0.0008735|0.0008735|0.001165|0.001165,1|1|1|1|1,3432|1716|1716|1144|1144
2833,15,0.4072,42.76,9962.0,0.004261,0.999999,ATM CDKN1A CHEK2 DCLRE1B DDX31 HEATR3 MDM2 MDM4 PPM1D PPM1G SURF2 TP53 USP28 WDR89 XPO7,"signal transduction by p53 class mediator|DNA damage response, signal transduction by p53 class mediator|cell cycle checkpoint|signal transduction in response to DNA damage|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",9.671e-15|1.075e-13|3.671e-13|5.915e-13|3.452e-12,1.526e-10|8.479e-10|1.93e-09|2.333e-09|1.089e-08,93.08|121.7|58.12|94.23|142
2834,6,0.4285,6.4270000000000005,4934.0,0.0012980000000000001,0.998474,DACT1 FES PSKH1 RFX2 SUSD3 ZSCAN30,embryonic hindgut morphogenesis|negative regulation of beta-catenin-TCF complex assembly|regulation of beta-catenin-TCF complex assembly|hindgut morphogenesis|hindgut development,0.0008735|0.0008735|0.0008735|0.002037|0.002328,1|1|1|1|1,1716|1716|1716|572.1|490.4
2835,5,0.4094,4.093999999999999,3991.0,0.0010220000000000001,0.996692,NPHS2 NUDT17 RDX SUSD5 ZSCAN4,metanephric glomerular epithelial cell development|metanephric glomerular epithelial cell differentiation|metanephric glomerular visceral epithelial cell development|metanephric glomerular visceral epithelial cell differentiation|metanephric glomerular epithelium development,0.000728|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,2060|2060|2060|2060|2060
2836,5,0.4133,4.133,3876.0,0.001062,0.996692,GPR180 OR8H1 SRARP SV2B SYNDIG1,synaptic vesicle clustering|response to pheromone|positive regulation of intracellular estrogen receptor signaling pathway|positive regulation of intracellular steroid hormone receptor signaling pathway|regulation of intracellular estrogen receptor signaling pathway,0.002425|0.002667|0.003152|0.003636|0.01064,1|1|1|1|1,457.7|411.9|343.3|294.2|95.79
2837,7,0.4325,9.082,5804.0,0.001559,0.9992989999999999,ADPRHL1 CCDC113 GSG1L H1FNT PDE6C SEC16B SVOPL,spermatid nucleus elongation|protein de-ADP-ribosylation|protein localization to endoplasmic reticulum exit site|peroxisome fission|retinal cone cell differentiation,0.001358|0.002376|0.003054|0.003732|0.004071,1|1|1|1|1,980.7|490.4|367.8|294.2|267.5
2838,7,0.405,8.505,5861.0,0.001446,0.9992989999999999,DHX37 KCNIP2 PLB1 PRRT3 PYROXD2 SBNO1 SYCE1L,positive regulation of reproductive process|regulation of reproductive process|clustering of voltage-gated potassium channels|positive regulation of potassium ion export across plasma membrane|regulation of potassium ion export across plasma membrane,0.0003486|0.001304|0.001358|0.001358|0.002715,1|1|1|1|1,70.9|36.1|980.7|980.7|420.3
2839,8,0.4219,11.81,6639.0,0.001772,0.9996790000000001,CYP4V2 FAM19A4 HTR1F LMOD3 NHLRC1 NLRP11 SECTM1 SYCE3,fatty acid omega-oxidation|skeletal muscle thin filament assembly|adenylate cyclase-inhibiting serotonin receptor signaling pathway|pointed-end actin filament capping|skeletal myofibril assembly,0.002037|0.002376|0.002715|0.002715|0.003054,1|1|1|1|1,588.4|490.4|420.3|420.3|367.8
2840,8,0.4192,11.74,6645.0,0.001759,0.9996790000000001,BBS9 C22orf46 MEI1 OTULINL SEPT3 SMDT1 SYDE2 WBP2NL,male pronucleus assembly|female pronucleus assembly|egg activation|meiotic cell cycle|calcium import into the mitochondrion,0.001164|0.001164|0.002328|0.003267|0.004651,1|1|1|1|1,1287|1287|514.9|22.78|234
2841,6,0.4193,6.289,4944.0,0.001267,0.998474,CD5 CELA3B HPCAL1 IDUA PTHLH SYT8,heparin catabolic process|dermatan sulfate catabolic process|negative regulation of chondrocyte development|regulation of chondrocyte development|disaccharide metabolic process,0.0005824|0.0005824|0.001165|0.001746|0.00349,1|1|1|1|1,3432|3432|1144|686.5|312
2842,5,0.4224,4.224,3902.0,0.0010789999999999999,0.996692,ASB2 BSX HIRIP3 MSANTD2 SYTL1,mammary gland involution|eating behavior|mammary gland morphogenesis|skeletal muscle cell differentiation|feeding behavior,0.001698|0.007261|0.01088|0.01208|0.01999,1|1|1|1|1,686.5|142|93.61|84.06|50.23
2843,6,0.4269,6.403,4818.0,0.001324,0.998474,AKAP8 CALR3 DMRT3 MYPN SYTL3 TBC1D4,negative regulation of vesicle fusion|ventral spinal cord interneuron specification|cell fate specification involved in pattern specification|regulation of odontogenesis of dentin-containing tooth|cell fate commitment involved in pattern specification,0.002037|0.002328|0.002328|0.0032|0.00349,1|1|1|1|1,572.1|490.4|490.4|343.2|312
2844,5,0.4561,4.561,4049.0,0.0011220000000000002,0.996692,FAM180A KDELR1 POU4F2 TAC1 WASF1,cellular response to nerve growth factor stimulus|response to nerve growth factor|neuron projection extension|developmental cell growth|cell growth,6.963e-05|7.482e-05|9.15e-05|0.0001709|0.0001789,1|0.5901|0.4811|0.6738|0.5645,155.4|149.8|135|98.07|95.79
2845,5,0.4141,4.141,3974.0,0.001038,0.996692,ACKR2 PURB TAC4 TUSC1 VIPR1,negative regulation of sensory perception of pain|positive regulation of cytosolic calcium ion concentration|tachykinin receptor signaling pathway|regulation of cytosolic calcium ion concentration|positive regulation of sensory perception of pain,0.0009706|0.001856|0.002183|0.00239|0.002425,1|1|1|1|1,1373|29.11|514.9|25.58|457.7
2846,7,0.4027,8.456,5213.0,0.001615,0.9992989999999999,GNL2 IL31 INTS11 NOL9 RPF2 RRS1 TAGAP,ribosomal large subunit biogenesis|ribosome biogenesis|protein localization to nucleolus|ncRNA processing|ribonucleoprotein complex biogenesis,1.605e-06|2.34e-06|3.558e-06|6.584e-06|8.789e-06,0.02532|0.01846|0.01871|0.02596|0.02773,122.6|35.45|840.6|27.24|25.31
2847,6,0.4323,6.484,4766.0,0.001355,0.998474,BTBD7 CDK18 FGR KLHL20 MSANTD2 TATDN3,protein K33-linked ubiquitination|regulation of branching involved in salivary gland morphogenesis|negative regulation of natural killer cell activation|positive regulation of mast cell activation involved in immune response|positive regulation of mast cell degranulation,0.0005824|0.002328|0.002909|0.004361|0.004361,1|1|1|1|1,3432|490.4|381.4|245.2|245.2
2848,6,0.4305,6.457999999999999,4733.0,0.001359,0.998474,C19orf67 NIPSNAP3A NIPSNAP3B TBC1D13 TMEM220 TPD52L3,UNCLASSIFIED|biological_process|cellular process|regulation of biological process|regulation of cellular process,0.0002254|0.0002254|0.004476|0.005845|0.008451,1|1|1|1|1,6.252|0.1923|0.2216|0|0
2849,7,0.4128,8.669,5719.0,0.00151,0.9992989999999999,ADM2 MAN1C1 PRR5 SBF1 TBC1D22A WDR76 ZNF845,"Golgi apparatus mannose trimming|TORC2 signaling|regulation of DNA damage checkpoint|N-glycan processing|protein alpha-1,2-demannosylation",0.001358|0.002715|0.006101|0.006777|0.008465,1|1|1|1|1,980.7|420.3|173.1|154.8|122.6
2850,5,0.4288,4.288,4013.0,0.001065,0.996692,ADGRG1 LUC7L3 PDE5A TBC1D22B TOB2,cGMP catabolic process|cerebral cortex regionalization|vascular endothelial growth factor production|negative regulation of neuron migration|telencephalon regionalization,0.001456|0.001698|0.00194|0.00291|0.003152,1|1|1|1|1,823.8|686.5|588.4|374.5|343.3
2851,6,0.4124,6.186,4860.0,0.001268,0.998474,DHRS4 FRMD6 NRL TBC1D2B TMEM89 ZNF860,retinal rod cell development|retinal rod cell differentiation|camera-type eye photoreceptor cell differentiation|eye photoreceptor cell development|eye photoreceptor cell differentiation,0.0032|0.004071|0.008128|0.01015|0.0139,1|1|1|1|1,343.2|264|127.1|101|73.03
2852,6,0.4124,6.187,4881.0,0.001263,0.998474,ELOVL3 GRIN3B GTDC1 TBCCD1 TM7SF2 ZNF394,"maintenance of Golgi location|maintenance of centrosome location|fatty acid elongation, unsaturated fatty acid|fatty acid elongation, saturated fatty acid|fatty acid elongation, polyunsaturated fatty acid",0.001165|0.001456|0.002328|0.002328|0.002328,1|1|1|1|1,1144|858.1|490.4|490.4|490.4
2853,19,0.4093,69.99,12810.0,0.005416,1.0,AK6 C1orf109 DHX33 IMP3 KRR1 MYBBP1A NOL6 NOL9 PAK1IP1 POP5 PWP2 RPP21 SPATA5L1 TIMM10 TRMT112 URB1 UTP4 WDR18 WDR3,ribosome biogenesis|ribonucleoprotein complex biogenesis|rRNA processing|rRNA metabolic process|ncRNA processing,1.163e-18|8.185e-17|5.19e-16|7.754e-16|2.12e-15,1.834e-14|6.456e-13|2.729e-12|3.058e-12|6.687e-12,38.4|27.42|41.49|39.96|27.24
2854,13,0.4155,32.41,8428.0,0.003819,0.999993,BRAF DUSP4 ELAVL1 MAFF MAP2K1 MAP2K2 MAPK1 MITF PEA15 SOX10 SOX9 TFAP2A ZEB2,positive regulation of nitrogen compound metabolic process|positive regulation of cellular metabolic process|ERK1 and ERK2 cascade|positive regulation of macromolecule metabolic process|regulation of Golgi inheritance,1.316e-09|2.586e-09|4.368e-09|5.12e-09|6.853e-09,2.076e-05|2.039e-05|2.296e-05|2.019e-05|2.162e-05,6.217|5.871|211.2|5.541|1188
2855,5,0.4317,4.317,3988.0,0.0010789999999999999,0.996692,CLCA1 CMC1 CRYGB SLC9A9 TCF20,anion transmembrane transport|inorganic ion transmembrane transport|negative regulation of NAD metabolic process|negative regulation of glucose catabolic process to lactate via pyruvate|cation transport,0.0002117|0.0006281|0.001165|0.001165|0.001185,1|1|1|1|1,22.48|15.51|1144|1144|12.47
2856,17,0.4003,54.44,13660.0,0.00396,1.0,CEP170B FBLN5 GALNT16 GPR68 IFI27 PPP4R4 SERPINA1 SERPINA11 SERPINA12 SERPINA3 SERPINA4 SERPINA6 SERPINA9 SYNDIG1L TCL1B TMEM63C UBR7,negative regulation of endopeptidase activity|negative regulation of peptidase activity|negative regulation of hydrolase activity|negative regulation of proteolysis|regulation of endopeptidase activity,6.582e-10|8.634e-10|1.242e-09|6.571e-09|2.702e-08,1.038e-05|6.81e-06|6.532e-06|2.591e-05|8.525e-05,34.61|33.26|21.3|24.65|20
2857,6,0.4114,6.171,5087.0,0.001209,0.998474,CD47 ENOPH1 GPR171 IL36RN SIDT1 TCTA,negative regulation of myeloid cell differentiation|regulation of interferon-gamma production|regulation of interleukin-6 production|negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis|L-methionine salvage from S-adenosylmethionine,0.0002556|0.0004179|0.0006378|0.0008735|0.001165,1|1|1|1|1,81.73|63.56|51.23|1716|1144
2858,6,0.4123,6.184,4747.0,0.0012980000000000001,0.998474,ESR2 PCNX1 TDP1 VWA7 VWDE ZC3H12C,nucleic acid phosphodiester bond hydrolysis|single strand break repair|intracellular estrogen receptor signaling pathway|cellular response to estradiol stimulus|intracellular steroid hormone receptor signaling pathway,0.003151|0.00349|0.005812|0.01073|0.01505,1|1|1|1|1,22.66|312|180.7|95.35|67.3
2859,4,0.4551,2.7310000000000003,2881.0,0.0009443999999999999,0.9929309999999999,C3orf38 HIST1H3J NECAP1 TEAD3,asymmetric neuroblast division|neuroblast division|asymmetric cell division|neuroblast proliferation|hippo signaling,0.001019|0.002038|0.002474|0.004073|0.004218,1|1|1|1|1,1144|528.1|429.1|254.3|245.2
2860,14,0.4014,36.53,11560.0,0.0031420000000000003,0.9999969999999999,CDK3 DDX58 GALK1 GPR142 KCTD2 LGALS3BP MIF4GD OTOP2 RHBDF2 SEPT9 SPHK1 SSTR2 TMEM235 UBE2O,galactitol metabolic process|G0 to G1 transition|regulation of endosomal vesicle fusion|glycolytic process from galactose|sphingoid catabolic process,0.001358|0.001358|0.001358|0.001358|0.001358,1|1|1|1|1,1471|1471|1471|1471|1471
2861,5,0.4373,4.373,3855.0,0.0011300000000000001,0.996692,CDX2 PRKAR2A TENT5A UNC119B VPREB3,regulation of somitogenesis|negative regulation of cAMP-dependent protein kinase activity|lipoprotein transport|lipoprotein localization|trophectodermal cell differentiation,0.001698|0.002425|0.003394|0.003636|0.004604,1|1|1|1|1,686.5|457.7|316.8|294.2|228.8
2862,15,0.4035,42.37,11890.0,0.0035409999999999994,0.999999,ARHGEF10L ARMC1 C8orf44 CCNB1IP1 EVA1B INIP KIF26B MAP3K7CL NDRG3 NECAP2 RNF114 SDR39U1 TMEM39A TMEM39B ZNF286A,negative regulation of autophagosome maturation|regulation of autophagosome maturation|negative regulation of autophagosome assembly|positive regulation of viral genome replication|negative regulation of macroautophagy,1.381e-05|5.898e-05|7.514e-05|0.0002577|0.0003423,0.2178|0.4652|0.3951|1|1,457.7|196.1|171.6|88.58|76.28
2863,6,0.4077,6.1160000000000005,4919.0,0.001239,0.998474,FGD4 GUCY1B1 LCT NECAP1 NRG2 TESC,"nitric oxide-cGMP-mediated signaling pathway|trans-synaptic signaling by nitric oxide, modulating synaptic transmission|trans-synaptic signaling by soluble gas, modulating synaptic transmission|trans-synaptic signaling by nitric oxide|trans-synaptic signaling by soluble gas",0.0008735|0.0008735|0.0008735|0.001165|0.001165,1|1|1|1|1,1716|1716|1716|1144|1144
2864,6,0.4494,6.7410000000000005,4897.0,0.001371,0.998474,ARHGAP25 C2orf78 COCH NCF2 TESK2 ZNF213,phagocytosis|superoxide anion generation|respiratory burst|focal adhesion assembly|actin cytoskeleton organization,0.003634|0.004942|0.006391|0.008418|0.009117,1|1|1|1|1,21.06|214.5|163.5|122.6|13.1
2865,7,0.4039,8.482999999999999,5849.0,0.0014449999999999999,0.9992989999999999,BATF2 CD47 GULP1 MEX3D SCD5 TEX22 TNIP2,negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis|monounsaturated fatty acid biosynthetic process|mRNA localization resulting in posttranscriptional regulation of gene expression|ATP export|monounsaturated fatty acid metabolic process,0.001019|0.001019|0.001019|0.001358|0.001358,1|1|1|1|1,1471|1471|1471|980.7|980.7
2866,7,0.4076,8.559,5745.0,0.001484,0.9992989999999999,ADAM7 C3orf80 CHST1 DRD5 PLXND1 RPL35A TEX38,sensitization|norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure|negative regulation of NAD(P)H oxidase activity|dichotomous subdivision of terminal units involved in salivary gland branching|regulation of systemic arterial blood pressure by vasopressin,0.0006794|0.001019|0.001358|0.001698|0.002037,1|1|1|1|1,2942|1471|980.7|735.5|588.4
2867,7,0.401,8.422,5576.0,0.001504,0.9992989999999999,EVI5 IL4I1 PLCD4 RNF34 SSMEM1 TEX45 TMEM213,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis|regulation of oxygen metabolic process|regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis|cellular response to cold|L-phenylalanine catabolic process,0.001358|0.001358|0.002037|0.003732|0.004071,1|1|1|1|1,980.7|980.7|588.4|294.2|267.5
2868,6,0.4239,6.359,4229.0,0.001497,0.998474,ETV6 FLI1 HNRNPF TEX46 TRIM11 TRIM8,negative regulation of viral release from host cell|negative regulation of viral transcription|negative regulation of viral entry into host cell|negative regulation of viral life cycle|regulation of viral release from host cell,9.595e-06|1.079e-05|1.946e-05|2.663e-05|3.493e-05,0.1514|0.08513|0.1023|0.105|0.1102,457.7|429.1|312|264|228.8
2869,6,0.4107,6.1610000000000005,4704.0,0.0013039999999999998,0.998474,ABCB1 GALNTL5 QPCT TFPI2 ULBP1 ULBP3,natural killer cell mediated cytotoxicity|natural killer cell mediated immunity|leukocyte mediated cytotoxicity|natural killer cell activation|cell killing,2.29e-05|2.663e-05|5.767e-05|0.000112|0.0005137,0.3613|0.21|0.3033|0.4418|1,286|264|176|124.8|57.21
2870,7,0.4122,8.656,6016.0,0.001434,0.9992989999999999,ABLIM1 ELOVL7 FBLN2 NOX5 PDE1A RELT TGFA,epithelial cell proliferation|reductive iron assimilation|regulation of fusion of sperm to egg plasma membrane|cGMP catabolic process|anatomical structure formation involved in morphogenesis,0.0003994|0.0006794|0.0006794|0.002037|0.002335,1|1|1|1|1,66.12|2942|2942|588.4|10.15
2871,5,0.4349,4.349,3780.0,0.001146,0.996692,CXADR FAM186B FCN1 TGFB2 ZNF519,neutrophil chemotaxis|granulocyte chemotaxis|neutrophil migration|granulocyte migration|cardiocyte differentiation,0.0001441|0.0001669|0.000183|0.0002219|0.0002499,1|1|0.9623|0.8752|0.7885,107|99.25|94.69|85.81|80.76
2872,5,0.4503,4.503,3908.0,0.0011480000000000001,0.996692,ESM1 GON7 OR5T3 PCLO TH,chemical synaptic transmission|anterograde trans-synaptic signaling|trans-synaptic signaling|synaptic signaling|synaptic vesicle cycle,8.337e-05|8.337e-05|9.374e-05|0.000114|0.0003327,1|0.6575|0.4929|0.4497|1,29.42|29.42|28.28|26.46|69.81
2873,6,0.4014,6.022,4815.0,0.0012460000000000001,0.998474,ANKRD13D ATOH8 SCARF2 SLC8A3 THAP8 VSTM2B,myoblast proliferation|calcium ion export across plasma membrane|calcium ion export|positive regulation of endothelial cell differentiation|regulation of postsynaptic cytosolic calcium ion concentration,0.001456|0.001746|0.002909|0.00349|0.00349,1|1|1|1|1,858.1|686.5|381.4|312|312
2874,5,0.4215,4.215,3931.0,0.001068,0.996692,ABCA8 ARHGAP25 INSRR KIF2B THBS2,cellular response to alkaline pH|response to alkaline pH|cytoskeleton organization|sphingomyelin biosynthetic process|male sex determination,0.000728|0.0009706|0.001835|0.00194|0.002667,1|1|1|1|1,2060|1373|10.26|588.4|411.9
2875,7,0.4181,8.781,6116.0,0.00143,0.9992989999999999,ALDH1A2 ENAH FAM229B FOXP2 KLHDC7A SOST THBS4,putamen development|caudate nucleus development|retinoic acid receptor signaling pathway involved in somitogenesis|innate vocalization behavior|regulation of endothelial cell proliferation,0.0006794|0.0006794|0.0006794|0.0006794|0.0008889,1|1|1|1|1,2942|2942|2942|2942|43.91
2876,7,0.4058,8.521,5478.0,0.001549,0.9992989999999999,CD300LF CYB561D2 MIF4GD P2RX4 THEG TMEM132B TMEM233,interleukin-13-mediated signaling pathway|negative regulation of MyD88-dependent toll-like receptor signaling pathway|negative regulation of apoptotic cell clearance|positive regulation of interleukin-4-mediated signaling pathway|microglial cell migration,0.0006794|0.001019|0.001019|0.001019|0.001019,1|1|1|1|1,2942|1471|1471|1471|1471
2877,5,0.4443,4.4430000000000005,3810.0,0.0011619999999999998,0.996692,CSF3 CYP27B1 MARCH9 THRA TIMM21,negative regulation of RNA polymerase II transcription preinitiation complex assembly|female courtship behavior|thyroid hormone mediated signaling pathway|positive regulation of vitamin D receptor signaling pathway|positive regulation of vitamin D 24-hydroxylase activity,0.000728|0.000728|0.0009706|0.0009706|0.0009706,1|1|1|1|1,2060|2060|1373|1373|1373
2878,6,0.4357,6.535,4767.0,0.001366,0.998474,DAPP1 GCNT4 GLI1 OSTC THY1 TMPRSS11A,notochord regression|inter-male aggressive behavior|ventral midline development|regulation of Rho-dependent protein serine/threonine kinase activity|smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,0.0008735|0.0008735|0.001456|0.001746|0.001746,1|1|1|1|1,1716|1716|858.1|686.5|686.5
2879,6,0.4198,6.297000000000001,4914.0,0.001277,0.998474,IPCEF1 MOSPD3 PCDH18 RAB11FIP5 TICAM2 TSPYL4,positive regulation of interleukin-18-mediated signaling pathway|regulation of interleukin-18-mediated signaling pathway|TRAM-dependent toll-like receptor 4 signaling pathway|TRAM-dependent toll-like receptor signaling pathway|negative regulation of adiponectin secretion,0.0005824|0.0005824|0.001165|0.001165|0.001456,1|1|1|1|1,3432|3432|1144|1144|858.1
2880,6,0.4162,6.244,4814.0,0.001292,0.998474,ARHGAP25 EMC8 FLT3 PSTPIP2 TBC1D9B TIFA,activation of GTPase activity|pro-B cell differentiation|myeloid progenitor cell differentiation|common myeloid progenitor cell proliferation|actin filament organization,0.0004807|0.001456|0.002037|0.002328|0.002516,1|1|1|1|1,59.18|858.1|572.1|490.4|25.43
2881,8,0.4071,11.4,4659.0,0.002432,0.9996790000000001,CMIP CSDE1 DHX29 EIF4A1 EIF4G2 STK11 STRAP XRN1,regulation of translational initiation|regulation of translation|regulation of cellular amide metabolic process|translational initiation|posttranscriptional regulation of gene expression,5.591e-06|1.226e-05|2.291e-05|2.838e-05|5.728e-05,0.08819|0.09672|0.1204|0.1119|0.1807,83.72|24.87|21.19|48.01|16.73
2882,17,0.4056,55.16,11490.0,0.004763,1.0,CIAO1 CIAO2B CIAPIN1 FDX2 FDXR FXN HSCB LYRM4 NDOR1 NFS1 NUBP2 SLC25A37 SOD1 TIMM10 TIMM22 TIMM29 TIMM9,metallo-sulfur cluster assembly|iron-sulfur cluster assembly|sulfur compound metabolic process|protein insertion into mitochondrial inner membrane|protein insertion into mitochondrial membrane,3.661e-22|3.661e-22|6.81e-14|4.297e-10|6.403e-09,5.775e-18|2.888e-18|3.58e-10|1.694e-06|2.02e-05,474.1|474.1|32.83|440.5|201.9
2883,6,0.4079,6.117999999999999,4803.0,0.001269,0.998474,CAMKV CHCHD6 GOLGA4 NTS TIMP3 ZMYM2,positive regulation of TRAIL-activated apoptotic signaling pathway|regulation of TRAIL-activated apoptotic signaling pathway|negative regulation of metalloendopeptidase activity|regulation of metalloendopeptidase activity|negative regulation of metallopeptidase activity,0.001165|0.001456|0.001456|0.002037|0.002328,1|1|1|1|1,1144|858.1|858.1|572.1|490.4
2884,7,0.4114,8.64,5911.0,0.001456,0.9992989999999999,AP5M1 C10orf71 DEDD2 LMOD3 MAP3K7CL SLC24A5 TK2,deoxycytidine metabolic process|pyrimidine deoxyribonucleoside metabolic process|thymidine metabolic process|negative regulation of secondary metabolite biosynthetic process|negative regulation of melanin biosynthetic process,0.0006794|0.002037|0.002037|0.002037|0.002037,1|1|1|1|1,2942|588.4|588.4|588.4|588.4
2885,6,0.4152,6.228,4758.0,0.0013039999999999998,0.998474,ADARB1 ECHDC1 SRMS TKFC TMEM179 ZDHHC7,hypoglossal nerve morphogenesis|hypoglossal nerve development|regulation of Fas signaling pathway|regulation of protein localization to cell-cell junction|spinal cord ventral commissure morphogenesis,0.0005824|0.0005824|0.001165|0.001165|0.001165,1|1|1|1|1,3432|3432|1144|1144|1144
2886,5,0.4406,4.406000000000001,3652.0,0.001202,0.996692,N4BP2L1 OR4A15 OR4A16 OR4C15 TLR3,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,9.63e-05|0.0001148|0.0001283|0.0001584|0.000177,1|0.9052|0.6746|0.6247|0.5584,28.02|26.4|25.43|23.67|22.8
2887,5,0.4309,4.309,3874.0,0.001108,0.996692,BCL3 C1orf21 EVPLL LYSMD1 TLR4,T-helper 1 type immune response|positive regulation of interleukin-10 production|B cell activation involved in immune response|regulation of interleukin-10 production|negative regulation of tumor necrosis factor production,9.879e-06|3.48e-05|5.293e-05|7.482e-05|8.02e-05,0.1558|0.2745|0.2783|0.2951|0.253,433.6|222.6|179.1|149.8|144.5
2888,6,0.4365,6.547999999999999,4896.0,0.001332,0.998474,FGL1 HIRIP3 MYL5 NICN1 TLX3 ZNF662,epithelial cell proliferation involved in liver morphogenesis|hepatocyte proliferation|liver morphogenesis|regulation of respiratory gaseous exchange by nervous system process|regulation of respiratory system process,0.002715|0.002715|0.003054|0.004748|0.005763,1|1|1|1|1,420.3|420.3|367.8|226.3|183.9
2889,6,0.4179,6.269,4836.0,0.001291,0.998474,CABYR COX8C HOXD8 RNF149 TMC4 ZNF710,"tripartite regional subdivision|anterior/posterior axis specification, embryo|blastoderm segmentation|sperm capacitation|epithelial cilium movement involved in extracellular fluid movement",0.005232|0.005232|0.006101|0.007839|0.01015,1|1|1|1|1,201.9|201.9|171.6|132|101
2890,6,0.416,6.2410000000000005,4716.0,0.001318,0.998474,ADAM17 OMD SOCS1 SPN TMC8 UBLCP1,positive regulation of T cell migration|positive regulation of lymphocyte migration|regulation of T cell migration|regulation of lymphocyte migration|positive regulation of mononuclear cell migration,3.493e-05|5.213e-05|6.96e-05|0.0001414|0.000155,0.5509|0.4112|0.3659|0.5575|0.489,228.8|185.5|159.7|110.7|105.6
2891,7,0.4192,8.802999999999999,5790.0,0.0015140000000000002,0.9992989999999999,DCSTAMP DIO2 ENTHD1 IP6K3 NADSYN1 OTOA TMCO2,thyroid hormone catabolic process|positive regulation of macrophage fusion|regulation of macrophage fusion|osteoclast fusion|'de novo' NAD biosynthetic process,0.001019|0.002037|0.002037|0.002376|0.002715,1|1|1|1|1,1471|588.4|588.4|490.4|420.3
2892,23,0.4035,102.1,14730.0,0.006862,1.0,CNIH1 COG1 COG6 COG7 GET4 GOSR2 PTAR1 RAB18 RAB1A RAB1B SAR1A SCFD1 SEC23IP SEC31A SURF4 SYVN1 TM9SF3 TMED10 TMED2 TRAPPC12 TRAPPC13 TRAPPC2L UNC50,endoplasmic reticulum to Golgi vesicle-mediated transport|Golgi vesicle transport|COPII-coated vesicle budding|vesicle budding from membrane|COPII vesicle coating,3.898e-25|1.044e-22|2.208e-21|1.151e-19|1.796e-19,6.149e-21|8.235e-19|1.161e-17|4.54e-16|5.666e-16,68.53|36.18|140.7|95.63|142.1
2893,6,0.4001,6.002000000000001,5091.0,0.001175,0.998474,ATP10D CCDC96 POTED SELENOP TMED4 UNK,selenium compound metabolic process|negative regulation of cytoplasmic translation|regulation of cytoplasmic translation|phospholipid translocation|lipid translocation,0.001746|0.002619|0.006391|0.01361|0.01448,1|1|1|1|1,686.5|429.1|163.5|74.62|70.05
2894,5,0.4379,4.379,3859.0,0.001131,0.996692,IMMP1L LPP TBXAS1 TMED5 YWHAG,intracellular protein transport|mitochondrial transport|protein processing involved in protein targeting to mitochondrion|cellular chloride ion homeostasis|cellular monovalent inorganic anion homeostasis,0.0009867|0.001224|0.001456|0.00194|0.00194,1|1|1|1|1,12.7|35.97|823.8|588.4|588.4
2895,6,0.4443,6.665,4365.0,0.0015199999999999999,0.998474,IRF2BP1 IRF2BP2 IRF2BPL TMEM106A VGLL4 ZIC4,"regulation of macromolecule biosynthetic process|regulation of biosynthetic process|negative regulation of transcription, DNA-templated|negative regulation of nucleic acid-templated transcription|negative regulation of RNA biosynthetic process",4.954e-05|7.109e-05|0.0002085|0.0002098|0.0002111,0.7814|0.5607|1|0.8273|0.6658,5.222|4.916|10.66|10.64|10.63
2896,5,0.427,4.27,3939.0,0.00108,0.996692,NKX3-2 NLRP6 RTL6 TMEM106C UMOD,citric acid secretion|metanephric thick ascending limb development|juxtaglomerular apparatus development|thick ascending limb development|creatinine homeostasis,0.0004854|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,4119|2060|2060|2060|2060
2897,7,0.4032,8.468,4188.0,0.0020109999999999998,0.9992989999999999,AMBRA1 CCND2 CCND3 CDK6 DYRK1A MSI2 NFE2L2,regulation of G1/S transition of mitotic cell cycle|regulation of cell cycle G1/S phase transition|negative regulation of cardiac muscle cell apoptotic process|negative regulation of striated muscle cell apoptotic process|regulation of cardiac muscle cell apoptotic process,1.43e-05|2.057e-05|2.495e-05|3.204e-05|5.199e-05,0.2256|0.1622|0.1312|0.1263|0.164,58.07|51.32|280.2|245.2|189.8
2898,7,0.4128,8.669,5746.0,0.001503,0.9992989999999999,CASP5 FPR2 IGFBP5 TECRL TMEM125 TRIM9 ZDHHC2,regulation of vesicle-mediated transport|negative regulation of skeletal muscle hypertrophy|positive regulation of postsynaptic membrane organization|positive regulation of endosome to plasma membrane protein transport|positive regulation of AMPA glutamate receptor clustering,0.0005395|0.0006794|0.001019|0.001019|0.001019,1|1|1|1|1,16.84|2942|1471|1471|1471
2899,6,0.403,6.046,4824.0,0.0012490000000000001,0.998474,MC1R MGST2 NEDD4 OARD1 TMEM155 VPS9D1,secondary metabolic process|cellular response to UV|cellular response to light stimulus|development involved in symbiotic interaction|negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,0.0001201|0.0002925|0.0004971|0.0005824|0.0005824,1|1|1|1|1,120.4|76.28|58.18|3432|3432
2900,6,0.4249,6.374,4979.0,0.001276,0.998474,AGBL5 CHRND FAM177B PBK SLC25A15 TMEM156,protein branching point deglutamylation|mitochondrial L-ornithine transmembrane transport|skeletal muscle tissue growth|L-ornithine transmembrane transport|ornithine transport,0.0005824|0.001165|0.001165|0.002037|0.002328,1|1|1|1|1,3432|1144|1144|572.1|490.4
2901,6,0.4098,6.148,5124.0,0.001196,0.998474,ASIC4 CTSF FOXF2 FRRS1L GEM TMEM169,establishment of planar polarity of embryonic epithelium|negative regulation of high voltage-gated calcium channel activity|regulation of glutamate receptor signaling pathway|regulation of high voltage-gated calcium channel activity|negative regulation of voltage-gated calcium channel activity,0.001165|0.001746|0.002037|0.004361|0.004942,1|1|1|1|1,1144|686.5|572.1|245.2|214.5
2902,8,0.4081,11.43,7165.0,0.0015890000000000001,0.9996790000000001,ANKRD55 DMGDH KCTD6 KIAA1841 SLC35D3 STRADA TIGD4 TMEM17,amino-acid betaine catabolic process|UDP-N-acetylgalactosamine transmembrane transport|UDP-glucuronic acid transmembrane transport|UDP-N-acetylglucosamine transmembrane transport|choline catabolic process,0.001552|0.001552|0.001552|0.002328|0.002715,1|1|1|1|1,858.1|858.1|858.1|514.9|429.1
2903,10,0.5372,24.17,7174.0,0.0033490000000000004,0.999933,ATP13A1 AUP1 JOSD1 MMD PCNX1 STUB1 TM2D1 TM2D2 TM2D3 ZDHHC6,cellular response to misfolded protein|response to misfolded protein|protein quality control for misfolded or incompletely synthesized proteins|ubiquitin-dependent ERAD pathway|ERAD pathway,5.818e-05|6.847e-05|9.155e-05|0.0006084|0.000867,0.9177|0.54|0.4814|1|1,187.2|171.6|147.1|54.92|45.77
2904,5,0.4255,4.255,3837.0,0.001105,0.996692,CCDC151 GCC2 SLC35F6 TMEM178B ZIM2,recycling endosome to Golgi transport|late endosome to Golgi transport|negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway|Golgi ribbon formation|outer dynein arm assembly,0.000728|0.001456|0.002425|0.003394|0.005329,1|1|1|1|1,2060|823.8|457.7|316.8|196.1
2905,7,0.4234,8.89,5933.0,0.001493,0.9992989999999999,ADRA1D DCHS1 ELK3 RBPJL SCUBE3 SFRP4 TMEM19,negative regulation of sodium-dependent phosphate transport|positive regulation of keratinocyte apoptotic process|mitral valve formation|condensed mesenchymal cell proliferation|cell migration involved in endocardial cushion formation,0.0007765|0.001552|0.001552|0.00194|0.00194,1|1|1|1|1,2574|858.1|858.1|643.6|643.6
2906,6,0.4146,6.218999999999999,5138.0,0.001206,0.998474,BEND4 EIF5A2 KIAA0930 ORMDL1 TMEM192 TTC23,polyamine homeostasis|positive regulation of translational termination|cellular sphingolipid homeostasis|negative regulation of ceramide biosynthetic process|positive regulation of translational elongation,0.0005824|0.001456|0.001746|0.001746|0.001746,1|1|1|1|1,3432|858.1|686.5|686.5|686.5
2907,8,0.4036,11.3,6550.0,0.001718,0.9996790000000001,ADAP1 CYP2W1 DAGLB MICALL2 OAS1 PCDHB1 TMEM184A TMEM196,endocannabinoid signaling pathway|retrograde trans-synaptic signaling by endocannabinoid|retrograde trans-synaptic signaling by lipid|trans-synaptic signaling by endocannabinoid|trans-synaptic signaling by lipid,0.001552|0.001552|0.001552|0.002328|0.002328,1|1|1|1|1,858.1|858.1|858.1|514.9|514.9
2908,10,0.4147,18.66,7058.0,0.002629,0.999933,CCDC107 JKAMP MICALL2 PTP4A2 SLC3A2 SLC7A1 SLC7A5 TMEM203 TMEM60 TRPM7,aromatic amino acid transport|amino acid import across plasma membrane|amino acid import|phenylalanine transport|leucine import across plasma membrane,4.594e-08|5.828e-07|1.079e-06|1.271e-06|2.118e-06,0.0007247|0.004597|0.005673|0.005013|0.006683,475.3|187.2|150.7|2060|1373
2909,5,0.4372,4.372,3892.0,0.001119,0.996692,FOXN2 HIP1 SHCBP1L STXBP5 TMEM212,male meiosis cytokinesis|positive regulation of platelet-derived growth factor receptor-beta signaling pathway|positive regulation of platelet-derived growth factor receptor signaling pathway|meiotic cytokinesis|regulation of platelet-derived growth factor receptor-beta signaling pathway,0.0004854|0.0009706|0.001456|0.00194|0.002183,1|1|1|1|1,4119|1373|823.8|588.4|514.9
2910,6,0.4088,6.132999999999999,4707.0,0.0012980000000000001,0.998474,CDKN2B CNNM4 GNB1L LYG1 TCHHL1 TMEM214,cell wall macromolecule catabolic process|cell wall organization or biogenesis|cell wall macromolecule metabolic process|peptidoglycan metabolic process|peptidoglycan catabolic process,0.0008735|0.001165|0.001165|0.002037|0.002037,1|1|1|1|1,1716|1144|1144|572.1|572.1
2911,5,0.4546,4.546,3861.0,0.001173,0.996692,CD5 CD84 RAVER1 SECISBP2L TMEM219,negative regulation of granulocyte macrophage colony-stimulating factor production|negative regulation of interleukin-18 production|negative regulation of mast cell degranulation|translational readthrough|selenocysteine incorporation,0.0004854|0.0009706|0.001698|0.002183|0.002183,1|1|1|1|1,4119|1373|686.5|514.9|514.9
2912,6,0.404,6.06,4990.0,0.00121,0.998474,CHDH LHX9 LRSAM1 MANEAL MGST3 TMEM223,dorsal spinal cord interneuron anterior axon guidance|glycine betaine biosynthetic process from choline|glycine betaine biosynthetic process|glycine betaine metabolic process|gonad morphogenesis,0.0005824|0.0008735|0.0008735|0.0008735|0.0008735,1|1|1|1|1,3432|1716|1716|1716|1716
2913,6,0.4288,6.432,4847.0,0.001322,0.998474,BAIAP2L1 DPEP2 EPS8 FRAS1 TCAIM TMEM234,actin crosslink formation|actin filament bundle assembly|actin filament bundle organization|regulation of actin filament polymerization|regulation of actin polymerization or depolymerization,8.468e-06|0.0001242|0.000137|0.001052|0.001252,0.1336|0.9795|0.7202|1|1,490.4|118.4|112.5|39.68|36.32
2914,6,0.4132,6.1979999999999995,4699.0,0.001314,0.998474,C3orf67 GPR87 KLF13 NTM TMEM250 WWC2,negative regulation of erythrocyte differentiation|negative regulation of hippo signaling|G protein-coupled purinergic nucleotide receptor signaling pathway|negative regulation of adenylate cyclase activity|regulation of hippo signaling,0.00349|0.004071|0.004361|0.006101|0.006101,1|1|1|1|1,312|264|245.2|171.6|171.6
2915,6,0.4239,6.358,5035.0,0.001258,0.998474,ADCYAP1 AQP8 ARPIN CLUL1 PRR29 TMEM255B,negative regulation of acute inflammatory response to non-antigenic stimulus|negative regulation of lamellipodium morphogenesis|positive regulation of somatostatin secretion|directional locomotion|regulation of somatostatin secretion,0.0005824|0.0008735|0.0008735|0.001165|0.001165,1|1|1|1|1,3432|1716|1716|1144|1144
2916,5,0.4174,4.1739999999999995,3986.0,0.0010429999999999999,0.996692,C11orf40 ENTR1 PDE10A THBS1 TMEM263,negative regulation of cGMP-mediated signaling|regulation of cGMP-mediated signaling|negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|negative regulation of nitric oxide mediated signal transduction|negative regulation of dendritic cell antigen processing and presentation,1.319e-06|5.648e-06|0.0009706|0.0009706|0.001213,0.0208|0.04455|1|1|1,1373|588.4|1373|1373|1030
2917,7,0.4004,8.408,5904.0,0.001419,0.9992989999999999,C12orf75 CNPPD1 MCRIP1 MTFR2 PRADC1 QSOX1 TMEM266,mitochondrial fission|extracellular matrix assembly|negative regulation of macroautophagy|aerobic respiration|negative regulation of autophagy,0.007452|0.0115|0.01251|0.02621|0.02853,1|1|1|1|1,140.1|89.16|81.73|38.21|35.03
2918,5,0.4588,4.588,4055.0,0.001127,0.996692,CREB3L3 EPHB3 FOXP1 MEGF9 TMEM35B,substrate adhesion-dependent cell spreading|interleukin-21 production|cell-substrate adhesion|regulation of macrophage colony-stimulating factor production|osteoclast development,7.749e-05|0.000728|0.000805|0.001456|0.001456,1|1|1|1|1,147.1|2060|44.53|823.8|823.8
2919,5,0.4337,4.337,3902.0,0.0011070000000000001,0.996692,ARHGEF15 MAN1C1 POLM SLC36A2 TMEM37,negative regulation of synapse maturation|Golgi apparatus mannose trimming|proline transmembrane transport|proline transport|L-alanine transport,0.0009706|0.0009706|0.002183|0.002183|0.002667,1|1|1|1|1,1373|1373|514.9|514.9|411.9
2920,5,0.4486,4.486000000000001,3928.0,0.0011380000000000001,0.996692,CCBE1 HIST1H2AL TMEM38B TP53AIP1 UBE2QL1,lung development|respiratory tube development|positive regulation of lymphangiogenesis|respiratory system development|secretion by lung epithelial cell involved in lung growth,0.0006506|0.0006818|0.000728|0.000866|0.0009706,1|1|1|1|1,49.63|48.46|2060|42.91|1373
2921,6,0.4076,6.114,4858.0,0.001254,0.998474,ARHGAP28 GPR15 HOMER2 KLF13 LRRC30 TMEM40,negative regulation of GTP binding|negative regulation of erythrocyte differentiation|regulation of store-operated calcium entry|chemical homeostasis within a tissue|behavioral response to cocaine,0.001165|0.00349|0.004071|0.004361|0.004361,1|1|1|1|1,1144|312|264|245.2|245.2
2922,6,0.4003,6.004,5028.0,0.00119,0.998474,CLDN24 CTGF DCAF10 HEG1 PLAGL1 TMEM59,cell-cell junction assembly|lymph circulation|negative regulation of protein glycosylation in Golgi|cell-cell junction organization|negative regulation of protein glycosylation,0.0003843|0.000728|0.000728|0.0008136|0.0009706,1|1|1|1|1,64.87|2060|2060|44.29|1373
2923,7,0.4184,8.787,6088.0,0.001438,0.9992989999999999,B3GALNT2 MANEA MANEAL NRN1L SPRYD3 TMEM223 TMEM65,regulation of cardiac conduction|neuron projection extension|developmental cell growth|cell growth|protein O-linked glycosylation,0.01921|0.02088|0.02853|0.02919|0.03514,1|1|1|1|1,52.54|48.23|35.03|34.21|28.29
2924,7,0.424,8.902999999999999,5842.0,0.001518,0.9992989999999999,CTRB2 NETO2 PLEKHG4 PLN PTGES TMEM68 ZDHHC14,negative regulation of calcium ion import into sarcoplasmic reticulum|regulation of the force of heart contraction by cardiac conduction|negative regulation of calcium ion binding|regulation of calcium ion binding|regulation of kainate selective glutamate receptor activity,0.001019|0.001019|0.001358|0.001358|0.001358,1|1|1|1|1,1471|1471|980.7|980.7|980.7
2925,6,0.4243,6.365,4676.0,0.001356,0.998474,DDX19A DDX19B HACL1 KPNA5 TMEM79 VPS37D,intracellular protein transport|protein transport|peptide transport|intracellular transport|amide transport,1.376e-06|1.031e-05|1.135e-05|1.162e-05|1.268e-05,0.02171|0.08128|0.05969|0.04581|0.04002,17.64|11.73|11.5|11.45|11.25
2926,7,0.4116,8.644,5236.0,0.001644,0.9992989999999999,ART5 OR51I1 OR52B2 OR52M1 OR52N4 OR5P2 TMEM86A,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,9.422e-08|1.263e-07|1.521e-07|2.163e-07|2.604e-07,0.001486|0.0009961|0.0007998|0.0008531|0.0008214,33.36|31.43|30.27|28.18|27.14
2927,6,0.431,6.465,4865.0,0.001324,0.998474,C1orf61 IL22 KCNJ3 MATN3 RAD21L1 TMEM92,meiotic telomere tethering at nuclear periphery|atrial cardiac muscle cell membrane repolarization|membrane repolarization during atrial cardiac muscle cell action potential|meiotic attachment of telomere to nuclear envelope|telomere tethering at nuclear periphery,0.001456|0.001456|0.001456|0.001456|0.001456,1|1|1|1|1,823.8|823.8|823.8|823.8|823.8
2928,5,0.4463,4.463,3954.0,0.001125,0.996692,BCL2A1 BRINP2 GLRX2 GPR87 TMIGD3,DNA protection|aging|G protein-coupled purinergic nucleotide receptor signaling pathway|cellular response to stimulus|cellular response to superoxide,0.001456|0.001767|0.003636|0.003844|0.003878,1|1|1|1|1,823.8|29.85|294.2|3.042|274.6
2929,7,0.4036,8.475,5859.0,0.001441,0.9992989999999999,ACAT1 E2F5 ORMDL1 PHETA1 RTN4RL1 TMPRSS13 WNT7A,cholesterol esterification|sterol esterification|steroid esterification|metanephric proximal convoluted tubule development|proximal convoluted tubule development,1.977e-06|1.977e-06|1.977e-06|0.0007765|0.0007765,0.03119|0.0156|0.0104|1|1,1287|1287|1287|2574|2574
2930,6,0.4308,6.462000000000001,5001.0,0.001287,0.998474,ASB16 FAM124A GPR179 TMPRSS15 TNFAIP8L3 ZYX,stress fiber assembly|contractile actin filament bundle assembly|positive regulation of phosphatidylinositol 3-kinase activity|positive regulation of lipid kinase activity|intermembrane lipid transfer,0.004942|0.004942|0.01044|0.01159|0.01419,1|1|1|1|1,214.5|214.5|98.07|88.01|71.51
2931,5,0.4059,4.059,3859.0,0.001048,0.996692,CCSER1 OPRPN OR10A4 TMPRSS6 TRIM21,negative regulation of protein deubiquitination|self proteolysis|negative regulation of proteolysis|positive regulation by symbiont of entry into host|positive regulation of viral entry into host cell,0.001213|0.002183|0.00272|0.003152|0.003152,1|1|1|1|1,1030|514.9|23.95|343.3|343.3
2932,7,0.4064,8.533999999999999,5889.0,0.001443,0.9992989999999999,AMMECR1L CCDC34 DEPDC4 KCNN2 SCN1A TMTC4 VWA3B,cardiac muscle cell action potential involved in contraction|cardiac muscle cell contraction|cardiac muscle cell action potential|cardiac muscle contraction|heart contraction,7.671e-05|9.298e-05|0.0001252|0.0002861|0.0003994,1|0.7333|0.6582|1|1,154.8|140.1|120.1|78.46|66.12
2933,6,0.409,6.135,4138.0,0.0014759999999999999,0.998474,ACTG1 CAP1 CORO1C IMPAD1 IQGAP1 TNPO1,regulation of focal adhesion assembly|regulation of cell-substrate junction assembly|regulation of cell-substrate junction organization|regulation of cell-matrix adhesion|regulation of cell junction assembly,1.819e-06|1.819e-06|2.263e-06|1.223e-05|4.796e-05,0.0287|0.01435|0.0119|0.04823|0.1513,120.7|120.7|111.9|62.79|39.4
2934,19,0.4027,68.87,15170.0,0.004508,1.0,AK8 CERCAM CIZ1 DPP7 ENTPD2 FAM69B GLT6D1 LCN10 LCN15 LCN6 LCN8 NPDC1 NTMT1 OR1J4 PIP5KL1 RNF224 TOR1A TOR1B TUBB4B,protein localization to nucleus|chaperone cofactor-dependent protein refolding|'de novo' posttranslational protein folding|'de novo' protein folding|nuclear membrane organization,0.00046|0.0004977|0.000646|0.0007782|0.00138,1|1|1|1|1,19.83|63.76|55.59|50.42|37.38
2935,8,0.412,11.54,6661.0,0.001725,0.9996790000000001,APOBEC3C APOBEC3F C9orf43 FBXL13 HIGD1B SPATA31E1 TCN2 TOR4A,DNA cytosine deamination|cytidine metabolic process|cytidine catabolic process|cytidine deamination|cytidine to uridine editing,8.691e-06|1.198e-05|1.198e-05|1.198e-05|1.198e-05,0.1371|0.09447|0.06298|0.04723|0.03779,514.9|429.1|429.1|429.1|429.1
2936,6,0.4237,6.356,4977.0,0.0012720000000000001,0.998474,FAM114A2 IL17RA NAXD TAS2R8 TP53INP1 ZRANB3,metabolite repair|DNA rewinding|cellular response to methyl methanesulfonate|response to methyl methanesulfonate|response to UV,0.0005824|0.0005824|0.0005824|0.0005824|0.0008061,1|1|1|1|1,3432|3432|3432|3432|45.46
2937,5,0.4492,4.492,3839.0,0.001166,0.996692,APLNR BMP4 PUM3 TP53TG5 ZNF322,coronary vasculature development|positive regulation of endothelial cell proliferation|regulation of endothelial cell proliferation|bud dilation involved in lung branching|BMP signaling pathway involved in ureter morphogenesis,4.647e-05|0.0002042|0.0004271|0.0004854|0.0004854,0.733|1|1|0.2552|0.264,191.6|89.54|61.48|4119|4119
2938,7,0.4014,8.43,5865.0,0.0014320000000000001,0.9992989999999999,ITPRIPL1 MRPL51 SMAP1 TMEM247 TNFRSF11A TPBG WFDC1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling|positive regulation of fever generation by positive regulation of prostaglandin secretion|mesenchymal cell migration|olfactory learning|circadian temperature homeostasis,0.001164|0.001164|0.001164|0.001164|0.001552,1|1|1|1|1,1287|1287|1287|1287|858.1
2939,5,0.4015,4.015,3797.0,0.001053,0.996692,CLEC4G FOLR1 PRCC SYPL1 TPBGL,neural crest cell migration involved in heart formation|cellular response to folic acid|cell migration involved in heart formation|anterior neural tube closure|cardiac neural crest cell migration involved in outflow tract morphogenesis,0.0004854|0.000728|0.000728|0.0009706|0.001213,1|1|1|1|1,4119|2060|2060|1373|1030
2940,6,0.4133,6.199,4799.0,0.001287,0.998474,ATP6AP1L CD36 FAM71F2 PIK3CG SLC31A2 TPD52L2,cellular cation homeostasis|cellular ion homeostasis|cation homeostasis|inorganic ion homeostasis|cellular chemical homeostasis,1.317e-05|1.435e-05|1.975e-05|2.098e-05|2.505e-05,0.2077|0.1132|0.1038|0.08275|0.07902,21.59|21.12|19.48|19.18|18.33
2941,5,0.4295,4.295,4272.0,0.0010019999999999999,0.996692,ADCYAP1 ARHGDIA MCIDAS RFX8 TPMT,regulation of plasma membrane bounded cell projection organization|regulation of cell projection organization|negative regulation of neurogenesis|negative regulation of nervous system development|negative regulation of acute inflammatory response to non-antigenic stimulus,0.0002643|0.0002862|0.0004461|0.0004786|0.0004854,1|1|1|1|1,19.9|19.37|60.13|58.01|4119
2942,5,0.4387,4.387,3749.0,0.001166,0.996692,MTNR1A OAF SFRP2 SIAH1 TPO,thyroid hormone generation|thyroid hormone metabolic process|hydrogen peroxide catabolic process|hydrogen peroxide metabolic process|hormone biosynthetic process,1.206e-05|1.946e-05|3.275e-05|6.35e-05|9.677e-05,0.1903|0.1534|0.1722|0.2504|0.3053,403.8|312|236.7|167.4|134.6
2943,6,0.4157,6.236000000000001,4892.0,0.0012699999999999999,0.998474,ADCY9 CCDC153 CYSRT1 RETN SERPING1 TPPP2,"positive regulation of progesterone secretion|positive regulation of female gonad development|regulation of progesterone secretion|negative regulation of complement activation, lectin pathway|regulation of complement activation, lectin pathway",0.0005824|0.0005824|0.0008735|0.0008735|0.0008735,1|1|1|1|1,3432|3432|1716|1716|1716
2944,5,0.4031,4.031000000000001,3828.0,0.001049,0.996692,HGH1 JPT2 RHEBL1 SLC30A3 TPSD1,zinc ion import into synaptic vesicle|zinc ion import into organelle|regulation of sequestering of zinc ion|zinc ion transmembrane transport|zinc ion transport,0.000728|0.000728|0.001456|0.006054|0.00702,1|1|1|1|1,2060|2060|823.8|171.6|147.1
2945,27,0.407,142.8,20910.0,0.0067670000000000004,1.0,BICDL2 C16orf90 C16orf92 CDIP1 CLDN6 CLDN9 CLUAP1 CORO7 GLIS2 HAGH HCFC1R1 HMOX2 HS3ST6 KREMEN2 NMRAL1 NOXO1 OR1F1 OR2C1 PAQR4 PRSS21 PRSS27 PRSS33 SEPT12 TPSG1 ZNF213 ZNF500 ZSCAN10,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules|cellular macromolecule metabolic process|regulation of transcription from RNA polymerase II promoter involved in kidney development|bicellular tight junction assembly|tight junction assembly,0.0004106|0.00102|0.002617|0.002788|0.002974,1|1|1|1|1,72.65|0|762.8|26.3|25.43
2946,7,0.4289,9.007,5988.0,0.001498,0.9992989999999999,ARHGEF37 DOK3 HTR1E MDGA1 NCF1 POU4F3 TRAP1,negative regulation of cellular respiration|translational attenuation|negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide|regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide|regulation of synaptic membrane adhesion,0.0008734|0.00131|0.001746|0.001746|0.002182,1|1|1|1|1,2288|1144|762.8|762.8|572.1
2947,6,0.4483,6.725,4751.0,0.00141,0.998474,HIST1H3B HIST3H3 MRM1 SPSB1 THBS3 TRIM17,rRNA 2'-O-methylation|bone trabecula formation|bone trabecula morphogenesis|ossification involved in bone maturation|growth plate cartilage development,0.0009706|0.001553|0.002134|0.003104|0.003491,1|1|1|1|1,1287|735.5|514.9|343.2|302.9
2948,6,0.4005,6.007000000000001,4871.0,0.0012289999999999998,0.998474,DLX2 GSTO1 OXGR1 SORCS1 TLX1 TRIM27,negative regulation of calcium ion transport|positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion|cerebral cortex GABAergic interneuron fate commitment|positive regulation of amacrine cell differentiation|regulation of amacrine cell differentiation,0.0001284|0.0005824|0.0008735|0.0008735|0.001165,1|1|1|1|1,116.4|3432|1716|1716|1144
2949,5,0.4401,4.401,4131.0,0.001062,0.996692,CPT1C CR2 ITPR2 TRIM31 ZNF202,"complement receptor mediated signaling pathway|carnitine metabolic process|complement activation, alternative pathway|negative regulation of viral transcription|cellular response to ethanol",0.003394|0.003636|0.003878|0.00412|0.00412,1|1|1|1|1,316.8|294.2|274.6|257.4|257.4
2950,7,0.4267,8.96,5702.0,0.001565,0.9992989999999999,HTR2A KCNRG LCP1 LRRC63 SPERT STAC TRMT9B,negative regulation of potassium ion transport|regulation of ion transport|regulation of potassium ion transport|response to temperature stimulus|phospholipase C-activating serotonin receptor signaling pathway,5.857e-05|0.0005334|0.0007163|0.001351|0.001358,0.9238|1|1|1|1,178.3|8.802|49.04|35.45|980.7
2951,29,0.4011,162.8,21480.0,0.007504,1.0,BTN2A1 BTN2A2 GPX6 HIST1H1C HIST1H1E HIST1H1T HIST1H2AC HIST1H2AD HIST1H2AG HIST1H2BD HIST1H4C OR14J1 OR2B3 OR2B6 OR2J2 OR2J3 OR2W1 SLC17A2 SLC17A4 TMEM14B TRIM10 TRIM26 TRIM39 ZKSCAN4 ZNF165 ZNF184 ZNF322 ZSCAN16 ZSCAN31,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|sialic acid transport|detection of chemical stimulus,1.253e-05|1.746e-05|2.155e-05|2.953e-05|3.205e-05,0.1976|0.1377|0.1133|0.1164|0.1011,11.21|10.56|10.17|329.5|9.469
2952,6,0.4224,6.336,4868.0,0.001297,0.998474,ACAA1 MOBP MON1A OLR1 SLC41A3 TRIM52,phenylacetate catabolic process|central nervous system myelin formation|secretion by cell|export from cell|secretion,0.0008735|0.001746|0.001766|0.002036|0.002443,1|1|1|1|1,1716|686.5|10.86|10.34|9.705
2953,4,0.4184,2.511,3103.0,0.0008062999999999999,0.9929309999999999,CRELD1 NOXA1 SLC10A2 TRIM6,free ubiquitin chain polymerization|ubiquitin recycling|positive regulation of type I interferon-mediated signaling pathway|regulation of respiratory burst|superoxide anion generation,0.001359|0.001941|0.002716|0.003297|0.003297,1|1|1|1|1,858.1|572.1|396.1|321.8|321.8
2954,6,0.421,6.315,4864.0,0.0012929999999999999,0.998474,CIDEA DYRK4 GPN1 LEPR RIPOR3 TRIM7,negative regulation of growth hormone receptor signaling pathway|regulation of cold-induced thermogenesis|regulation of growth hormone receptor signaling pathway|response to stilbenoid|positive regulation of sequestering of triglyceride,0.001019|0.001023|0.002376|0.002376|0.003393,1|1|1|1|1,1471|40.86|490.4|490.4|326.9
2955,13,0.4019,31.35,8685.0,0.0035859999999999998,0.999993,AASDHPPT ADAT2 DCPS DNLZ FDXR METTL1 MRE11 SSB TPI1 TRMT10A TRMT61A WDR4 XPOT,tRNA modification|tRNA processing|RNA modification|tRNA metabolic process|tRNA methylation,1.458e-11|1.334e-10|5.817e-10|8.385e-10|1.398e-08,2.299e-07|1.052e-06|3.059e-06|3.307e-06|4.41e-05,105.6|72.01|55.91|52.52|154.6
2956,7,0.4194,8.807,5637.0,0.001556,0.9992989999999999,ADPRHL1 CCDC113 GSG1L H1FNT SEC16B SVOPL TROAP,spermatid nucleus elongation|protein de-ADP-ribosylation|protein localization to endoplasmic reticulum exit site|peroxisome fission|regulation of postsynaptic neurotransmitter receptor internalization,0.001358|0.002376|0.003054|0.003732|0.004409,1|1|1|1|1,980.7|490.4|367.8|294.2|245.2
2957,6,0.4154,6.232,4774.0,0.0013,0.998474,LANCL1 PDE8A POSTN TRPC4 ZNF776 ZNF865,regulation of oxidative stress-induced cell death|regulation of cellular response to oxidative stress|regulation of response to oxidative stress|gamma-aminobutyric acid secretion|cellular response to vitamin K,0.0001458|0.0002048|0.0002556|0.0008735|0.0008735,1|1|1|1|1,109|91.53|81.73|1716|1716
2958,6,0.4191,6.2860000000000005,5009.0,0.00125,0.998474,AHI1 CXXC4 GUCA2B MKI67 RSPH1 TRPV3,axis specification|pronephric duct morphogenesis|pronephric duct development|pronephric nephron tubule morphogenesis|pronephric nephron morphogenesis,0.0002737|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,78.91|3432|3432|3432|3432
2959,8,0.4275,11.97,6703.0,0.001778,0.9996790000000001,CLDN24 KLHL2 MCM8 MRPL52 PLAGL1 RGS10 SMIM14 TSPAN5,recombinational interstrand cross-link repair|G protein-coupled acetylcholine receptor signaling pathway|protein localization to chromatin|blastocyst hatching|organism emergence from protective structure,0.001164|0.007741|0.009283|0.01044|0.01044,1|1|1|1|1,1287|135.5|111.9|99.01|99.01
2960,11,0.4089,22.49,8773.0,0.00255,0.999969,C22orf46 DESI1 MEI1 MPPED2 PARVB PMM1 PNPLA5 SEPT3 SMDT1 SULT4A1 TSPO,establishment or maintenance of cell polarity regulating cell shape|response to vitamin B1|GDP-mannose biosynthetic process|maintenance of protein location in mitochondrion|peripheral nervous system axon regeneration,0.001601|0.002134|0.003199|0.003199|0.003731,1|1|1|1|1,936.1|624.1|374.5|374.5|312
2961,6,0.4517,6.776,4925.0,0.001371,0.998474,DCAF13 DGAT1 DNAJB2 GDF11 SLC39A11 TSPYL6,spinal cord anterior/posterior patterning|negative regulation of protein deubiquitination|regulation of chaperone-mediated protein folding|monoacylglycerol biosynthetic process|acylglycerol acyl-chain remodeling,0.0005824|0.001456|0.001746|0.002328|0.002619,1|1|1|1|1,3432|858.1|686.5|490.4|429.1
2962,9,0.408,14.69,7278.0,0.002009,0.9998530000000001,BBS5 CRYGD HOXD10 HOXD11 HOXD12 HOXD4 HOXD8 TTC30A TTC30B,pattern specification process|regionalization|animal organ morphogenesis|embryo development|skeletal system development,6.27e-09|6.935e-06|2.225e-05|2.536e-05|3.206e-05,9.89e-05|0.05469|0.117|0.1|0.1011,32.46|28.78|12.11|11.78|19.43
2963,6,0.4206,6.31,4932.0,0.001275,0.998474,AMIGO3 ITPR1 KCNG1 KCNJ1 TTC31 ZNRF4,inorganic cation transmembrane transport|cation transmembrane transport|inorganic ion transmembrane transport|potassium ion transmembrane transport|potassium ion transport,0.0004062|0.0005564|0.0006281|0.000881|0.0009936,1|1|1|1|1,18|16.17|15.51|43.45|40.86
2964,8,0.4088,11.45,6638.0,0.0017170000000000002,0.9996790000000001,IGDCC3 IGF2BP2 IZUMO4 SCAMP2 SCAMP5 TBC1D21 TRH TTC7B,macromolecule localization|positive regulation of gamma-aminobutyric acid secretion|negative regulation of glutamate secretion|imidazole-containing compound metabolic process|histamine metabolic process,0.001182|0.001552|0.002328|0.002715|0.002715,1|1|1|1|1,5.048|858.1|514.9|429.1|429.1
2965,6,0.441,6.615,5094.0,0.001294,0.998474,IFI6 MDM1 PER3 TARBP1 TMEM178A TTLL4,regulation of blastocyst development|negative regulation of mitochondrial depolarization|negative regulation of membrane depolarization|negative regulation of centriole replication|negative regulation of centrosome duplication,0.001456|0.002037|0.002328|0.002328|0.003781,1|1|1|1|1,858.1|572.1|490.4|490.4|286
2966,5,0.4043,4.043,3696.0,0.00109,0.996692,ATP6V0E1 FBF1 RESP18 TTLL7 VPS8,endosomal vesicle fusion|protein polyglutamylation|organelle organization|vacuolar acidification|phagosome acidification,0.002183|0.003394|0.003913|0.005812|0.00702,1|1|1|1|1,514.9|316.8|4.61|179.1|147.1
2967,7,0.4008,8.416,5722.0,0.001465,0.9992989999999999,DAZL IGFBP6 LAIR1 LILRB5 MTMR11 NLRP9 TTLL9,positive regulation of interleukin-18 production|regulation of interleukin-18 production|protein polyglutamylation|pyroptosis|3'-UTR-mediated mRNA stabilization,0.002037|0.003393|0.004748|0.006439|0.007114,1|1|1|1|1,588.4|326.9|226.3|163.5|147.1
2968,5,0.4376,4.376,3983.0,0.0010949999999999998,0.996692,C6orf120 COL1A1 RFTN1 TNFRSF8 TTPAL,cellular response to mechanical stimulus|cellular response to fluoride|positive regulation of TRAIL production|regulation of TRAIL production|cellular response to vitamin E,0.0001515|0.0004854|0.000728|0.000728|0.000728,1|1|1|1|1,104.3|4119|2060|2060|2060
2969,6,0.4186,6.279,4967.0,0.001259,0.998474,FBXO25 MFGE8 NPAS3 SYNJ2BP TTR WNT5A,establishment or maintenance of epithelial cell apical/basal polarity|establishment or maintenance of apical/basal cell polarity|establishment or maintenance of bipolar cell polarity|amyloid fibril formation|non-canonical Wnt signaling pathway involved in heart development,7.275e-05|8.956e-05|8.956e-05|0.0001504|0.0005824,1|0.7064|0.4709|0.593|0.6562,156|140.1|140.1|107.3|3432
2970,6,0.4455,6.682,4802.0,0.0013859999999999999,0.998474,DCAF13 DGAT1 DNAJB2 GDF11 TSPYL6 TUBB6,spinal cord anterior/posterior patterning|negative regulation of protein deubiquitination|regulation of chaperone-mediated protein folding|monoacylglycerol biosynthetic process|acylglycerol acyl-chain remodeling,0.0005824|0.001456|0.001746|0.002328|0.002619,1|1|1|1|1,3432|858.1|686.5|490.4|429.1
2971,23,0.404,102.2,15610.0,0.006487000000000001,1.0,ABCG1 BUB3 CNIH4 DUX4 HSPE1 NEDD1 OR2A25 PAFAH1B1 RPL11 RPL12 RPL13 RPL17 RPL18A RPL23 RPL23A RPL37 RPL4 RPL9 RPLP0 RPLP2 RPS13 RPS15A RPS6,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,4.339e-29|8.768e-29|3.264e-28|5.354e-28|6.044e-28,6.844e-25|6.915e-25|1.716e-24|2.111e-24|1.907e-24,134.1|127.4|116|111.9|111
2972,5,0.4197,4.197,3940.0,0.0010609999999999999,0.996692,CBLN1 NCKIPSD OR11L1 OR2L3 TULP3,negative regulation of inhibitory synapse assembly|bronchus morphogenesis|negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning|central nervous system neuron differentiation|regulation of inhibitory synapse assembly,0.0004854|0.000728|0.000728|0.0007712|0.001213,1|1|1|1|1,4119|2060|2060|45.51|1030
2973,5,0.456,4.56,3828.0,0.001187,0.996692,CRHR2 HMSD MMD2 PRR4 TUSC3,cellular response to corticotropin-releasing hormone stimulus|response to corticotropin-releasing hormone|magnesium ion transmembrane transport|magnesium ion transport|protein N-linked glycosylation via asparagine,0.001746|0.001746|0.004942|0.005232|0.008996,1|1|1|1|1,686.5|686.5|214.5|201.9|114.4
2974,4,0.4597,2.758,2998.0,0.0009166,0.9929309999999999,CD163 TLR2 TMEM115 TUT1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus|positive regulation of response to macrophage colony-stimulating factor|detection of diacyl bacterial lipopeptide|detection of triacyl bacterial lipopeptide|U6 snRNA 3'-end processing,0.0005825|0.0005825|0.0005825|0.0005825|0.0005825,1|1|1|1|1,2574|2574|2574|2574|2574
2975,8,0.419,11.73,6692.0,0.0017460000000000002,0.9996790000000001,C10orf67 FOXI2 GPR4 OTP OTX2 PDE4B SIAE UBAP1L,negative regulation of relaxation of cardiac muscle|neurohypophysis development|negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process|regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process|negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,0.001164|0.001164|0.001552|0.001552|0.00194,1|1|1|1|1,1287|1287|858.1|858.1|643.6
2976,6,0.4192,6.289,4930.0,0.001271,0.998474,ACVR1 ANGPTL3 ECHDC3 EREG POU4F2 UBE2U,circulatory system development|angiogenesis|regulation of locomotion|regulation of cellular component movement|blood vessel morphogenesis,4.172e-05|6.975e-05|7.474e-05|8.594e-05|0.0001486,0.658|0.5501|0.393|0.3389|0.4688,16.1|32.79|13.87|13.38|25.36
2977,20,0.404,76.76,16120.0,0.004727,1.0,AK4 ALG10 ARNTL2 BICD1 C12orf71 ETFBKMT FAR2 IL17RE ITPR2 KIAA1551 KLHL42 LMNTD1 MANSC4 RASSF8 SLCO1C1 STK38L SYT10 TM7SF3 TMTC1 TSPAN11,regulation of microtubule-based process|negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway|negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase|regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase|negative regulation of electron transfer activity,0.001498|0.001939|0.001939|0.001939|0.001939,1|1|1|1|1,13.15|1030|1030|1030|1030
2978,10,0.4046,18.21,8390.0,0.00216,0.999933,CACNB1 GRN HOXB9 LRRC46 OSBPL7 RSAD1 SCRN2 TBKBP1 UBE4A UBXN4,ubiquitin-dependent ERAD pathway|ERAD pathway|positive regulation of lysosome organization|positive regulation of inflammatory response to wounding|negative regulation of neutrophil activation,0.0006084|0.000867|0.0009704|0.001455|0.00194,1|1|1|1|1,54.92|45.77|2060|1030|686.5
2979,5,0.4375,4.375,3985.0,0.001094,0.996692,SI SNX13 SNX14 TREML4 UBL3,positive regulation of toll-like receptor 7 signaling pathway|polysaccharide digestion|regulation of toll-like receptor 7 signaling pathway|positive regulation of toll-like receptor signaling pathway|autophagosome maturation,0.001698|0.001698|0.00194|0.006778|0.007261,1|1|1|1|1,686.5|686.5|588.4|152.6|142
2980,6,0.4033,6.0489999999999995,5115.0,0.001178,0.998474,ANGPTL2 CYP27A1 MYO7B NLRC4 PLPPR1 UBQLN3,cellular alcohol biosynthetic process|cellular alcohol metabolic process|calcitriol biosynthetic process from calciol|vitamin D biosynthetic process|brush border assembly,0.001456|0.001456|0.001456|0.001456|0.001746,1|1|1|1|1,858.1|858.1|858.1|858.1|686.5
2981,7,0.4188,8.795,5778.0,0.001516,0.9992989999999999,BLMH CER1 LCA5L PPP1R3B SLC28A2 THAP6 UBR1,inosine transport|negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry|negative regulation of nodal signaling pathway involved in determination of left/right asymmetry|growth plate cartilage chondrocyte proliferation|ubiquitin-dependent protein catabolic process via the N-end rule pathway,0.0006794|0.001019|0.001019|0.001019|0.001358,1|1|1|1|1,2942|1471|1471|1471|980.7
2982,8,0.4102,11.49,6371.0,0.001795,0.9996790000000001,AIMP1 ENPP1 ENPP3 ISM1 TAAR6 TAAR8 TMEM52 UBTD1,nucleoside triphosphate catabolic process|nucleoside phosphate catabolic process|nucleoside triphosphate metabolic process|negative regulation of hh target transcription factor activity|nucleobase-containing small molecule biosynthetic process,1.579e-05|0.0004635|0.0005545|0.0007765|0.0008755,0.2491|1|1|1|1,367.8|62.03|56.58|2574|44.77
2983,6,0.4179,6.269,4858.0,0.001285,0.998474,ATRNL1 CSF3R DNPEP S100A14 SPINK2 UBXN10,negative regulation of serine-type peptidase activity|negative regulation of serine-type endopeptidase activity|regulation of serine-type peptidase activity|regulation of serine-type endopeptidase activity|acrosome assembly,0.002328|0.002328|0.002909|0.002909|0.004942,1|1|1|1|1,490.4|490.4|381.4|381.4|214.5
2984,6,0.405,6.074,4557.0,0.001328,0.998474,N4BP2L1 OR4A15 OR4A16 OR4C15 SOX15 UCN2,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|G protein-coupled receptor signaling pathway|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus,0.0001895|0.0002256|0.0002355|0.000252|0.0003108,1|1|1|0.9939|0.9804,23.35|22|10.33|21.19|19.73
2985,7,0.4206,8.832,5940.0,0.0014810000000000001,0.9992989999999999,CABLES1 CAPRIN2 LMO3 UCN2 UCP1 ZADH2 ZNF776,regulation of fat cell differentiation|positive regulation of glucocorticoid receptor signaling pathway|regulation of glucocorticoid receptor signaling pathway|positive regulation of peroxisome proliferator activated receptor signaling pathway|cellular response to cold,0.0008127|0.001019|0.003054|0.003054|0.003732,1|1|1|1|1,45.97|1471|367.8|367.8|294.2
2986,6,0.4417,6.626,5092.0,0.001296,0.998474,FAM229A MEIG1 PLEKHJ1 RHO SYNE2 UGT1A3,retinoid metabolic process|diterpenoid metabolic process|terpenoid metabolic process|absorption of visible light|light absorption,0.0004179|0.0004646|0.0005478|0.0005824|0.0005824,1|1|1|1|1,63.56|60.22|55.36|3432|3432
2987,5,0.4276,4.276,3828.0,0.001113,0.996692,GSTK1 QRFPR RELCH SPTA1 UHMK1,intracellular transport|intracellular cholesterol transport|intracellular sterol transport|glutathione derivative biosynthetic process|glutathione derivative metabolic process,0.003459|0.004845|0.005087|0.005571|0.005571,1|1|1|1|1,8.243|216.8|205.9|187.2|187.2
2988,6,0.4265,6.398,4839.0,0.001317,0.998474,FUT2 PLEKHA7 SLC1A7 SLC25A47 TNFRSF18 UMODL1,amino acid transport|zonula adherens maintenance|acyl carnitine transmembrane transport|acyl carnitine transport|adherens junction maintenance,0.0006192|0.001165|0.001456|0.001746|0.002037,1|1|1|1|1,52.01|1144|858.1|686.5|572.1
2989,5,0.4648,4.648,3967.0,0.001167,0.996692,CETN1 HAUS8 KCTD19 TTC38 UNC5CL,centrosome cycle|microtubule organizing center organization|netrin-activated signaling pathway|cell division|centriole replication,0.0001872|0.0002404|0.002667|0.00547|0.005812,1|1|1|1|1,93.61|82.38|411.9|16.74|179.1
2990,5,0.4509,4.5089999999999995,3920.0,0.001146,0.996692,KLHDC3 KLHDC9 TMPRSS11E TSPYL1 UNC5D,netrin-activated signaling pathway|IRE1-mediated unfolded protein response|reciprocal meiotic recombination|reciprocal homologous recombination|homologous recombination,0.002667|0.01352|0.01376|0.01376|0.01424,1|1|1|1|1,411.9|74.89|73.55|73.55|71.02
2991,5,0.4327,4.327,4139.0,0.001042,0.996692,CMSS1 KNCN LCLAT1 PACRG UNC79,cardiolipin acyl-chain remodeling|CDP-diacylglycerol biosynthetic process|CDP-diacylglycerol metabolic process|cardiolipin metabolic process|phosphatidylinositol acyl-chain remodeling,0.002183|0.003394|0.003636|0.00412|0.004604,1|1|1|1|1,514.9|316.8|294.2|257.4|228.8
2992,17,0.4091,55.63,13420.0,0.004117,1.0,C6orf203 CGAS COL19A1 DDX43 DOPEY1 DPPA5 ENPP3 FAM135A GABRR1 KHDC1 KHDC1L KHDC3L LGSN SMAP1 TAAR6 TCF21 VNN2,muscle organ development|regulation of double-strand break repair|basophil activation involved in immune response|glutamine biosynthetic process|activation of cysteine-type endopeptidase activity involved in apoptotic process,0.00151|0.002351|0.002472|0.002472|0.002621,1|1|1|1|1,12.98|28.17|605.7|605.7|26.63
2993,5,0.4381,4.381,3793.0,0.001151,0.996692,GNG4 PRSS38 PUM2 USF1 USF2,positive regulation of transcription from RNA polymerase II promoter by glucose|regulation of transcription from RNA polymerase II promoter by glucose|positive regulation of transcription by glucose|late viral transcription|carbon catabolite activation of transcription from RNA polymerase II promoter,4.712e-07|4.712e-07|7.067e-07|7.067e-07|7.067e-07,0.007432|0.003716|0.003716|0.002787|0.00223,2746|2746|2060|2060|2060
2994,7,0.4236,8.895,6039.0,0.001467,0.9992989999999999,BHMT2 CBS CEP126 KRTAP20-3 MCIDAS SLC36A4 USF3,sulfur amino acid biosynthetic process|sulfur amino acid metabolic process|alpha-amino acid biosynthetic process|cellular amino acid biosynthetic process|S-methylmethionine metabolic process,1.688e-05|6.916e-05|0.0002101|0.0003011|0.0006794,0.2662|0.5455|1|1|1,346.1|163.5|91.94|76.42|2942
2995,6,0.4171,6.256,4974.0,0.001253,0.998474,GALK1 LCN10 RFESD TNFSF18 TTC21A USP12,galactitol metabolic process|glycolytic process from galactose|glycolytic process through glucose-1-phosphate|negative regulation of T-helper 17 cell lineage commitment|hexitol metabolic process,0.0005824|0.0005824|0.0008735|0.001165|0.001165,1|1|1|1|1,3432|3432|1716|1144|1144
2996,5,0.4538,4.538,3781.0,0.001196,0.996692,CCL17 CD300LD ITPA RPS6KB1 USP24,ITP catabolic process|purine ribonucleoside triphosphate catabolic process|cellular response to interferon-gamma|ITP metabolic process|ribonucleoside triphosphate catabolic process,0.0004854|0.0004854|0.0005904|0.000728|0.000728,1|1|1|1|1,4119|4119|52.14|2060|2060
2997,9,0.4008,14.43,7209.0,0.0019920000000000003,0.9998530000000001,ABCB11 BBS5 BTNL9 CRYGA CRYGB CRYGC CRYGD FBXL14 USP44,visual perception|sensory perception of light stimulus|lens development in camera-type eye|camera-type eye development|eye development,1.651e-08|1.806e-08|2.616e-08|6.935e-06|1.201e-05,0.0002604|0.0001425|0.0001375|0.02735|0.03788,52.97|52.01|120.4|28.78|25.01
2998,5,0.4079,4.079,3912.0,0.001039,0.996692,COA1 GRIN2C RBM23 RECQL5 VAMP8,mucus secretion|directional locomotion|autophagosome membrane docking|cellular response to camptothecin|response to camptothecin,0.000728|0.0009706|0.001213|0.001213|0.001456,1|1|1|1|1,2060|1373|1030|1030|823.8
2999,5,0.4151,4.151,3923.0,0.0010539999999999998,0.996692,CDC20B GYPE THEM6 TNFSF9 VAPB,negative regulation by host of viral release from host cell|positive regulation of cytotoxic T cell differentiation|negative regulation by virus of viral protein levels in host cell|regulation of cytotoxic T cell differentiation|positive regulation of anaphase-promoting complex-dependent catabolic process,0.0004854|0.000728|0.000728|0.0009706|0.0009706,1|1|1|1|1,4119|2060|2060|1373|1373
3000,5,0.4511,4.511,4018.0,0.001119,0.996692,CD79A DYRK4 EHD1 LEPR VASH2,negative regulation of growth hormone receptor signaling pathway|positive regulation of intracellular transport|endosomal transport|regulation of growth hormone receptor signaling pathway|positive regulation of endocytic recycling,0.0008735|0.001792|0.001886|0.002037|0.002037,1|1|1|1|1,1716|30.24|29.46|572.1|572.1
3001,24,0.4008,110.6,19010.0,0.0057729999999999995,1.0,ADAMTS7 BNIP2 C15orf53 CHRNA7 CSNK1G1 CSPG4 DUOXA1 DUOXA2 EPB42 GABRA5 GOLGA6B MAP2K5 MYO5C NIPA2 PLA2G4D PLA2G4E PLEKHO2 PPIB RAB8B SCAMP2 SLC24A1 SNURF SNX22 TGM5,positive regulation of hydrogen peroxide biosynthetic process|regulation of thyroid hormone generation|positive regulation of hydrogen peroxide metabolic process|regulation of hydrogen peroxide biosynthetic process|regulation of postsynaptic membrane potential,2.953e-05|3.934e-05|5.054e-05|6.313e-05|0.000257,0.4657|0.3103|0.2657|0.2489|0.8108,329.5|274.6|235.4|205.9|24.71
3002,6,0.4072,6.107,4863.0,0.001251,0.998474,GAD2 RGS18 SLC2A5 SLC45A3 VGF ZNF117,hexose transmembrane transport|monosaccharide transmembrane transport|carbohydrate transmembrane transport|carbohydrate transport|fructose import across plasma membrane,5.213e-05|5.767e-05|6.35e-05|0.0002211|0.0005824,0.8223|0.4549|0.3339|0.8721|1,185.5|176|167.4|88.01|3432
3003,8,0.4005,11.21,6312.0,0.0017690000000000002,0.9996790000000001,ADAMDEC1 CCDC71 CEP85 GNAT1 KRT39 LBX1 PFKFB4 VIT,"spinal cord development|fructose 2,6-bisphosphate metabolic process|positive regulation of cyclic-nucleotide phosphodiesterase activity|sensory perception of umami taste|negative regulation of cyclic-nucleotide phosphodiesterase activity",0.0007195|0.002328|0.002328|0.002715|0.002715,1|1|1|1|1,49.51|514.9|514.9|429.1|429.1
3004,5,0.441,4.41,3879.0,0.0011330000000000001,0.996692,BCL2L14 DPPA4 KIRREL2 RMDN2 VMAC,positive regulation of extrinsic apoptotic signaling pathway|somatic stem cell population maintenance|positive regulation of apoptotic signaling pathway|stem cell population maintenance|maintenance of cell number,0.01184|0.01592|0.0295|0.03045|0.03092,1|1|1|1|1,85.81|63.37|33.76|32.69|32.18
3005,15,0.4131,43.38,10400.0,0.004142,0.999999,AK6 C18orf21 C1D DIMT1 EXOSC1 EXOSC10 EXOSC8 HEATR1 MTREX NOP9 PPWD1 SRFBP1 TENT4B WDR43 ZCCHC7,rRNA processing|rRNA metabolic process|ribosome biogenesis|ncRNA processing|ribonucleoprotein complex biogenesis,6.83e-18|1.023e-17|9.374e-17|1.586e-15|3.5e-15,1.077e-13|8.067e-14|4.929e-13|6.254e-12|1.104e-11,54.46|52.44|42.65|32.78|30.45
3006,6,0.4009,6.013999999999999,4934.0,0.001214,0.998474,IL17RD LRRC14B NR2E1 PCSK2 PSD3 VSX1,insulin processing|islet amyloid polypeptide processing|retina development in camera-type eye|enkephalin processing|regulation of timing of neuron differentiation,0.0005824|0.0005824|0.0007956|0.0008735|0.001165,1|1|1|1|1,3432|3432|45.77|1716|1144
3007,5,0.4248,4.248,3952.0,0.0010710000000000001,0.996692,BHMT2 C11orf52 GPR12 NEB VTCN1,S-methylmethionine metabolic process|cardiac muscle thin filament assembly|somatic muscle development|L-methionine salvage|L-methionine biosynthetic process,0.0004854|0.0009706|0.0009706|0.00194|0.00194,1|1|1|1|1,4119|1373|1373|588.4|588.4
3008,7,0.4271,8.968,5756.0,0.001552,0.9992989999999999,C14orf119 DNAH14 EXOSC9 IGIP PCDHGB7 VXN ZIK1,U5 snRNA 3'-end processing|U1 snRNA 3'-end processing|polyadenylation-dependent mRNA catabolic process|nuclear polyadenylation-dependent mRNA catabolic process|tRNA surveillance,0.001358|0.001358|0.001698|0.001698|0.002376,1|1|1|1|1,980.7|980.7|735.5|735.5|490.4
3009,5,0.4176,4.176,3747.0,0.0011099999999999999,0.996692,CXCL9 DGUOK FDPS SREBF2 WDFY2,regulation of cholesterol biosynthetic process|regulation of sterol biosynthetic process|regulation of cholesterol metabolic process|regulation of alcohol biosynthetic process|regulation of steroid biosynthetic process,4.857e-05|4.857e-05|8.295e-05|0.0001264|0.0001872,0.7662|0.3831|0.4362|0.4985|0.5904,187.2|187.2|142|114.4|93.61
3010,5,0.4147,4.147,4048.0,0.001021,0.996692,CPNE6 MYADM PLEKHF1 WDR66 ZC3H7B,protein localization to plasma membrane|protein localization to cell periphery|negative regulation of protein kinase C signaling|regulation of cell morphogenesis|negative regulation of heterotypic cell-cell adhesion,0.0005391|0.0007724|0.0009706|0.001328|0.002134,1|1|1|1|1,52.81|44.01|1287|33.43|514.9
3011,7,0.4218,8.857000000000001,5572.0,0.001583,0.9992989999999999,CARF CTAGE1 ESD KCNRG MX1 RNF6 WDR93,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion|positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus|cellular response to calcium ion|response to calcium ion|formaldehyde catabolic process,7.913e-07|3.94e-05|0.0004855|0.00149|0.001552,0.01248|0.3108|1|1|1,2574|223.9|60.57|34.1|858.1
3012,6,0.4187,6.281000000000001,4965.0,0.00126,0.998474,KLRC2 PNMA8A SFT2D1 SPSB2 WIF1 YIF1A,positive regulation of natural killer cell degranulation|regulation of natural killer cell degranulation|positive regulation of natural killer cell activation|positive regulation of leukocyte degranulation|positive regulation of natural killer cell mediated cytotoxicity,0.001746|0.001746|0.00697|0.00755|0.00755,1|1|1|1|1,686.5|686.5|149.2|137.3|137.3
3013,5,0.4219,4.218999999999999,4063.0,0.001035,0.996692,BIRC7 NUDT15 RXFP3 WDR86 WNT6,regulation of natural killer cell apoptotic process|dGTP catabolic process|dGTP metabolic process|purine deoxyribonucleoside triphosphate catabolic process|DNA protection,0.0004854|0.0009706|0.001213|0.001456|0.001456,1|1|1|1|1,4119|1373|1030|823.8|823.8
3014,7,0.4005,8.411,5674.0,0.0014759999999999999,0.9992989999999999,CAPG GNLY LYAR SEMA4F STON1 TLX2 WTIP,negative regulation of neurogenesis|negative regulation of nervous system development|negative regulation of cell development|negative regulation of cellular component organization|negative regulation of cell projection organization,0.001232|0.001321|0.002008|0.002095|0.002098,1|1|1|1|1,37.58|36.26|29.25|10.76|28.6
3015,20,0.4072,77.37,15860.0,0.004842,1.0,A2M BICD1 CLEC4D CLEC6A ETFBKMT GYS2 IAPP ITPR2 KCNJ8 KIAA1551 KLHL42 MANSC4 PKP2 RASSF8 SLCO1B1 SLCO1B3 SLCO1C1 TAS2R20 TM7SF3 TSPAN11,sodium-independent organic anion transport|bile acid and bile salt transport|pigment catabolic process|porphyrin-containing compound catabolic process|tetrapyrrole catabolic process,7.492e-07|5.941e-06|0.0001355|0.0001355|0.0001355,0.01182|0.04686|0.7127|0.5345|0.4276,193.1|90.86|128.7|128.7|128.7
3016,5,0.4383,4.383,3955.0,0.001104,0.996692,HSPA4L KRTAP4-12 PARPBP TCF23 WWP1,negative regulation of nucleobase-containing compound metabolic process|negative regulation of double-strand break repair via homologous recombination|decidualization|negative regulation of double-strand break repair|maternal placenta development,0.00356|0.004845|0.006054|0.008226|0.008226,1|1|1|1|1,8.162|216.8|171.6|124.8|124.8
3017,6,0.424,6.359,4997.0,0.001268,0.998474,BTBD10 ERGIC1 FOXA3 LAMB1 LDLRAD4 XKR3,neuronal-glial interaction involved in cerebral cortex radial glia guided migration|negative regulation of SMAD protein complex assembly|regulation of SMAD protein complex assembly|type B pancreatic cell proliferation|basement membrane assembly,0.0008735|0.001746|0.002037|0.002909|0.0032,1|1|1|1|1,1716|686.5|572.1|381.4|343.2
3018,5,0.4634,4.6339999999999995,4033.0,0.001145,0.996692,EVPLL GRHL3 HGF LYSMD1 XYLB,xylulose catabolic process|regulation of animal organ morphogenesis|D-xylose metabolic process|regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling|xylulose metabolic process,0.0004854|0.0007712|0.0009706|0.0009706|0.001213,1|1|1|1|1,4119|45.51|1373|1373|1030
3019,5,0.422,4.22,3913.0,0.001074,0.996692,BTG4 KRTAP19-8 LGALS16 TMEM225 YIPF4,positive regulation of T cell apoptotic process|positive regulation of lymphocyte apoptotic process|positive regulation of leukocyte apoptotic process|regulation of T cell apoptotic process|regulation of lymphocyte apoptotic process,0.003636|0.004362|0.00702|0.008949|0.01352,1|1|1|1|1,294.2|242.3|147.1|114.4|74.89
3020,5,0.4312,4.312,3966.0,0.001083,0.996692,HIVEP2 KLC4 PPP3CA PPP3R1 YJEFN3,"calcineurin-NFAT signaling cascade|calcineurin-mediated signaling|inositol phosphate-mediated signaling|Wnt signaling pathway, calcium modulating pathway|non-canonical Wnt signaling pathway",4.284e-06|6.401e-06|1.528e-05|3.48e-05|0.0004334,0.06758|0.05048|0.08035|0.1372|1,686.5|549.2|343.3|222.6|61.02
3021,10,0.4145,18.65,7762.0,0.002391,0.999933,CDK18 CHIT1 NFASC RGS13 RGS18 RGS2 RGS21 TMEM206 TROVE2 YOD1,regulation of G protein-coupled receptor signaling pathway|negative regulation of G protein-coupled receptor signaling pathway|regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway|negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process|regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,2.021e-05|0.0001601|0.0007765|0.0007765|0.0007765,0.3189|1|1|1|1,52.9|107.3|2574|2574|2574
3022,5,0.4207,4.207,3927.0,0.001068,0.996692,EDN2 NECAP1 TEAD3 TEKT2 ZBBX,hormonal regulation of the force of heart contraction|cilium movement|positive regulation of the force of heart contraction by chemical signal|vein smooth muscle contraction|positive regulation of prostaglandin-endoperoxide synthase activity,0.0004854|0.000492|0.0009706|0.001213|0.001213,1|1|1|1|1,4119|57.21|1373|1030|1030
3023,6,0.417,6.255,4511.0,0.001381,0.998474,CCDC71L LRIF1 MKLN1 SMCHD1 U2AF1L4 ZBED3,"dosage compensation by inactivation of X chromosome|dosage compensation|inactivation of X chromosome by DNA methylation|inactivation of X chromosome by heterochromatin assembly|regulation of gene expression, epigenetic",1.51e-05|1.875e-05|0.0006794|0.0006794|0.001432,0.2382|0.1479|1|1|1,367.8|326.9|2942|2942|34.41
3024,5,0.4036,4.0360000000000005,3877.0,0.001037,0.996692,AMPD3 ARVCF MMP10 PPIF ZBED6CL,"regulation of proton-transporting ATPase activity, rotational mechanism|negative regulation of oxidative phosphorylation uncoupler activity|AMP catabolic process|regulation of mitochondrial membrane permeability involved in programmed necrotic cell death|regulation of oxidative phosphorylation uncoupler activity",0.0004854|0.000728|0.000728|0.0009706|0.001213,1|1|1|1|1,4119|2060|2060|1373|1030
3025,7,0.4091,8.591000000000001,5983.0,0.00143,0.9992989999999999,C1RL EDN3 IBTK NT5DC3 RRAS TREML1 ZBP1,pallium cell proliferation in forebrain|regulation of mRNA stability involved in response to stress|positive regulation of necroptotic process|positive regulation of programmed necrotic cell death|cellular magnesium ion homeostasis,0.0007765|0.001552|0.001552|0.00194|0.00194,1|1|1|1|1,2574|858.1|858.1|643.6|643.6
3026,26,0.4028,130.9,20300.0,0.006391,1.0,ADCY10 ATXN7L3B C8orf44 CARNS1 CCDC25 CCNB1IP1 EPB41L5 FAIM FEZF2 KIF26B LRRN1 LYRM1 MAP3K7CL MCOLN3 NDRG3 NECAP2 NIPSNAP3B PCDHB12 PCDHGA9 PLEKHB1 RAB22A RNF114 SDR39U1 SLC25A36 TEX12 ZNF286A,"homologous chromosome pairing at meiosis|substrate-dependent cell migration, cell attachment to substrate|carnosine biosynthetic process|homologous chromosome segregation|chromosome organization involved in meiotic cell cycle",0.002183|0.002617|0.002617|0.003166|0.003774,1|1|1|1|1,29.91|762.8|762.8|24.61|22.43
3027,5,0.4373,4.373,3961.0,0.0011,0.996692,A2ML1 PLD4 RNASEK SH3TC1 ZBTB22,"nucleic acid phosphodiester bond hydrolysis|regulation of cytokine production involved in inflammatory response|inositol phosphate metabolic process|hematopoietic progenitor cell differentiation|RNA phosphodiester bond hydrolysis, endonucleolytic",0.002121|0.01184|0.01448|0.02118|0.02166,1|1|1|1|1,27.19|85.81|69.81|47.34|46.28
3028,18,0.4136,63.28,12400.0,0.0050609999999999995,1.0,ARHGAP45 CCND2 HERPUD1 IKBKB IKZF3 IRF4 IRS1 MAF MANF MEF2C NFKB1 POU2AF1 PRDM1 RELA RELB SMAD7 TCF3 UBALD2,positive regulation of macromolecule metabolic process|positive regulation of metabolic process|regulation of transcription by RNA polymerase II|positive regulation of transcription by RNA polymerase II|positive regulation of macromolecule biosynthetic process,4.266e-09|1.339e-08|2.559e-08|2.785e-08|1.223e-07,6.729e-05|0.0001056|0.0001345|0.0001098|0.000386,4.739|4.372|5.449|8.988|6.435
3029,5,0.4275,4.275,4113.0,0.001036,0.996692,DOK5 KCNQ2 MCCC1 TKTL2 ZBTB4,leucine catabolic process|leucine metabolic process|biotin metabolic process|regulation of neurotrophin TRK receptor signaling pathway|branched-chain amino acid catabolic process,0.001698|0.002183|0.002425|0.003152|0.005329,1|1|1|1|1,686.5|514.9|457.7|343.3|196.1
3030,5,0.4369,4.369,3846.0,0.001132,0.996692,CCDC14 COL20A1 FRA10AC1 HRCT1 ZBTB40,protein localization to centrosome|protein localization to microtubule organizing center|protein localization to microtubule cytoskeleton|protein localization to cytoskeleton|substantia nigra development,0.005812|0.006054|0.009431|0.01039|0.01136,1|1|1|1|1,179.1|171.6|108.4|98.07|89.54
3031,25,0.4004,120.1,19450.0,0.006123,1.0,ADCY10 AP5M1 ARMC1 ATXN7L3B CCNB1IP1 FEZF2 KIAA1257 KIF26B LRRN1 LYRM1 MAP3K7CL NECAP2 NIPSNAP3B PCDHA4 PCDHB12 PCDHB13 PCDHGA9 RNF114 SDR39U1 SLC25A36 TMEM100 TMEM39A TMEM39B ZNF286A ZNF512B,negative regulation of autophagosome maturation|homophilic cell adhesion via plasma membrane adhesion molecules|regulation of autophagosome maturation|response to stimulus|negative regulation of autophagosome assembly,4.26e-05|5.918e-05|0.0001815|0.0002228|0.000231,0.672|0.4668|0.9541|0.8784|0.7288,264|18.97|113.2|0.1865|99.01
3032,6,0.4093,6.138999999999999,4743.0,0.0012900000000000001,0.998474,CLIC4 CMBL MACO1 PPP1R18 STK10 ZC2HC1A,lymphocyte aggregation|neuronal signal transduction|leukocyte aggregation|retina vasculature morphogenesis in camera-type eye|endothelial cell morphogenesis,0.001746|0.002328|0.00349|0.00349|0.004071,1|1|1|1|1,686.5|490.4|312|312|264
3033,5,0.4295,4.295,3865.0,0.0011070000000000001,0.996692,BPHL FOXF2 SLC6A12 WFIKKN1 ZC3H11A,roof of mouth development|establishment of planar polarity of embryonic epithelium|gamma-aminobutyric acid reuptake|amino acid neurotransmitter reuptake|gamma-aminobutyric acid transport,0.0001872|0.0009706|0.001213|0.001698|0.002425,1|1|1|1|1,93.61|1373|1030|686.5|457.7
3034,6,0.4026,6.039,5078.0,0.001185,0.998474,AGBL1 MMAA MYCT1 PTPRH UBTD1 ZC3H6,protein side chain deglutamylation|C-terminal protein deglutamylation|protein deglutamylation|short-chain fatty acid catabolic process|C-terminal protein amino acid modification,0.002037|0.002037|0.003054|0.003393|0.005425,1|1|1|1|1,588.4|588.4|367.8|326.9|196.1
3035,6,0.4276,6.414,4952.0,0.001291,0.998474,ABHD12 BTN1A1 LPCAT4 PSKH1 UBL4B ZC3HAV1L,phosphatidylserine metabolic process|cellular modified amino acid metabolic process|phosphatidylserine catabolic process|monoacylglycerol catabolic process|protein depalmitoylation,4.946e-05|0.001304|0.001456|0.002328|0.0032,0.7803|1|1|1|1,190.7|35.57|858.1|490.4|343.2
3036,6,0.4083,6.124,4843.0,0.00126,0.998474,COL5A1 FNDC11 GGCT KCNH2 NUDT12 ZCWPW2,integrin biosynthetic process|regulation of heart rate by hormone|NAD-cap decapping|negative regulation of endodermal cell differentiation|NADP catabolic process,0.0005824|0.0008735|0.0008735|0.001165|0.001165,1|1|1|1|1,3432|1716|1716|1144|1144
3037,6,0.4002,6.002000000000001,4725.0,0.001265,0.998474,ERAP1 SLC13A1 SYNC TNIK ZDHHC16 ZP1,asparaginyl-tRNA aminoacylation|activation of JNKK activity|microvillus assembly|microvillus organization|sulfate transmembrane transport,0.001358|0.003732|0.004071|0.004748|0.006101,1|1|1|1|1,980.7|294.2|267.5|226.3|173.1
3038,8,0.4041,11.31,6294.0,0.00179,0.9996790000000001,IL7R PHLPP1 RNF219 TMEM267 UGT3A1 USP46 WDR20 ZDHHC24,cellular protein modification process|protein modification process|regulation of T cell anergy|righting reflex|regulation of lymphocyte anergy,0.002578|0.002578|0.003103|0.003103|0.003103,1|1|1|1|1,4.264|4.264|367.8|367.8|367.8
3039,6,0.4055,6.082999999999999,4994.0,0.001214,0.998474,CD84 FBXL13 PIAS3 SFI1 ZFHX2 ZNF70,negative regulation of granulocyte macrophage colony-stimulating factor production|negative regulation of interleukin-18 production|TNFSF11-mediated signaling pathway|negative regulation of mast cell degranulation|negative regulation of mast cell activation involved in immune response,0.0005824|0.001165|0.001456|0.002037|0.002619,1|1|1|1|1,3432|1144|858.1|572.1|429.1
3040,5,0.4368,4.368,3951.0,0.001102,0.996692,CYP2U1 HADH NHLH2 PHLDA3 ZFP36,"negative regulation of polynucleotide adenylyltransferase activity|regulation of polynucleotide adenylyltransferase activity|p38MAPK cascade|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation",5.936e-07|9.891e-07|4.447e-06|1.037e-05|1.037e-05,0.009363|0.007801|0.02338|0.04089|0.03271,2942|1961|735.5|452.6|452.6
3041,10,0.4067,18.3,8177.0,0.002228,0.999933,ACACB ARL6IP4 HCAR2 HCAR3 HIP1R OASL P2RX4 PHETA1 PITPNM2 VPS37B,negative regulation of lipid catabolic process|regulation of lipid catabolic process|endosome organization|negative regulation of lipid metabolic process|positive regulation of lipid localization,7.393e-05|0.0003947|0.0006403|0.001023|0.001326,1|1|1|1|1,164.8|68.65|53.49|42.03|36.78
3042,5,0.4262,4.262,3627.0,0.00117,0.996692,CHMP2A CHMP3 NAB1 VTA1 ZFYVE21,late endosome to vacuole transport|viral budding|multivesicular body assembly|endosome transport via multivesicular body sorting pathway|multivesicular body organization,2.245e-08|2.245e-08|3.737e-08|4.098e-08|4.098e-08,0.0003541|0.000177|0.0001965|0.0001616|0.0001293,494.3|494.3|411.9|398.6|398.6
3043,6,0.4155,6.233,4489.0,0.0013830000000000001,0.998474,IRF8 LYST MEF2D SIK3 SLC17A9 ZFYVE26,defense response to protozoan|response to protozoan|plasmacytoid dendritic cell differentiation|mast cell secretory granule organization|guanine nucleotide transport,2.29e-05|2.473e-05|0.0005824|0.0008735|0.0008735,0.3613|0.1951|1|1|1,286|274.6|3432|1716|1716
3044,6,0.402,6.031000000000001,4730.0,0.0012699999999999999,0.998474,C12orf56 FFAR3 IFNL2 MORN2 SAV1 ZNF146,mucosal immune response|organ or tissue specific immune response|positive regulation of acute inflammatory response to non-antigenic stimulus|regulation of acute inflammatory response to non-antigenic stimulus|negative regulation of cardiac muscle cell proliferation,3.718e-05|4.687e-05|0.0008735|0.001165|0.004361,0.5864|0.3696|1|1|1,221.5|196.1|1716|1144|245.2
3045,5,0.4526,4.526,3947.0,0.001143,0.996692,C19orf33 FAM69C PLA2G7 TUBB3 ZNF169,plasma lipoprotein particle oxidation|ether catabolic process|glycerol ether catabolic process|platelet activating factor catabolic process|dorsal root ganglion development,0.0004854|0.000728|0.000728|0.000728|0.001698,1|1|1|1|1,4119|2060|2060|2060|686.5
3046,6,0.4162,6.242999999999999,4596.0,0.001353,0.998474,CHCHD2 KCNF1 KLK14 MRPS18A TMEM174 ZNF17,seminal clot liquefaction|positive regulation of mitochondrial ATP synthesis coupled electron transport|regulation of mitochondrial ATP synthesis coupled electron transport|insemination|regulation of cellular response to hypoxia,0.0005824|0.001456|0.002037|0.003781|0.003781,1|1|1|1|1,3432|858.1|572.1|286|286
3047,6,0.4291,6.436,4905.0,0.001307,0.998474,CYP2R1 DMRT3 HSBP1L1 MGARP PCDHGB7 ZNF18,response to cesium ion|cellular alcohol biosynthetic process|cellular alcohol metabolic process|calcitriol biosynthetic process from calciol|vitamin D biosynthetic process,0.0005824|0.001456|0.001456|0.001456|0.001456,1|1|1|1|1,3432|858.1|858.1|858.1|858.1
3048,6,0.4061,6.0920000000000005,4677.0,0.0012980000000000001,0.998474,C4orf17 CLDN12 PURA SCG3 TRIM29 ZNF215,protein localization to secretory granule|dendritic transport of messenger ribonucleoprotein complex|dendritic transport of ribonucleoprotein complex|dendritic transport|axo-dendritic protein transport,0.001165|0.001165|0.001165|0.0032|0.004071,1|1|1|1|1,1144|1144|1144|343.2|264
3049,5,0.4233,4.2330000000000005,4026.0,0.001048,0.996692,ATP6V1B1 CC2D2A FEZ2 SPINT2 ZNF223,embryonic organ development|neural tube closure|embryonic morphogenesis|tube closure|primary neural tube formation,8.754e-05|0.0001956|0.0001959|0.0001999|0.0002219,1|1|1|0.7881|0.7002,28.94|91.53|22.03|90.53|85.81
3050,6,0.4071,6.106,4725.0,0.001287,0.998474,CCHCR1 CRB2 RNF219 TBC1D1 ZBTB41 ZNF260,ingression involved in gastrulation with mouth forming second|notochord formation|notochord morphogenesis|maintenance of epithelial cell apical/basal polarity|retinal cone cell differentiation,0.0005824|0.001456|0.0032|0.00349|0.00349,1|1|1|1|1,3432|858.1|343.2|312|312
3051,7,0.4076,8.56,4647.0,0.0018329999999999998,0.9992989999999999,MAPK1 SHOC2 WIZ ZBTB2 ZNF292 ZNF592 ZNF644,fibroblast growth factor receptor signaling pathway|cellular response to fibroblast growth factor stimulus|response to fibroblast growth factor|cytosine metabolic process|diadenosine tetraphosphate biosynthetic process,0.0003324|0.0006259|0.0006932|0.001019|0.001358,1|1|1|1|1,72.65|52.54|49.87|1471|980.7
3052,6,0.4213,6.319,4691.0,0.001342,0.998474,FAM83A FBXO43 HNF4G NSMAF RBM47 ZNF3,negative regulation of meiotic nuclear division|positive regulation of ceramide biosynthetic process|positive regulation of sphingolipid biosynthetic process|cytidine to uridine editing|negative regulation of meiotic cell cycle,0.002909|0.003781|0.003781|0.003781|0.005232,1|1|1|1|1,381.4|286|286|286|201.9
3053,4,0.4413,2.648,2993.0,0.0008814999999999999,0.9929309999999999,EN1 PCDHB3 SLC12A2 ZNF317,positive regulation of cell volume|inorganic anion import across plasma membrane|positive regulation of aspartate secretion|regulation of aspartate secretion|transepithelial ammonium transport,0.0003883|0.0005825|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|2574|2574|2574|1716
3054,5,0.4203,4.203,3882.0,0.0010789999999999999,0.996692,GCC1 GRIN2D KLK6 SNX2 ZNF331,lamellipodium morphogenesis|excitatory chemical synaptic transmission|early endosome to Golgi transport|amyloid precursor protein metabolic process|startle response,0.001456|0.002425|0.002425|0.005812|0.006054,1|1|1|1|1,823.8|457.7|457.7|179.1|171.6
3055,5,0.4307,4.3069999999999995,3935.0,0.001091,0.996692,DAAM2 SGK2 WDR17 ZNF354C ZNF639,negative regulation of oligodendrocyte differentiation|negative regulation by host of viral transcription|regulation of cell growth|positive regulation by host of viral transcription|dorsal spinal cord development,0.00291|0.003878|0.003963|0.00412|0.005087,1|1|1|1|1,374.5|274.6|19.76|257.4|205.9
3056,5,0.4313,4.313,3996.0,0.001075,0.996692,CNTNAP3 HSF2BP SESTD1 SLC41A2 ZNF385B,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel|double-strand break repair involved in meiotic recombination|regulation of calcium ion transmembrane transport via high voltage-gated calcium channel|male meiosis I|negative regulation of calcium ion transmembrane transport,0.000728|0.001698|0.003152|0.005812|0.009672,1|1|1|1|1,2060|686.5|343.3|179.1|105.6
3057,6,0.4072,6.109,4703.0,0.001294,0.998474,LHB SIGLECL1 SLC34A1 SPHK2 SULT2B1 ZNF419,alcohol metabolic process|organic hydroxy compound metabolic process|indole metabolic process|histone H2A-K5 acetylation|histone H2B-K12 acetylation,0.0001421|0.000428|0.0006794|0.0006794|0.0006794,1|1|1|1|1,26.59|18.24|2942|2942|2942
3058,6,0.4054,6.08,4509.0,0.001343,0.998474,FOLR2 GDPD4 LKAAEAR1 MORN2 TRIM49D1 ZNF436,cellular response to folic acid|folate import across plasma membrane|folate transmembrane transport|folic acid transport|response to folic acid,0.000728|0.001456|0.001698|0.002183|0.00291,1|1|1|1|1,2060|823.8|686.5|514.9|374.5
3059,18,0.4002,61.24,14270.0,0.004262,1.0,A1BG ACR ANHX SLC27A5 ZBTB45 ZNF132 ZNF135 ZNF324 ZNF324B ZNF497 ZNF544 ZNF586 ZNF587 ZNF667 ZNF8 ZNF837 ZNF891 ZSCAN22,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",1.771e-11|1.222e-09|1.227e-09|1.253e-09|3.652e-09,2.794e-07|9.639e-06|6.453e-06|4.941e-06|1.152e-05,6.637|4.955|4.953|4.946|4.591
3060,6,0.4051,6.0760000000000005,4892.0,0.0012369999999999998,0.998474,CDH23 OMA1 OPA3 SDC4 TDGF1 ZNF579,inner ear receptor cell stereocilium organization|inner ear receptor cell development|inner ear receptor cell differentiation|mechanoreceptor differentiation|inner ear development,4.687e-05|7.927e-05|0.0001242|0.0001458|0.001278,0.7393|0.6252|0.653|0.5751|1,196.1|149.2|118.4|109|35.94
3061,37,0.4006,266.8,29970.0,0.008801,1.0,C5AR1 ERVV-2 FFAR3 GPR32 KIR2DL1 KIR2DL3 KLK11 KLK3 LAIR1 LAIR2 LILRA1 LILRA4 LILRB2 LILRB4 LILRB5 NLRP11 NLRP4 NLRP9 PSG2 PTPRH SIGLEC12 SIGLEC5 SULT2B1 VN1R4 ZFP28 ZNF28 ZNF320 ZNF415 ZNF528 ZNF534 ZNF571 ZNF578 ZNF580 ZNF610 ZNF665 ZNF701 ZNF880,immune response-inhibiting cell surface receptor signaling pathway|immune response-inhibiting signal transduction|defense response|interleukin-10-mediated signaling pathway|negative regulation of T cell costimulation,1.019e-06|1.762e-06|7.788e-06|2.084e-05|3.469e-05,0.01608|0.0139|0.04095|0.08217|0.1094,198|158.4|4.475|528.1|352.1
3062,7,0.4101,8.612,5838.0,0.00147,0.9992989999999999,ITGB4 KRT84 LALBA MSI1 NR4A1 SPATA33 ZNF641,nail development|trophoblast cell migration|lactose biosynthetic process|lactose metabolic process|peripheral nervous system myelin formation,5.435e-06|0.0006794|0.001358|0.001358|0.001358,0.08573|1|1|1|1,653.8|2942|980.7|980.7|980.7
3063,5,0.4186,4.186,3921.0,0.001064,0.996692,ARMT1 SACS VPS9D1 ZNF681 ZNF695,"negative regulation of inclusion body assembly|regulation of inclusion body assembly|ATP synthesis coupled proton transport|energy coupled proton transport, down electrochemical gradient|ATP biosynthetic process",0.00291|0.004604|0.006054|0.006054|0.008949,1|1|1|1|1,374.5|228.8|171.6|171.6|114.4
3064,65,0.4009,833.9,50930.0,0.016069999999999997,1.0,APOC2 C5AR1 CBLC CCDC61 CEACAM19 CEACAM4 CEACAM6 CLC CYP2A13 CYP2B6 EML2 FFAR2 FFAR3 HKR1 IFNL1 IFNL3 IGFL1 IGFL2 IGFL3 IGFL4 LGALS13 LGALS14 LGALS16 LGALS7B MAG PGLYRP1 PLEKHG2 PSG11 PSG2 PSG3 PSG4 PSG6 PSG8 PSG9 PVR UPK1A WDR87 ZFP82 ZNF155 ZNF222 ZNF226 ZNF230 ZNF233 ZNF284 ZNF285 ZNF302 ZNF382 ZNF383 ZNF45 ZNF461 ZNF527 ZNF540 ZNF546 ZNF566 ZNF568 ZNF569 ZNF570 ZNF571 ZNF573 ZNF585B ZNF599 ZNF607 ZNF780B ZNF790 ZNF792,"regulation of transcription by RNA polymerase II|cellular process|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process",4.768e-10|1.538e-09|2.18e-08|2.195e-08|2.272e-08,7.521e-06|1.213e-05|0.0001146|8.655e-05|7.167e-05,3.447|0.5359|2.751|2.75|2.746
3065,5,0.4103,4.103,4051.0,0.001009,0.996692,ARL4C IL27 SPP2 UGT1A7 ZNF770,flavone metabolic process|negative regulation of cellular glucuronidation|coumarin metabolic process|phenylpropanoid metabolic process|negative regulation of glucuronosyltransferase activity,0.002037|0.002619|0.002619|0.002619|0.002619,1|1|1|1|1,572.1|429.1|429.1|429.1|429.1
3066,4,0.4531,2.718,2943.0,0.0009204,0.9929309999999999,BTN3A3 OR13G1 RASIP1 ZNF780A,negative regulation of Rho-dependent protein serine/threonine kinase activity|regulation of Rho-dependent protein serine/threonine kinase activity|negative regulation of membrane permeability|positive regulation of integrin activation|regulation of integrin activation,0.0007766|0.001165|0.001747|0.002328|0.003491,1|1|1|1|1,1716|1030|643.6|468.1|302.9
3067,8,0.4001,11.2,6220.0,0.0017929999999999999,0.9996790000000001,COL9A2 ISCU OXT PPAN PSMA2 RPL18A UBA52 ZNF784,ribosome biogenesis|pre-replicative complex assembly|regulation of transcription from RNA polymerase II promoter in response to hypoxia|anaphase-promoting complex-dependent catabolic process|ribonucleoprotein complex biogenesis,0.0002246|0.000288|0.0004106|0.000508|0.000599,1|1|1|1|1,23.26|79.21|66.01|59.18|16.61
3068,5,0.4456,4.456,3970.0,0.001118,0.996692,ASCL2 CASP7 ETFDH FAT1 ZNF846,establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis|spongiotrophoblast layer development|cellular response to staurosporine|response to staurosporine|negative regulation of Schwann cell proliferation,0.0004854|0.0004854|0.001456|0.001456|0.001698,1|1|1|1|1,4119|4119|823.8|823.8|686.5
3069,6,0.4185,6.278,4705.0,0.0013289999999999999,0.998474,AKR1E2 GCSAM NKAIN2 PABPN1L SMO ZP3,ventral midline determination|mesenchymal to epithelial transition involved in metanephric renal vesicle formation|positive regulation of type IV hypersensitivity|mesenchymal to epithelial transition involved in renal vesicle formation|positive regulation of antral ovarian follicle growth,0.0005824|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,3432|3432|3432|3432|3432
3070,7,0.4016,8.433,5738.0,0.001464,0.9992989999999999,COL12A1 DNAJB9 GALR3 INTU MYOM3 RBM43 ZSCAN2,galanin-activated signaling pathway|negative regulation of IRE1-mediated unfolded protein response|tongue morphogenesis|negative regulation of keratinocyte proliferation|regulation of IRE1-mediated unfolded protein response,0.001019|0.002037|0.003732|0.004748|0.005425,1|1|1|1|1,1471|588.4|294.2|226.3|196.1
3071,6,0.4118,6.1770000000000005,4824.0,0.001276,0.998474,CCDC177 CDC25C CPA3 DKK1 LRRC25 ZSCAN32,"negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment|negative regulation of Wnt-Frizzled-LRP5/6 complex assembly|regulation of Wnt-Frizzled-LRP5/6 complex assembly|negative regulation of canonical Wnt signaling pathway involved in heart development|regulation of Wnt signaling pathway, calcium modulating pathway",0.0006794|0.0006794|0.0006794|0.0006794|0.0006794,1|1|1|1|1,2942|2942|2942|2942|2942
3072,6,0.4322,6.483,5087.0,0.0012699999999999999,0.998474,CFAP61 GKN1 HCST RSPH1 TFPI ZSWIM2,"negative regulation of blood coagulation, extrinsic pathway|regulation of blood coagulation, extrinsic pathway|blood coagulation, extrinsic pathway|negative regulation of protein activation cascade|regulation of protein activation cascade",0.001456|0.001456|0.001456|0.0032|0.00349,1|1|1|1|1,858.1|858.1|858.1|343.2|312
3073,6,0.4084,6.126,4641.0,0.001315,0.998474,BAG5 CES4A GLCCI1 MARCH11 ZNF446 ZSWIM3,negative regulation of protein refolding|regulation of protein refolding|negative regulation of protein folding|regulation of protein folding|negative regulation of ubiquitin-protein transferase activity,0.001456|0.001456|0.002037|0.003781|0.005232,1|1|1|1|1,858.1|858.1|572.1|286|201.9
3074,9,0.4003,14.41,6475.0,0.002215,0.9998530000000001,DVL1 FGFRL1 FZD5 KIRREL1 LGR4 LRP5 NF2 RNF146 WLS,cell-cell signaling by wnt|Wnt signaling pathway|cell surface receptor signaling pathway involved in cell-cell signaling|canonical Wnt signaling pathway|tissue morphogenesis,4.974e-11|4.974e-11|1.749e-10|3.324e-10|5.921e-08,7.846e-07|3.923e-07|9.196e-07|1.311e-06|0.0001868,41.31|41.31|34.41|122.6|23.23
